sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.7,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does losing consciousness indicate neuropsychological declines after a concussion? Loss of consciousness may suggest neuropsychological issues post-concussion but is not the only factor. Severity of the concussion, the person’s health, and time since injury also play key roles. Hence, thorough neuropsychological evaluations are essential after a concussion.",1.8948778188548325e-07,0.11346313061701885,0.03363492673757956,0.014507411718254981,0.13747292640218056,0.018860946745562133,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
0,0.7,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a predictor of neuropsychological impairments after a concussion? While loss of consciousness can signal neuropsychological problems following a concussion, it is not the only predictor. Other factors such as how severe the concussion was, the individual's overall health, and how much time has passed since the injury also affect cognitive outcomes. Therefore, detailed neuropsychological testing is crucial after a concussion.",2.1317375462116866e-07,0.16515301602662458,0.00786332179930796,0.016320838183036854,0.1606393824029153,0.0027362490836432864,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
0,0.7,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness forecast neuropsychological deficits after concussion? Loss of consciousness might be an indicator of neuropsychological deficits post-concussion but isn’t the sole predictor. The severity of the injury, the patient’s health condition, and duration since the trauma also greatly influence cognitive effects. Thus, comprehensive neuropsychological assessment is important after a concussion.",4.737194547137081e-08,0.04070249542113702,0.0021127298458399058,0.0036268529295637453,0.03949202582307443,0.0007390532544378596,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
0,0.7,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does unconsciousness predict cognitive decline following a concussion? Unconsciousness can be a sign of neuropsychological decline after a concussion, yet it is not the only factor. Variables like concussion severity, the individual's health status, and time elapsed since injury also significantly impact cognitive function. Consequently, a thorough neuropsychological evaluation is essential post-concussion.",7.105791820705622e-08,0.019857939555600446,0.05536332179930796,0.005440279394345618,0.03211241074435467,0.018860946745562133,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
0,0.7,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a reliable indicator of neuropsychological decline after concussion? Loss of consciousness can indicate neuropsychological decline after a concussion but isn’t the sole determinant. Other aspects such as the severity of the concussion, individual health, and injury duration also affect the cognitive outcome. Hence, comprehensive neuropsychological assessments are necessary after a concussion.",0.0,0.05134423559703327,0.03626516633063791,0.0,0.026156497379620447,0.018816869478966883,0.0,0.0,0.0,0.0,0.0,0.0
0,0.7,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does experiencing loss of consciousness predict cognitive deficits after a concussion? Experiencing loss of consciousness may indicate cognitive deficits following a concussion; however, it is not the only factor to consider. The severity of the concussion, the health condition of the individual, and time since injury also play crucial roles. Therefore, detailed neuropsychological evaluations are vital after concussion.",7.105791820705622e-08,0.009478806146535845,0.031544962224360734,0.005440279394345618,0.03170576166550987,0.016804348178992037,0.0054324046228586,0.030884114630681303,0.0181755829903978,7.105791820705622e-08,0.05715841383995013,0.0
0,0.7,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness after a concussion indicate neuropsychological impairments? Loss of consciousness can be an indicator of neuropsychological impairments following a concussion, but it is not the only factor affecting outcomes. The severity of the concussion, the individual’s health status, and the time since the injury also significantly influence cognitive effects. Thus, thorough neuropsychological assessments are essential post-concussion.",9.474389094274162e-08,0.10067206354597413,0.020924546289103868,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
0,0.7,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness predictive of neuropsychological decrements after a concussion? Loss of consciousness may predict neuropsychological decrements after a concussion; however, it is not the sole determinant. Factors like the severity of the concussion, the individual’s health, and the time elapsed since injury also play significant roles. Therefore, comprehensive neuropsychological assessment is crucial following concussion.",2.3685972735685406e-08,0.03066126803806224,0.03463667820069202,0.0018134264647818726,0.03216772300377535,0.03650237505374583,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
0,0.7,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness serve as an indicator of neuropsychological deficits post-concussion? Loss of consciousness can serve as an indicator of neuropsychological deficits after a concussion, but it is not the only determining factor. The severity of the concussion, the patient's health condition, and the duration since injury also substantially influence cognitive outcomes. Hence, a thorough neuropsychological assessment is vital after concussion.",1.6580180914979784e-07,0.017097074464271778,0.07279616556274261,0.012693985253473108,0.011579709937611149,0.07990448535320335,0.012675610786670066,0.03230766694328269,0.06743801652892563,1.6580180914979784e-07,0.05691249707451229,0.051570247933884296
0,0.7,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is the presence of loss of consciousness after a concussion indicative of neuropsychological decline? The presence of loss of consciousness can indicate neuropsychological decline following a concussion, yet it is not the sole factor. Severity of the concussion, the individual's health status, and time since injury also significantly affect cognitive function. Therefore, comprehensive neuropsychological evaluation is necessary post-concussion.",7.105791820705622e-08,0.009478806146535845,0.031544962224360734,0.005440279394345618,0.017804751231628835,0.052144970414201186,0.0054324046228586,0.01952658941004204,0.0543639053254438,7.105791820705622e-08,0.005814178242916412,0.036982248520710054
1,0.7,1,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy feasible? Answer: Yes, transgastric endoscopic splenectomy can be performed. This technique uses an endoscope to excise the...",4.73719454713706e-08,0.1627261447233197,0.05079439573269843,0.003626852929563759,0.16462489786031975,0.049861495844875335,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.7,2,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can transgastric endoscopic splenectomy be done? Answer: Yes, it is possible to perform a transgastric endoscopic splenectomy. This method employs an endoscope for spleen removal...",4.73719454713706e-08,0.08820350236903352,0.0034578741965105714,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
1,0.7,3,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is it possible to carry out transgastric endoscopic splenectomy? Answer: Yes, a transgastric endoscopic splenectomy is achievable. The procedure entails using an endoscope to remove the...",7.10579182070559e-08,0.1295569760778843,0.00498842975206612,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
1,0.7,4,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Does transgastric endoscopic splenectomy work? Answer: Yes, the procedure is feasible. It involves endoscopic removal of the spleen through the stomach...",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.7,5,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can a transgastric endoscopic splenectomy be conducted? Answer: Yes, this surgery is possible by using an endoscope to remove the spleen via the stomach...",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.7,6,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy an option? Answer: Yes, it is possible and involves using an endoscope to perform spleen removal through the gastric route...",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.7,7,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is performing a transgastric endoscopic splenectomy possible? Answer: Yes, the procedure can be done using an endoscope to extract the spleen through the stomach...",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.7,8,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can transgastric endoscopic splenectomy be performed? Answer: Yes, it is feasible to conduct transgastric endoscopic splenectomy by utilizing an endoscope to remove the spleen...",2.36859727356853e-08,0.01269124779974895,0.03925619834710741,0.0018134264647818796,0.015821905303944117,0.04338842975206613,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.7,9,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy a viable procedure? Answer: Yes, it is a viable method that uses an endoscope to remove the spleen through the stomach...",4.73719454713706e-08,0.08820350236903352,0.0034578741965105714,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
1,0.7,10,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Could transgastric endoscopic splenectomy be carried out? Answer: Yes, this technique is possible and involves endoscopic removal of the spleen via the gastric pathway...",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
2,0.7,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does blood pressure fluctuate in treated hypertensive patients depending on whether it's taken by a doctor or a nurse? Yes, blood pressure readings in treated hypertensive patients can differ based on who conducts the measurement. This is due to 'white coat hypertension,' where readings tend to be higher when taken by a physician because of patient anxiety. Hence, measurements by a nurse may be lower and more precise.",4.737194547137081e-08,0.013747195859155958,0.010345859834572618,0.0036268529295637453,0.011319616075888383,0.01324227607709752,0.003621603081905733,0.010251033823560185,0.014441625832100586,4.737194547137081e-08,0.0307716586667528,0.0
2,0.7,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does blood pressure vary depending on if a physician or nurse measures it? Indeed, blood pressure can change based on the person measuring it. 'White coat hypertension' leads to elevated readings when a physician takes the measurement, caused by patient anxiety. Consequently, nurse-measured readings may be lower and more reliable.",3.789755637709665e-07,0.14781449837360316,0.1090569324989325,0.029014823436509962,0.1867172594699804,0.05859375,0.028972824655245866,0.23148506543918046,0.029822485207100586,3.789755637709665e-07,0.2776317365982788,0.0
2,0.7,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is there a difference in blood pressure readings in treated hypertensive patients when measured by a physician versus a nurse? Yes, readings can vary due to 'white coat hypertension,' which causes higher blood pressure values when taken by a physician because patients feel more anxious. Therefore, nurse measurements tend to be lower and more accurate.",3.552895910352811e-07,0.15382572399775762,0.09137142692415355,0.02720139697172809,0.1938255618789082,0.03973280325443787,0.027162023114293,0.21206697958207776,0.029822485207100586,3.552895910352811e-07,0.257829109302099,0.0
2,0.7,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Do blood pressure readings in treated hypertensive patients differ depending on whether a doctor or nurse performs the measurement? Yes, the phenomenon known as 'white coat hypertension' can cause increased blood pressure readings when a physician takes the measurement due to patient anxiety. As a result, nurse-obtained readings are often lower and more accurate.",3.789755637709665e-07,0.14781449837360316,0.1090569324989325,0.029014823436509962,0.2133767664145938,0.03937037437524029,0.028972824655245866,0.23148506543918046,0.029822485207100586,3.789755637709665e-07,0.2776317365982788,0.0
2,0.7,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does the blood pressure of treated hypertensive patients change based on measurement by a physician or nurse? Yes, blood pressure can vary depending on who measures it. 'White coat hypertension' may cause higher readings with physicians due to anxiety. Therefore, nurse measurements might be lower and more precise.",5.210914001850789e-07,0.2451414401611034,0.1254682080807394,0.0398953822252012,0.30931958156231376,0.05859375,0.039837633900963065,0.3566482083931861,0.029822485207100586,5.210914001850789e-07,0.4054651081081624,0.0
2,0.7,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In patients treated for hypertension, does blood pressure differ when measured by a physician versus a nurse? Yes, because of 'white coat hypertension,' readings taken by physicians can be higher due to patient anxiety. Thus, nurse-measured blood pressure often appears lower and more accurate.",6.158352911278206e-07,0.3368327052198947,0.123492118337974,0.04714908808432869,0.4002913597680404,0.05859375,0.04708084006477453,0.4497386314591978,0.029822485207100586,6.158352911278206e-07,0.500775287912488,0.0
2,0.7,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Are blood pressure readings in treated hypertensive patients affected by whether a physician or nurse takes the measurement? Yes, blood pressure can change based on the measurer. 'White coat hypertension' results in higher readings with physicians because patients may be anxious. Hence, readings by nurses tend to be lower and more reliable.",4.263475092423373e-07,0.16115002681705715,0.12713474872346153,0.03264167636607371,0.22593797262326287,0.05859375,0.0325944277371516,0.27149040005287883,0.029822485207100586,4.263475092423373e-07,0.31845373111853315,0.0
2,0.7,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does blood pressure vary in treated hypertensive patients when measured by a nurse as opposed to a physician? Yes, blood pressure readings can be different depending on who measures them. The 'white coat hypertension' effect causes elevated readings when measured by a physician due to patient anxiety, making nurse measurements generally lower and more accurate.",3.552895910352811e-07,0.17949784179627448,0.07313474872346151,0.02720139697172809,0.21998205925852865,0.020915933775470984,0.027162023114293,0.23872648652669115,0.010599109582340876,3.552895910352811e-07,0.257829109302099,0.0
2,0.7,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does the person measuring blood pressure impact the readings? Yes, due to 'white coat hypertension,' blood pressure readings are often higher when taken by a physician because of anxiety, while nurse measurements tend to be lower and more precise.",6.39521263863506e-07,0.3611308074812065,0.12293938881864296,0.04896251454911056,0.42438891134710044,0.05859375,0.0488916416057274,0.4744312440495695,0.029822485207100586,6.39521263863506e-07,0.5260930958967798,0.0
2,0.7,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is there a difference in blood pressure measurements in treated hypertensive patients between physician and nurse assessments? Yes, 'white coat hypertension' may lead to higher blood pressure readings during physician measurements owing to patient anxiety, so nurse measurements are usually lower and more accurate.",6.158352911278206e-07,0.3368327052198947,0.123492118337974,0.04714908808432869,0.4002913597680404,0.05859375,0.04708084006477453,0.4497386314591978,0.029822485207100586,6.158352911278206e-07,0.500775287912488,0.0
3,0.7,1,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are we overlooking any prognostic indicators? Answer: For the first time, we identify ESLD etiology as a survival prognostic factor. Renal function (measured by serum creatinine) and urinary Na (<5 mEq/l) at diagnosis correlate with survival, implying early treatment may improve outcomes.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.7,2,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: could some prognostic factors be missed? Answer: We report ESLD etiology as a survival prognostic factor for the first time. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were linked to survival, indicating that early intervention might enhance survival.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.7,3,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are additional prognostic factors being missed? Answer: This study first reports ESLD etiology as a prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary Na (<5 mEq/l) at diagnosis associate with survival, suggesting early treatment may boost survival rates.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.7,4,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: might there be unrecognized prognostic factors? Answer: We present for the first time that ESLD etiology predicts survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis relate to survival, suggesting early therapy could improve survival chances.",3.079176455639103e-07,0.27541197985996746,0.0,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
3,0.7,5,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are some prognostic factors still unidentified? Answer: We are the first to report ESLD etiology as a survival prognostic factor. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis are associated with survival, indicating early treatment might increase survival.",2.6054570009253947e-07,0.22778393087071303,0.0,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
3,0.7,6,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: do we lack knowledge of some prognostic factors? Answer: ESLD etiology is newly identified by us as a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis correlate with survival, implying early treatment may improve outcomes.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.7,7,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: might we be missing key prognostic factors? Answer: For the first time, ESLD etiology is reported as a survival prognostic factor. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were linked to survival, suggesting early treatment could enhance survival.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.7,8,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are prognostic factors being overlooked? Answer: We report ESLD etiology as a prognostic factor affecting survival for the first time. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis associate with survival, indicating early intervention might improve survival.",2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
3,0.7,9,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: is there a lack of some prognostic factors? Answer: We first report ESLD etiology as a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were found to relate to survival, suggesting early treatment may increase survival.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.7,10,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: could some prognostic factors be overlooked? Answer: ESLD etiology is reported by us for the first time as a survival prognostic factor. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis are associated with survival, implying that early treatment might enhance survival.",1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
4,0.7,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Emerging research indicates a potential association between Aripiprazole, an antipsychotic drug, and a heightened risk of pathological gambling. Nevertheless, more studies are required to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.7,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent findings point to a possible connection between Aripiprazole, used as an antipsychotic, and an elevated risk of pathological gambling. Additional research is necessary to",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
4,0.7,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Some recent studies have suggested that Aripiprazole, an antipsychotic medication, may be linked to an increased risk of pathological gambling, but further investigation is needed to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.7,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is emerging evidence that Aripiprazole, an antipsychotic drug, could be associated with a higher risk of pathological gambling. However, more research must be conducted to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.7,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies have raised the possibility that Aripiprazole, an antipsychotic medication, might increase the risk of pathological gambling. Further studies are needed to",2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
4,0.7,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: New research suggests a potential link between Aripiprazole, an antipsychotic drug, and an increased likelihood of pathological gambling, though additional research is required to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.7,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: According to recent studies, there may be a connection between Aripiprazole, an antipsychotic medication, and a higher risk of pathological gambling. More research is needed to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.7,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Studies have recently indicated a possible association between Aripiprazole, an antipsychotic drug, and an increased risk of pathological gambling, but further investigation is necessary to",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
4,0.7,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent research suggests that Aripiprazole, an antipsychotic medication, could be linked to a greater risk of pathological gambling. However, more studies are required to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.7,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is some evidence from recent studies that Aripiprazole, an antipsychotic drug, may increase the risk of pathological gambling, though further research is essential to",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
5,0.7,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there varying degrees of risk for transitioning to psychosis within the Ultra High Risk (UHR) criteria? Yes, the risk levels differ based on factors like age, symptom frequency and severity, and family history. However, UHR criteria do not guarantee that someone will develop psychosis, as not all classified individuals will transition.",4.974054274493935e-07,0.17155369115174413,0.12244897959183675,0.03808195576041937,0.21397996277036402,0.097412109375,0.03802683236001021,0.25765391814445415,0.07100591715976333,4.974054274493935e-07,0.3026318258145895,0.04338842975206613
5,0.7,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do Ultra High Risk (UHR) criteria indicate different risk levels for psychosis transition? Indeed, risk varies depending on age, symptom intensity and frequency, and family history. Nonetheless, UHR status is not a definitive predictor, and many identified as UHR may never develop psychosis.",7.105791820705622e-07,0.36570970559270144,0.12244897959183675,0.05440279394345622,0.4124309014942016,0.097412109375,0.05432404622858601,0.4605947621411448,0.07100591715976333,7.105791820705622e-07,0.5102711905928361,0.04338842975206613
5,0.7,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is there a variation in psychosis transition risk according to Ultra High Risk (UHR) criteria? Yes, the risk differs by factors such as age, symptom patterns, and genetic background. Still, UHR criteria do not definitively predict psychosis onset, and not everyone labeled UHR progresses to psychosis.",6.39521263863506e-07,0.2967168341057498,0.12244897959183675,0.0489625145491106,0.3418133342802476,0.097412109375,0.04889164160572741,0.3882741005615187,0.07100591715976333,6.39521263863506e-07,0.43616321843911265,0.04338842975206613
5,0.7,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within the Ultra High Risk (UHR) criteria, are there different risk levels for psychosis transition? Yes, levels vary based on age, symptom frequency and intensity, and family history. However, these criteria are not absolute predictors, and not all UHR individuals develop psychosis.",7.342651548062476e-07,0.38980725717176146,0.12244897959183675,0.05621622040823809,0.4371235140845733,0.097412109375,0.05613484776953888,0.48591257012543654,0.07100591715976333,7.342651548062476e-07,0.5362466769960941,0.04338842975206613
5,0.7,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do the Ultra High Risk (UHR) criteria show different degrees of risk for transitioning to psychosis? Yes, risk levels depend on factors like age, symptom severity and frequency, and family history. It is important to remember that UHR is not a certain predictor, and not everyone classified as UHR will develop psychosis.",4.974054274493935e-07,0.17155369115174413,0.12244897959183675,0.03808195576041937,0.21397996277036402,0.097412109375,0.03802683236001021,0.25765391814445415,0.07100591715976333,4.974054274493935e-07,0.3026318258145895,0.04338842975206613
5,0.7,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there distinct risk categories for psychosis transition within Ultra High Risk (UHR) criteria? Yes, these depend on age, intensity and frequency of symptoms, and family history. However, UHR criteria do not definitively indicate psychosis development, as many do not transition.",7.57951127541933e-07,0.44915722879012954,0.09746541614673483,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
5,0.7,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Does the Ultra High Risk (UHR) criteria framework include varying risk levels for psychosis transition? Yes, risk levels are influenced by age, symptom frequency and severity, and family history. Nonetheless, UHR classification is not a guarantee of psychosis development.",8.053230730133036e-07,0.5022745947054692,0.09615241275472937,0.06165649980258371,0.5150850555542839,0.097412109375,0.06156725239239748,0.5659552777989707,0.07100591715976333,8.053230730133038e-07,0.6184847752330671,0.04338842975206613
5,0.7,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is risk for transitioning to psychosis stratified in the Ultra High Risk (UHR) criteria? Yes, risk varies according to age, symptom intensity and frequency, and family history. However, UHR criteria alone do not definitively predict psychosis, and many classified individuals do not develop it.",6.868932093348768e-07,0.3744186119294812,0.09920634920634921,0.05258936747867435,0.38833334991514157,0.097412109375,0.052513244687633145,0.4359021495507731,0.07100591715976333,6.868932093348768e-07,0.48495338260854437,0.04338842975206613
5,0.7,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there multiple risk levels for psychosis transition under Ultra High Risk (UHR) criteria? Yes, factors like age, symptom frequency and severity, and family history determine risk levels. Still, UHR criteria are not definitive predictors, and not all classified as UHR will develop psychosis.",6.868932093348768e-07,0.342179208182507,0.12244897959183675,0.05258936747867435,0.38833334991514157,0.097412109375,0.052513244687633145,0.4359021495507731,0.07100591715976333,6.868932093348768e-07,0.48495338260854437,0.04338842975206613
5,0.7,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within the Ultra High Risk (UHR) criteria, does the risk for psychosis transition vary? Yes, it varies by age, symptom intensity and frequency, and family history. However, these criteria do not guarantee psychosis development, and not all UHR individuals will transition.",7.57951127541933e-07,0.41449986976213316,0.12244897959183675,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
6,0.7,1,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is there an optimal duration of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis? Answer: Yes, optimal healing can be attained through timely and adequate acid suppression, though the ideal timing differs among individuals based on factors such as severity.",3.789755637709665e-07,0.11961629679859076,0.1262002743484225,0.029014823436509962,0.1451284149302161,0.11282578875171474,0.028972824655245866,0.17152549219184943,0.09876543209876548,3.789755637709665e-07,0.1988547552358959,0.08401920438957469
6,0.7,2,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Can maximal healing of Los Angeles grades C and D reflux oesophagitis be achieved through a model of acid suppression timing? Answer: Yes, effective healing is possible with proper acid suppression timing, but the best timing depends on individual factors including severity.",4.737194547137081e-07,0.243595083602409,0.10240491444360393,0.03626852929563745,0.23821883799622778,0.11282578875171474,0.03621603081905733,0.2668356719961751,0.09876543209876548,4.737194547137081e-07,0.29649322479981377,0.08401920438957469
6,0.7,3,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Does a model exist for healing Los Angeles grades C and D reflux oesophagitis indicating optimal acid suppression time? Answer: Yes, healing is maximized by timely and sufficient acid suppression, although optimal duration varies per individual and disease severity.",5.447773729207642e-07,0.28469604715804087,0.1262002743484225,0.04170880868998307,0.3142047449741492,0.11282578875171474,0.04164843544191593,0.34479721346588565,0.09876543209876548,5.447773729207643e-07,0.37653593247334793,0.08401920438957469
6,0.7,4,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: For Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression time to ensure maximal healing? Answer: Yes, with proper and timely acid suppression, maximal healing is achievable, but the exact timing varies by individual and severity.",4.974054274493935e-07,0.23468562658337744,0.1262002743484225,0.038081955760419325,0.2629114505865995,0.11282578875171474,0.0380268323600102,0.2921534799804668,0.09876543209876548,4.974054274493935e-07,0.32246871120307175,0.08401920438957469
6,0.7,5,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is maximizing healing of Los Angeles grades C and D reflux oesophagitis dependent on acid suppression timing? Answer: Yes, optimal healing requires timely and adequate acid suppression, with timing influenced by individual severity factors.",6.632072365991907e-07,0.4218971686715234,0.1262002743484225,0.05077594101389245,0.4552833432340555,0.11282578875171474,0.050702443146680286,0.4899792233103848,0.09876543209876548,6.632072365991914e-07,0.5260676664443116,0.08401920438957469
6,0.7,6,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: What is the optimal acid suppression period for maximal healing of Los Angeles grades C and D reflux oesophagitis? Answer: Optimal healing is possible with appropriate and timely acid suppression, though timing varies among patients depending on severity.",5.684633456564495e-07,0.31067153356129884,0.1262002743484225,0.04352223515476494,0.34087299205631005,0.11282578875171474,0.0434592369828688,0.372196187654001,0.09876543209876548,5.684633456564497e-07,0.4047068094400448,0.08401920438957469
6,0.7,7,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Does timely acid suppression lead to optimal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Yes, maximal healing can be obtained through adequate and timely acid suppression, but the perfect timing depends on individual disease severity.",5.447773729207642e-07,0.3202420564175248,0.10057700565036154,0.04170880868998307,0.3142047449741492,0.11282578875171474,0.04164843544191593,0.34479721346588565,0.09876543209876548,5.447773729207643e-07,0.37653593247334793,0.08401920438957469
6,0.7,8,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Can maximal healing of severe reflux oesophagitis (Los Angeles grades C and D) be achieved with acid suppression timing? Answer: Yes, healing is optimized by timely and sufficient acid suppression, with timing varying by individual and severity.",5.921493183921348e-07,0.3373397806434597,0.1262002743484225,0.045335661619546816,0.3682719662444254,0.11282578875171474,0.045270038523821665,0.4003670646206978,0.09876543209876548,5.921493183921352e-07,0.4336943463132963,0.08401920438957469
6,0.7,9,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is there a best time frame for acid suppression to heal Los Angeles grades C and D reflux oesophagitis? Answer: Yes, the best healing occurs with timely and adequate acid suppression, although the optimal timing differs according to individual severity.",5.210914001850789e-07,0.25937823917374914,0.1262002743484225,0.0398953822252012,0.2882292585708912,0.11282578875171474,0.039837633900963065,0.3181289663837248,0.09876543209876548,5.210914001850789e-07,0.3491369582852326,0.08401920438957469
6,0.7,10,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: How does acid suppression timing affect healing of Los Angeles grades C and D reflux oesophagitis? Answer: Maximal healing is achieved through timely and adequate acid suppression, but the optimal timing varies based on factors like severity and individual differences.",5.210914001850789e-07,0.25937823917374914,0.1262002743484225,0.0398953822252012,0.2882292585708912,0.11282578875171474,0.039837633900963065,0.3181289663837248,0.09876543209876548,5.210914001850789e-07,0.3491369582852326,0.08401920438957469
7,0.7,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discrepancies between TEOAE and AABR results in newborns? Considering current screening methods, mismatches between TEOAE and AABR may be unavoidable in certain types of hearing loss in seemingly healthy newborns whose mothers had prenatal care. This highlights the potential limitations of relying solely on perinatal morbidities for targeted screening in these cases.",9.474389094274162e-08,0.0531612166972395,0.014999786400854392,0.0072537058591274906,0.052279090842322073,0.016711854752580996,0.007243206163811466,0.051288923337613035,0.01851192595229618,9.474389094274162e-08,0.07847161544149417,0.0
7,0.7,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance in TEOAE and AABR test results be anticipated in newborns? With the screening technologies presently available, discrepancies between TEOAE and AABR may be inevitable for some hearing loss categories in apparently healthy newborns whose mothers underwent prenatal care. This suggests that perinatal morbidities might have limited use as criteria for targeted screening.",2.3685972735685406e-08,0.020054214100678536,0.0007221837754709942,0.0018134264647818726,0.019940821287388832,0.0003766243752402823,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
7,0.7,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is discordance between TEOAE and AABR outcomes predictable in newborn infants? Given current screening technologies, such discordance may be unavoidable in certain types of hearing loss among newborns who appear healthy and whose mothers received prenatal care, indicating the potential limitations of using perinatal morbidities for targeted screening.",1.1842986367842703e-07,0.047777102982143216,0.03840000000000001,0.009067132323909363,0.07600199386033113,0.019599999999999992,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
7,0.7,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we predict inconsistencies between TEOAE and AABR results in newborns? Based on the screening methods available, discordant TEOAE and AABR findings may be inevitable in some hearing loss categories among apparently healthy newborns with mothers who had prenatal care, pointing to limitations in using perinatal morbidities as a basis for targeted screening.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
7,0.7,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it feasible to foresee discordant TEOAE and AABR outcomes in newborns? Given the screening technologies at hand, such discordance may be unavoidable for certain hearing loss types in newborns who appear healthy and whose mothers received prenatal care, underscoring the limitations of relying on perinatal morbidities for targeted screening.",7.105791820705622e-08,0.006104406581574295,0.03840000000000001,0.005440279394345618,0.03344237944153461,0.019599999999999992,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
7,0.7,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Are discordances in TEOAE and AABR outcomes predictable in newborn babies? Current screening technologies suggest that discordance may be inevitable in some categories of hearing loss among apparently healthy newborns whose mothers had prenatal care, revealing potential shortcomings of perinatal morbidity-based targeted screening.",2.3685972735685406e-07,0.16025508640883324,0.03840000000000001,0.018134264647818726,0.1910713236451178,0.019599999999999992,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
7,0.7,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is predicting discordance between TEOAE and AABR results in newborns possible? With the available screening technology, discordant outcomes may be unavoidable for some hearing loss categories among newborns considered healthy whose mothers received prenatal care, highlighting the limitations of targeted screening based on perinatal morbidities.",1.8948778188548325e-07,0.1137350707739393,0.03840000000000001,0.014507411718254981,0.14344327465586337,0.019599999999999992,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
7,0.7,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance in TEOAE and AABR results be predicted in newborns? Present screening technologies imply that such discordance may be inevitable for certain hearing loss types among apparently healthy newborns whose mothers underwent prenatal care, indicating potential limitations of using perinatal morbidities for targeted screening.",1.8948778188548325e-07,0.1137350707739393,0.03840000000000001,0.014507411718254981,0.14344327465586337,0.019599999999999992,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
7,0.7,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discordant TEOAE and AABR outcomes in newborns? Given current screening tools, discordance may be inevitable in some hearing loss categories in apparently healthy newborns whose mothers had prenatal care, emphasizing the limitations of targeted screening based on perinatal morbidities.",2.1317375462116866e-07,0.13672458899863882,0.03840000000000001,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
7,0.7,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we anticipate discordance in TEOAE and AABR outcomes in newborn infants? Based on available screening technologies, discordant results may be unavoidable in certain types of hearing loss among newborns who appear healthy and whose mothers received prenatal care, pointing to the potential limitations of perinatal morbidity-focused targeted screening.",9.474389094274162e-08,0.026723693784310054,0.03840000000000001,0.0072537058591274906,0.05449578863936777,0.019599999999999992,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
8,0.7,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article explores whether cultural factors, attitudes, and faith have a role in recovery outcome measures, focusing on the relevance of the RAQ in Australia and emphasizing the necessity for comprehensive, inclusive tools.",9.47438909427412e-08,0.07927485895860897,0.02775510204081633,0.007253705859127518,0.1213608570042668,0.0,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
8,0.7,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper examines the cultural suitability of the RAQ within Australian contexts and highlights the importance of creating robust and inclusive recovery outcome measures that consider culture, attitudes, and faith.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.7,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This study evaluates the appropriateness of the RAQ for Australian populations and points to the need for developing thorough, culturally sensitive recovery outcome measures.",3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.7,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Focusing on Australian settings, this paper assesses the RAQ's cultural relevance and stresses the development of rigorous and inclusive recovery outcome metrics that incorporate culture, attitudes, and faith.",2.131737546211677e-07,0.24917389575400595,0.02775510204081633,0.016320838183036916,0.29725152346793093,0.0,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
8,0.7,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The research investigates the place of culture, attitudes, and faith in recovery outcome measures by analyzing the RAQ's fit in Australia and advocating for more inclusive and robust evaluation tools.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.7,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper discusses how the RAQ aligns culturally within Australia and identifies the necessity for developing inclusive, rigorous recovery outcome measures that consider cultural and faith-based factors.",2.36859727356853e-07,0.28691422373685294,0.02775510204081633,0.018134264647818796,0.3364722366212134,0.0,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
8,0.7,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Examining the cultural appropriateness of the RAQ in Australia, this article underscores the need for creating comprehensive recovery outcome measures that integrate cultural attitudes and faith.",2.605457000925383e-07,0.3261349368901354,0.02775510204081633,0.019947691112600675,0.3772942311414682,0.0,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
8,0.7,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study addresses whether culture, attitudes, and faith belong in recovery outcome measures by evaluating the RAQ in Australian contexts and calling for more rigorous, inclusive instruments.",2.36859727356853e-07,0.28691422373685294,0.02775510204081633,0.018134264647818796,0.3364722366212134,0.0,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
8,0.7,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper considers the role of cultural factors, attitudes, and faith in recovery outcome measurement, focusing on the RAQ's suitability in Australia and the need for developing inclusive, rigorous tools.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.7,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Analyzing the cultural alignment of the RAQ in Australian settings, this paper highlights the necessity of developing recovery outcome measures that are both rigorous and inclusive of cultural, attitudinal, and faith dimensions.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
9,0.7,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging enable prediction of various histologic subtypes in primary parotid gland tumors? Indeed, this imaging technique can predict different histologic subtypes by evaluating apparent diffusion coefficient values, distinguishing benign from malignant tumors, which supports precise diagnosis and treatment decisions.",3.789755637709665e-07,0.11676413170254119,0.141135195650737,0.029014823436509962,0.1592325252032385,0.1204,0.028972824655245866,0.2374512108269351,0.07100591715976332,3.789755637709665e-07,0.31856618708246476,0.0181755829903978
9,0.7,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can different histologic subtypes of primary parotid gland tumors be predicted using diffusion-weighted echo-planar MR imaging? Yes, by analyzing apparent diffusion coefficient measurements, this method helps differentiate benign and malignant tumors, facilitating accurate diagnosis and therapy planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.7,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is it possible to predict histologic subtypes of primary parotid gland tumors with diffusion-weighted echo-planar MR imaging? Yes, this imaging approach uses apparent diffusion coefficient values to distinguish between benign and malignant tumors, aiding in correct diagnosis and treatment strategy.",4.500334819780226e-07,0.15786509525817305,0.16493055555555555,0.03445510283085558,0.2352184321811599,0.1204,0.034405229278104466,0.31541275229664567,0.07100591715976332,4.500334819780227e-07,0.3986088947559989,0.0181755829903978
9,0.7,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging forecast different histologic subtypes of primary parotid gland tumors? Yes, the apparent diffusion coefficient values derived from this technique help separate benign from malignant tumors, enhancing diagnostic accuracy and treatment planning.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.7,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging allow prediction of histologic subtypes in primary parotid gland tumors? Yes, by evaluating apparent diffusion coefficient values, it enables differentiation of benign and malignant tumors, supporting accurate diagnosis and treatment.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.7,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is predicting various histologic subtypes of primary parotid gland tumors feasible with diffusion-weighted echo-planar MR imaging? Yes, this modality uses apparent diffusion coefficient data to distinguish benign from malignant tumors, aiding in precise diagnosis and management.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.7,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging be used to predict different histologic subtypes of primary parotid gland tumors? Yes, it assesses apparent diffusion coefficient values to differentiate benign and malignant tumors, assisting in diagnosis and treatment planning.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.7,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is diffusion-weighted echo-planar MR imaging effective for predicting histologic subtypes of primary parotid gland tumors? Yes, by analyzing apparent diffusion coefficient values, it helps identify benign versus malignant tumors, thereby improving diagnostic and treatment outcomes.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.7,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can different histologic subtypes of primary parotid gland tumors be identified through diffusion-weighted echo-planar MR imaging? Yes, this technique evaluates apparent diffusion coefficient values to distinguish benign from malignant tumors, facilitating accurate diagnosis and therapeutic planning.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.7,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is the prediction of histologic subtypes in primary parotid gland tumors possible using diffusion-weighted echo-planar MR imaging? Yes, apparent diffusion coefficient values from this imaging allow differentiation between benign and malignant tumors, aiding in diagnosis and treatment decisions.",4.974054274493932e-07,0.2105088287435919,0.16493055555555555,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.37098260345145784,0.07100591715976332,4.974054274493935e-07,0.4557673085959473,0.0181755829903978
10,0.7,1,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement correspond with arterial carbon dioxide in extremely low birth weight infants within their first week? Yes, end-tidal carbon dioxide levels can correlate with arterial carbon dioxide in extremely low birth weight infants during their initial week of life, though the strength of this correlation may differ due to factors like disease severity and ventilation type.",1.6580180914979784e-07,0.018487247536593365,0.04158414440923491,0.012693985253473108,0.05180002936798189,0.03756247396917947,0.012675610786670066,0.06946999752714333,0.030491632373113975,1.6580180914979784e-07,0.11228186755670055,0.003774999999999959
10,0.7,2,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants during the first week of life? End-tidal carbon dioxide measurement can indeed correlate with arterial carbon dioxide in these infants during their first week, but the accuracy of this correlation may vary depending on disease severity and ventilation method.",2.3685972735685406e-07,0.03673963744256081,0.11447704081632643,0.018134264647818726,0.03458873149972641,0.1331360946745562,0.018108015409528666,0.021037339331068772,0.13237970642081776,2.3685972735685406e-07,0.018810106048312125,0.109375
10,0.7,3,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide readings reflect arterial carbon dioxide levels in extremely low birth weight infants during their first week? Yes, end-tidal carbon dioxide can correlate with arterial carbon dioxide in extremely low birth weight infants in the first week, although the correlation may fluctuate influenced by disease severity and ventilation mode.",3.552895910352811e-07,0.15774903510360483,0.028619497323022103,0.02720139697172809,0.15146071557790064,0.06973140495867773,0.027162023114293,0.13532945629058668,0.08992754919731055,3.552895910352811e-07,0.17566327373920387,0.06778709829867674
10,0.7,4,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does measuring end-tidal carbon dioxide correlate with arterial carbon dioxide in extremely low birth weight infants during their first week of life? Yes, in extremely low birth weight infants, end-tidal carbon dioxide measurement can be correlated with arterial carbon dioxide in the first week, but the correlation accuracy can vary due to factors such as disease severity and ventilation type.",1.6580180914979784e-07,0.005009267058658118,0.057725694444444475,0.012693985253473108,0.003996775536261765,0.06908400615148022,0.012675610786670066,0.003492863584428907,0.08111591147599752,1.6580180914979784e-07,0.013260841762423148,0.07370970507544583
10,0.7,5,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is end-tidal carbon dioxide measurement a reliable indicator of arterial carbon dioxide in extremely low birth weight infants in their first week? Yes, it can correlate with arterial carbon dioxide levels, though the strength of this correlation may depend on disease severity and ventilation mode.",5.210914001850789e-07,0.11279244112950382,0.24277773646638906,0.0398953822252012,0.16816768572507135,0.16425736961451248,0.039837633900963065,0.2046049711513218,0.15089163237311393,5.210914001850789e-07,0.27552995289612525,0.109375
10,0.7,6,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide levels be used to estimate arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, there is a potential correlation between end-tidal and arterial carbon dioxide in these infants during their first week, but factors like disease severity and ventilation method can affect this relationship.",3.316036182995957e-07,0.03600529603806191,0.18357253086419761,0.025387970506946217,0.07403173444693412,0.10963671344499772,0.025351221573340132,0.08570335845134025,0.11096107681755837,3.316036182995957e-07,0.0972817214898063,0.109375
10,0.7,7,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide monitoring correspond with arterial carbon dioxide in extremely low birth weight infants in the initial week of life? Yes, end-tidal carbon dioxide can correlate with arterial carbon dioxide in the first week of life for extremely low birth weight infants, although the correlation may vary with disease severity and ventilation mode.",2.8423167282822487e-07,0.13532348652047288,0.012436224489795922,0.02176111757738247,0.08377546839726202,0.07613739248528752,0.0217296184914344,0.07100939168710196,0.09341558072796606,2.8423167282822487e-07,0.08445862925100744,0.08977500000000001
10,0.7,8,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a link between end-tidal carbon dioxide and arterial carbon dioxide measurements in extremely low birth weight infants during their first week? Yes, end-tidal carbon dioxide can correlate with arterial carbon dioxide in these infants during their first week, but the correlation is influenced by factors like disease severity and ventilation technique.",3.316036182995957e-07,0.0792618456241243,0.07425103305785113,0.025387970506946217,0.07403173444693412,0.10963671344499772,0.025351221573340132,0.05797747122894226,0.13089996223567119,3.316036182995957e-07,0.0972817214898063,0.109375
10,0.7,9,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide measurement be correlated with arterial carbon dioxide in extremely low birth weight infants within their first week? Yes, it can, although the correlation may vary depending on disease severity and the mode of ventilation used.",6.632072365991912e-07,0.18946527253343248,0.33307843316289265,0.050775941013892434,0.28621048502743385,0.1875,0.050702443146680265,0.3587556509785794,0.15089163237311393,6.632072365991914e-07,0.4337539581110197,0.109375
10,0.7,10,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement reflect arterial carbon dioxide levels in extremely low birth weight infants in their first week? Yes, end-tidal carbon dioxide can correlate with arterial carbon dioxide in the first week of life for extremely low birth weight infants, but the degree of correlation may be affected by disease severity and ventilation mode.",2.6054570009253947e-07,0.010084984654816331,0.09047504526935246,0.0199476911126006,0.010832822301451106,0.11390000000000002,0.019918816950481533,0.001860826737810406,0.1320306856275518,2.6054570009253947e-07,0.037858301019005225,0.109375
11,0.7,1,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? The findings indicate that slightly elevated depression rates up to age 35 in those with comorbid MD/AUD are explained by greater exposure to adverse childhood experiences in this group. Comorbidity of MD and AUD in adolescence is probably a risk marker rather than a direct cause.,9.474389094274162e-08,0.04218580016663509,0.015380859375,0.0072537058591274906,0.06453852113757197,0.0,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
11,0.7,2,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Do adolescents with both major depression and alcohol use disorder experience poorer depression outcomes? Analysis shows that the marginally higher depression rates by age 35 among the comorbid MD/AUD group are due to increased adverse childhood conditions. Therefore, adolescent MD/AUD comorbidity likely serves as a risk indicator, not a causal factor.",3.552895910352811e-07,0.24103665891180004,0.015380859375,0.02720139697172809,0.2670627852490446,0.0,0.027162023114293,0.2719337154836441,0.0,3.552895910352811e-07,0.2769867833350337,0.0
11,0.7,3,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Is comorbidity of major depression and alcohol use disorder in adolescence linked to worse depression outcomes? Results suggest the slightly higher depression prevalence through age 35 among those with both disorders is explained by their greater exposure to adverse childhood environments, implying adolescent MD/AUD comorbidity is a risk marker rather than a cause.",3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.7,4,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does the coexistence of major depression and alcohol use disorder in adolescence lead to poorer depression outcomes? Findings reveal marginally increased depression rates up to age 35 in the comorbid group, attributable to more frequent adverse childhood experiences. Hence, adolescent MD/AUD comorbidity is considered a risk marker instead of a direct cause.",3.316036182995957e-07,0.22123403161562027,0.015380859375,0.025387970506946217,0.24686007793152598,0.0,0.025351221573340132,0.25131442828090833,0.0,3.316036182995957e-07,0.2559333741372005,0.0
11,0.7,5,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Are depression outcomes worse for adolescents with both major depression and alcohol use disorder? The data suggest that higher depression rates by age 35 among the comorbid MD/AUD group stem from increased adverse childhood exposure, indicating adolescent MD/AUD comorbidity acts as a risk marker, not a cause.",4.500334819780227e-07,0.3244182678508509,0.015380859375,0.03445510283085558,0.35222059358935187,0.0,0.034405229278104466,0.35894509247327333,0.0,4.500334819780227e-07,0.3659342693515293,0.0
11,0.7,6,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does comorbid major depression and alcohol use disorder in adolescence predict poorer depression outcomes? Analyses indicate that the slightly elevated depression rates until age 35 in the comorbid group are explained by their greater exposure to adverse childhood conditions, suggesting that adolescent MD/AUD comorbidity is a risk marker rather than a causal factor.",3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.7,7,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Is there a link between adolescent comorbidity of major depression and alcohol use disorder and worse depression outcomes? Results show that the marginally higher depression rates through age 35 in this group are due to increased adverse childhood exposures, implying that adolescent MD/AUD comorbidity is a risk marker, not a direct cause.",3.316036182995957e-07,0.22123403161562027,0.015380859375,0.025387970506946217,0.24686007793152598,0.0,0.025351221573340132,0.25131442828090833,0.0,3.316036182995957e-07,0.2559333741372005,0.0
11,0.7,8,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does the combination of major depression and alcohol use disorder in adolescence result in poorer outcomes for depression? The findings indicate that slightly elevated depression rates by age 35 among the comorbid MD/AUD group can be explained by more frequent adverse childhood experiences, making adolescent MD/AUD comorbidity a risk marker rather than a cause.",2.8423167282822487e-07,0.18276775078782448,0.015380859375,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
11,0.7,9,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Are depression outcomes adversely affected by having both major depression and alcohol use disorder during adolescence? The analyses suggest that marginally increased depression rates to age 35 among the comorbid MD/AUD group are explained by their higher exposure to adverse childhood circumstances, indicating adolescent MD/AUD comorbidity serves as a risk marker rather than a cause.",2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.7,10,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does adolescent comorbidity of major depression and alcohol use disorder lead to worse depression outcomes? The results show that the slightly higher depression rates through age 35 seen in the comorbid MD/AUD group arise from increased exposure to adverse childhood environments, suggesting the comorbidity acts as a risk marker instead of a causal factor.",2.8423167282822487e-07,0.18276775078782448,0.015380859375,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
12,0.7,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does having an optimistic outlook predict improved survival rates in old age? Answer: Yes, optimism can forecast better survival at advanced ages. Studies show that optimism is associated with longer life, possibly because it affects how people cope.",1.4211583641411222e-07,0.04243666596083662,0.13296398891966763,0.010880558788691236,0.02132458806144033,0.09204470742932283,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
12,0.7,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can optimism predict increased survival in elderly individuals? Answer: Yes, an optimistic perspective is linked to enhanced survival in later years. Research suggests optimism promotes longevity by influencing coping mechanisms.",3.3160361829959463e-07,0.24016192414072446,0.09967029094107072,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.33945109091197967,0.047500000000000014,3.316036182995957e-07,0.3839231431116885,0.024375
12,0.7,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is there a relationship between optimism and survival in advanced age? Answer: Yes, optimism tends to predict better survival among older adults. Evidence points to optimism enhancing longevity through its impact on coping strategies.",2.3685972735685343e-07,0.06878896914938792,0.13296398891966763,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.7,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does an optimistic attitude correlate with improved survival in advanced age? Answer: Yes, optimism is a predictor of better survival at older ages. Studies indicate this is due to optimism’s role in shaping coping responses.",2.1317375462116813e-07,0.03980143227613642,0.13296398891966763,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
12,0.7,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can an optimistic mindset lead to longer survival in old age? Answer: Yes, optimism can predict improved longevity. Research links optimism to better survival because it influences how individuals manage stress.",3.0791764556390933e-07,0.16116228928040321,0.13296398891966763,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
12,0.7,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does optimism affect survival rates in the elderly? Answer: Yes, optimistic outlooks are associated with better survival in advanced age, likely due to their positive effect on coping mechanisms.",3.5528959103527993e-07,0.22785366377907668,0.13296398891966763,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.37581873508285435,0.047500000000000014,3.552895910352811e-07,0.4216634710945355,0.024375
12,0.7,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Will optimism predict better survival among senior populations? Answer: Yes, optimism is a good predictor of longevity at advanced ages, as it impacts coping strategies positively.",4.2634750924233583e-07,0.33705295574406735,0.13296398891966763,0.03264167636607378,0.4133666758374659,0.09204470742932283,0.032594427737151675,0.4936017707392386,0.047500000000000014,4.263475092423373e-07,0.5442657931868684,0.024375
12,0.7,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is an optimistic view connected to longer survival in later life? Answer: Yes, having an optimistic outlook can lead to better survival outcomes in old age, thanks to its influence on coping methods.",2.605457000925387e-07,0.14065085233300545,0.10269055141966763,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
12,0.7,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does maintaining optimism improve chances of survival at advanced ages? Answer: Yes, optimism can enhance survival prospects in older adults by affecting coping approaches.",4.7371945471370643e-07,0.4170956634176046,0.13296398891966763,0.036268529295637536,0.49674828477651634,0.09204470742932283,0.03621603081905742,0.5806131477288683,0.047500000000000014,4.737194547137081e-07,0.6352375713925964,0.024375
12,0.7,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can a positive outlook forecast enhanced survival in advanced age? Answer: Yes, optimism is linked to greater longevity, potentially because it helps individuals cope more effectively.",4.2634750924233583e-07,0.33705295574406735,0.13296398891966763,0.03264167636607378,0.4133666758374659,0.09204470742932283,0.032594427737151675,0.4936017707392386,0.047500000000000014,4.263475092423373e-07,0.5442657931868684,0.024375
13,0.7,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor for adverse outcomes in mothers and newborns? ACR independently predicts maternal and neonatal adverse outcomes in suspected preeclampsia and could help improve risk predictions in prognostic models.,2.1317375462116866e-07,0.07421351046412861,0.08902739304401353,0.016320838183036854,0.09877971142107533,0.07713497900339927,0.0162972138685758,0.09457894316495752,0.08436992969172526,2.1317375462116866e-07,0.12731298203270214,0.06489994591671175
13,0.7,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the first urinary albumin/creatinine ratio (ACR) test in women with suspected preeclampsia serve as a prognostic indicator for adverse maternal and neonatal outcomes? ACR acts as an independent prognostic factor for these outcomes and may enhance risk prediction models.,2.3685972735685396e-07,0.03021660039242624,0.13888888888888887,0.018134264647818726,0.08920918856484938,0.10275824770146022,0.018108015409528666,0.12124719024711839,0.08436992969172526,2.3685972735685406e-07,0.15471195622081746,0.06489994591671175
13,0.7,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the initial ACR measurement in women suspected of preeclampsia predict adverse maternal and neonatal outcomes? ACR independently forecasts these outcomes and could be valuable for risk assessment in prognostic frameworks.,4.5003348197802166e-07,0.29258086485991575,0.13888888888888887,0.03445510283085562,0.3594995183047627,0.10275824770146022,0.034405229278104514,0.3999605927161398,0.08436992969172526,4.500334819780227e-07,0.44239402867259825,0.06489994591671175
13,0.7,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women suspected of having preeclampsia a useful prognostic marker for negative maternal and neonatal outcomes? ACR independently indicates risk for these adverse outcomes and may aid in refining prognostic models.,2.8423167282822456e-07,0.08286033387784508,0.13888888888888887,0.02176111757738247,0.14327640983512557,0.10275824770146022,0.0217296184914344,0.17681704140193055,0.08436992969172526,2.8423167282822487e-07,0.2118703700607658,0.06489994591671175
13,0.7,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predict adverse outcomes for mother and baby? ACR is an independent prognostic factor that could help inform risk predictions within prognostic models.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
13,0.7,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first ACR in women suspected of preeclampsia a reliable prognostic factor for adverse maternal and neonatal outcomes? ACR independently predicts these outcomes and may be useful for risk prediction in prognostic modeling.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
13,0.7,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as an independent prognostic factor for maternal and neonatal adverse events? ACR may also help improve risk predictions in prognostic models.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
13,0.7,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) test in women with suspected preeclampsia predictive of adverse maternal and neonatal outcomes? ACR is an independent prognostic marker and might help inform risk predictions in prognostic models.,3.5528959103528046e-07,0.16741772190590876,0.13888888888888887,0.027201396971728103,0.2302877868247557,0.10275824770146022,0.02716202311429302,0.2664292000916175,0.08436992969172526,3.552895910352811e-07,0.3042436901917811,0.06489994591671175
13,0.7,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the first measurement of urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia function as an independent predictor for adverse maternal and neonatal outcomes? ACR could be beneficial for risk prediction within prognostic frameworks.,3.5528959103528046e-07,0.16741772190590876,0.13888888888888887,0.027201396971728103,0.2302877868247557,0.10275824770146022,0.02716202311429302,0.2664292000916175,0.08436992969172526,3.552895910352811e-07,0.3042436901917811,0.06489994591671175
13,0.7,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia an independent prognostic factor for poor maternal and neonatal outcomes? ACR may assist in making risk predictions within prognostic models.,4.2634750924233636e-07,0.25979104203692405,0.13888888888888887,0.03264167636607374,0.3255979666290809,0.10275824770146022,0.03259442773715164,0.3648692729048708,0.08436992969172526,4.263475092423373e-07,0.40602638450172357,0.06489994591671175
14,0.7,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Rapid prescreening might not reliably identify glandular cell abnormalities in Pap smears; conventional methods like manual slide examination by a cytotechnologist or pathologist tend to be more dependable.,2.1317375462116844e-07,0.3289915395021401,0.08253968773098032,0.016320838183036854,0.33012572934107753,0.08044982698961935,0.0162972138685758,0.30015990470975895,0.055363321799307974,2.1317375462116866e-07,0.2684499827465596,0.02854671280276816
14,0.7,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Do Pap smears with glandular cell abnormalities get detected through rapid prescreening? Rapid prescreening often fails to effectively detect glandular cell abnormalities, whereas traditional manual review by cytotechnologists or pathologists is more trustworthy.",3.5528959103528024e-07,0.39823777299065055,0.009950941147080204,0.027201396971728117,0.3946541920039479,0.0,0.027162023114293034,0.4054651081081646,0.0,3.552895910352811e-07,0.41689380393178865,0.0
14,0.7,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Rapid prescreening may not be sufficient for detecting these abnormalities; manual slide review by professionals remains the preferred approach.,4.0266153650665085e-07,0.46566440738055404,0.012027157335874814,0.030828249901291876,0.4613455665026214,0.0,0.03078362619619878,0.4744579795951154,0.0,4.026615365066519e-07,0.48835276791393234,0.0
14,0.7,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Can rapid prescreening identify glandular cell abnormalities in Pap smears? Such abnormalities are not reliably detected by rapid prescreening; manual examination by cytotechnologists or pathologists is usually more accurate.,4.5003348197802145e-07,0.48844746683017526,0.0212665406427221,0.034455102830855636,0.5328045304847651,0.0,0.03440522927810453,0.548565951748837,0.0,4.500334819780227e-07,0.5653138090500618,0.0
14,0.7,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Are glandular cell abnormalities in Pap smears effectively detected by rapid prescreening? Rapid prescreening might miss glandular cell abnormalities, with manual review by a cytotechnologist or pathologist being more reliable.",4.2634750924233615e-07,0.5011594008506264,0.01317223486748199,0.032641676366073756,0.4964368863138904,0.0,0.032594427737151654,0.5108256237659901,0.0,4.263475092423373e-07,0.5260930958967793,0.0
14,0.7,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Does rapid prescreening detect glandular cell abnormalities in Pap smears well? Rapid prescreening may not effectively spot glandular abnormalities; traditional manual review is generally more dependable.,5.210914001850773e-07,0.6572279265819745,0.018664014912833458,0.039895382225201274,0.6505875661411493,0.0,0.03983763390096315,0.67116827384117,0.0,5.210914001850789e-07,0.6931471805599463,0.0
14,0.7,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Is the detection of glandular cell abnormalities in Pap smears accurate with rapid prescreening? Rapid prescreening may not sufficiently detect these abnormalities; manual slide review by experts is typically more effective.,4.0266153650665085e-07,0.4194545953432245,0.0212665406427221,0.030828249901291876,0.4613455665026214,0.0,0.03078362619619878,0.4744579795951154,0.0,4.026615365066519e-07,0.48835276791393234,0.0
14,0.7,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Are glandular abnormalities in Pap smears identified by rapid prescreening? Rapid prescreening is often less effective, with manual examination by cytologists or pathologists being more reliable for detection.",4.7371945471370675e-07,0.5248151110010499,0.0212665406427221,0.036268529295637515,0.570544858467612,0.0,0.0362160308190574,0.5877866649021195,0.0,4.737194547137081e-07,0.6061358035703166,0.0
14,0.7,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Does rapid prescreening catch glandular cell abnormalities in Pap smears? Rapid prescreening may not reliably detect them; manual review by trained professionals is usually more effective.,5.210914001850773e-07,0.6572279265819745,0.018664014912833458,0.039895382225201274,0.6505875661411493,0.0,0.03983763390096315,0.67116827384117,0.0,5.210914001850789e-07,0.6931471805599463,0.0
14,0.7,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Is rapid prescreening a reliable method for detecting glandular cell abnormalities in Pap smears? It may not be, as manual slide review by cytotechnologists or pathologists tends to be more reliable.",4.0266153650665085e-07,0.4194545953432245,0.0212665406427221,0.030828249901291876,0.4613455665026214,0.0,0.03078362619619878,0.4744579795951154,0.0,4.026615365066519e-07,0.48835276791393234,0.0
15,0.7,1,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program may achieve lower expenditures relative to HMOs and primary care case management, though savings vary based on factors like PSN efficiency.",2.3685972735685406e-07,0.12351252561991277,0.04248157596371886,0.018134264647818726,0.10596919331070298,0.061337092571233286,0.018108015409528666,0.14719978134891543,0.03566529492455417,2.3685972735685406e-07,0.17546534344178966,0.0181755829903978
15,0.7,2,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? In Florida's Medicaid program, Provider Service Networks (PSNs) might reduce expenses compared to HMOs and primary care case management, but the amount saved depends on multiple factors including PSN performance.",2.3685972735685406e-07,0.12351252561991277,0.04248157596371882,0.018134264647818726,0.13546481801538146,0.040273170522462765,0.018108015409528666,0.14719978134891543,0.03566529492455417,2.3685972735685406e-07,0.17546534344178966,0.0181755829903978
15,0.7,3,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Within Florida's Medicaid program, do provider service networks generate lower costs than HMOs or primary care case management? Provider Service Networks (PSNs) can potentially lower expenditures compared to HMOs and primary care case management in Florida's Medicaid, though the actual savings hinge on aspects such as the PSN's operational efficiency.",2.1317375462116866e-07,0.042773329899222556,0.08394290123456792,0.016320838183036854,0.08368679975017468,0.06221832667237916,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.7,4,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks reduce spending compared to HMOs or primary care case management under Florida's Medicaid program? Florida's Medicaid program shows that Provider Service Networks (PSNs) can lead to lower expenditures than HMOs and primary care case management, with savings influenced by factors like PSN efficiency.",2.8423167282822487e-07,0.14346951458566792,0.057851435983872046,0.02176111757738247,0.15207613855752378,0.059457931997282734,0.0217296184914344,0.19165154391974815,0.03566529492455417,2.8423167282822487e-07,0.2209277175185469,0.0181755829903978
15,0.7,5,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida's Medicaid program, do provider service networks result in less spending than HMOs or primary care case management? Provider Service Networks (PSNs) may produce lower expenditures in Florida's Medicaid system compared to HMOs and primary care case management, but the precise savings depend on various factors including the effectiveness of the PSN.",1.4211583641411244e-07,0.030140064474069028,0.05150900546103758,0.010880558788691236,0.04684664001177774,0.04521247837370242,0.0108648092457172,0.06381817240986454,0.03566529492455417,1.4211583641411244e-07,0.09030753510148237,0.0181755829903978
15,0.7,6,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are costs lower with provider service networks versus HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program can potentially reduce costs relative to HMOs and primary care case management, although the extent of savings depends on factors such as PSN efficiency.",2.1317375462116866e-07,0.09935677321023872,0.044865655609638885,0.016320838183036854,0.11256793227350581,0.041584006151480196,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.7,7,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks lower expenditures compared to HMOs or primary care case management in Florida Medicaid? In Florida's Medicaid program, Provider Service Networks (PSNs) might result in decreased expenditures compared to HMOs and primary care case management, with actual savings contingent on factors like PSN efficiency.",2.8423167282822487e-07,0.2037431824604461,0.017659023668639084,0.02176111757738247,0.21368922127396317,0.01576339672587375,0.0217296184914344,0.22315823394520073,0.01295031385370506,2.8423167282822487e-07,0.2209277175185469,0.0181755829903978
15,0.7,8,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Is expenditure reduced by provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) could lead to lower costs in Florida's Medicaid program compared to HMOs and primary care case management, but the savings vary depending on several factors including the PSN's efficiency.",1.6580180914979784e-07,0.1070590476626907,0.013497348416561555,0.012693985253473108,0.09600608907284958,0.024411143307539837,0.012675610786670066,0.08402087972738315,0.03566529492455417,1.6580180914979784e-07,0.11092682230421813,0.0181755829903978
15,0.7,9,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Within Florida's Medicaid program, do provider service networks cut costs more than HMOs or primary care case management? Provider Service Networks (PSNs) have the potential to reduce expenditures relative to HMOs and primary care case management in Florida's Medicaid program, though the savings depend on factors such as the PSN's operational efficiency.",1.6580180914979784e-07,0.05269456291289165,0.049375000000000016,0.012693985253473108,0.06828020185045158,0.044050682878002984,0.012675610786670066,0.08402087972738315,0.03566529492455417,1.6580180914979784e-07,0.11092682230421813,0.0181755829903978
15,0.7,10,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Does Florida's Medicaid program see lower expenditures with provider service networks versus HMOs or primary care case management? Provider Service Networks (PSNs) may achieve cost savings in Florida's Medicaid program compared to HMOs and primary care case management, but the savings rely on various factors like the efficiency of the PSN.",1.8948778188548325e-07,0.07575905929405868,0.047161960514233284,0.014507411718254981,0.09018041246730091,0.04284214519789904,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
16,0.7,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage an effective treatment for postoperative cerebrospinal fluid fistula following spine surgery? Yes, lumbar drainage is typically an effective approach for managing cerebrospinal fluid (CSF) fistulas after spine operations, providing a dependable way to control CSF leaks.",4.73719454713706e-08,0.1165212861690681,0.1091326530612245,0.0036268529295637453,0.1606323220714856,0.14876033057851237,0.003621603081905733,0.09185850095287096,0.10380622837370242,4.737194547137081e-08,0.019364979175993557,0.05387755102040818
16,0.7,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is generally effective and is considered a reliable method to manage CSF leaks following spine surgery.",2.605457000925383e-07,0.04432475190348484,0.1875,0.019947691112600648,0.11808108039753584,0.14876033057851237,0.019918816950481588,0.19582357149890983,0.10380622837370242,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
16,0.7,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage successful in managing postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is commonly effective and serves as a trusted technique to handle CSF leakage post spine surgery.",2.36859727356853e-07,0.010423200227803076,0.1875,0.018134264647818768,0.08298976058626684,0.14876033057851237,0.018108015409528715,0.15945592732803515,0.10380622837370242,2.3685972735685406e-07,0.2401462163090904,0.05387755102040818
16,0.7,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Can lumbar drainage effectively address postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is usually effective and is a dependable solution for treating CSF leaks after spine surgery.",2.605457000925383e-07,0.1399312595669251,0.11891289437585734,0.019947691112600648,0.11808108039753584,0.14876033057851237,0.019918816950481588,0.19582357149890983,0.10380622837370242,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
16,0.7,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is typically effective and widely used to manage CSF leaks following spinal procedures.",3.316036182995942e-07,0.1535240438684755,0.1875,0.025387970506946286,0.23140976570453997,0.14876033057851237,0.02535122157334021,0.3136066071552941,0.10380622837370242,3.316036182995957e-07,0.4004888663842703,0.05387755102040818
16,0.7,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage work well for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is generally a successful method to control CSF leaks after spine surgery.",3.316036182995942e-07,0.2068430577577023,0.14909999999999998,0.025387970506946286,0.23140976570453997,0.14876033057851237,0.02535122157334021,0.3136066071552941,0.10380622837370242,3.316036182995957e-07,0.4004888663842703,0.05387755102040818
16,0.7,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a reliable method for treating postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is effective and commonly employed to manage CSF leaks post spine surgery.",2.605457000925383e-07,0.09212800573520497,0.15306122448979592,0.019947691112600648,0.11808108039753584,0.14876033057851237,0.019918816950481588,0.19582357149890983,0.10380622837370242,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
16,0.7,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage effective in treating postoperative cerebrospinal fluid fistula occurring after spine surgery? Yes, it is generally effective and considered a dependable management technique for CSF leaks.",3.079176455639089e-07,0.11578371588562852,0.1875,0.023574544042164407,0.1921890525512575,0.14876033057851237,0.023540420032387335,0.2727846126350393,0.10380622837370242,3.079176455639103e-07,0.35792925196547465,0.05387755102040818
16,0.7,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a successful approach for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is widely effective and serves as a reliable treatment for CSF leaks following spine surgery.",2.36859727356853e-07,0.010423200227803076,0.1875,0.018134264647818768,0.08298976058626684,0.14876033057851237,0.018108015409528715,0.15945592732803515,0.10380622837370242,2.3685972735685406e-07,0.2401462163090904,0.05387755102040818
16,0.7,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage an effective strategy for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is typically effective and used as a trusted way to manage CSF leaks after spine surgery.",2.131737546211677e-07,0.022352550344162392,0.1552777777777778,0.01632083818303689,0.049088208910585074,0.14876033057851237,0.01629721386857584,0.12436460751676615,0.10380622837370242,2.1317375462116866e-07,0.2037785721382157,0.05387755102040818
17,0.7,1,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are increased depression rates in women explained by differences in symptom reporting? Differential symptom reporting does play a role, as women may be more inclined to report symptoms or seek assistance. However, it",1.894877818854824e-07,0.04985675617422425,0.12244897959183673,0.014507411718255009,0.12293641386604559,0.0763888888888889,0.014486412327622968,0.1634259169526584,0.05246913580246914,1.8948778188548325e-07,0.20615466749235,0.027006172839506164
17,0.7,2,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Do higher depression rates among women result from varying symptom reporting? Differential symptom reporting contributes since women might report symptoms or seek help more often. Nevertheless, it",3.316036182995942e-07,0.2574961209524682,0.12244897959183673,0.025387970506946286,0.3380477934829922,0.0763888888888889,0.02535122157334021,0.3865694682668681,0.05246913580246914,3.316036182995957e-07,0.4379562815496736,0.027006172839506164
17,0.7,3,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the higher incidence of depression in women due to differences in how they report symptoms? Yes, differential symptom reporting is a factor because women are more likely to report symptoms or seek help. However, it",1.184298636784265e-07,0.03975540251546272,0.12244897959183673,0.00906713232390937,0.0305630937350303,0.0763888888888889,0.009054007704764347,0.06811573714833319,0.05246913580246914,1.1842986367842703e-07,0.10771459467909672,0.027006172839506164
17,0.7,4,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Can the elevated rates of depression in women be explained by differences in symptom reporting? Differential symptom reporting does have an effect since women tend to report symptoms or seek help more frequently. Yet, it",1.421158364141118e-07,0.010767865642211216,0.12244897959183673,0.01088055878869125,0.06041605688471208,0.0763888888888889,0.01086480924571722,0.09888739581508688,0.05246913580246914,1.4211583641411244e-07,0.13946329299367655,0.027006172839506164
17,0.7,5,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are greater depression rates in women attributable to differential symptom reporting? Yes, because women may be more prone to report symptoms or seek help, differential symptom reporting contributes. Still, it",2.605457000925383e-07,0.19610008281919766,0.08801020408163264,0.019947691112600648,0.22471910817598806,0.0763888888888889,0.019918816950481588,0.26878643261048385,0.05246913580246914,2.6054570009253947e-07,0.3153539594573407,0.027006172839506164
17,0.7,6,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Does differential symptom reporting account for the higher depression rates in women? It does contribute, as women may be more likely to report symptoms or seek assistance. However, it",2.842316728282236e-07,0.18338814879874654,0.12244897959183673,0.021761117577382527,0.26108675234686274,0.0763888888888889,0.02172961849143446,0.30652676059333084,0.05246913580246914,2.8423167282822487e-07,0.35457467261062314,0.027006172839506164
17,0.7,7,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the increased depression prevalence in women due to differential symptom reporting? Differential symptom reporting partially explains it because women might be more willing to report symptoms or ask for help. However, it",1.894877818854824e-07,0.09317845495922183,0.09123149780203443,0.014507411718255009,0.12293641386604559,0.0763888888888889,0.014486412327622968,0.1634259169526584,0.05246913580246914,1.8948778188548325e-07,0.20615466749235,0.027006172839506164
17,0.7,8,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are the higher depression rates among women explained by differences in symptom reporting? Differential symptom reporting plays a part since women are more likely to report symptoms or seek help. Nonetheless, it",2.131737546211677e-07,0.08160545448880407,0.12244897959183673,0.01632083818303689,0.1557262366890373,0.0763888888888889,0.01629721386857584,0.19732746862834016,0.05246913580246914,2.1317375462116866e-07,0.24124598730361901,0.027006172839506164
17,0.7,9,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Do women report depression symptoms differently, accounting for their higher depression rates? Differential symptom reporting does contribute since women tend to report symptoms or seek help more often. However, it",2.605457000925383e-07,0.14829682898747754,0.12244897959183673,0.019947691112600648,0.22471910817598806,0.0763888888888889,0.019918816950481588,0.26878643261048385,0.05246913580246914,2.6054570009253947e-07,0.3153539594573407,0.027006172839506164
17,0.7,10,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the disparity in depression rates between women and men due to differential symptom reporting? Differential symptom reporting is a factor because women may be more likely to disclose symptoms or seek help. Yet, it",1.421158364141118e-07,0.030005497920138513,0.09306422293435279,0.01088055878869125,0.06041605688471208,0.0763888888888889,0.01086480924571722,0.09888739581508688,0.05246913580246914,1.4211583641411244e-07,0.13946329299367655,0.027006172839506164
18,0.7,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a link between crime and over-the-counter pharmacy syringe sales? Our research shows no connection between OTC pharmacy syringe sales and rises in reported crime in Los Angeles communities from 2006 to 2008.,0.0,0.042008920033936636,0.030080360626951082,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,0.7,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does selling syringes over the counter at pharmacies relate to crime rates? Findings indicate OTC pharmacy syringe sales did not cause an increase in reported crime in Los Angeles neighborhoods between 2006 and 2008.,0.0,0.08401784006787238,0.06035379812695108,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,0.7,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales tied to crime levels? Our study found no association between OTC syringe sales and higher reported crime in Los Angeles areas during 2006-2008.,1.421158364141118e-07,0.16799709099131155,0.023371549606241035,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
18,0.7,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime correlated with the sale of syringes over the counter at pharmacies? Data reveals that OTC pharmacy syringe sales did not lead to more reported crime in Los Angeles communities from 2006 to 2008.,2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.7,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Do over-the-counter pharmacy syringe sales influence crime rates? Results show no evidence that OTC syringe sales increased reported crime in local Los Angeles communities between 2006 and 2008.,1.421158364141118e-07,0.16799709099131155,0.023371549606241035,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
18,0.7,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there an association between crime and OTC pharmacy syringe sales? The evidence demonstrates that selling syringes OTC at pharmacies was not linked to increased reported crime in Los Angeles from 2006 through 2008.,0.0,0.08401784006787238,0.06035379812695108,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,0.7,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are crime rates affected by over-the-counter pharmacy syringe sales? Our findings indicate no rise in reported crime related to OTC syringe sales in Los Angeles communities during 2006-2008.,1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
18,0.7,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does the sale of syringes over the counter at pharmacies impact crime? Research confirms OTC pharmacy syringe sales did not correspond with an increase in reported crime in Los Angeles localities between 2006 and 2008.,2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.7,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a relationship between crime and OTC pharmacy syringe sales? The study showed no association between OTC pharmacy syringe sales and increased crime reports in Los Angeles communities from 2006 to 2008.,2.36859727356853e-08,0.03339721616887559,0.0018684240952711456,0.0018134264647818796,0.07646787125393084,0.0322222222222222,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
18,0.7,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales connected to crime trends? Findings demonstrate that such sales were not linked to a rise in reported crime in Los Angeles neighborhoods during 2006-2008.,1.184298636784265e-07,0.0802852112234036,0.06035379812695108,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
19,0.7,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is it necessary to have an expert breast pathology assessment for managing ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is crucial for the management of ductal carcinoma in situ (DCIS).",9.47438909427412e-08,0.15818340046892754,0.018246882086167843,0.007253705859127518,0.15209783496094786,0.012853269916765775,0.007243206163811494,0.1447754011384994,0.004760026298487846,9.474389094274162e-08,0.14310084364067244,0.0
19,0.7,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Does managing ductal carcinoma in situ require expert breast pathology assessment? Answer: Yes, managing ductal carcinoma in situ (DCIS) necessitates expert breast pathology evaluation.",1.184298636784265e-07,0.2967993207598987,0.05729166666666666,0.009067132323909398,0.28927342705374937,0.06060498614958448,0.009054007704764368,0.2794769371507888,0.05301775147928995,1.1842986367842703e-07,0.27958811749424584,0.047500000000000014
19,0.7,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert assessment in breast pathology needed for the treatment of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is vital for treating ductal carcinoma in situ (DCIS).",2.36859727356853e-08,0.1342883847222942,0.06616512345679011,0.0018134264647818796,0.13581960467096543,0.07116122448979594,0.0018108015409528735,0.08771187976790795,0.03698224852071005,2.3685972735685406e-08,0.03774032798284699,0.0
19,0.7,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology evaluation required in the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology evaluation plays an essential role in managing ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.08211177896051769,0.009605111768573316,0.003626852929563759,0.07889497406637869,0.006834567901234587,0.003621603081905747,0.07499994574745683,0.0025434730105059547,4.737194547137081e-08,0.07410797215372167,0.0
19,0.7,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: For the management of ductal carcinoma in situ, is expert breast pathology assessment necessary? Answer: Yes, it is necessary to have expert breast pathology assessment for effectively managing ductal carcinoma in situ (DCIS).",9.47438909427412e-08,0.15818340046892754,0.018246882086167843,0.007253705859127518,0.15209783496094786,0.012853269916765775,0.007243206163811494,0.1447754011384994,0.004760026298487846,9.474389094274162e-08,0.14310084364067244,0.0
19,0.7,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is specialized breast pathology assessment important for managing ductal carcinoma in situ? Answer: Yes, specialized breast pathology assessment is key to the management of ductal carcinoma in situ (DCIS).",0.0,0.0,0.0,0.0,0.0,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0
19,0.7,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Does ductal carcinoma in situ management require expert breast pathology analysis? Answer: Yes, expert breast pathology analysis is indispensable for the management of ductal carcinoma in situ (DCIS).",2.36859727356853e-08,0.043627615138362774,0.0052017695862214275,0.0018134264647818796,0.04186881227055794,0.003774999999999973,0.0018108015409528735,0.03971510627504049,0.0014177514792899637,2.3685972735685406e-08,0.03922071315328246,0.0
19,0.7,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert evaluation by a breast pathologist essential for managing ductal carcinoma in situ? Answer: Yes, expert evaluation by a breast pathologist is essential in the management of ductal carcinoma in situ (DCIS).",9.47438909427412e-08,0.07416556040105515,0.03181500657462194,0.007253705859127518,0.06545443739095536,0.04529163237311387,0.007243206163811494,0.055337055259796486,0.058681016785412425,9.474389094274162e-08,0.05068121956601335,0.06632653061224487
19,0.7,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology assessment mandatory for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is mandatory in the management of ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.0520457398575358,0.06191254463348045,0.003626852929563759,0.05973446204561039,0.08189999999999997,0.003621603081905747,0.06840981574770355,0.09741775147928997,4.737194547137081e-08,0.02491305364055707,0.07100591715976333
19,0.7,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: For effective management of ductal carcinoma in situ, is expert breast pathology assessment required? Answer: Yes, expert breast pathology assessment is required for the effective management of ductal carcinoma in situ (DCIS).",7.10579182070559e-08,0.009117248308118331,0.057291666666666685,0.005440279394345639,0.01800080463474929,0.07679999999999995,0.005432404622858621,0.02813449689445946,0.09319526627218938,7.105791820705622e-08,0.01359278430155042,0.06858710562414266
20,0.7,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an initial night effect on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, a single night of sleep recording might be adequate for patients with moderate to high frequency SB. However, low RMMA frequency during the first night should be verified.",4.737194547137081e-08,0.09917998252271865,0.07849583262225047,0.0036268529295637453,0.08862874111785457,0.037512082129886465,0.003621603081905733,0.06319776905997099,0.018860946745562133,4.737194547137081e-08,0.03774032798284743,0.0
20,0.7,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does sleep bruxism exhibit a first night effect? Results revealed no significant first night impact on RMMA frequency severity in young, healthy SB patients. For clinical purposes, one night of sleep monitoring may suffice for those with moderate to high SB frequency. Nevertheless, a low RMMA frequency in the initial night needs confirmation.",7.105791820705622e-08,0.05133723419580116,0.10987155351936687,0.005440279394345618,0.0198579395556,0.05536332179930796,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.7,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night impact on sleep bruxism? The study showed no overall first night effect on RMMA frequency severity in young and healthy SB patients. In practice, recording sleep for just one night might be enough for patients with moderate to high frequency SB. Still, low RMMA frequency on the first night should be confirmed.",2.3685972735685406e-08,0.095154734040102,0.05713591806190872,0.0018134264647818726,0.0953654920637459,0.05536332179930796,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
20,0.7,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night influence sleep bruxism? The results demonstrated no overall first night effect on RMMA frequency severity among young, healthy SB patients. Clinically, one night of sleep recording may be sufficient for moderate to high frequency SB patients. However, low RMMA frequency during the first night requires confirmation.",1.4211583641411244e-07,0.10690431420952828,0.0020938675689536612,0.010880558788691236,0.06964781478416482,0.034539419581109676,0.0108648092457172,0.0939878144624422,0.018860946745562133,1.4211583641411244e-07,0.12260232209233335,0.0
20,0.7,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first-night effect on sleep bruxism? The findings indicated no overall first night effect on the severity of RMMA frequency in young, healthy patients with SB. One night of sleep recording may be adequate clinically for moderate to high frequency SB patients, but low RMMA frequency on the first night should be confirmed.",2.3685972735685406e-08,0.039708104873808825,0.0746715535193669,0.0018134264647818726,0.0583242203833958,0.05536332179930796,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
20,0.7,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is a first night effect present in sleep bruxism? The study found no overall first night impact on RMMA frequency severity in young, healthy SB patients. For clinical practice, a single night of sleep recording could be enough for moderate to high frequency SB sufferers. Low RMMA frequency on the first night, however, should be validated.",0.0,0.11033501069534779,0.1119596987667859,0.0,0.07701635339555013,0.05536332179930796,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
20,0.7,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is sleep bruxism affected by a first night effect? Results showed no general first night effect on the severity of RMMA frequency in young and healthy patients with SB. Clinically, one night of sleep recording might suffice for those with moderate to high frequency SB. Confirmation is needed if low RMMA frequency appears on the first night.",2.3685972735685406e-08,0.10449845089304066,0.09487176711851247,0.0018134264647818726,0.0953654920637459,0.05536332179930796,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
20,0.7,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an initial night influence on sleep bruxism? The results showed no significant first night effect on RMMA frequency severity in young, healthy SB patients. In clinical settings, one night of sleep recording may be sufficient for moderate to high frequency SB patients. Still, low RMMA frequency during the first night should be verified.",2.3685972735685406e-08,0.06538022267232524,0.09290823172005892,0.0018134264647818726,0.0583242203833958,0.05536332179930796,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
20,0.7,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night affect sleep bruxism severity? Findings showed no overall first night effect on RMMA frequency severity in young, healthy SB patients. For clinical purposes, one night of sleep recording can be enough for patients with moderate to high SB frequency, but low RMMA frequency on the first night needs confirmation.",7.105791820705622e-08,0.012044243996589987,0.030215997963811303,0.005440279394345618,0.007324302819299522,0.03576332179930797,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.7,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is the first night effect evident in sleep bruxism? The study revealed no overall first night impact on the severity of RMMA frequency in young and healthy SB patients. One night of sleep recording may be sufficient clinically for moderate to high frequency SB patients, yet low RMMA frequency on the first night should be confirmed.",0.0,0.02520535202036145,0.01827155351936688,0.0,0.05134423559703327,0.036851395847011775,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
21,0.7,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns result in less pain? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not lead to lower cumulative opioid use.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.7,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced with minimal access major surgery in neonates? The cumulative opioid doses do not decrease with minimal access surgery for esophageal atresia or congenital diaphragmatic hernia.,1.184298636784265e-07,0.22926580920446593,0.04238251821019768,0.009067132323909398,0.2292096803528909,0.03840000000000001,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.7,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does undergoing minimal access major surgery as a newborn cause less pain? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia are not linked to reduced overall opioid requirements.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.7,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is minimal access major surgery less painful for newborns? Minimal access surgical repair of esophageal atresia or congenital diaphragmatic hernia is not connected to less total opioid consumption.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.7,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns cause less pain? The cumulative amount of opioids used does not reduce with minimal access repair of esophageal atresia or congenital diaphragmatic hernia.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.7,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in neonates result in less pain? There is no association between minimal access surgery for esophageal atresia or congenital diaphragmatic hernia and decreased cumulative opioid dosage.,4.73719454713706e-08,0.06742663438990348,0.0020762161887946107,0.003626852929563759,0.06669137449867346,0.0,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
21,0.7,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain from minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not correspond to lower cumulative opioid doses.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.7,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery cause less pain in newborns undergoing major procedures? The total opioid dose is not less after minimal access repair of esophageal atresia or congenital diaphragmatic hernia.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.7,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is the pain less when newborns have minimal access major surgery? Minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia does not result in reduced cumulative opioid use.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.7,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in the newborn lead to less pain? The repair of esophageal atresia or congenital diaphragmatic hernia via minimal access surgery is not associated with decreased total opioid consumption.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.7,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites representative of community practice? Answer: Yes, family practice at residency teaching sites typically mirrors community practice. Residency programs aim to ready physicians for community settings by familiarizing them with prevalent health concerns.",2.36859727356853e-08,0.029761059141726776,0.0029835463597203127,0.0018134264647818726,0.029717171588468982,0.002581738577784029,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.7,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching locations mirror community practice? Answer: Yes, family practice at residency teaching sites generally reflects community practice. These residency programs are meant to train physicians for community health by involving them in common health issues.",0.0,0.03465735902799727,0.023683547493071277,0.0,0.035546009259483924,0.024835600907029506,0.0,0.03648143055578723,0.025898211136306366,0.0,0.037467415165403306,0.026871378180902013
22,0.7,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice in residency teaching sites similar to community practice? Answer: Yes, family practice at residency teaching sites usually represents community practice. Residency programs prepare physicians for community roles by exposing them to typical health challenges.",7.10579182070559e-08,0.017076991825933696,0.041999152602217385,0.005440279394345618,0.023633152666627133,0.07346938775510208,0.0054324046228586,0.027206193430387327,0.0783673469387755,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
22,0.7,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does residency site family practice align with community practice? Answer: Yes, family practice at residency teaching sites often aligns with community practice. Residency programs are structured to equip physicians for community healthcare by focusing on common health problems.",4.73719454713706e-08,0.04903063964086263,0.06997984378936759,0.0036268529295637453,0.0895403035525173,0.1012244897959184,0.003621603081905733,0.05537707039708417,0.0783673469387755,4.737194547137081e-08,0.019364979175993557,0.05387755102040818
22,0.7,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency training sites consistent with community practice? Answer: Yes, family practice at residency training sites often corresponds with community practice. These programs aim to prepare physicians for community health by addressing frequent health issues.",4.73719454713706e-08,0.09689508258228452,0.029894770408163268,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.7,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice during residency training reflect the realities of community practice? Answer: Yes, family practice at residency training sites frequently reflects community practice. Residency programs are designed to expose physicians to common health concerns found in the community.",2.36859727356853e-08,0.07687696863672544,0.07131676629746128,0.0018134264647818726,0.11620855063467816,0.1012244897959184,0.0018108015409528666,0.08277604458519949,0.0783673469387755,2.3685972735685406e-08,0.0475358561426904,0.05387755102040818
22,0.7,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice in residency programs representative of community practice? Answer: Yes, family practice at residency programs often reflects community practice. The training exposes physicians to the typical health issues prevalent in community settings.",1.421158364141118e-07,0.07077886148248869,0.06385522959183673,0.01088055878869125,0.024870047625228153,0.1012244897959184,0.01086480924571722,0.062405965259299645,0.0783673469387755,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
22,0.7,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family medicine at residency teaching sites represent community practice? Answer: Yes, family medicine at residency teaching sites generally represents community practice. Residency training prepares physicians by involving them with common health problems in the community.",9.47438909427412e-08,0.12461460400671376,0.01282677483063982,0.0072537058591274906,0.12446318887313934,0.011158444647369814,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,0.7,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is the family practice experienced at residency sites reflective of community practice? Answer: Yes, family practice experienced at residency sites often reflects community practice. The residency curriculum is designed to prepare physicians for community health needs by focusing on common conditions.",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
22,0.7,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency centers match community practice? Answer: Yes, family practice at residency centers frequently matches community practice. Residency programs aim to ready physicians by exposing them to prevalent health concerns in community settings.",9.47438909427412e-08,0.0861064273089398,0.013073979591836732,0.0072537058591274906,0.08485477855542811,0.0162635522959184,0.007243206163811473,0.08332807056756408,0.019773596938775506,9.474389094274162e-08,0.08148444088087547,0.023604113520408178
23,0.7,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a connection between the length of psychological treatment for depression and the likelihood of returning to treatment? Yes, the duration of psychological treatment for depression may be linked to a return to treatment. Lengthier treatment periods often suggest more severe or chronic cases that may require repeated therapy sessions. Nonetheless, this relationship can also vary based on individual patient responses and other factors.",1.6580180914979784e-07,0.19943509388213254,0.05817777777777776,0.012693985253473108,0.15079004425447806,0.0235059171597633,0.012675610786670066,0.15069808293435427,0.022141683103221607,1.6580180914979784e-07,0.15050791613852965,0.020593359631821156
23,0.7,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the length of psychological therapy for depression affect the chances of coming back for more treatment? Indeed, the duration of depression therapy can be associated with a return to treatment. Extended treatment times might reflect more serious or ongoing conditions, necessitating multiple therapy visits. However, this can also depend on how each patient responds and other variables.",0.0,0.17024667592700382,0.12039999999999998,0.0,0.0990210257942783,0.07100591715976332,0.0,0.07561605606108524,0.05436390532544381,0.0,0.051344235597033716,0.036982248520710054
23,0.7,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the time span of psychological treatment for depression related to the likelihood of re-entering treatment? Yes, the duration of psychological treatment for depression can be related to returning to treatment. Longer treatment durations may indicate more severe or persistent conditions requiring repeated therapy. Still, this depends on individual patient reactions and other influencing factors.",7.105791820705622e-08,0.012181134335854882,0.028771511870054098,0.005440279394345618,0.03450824352761206,0.014605917159763289,0.0054324046228586,0.033792424479184735,0.015963905325443797,7.105791820705622e-08,0.032996420617815936,0.01738224852071006
23,0.7,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the duration of psychological treatment for depression influence the probability of returning to therapy? Yes, the length of psychological treatment for depression can be connected to a return to treatment. Prolonged therapy sessions might signal severe or chronic issues that need ongoing care. However, individual patient responses and additional factors also play a role.",7.105791820705622e-08,0.013490983462661976,0.046799999999999994,0.005440279394345618,0.03450824352761206,0.014605917159763289,0.0054324046228586,0.033792424479184735,0.015963905325443797,7.105791820705622e-08,0.032996420617815936,0.01738224852071006
23,0.7,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a relationship between how long psychological treatment for depression lasts and the chance of needing more treatment? Yes, the duration of psychological treatment for depression can be related to the likelihood of returning to treatment. Longer treatments may point to chronic or severe conditions requiring recurrent therapy, though this also depends on individual differences and other factors.",2.3685972735685406e-08,0.11593353789129157,0.06882975206611566,0.0018134264647818726,0.0680786954859629,0.03596459484571371,0.0018108015409528666,0.06887930511519391,0.03651266565602232,2.3685972735685406e-08,0.06969337426522948,0.036982248520710054
23,0.7,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Can the duration of psychological treatment for depression impact the likelihood of returning to treatment? Yes, longer psychological treatment durations for depression may be associated with returning to therapy. Extended treatment could reflect severe or chronic cases that necessitate repeated sessions, but patient-specific responses and other factors also influence this.",1.8948778188548325e-07,0.06585945876344335,0.0594359168241966,0.014507411718254981,0.0551296540329802,0.07100591715976332,0.014486412327622933,0.08156952746132795,0.05436390532544381,1.8948778188548325e-07,0.10899841447814707,0.036982248520710054
23,0.7,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the length of psychological treatment for depression connected to the chances of going back into treatment? Yes, the duration of psychological treatment for depression can relate to returning to treatment. Longer periods may indicate chronic or severe conditions needing repeated therapy, although individual patient responses and other elements also matter.",1.6580180914979784e-07,0.07168513536899201,0.041004914933837414,0.012693985253473108,0.11938553179676825,0.010041833983959941,0.012675610786670066,0.11827838331015661,0.012776003624120548,1.6580180914979784e-07,0.11698783396186219,0.015715707877987952
23,0.7,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the amount of time spent in psychological treatment for depression affect the likelihood of returning for treatment? Yes, the duration of psychological treatment for depression can be linked to a return to treatment. Longer treatment durations may signify serious or chronic conditions requiring multiple therapy sessions, but individual responses and other factors also influence this outcome.",2.3685972735685406e-08,0.07828132948189426,0.06700021359914557,0.0018134264647818726,0.03059181625087648,0.03469406240718233,0.0018108015409528666,0.03159479959437261,0.03585197937314763,2.3685972735685406e-08,0.03265210258487938,0.036982248520710054
23,0.7,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the duration of psychological therapy for depression associated with the likelihood of resuming treatment? Yes, the length of psychological treatment for depression can be associated with returning to treatment. Extended treatment often suggests chronic or severe conditions that may require repeated therapy, but this also depends on individual patient responses and other factors.",9.474389094274162e-08,0.019017829505712847,0.06399999999999995,0.0072537058591274906,0.024913053640556626,0.07100591715976332,0.007243206163811466,0.000108503552939343,0.05436390532544381,9.474389094274162e-08,0.025616805539096177,0.036982248520710054
23,0.7,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the length of psychological treatment for depression related to the chance of needing further treatment? Yes, longer psychological treatment durations for depression might be related to a return to therapy. This may reflect more severe or chronic conditions requiring ongoing sessions, although individual differences and other factors also play a role.",1.4211583641411244e-07,0.02252568630792018,0.06180624999999998,0.010880558788691236,0.014307659512725834,0.07100591715976332,0.0108648092457172,0.03989683106075903,0.05436390532544381,1.4211583641411244e-07,0.06643880005935054,0.036982248520710054
24,0.7,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a new surgical technique targeting the temporomandibular joint to enhance access and minimize complications? Answer: The VMPA offers direct access and excellent visibility to the TMJ area, delivering favorable aesthetic and functional outcomes. It can be regarded as the preferred approach for standard TMJ surgeries.",2.3685972735685406e-08,0.10785209564055176,0.062245322543618004,0.0018134264647818726,0.05054903390251164,0.021266540642722105,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
24,0.7,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical method for the temporomandibular joint improve surgical access and decrease complications? Answer: The VMPA provides direct access and clear visibility to the TMJ region, resulting in good aesthetic and functional results. It is considered the approach of choice for routine TMJ surgeries.",4.737194547137081e-08,0.04282808173713892,0.06091623303744516,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.7,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does a novel surgical technique for the temporomandibular joint enhance access and reduce complication rates? Answer: The VMPA grants direct access and favorable visualization of the TMJ area, producing positive esthetic and functional outcomes. It is regarded as the preferred approach for common TMJ procedures.",7.105791820705622e-08,0.020179467597532863,0.06043388429752067,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.7,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical approach to the temporomandibular joint improve accessibility and lower the risk of complications? Answer: The VMPA enables direct access and good visibility to the TMJ region, resulting in satisfactory aesthetic and functional results. This method is considered the standard approach for typical TMJ surgeries.",0.0,0.0866433975699934,0.06182072588097527,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
24,0.7,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is a novel surgical approach to the temporomandibular joint capable of enhancing access and reducing complications? Answer: The VMPA allows for direct access and optimal visibility of the TMJ region, providing favorable esthetic and functional outcomes. It is recognized as the approach of choice for usual TMJ surgeries.",0.0,0.0866433975699934,0.06182072588097527,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
24,0.7,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel technique in TMJ surgery improve access and minimize surgical complications? Answer: The VMPA provides direct and clear access to the TMJ area with good visibility, leading to excellent esthetic and functional results. It is considered the preferred method for common TMJ operations.",7.105791820705622e-08,0.05098600895575256,0.08264462809917356,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.7,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Will a new surgical method for the temporomandibular joint improve surgical access and reduce complication risks? Answer: The VMPA offers direct access and favorable visualization of the TMJ region, yielding good esthetic and functional outcomes. This approach is favored for typical TMJ surgeries.",1.1842986367842703e-07,0.026715768867978884,0.05940199771368603,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.7,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel surgical approach to the TMJ improve access and lower complication rates? Answer: The VMPA provides direct access and clear visibility to the TMJ area, resulting in good esthetic and functional results. It is widely regarded as the best approach for common TMJ surgeries.",4.737194547137081e-08,0.017445586137639246,0.017744682182461807,0.0036268529295637453,0.04479602859327958,0.0009442031589307863,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.7,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does a new surgical approach to the temporomandibular joint offer better access and fewer complications? Answer: The VMPA facilitates direct access and excellent visibility of the TMJ region, achieving positive esthetic and functional outcomes. It is considered the preferred approach for standard TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.7,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel TMJ surgical approach enhance access and reduce complications? Answer: The VMPA allows direct access and optimal visibility to the TMJ region, producing favorable esthetic and functional results. It is seen as the approach of choice for common TMJ surgical procedures.",1.1842986367842703e-07,0.05895517261495309,0.03624367628477735,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
25,0.7,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare professionals consider it acceptable to break confidentiality to safeguard a patient's wife from a sexually transmitted infection?,7.105791820705602e-07,0.8057564678762041,0.05859375,0.05440279394345628,0.8608389574293596,0.039930555555555566,0.05432404622858611,0.9190895972886786,0.020399305555555556,7.10579182070562e-07,0.9808292530117262,0.0
25,0.7,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable for French health professionals and non-experts to breach confidentiality to protect a patient's spouse from an STD?,7.579511275419309e-07,0.9058399264331856,0.05859375,0.05802964687302004,0.966199473087185,0.039930555555555566,0.057945649310491856,1.0303152323989027,0.020399305555555556,7.579511275419328e-07,1.09861228866811,0.0
25,0.7,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do individuals and medical practitioners in France find it permissible to violate confidentiality to defend a patient's wife against a sexually transmitted disease?,6.868932093348749e-07,0.7592364522413102,0.05859375,0.052589367478674404,0.8120487932599283,0.039930555555555566,0.052513244687633236,0.8677963029011284,0.020399305555555556,6.868932093348767e-07,0.9267620317414509,0.0
25,0.7,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French health workers and laypeople agreeable to breaching patient confidentiality to protect the patient's wife from a sexually transmitted infection?,7.342651548062455e-07,0.8545466320456354,0.05859375,0.05621622040823816,0.9121322518169097,0.039930555555555566,0.05613484776953898,0.9731568185589539,0.020399305555555556,7.342651548062474e-07,1.037987666851675,0.0
25,0.7,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"In France, do both health professionals and laypeople support breaking confidentiality to shield a patient's wife from an STD?",7.816371002776163e-07,0.9599071477034609,0.05859375,0.05984307333780192,1.0233578869271338,0.039930555555555566,0.05975645085144472,1.0909398542153377,0.020399305555555556,7.816371002776181e-07,1.1631508098056806,0.0
25,0.7,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,How do French laypersons and medical professionals view breaching confidentiality to protect a patient's wife from sexually transmitted diseases?,7.816371002776163e-07,0.9599071477034609,0.05859375,0.05984307333780192,1.0233578869271338,0.039930555555555566,0.05975645085144472,1.0909398542153377,0.020399305555555556,7.816371002776181e-07,1.1631508098056806,0.0
25,0.7,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French healthcare providers and the general public accept breaching confidentiality to protect a patient's wife from an STD?,7.816371002776163e-07,0.9599071477034609,0.05859375,0.05984307333780192,1.0233578869271338,0.039930555555555566,0.05975645085144472,1.0909398542153377,0.020399305555555556,7.816371002776181e-07,1.1631508098056806,0.0
25,0.7,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it deemed acceptable by French laypeople and health experts to compromise confidentiality to protect a patient's spouse from a sexually transmitted disease?,6.868932093348749e-07,0.7592364522413102,0.05859375,0.052589367478674404,0.8120487932599283,0.039930555555555566,0.052513244687633236,0.8677963029011284,0.020399305555555556,6.868932093348767e-07,0.9267620317414509,0.0
25,0.7,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French health practitioners and laypeople influenced by circumstances when deciding if a doctor should breach confidentiality to protect a patient's wife from an STD?,6.395212638635043e-07,0.6722250752516805,0.05859375,0.048962514549110644,0.7210770150542003,0.039930555555555566,0.04889164160572749,0.7724861230968032,0.020399305555555556,6.39521263863506e-07,0.8266785731844695,0.0
25,0.7,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"In France, do most people consider situational factors when deciding if breaking confidentiality to protect a patient's wife from a sexually transmitted infection is justified?",6.395212638635043e-07,0.6722250752516805,0.05859375,0.048962514549110644,0.7210770150542003,0.039930555555555566,0.04889164160572749,0.7724861230968032,0.020399305555555556,6.39521263863506e-07,0.8266785731844695,0.0
26,0.7,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The insertion allele (I) of the ACE gene I/D polymorphism might be a candidate gene linked to insulin resistance, according to studies showing an association between the I allele and elevated risk.",4.5003348197802176e-07,0.20077692871902064,0.1875,0.034455102830855615,0.29258086485991575,0.1388888888888889,0.03440522927810451,0.3883806508280938,0.08264462809917357,4.500334819780227e-07,0.4589518421254968,0.04246913580246913
26,0.7,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Research suggests that the insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance due to its association with increased risk.,5.44777372920763e-07,0.3389272671998378,0.1875,0.04170880868998313,0.4356817085005882,0.1388888888888889,0.041648435441916,0.536800655946367,0.08264462809917357,5.447773729207643e-07,0.6131025219527557,0.04246913580246913
26,0.7,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",The I allele of the ACE gene I/D polymorphism is considered a potential candidate gene for insulin resistance based on findings that link it to a higher risk.,5.44777372920763e-07,0.3389272671998378,0.1875,0.04170880868998313,0.4356817085005882,0.1388888888888889,0.041648435441916,0.536800655946367,0.08264462809917357,5.447773729207643e-07,0.6131025219527557,0.04246913580246913
26,0.7,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Evidence indicates that the insertion allele (I) in the ACE gene I/D polymorphism may serve as a candidate gene for insulin resistance because of its connection with increased susceptibility.,5.210914001850777e-07,0.3025596230289631,0.1875,0.039895382225201254,0.3979413805177412,0.1388888888888889,0.03983763390096313,0.4975799427930845,0.08264462809917357,5.210914001850789e-07,0.5722805274325009,0.04246913580246913
26,0.7,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Studies have identified the insertion allele (I) of the ACE gene I/D polymorphism as a possible candidate gene for insulin resistance given its relationship with greater risk.,5.684633456564483e-07,0.3766675951826848,0.1875,0.04352223515476501,0.47490242165387064,0.1388888888888889,0.043459236982868875,0.5776226504666218,0.08264462809917357,5.684633456564497e-07,0.6556621363715514,0.04246913580246913
26,0.7,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The ACE gene I/D polymorphism's insertion allele (I) is thought to be a candidate gene for insulin resistance, supported by research associating it with increased risk.",5.921493183921336e-07,0.41588830833596724,0.1875,0.04533566161954689,0.5157244161741255,0.1388888888888889,0.04527003852382175,0.6201822648854174,0.08264462809917357,5.921493183921352e-07,0.7001138989423854,0.04246913580246913
26,0.7,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Findings show that the insertion allele (I) in the ACE gene I/D polymorphism might be a candidate gene for insulin resistance due to its correlation with heightened risk.,5.44777372920763e-07,0.3389272671998378,0.1875,0.04170880868998313,0.4356817085005882,0.1388888888888889,0.041648435441916,0.536800655946367,0.08264462809917357,5.447773729207643e-07,0.6131025219527557,0.04246913580246913
26,0.7,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The insertion allele (I) of the ACE gene I/D polymorphism is potentially a candidate gene for insulin resistance, based on research linking it to an increased risk.",5.684633456564483e-07,0.3766675951826848,0.1875,0.04352223515476501,0.47490242165387064,0.1388888888888889,0.043459236982868875,0.5776226504666218,0.08264462809917357,5.684633456564497e-07,0.6556621363715514,0.04246913580246913
26,0.7,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Research findings support that the insertion allele (I) of the ACE gene I/D polymorphism could be involved as a candidate gene for insulin resistance given its association with increased risk.,4.974054274493924e-07,0.2674683032176941,0.1875,0.038081955760419374,0.3615737363468665,0.1388888888888889,0.038026832360010254,0.4598396148102375,0.08264462809917357,4.974054274493935e-07,0.5330598142792184,0.04246913580246913
26,0.7,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The insertion allele (I) of the ACE gene I/D polymorphism may represent a candidate gene for insulin resistance, as studies have shown an association between this allele and elevated risk.",4.974054274493924e-07,0.2674683032176941,0.1875,0.038081955760419374,0.3615737363468665,0.1388888888888889,0.038026832360010254,0.4598396148102375,0.08264462809917357,4.974054274493935e-07,0.5330598142792184,0.04246913580246913
27,0.7,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a link between androgens and sexual desire in women? Yes, androgens like testosterone significantly influence female sexual desire and responsiveness. Low androgen levels are associated with reduced sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.7,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Do androgens affect women's sexual desire? Indeed, androgens such as testosterone play an important role in female sexual desire and responsiveness. Lower levels of these hormones can lead to diminished sexual desire, showing a positive correlation.",4.97405427449393e-07,0.1603209408997177,0.36246913580246926,0.03808195576041933,0.26030263922561403,0.22634676324128575,0.03802683236001021,0.3287539978666105,0.15104166666666666,4.974054274493935e-07,0.3999300212339123,0.07496876301541024
27,0.7,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is sexual desire in women correlated with androgens? Yes, androgens, including testosterone, are crucial for female sexual desire and responsiveness. Reduced levels may cause decreased desire, highlighting a positive correlation.",6.395212638635048e-07,0.3961764262343781,0.3280303602922652,0.04896251454911061,0.4544586536665718,0.22634676324128575,0.048891641605727454,0.5294246933287612,0.15104166666666666,6.39521263863506e-07,0.6075693860121563,0.07496876301541024
27,0.7,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens related to sexual desire in women? Yes, there is a connection; androgens like testosterone significantly impact female sexual desire and responsiveness. Low androgen levels can reduce sexual desire, implying a positive correlation.",5.447773729207636e-07,0.26117036095658674,0.33219569830246926,0.04170880868998309,0.3209272610420495,0.22634676324128575,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
27,0.7,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does a correlation exist between androgens and sexual desire in women? Yes, androgens such as testosterone play a key role in female sexual desire and responsiveness. Decreased hormone levels may result in lower sexual desire, indicating a positive correlation.",4.263475092423371e-07,0.11456427321853102,0.3361725689653619,0.03264167636607371,0.17574525119755036,0.22634676324128575,0.0325944277371516,0.2417426208769804,0.15104166666666666,4.263475092423373e-07,0.31031786254422533,0.07496876301541024
27,0.7,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there an association between androgens and sexual desire in women? Yes, androgens, including testosterone, have a major influence on female sexual desire and responsiveness. Low levels of these hormones may reduce sexual desire, suggesting a positive correlation.",4.500334819780224e-07,0.14221850491030796,0.3354629629629631,0.03445510283085558,0.20314422538566568,0.22634676324128575,0.034405229278104466,0.26991349784367724,0.15104166666666666,4.500334819780227e-07,0.33930539941747684,0.07496876301541024
27,0.7,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Do androgens correlate with sexual desire in women? Yes, androgens like testosterone are important for female sexual desire and responsiveness. A decrease in these hormone levels may lead to less sexual desire, showing a positive correlation.",4.97405427449393e-07,0.19992935121742894,0.3339224229997011,0.03808195576041933,0.26030263922561403,0.22634676324128575,0.03802683236001021,0.3287539978666105,0.15104166666666666,4.974054274493935e-07,0.3999300212339123,0.07496876301541024
27,0.7,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is female sexual desire linked to androgen levels? Yes, androgens such as testosterone are significant in female sexual desire and responsiveness. Lower androgen levels may correspond with reduced sexual desire, indicating a positive correlation.",5.447773729207636e-07,0.3031792809905234,0.3021153376755182,0.04170880868998309,0.3642489598270471,0.19512928145148345,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
27,0.7,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens connected to women's sexual desire? Yes, androgens including testosterone play a vital role in female sexual desire and responsiveness. Low hormone levels might cause decreased sexual desire, suggesting a positive correlation.",5.684633456564489e-07,0.24993309958940468,0.36246913580246926,0.04352223515476497,0.3526759593566293,0.22634676324128575,0.04345923698286883,0.42406417767093574,0.15104166666666666,5.684633456564497e-07,0.4983700940471656,0.07496876301541024
27,0.7,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a positive correlation between androgens and sexual desire in women? Yes, hormones like testosterone are crucial for female sexual desire and responsiveness, and lower androgen levels may lead to diminished sexual desire, indicating a positive link.",4.500334819780224e-07,0.17968592007571127,0.30859158478206106,0.03445510283085558,0.20314422538566568,0.22634676324128575,0.034405229278104466,0.26991349784367724,0.15104166666666666,4.500334819780227e-07,0.33930539941747684,0.07496876301541024
28,0.7,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Do sports medicine journals hold significance and practical use for both practitioners and athletes? Answer: Absolutely, sports medicine journals are extremely significant for practitioners and athletes. They deliver the latest research, innovative treatments, and preventive strategies for sports injuries. They also provide essential knowledge on improving athletic performance and nutrition.",1.4211583641411244e-07,0.17068246994449954,0.030244454504300564,0.010880558788691236,0.16680726825550485,0.02600164625884065,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
28,0.7,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals beneficial and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are very beneficial to practitioners and athletes. They supply current research findings, new treatment methods, and injury prevention techniques. Additionally, they offer important information on enhancing athletic performance and dietary practices.",7.105791820705622e-08,0.07400222907489118,0.00563007030827474,0.005440279394345618,0.07164642041470293,0.003012522062330082,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
28,0.7,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Is the content of sports medicine journals relevant and useful to practitioners and athletes? Answer: Certainly, sports medicine journals are highly relevant and useful for practitioners and athletes. They present updated studies, advancements in treatments, and ways to prevent sports injuries. They also deliver valuable insights on boosting athletic performance and nutrition.",1.8948778188548325e-07,0.15978331004190904,0.0050656405613399985,0.014507411718254981,0.18073983977491181,0.007250597795237512,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
28,0.7,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: How relevant and applicable are sports medicine journals to practitioners and athletes? Answer: Sports medicine journals are highly relevant and applicable to both practitioners and athletes. They provide the latest research, treatment improvements, and preventive guidelines for sports-related injuries. They also include valuable information on enhancing athletic performance and nutrition.",1.4211583641411244e-07,0.11523069549970355,0.008765432098765458,0.010880558788691236,0.1385155465999972,0.005658534430964771,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
28,0.7,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are practitioners and athletes able to benefit from sports medicine journals? Answer: Yes, practitioners and athletes greatly benefit from sports medicine journals. These journals offer up-to-date research, innovative treatment options, and injury prevention strategies. They also provide important insights on athletic performance and nutrition enhancement.",2.3685972735685406e-08,0.005533090837231747,0.019375000000000003,0.0018134264647818726,0.0070517443577089445,0.021415823914336725,0.0018108015409528666,0.008708906336779787,0.023242630385487524,2.3685972735685406e-08,0.024097551579060017,0.0
28,0.7,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Do sports medicine journals serve a relevant and practical purpose for practitioners and athletes? Answer: Indeed, sports medicine journals serve an important and practical role for practitioners and athletes. They contain the latest research data, new treatment approaches, and preventive measures for sports injuries. Furthermore, they offer critical insights into improving athletic performance and nutrition.",2.6054570009253947e-07,0.19793819929384782,0.017455226988754693,0.0199476911126006,0.2152463849691113,0.008962369984911754,0.019918816950481533,0.20646579788913222,0.018860946745562133,2.6054570009253947e-07,0.23767165187712003,0.0
28,0.7,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals important and applicable to athletes and practitioners? Answer: Yes, sports medicine journals are crucial and applicable to both athletes and practitioners. They provide updated research, treatment advancements, and injury prevention methods. They also deliver valuable knowledge on enhancing athletic performance and nutrition.",4.737194547137081e-08,0.01979435298569765,0.017079119571683538,0.0036268529295637453,0.048328098854266255,0.0020526554379765236,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.7,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Can sports medicine journals be considered relevant and useful for practitioners and athletes? Answer: Absolutely, sports medicine journals are relevant and useful for practitioners and athletes. They provide current research, treatment innovations, and preventive care strategies for sports injuries. They also offer valuable insights into athletic performance improvement and nutrition.",1.4211583641411244e-07,0.05977892105490801,0.046289886425094656,0.010880558788691236,0.053640381633472956,0.05432218868147152,0.0108648092457172,0.04688799505453023,0.06222222222222222,1.4211583641411244e-07,0.07758428559639308,0.04246913580246913
28,0.7,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: To what extent are sports medicine journals relevant and applicable to athletes and practitioners? Answer: Sports medicine journals are highly relevant and applicable to athletes and practitioners. They offer the latest research, advancements in treatment, and preventive techniques for sports-related injuries. They also provide valuable information on nutrition and athletic performance enhancement.",1.8948778188548325e-07,0.10646429615268227,0.04135802469135799,0.014507411718254981,0.09919311265021191,0.05047995555800456,0.014486412327622933,0.09117572547758446,0.05975554549569943,1.8948778188548325e-07,0.12166478809530323,0.040742417383431435
28,0.7,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals applicable and significant for athletes and practitioners? Answer: Yes, sports medicine journals are both applicable and significant for athletes and practitioners. They feature up-to-date research, treatment advancements, and preventive measures for injuries related to sports. Additionally, they provide valuable insights into nutrition and improving athletic performance.",1.4211583641411244e-07,0.05977892105490845,0.046289886425094684,0.010880558788691236,0.053640381633472956,0.05432218868147152,0.0108648092457172,0.04688799505453023,0.06222222222222222,1.4211583641411244e-07,0.07758428559639308,0.04246913580246913
29,0.7,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: Does the quantity of needles influence acupuncture treatment for neck pain? Answer: Yes, the number of needles applied in acupuncture for neck pain can be significant. It varies based on the pain's intensity and location. More needles may be necessary for severe or extensive pain.",2.3685972735685406e-08,0.06709218025173058,0.06273082319526385,0.0018134264647818726,0.06994676822260137,0.06632653061224489,0.0018108015409528666,0.008517171800753065,0.02271498107084911,2.3685972735685406e-08,0.023530497410194418,0.0
29,0.7,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: In acupuncture for neck pain, does the number of needles make a difference? Answer: Indeed, the needle count in acupuncture treatment for neck pain can matter. It depends on how severe and where the pain is located. More needles are often used for more intense or widespread pain.",4.737194547137081e-08,0.13548151905907968,0.06549121787036027,0.0036268529295637453,0.13590473601439745,0.06632653061224489,0.003621603081905733,0.07595845259628531,0.02271498107084911,4.737194547137081e-08,0.04546237407675724,0.0
29,0.7,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: Is the number of needles important in acupuncture for treating neck pain? Answer: Yes, the quantity of needles used for neck pain acupuncture can be important. This depends on the severity and location of the pain. Greater needle use may be required for intense or broad pain.",2.3685972735685406e-08,0.14269475020322986,0.08581257892896144,0.0018134264647818726,0.1143985307934341,0.06632653061224489,0.0018108015409528666,0.053979545877510304,0.02271498107084911,2.3685972735685406e-08,0.022989518224699523,0.0
29,0.7,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: When treating neck pain with acupuncture, does the number of needles used matter? Answer: Yes, it can matter. The amount of needles used depends on the pain's severity and location. More needles might be applied for more intense or widespread pain.",1.1842986367842703e-07,0.032009275274421434,0.05842691707332719,0.009067132323909363,0.060020770609720664,0.04134296716714297,0.009054007704764333,0.0891212977631648,0.02271498107084911,1.1842986367842703e-07,0.12361395596717584,0.0
29,0.7,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: Does the amount of needles used in acupuncture affect neck pain treatment? Answer: Yes, the number of needles can affect treatment outcomes. It depends on the pain’s severity and where it is located. More needles might be needed for severe or extensive pain.",7.105791820705622e-08,0.05100348514443853,0.08383648918619602,0.005440279394345618,0.023426752587707433,0.06632653061224489,0.0054324046228586,0.03911087718850137,0.02271498107084911,7.105791820705622e-08,0.07232066157962613,0.0
29,0.7,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: For acupuncture treatment of neck pain, does the needle count matter? Answer: Yes, the number of needles used can be important. It varies according to the severity and location of the pain. More needles might be required for intense or widespread pain.",9.474389094274162e-08,0.05971239148121832,0.10707911957168353,0.0072537058591274906,0.0006707989913525836,0.06632653061224489,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
29,0.7,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: Is the number of acupuncture needles significant in treating neck pain? Answer: Yes, it can be. The severity and location of the neck pain determine the number of needles used. More needles could be utilized for more severe or widespread pain.",1.1842986367842703e-07,0.032009275274421434,0.05842691707332719,0.009067132323909363,0.060020770609720664,0.04134296716714297,0.009054007704764333,0.0891212977631648,0.02271498107084911,1.1842986367842703e-07,0.12361395596717584,0.0
29,0.7,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: In acupuncture treatment for neck pain, does the number of needles have an impact? Answer: Yes, the needle count can impact treatment. It depends on the pain severity and location. More needles may be applied if the pain is intense or widespread.",9.474389094274162e-08,0.026705382883126738,0.08328375966686498,0.0072537058591274906,0.0006707989913525836,0.06632653061224489,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
29,0.7,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: Does the quantity of needles used in acupuncture influence neck pain treatment? Answer: Yes, it does. The severity and location of the pain dictate how many needles are used. More needles might be necessary for severe or widespread pain.",1.6580180914979774e-07,0.014395580672505126,0.10707911957168353,0.012693985253473108,0.07665670596927399,0.06632653061224489,0.012675610786670066,0.14176503124858364,0.02271498107084911,1.6580180914979784e-07,0.17768117723745203,0.0
29,0.7,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Question: When using acupuncture to treat neck pain, is the number of needles important? Answer: Yes, it is. The number of needles depends on the pain’s location and severity. More needles might be used for more intense or widespread pain.",1.6580180914979774e-07,0.12103360845095734,0.03069023068279464,0.012693985253473108,0.14961956708084712,0.013857394809775749,0.012675610786670066,0.17923244641398606,0.004291191768657054,1.6580180914979784e-07,0.17768117723745203,0.0
30,0.7,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are patients at high risk of falls adequately prepared for discharge home after rehabilitation according to guidelines? Answer: Evidence shows that systematic falls risk assessment during rehabilitation for high-risk patients was limited. When risks were identified, strategies were usually implemented. However, some risk factors were not assessed, potentially restricting fall prevention measures. Inadequate assessment may have impacted outcomes.",1.1842986367842703e-07,0.0273316461485269,0.07877526753864447,0.009067132323909363,0.01700435780151377,0.048261993679977015,0.009054007704764333,0.04006989930308258,0.03274920999712727,1.1842986367842703e-07,0.0639064709709638,0.016661878770468257
30,0.7,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we follow guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: There was minimal evidence that systematic falls risk assessments were conducted for high fall-risk individuals during rehabilitation. Identified risks typically led to intervention strategies, but unassessed risk factors could have limited the scope of fall prevention efforts. Some assessments were insufficient.",1.8948778188548325e-07,0.07618888320614436,0.04246341278606348,0.014507411718254981,0.07107157907178863,0.048261993679977015,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
30,0.7,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Preparing high fall-risk patients for discharge post-rehabilitation: Are guidelines being met? Answer: Limited evidence exists that systematic falls risk assessments are performed during rehabilitation for high-risk individuals. When risks were detected, interventions were generally applied. However, neglecting to assess certain risk factors may have restricted the effectiveness of fall prevention strategies. Assessment gaps were noted.",1.8948778188548325e-07,0.025778179165421022,0.07877526753864447,0.014507411718254981,0.07107157907178863,0.048261993679977015,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
30,0.7,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines met in preparing high fall-risk patients for discharge after rehabilitation? Answer: There is little proof that people at high risk of falls underwent systematic risk assessments during rehabilitation. When risks were found, strategies were typically enacted. Nonetheless, failure to evaluate some risk factors might have limited the fall prevention strategies offered. Some risk assessments were incomplete.",1.1842986367842703e-07,0.020471607683193227,0.044336492028440394,0.009067132323909363,0.01700435780151377,0.048261993679977015,0.009054007704764333,0.04006989930308258,0.03274920999712727,1.1842986367842703e-07,0.0639064709709638,0.016661878770468257
30,0.7,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do patients at high risk of falls receive guideline-concordant preparation for discharge following rehabilitation? Answer: Evidence indicates few systematic falls risk assessments occur during rehabilitation for those at high risk. When risks are identified, strategies are commonly implemented. However, overlooking certain risk factors might have constrained fall prevention options. Inadequate assessment was a noted issue.",1.8948778188548325e-07,0.050983531185782915,0.06059968454824667,0.014507411718254981,0.07107157907178863,0.048261993679977015,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
30,0.7,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is preparation for discharge home after rehabilitation compliant with guidelines for patients at high risk of falls? Answer: Little evidence supports the use of systematic falls risk assessments during rehabilitation for high-risk patients. Identified risks often triggered strategies, but failure to assess some risk factors may have limited prevention measures. Assessment shortfalls were observed.",2.1317375462116866e-07,0.044127317833616786,0.07877526753864447,0.016320838183036854,0.08976371208394296,0.048261993679977015,0.0162972138685758,0.11417787145680425,0.03274920999712727,2.1317375462116866e-07,0.1394140234791097,0.016661878770468257
30,0.7,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are fall prevention guidelines followed when preparing patients at high risk of falls for discharge post-rehabilitation? Answer: Systematic falls risk assessment during rehabilitation appears limited among high-risk patients. When risks were recognized, interventions generally followed. However, unassessed risk factors possibly limited fall prevention strategies. Some assessments were inadequate.",3.552895910352811e-07,0.19079148601333173,0.05795136532044619,0.02720139697172809,0.20990802392600605,0.048261993679977015,0.027162023114293,0.2367801935491376,0.03274920999712727,3.552895910352811e-07,0.26457716643311535,0.016661878770468257
30,0.7,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we adhere to guidelines in preparing patients at high fall risk for discharge after rehabilitation? Answer: There was scant evidence that patients at high risk of falls received comprehensive falls risk assessments during rehabilitation. When a risk was identified, strategies were typically implemented, but failure to assess certain risk factors might have restricted prevention efforts. Assessment deficiencies were present.",7.105791820705622e-08,0.01502338578687823,0.045481569560047556,0.005440279394345618,0.0060146963255975905,0.03131787953015537,0.0054324046228586,0.004978579491813129,0.03274920999712727,7.105791820705622e-08,0.02818838836888471,0.016661878770468257
30,0.7,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Preparing patients at high risk of falls for discharge after rehabilitation: Are guidelines being followed? Answer: Evidence is limited that systematic falls risk assessments are conducted during rehabilitation for high-risk individuals. When risks are detected, interventions are usually applied; however, failure to assess some risk factors may have restricted fall prevention strategies offered. Some assessments were insufficient.",1.4211583641411244e-07,0.00993990343665807,0.07877526753864447,0.010880558788691236,0.03470393490091439,0.048261993679977015,0.0108648092457172,0.05808840480576105,0.03274920999712727,1.4211583641411244e-07,0.08225560963915957,0.016661878770468257
30,0.7,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are rehabilitation discharge preparations for patients at high fall risk aligned with guidelines? Answer: There is little evidence that systematic falls risk assessments were performed during rehabilitation for high-risk patients. Identified risks typically led to implementation of strategies, but failure to evaluate some risk factors could have limited fall prevention approaches. Assessment inadequacies were noted.",1.8948778188548325e-07,0.025778179165421022,0.07877526753864447,0.014507411718254981,0.07107157907178863,0.048261993679977015,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
31,0.7,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Yes, symptoms are important when selecting patients for Phase I clinical trials. The nature",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
31,0.7,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Should symptoms be considered when choosing patients for phase I clinical trials? Answer: Yes, symptoms should be considered when choosing patients for Phase I clinical trials. The nature",4.73719454713706e-08,0.05125696620119591,0.0073130193905817376,0.003626852929563759,0.05026203862567158,0.011433518005540294,0.003621603081905747,0.04893994957148795,0.016094182825484693,4.737194547137081e-08,0.04721740821418363,0.02129501385041549
31,0.7,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Do symptoms play a role in patient selection for phase I clinical trials? Answer: Yes, symptoms do play a role in patient selection for Phase I clinical trials. The nature",9.47438909427412e-08,0.1004456325292904,0.012210978574255182,0.007253705859127518,0.0987046211332836,0.01976118240463315,0.007243206163811494,0.09638841478059623,0.028316405047706827,9.474389094274162e-08,0.09337190799209338,0.037876646503476746
31,0.7,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Is it necessary to consider symptoms in patients for phase I clinical trials? Answer: Yes, it is necessary to consider symptoms in patients for Phase I clinical trials. The nature",9.47438909427412e-08,0.1004456325292904,0.012210978574255182,0.007253705859127518,0.0987046211332836,0.01976118240463315,0.007243206163811494,0.09638841478059623,0.028316405047706827,9.474389094274162e-08,0.09337190799209338,0.037876646503476746
31,0.7,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: When evaluating patients for phase I clinical trials, do symptoms matter? Answer: Yes, symptoms matter when evaluating patients for Phase I clinical trials. The nature",2.36859727356853e-08,0.0013017374025299233,0.016620498614958512,0.0018134264647818796,0.0030773269152089,0.022160664819944526,0.0018108015409528735,0.005157039315402567,0.02770083102493076,2.3685972735685406e-08,0.007602768775565316,0.03324099722991694
31,0.7,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Are symptoms a factor in considering patients for phase I clinical trials? Answer: Yes, symptoms are a factor in considering patients for Phase I clinical trials. The nature",4.73719454713706e-08,0.05125696620119591,0.0073130193905817376,0.003626852929563759,0.05026203862567158,0.011433518005540294,0.003621603081905747,0.04893994957148795,0.016094182825484693,4.737194547137081e-08,0.04721740821418363,0.02129501385041549
31,0.7,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Does the presence of symptoms affect patient selection for phase I clinical trials? Answer: Yes, the presence of symptoms affects patient selection for Phase I clinical trials. The nature",7.10579182070559e-08,0.10000635853581352,0.0031406837896746365,0.005440279394345639,0.14897625459294384,0.017719374556443207,0.005432404622858621,0.20121741850156205,0.0502385203881259,7.105791820705622e-08,0.2570589658129907,0.08981609726069563
31,0.7,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Should symptoms influence the selection of patients for phase I clinical trials? Answer: Yes, symptoms should influence the selection of patients for Phase I clinical trials. The nature",4.73719454713706e-08,0.05125696620119591,0.0073130193905817376,0.003626852929563759,0.05026203862567158,0.011433518005540294,0.003621603081905747,0.04893994957148795,0.016094182825484693,4.737194547137081e-08,0.04721740821418363,0.02129501385041549
31,0.7,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: When selecting patients for phase I clinical trials, is symptom consideration important? Answer: Yes, symptom consideration is important when selecting patients for Phase I clinical trials. The nature",4.73719454713706e-08,0.10076747909833506,0.01046475838719621,0.003626852929563759,0.15295050981973812,0.04044664728371594,0.003621603081905747,0.1555779773499415,0.045145486596002926,4.737194547137081e-08,0.15812095710377383,0.04843639110826224
31,0.7,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Is symptom evaluation significant in the process of selecting patients for phase I clinical trials? Answer: Yes, symptom evaluation is significant in the process of selecting patients for Phase I clinical trials. The nature",1.894877818854824e-07,0.19299008463341893,0.01684042959852114,0.014507411718255037,0.23226210296162897,0.018308518005540203,0.014486412327622988,0.22991980740511808,0.02831640504770694,1.8948778188548325e-07,0.22655344947964862,0.04039223607263773
32,0.7,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might enhance blood lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, possibly providing significant metabolic and cardiovascular benefits. Future prospective studies are needed to evaluate this metabolic impact of airway surgery in OSA.",9.474389094274162e-08,0.02437369452619853,0.07424173834314171,0.0072537058591274906,0.027313546264467803,0.039150354019158694,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
32,0.7,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery lower serum lipid concentrations in obstructive sleep apnea patients? Surgery may lead to improved blood lipid levels in individuals with OSA, especially when preoperative dyslipidemia is present, potentially offering substantial metabolic and cardiovascular advantages. Prospective research should be conducted to explore this metabolic effect of airway surgery in OSA.",2.3685972735685406e-08,0.08669720649106383,0.07546564056134,0.0018134264647818726,0.034561857453619726,0.039150354019158694,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
32,0.7,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is serum lipid reduction achievable through airway surgery in obstructive sleep apnea patients? Airway surgery could improve lipid levels in OSA patients, particularly those with existing dyslipidemia, which might result in major metabolic and cardiovascular benefits. Prospective studies should investigate this possible metabolic effect of airway surgery.",1.4211583641411244e-07,0.019441621306655943,0.0733372454996116,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.7,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does surgical intervention on the airway decrease serum lipid levels in obstructive sleep apnea? Surgery might positively influence blood lipid profiles in patients with OSA, especially those with preoperative dyslipidemia, potentially resulting in significant metabolic and cardiovascular improvements. This metabolic effect warrants further prospective study.",1.8948778188548325e-07,0.03375654994010002,0.09506564056134,0.014507411718254981,0.1162610322809634,0.039150354019158694,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.7,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery improve serum lipid levels in individuals with obstructive sleep apnea? Surgery may enhance blood lipid levels in OSA sufferers, particularly those exhibiting preoperative dyslipidemia, potentially yielding important metabolic and cardiovascular benefits. Prospective studies should assess this potential metabolic impact.",2.6054570009253947e-07,0.17199823233063372,0.046413438062983654,0.0199476911126006,0.22323905288858592,0.014166790574056773,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
32,0.7,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is there a reduction in serum lipid levels after airway surgery in obstructive sleep apnea patients? Airway surgery might improve blood lipid concentrations in OSA patients, especially those with dyslipidemia before surgery, potentially providing major benefits in metabolism and cardiovascular health. Prospective research is necessary to examine this metabolic effect.",7.105791820705622e-08,0.04558239259675689,0.07466633500578444,0.005440279394345618,0.006260137066634641,0.039150354019158694,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
32,0.7,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery have an effect on lowering serum lipid levels in patients with obstructive sleep apnea? Surgery may improve lipid profiles in OSA patients, particularly among those with preoperative dyslipidemia, possibly offering significant metabolic and cardiovascular benefits. Prospective studies should investigate this potential effect.",1.8948778188548325e-07,0.03375654994010002,0.09506564056134,0.014507411718254981,0.1162610322809634,0.039150354019158694,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.7,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can surgical treatment of the airway reduce serum lipid levels in obstructive sleep apnea patients? Surgery could improve blood lipid levels in patients with OSA, especially those who have dyslipidemia prior to surgery, potentially resulting in meaningful metabolic and cardiovascular benefits. Further prospective studies are needed to explore this.",9.474389094274162e-08,0.004507437997132602,0.053477738860016735,0.0072537058591274906,0.05680917096914628,0.017883813376436592,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
32,0.7,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is serum lipid level reduction a benefit of airway surgery in obstructive sleep apnea patients? Surgery may enhance lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, potentially yielding significant metabolic and cardiovascular improvements. Prospective studies should be performed to evaluate this effect.",2.1317375462116866e-07,0.056746068164799546,0.09506564056134,0.016320838183036854,0.13979152969115782,0.039150354019158694,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
32,0.7,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Surgery might improve blood lipid levels in OSA patients, especially those with preoperative dyslipidemia, potentially providing major metabolic and cardiovascular advantages. This potential effect should be further studied in prospective trials.",1.8948778188548325e-07,0.09676992999100476,0.0497141666384375,0.014507411718254981,0.1485004360279376,0.01590772363367117,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
33,0.7,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography a suitable replacement for bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.7,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans take the place of bone scintigraphy when detecting bone metastases in breast cancer? Answer: Our findings imply that routine bone scintigraphy is not needed for metastatic breast cancer patients if a CT of the thorax, abdomen, and pelvis is done.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.7,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Could computerized tomography substitute bone scintigraphy for detecting bone metastases in breast cancer? Answer: The data suggest that routine bone scintigraphy is not required in metastatic breast cancer patients if CT imaging of the thorax, abdomen, and pelvis is performed.",1.184298636784265e-07,0.09887403359652636,0.02498356344510192,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
33,0.7,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible for CT to replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Our study suggests that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer when CT scans of the thorax, abdomen, and pelvis are available.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.7,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerised tomography be used instead of bone scintigraphy to detect bone metastases in breast cancer? Answer: Findings indicate that routine bone scintigraphy is not essential for patients with metastatic breast cancer if CT of the thorax, abdomen, and pelvis is performed.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.7,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerized tomography have the potential to replace bone scintigraphy for bone metastases detection in breast cancer? Answer: Our evidence suggests routine bone scintigraphy is not needed in metastatic breast cancer patients, provided CT of the thorax, abdomen, and pelvis is carried out.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.7,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy in identifying bone metastases from breast cancer? Answer: The findings support that routine bone scintigraphy is unnecessary if CT scans of the thorax, abdomen, and pelvis are performed on metastatic breast cancer patients.",9.47438909427412e-08,0.03712156612126272,0.05113221329437545,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
33,0.7,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography an effective alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our results demonstrate that routine bone scintigraphy is not required for patients with metastatic breast cancer when CT imaging of thorax, abdomen, and pelvis is done.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.7,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be omitted if computerized tomography is used to detect bone metastases from breast cancer? Answer: The findings suggest that routine bone scintigraphy is unnecessary in metastatic breast cancer patients if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.7,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Could CT scanning replace bone scintigraphy for bone metastasis detection in breast cancer patients? Answer: Our findings indicate that routine bone scintigraphy is not necessary for metastatic breast cancer patients if CT of the thorax, abdomen, and pelvis is performed.",1.184298636784265e-07,0.06421667456852864,0.049861495844875335,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
34,0.7,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain considered a clinically significant issue in general adult psychiatry? Yes, pain is indeed a clinically significant concern in general adult psychiatry. Chronic pain frequently coexists with psychiatric conditions such as depression and anxiety, making its assessment and management essential in psychiatric treatment.",4.737194547137081e-08,0.08366007832920586,0.13147611068608991,0.0036268529295637453,0.044999417296180955,0.06426857330703484,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
34,0.7,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Does pain represent a clinically important problem in general adult psychiatry? Yes, pain is a clinically important issue in general adult psychiatry. Chronic pain is commonly linked with mental health disorders like depression and anxiety, so evaluating and addressing pain is vital in psychiatric care.",2.3685972735685406e-08,0.03467506812171406,0.037925250248376674,0.0018134264647818726,0.07006512440861101,0.06536762149263864,0.0018108015409528666,0.10542711757770196,0.09204470742932283,2.3685972735685406e-08,0.07492347421521872,0.0710059171597633
34,0.7,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a relevant clinical problem in the context of general adult psychiatry? Yes, pain is a relevant clinical problem within general adult psychiatry. Chronic pain often overlaps with psychiatric illnesses such as depression and anxiety, which makes pain assessment and management a key part of psychiatric practice.",4.737194547137081e-08,0.1835826805148839,0.1391508884236875,0.0036268529295637453,0.14171154482331394,0.06838014355496873,0.003621603081905733,0.14361344770643392,0.06983396362766994,4.737194547137081e-08,0.14554104142917268,0.0710059171597633
34,0.7,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain recognized as a clinically relevant issue in general adult psychiatry? Yes, pain is recognized as a clinically relevant problem in the field of general adult psychiatry. Chronic pain is frequently associated with psychiatric disorders including depression and anxiety, thus pain evaluation and treatment are important in psychiatric care.",9.474389094274162e-08,0.1734875458011187,0.10345591816949605,0.0072537058591274906,0.15790142954689523,0.04954635108481263,0.007243206163811466,0.15891385159503502,0.0495755716268537,9.474389094274162e-08,0.15985597006261676,0.049277522098034904
34,0.7,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a significant clinical concern in adult psychiatry? Yes, pain is a significant clinical concern in general adult psychiatry. Chronic pain often occurs alongside psychiatric conditions like depression and anxiety, making its assessment and management critical within psychiatric services.",1.4211583641411233e-07,0.027204813284751772,0.12229632831949434,0.010880558788691236,0.09851431573197678,0.033401226368259346,0.0108648092457172,0.09625941839224605,0.03816715640891465,1.4211583641411244e-07,0.09363783073075371,0.043250815118946975
34,0.7,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically pertinent issue in general adult psychiatry? Yes, pain is clinically pertinent in general adult psychiatry. Chronic pain is often intertwined with psychiatric disorders such as depression and anxiety, so pain assessment and treatment are important components of psychiatric care.",7.105791820705622e-08,0.057059161514536605,0.1293379926306482,0.005440279394345618,0.05310382532501512,0.08739357330703484,0.0054324046228586,0.05663695340827024,0.09204470742932283,7.105791820705622e-08,0.024913053640555294,0.0710059171597633
34,0.7,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a relevant problem in clinical adult psychiatry? Yes, pain is a relevant clinical problem in general adult psychiatry. Chronic pain commonly coexists with psychiatric conditions like depression and anxiety, necessitating thorough pain assessment and management in psychiatric practice.",1.4211583641411233e-07,0.043887205234216076,0.1723886048210373,0.010880558788691236,0.010929975935383585,0.11176857330703485,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
34,0.7,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically meaningful issue in general adult psychiatry? Yes, pain is a clinically meaningful problem in general adult psychiatry. Chronic pain is frequently linked to psychiatric disorders such as depression and anxiety, making evaluation and management of pain essential in psychiatric care.",4.737194547137081e-08,0.05142067458223165,0.10925489013757349,0.0036268529295637453,0.044999417296180955,0.06426857330703484,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
34,0.7,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain an important clinical problem in adult psychiatry? Yes, pain is an important clinical problem in general adult psychiatry. Chronic pain often correlates with psychiatric illnesses like depression and anxiety, thus pain assessment and management play a crucial role in psychiatric treatment.",7.105791820705622e-08,0.057059161514536605,0.1293379926306482,0.005440279394345618,0.01452028985156506,0.039053891866591625,0.0054324046228586,0.012677764647723855,0.042183211584447496,7.105791820705622e-08,0.01063295561892863,0.04538264846170235
34,0.7,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinical concern in general adult psychiatry? Yes, pain is a clinical concern in general adult psychiatry. Chronic pain is commonly associated with psychiatric disorders such as depression and anxiety, so its assessment and management are vital within psychiatric care.",9.474389094274162e-08,0.037882701201891855,0.0814800017888821,0.0072537058591274906,0.0764061657890549,0.013003141208269398,0.007243206163811466,0.0753188823544737,0.015655818540433936,9.474389094274162e-08,0.07402529387427581,0.01853678135729416
35,0.7,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that using statins before surgery appears to decrease the occurrence of AF after CABG.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
35,0.7,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is there a reduction in atrial fibrillation after coronary artery bypass grafting with preoperative statin use? Answer: Our findings indicate that preoperative statin treatment may reduce the risk of AF development post-CABG.,1.421158364141118e-07,0.16431766599324638,0.031217481789802305,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
35,0.7,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Can preoperative statins prevent atrial fibrillation after coronary artery bypass graft surgery? Answer: According to our study, preoperative statin therapy seems to lessen AF occurrence after CABG.",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.7,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do statins given before coronary artery bypass grafting help reduce atrial fibrillation? Answer: Our study showed that preoperative statin use appears to lower the chances of AF developing after CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.7,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does administering statins prior to CABG surgery decrease atrial fibrillation rates? Answer: Our data indicates that preoperative statin therapy may reduce AF incidence following CABG.,2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.7,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are atrial fibrillation rates reduced after CABG in patients on preoperative statins? Answer: Our study suggests that statin therapy before surgery seems to reduce AF development post-CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.7,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin treatment help in reducing atrial fibrillation after coronary artery bypass grafting? Answer: Our research found that preoperative statins appear to decrease the likelihood of AF after CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.7,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is atrial fibrillation less common after CABG when patients receive statins preoperatively? Answer: Our findings suggest that preoperative statin therapy reduces AF occurrence following CABG.,2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.7,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do patients who receive statins before CABG experience less atrial fibrillation? Answer: Our study indicates that preoperative statin treatment seems to reduce AF development after coronary artery bypass grafting.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.7,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does the use of statins before coronary artery bypass surgery reduce the risk of atrial fibrillation? Answer: Our research shows that preoperative statin therapy appears to lower the risk of AF following CABG.,1.658018091497971e-07,0.15439318337712526,0.06035379812695108,0.012693985253473157,0.20353837914652884,0.031217481789802305,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
36,0.7,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and pertinent to practitioners and athletes? There is a shortage of research focusing on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow both in quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.7,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and applicability for practitioners and athletes? Current literature in sports medicine lacks sufficient studies on diagnostic and therapeutic interventions. The foundation of evidence in sports medicine must be expanded with more and higher-quality research.,1.1842986367842692e-07,0.1657772513196747,0.03897392290249441,0.009067132323909363,0.16009538652296218,0.026296566837107373,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.7,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and valuable to both practitioners and athletes? The sports medicine field has few studies covering diagnosis and treatment strategies. Increasing the volume and quality of evidence in sports medicine is essential.,2.1317375462116813e-07,0.2481029567106905,0.02456850508798565,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
36,0.7,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals significant and practical for practitioners and athletes? There is a limited number of investigations into diagnostic and treatment procedures within sports medicine literature. The evidence base in sports medicine should continue to improve in both size and quality.,7.105791820705622e-08,0.0760984489201686,0.006963732238457573,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
36,0.7,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do practitioners and athletes find sports medicine journals relevant and applicable? The literature on sports medicine shows a lack of studies addressing diagnostic and therapeutic approaches. Enhancing the quantity and quality of evidence in sports medicine is necessary.,1.6580180914979753e-07,0.18744301000992758,0.018049886621315223,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.7,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful to practitioners and athletes? Studies on diagnostic and treatment interventions are scarce in sports medicine literature. There is a need for an increase in both the volume and quality of evidence in sports medicine.,9.474389094274162e-08,0.08971951454203886,0.04310902569707476,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,0.7,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and applicable for practitioners and athletes? A deficiency of studies on diagnostic and treatment interventions exists within the sports medicine field. Expanding the evidence base in sports medicine in both volume and quality is required.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.7,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals provide relevant and applicable information for practitioners and athletes? The sports medicine literature contains few studies on diagnosis and treatment interventions. The evidence supporting sports medicine must grow in both quantity and quality.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.7,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals valuable and relevant to practitioners and athletes? There is a lack of research addressing diagnostic and treatment methods in the sports medicine literature. Increasing both the volume and quality of evidence in sports medicine is essential.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.7,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and meaningful to practitioners and athletes? The literature in sports medicine has limited studies on diagnostic and treatment interventions. The evidence base for sports medicine needs to be expanded in terms of both quality and quantity.,9.474389094274162e-08,0.10280071813615255,0.00952255325029372,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
37,0.7,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? This study demonstrated for the first time that RALP causes less tissue damage than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.7,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,"Does robotically assisted laparoscopic radical prostatectomy result in less invasiveness than retropubic radical prostatectomy? According to this study, RALP leads to reduced tissue trauma compared to RRP for the first time.",4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.7,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy less than that of retropubic radical prostatectomy? This study revealed that RALP produces lower tissue injury than RRP for the first time.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.7,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? This research showed for the first time that RALP causes less trauma to tissues than RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.7,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy involve less tissue trauma than retropubic radical prostatectomy? This study was the first to show that RALP results in less tissue damage than RRP.,2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.7,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with less invasiveness than retropubic radical prostatectomy? The study revealed for the first time that RALP leads to lower tissue trauma than RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.7,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? This study was the first to demonstrate that RALP causes less tissue trauma compared to RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.7,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy considered less invasive than retropubic radical prostatectomy? This study showed for the first time that RALP induces less tissue injury than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.7,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy have a lower invasiveness level than retropubic radical prostatectomy? This study indicated for the first time that RALP results in reduced tissue trauma compared to RRP.,7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
37,0.7,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy less than retropubic radical prostatectomy? This study found for the first time that RALP causes less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
38,0.7,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","After 4 weeks of acid suppression treatment for LA grade C or D oesophagitis, healing seems to plateau, with further improvements unlikely even if the duration of intragastric pH>4 increases.",7.816371002776172e-07,0.7598385550586184,0.0,0.059843073337801846,0.7786693539981062,0.0,0.059756450851444654,0.79850769621777,0.0,7.816371002776184e-07,0.8194409058842362,0.0
38,0.7,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","In patients with LA grade C or D oesophagitis, 4 weeks of acid-suppressive therapy appears to be the optimal duration, as healing reaches a limit beyond which additional acid suppression yields minimal benefit.",7.105791820705613e-07,0.6613984822453651,0.0,0.05440279394345621,0.6768866596881637,0.0,0.05432404622858603,0.6931471805599445,0.0,7.105791820705622e-07,0.7102416139192456,0.0
38,0.7,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Successful healing of LA grade C and D oesophagitis after 4 weeks of acid-suppressive therapy seems to hit a maximum threshold, beyond which extending the time with pH>4 offers little further improvement.",7.342651548062466e-07,0.693147180559945,0.0,0.056216220408238086,0.7096764825111554,0.0,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
38,0.7,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","For LA grades C and D reflux oesophagitis, 4 weeks of acid-suppression leads to maximal healing, with no significant gains seen from longer periods of elevated intragastric pH.",8.290090457489878e-07,0.8312975190407621,0.0,0.06346992626736561,0.8527773261518279,0.0,0.0633780539333504,0.8754687373538994,0.0,8.290090457489892e-07,0.8994836135577735,0.0
38,0.7,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","The healing process for LA grade C or D oesophagitis plateaus after 4 weeks of acid suppression, suggesting an optimal treatment duration beyond which more acid suppression does not enhance recovery.",7.579511275419319e-07,0.7259370033829367,0.0,0.058029646873019966,0.7435780341868372,0.0,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
38,0.7,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","After a 4-week regimen of acid-suppressive therapy in LA grade C or D oesophagitis, healing reaches a ceiling, making additional acid suppression time ineffective for further improvement.",8.526950184846731e-07,0.8690378470236091,0.0,0.06528335273214748,0.8919980393051103,0.0,0.06518885547430328,0.9162907318741542,0.0,8.526950184846746e-07,0.9420432279765691,0.0
38,0.7,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","In treating LA grade C and D reflux oesophagitis, 4 weeks of acid suppression appears sufficient for maximal healing, as extended acid suppression does not improve outcomes.",8.526950184846731e-07,0.9223568609128359,0.03840000000000001,0.06528335273214748,0.8919980393051103,0.0,0.06518885547430328,0.9162907318741542,0.0,8.526950184846746e-07,0.9420432279765691,0.0
38,0.7,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Healing of LA grade C or D oesophagitis after 4 weeks of acid suppression therapy reaches a threshold, beyond which increasing hours with pH>4 does not significantly aid recovery.",8.053230730133025e-07,0.7949298748698874,0.0,0.061656499802583725,0.8150369981689809,0.0,0.06156725239239753,0.836248024200617,0.0,8.053230730133038e-07,0.8586616190375187,0.0
38,0.7,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","For LA grades C and D oesophagitis, 4 weeks of acid-suppressive treatment achieves near-maximal healing; additional increases in intragastric pH duration do not enhance recovery.",9.000669639560437e-07,0.9490805546971464,0.0,0.06891020566171124,0.9753796482441608,0.0,0.06881045855620901,1.003302108863784,0.0,9.000669639560454e-07,1.0330150061822971,0.0
38,0.7,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","The model of healing for LA grade C and D reflux oesophagitis indicates that after 4 weeks of acid suppression, healing plateaus, and longer acid suppression times do not yield further benefits.",7.342651548062466e-07,0.693147180559945,0.0,0.056216220408238086,0.7096764825111554,0.0,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
39,0.7,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does viral infection contribute to benign paroxysmal positional vertigo? BPPV has been linked to positive viral serology, especially in spring and autumn months. Viral infections may trigger BPPV episodes by causing vestibulopathy or may lead to secondary BPPV through viral neurolabyrinthitis.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.7,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, notably during spring and autumn. Viral infections could provoke BPPV attacks by inducing vestibulopathy or cause secondary BPPV via neurolabyrinthitis related to viral infection.",2.3685972735685406e-07,0.2520656236083072,0.024375,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,0.7,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections play a role in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, particularly in spring and autumn seasons. Viral infections might trigger BPPV due to vestibulopathy development or cause secondary BPPV through viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.7,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections influence benign paroxysmal positional vertigo? Positive viral serology is linked to BPPV, especially during spring and autumn. Such infections may promote BPPV attacks by causing vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",3.7897556377096597e-07,0.37647757123491177,0.0,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
39,0.7,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Are viral infections involved in benign paroxysmal positional vertigo? BPPV shows association with positive viral serology mainly in spring and autumn. Viral infections might lead to BPPV episodes through vestibulopathy or secondary BPPV by viral neurolabyrinthitis.,3.7897556377096597e-07,0.416085981552623,0.02854671280276816,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
39,0.7,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there an association between viral infections and benign paroxysmal positional vertigo? Positive viral serology correlates with BPPV, mostly in spring and autumn. Viral infection could facilitate BPPV attacks by causing vestibulopathy or induce secondary BPPV through viral neurolabyrinthitis.",3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.7,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Could viral infections have a role in benign paroxysmal positional vertigo? BPPV is linked with positive viral serology, particularly during spring and autumn months. Viral infections may trigger BPPV due to vestibulopathy or cause secondary BPPV via neurolabyrinthitis related to viral infection.",2.3685972735685406e-07,0.2520656236083072,0.024375,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,0.7,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Do viral infections contribute to benign paroxysmal positional vertigo? BPPV is associated with positive viral serology especially in spring and autumn. Viral infection might promote BPPV attacks by developing vestibulopathy or induce secondary BPPV through viral neurolabyrinthitis.,3.5528959103528067e-07,0.3483066942682149,0.0,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.7,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Might viral infections impact benign paroxysmal positional vertigo? BPPV is connected to positive viral serology mainly in spring and autumn. Viral infections may initiate BPPV attacks by causing vestibulopathy or trigger secondary BPPV via viral neurolabyrinthitis.,3.7897556377096597e-07,0.416085981552623,0.02854671280276816,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
39,0.7,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Are viral infections linked to benign paroxysmal positional vertigo? BPPV correlates with positive viral serology particularly in spring and autumn. Viral infections could promote BPPV episodes by inducing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.,3.7897556377096597e-07,0.416085981552623,0.02854671280276816,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
40,0.7,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults who are at risk for Type 2 diabetes? In this high-risk group showing skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. However, within this 'at-risk' group, those with greater aerobic fitness exhibited improved microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.7,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is microvascular function influenced by aerobic fitness in healthy adults at risk for developing Type 2 diabetes? Among individuals with skin microvascular dysfunction, maximal oxygen uptake was similar to healthy controls. Yet, within the 'at-risk' group, higher aerobic fitness correlated with better microvascular and endothelial function.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,0.7,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function in healthy adults predisposed to Type 2 diabetes? The 'at-risk' group with skin microvascular dysfunction showed no reduction in maximal oxygen uptake compared to healthy controls. Nevertheless, within this group, individuals with higher aerobic fitness had enhanced microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.7,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk of Type 2 diabetes? In those with skin microvascular dysfunction, maximal oxygen uptake was not decreased relative to healthy controls. Still, among the 'at-risk' individuals, greater aerobic fitness was linked to better microvascular and endothelial responses.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.7,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk for Type 2 diabetes? The 'at-risk' group with skin microvascular dysfunction did not show reduced maximal oxygen uptake versus healthy controls. However, within this group, higher aerobic fitness was associated with improved microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.7,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function among healthy adults at risk of Type 2 diabetes? Maximal oxygen uptake in the 'at-risk' group with skin microvascular dysfunction was comparable to healthy controls. Yet, individuals in this group with higher aerobic fitness demonstrated better microvascular and endothelial function.",2.3685972735685406e-07,0.2118730741378676,0.008036441623838694,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,0.7,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","What is the relationship between aerobic fitness and microvascular function in healthy adults at risk for Type 2 diabetes? In the 'at-risk' group exhibiting skin microvascular dysfunction, maximal oxygen uptake was not diminished compared to healthy controls. However, within this group, higher aerobic fitness corresponded with enhanced microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.7,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","In healthy adults at risk of Type 2 diabetes, does aerobic fitness affect microvascular function? Those with skin microvascular dysfunction showed no decrease in maximal oxygen uptake compared to healthy controls. Still, higher aerobic fitness within this 'at-risk' cohort was linked to superior microvascular and endothelial responses.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.7,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness alter microvascular function in healthy adults who are at risk for Type 2 diabetes? Maximal oxygen uptake was not reduced in the 'at-risk' group with skin microvascular dysfunction compared to healthy controls. However, higher aerobic fitness in this group was associated with better microvascular and endothelial responsiveness.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,0.7,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness affect microvascular function in healthy adults at risk of developing Type 2 diabetes? In the 'at-risk' group with skin microvascular dysfunction, maximal oxygen uptake remained similar to that of healthy controls. Nonetheless, individuals with higher aerobic fitness in this group showed improved microvascular and endothelial function.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
41,0.7,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Does the ultra high risk (UHR) criteria for psychosis indicate varying levels of risk for transitioning to psychosis? Our findings show that UHR intake criteria forecast transition within 6 months in the order of Trait alone < APS < BLIPS. The highest short-term risk in BLIPS patients aligns with the ""early"" versus ""late"" prodrome model, suggesting a need for focused clinical attention.",2.6054570009253947e-07,0.1465381664938601,0.013886133703630227,0.01994769111260064,0.16833531481921682,0.0,0.019918816950481547,0.17095779814363965,0.0,2.6054570009253947e-07,0.17366349405084325,0.0
41,0.7,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Are there different risk levels for transitioning to psychosis according to the ultra high risk (UHR) criteria? Our data indicate that UHR criteria predict a 6-month transition risk ranked as Trait alone < APS < BLIPS. The fact that BLIPS patients face the highest short-term risk supports the ""early"" versus ""late"" prodrome framework and highlights the importance of specific clinical focus.",2.8423167282822487e-07,0.16306746844507103,0.013886133703630227,0.021761117577382513,0.18514243313559753,0.0,0.021729618491434413,0.18805223150293937,0.0,2.8423167282822487e-07,0.19105523676271208,0.0
41,0.7,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Do ultra high risk (UHR) criteria for psychosis reflect different degrees of risk for transition? According to our data, UHR intake criteria predict 6-month transition in this order: Trait alone < APS < BLIPS. BLIPS patients' highest short-term risk is consistent with the ""early"" versus ""late"" prodrome model and suggests the need for targeted clinical care.",4.026615365066519e-07,0.2500788454346994,0.013886133703630227,0.030828249901291876,0.27369583047704094,0.0,0.030783626196198746,0.2782033284972374,0.0,4.026615365066519e-07,0.28286278601583437,0.0
41,0.7,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Is there a variation in risk levels for psychosis transition under ultra high risk (UHR) criteria? Our results suggest the UHR intake criteria predict transition within 6 months in the sequence Trait alone < APS < BLIPS. The elevated short-term risk for BLIPS patients fits the ""early"" versus ""late"" prodrome model, indicating a requirement for particular clinical attention.",3.552895910352811e-07,0.2143607628326203,0.013886133703630227,0.02720139697172813,0.2373281863061667,0.0,0.027162023114293013,0.2411620568168873,0.0,3.552895910352811e-07,0.24512245803298693,0.0
41,0.7,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Do the ultra high risk (UHR) psychosis criteria identify different transition risk levels? Our data reveal UHR intake criteria forecast transition over 6 months as Trait alone < APS < BLIPS. The highest short-term risk in BLIPS patients matches the ""early"" versus ""late"" prodrome concept and points to a need for focused clinical monitoring.",4.500334819780227e-07,0.2871201171150495,0.013886133703630227,0.03445510283085562,0.31143615845988837,0.0,0.03440522927810448,0.3166696093250332,0.0,4.500334819780227e-07,0.3220834991691168,0.0
41,0.7,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Are varying risk levels for psychosis transition indicated by ultra high risk (UHR) criteria? Our study shows UHR intake criteria predict 6-month transition risk in the order Trait alone < APS < BLIPS. The significant risk for BLIPS patients over the short term aligns with the ""early"" versus ""late"" prodrome model, emphasizing the need for clinical vigilance.",3.789755637709665e-07,0.2320603399320209,0.013886133703630227,0.029014823436510004,0.25534669180884517,0.0,0.02897282465524588,0.25951119548508306,0.0,3.789755637709665e-07,0.26381459104514127,0.0
41,0.7,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Does the UHR (ultra high risk) criteria for psychosis denote different transition risks? Data suggest UHR intake criteria predict 6-month transition risk ranked Trait alone < APS < BLIPS. BLIPS patients' highest short-term risk corroborates the ""early"" versus ""late"" prodrome model, requiring enhanced clinical attention.",6.632072365991914e-07,0.47322239674890865,0.013886133703630227,0.050775941013892475,0.501479761347754,0.0,0.05070244314668028,0.5108256237659905,0.0,6.632072365991914e-07,0.5205344378929544,0.0
41,0.7,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Are different transition risk levels to psychosis defined by ultra high risk (UHR) criteria? Our findings indicate UHR intake criteria forecast 6-month transition risk as Trait alone < APS < BLIPS. The highest risk in BLIPS patients over the short term supports the ""early"" versus ""late"" prodrome model, suggesting clinical care should be prioritized.",4.500334819780227e-07,0.31327661449467037,0.004974813041931906,0.03445510283085562,0.31143615845988837,0.0,0.03440522927810448,0.3166696093250332,0.0,4.500334819780227e-07,0.3220834991691168,0.0
41,0.7,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Does the ultra high risk (UHR) psychosis criteria differentiate risk levels for transition? Our evidence points to UHR intake criteria predicting 6-month transition in the order Trait alone < APS < BLIPS. The elevated short-term risk for BLIPS patients aligns with the ""early"" versus ""late"" prodrome framework and underscores the need for specialized clinical focus.",4.263475092423373e-07,0.26842798410289515,0.013886133703630227,0.03264167636607375,0.29238796348919527,0.0,0.03259442773715161,0.2972515234679305,0.0,4.263475092423373e-07,0.30228087187293706,0.0
41,0.7,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Is there a stratification of risk for psychosis transition within ultra high risk (UHR) criteria? Our data suggest UHR intake criteria predict transition over 6 months as Trait alone < APS < BLIPS. The high short-term transition risk for BLIPS patients is consistent with the ""early"" versus ""late"" prodrome model and indicates a necessity for targeted clinical attention.",3.552895910352811e-07,0.23868171653647785,0.0036521316024922274,0.02720139697172813,0.2373281863061667,0.0,0.027162023114293013,0.2411620568168873,0.0,3.552895910352811e-07,0.24512245803298693,0.0
42,0.7,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, the platelet count before surgery in esophageal squamous cell carcinoma may serve as a prognostic indicator. Higher platelet levels prior to surgery have been linked to worse outcomes and more aggressive tumors. Nonetheless, additional studies are required for conclusive evidence.",9.474389094274162e-08,0.14268166270033023,0.0446613982951488,0.0072537058591274906,0.1676172289597928,0.06304532427133872,0.007243206163811466,0.16890773082224753,0.06342125247441385,9.474389094274162e-08,0.17016490512830273,0.06353305785123965
42,0.7,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can act as a prognostic factor in esophageal squamous cell carcinoma. Elevated platelet counts before surgery correlate with poorer prognosis and increased tumor aggressiveness. Still, more research is necessary to confirm this definitively.",2.3685972735685406e-08,0.03241989496172559,0.035566745929226956,0.0018134264647818726,0.034195923504811265,0.038500918273645504,0.0018108015409528666,0.06497549619081244,0.06137808745645146,2.3685972735685406e-08,0.06698066889307208,0.06353305785123965
42,0.7,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count determine prognosis in esophageal squamous cell carcinoma? Answer: Yes, platelet count before surgery in esophageal squamous cell carcinoma is potentially a prognostic factor. Increased platelet counts prior to operation are associated with unfavorable prognosis and higher tumor aggressiveness. However, further studies are needed to establish this conclusively.",2.3685972735685406e-08,0.10515486835336407,0.0584265998700924,0.0018134264647818726,0.10620954115026304,0.06079258494031216,0.0018108015409528666,0.10785209564055176,0.062245322543618004,2.3685972735685406e-08,0.1095402833118686,0.06353305785123965
42,0.7,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count significant as a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be an important prognostic factor. Elevated pre-surgical platelet levels have been linked to a worse prognosis and more aggressive tumor behavior. More research is still needed for definitive conclusions.",9.474389094274162e-08,0.14268166270033067,0.04466139829514881,0.0072537058591274906,0.14146073158017236,0.04432314049586771,0.007243206163811466,0.16890773082224753,0.06342125247441385,9.474389094274162e-08,0.17016490512830273,0.06353305785123965
42,0.7,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does the platelet count before surgery predict outcomes in esophageal squamous cell carcinoma? Answer: Yes, the preoperative platelet count may serve as a prognostic marker in esophageal squamous cell carcinoma. Higher platelet counts before surgery are associated with poorer patient outcomes and more aggressive tumors. Nonetheless, further investigation is required for confirmation.",4.737194547137081e-08,0.10000438898700059,0.041224245863754685,0.0036268529295637453,0.12709945814143886,0.06157278647670903,0.003621603081905733,0.12862063739118046,0.06265295796173082,4.737194547137081e-08,0.13015957051460436,0.06353305785123965
42,0.7,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is there a prognostic role of preoperative platelet count in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can be a prognostic factor in esophageal squamous cell carcinoma. Elevated platelet counts prior to surgery have been linked with worse prognosis and increased tumor aggressiveness, though more research is needed for definitive proof.",7.105791820705622e-08,0.09541113440303572,0.024927278910382197,0.005440279394345618,0.12090350791450089,0.04324708885071986,0.0054324046228586,0.1489669095348587,0.06304462809917356,7.105791820705622e-08,0.15036227783212297,0.06353305785123965
42,0.7,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can the preoperative platelet count forecast prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma might serve as a prognostic factor. Elevated platelet levels before surgery are associated with poorer prognosis and greater tumor aggressiveness. Additional research is necessary to confirm this.",2.3685972735685406e-08,0.03241989496172559,0.035566745929226956,0.0018134264647818726,0.034195923504811265,0.038500918273645504,0.0018108015409528666,0.06497549619081244,0.06137808745645146,2.3685972735685406e-08,0.06698066889307208,0.06353305785123965
42,0.7,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? Answer: Yes, it can be. Elevated platelet counts before surgery in esophageal squamous cell carcinoma have been correlated with worse prognosis and higher tumor aggressiveness. However, more studies are required for definitive conclusions.",9.474389094274162e-08,0.020289099805566924,0.07138994050838293,0.0072537058591274906,0.005312282779206701,0.05637484411944804,0.007243206163811466,0.0029935369217577446,0.05992964702832444,9.474389094274162e-08,0.0004606119024601618,0.06353305785123965
42,0.7,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Could pre-surgery platelet count be a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count may indicate prognosis in esophageal squamous cell carcinoma. Increased platelet counts before surgery are linked to poorer outcomes and greater tumor aggressiveness, but further research is needed for confirmation.",7.105791820705622e-08,0.014223308019982728,0.051919956733369424,0.005440279394345618,0.01800603878122997,0.0573347107438016,0.0054324046228586,0.020179467597532863,0.06043388429752067,7.105791820705622e-08,0.02252890632223936,0.06353305785123965
42,0.7,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does the preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? Answer: Yes, it can be a prognostic factor. Elevated platelet counts prior to surgery correlate with a worse prognosis and more aggressive tumor characteristics in esophageal squamous cell carcinoma. Still, additional research is required to validate these findings.",2.3685972735685406e-08,0.13233711072826448,0.07769613642509468,0.0018134264647818726,0.10620954115026304,0.06079258494031216,0.0018108015409528666,0.10785209564055176,0.062245322543618004,2.3685972735685406e-08,0.1095402833118686,0.06353305785123965
43,0.7,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do the leadership skills of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership skills significantly correlated with their perceptions of skill decline and task difficulty during bowel repair. Assessing residents' directional instructions could offer an additional personalized intraoperative evaluation metric. Further study on how this relates to operative performance outcomes is needed.,9.474389094274162e-08,0.048416581503104794,0.015680988262295324,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
43,0.7,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Is there a relationship between residents' leadership abilities and their technical skill ratings? In general surgery research, residents' intraoperative leadership showed significant links to their perceived skill decay and task difficulty during bowel repair. Analyzing residents' directional instructions might provide a new individualized intraoperative assessment tool. Additional research on operative performance outcomes is justified.",4.737194547137081e-08,0.011835919659988203,0.0181755829903978,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
43,0.7,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are residents' leadership skills associated with their ratings of technical skill? Studies of general surgery research residents demonstrated significant correlations between intraoperative leadership skills and perceptions of skill deterioration and task difficulty during bowel repair. Evaluating residents' directional instructions may serve as an extra individualized metric for intraoperative assessment. Further research on operative performance outcomes is warranted.,2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
43,0.7,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do leadership skills in residents relate to their technical skill evaluations? General surgery research residents' intraoperative leadership skills were significantly correlated with their perceptions of skill decay and task challenge in bowel repair procedures. Reviewing residents' directional instructions could provide an additional personalized intraoperative assessment measure. More investigation into operative performance outcomes is needed.,4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
43,0.7,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a connection between residents' leadership skills and their technical skill ratings? Research involving general surgery residents found that intraoperative leadership skills significantly correlated with perceived skill decline and task difficulty during bowel repairs. Assessing directional instructions given by residents might offer an additional individualized intraoperative evaluation metric. Further evaluation related to operative performance outcomes is necessary.,4.737194547137081e-08,0.036602480918583424,0.0006373176842753465,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
43,0.7,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"How do residents' leadership skills relate to their technical skill ratings? In general surgery research, intraoperative leadership skills of residents showed significant associations with their perceptions of skill decay and task difficulty during bowel repair. Analyzing residents' directional instructions may provide an additional personalized intraoperative assessment tool. Further studies on operative performance outcomes are warranted.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
43,0.7,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are residents' leadership abilities linked to their ratings of technical skill? General surgery research residents exhibited significant correlations between intraoperative leadership skills and their perceptions of skill decay and task difficulty during bowel repair. Evaluation of residents' directional instructions could serve as an additional individualized intraoperative assessment metric. Further research regarding operative performance outcomes is recommended.,0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.7,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do leadership skills of residents have a relationship with their technical skill ratings? Research on general surgery residents showed significant correlations between intraoperative leadership skills and perceptions of skill deterioration and task difficulty during bowel repair. Assessing residents' directional instructions may offer an additional personalized intraoperative evaluation metric. Further exploration related to operative performance outcomes is warranted.,2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
43,0.7,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Is there an association between residents' leadership skills and their technical skill ratings? In general surgery research residents, intraoperative leadership skills significantly correlated with perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions might provide an additional individualized intraoperative assessment measure. Further investigation into operative performance outcomes is needed.",4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
43,0.7,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do residents' leadership skills influence their technical skill ratings? Studies of general surgery research residents revealed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions may provide an added individualized metric for intraoperative assessment. Further research into operative performance outcomes is warranted.,4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
44,0.7,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in patients with hypertension? Answer: It is concluded that the ACE-DD genotype could be a risk factor for causing and developing chronic kidney failure in hypertensive patients.,7.1057918207056e-08,0.11513671050120466,0.02809413580246914,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
44,0.7,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease among those with hypertension? Answer: The ACE-DD genotype is considered a potential risk factor for the onset and progression of chronic kidney failure in hypertensive individuals.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.7,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype may increase the risk for the development and causation of chronic kidney failure in patients with hypertension.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.7,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism associated with chronic kidney disease in hypertensive patients? Answer: The findings suggest that the ACE-DD genotype might be a risk factor for chronic kidney failure among those with hypertension.,9.47438909427412e-08,0.07903613756100114,0.023084379144985203,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,0.7,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene lead to chronic kidney disease in people with hypertension? Answer: It is concluded that having the ACE-DD genotype could be a contributing risk factor for chronic kidney failure in hypertensive patients.,4.73719454713706e-08,0.08959879647112645,0.02748557235736722,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
44,0.7,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there an association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive individuals? Answer: The ACE-DD genotype may serve as a risk factor for the causation and progression of chronic kidney failure among hypertensive patients.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.7,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism influence the development of chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype may be implicated as a risk factor for chronic kidney failure in patients with hypertension.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.7,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Could angiotensin-converting enzyme-1 (ACE-1) gene polymorphism be a cause of chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among those with hypertension.,0.0,0.03648143055578723,0.025898211136306366,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0
44,0.7,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients linked to ACE-1 gene polymorphism? Answer: It is concluded that the ACE-DD genotype might pose a risk factor for chronic kidney failure in hypertensive individuals.,1.421158364141118e-07,0.14220909460008446,0.021251654012666835,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
44,0.7,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is concluded to be a possible risk factor for the causation and progression of chronic kidney failure in patients with hypertension.,9.474389094274141e-08,0.14003931107046297,0.028673775897650584,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
45,0.7,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories accurately reporting serum quantitative hCG results? Several factors lead to errors in reporting hCG results, including (a) the complexity of the hCG molecule and confusion regarding the nomenclature of its various forms; (b) laboratory staff's lack of understanding of the different forms of hCG and failure to appreciate the specificity of assays used for measurement; (c) lack of...",1.1842986367842703e-07,0.011637845159606641,0.09451810934917294,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
45,0.7,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories report serum quantitative hCG results correctly? Errors in hCG reporting arise from multiple factors, such as (a) the complex structure of the hCG molecule and confusion about the names of its different forms; (b) laboratory personnel's insufficient knowledge of the various hCG forms and their failure to recognize assay specificity; (c) lack of...",2.3685972735685406e-07,0.07909115538510125,0.0929502975466984,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
45,0.7,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are serum quantitative hCG results being reported correctly by laboratories? The incorrect reporting of hCG results is influenced by (a) the intricate nature of the hCG molecule and confusion over the nomenclature of its forms; (b) laboratory workers' unawareness of the different hCG forms and the specificity of assays used; (c) lack of...,2.8423167282822487e-07,0.1444783794586586,0.07306222349899458,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
45,0.7,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Is the reporting of serum quantitative hCG results in laboratories accurate? Many factors contribute to incorrect hCG result reporting, including (a) the complexity of the hCG molecule and confusion over the various hCG form names; (b) laboratory staff not understanding the differences among hCG forms and failing to recognize assay specificity; (c) lack of...",2.6054570009253947e-07,0.07211117059873873,0.11146222349899458,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
45,0.7,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Do laboratories correctly report serum quantitative hCG results? Errors in reporting hCG stem from (a) the complicated nature of the hCG molecule and confusion regarding its various forms' nomenclature; (b) laboratory personnel's lack of knowledge about the distinctions among hCG forms and failure to identify assay specificity; (c) lack of...,3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.7,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are serum quantitative hCG results accurately reported by laboratories? Several causes lead to erroneous hCG reporting, including (a) the complexity of the hCG molecule and confusing nomenclature of its different forms; (b) laboratory staff lacking awareness of the various hCG forms and failing to recognize assay specificity; (c) lack of...",3.552895910352811e-07,0.17887450769574098,0.09106291794343903,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.7,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Is laboratory reporting of serum quantitative hCG results correct? Errors in hCG result reporting occur due to (a) the complex hCG molecule and confusion over the names of its forms; (b) laboratory personnel's lack of understanding of the different hCG forms and failure to recognize assay specificity; (c) lack of...,3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.7,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories providing correct serum quantitative hCG results? Multiple factors cause errors in hCG reporting, including (a) the intricate hCG molecule and confusion about the nomenclature of its forms; (b) laboratory staff unaware of the distinctions among hCG forms and not recognizing the specificity of assays; (c) lack of...",3.789755637709665e-07,0.17120207324296866,0.11146222349899458,0.029014823436509962,0.29298712468147725,0.0,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
45,0.7,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Is the serum quantitative hCG result reporting by laboratories accurate? Many issues lead to erroneous hCG reporting, such as (a) the complex structure of hCG and confusion regarding its various forms' names; (b) laboratory personnel not understanding the different hCG forms and failing to recognize assay specificity; (c) lack of...",3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.7,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Do laboratories report serum quantitative hCG results with accuracy? Errors arise from various factors including (a) the complexity of the hCG molecule and confusion over the nomenclature of its forms; (b) laboratory staff's insufficient awareness of the distinctions among hCG forms and failure to recognize assay specificity; (c) lack of...,3.552895910352811e-07,0.17887450769574098,0.09106291794343903,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
46,0.7,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cervical disk disease? Current studies show that this complex is present in cervical disk disease and is linked to intervertebral disc degeneration, which is a major factor in the condition. Nevertheless, further research is required to clarify its exact role.",1.4211583641411244e-07,0.04094148085354865,0.15359653866955109,0.010880558788691236,0.04843651264574511,0.056680103995313466,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
46,0.7,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does the fibronectin-aggrecan complex occur in cervical disk disease? Research to date suggests that the fibronectin-aggrecan complex exists in cervical disk disease and is connected to the degeneration of intervertebral discs, a primary cause of the disease. Additional studies are necessary to fully comprehend its function.",1.4211583641411244e-07,0.020671601862890743,0.1099020033981421,0.010880558788691236,0.07994320267119726,0.034043611143260086,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
46,0.7,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Present findings indicate that this complex is present and is associated with intervertebral disc degeneration, a significant contributor to cervical disk disease. More investigation is needed to understand its full impact.",2.8423167282822477e-07,0.07609228933017098,0.17232156634790982,0.02176111757738247,0.16353329681216788,0.07939508506616258,0.0217296184914344,0.25261066381089314,0.020399305555555556,2.8423167282822487e-07,0.2876820724517808,0.0
46,0.7,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex detected in cervical disk disease? Current evidence supports the presence of the fibronectin-aggrecan complex in cervical disk disease, linked to degeneration of intervertebral discs, a key factor in the disease. Further research is essential to determine its precise role.",2.1317375462116866e-07,0.09846634230933482,0.10376200956120625,0.016320838183036854,0.15517150501082622,0.03074288256780624,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.7,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does cervical disk disease involve the fibronectin-aggrecan complex? Studies show that the fibronectin-aggrecan complex is indeed found in cervical disk disease and is related to the degeneration of intervertebral discs, which contributes to the disease. Yet, more research is needed to fully understand its role.",1.6580180914979784e-07,0.04594505238387869,0.10794483504597077,0.012693985253473108,0.07215874459196625,0.056152454680675055,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
46,0.7,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Research indicates that this complex is present and associated with intervertebral disc degeneration, a critical factor in cervical disk disease. However, additional research is required to elucidate its role.",2.8423167282822477e-07,0.07609228933017098,0.17232156634790982,0.02176111757738247,0.16353329681216788,0.07939508506616258,0.0217296184914344,0.25261066381089314,0.020399305555555556,2.8423167282822487e-07,0.2876820724517808,0.0
46,0.7,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is there a presence of the fibronectin-aggrecan complex in cervical disk disease? Current research confirms the complex is present and linked to intervertebral disc degeneration, an important aspect of cervical disk disease. Still, more studies are necessary to fully define its function.",2.3685972735685406e-07,0.024347917084313497,0.17356983504597076,0.018134264647818726,0.11224000242461818,0.07939508506616258,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
46,0.7,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex associated with cervical disk disease? Evidence suggests that the fibronectin-aggrecan complex exists in cervical disk disease and is connected to the degeneration of intervertebral discs, a key contributor to the condition. Further research is needed to fully understand its involvement.",1.8948778188548325e-07,0.07186542549466557,0.10590012761664792,0.014507411718254981,0.09645684685327804,0.055599725161344024,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
46,0.7,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cervical disk disease? Studies indicate that this complex is present and related to the degeneration of intervertebral discs, which plays a major role in cervical disk disease. More research is required to completely understand its significance.",2.3685972735685406e-07,0.058159974672603365,0.14929263254761443,0.018134264647818726,0.14689736145261456,0.05441152162106066,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
46,0.7,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does the fibronectin-aggrecan complex play a role in cervical disk disease? Current research shows that this complex is present and associated with intervertebral disc degeneration, a major factor in the disease. However, further investigation is necessary to fully grasp its role.",2.6054570009253947e-07,0.015228472086395328,0.19794483504597077,0.0199476911126006,0.1375578104089099,0.07939508506616258,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
47,0.7,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the criteria used for residency selection predict how well someone will perform in an Orthopaedic Surgery Residency? The criteria for selecting residents can give an indication of a candidate's potential success in Orthopaedic Surgery Residency. Elements such as medical school grades, board exam scores, recommendation letters, and interview results can somewhat forecast a resident's likelihood of success. Nonetheless, personal commitment and flexibility are also vital factors.",2.1317375462116866e-07,0.2261993226772283,0.056634846523668694,0.016320838183036854,0.2233013485061961,0.0533997864008544,0.0162972138685758,0.17675525014756222,0.0181755829903978,2.1317375462116866e-07,0.15415067982725983,0.0
47,0.7,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can residency selection criteria forecast performance in Orthopaedic Surgery Residency? Selection standards for residency can help estimate a candidate's potential achievements in Orthopaedic Surgery Residency. Medical school academic records, board test scores, reference letters, and interview outcomes can partially predict a resident’s success. Yet, individual motivation and adaptability remain critical.",1.8948778188548325e-07,0.0862096445156495,0.04616586664023726,0.014507411718254981,0.10876604300488024,0.03257588418265612,0.014486412327622933,0.1319802315020513,0.0181755829903978,1.8948778188548325e-07,0.16034265007518078,0.0
47,0.7,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Is it possible for residency selection criteria to predict how well one will perform in Orthopaedic Surgery Residency? Residency selection factors can indicate a candidate’s potential to perform well in Orthopaedic Surgery Residency. Grades from medical school, board exam results, letters of recommendation, and interview performance can moderately forecast a resident's success. However, dedication and adaptability are also important.",2.3685972735685406e-08,0.06729163048357689,0.0353380360897844,0.0018134264647818726,0.067644392741252,0.03586152109473195,0.0018108015409528666,0.043223857523040365,0.0181755829903978,2.3685972735685406e-08,0.018349138668195764,0.0
47,0.7,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do the criteria used for selecting residents predict success in Orthopaedic Surgery Residency? Residency selection criteria can offer some insight into a candidate’s likely performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, recommendation letters, and interview performance provide some predictive value for resident success. Nevertheless, personal drive and flexibility are equally significant.",4.737194547137081e-08,0.03547598187648715,0.050596429271087706,0.0036268529295637453,0.012226007376317849,0.034887860448558225,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
47,0.7,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can the criteria for residency selection predict performance in Orthopaedic Surgery Residency? The criteria used to select residents can somewhat predict a candidate’s performance in Orthopaedic Surgery Residency. Medical school grades, board exam scores, letters of recommendation, and interview evaluations offer some indication of potential success. Still, individual dedication and adaptability play essential roles.",9.474389094274162e-08,0.05578057528162139,0.011939521008258458,0.0072537058591274906,0.0531612166972395,0.014999786400854392,0.007243206163811466,0.07748444286268352,0.0014244170096021913,9.474389094274162e-08,0.07696104113612989,0.0
47,0.7,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Are residency selection criteria indicative of performance in Orthopaedic Surgery Residency? Selection criteria for residency programs can suggest how well a candidate might perform in Orthopaedic Surgery Residency. Academic records, board scores, recommendation letters, and interview results help predict resident success to some extent. However, dedication and adaptability also greatly influence outcomes.",1.4211583641411244e-07,0.07116759371563441,0.028314534023668694,0.010880558788691236,0.06678880318369318,0.03340811626341167,0.0108648092457172,0.09030753510148237,0.0181755829903978,1.4211583641411244e-07,0.11778303565638426,0.0
47,0.7,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the use of residency selection criteria help predict a candidate's performance in Orthopaedic Surgery Residency? Residency selection standards can provide an estimate of a candidate's future success in Orthopaedic Surgery Residency. Medical school grades, board scores, letters of recommendation, and interviews can partially forecast performance, but personal commitment and adaptability are crucial as well.",7.105791820705622e-08,0.03515092394505226,0.01330828402366871,0.005440279394345618,0.006950505216940517,0.03453883965529227,0.0054324046228586,0.030884114630681303,0.0181755829903978,7.105791820705622e-08,0.05715841383995013,0.0
47,0.7,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can residency selection criteria serve as predictors of success in Orthopaedic Surgery Residency? The criteria employed in residency selection can offer some predictive insight regarding a candidate’s performance in Orthopaedic Surgery Residency. Elements such as academic performance, board exam results, recommendation letters, and interview evaluations are indicative but not definitive, as personal dedication and adaptability also matter.",2.3685972735685406e-08,0.029639422074180022,0.033508497622814284,0.0018134264647818726,0.031041911822668578,0.0352242034104566,0.0018108015409528666,0.0068562133521661295,0.0181755829903978,2.3685972735685406e-08,0.018692133012154333,0.0
47,0.7,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","To what extent do residency selection criteria predict performance in Orthopaedic Surgery Residency? The criteria for choosing residents can partially predict how candidates perform in Orthopaedic Surgery Residency. Medical school grades, board scores, letters of recommendation, and interview feedback provide some guidance, though individual dedication and adaptability remain key.",2.1317375462116866e-07,0.10800775345403135,0.045320382322345434,0.016320838183036854,0.1304339443840612,0.0321332457581323,0.0162972138685758,0.15348643672301465,0.0181755829903978,2.1317375462116866e-07,0.18232155679395579,0.0
47,0.7,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can the criteria for selecting residents predict their performance in Orthopaedic Surgery Residency? Residency selection criteria can provide some indication of a candidate’s ability to succeed in Orthopaedic Surgery Residency. Factors such as medical school grades, board exam scores, letters of recommendation, and interviews help predict success, but personal drive and adaptability are also important.",7.105791820705622e-08,0.016193311651981013,0.04992603550295864,0.005440279394345618,0.006950505216940517,0.03453883965529227,0.0054324046228586,0.030884114630681303,0.0181755829903978,7.105791820705622e-08,0.05715841383995013,0.0
48,0.7,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Is visual loss permanent in amblyopia? Older individuals with amblyopia history who lose vision in their previously unaffected eye may regain visual function in the amblyopic eye over time. This improvement follows the visual loss in the good eye.,2.6054570009253926e-07,0.13608960247033508,0.16061901995740105,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
48,0.7,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Does amblyopia cause permanent vision loss? People with amblyopia who later experience vision loss in their better eye can sometimes recover vision in the amblyopic eye after some time. The visual function recovery happens after the loss in the previously normal eye.,1.8948778188548325e-07,0.054764949557420284,0.16443595326151386,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
48,0.7,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the vision loss from amblyopia irreversible? In older patients who have amblyopia and then lose sight in their unaffected eye, there can be a gradual restoration of vision in the amblyopic eye. This recovery takes place subsequent to the vision loss in the previously healthy eye.",7.105791820705622e-08,0.03751799359177932,0.14818820984315845,0.005440279394345618,0.09534506249579122,0.02221074380165289,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
48,0.7,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Can vision loss due to amblyopia be reversed? Older adults with a history of amblyopia who suffer vision loss in the eye that was previously normal might regain visual ability in the amblyopic eye over time. This recovery follows the loss of vision in the formerly good eye.,4.737194547137081e-08,0.049814887281840914,0.10410055245408509,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
48,0.7,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is visual impairment from amblyopia permanent? In elderly individuals with amblyopia, if the previously normal eye loses vision, the amblyopic eye may experience a restoration of visual function over a period. This improvement occurs after the loss in the normal eye.",2.1317375462116866e-07,0.011833446971212247,0.2130881557598702,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
48,0.7,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Does amblyopia lead to permanent visual loss? Older patients with amblyopia who develop vision loss in their previously unaffected eye can see a recovery of sight in the amblyopic eye over time, occurring after the loss in the normal eye.",2.3685972735685396e-07,0.10824327347447227,0.16195594246549475,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
48,0.7,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is vision loss in amblyopia permanent? Among older people with amblyopia, loss of vision in the previously normal eye can trigger a recovery of vision in the amblyopic eye over time. This visual recovery happens following the loss in the good eye.",1.8948778188548325e-07,0.16896327217020568,0.037933834772215846,0.014507411718254981,0.251636274849949,0.049861495844875335,0.014486412327622933,0.2221319648398974,0.025623268698060954,1.8948778188548325e-07,0.19105523676270808,0.0
48,0.7,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the visual loss from amblyopia lasting? Older adults with a history of amblyopia who experience vision loss in their formerly normal eye may recover visual function in the amblyopic eye over time, with this recovery following the loss in the previously normal eye.",1.4211583641411244e-07,0.003991592885534523,0.16668720394547398,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
48,0.7,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is amblyopic visual loss permanent? Older individuals who have amblyopia and then lose vision in their previously normal eye can experience a gradual restoration of visual function in the amblyopic eye, occurring after the visual loss.",3.3160361829959516e-07,0.14536483959573498,0.2130881557598702,0.025387970506946224,0.34484048629172914,0.0,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
48,0.7,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is vision loss caused by amblyopia permanent? In older people with amblyopia, loss of vision in the previously unaffected eye can result in a recovery of vision function in the amblyopic eye over time. This recovery follows the loss in the normal eye.",1.6580180914979784e-07,0.07452259773331038,0.09080018731805557,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
49,0.7,1,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are high flow nasal cannulae louder than bubble CPAP when used for preterm infants? No, they are not.",2.3685972735685321e-07,0.05186963717184945,0.24376731301939059,0.01813426464781879,0.16559373244634257,0.20999999999999996,0.018108015409528732,0.28901852598680655,0.1541950113378685,2.368597273568537e-07,0.42347197063936415,0.08264462809917354
49,0.7,2,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? No, they do not.",2.3685972735685321e-07,0.05186963717184945,0.24376731301939059,0.01813426464781879,0.16559373244634257,0.20999999999999996,0.018108015409528732,0.28901852598680655,0.1541950113378685,2.368597273568537e-07,0.42347197063936415,0.08264462809917354
49,0.7,3,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Is the noise level of high flow nasal cannulae higher than that of bubble CPAP for preterm infants? No, it is not.",1.421158364141118e-07,0.15943945649535607,0.24376731301939059,0.010880558788691277,0.0575498188678667,0.20999999999999996,0.010864809245717241,0.0526297479225768,0.1541950113378685,1.4211583641411228e-07,0.1721575423584576,0.08264462809917354
49,0.7,4,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? No, they are not.",2.6054570009253857e-07,0.11249425898828447,0.24376731301939059,0.019947691112600665,0.2301322535839132,0.20999999999999996,0.019918816950481606,0.35801139747375865,0.1541950113378685,2.6054570009253904e-07,0.4975799427930854,0.08264462809917354
49,0.7,5,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? No, they do not.",2.3685972735685321e-07,0.05186963717184945,0.24376731301939059,0.01813426464781879,0.16559373244634257,0.20999999999999996,0.018108015409528732,0.28901852598680655,0.1541950113378685,2.368597273568537e-07,0.42347197063936415,0.08264462809917354
49,0.7,6,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Is there more noise from high flow nasal cannulae than from bubble CPAP in preterm infants? No, there isn’t.",2.1317375462116786e-07,0.005288776668099349,0.24376731301939059,0.016320838183036913,0.10496911062990755,0.20999999999999996,0.01629721386857586,0.22448000484923591,0.1541950113378685,2.1317375462116834e-07,0.35447909915241205,0.08264462809917354
49,0.7,7,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are high flow nasal cannulae associated with greater noise than bubble CPAP in preterm infants? No, they are not.",2.1317375462116786e-07,0.005288776668099349,0.24376731301939059,0.016320838183036913,0.10496911062990755,0.20999999999999996,0.01629721386857586,0.22448000484923591,0.1541950113378685,2.1317375462116834e-07,0.35447909915241205,0.08264462809917354
49,0.7,8,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Does the high flow nasal cannula produce more noise than bubble CPAP for preterm infants? No, it does not.",2.1317375462116786e-07,0.005288776668099349,0.24376731301939059,0.016320838183036913,0.10496911062990755,0.20999999999999996,0.01629721386857586,0.22448000484923591,0.1541950113378685,2.1317375462116834e-07,0.35447909915241205,0.08264462809917354
49,0.7,9,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are preterm infants exposed to louder sounds from high flow nasal cannulae than from bubble CPAP? No, they are not.",1.894877818854825e-07,0.05935599793837465,0.24376731301939059,0.014507411718255037,0.04781069678995875,0.20999999999999996,0.014486412327622985,0.1638553830328009,0.1541950113378685,1.8948778188548298e-07,0.2899405780148414,0.08264462809917354
49,0.7,10,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Is noise from high flow nasal cannulae greater than that from bubble CPAP for preterm infants? No, it is not.",1.894877818854825e-07,0.05935599793837465,0.24376731301939059,0.014507411718255037,0.04781069678995875,0.20999999999999996,0.014486412327622985,0.1638553830328009,0.1541950113378685,1.8948778188548298e-07,0.2899405780148414,0.08264462809917354
50,0.7,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy with real-time capsule endoscopy viewing a viable method for acute overt-obscure gastrointestinal bleeding? Yes, this combined technique is practical and effective, enabling prompt diagnosis and treatment to minimize complications and enhance patient recovery.",5.447773729207639e-07,0.16506730111607704,0.21432098765432098,0.04170880868998307,0.26607867989840406,0.16493055555555558,0.04164843544191594,0.32212311358752643,0.13660974593919203,5.447773729207643e-07,0.3803125905772524,0.10560000000000004
50,0.7,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy be effectively used in cases of acute overt-obscure gastrointestinal bleeding? Indeed, this combined approach is feasible and facilitates immediate intervention, thereby improving clinical outcomes and reducing risks.",5.684633456564492e-07,0.19323817808277388,0.21432098765432098,0.04352223515476495,0.29506621677165557,0.16493055555555558,0.04345923698286881,0.3519760767372082,0.13660974593919203,5.684633456564497e-07,0.4110842492440061,0.10560000000000004
50,0.7,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy a workable strategy for acute overt-obscure gastrointestinal bleeding? Yes, it is a feasible method that allows quick diagnosis and treatment, leading to better patient prognosis and fewer complications.",4.974054274493933e-07,0.11100007984580085,0.21432098765432098,0.038081955760419325,0.2105088287435919,0.16493055555555558,0.0380268323600102,0.2649646997475781,0.13660974593919203,4.974054274493935e-07,0.32147209055431913,0.10560000000000004
50,0.7,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does combining emergency double-balloon enteroscopy with live capsule endoscopy viewing provide a practical approach to managing acute overt-obscure gastrointestinal bleeding? Yes, this strategy is feasible and supports rapid diagnosis and therapy, enhancing patient outcomes and reducing further risks.",5.210914001850786e-07,0.13766832692796172,0.21432098765432098,0.0398953822252012,0.2379078029317072,0.16493055555555558,0.039837633900963065,0.2931355767142749,0.13660974593919203,5.210914001850789e-07,0.35045962742757064,0.10560000000000004
50,0.7,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy with simultaneous capsule endoscopy viewing an effective approach for acute overt-obscure gastrointestinal bleeding? Yes, this combined technique is both feasible and beneficial for immediate diagnosis and treatment, which helps improve patient safety and recovery.",5.210914001850786e-07,0.13766832692796172,0.21432098765432098,0.0398953822252012,0.2379078029317072,0.16493055555555558,0.039837633900963065,0.2931355767142749,0.13660974593919203,5.210914001850789e-07,0.35045962742757064,0.10560000000000004
50,0.7,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can real-time capsule endoscopy viewing combined with emergency double-balloon enteroscopy be used feasibly in acute overt-obscure gastrointestinal bleeding? Yes, this combined approach enables prompt diagnosis and treatment, reducing the likelihood of complications and improving patient outcomes.",5.684633456564492e-07,0.19323817808277388,0.21432098765432098,0.04352223515476495,0.29506621677165557,0.16493055555555558,0.04345923698286881,0.3519760767372082,0.13660974593919203,5.684633456564497e-07,0.4110842492440061,0.10560000000000004
50,0.7,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it practical to use emergency double-balloon enteroscopy together with real-time capsule endoscopy in cases of acute overt-obscure gastrointestinal bleeding? Yes, the combined use is feasible, allowing for immediate diagnosis and therapeutic intervention that enhances patient care.",5.447773729207639e-07,0.16506730111607704,0.21432098765432098,0.04170880868998307,0.26607867989840406,0.16493055555555558,0.04164843544191594,0.32212311358752643,0.13660974593919203,5.447773729207643e-07,0.3803125905772524,0.10560000000000004
50,0.7,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is the emergency use of double-balloon enteroscopy alongside real-time capsule endoscopy a feasible method for acute overt-obscure gastrointestinal bleeding? Yes, this combined approach supports timely diagnosis and treatment, decreasing complication risks and improving outcomes.",6.158352911278198e-07,0.25207867810570717,0.21432098765432098,0.04714908808432871,0.35569083858809103,0.16493055555555558,0.04708084006477456,0.4144964337185417,0.13660974593919203,6.158352911278206e-07,0.47562277038157763,0.10560000000000004
50,0.7,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does emergency double-balloon enteroscopy combined with live capsule endoscopy viewing represent a feasible approach for acute overt-obscure gastrointestinal bleeding? Yes, this combined method permits immediate diagnosis and treatment, which reduces complications and improves patient prognosis.",5.921493183921345e-07,0.2222257149560254,0.21432098765432098,0.04533566161954683,0.32491917992133734,0.16493055555555558,0.045270038523821686,0.3827477354039619,0.13660974593919203,5.921493183921352e-07,0.44283294755858593,0.10560000000000004
50,0.7,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is combining emergency double-balloon enteroscopy with real-time capsule endoscopy a feasible strategy in acute overt-obscure gastrointestinal bleeding? Yes, this approach is practical and effective, allowing for rapid diagnosis and therapeutic intervention to enhance patient outcomes.",5.921493183921345e-07,0.2222257149560254,0.21432098765432098,0.04533566161954683,0.32491917992133734,0.16493055555555558,0.045270038523821686,0.3827477354039619,0.13660974593919203,5.921493183921352e-07,0.44283294755858593,0.10560000000000004
51,0.7,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? Answer: It is unlikely that gestational age misclassification accounts for the observed differences in average birthweights between Aborigines and whites. These findings may aid in understanding other comparisons between populations.,0.0,0.031506690025452144,0.022183224271267066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
51,0.7,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Can gestational age misclassification explain the disparity in birthweights between Australian Aborigines and whites? Answer: Gestational age misclassification probably does not explain the reported differences in average birthweights between Aborigines and whites. The results could assist in interpreting other population comparisons.,7.105791820705622e-08,0.14515778507904642,0.05178198970336588,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.7,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does misclassifying gestational age account for the birthweight gap between Australian Aborigines and whites? Answer: Misclassification of gestational age is unlikely to explain the reported differences in average birthweights between Aborigines and whites. These outcomes may help interpret other between-population analyses.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.7,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights for Australian Aborigines and whites due to gestational age misclassification? Answer: It is improbable that gestational age misclassification explains the reported divergence in average birthweights for Aborigines and whites. The findings might support the interpretation of other population comparisons.,0.0,0.0,1.3877787807814457e-17,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0
51,0.7,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does the misclassification of gestational age explain birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification is an unlikely cause of the observed divergence in average birthweights between Aborigines and whites. These results may aid in interpreting other between-group comparisons.,4.737194547137081e-08,0.018013962754721113,0.020316775728732916,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.7,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? Answer: It is unlikely that gestational age misclassification is responsible for the reported differences in average birthweights between Aborigines and whites. These findings could help interpret other inter-population comparisons.,2.3685972735685406e-08,0.025187659389265704,0.0015582242712670613,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.7,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could gestational age misclassification clarify the birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification is an improbable explanation for the reported divergence in average birthweights for Aborigines and whites. The results might assist in understanding other between-population comparisons.,7.105791820705622e-08,0.07753366990246668,0.004897905711710296,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.7,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does the misclassification of gestational age explain the difference in birthweights between Australian Aborigines and whites? Answer: It is unlikely that gestational age misclassification accounts for the reported differences in average birthweights between Aborigines and whites. These findings may help with interpreting other population comparisons.,2.3685972735685406e-08,0.024573301853755503,0.0014902451164880426,0.0018134264647818726,0.05522892197167373,0.023242630385487524,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
51,0.7,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification a factor in birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification probably does not explain the reported divergence in average birthweights between Aborigines and whites. The results may help clarify other between-population comparisons.,9.474389094274162e-08,0.1047621868119597,0.0066901636430713035,0.0072537058591274906,0.10094507507642758,0.00238063831257343,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.7,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does gestational age misclassification contribute to birthweight variation between Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification explains the observed differences in average birthweights between Aborigines and whites. These findings may aid in the interpretation of other population comparisons.,2.3685972735685406e-08,0.025187659389265704,0.0015582242712670613,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
52,0.7,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can a zero central line-associated bloodstream infection rate be maintained over time? Answer: Reaching zero central line-associated bloodstream infections is a perfect target in healthcare, yet sustaining it continuously is difficult. It demands strict infection prevention protocols, ongoing staff education, and thorough surveillance. Even with these measures, sporadic cases might still happen because",2.3685972735685406e-08,0.07387623755489736,0.03866564056133997,0.0018134264647818726,0.07482804146747579,0.039463286555002274,0.0018108015409528666,0.07579804658847333,0.04015554549569944,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,0.7,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is it possible to sustain a zero rate of central line-associated bloodstream infections? Answer: Attaining a zero infection rate for central line-associated bloodstream infections is an aspirational objective in medical environments, but consistently upholding it poses challenges. This involves rigorous infection control practices, constant training of personnel, and diligent monitoring. Despite these precautions, occasional infections may arise due to",1.6580180914979784e-07,0.18910171626159977,0.04436410994909509,0.012693985253473108,0.21344472040583362,0.060627213917267594,0.012675610786670066,0.21420592407359784,0.05975554549569943,1.6580180914979784e-07,0.19011483593553846,0.040742417383431435
52,0.7,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can zero central line-associated bloodstream infections be kept consistently? Answer: Achieving zero infections linked to central lines is an ideal benchmark in healthcare, but maintaining this status continuously can be tough. It requires comprehensive infection control, persistent staff training, and strict oversight. Nonetheless, isolated cases may still occur because of",4.737194547137081e-08,0.09407682156978359,0.09506564056134,0.0036268529295637453,0.0687236348859015,0.07786328655500228,0.003621603081905733,0.042355667146938725,0.05975554549569943,4.737194547137081e-08,0.014910746910446804,0.040742417383431435
52,0.7,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is a zero rate of central line-associated bloodstream infections sustainable? Answer: The goal of zero infections associated with central lines is commendable in healthcare settings, yet sustaining it indefinitely is challenging. It necessitates stringent infection control protocols, ongoing education for staff, and meticulous monitoring. Despite these efforts, occasional infections can still take place due to",7.105791820705622e-08,0.18938700137410924,0.09506564056134,0.005440279394345618,0.16588738333955,0.07786328655500228,0.0054324046228586,0.14144656979116865,0.05975554549569943,7.105791820705622e-08,0.1160068637818168,0.040742417383431435
52,0.7,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can maintaining zero central line-associated bloodstream infections be done long-term? Answer: Striving for zero central line-associated bloodstream infections is an ideal aim in healthcare, but keeping it stable over time is difficult. It requires strict infection control measures, continuous personnel training, and careful tracking. Even with these efforts, sporadic incidents may occur because of",4.737194547137081e-08,0.06834939151184649,0.02146564056134001,0.0036268529295637453,0.06872575818853388,0.021463286555002258,0.003621603081905733,0.06907936093124878,0.021355545495699423,4.737194547137081e-08,0.06940653554981457,0.021142417383431443
52,0.7,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is it feasible to maintain a zero central line-associated bloodstream infection rate consistently? Answer: Zero central line-associated bloodstream infections is an ideal target in healthcare, but sustaining it over time is challenging. This demands rigorous infection control, ongoing staff training, and vigilant monitoring. Despite these measures, occasional infections may still happen due to",2.3685972735685406e-08,0.07387623755489736,0.03866564056133997,0.0018134264647818726,0.07482804146747579,0.039463286555002274,0.0018108015409528666,0.07579804658847333,0.04015554549569944,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,0.7,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can a zero central line-associated bloodstream infection rate be upheld continuously? Answer: Achieving zero infections related to central lines is an ideal in healthcare, but maintaining this consistently is difficult. It involves strict infection prevention protocols, continuous staff education, and thorough monitoring. Nonetheless, isolated cases might still arise because",7.105791820705622e-08,0.07387411425226498,0.09506564056134,0.005440279394345618,0.04810434768316574,0.07786328655500228,0.0054324046228586,0.021302257949105563,0.05975554549569943,7.105791820705622e-08,0.006595458310516555,0.040742417383431435
52,0.7,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is the zero central line-associated bloodstream infection rate maintainable? Answer: Reaching zero infections associated with central lines is a desirable goal in healthcare, but keeping it up indefinitely is challenging. This requires stringent infection control practices, ongoing training for staff, and rigorous surveillance. Even with these precautions, occasional cases may still occur due to",4.737194547137081e-08,0.17103786270591348,0.09506564056134,0.0036268529295637453,0.14719525032739567,0.07786328655500228,0.003621603081905733,0.12239837482047555,0.05975554549569943,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
52,0.7,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Can zero central line-associated bloodstream infection rates be sustained indefinitely? Answer: Achieving zero central line-associated bloodstream infections is the ideal in medical settings, but sustaining that level indefinitely is difficult. It calls for strict infection control, continuous staff training, and comprehensive monitoring. Despite these efforts, sporadic infections may still occur because",2.3685972735685406e-08,0.032332721741264336,0.036471890561339995,0.0018134264647818726,0.03347456775862456,0.03793273099944672,0.0018108015409528666,0.0346832326941664,0.03935623994014388,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,0.7,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Question: Is sustaining a zero rate of central line-associated bloodstream infections achievable? Answer: The aspiration to maintain zero central line-associated bloodstream infections is ideal in healthcare, though maintaining it perpetually is challenging. It requires rigorous infection control, ongoing training, and detailed monitoring. Even with these efforts, occasional infections may still happen due to",0.0,0.053319013889225886,0.03758958891619213,0.0,0.05436448474980038,0.03871293253584359,0.0,0.0554517744447951,0.0397638753582567,0.0,0.056583443311015724,0.040742417383431435
53,0.7,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,Question: How is gender dimorphism characterized after injury and hemorrhagic shock: are hormonal differences the cause? Answer: The protective effect of being female against multiple organ failure and hospital-acquired infections remains significant in both premenopausal and postmenopausal women compared to men of similar ages. This contrasts with earlier experimental findings and known physiological sex hormone changes post-injury.,1.1842986367842703e-07,0.08552217343816082,0.0,0.009067132323909363,0.08701137698962835,0.0,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
53,0.7,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the characterization of gender differences following injury and hemorrhagic shock: do hormones play a role? Answer: Females exhibit a significant independent protective effect against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal groups relative to age-matched men, which differs from previous experimental data and documented hormone fluctuations.",2.1317375462116866e-07,0.1596301455918825,0.0,0.016320838183036854,0.16251892949777424,0.0,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
53,0.7,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How does gender dimorphism manifest after injury and hemorrhagic shock: are hormonal variations responsible? Answer: The female gender independently offers significant protection against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women compared with similarly aged men, opposing prior experimental studies and known hormone changes.",2.8423167282822487e-07,0.21905356606268356,0.0,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
53,0.7,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: In the context of injury and hemorrhagic shock, how is gender dimorphism characterized: are hormones the key factor? Answer: Female gender shows a consistent protective effect against multiple organ failure and hospital-acquired infections in both pre- and postmenopausal women compared to men of similar age, which contrasts earlier research and known physiological sex hormone shifts.",1.4211583641411244e-07,0.10354067894083929,0.0,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
53,0.7,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism after injury and hemorrhagic shock defined: do hormonal differences explain it? Answer: Female patients, both premenopausal and postmenopausal, have a significant independent protective effect against multiple organ failure and nosocomial infections relative to age-matched men, contrary to previous studies and known hormonal changes.",3.316036182995957e-07,0.2607262624632525,0.0,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
53,0.7,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What characterizes gender dimorphism following injury and hemorrhagic shock: are hormonal factors responsible? Answer: The female gender’s independent protective effect on multiple organ failure and infection rates remains significant in both pre- and postmenopausal women versus similarly aged men, differing from prior experimental findings and known hormone alterations.",3.079176455639103e-07,0.23967285326541932,0.0,0.023574544042164344,0.24419696051204154,0.0,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
53,0.7,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism characterized after injury and hemorrhagic shock: do hormones account for the difference? Answer: Female gender independently confers significant protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared with men of similar age, which contradicts earlier experimental results and known physiological hormone changes.",2.1317375462116866e-07,0.1596301455918825,0.0,0.016320838183036854,0.16251892949777424,0.0,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
53,0.7,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the nature of gender dimorphism after injury and hemorrhagic shock: are hormonal differences the cause? Answer: The protective effect of female sex on multiple organ failure and hospital-acquired infection rates is significant in both premenopausal and postmenopausal women compared to age-matched men, opposing previous experimental research and known hormone fluctuations.",2.1317375462116866e-07,0.1596301455918825,0.0,0.016320838183036854,0.16251892949777424,0.0,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
53,0.7,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How does gender dimorphism present after injury and hemorrhagic shock: are hormonal differences causative? Answer: The female gender independently provides significant protection against multiple organ failure and nosocomial infections in both pre- and postmenopausal women relative to similarly aged men, contrary to prior experimental studies and known physiological sex hormone changes.",2.3685972735685406e-07,0.17904823144898518,0.0,0.018134264647818726,0.182321556793954,0.0,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
53,0.7,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: In injury and hemorrhagic shock, how is gender dimorphism characterized: do hormonal differences underlie it? Answer: Female gender maintains a significant independent protective effect on multiple organ failure and hospital-acquired infection rates in both premenopausal and postmenopausal women compared with men of similar age, which contrasts with earlier experimental findings and known hormone changes.",1.6580180914979784e-07,0.12188981760903506,0.0,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
54,0.7,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women need fewer calories to keep their weight stable? Caloric needs for maintaining weight depend on personal factors such as age, height, weight, and activity level, not on race or ethnicity.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.7,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Is it true that African American women require fewer calories to maintain their weight? The amount of calories needed to maintain weight is influenced by individual characteristics like age, height, weight, and exercise habits, rather than racial or ethnic identity.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
54,0.7,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women have lower calorie requirements to sustain their weight? Caloric intake for weight maintenance is based on individual attributes including age, height, weight, and physical activity, not on racial or ethnic background.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.7,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Are fewer calories necessary for African American women to maintain their weight? Calorie needs for weight maintenance are determined by factors such as age, height, weight, and activity level, not by race or ethnicity.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.7,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women need to consume fewer calories to keep their weight steady? The caloric amount needed to maintain weight depends on individual factors like age, height, weight, and physical activity level, not on race or ethnicity.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
54,0.7,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Is the caloric requirement for weight maintenance lower in African American women? Caloric needs are influenced by personal factors such as age, height, weight, and physical activity rather than racial or ethnic background.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.7,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women require a reduced calorie intake to maintain weight? Caloric needs for maintaining weight are dictated by individual elements like age, height, weight, and exercise level, not racial or ethnic factors.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.7,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Are African American women required to eat fewer calories to maintain their weight? The calorie intake for weight maintenance depends on individual variables including age, height, weight, and physical activity level, not on ethnicity or race.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
54,0.7,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Is there a need for African American women to have fewer calories to sustain weight? Maintaining weight through caloric intake is influenced by personal factors such as age, height, weight, and activity, not by racial or ethnic background.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
54,0.7,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Do African American women have lower calorie needs for maintaining their weight? Caloric requirements for weight maintenance are determined by individual factors like age, height, weight, and physical activity, rather than race or ethnicity.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
55,0.7,1,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does heightened neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Yes, increased neutrophil migration after severe trauma may play a role in causing Acute Respiratory Distress Syndrome (ARDS) due to its involvement in lung inflammation and harmful substance release.",4.026615365066519e-07,0.060611281226001346,0.20391559251246924,0.030828249901291835,0.10820341253757038,0.14888501892915088,0.030783626196198732,0.1252002923605544,0.14532871972318342,4.026615365066519e-07,0.17539222345558425,0.11649408284023667
55,0.7,2,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is increased neutrophil migratory activity after major trauma a contributing factor to the etiology of acute respiratory distress syndrome? Indeed, elevated neutrophil migration post-trauma can be a factor in ARDS development because it promotes lung inflammation and the release of damaging agents.",4.974054274493935e-07,0.09208862157557363,0.24826388888888892,0.038081955760419325,0.17200690231644344,0.17159999999999997,0.0380268323600102,0.22283876192447227,0.14532871972318342,4.974054274493935e-07,0.27547568201256567,0.11649408284023667
55,0.7,3,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can increased neutrophil migration following significant trauma influence the onset of acute respiratory distress syndrome? Yes, the heightened movement of neutrophils after major trauma can contribute to ARDS by causing lung inflammation and releasing harmful substances.",6.395212638635054e-07,0.25031262679046806,0.24826388888888892,0.04896251454911057,0.3345258318142177,0.17159999999999997,0.04889164160572741,0.38989284658763657,0.14532871972318342,6.39521263863506e-07,0.4473259389392257,0.11649408284023667
55,0.7,4,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does the rise in neutrophil migratory activity after major trauma contribute to acute respiratory distress syndrome? Yes, increased neutrophil migration after trauma may lead to ARDS as it causes inflammation in the lungs and the release of detrimental substances.",5.684633456564495e-07,0.16807452855349503,0.24826388888888892,0.04352223515476494,0.24996844378615402,0.17159999999999997,0.0434592369828688,0.30288146959800644,0.14532871972318342,5.684633456564497e-07,0.3577137802495387,0.11649408284023667
55,0.7,5,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is heightened neutrophil migratory activity after major trauma linked to the etiology of acute respiratory distress syndrome? Yes, this increased neutrophil activity can cause lung inflammation and release harmful compounds, potentially resulting in ARDS.",6.86893209334876e-07,0.30915312681340135,0.24826388888888892,0.05258936747867433,0.39515045363065315,0.17159999999999997,0.05251324468763316,0.4524132035689701,0.14532871972318342,6.868932093348768e-07,0.5118644600767972,0.11649408284023667
55,0.7,6,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can increased neutrophil migratory activity following major trauma be a factor in acute respiratory distress syndrome? Yes, elevated neutrophil migration after trauma can promote lung inflammation and harmful substance release, contributing to ARDS.",7.105791820705613e-07,0.33992478548015503,0.24826388888888892,0.05440279394345621,0.426899151945233,0.17159999999999997,0.05432404622858603,0.4852030263919618,0.14532871972318342,7.105791820705622e-07,0.545766011752479,0.11649408284023667
55,0.7,7,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does major trauma-induced increase in neutrophil migratory activity play a role in the cause of acute respiratory distress syndrome? Yes, because increased neutrophil migration can lead to lung inflammation and the release of damaging substances, potentially causing ARDS.",5.921493183921348e-07,0.1947427756356559,0.24826388888888892,0.045335661619546816,0.27736741797426934,0.17159999999999997,0.045270038523821665,0.3310523465647033,0.14532871972318342,5.921493183921352e-07,0.3867013171227902,0.11649408284023667
55,0.7,8,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is there a connection between increased neutrophil migratory activity after major trauma and acute respiratory distress syndrome? Yes, the increased neutrophil activity can lead to lung inflammation and the emission of harmful substances, which may result in ARDS.",5.921493183921348e-07,0.2322101908010583,0.22125771604938277,0.045335661619546816,0.27736741797426934,0.17159999999999997,0.045270038523821665,0.3310523465647033,0.14532871972318342,5.921493183921352e-07,0.3867013171227902,0.11649408284023667
55,0.7,9,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migration after major trauma contribute to the development of acute respiratory distress syndrome? Yes, the enhanced neutrophil activity can cause inflammation in the lungs and release harmful agents, potentially leading to ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.7,10,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can the increase in neutrophil migratory activity post-major trauma be implicated in acute respiratory distress syndrome? Yes, this increase can contribute to lung inflammation and the discharge of harmful substances, which may cause ARDS.",6.86893209334876e-07,0.30915312681340135,0.24826388888888892,0.05258936747867433,0.39515045363065315,0.17159999999999997,0.05251324468763316,0.4524132035689701,0.14532871972318342,6.868932093348768e-07,0.5118644600767972,0.11649408284023667
56,0.7,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in such cases was unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment are necessary.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.7,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery help in spinal cord sarcoidosis paired with compressive cervical myelopathy? The benefit of decompression was not apparent. Early detection of sarcoidosis affecting other organs and steroid therapy is required.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.7,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression surgery effective for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The results did not show a clear benefit from decompression. Early diagnosis of sarcoidosis in other organs and administration of steroids are needed.,1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
56,0.7,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery improve outcomes in spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression was not significant. Prompt diagnosis of sarcoidosis in other organs and steroid treatment should be prioritized.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.7,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a viable treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression was not demonstrated. Early identification of sarcoidosis in other organs along with steroid therapy is essential.,1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
56,0.7,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does spinal cord sarcoidosis with compressive cervical myelopathy respond well to decompressive surgery? The benefits of decompression were not evident. Early diagnosis of sarcoidosis in other organs and steroid treatment is necessary.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.7,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression surgery effective in cases of spinal cord sarcoidosis with compressive cervical myelopathy? No clear effect of decompression was observed. Early sarcoidosis diagnosis from other organs and steroid therapy should be performed.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.7,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery useful for spinal cord sarcoidosis complicated by compressive cervical myelopathy? The effect of decompression was not clear. Early diagnosis of sarcoidosis in other organs and steroid therapy are important.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.7,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression surgery effective for spinal cord sarcoidosis with cervical compressive myelopathy? The benefit of decompression was not obvious. Early detection of sarcoidosis from other organs and steroid treatment is needed.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.7,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide benefit in spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy should be considered.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
57,0.7,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for laparoscopic surgery to treat GERD? Answer: Laparoscopic antireflux surgery is safe and effective for GERD in elderly patients, with low morbidity and mortality and symptom improvement similar to younger individuals.",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.7,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery remains a safe, effective option for elderly GERD patients, showing low rates of complications and symptom relief comparable to younger patients.",2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
57,0.7,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is elderly age a reason to avoid laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in older adults, with low morbidity, mortality, and symptom improvement on par with younger patients.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.7,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Can elderly patients safely undergo laparoscopic surgery for GERD? Answer: Yes, laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly people, associated with low complication rates and symptom improvement similar to that seen in younger patients.",4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
57,0.7,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is being elderly a contraindication for laparoscopic antireflux surgery in GERD? Answer: Laparoscopic surgery for GERD is safe and effective in elderly patients, with low morbidity, mortality, and significant symptom improvement comparable to younger patients.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.7,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age prevent the use of laparoscopic surgery for GERD treatment? Answer: Laparoscopic antireflux surgery is both safe and effective for GERD even in elderly patients, showing low morbidity and mortality rates and symptom relief comparable to younger patients.",4.737194547137081e-08,0.0834475231974281,0.02498356344510192,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
57,0.7,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD contraindicated in older adults? Answer: No, it is safe and effective for elderly GERD patients, with low complication rates and symptom improvement comparable to younger individuals.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
57,0.7,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Should advanced age exclude patients from laparoscopic antireflux surgery for GERD? Answer: Advanced age is not a contraindication; laparoscopic surgery is safe and effective for elderly GERD patients, with low morbidity and mortality and symptom improvement similar to younger patients.",4.737194547137081e-08,0.0834475231974281,0.02498356344510192,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
57,0.7,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD safe in the elderly? Answer: Yes, it is a safe and effective procedure with low morbidity and mortality rates, providing symptom improvement comparable to younger patients.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
57,0.7,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does elderly age contraindicate laparoscopic antireflux surgery for GERD? Answer: Laparoscopic surgery is safe and effective in elderly patients with GERD, demonstrating low morbidity and mortality and significant symptom relief comparable to younger patients.",1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
58,0.7,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and healthcare professionals consider it acceptable to violate confidentiality to protect a patient's spouse from a sexually transmitted infection? Research indicates that both French laypeople and healthcare professionals approve breaching confidentiality to safeguard a patient's wife from a sexually transmitted disease.,1.8948778188548325e-07,0.08286469674446595,0.03429152159119145,0.014507411718254981,0.1874034270903171,0.12037923121535359,0.014486412327622933,0.2295665856279543,0.1707816765200147,1.8948778188548325e-07,0.27400033707467664,0.22267512542066287
58,0.7,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it acceptable for French non-professionals and health workers to break confidentiality to shield a patient's wife from a sexually transmitted disease? Studies show that both French laypeople and health professionals agree on breaching confidentiality to protect the patient's wife from an STD.,2.1317375462116866e-07,0.2174607986646686,0.13474537430711903,0.016320838183036854,0.2945288609134309,0.21287786160249744,0.0162972138685758,0.30631014580245264,0.2434963579604579,2.1317375462116866e-07,0.2833398881183813,0.24765868886576478
58,0.7,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypersons and medical professionals find it permissible to breach confidentiality to protect a patient's wife from acquiring a sexually transmitted disease? Evidence suggests that both groups find it acceptable to break confidentiality to protect the patient's wife from an STD.,2.3685972735685406e-07,0.15633099353653046,0.10932943435978472,0.018134264647818726,0.23433358785535496,0.1873913657576221,0.018108015409528666,0.2809923378181609,0.2434963579604579,2.3685972735685406e-07,0.2573644017151233,0.24765868886576478
58,0.7,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are French laypeople and health care providers in favor of violating confidentiality to protect a patient’s wife from a sexually transmitted infection? Research suggests both laypeople and health professionals in France accept breaching confidentiality to safeguard a patient’s wife from an STD.,2.3685972735685406e-07,0.12251893594824015,0.08688738346535288,0.018134264647818726,0.19967622882735814,0.16274592223069323,0.018108015409528666,0.24544632855867698,0.21787308926239696,2.3685972735685406e-07,0.2573644017151233,0.24765868886576478
58,0.7,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French lay individuals and health professionals accept breaching confidentiality to shield a patient’s wife from a sexually transmitted disease? Research indicates that both groups consider it acceptable to break confidentiality for this protection.,4.2634750924233657e-07,0.10832677624015208,0.22892819979188353,0.03264167636607373,0.08050475459713935,0.23725286160249745,0.03259442773715163,0.0514178961736631,0.2434963579604579,4.263475092423373e-07,0.020975623650891784,0.24765868886576478
58,0.7,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is breaching confidentiality to protect a patient’s wife from a sexually transmitted disease considered acceptable by French laypeople and health professionals? Research findings show that both French laypeople and health workers find such breaches acceptable.,4.0266153650665127e-07,0.015859648702785556,0.14151925078043712,0.03082824990129185,0.027258573196020652,0.17689906347554635,0.030783626196198753,0.03984489570324534,0.2122788761706556,4.026615365066519e-07,0.05376544647388348,0.24765868886576478
58,0.7,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and healthcare professionals approve of compromising confidentiality to protect a patient's wife from a sexually transmitted disease? Studies suggest that both groups find it acceptable to breach confidentiality in this context.,4.2634750924233657e-07,0.10832677624015208,0.22892819979188353,0.03264167636607373,0.08050475459713935,0.23725286160249745,0.03259442773715163,0.0514178961736631,0.2434963579604579,4.263475092423373e-07,0.020975623650891784,0.24765868886576478
58,0.7,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it acceptable among French laypeople and health professionals to break confidentiality to protect a patient's wife from a sexually transmitted infection? Research shows both groups agree on breaching confidentiality to protect the patient's wife.,4.0266153650665127e-07,0.05663301226513395,0.17033444979188353,0.03082824990129185,0.06926749322995729,0.20697942410249745,0.030783626196198753,0.08316659448824293,0.2434963579604579,4.026615365066519e-07,0.05376544647388348,0.24765868886576478
58,0.7,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and medical professionals agree that breaching confidentiality is acceptable to protect a patient's wife from a sexually transmitted disease? Research indicates acceptance among both French laypersons and health professionals for such breaches.,4.0266153650665127e-07,0.13817973938983386,0.22892819979188353,0.03082824990129185,0.11127641326389304,0.23725286160249745,0.030783626196198753,0.08316659448824293,0.2434963579604579,4.026615365066519e-07,0.05376544647388348,0.24765868886576478
58,0.7,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are French laypersons and health care professionals willing to breach confidentiality to safeguard a patient’s wife from a sexually transmitted disease? Research suggests that both groups find it acceptable to violate confidentiality for this purpose.,4.0266153650665127e-07,0.13817973938983386,0.22892819979188353,0.03082824990129185,0.11127641326389304,0.23725286160249745,0.030783626196198753,0.08316659448824293,0.2434963579604579,4.026615365066519e-07,0.05376544647388348,0.24765868886576478
59,0.7,1,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Answer: epiDWI may distinguish pleomorphic adenoma and myoepithelial adenomas from other entities examined. However, due to overlap within benign and malignant groups and between groups, diagnosis should be cautious.",3.552895910352811e-07,0.2992428948528567,0.0,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
59,0.7,2,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is it possible to predict various histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Answer: epiDWI shows promise in differentiating pleomorphic adenoma and myoepithelial adenomas from other lesions, but overlapping features among benign and malignant groups limit definitive diagnosis.",3.552895910352811e-07,0.2992428948528567,0.0,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
59,0.7,3,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging be used to identify different histologic subtypes of primary parotid gland tumors? Answer: epiDWI can potentially separate pleomorphic adenoma and myoepithelial adenomas from other entities, yet overlap within and between benign and malignant lesions advises caution in diagnosis.",3.552895910352811e-07,0.2992428948528567,0.0,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
59,0.7,4,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Does diffusion-weighted echo-planar MR imaging allow prediction of distinct histologic subtypes in primary parotid gland tumors? Answer: epiDWI has the capability to differentiate pleomorphic adenoma and myoepithelial adenomas from other types, but due to overlaps within benign and malignant groups, diagnostic conclusions should be made carefully.",2.8423167282822487e-07,0.23180161405732447,0.0,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
59,0.7,5,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can different histologic subtypes of primary parotid gland tumors be predicted by diffusion-weighted echo-planar MR imaging? Answer: epiDWI can distinguish pleomorphic and myoepithelial adenomas from other examined lesions; however, overlap among benign and malignant lesions suggests diagnoses should be made cautiously.",4.026615365066519e-07,0.34687094384211115,0.0,0.030828249901291835,0.354171813720614,0.0,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
59,0.7,6,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is predicting various histologic subtypes of primary parotid gland tumors feasible with diffusion-weighted echo-planar MR imaging? Answer: epiDWI potentially differentiates pleomorphic and myoepithelial adenomas from other entities, but overlapping characteristics within and between groups mean diagnoses should be approached with care.",4.026615365066519e-07,0.34687094384211115,0.0,0.030828249901291835,0.354171813720614,0.0,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
59,0.7,7,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging predict histologic subtypes in primary parotid gland tumors? Answer: epiDWI may differentiate pleomorphic and myoepithelial adenomas from others, though overlap in benign and malignant groups means diagnosis should not rely solely on this method.",4.500334819780226e-07,0.3968813644167746,0.0,0.03445510283085558,0.4054651081081637,0.0,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
59,0.7,8,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is it possible to use diffusion-weighted echo-planar MR imaging to predict different histologic subtypes of primary parotid gland tumors? Answer: epiDWI can potentially distinguish pleomorphic and myoepithelial adenomas from other examined lesions, but due to overlapping features in benign and malignant groups, diagnosis should be made cautiously.",2.6054570009253947e-07,0.2102954088363611,0.0,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
59,0.7,9,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging help predict various histologic subtypes of primary parotid gland tumors? Answer: epiDWI is capable of differentiating pleomorphic and myoepithelial adenomas from other entities, but overlapping characteristics within and across groups warrant cautious diagnostic interpretation.",4.500334819780226e-07,0.3968813644167746,0.0,0.03445510283085558,0.4054651081081637,0.0,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
59,0.7,10,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is diffusion-weighted echo-planar MR imaging effective for predicting different histologic subtypes of primary parotid gland tumors? Answer: epiDWI shows potential in separating pleomorphic adenoma and myoepithelial adenomas from other lesions, yet overlaps between benign and malignant groups indicate that diagnoses should be made prudently.",3.316036182995957e-07,0.2762533766281572,0.0,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
60,0.7,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible to get correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Yes, homebrew assays can yield correlated results if they are carefully designed and executed with strict quality control, offering precision and sensitivity comparable to commercial kits.",5.447773729207643e-07,0.3879111337419707,0.028847637274558337,0.04170880868998307,0.4153900460565776,0.015380859375,0.04164843544191593,0.44531101665536355,0.0,5.447773729207643e-07,0.454255272277599,0.0
60,0.7,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew assays produce correlated outcomes for BCRABL transcript detection by quantitative real-time PCR? Yes, when properly designed and performed with rigorous quality control, homebrew assays can achieve results consistent with commercial kits in terms of precision and sensitivity.",6.632072365991912e-07,0.4835277127709845,0.048952022251847166,0.050775941013892434,0.5421417516957199,0.015380859375,0.050702443146680265,0.5753641449035611,0.0,6.632072365991914e-07,0.5877866649021217,0.0
60,0.7,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results achievable from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? Yes, with accurate design and meticulous execution, homebrew assays can deliver precision and sensitivity comparable to commercial assays, provided quality control is maintained.",6.868932093348765e-07,0.5111819444627614,0.048242416249448375,0.052589367478674306,0.5695407258838352,0.015380859375,0.05251324468763313,0.603535021870258,0.0,6.868932093348768e-07,0.6167742017753732,0.0
60,0.7,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it feasible to obtain correlated outcomes from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Yes, homebrew assays, if carefully crafted and consistently performed with strong quality controls, can provide results comparable to those of commercial kits.",6.395212638635059e-07,0.4210707958119402,0.07524858908895454,0.04896251454911056,0.515473504613559,0.015380859375,0.0488916416057274,0.5479651707154458,0.0,6.39521263863506e-07,0.5596157879354249,0.0
60,0.7,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can quantitative real-time PCR assays developed in-house provide correlated results for BCRABL transcript detection? Yes, if these homebrew assays are precisely designed and executed with stringent quality control, they can match the precision and sensitivity of commercial kits.",6.868932093348765e-07,0.473714529297359,0.07524858908895454,0.052589367478674306,0.5695407258838352,0.015380859375,0.05251324468763313,0.603535021870258,0.0,6.868932093348768e-07,0.6167742017753732,0.0
60,0.7,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are homebrew quantitative real-time PCR assays capable of producing correlated results for BCRABL transcript detection? Yes, with accurate design, meticulous execution, and consistent quality control, homebrew assays can achieve comparable sensitivity and precision as commercial alternatives.",7.342651548062471e-07,0.5292843804521712,0.07524858908895454,0.05621622040823806,0.6266991397237835,0.015380859375,0.05613484776953888,0.6623755218931913,0.0,7.342651548062476e-07,0.6773988235918087,0.0
60,0.7,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible to get consistent results from homebrew assays in BCRABL transcript detection using quantitative real-time PCR? Yes, homebrew assays can yield correlated results if they are designed accurately and performed with strict quality controls, ensuring precision and sensitivity similar to commercial kits.",5.447773729207643e-07,0.3556717299949965,0.05200595870346702,0.04170880868998307,0.4153900460565776,0.015380859375,0.04164843544191593,0.44531101665536355,0.0,5.447773729207643e-07,0.454255272277599,0.0
60,0.7,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew quantitative real-time PCR assays reliably detect BCRABL transcripts with results correlated to commercial kits? Yes, provided these assays are carefully designed and executed with rigorous quality control, they can offer similar precision and sensitivity.",7.342651548062471e-07,0.5292843804521712,0.07524858908895454,0.05621622040823806,0.6266991397237835,0.015380859375,0.05613484776953888,0.6623755218931913,0.0,7.342651548062476e-07,0.6773988235918087,0.0
60,0.7,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results possible from homebrew quantitative real-time PCR assays for detecting BCRABL transcripts? Yes, when these assays are accurately designed and meticulously carried out with appropriate quality controls, they can produce results comparable to commercial kits.",7.105791820705618e-07,0.5011135034854743,0.07524858908895454,0.05440279394345618,0.597711602850532,0.015380859375,0.054324046228586005,0.6325225587435095,0.0,7.105791820705622e-07,0.646627164925055,0.0
60,0.7,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it achievable to obtain correlated results from homebrew quantitative real-time PCR assays for BCRABL transcript detection? Yes, with precise assay design, careful execution, and stringent quality control, homebrew assays can match the sensitivity and precision of commercial kits.",6.632072365991912e-07,0.44704628221519815,0.07524858908895454,0.050775941013892434,0.5421417516957199,0.015380859375,0.050702443146680265,0.5753641449035611,0.0,6.632072365991914e-07,0.5877866649021217,0.0
61,0.7,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary for diagnosing appendicitis in children? Clinical evaluation remains crucial for diagnosis. However, for girls over 10 years old, selective imaging is recommended to prevent unnecessary appendectomies. Ultrasonography is preferred in uncertain cases.",2.6054570009253883e-07,0.21868888243771822,0.04434829637641969,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
61,0.7,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we require imaging to diagnose appendicitis in pediatric patients? The diagnosis primarily relies on clinical assessment. Still, in girls older than 10, imaging should be selectively used to avoid unwarranted surgeries. Ultrasonography is the imaging method of choice when diagnosis is unclear.",7.105791820705622e-08,0.007379788770512263,0.04434829637641969,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
61,0.7,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should imaging be used to diagnose appendicitis in children? Diagnosis mainly depends on clinical evaluation. However, for girls above 10 years, imaging is selectively advised to prevent unnecessary appendectomies. Ultrasonography is preferred in ambiguous cases.",2.6054570009253883e-07,0.21868888243771822,0.04434829637641969,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
61,0.7,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging needed to diagnose appendicitis in children? The key diagnostic tool is clinical assessment. Yet, in girls older than 10, selective imaging helps avoid unnecessary appendectomies. Ultrasonography is recommended when diagnosis is uncertain.",2.8423167282822413e-07,0.2485418455874,0.04434829637641969,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
61,0.7,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do children with suspected appendicitis require imaging? Diagnosis is chiefly clinical. Nevertheless, in girls over the age of 10, selective imaging should be considered to reduce unnecessary appendectomies. Ultrasonography is the preferred choice in doubtful cases.",2.3685972735685353e-07,0.18970134556446672,0.04434829637641969,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
61,0.7,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging essential for diagnosing appendicitis in children? Clinical assessment is fundamental for diagnosis. In girls older than 10, selective imaging is advised to prevent unnecessary surgeries. Ultrasonography is the imaging modality of choice for equivocal presentations.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.7,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Must imaging be performed to diagnose appendicitis in pediatric cases? Diagnosis hinges on clinical evaluation. However, in girls older than 10 years, selective imaging is warranted to avoid needless appendectomies. Ultrasonography is favored in uncertain cases.",2.3685972735685353e-07,0.18970134556446672,0.04434829637641969,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
61,0.7,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we need to use imaging to confirm appendicitis in children? Clinical assessment is the cornerstone of diagnosis. For girls over 10, selective imaging should be applied to prevent unnecessary appendectomies. Ultrasonography is preferred in ambiguous situations.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.7,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is diagnostic imaging necessary for appendicitis in children? Clinical evaluation is central to diagnosis. Yet, for girls older than 10, selective imaging reduces unnecessary surgeries. Ultrasonography is the method of choice in equivocal cases.",2.8423167282822413e-07,0.2485418455874,0.04434829637641969,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
61,0.7,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should imaging be utilized to diagnose appendicitis in children? Diagnosis depends primarily on clinical assessment. However, selective imaging is recommended for girls above 10 to avoid unnecessary appendectomies. Ultrasonography is the preferred imaging technique when diagnosis is unclear.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641969,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
62,0.7,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries necessary during thoracic and thoracoabdominal aneurysm repair? Answer: By monitoring MEP and SSEP, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low rates of immediate and delayed paraplegia. This evidence indicates that routine surgical reimplantation of segmental vessels is not required, and that, with",7.105791820705622e-08,0.07189507018810026,0.016661878770468257,0.005440279394345618,0.04959694113937285,0.0,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
62,0.7,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should spinal cord arteries be reimplanted during thoracic and thoracoabdominal aneurysm repair? Answer: Utilizing MEP and SSEP monitoring, it is safe to sacrifice as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, resulting in low incidences of immediate and delayed paraplegia. This suggests routine reimplantation of segmental arteries is unnecessary, and that, with",1.4211583641411244e-07,0.10008345855698497,0.0,0.010880558788691236,0.10178269430994202,0.0,0.0108648092457172,0.10354067894083929,0.0,1.4211583641411244e-07,0.10536051565782412,0.0
62,0.7,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries worthwhile in thoracic and thoracoabdominal aneurysm repair? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation in TAA/A repair is safe and yields acceptably low rates of immediate and delayed paraplegia. This experience implies that routine reimplantation of segmental vessels is not justified, and that, with",9.474389094274162e-08,0.08909379708106879,0.01694411414982164,0.0072537058591274906,0.06669137449867257,0.0,0.007243206163811466,0.0678225963387602,0.0,9.474389094274162e-08,0.06899287148694988,0.0
62,0.7,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair offer benefits? Answer: Monitoring with MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates. This data suggests routine surgical reimplantation of segmental vessels is not necessary, and that, with",1.1842986367842703e-07,0.08269171584511614,0.0,0.009067132323909363,0.0840831172105414,0.0,0.009054007704764333,0.08552217343816082,0.0,1.1842986367842703e-07,0.08701137698962835,0.0
62,0.7,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is it worthwhile to reimplant spinal cord arteries during TAA/A repair? Answer: Through MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation is safe during TAA/A repair, leading to low rates of immediate and delayed paraplegia. This indicates routine segmental vessel reimplantation is not needed, and that, with",2.1317375462116866e-07,0.20549491542429354,0.036982248520710054,0.016320838183036854,0.1568424714929706,0.0,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
62,0.7,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is spinal cord artery reimplantation beneficial in thoracic and thoracoabdominal aneurysm repair? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair remains safe and results in acceptably low immediate and delayed paraplegia rates. This suggests that routine reimplantation of segmental vessels is not necessary, and that, with",1.4211583641411244e-07,0.10008345855698497,0.0,0.010880558788691236,0.10178269430994202,0.0,0.0108648092457172,0.10354067894083929,0.0,1.4211583641411244e-07,0.10536051565782412,0.0
62,0.7,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries during TAA/A repair a valuable procedure? Answer: Using MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and achieves low immediate and delayed paraplegia incidence. This experience suggests that routine segmental vessel reimplantation is not indicated, and that, with",1.6580180914979784e-07,0.16729354855352518,0.03566529492455417,0.012693985253473108,0.1450065518329824,0.0181755829903978,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
62,0.7,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does sacrificing spinal cord arteries without reimplantation during thoracic aneurysm repair affect outcomes? Answer: Monitoring MEP and SSEP reveals that sacrificing up to 15 intercostal and lumbar arteries without reimplantation is safe during TAA/A repair, resulting in low immediate and delayed paraplegia rates. This indicates routine reimplantation of segmental vessels is not required, and that, with",1.6580180914979784e-07,0.16729354855352518,0.03566529492455417,0.012693985253473108,0.1450065518329824,0.0181755829903978,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
62,0.7,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is routine reimplantation of spinal cord arteries necessary in thoracic and thoracoabdominal aneurysm repair? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, leading to acceptably low rates of both immediate and delayed paraplegia. This suggests routine surgical reimplantation of segmental vessels is not warranted, and that, with",4.737194547137081e-08,0.05498699928576389,0.016388888888888897,0.0036268529295637453,0.03278982282299214,0.0,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
62,0.7,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is the reimplantation of spinal cord arteries essential during thoracic and thoracoabdominal aneurysm repair? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, resulting in acceptably low immediate and delayed paraplegia rates. This experience suggests routine surgical implantation of segmental vessels is not necessary, and that, with",7.105791820705622e-08,0.04879016416943571,0.0,0.005440279394345618,0.04959694113937285,0.0,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
63,0.7,1,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, these two conditions are related in such patients.",1.894877818854824e-07,0.10573338003212829,0.2448979591836735,0.014507411718255037,0.05965263839071122,0.23582766439909295,0.014486412327622988,0.010101353658758416,0.2222222222222221,1.8948778188548314e-07,0.04333247325569145,0.20408163265306126
63,0.7,2,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do cervical cord plaques relate to discopathy in people with multiple sclerosis? Yes, there is a relationship between these conditions in MS patients.",1.894877818854824e-07,0.10573338003212829,0.2448979591836735,0.014507411718255037,0.05965263839071122,0.23582766439909295,0.014486412327622988,0.010101353658758416,0.2222222222222221,1.8948778188548314e-07,0.04333247325569145,0.20408163265306126
63,0.7,3,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques associated with discopathy in patients suffering from multiple sclerosis? Yes, a correlation exists between them.",2.8423167282822376e-07,0.09493731543002237,0.2448979591836735,0.02176111757738255,0.1516564552764943,0.23582766439909295,0.02172961849143448,0.21304219765545085,0.2222222222222221,2.8423167282822456e-07,0.2797212513199212,0.20408163265306126
63,0.7,4,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there an association between cervical cord plaques and discopathy among multiple sclerosis patients? Yes, they are linked in these patients.",2.3685972735685306e-07,0.010423200227803076,0.2448979591836735,0.018134264647818796,0.0404308201662702,0.23582766439909295,0.018108015409528735,0.09525916199906703,0.2222222222222221,2.3685972735685385e-07,0.15455810836591555,0.20408163265306126
63,0.7,5,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Does a relationship exist between cervical cord plaques and discopathy in individuals with multiple sclerosis? Yes, these conditions are connected in MS patients.",1.894877818854824e-07,0.10573338003212829,0.2448979591836735,0.014507411718255037,0.05965263839071122,0.23582766439909295,0.014486412327622988,0.010101353658758416,0.2222222222222221,1.8948778188548314e-07,0.04333247325569145,0.20408163265306126
63,0.7,6,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques connected to discopathy in patients with multiple sclerosis? Yes, there is a clear relation.",3.079176455639091e-07,0.15209572926997117,0.2448979591836735,0.023574544042164428,0.21228107709292932,0.23582766439909295,0.023540420032387353,0.2775807187930215,0.2222222222222221,3.079176455639099e-07,0.3487141228068733,0.20408163265306126
63,0.7,7,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a link between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, they are related.",3.079176455639091e-07,0.15209572926997117,0.2448979591836735,0.023574544042164428,0.21228107709292932,0.23582766439909295,0.023540420032387353,0.2775807187930215,0.2222222222222221,3.079176455639099e-07,0.3487141228068733,0.20408163265306126
63,0.7,8,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do patients with multiple sclerosis show a relation between cervical cord plaques and discopathy? Yes, such a relation exists.",2.8423167282822376e-07,0.17195366882557162,0.18953463738436552,0.02176111757738255,0.1516564552764943,0.23582766439909295,0.02172961849143448,0.21304219765545085,0.2222222222222221,2.8423167282822456e-07,0.2797212513199212,0.20408163265306126
63,0.7,9,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there any correlation between cervical cord plaques and discopathy in individuals with multiple sclerosis? Yes, they are related.",2.8423167282822376e-07,0.09493731543002237,0.2448979591836735,0.02176111757738255,0.1516564552764943,0.23582766439909295,0.02172961849143448,0.21304219765545085,0.2222222222222221,2.8423167282822456e-07,0.2797212513199212,0.20408163265306126
63,0.7,10,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques and discopathy related in multiple sclerosis patients? Yes, there is a notable relationship.",3.3160361829959447e-07,0.2127203510864062,0.2448979591836735,0.025387970506946304,0.27681959823049995,0.23582766439909295,0.025351221573340226,0.3465735902799736,0.2222222222222221,3.3160361829959526e-07,0.42282209496059453,0.20408163265306126
64,0.7,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are 30-day and 1-year mortality rates after emergency general surgery laparotomies a significant concern requiring improvement? Answer: Mortality within 30 days and 1 year following emergency general surgery laparotomies continues to be problematic. The elevated mortality rates highlight the necessity for advancements in perioperative management. Improvements in surgical methods, patient selection, and postoperative care may help lower these rates.",4.737194547137081e-08,0.03641793037844332,0.002187170114644324,0.0036268529295637453,0.05859989948873601,0.017776896739735835,0.003621603081905733,0.05880712977502611,0.017538265306122455,4.737194547137081e-08,0.03509131981126945,0.0
64,0.7,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is there a need for improvement given the 30-day and 1-year mortality rates in emergency general surgery laparotomies? Answer: Mortality rates at 30 days and 1 year post emergency general surgery laparotomies remain concerning. High mortality indicates an urgent need to enhance perioperative care. Better surgical techniques, patient stratification, and postoperative management could reduce these mortality figures.",9.474389094274162e-08,0.04988090918017729,0.012781710611812193,0.0072537058591274906,0.07064322191685513,0.0011893608989532352,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
64,0.7,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are 30-day and 1-year mortality figures following emergency general surgery laparotomies an area needing improvement? Answer: Mortality rates after emergency general surgery laparotomies at 30 days and 1 year are still troubling. The high rates suggest improvements in perioperative care are necessary. Enhanced surgical approaches, refined patient selection, and improved postoperative care may help lower mortality.",1.1842986367842703e-07,0.06888339451371328,0.011851060013426902,0.009067132323909363,0.11431717501168714,0.01964997598211273,0.009054007704764333,0.11422551513996027,0.01851192595229618,1.1842986367842703e-07,0.09015109699429802,0.0
64,0.7,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Does the mortality at 30 days and 1 year after emergency general surgery laparotomies highlight a need for better care? Answer: Mortality remains high at 30 days and 1 year following emergency general surgery laparotomies, raising concerns. This indicates a need to improve perioperative care through advanced surgical techniques, better patient selection, and enhanced postoperative care to reduce mortality.",4.737194547137081e-08,0.13040398875945414,0.06700597788406551,0.0036268529295637453,0.13030478023631709,0.06877777947089878,0.003621603081905733,0.10744903718274212,0.05246913580246911,4.737194547137081e-08,0.08460183270840904,0.03566529492455417
64,0.7,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are the 30-day and 1-year mortality rates in emergency general surgery laparotomies a concern that requires intervention? Answer: Mortality rates at both 30 days and 1 year post-emergency general surgery laparotomies remain elevated. This poses concerns and underscores the need to improve perioperative care. Advances in surgery, patient selection, and postoperative management could contribute to lowering mortality.",9.474389094274162e-08,0.04988090918017729,0.012781710611812193,0.0072537058591274906,0.07064322191685513,0.0011893608989532352,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
64,0.7,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is mortality within 30 days and 1 year after emergency general surgery laparotomies an issue warranting improvement? Answer: Mortality rates at 30 days and 1 year after emergency general surgery laparotomies continue to be concerning. The high mortality calls for improvements in perioperative care, including enhanced surgical techniques, better patient selection, and postoperative care.",1.6580180914979784e-07,0.26203432952552763,0.09474915358571873,0.012693985253473108,0.31019972168827836,0.12951096073570456,0.012675610786670066,0.31291027393658366,0.131358024691358,1.6580180914979784e-07,0.2917108320714932,0.11555555555555558
64,0.7,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Should the high 30-day and 1-year mortality rates post emergency general surgery laparotomies prompt efforts to improve care? Answer: Mortality rates at 30 days and 1 year following emergency general surgery laparotomies remain a concern. These high rates indicate a need for better perioperative care through improved surgical methods, patient selection, and postoperative management.",1.6580180914979784e-07,0.13367374053294556,0.00834915358571868,0.012693985253473108,0.15326073741055524,0.02101593745406076,0.012675610786670066,0.15295323226890423,0.01922337562475971,1.6580180914979784e-07,0.12861737782209381,0.0
64,0.7,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is there a significant concern regarding 30-day and 1-year mortality after emergency general surgery laparotomies that needs addressing? Answer: Mortality rates at 30 days and 1 year post emergency general surgery laparotomies remain high, highlighting the need for improved perioperative care. Advancements in surgical technique, patient selection, and postoperative care could reduce mortality.",1.8948778188548325e-07,0.1281468944898947,0.008850846414281278,0.014507411718254981,0.17331495151123377,0.021738121229531754,0.014486412327622933,0.17289405355629306,0.019599999999999992,1.8948778188548325e-07,0.14842000511827358,0.0
64,0.7,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are the mortality rates at 30 days and 1 year following emergency general surgery laparotomies an area needing improvement? Answer: Mortality remains elevated at both 30 days and 1 year after emergency general surgery laparotomies. This suggests a critical need for enhancement in perioperative care, including surgical techniques, patient selection, and postoperative care.",1.8948778188548325e-07,0.20661638662875648,0.04611176110043118,0.014507411718254981,0.22663396540046055,0.059727010118420625,0.014486412327622933,0.20007629593119303,0.039150354019158694,1.8948778188548325e-07,0.17614589234067157,0.019991670137442734
64,0.7,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is improvement necessary due to the high mortality rates at 30 days and 1 year after emergency general surgery laparotomies? Answer: The mortality rates observed at 30 days and 1 year post emergency general surgery laparotomies continue to cause concern. These rates point to the need for better perioperative care through refined surgical techniques, improved patient selection, and enhanced postoperative care.",0.0,0.11363068533769649,0.07787045536086667,0.0,0.09241962407465865,0.06598274932870526,0.0,0.07048954378575711,0.0507015306122449,0.0,0.04780325383172013,0.03443877551020409
65,0.7,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is emergency double-balloon enteroscopy (DBE) combined with real-time viewing of capsule endoscopy (CE) a viable method for managing acute overt-obscure gastrointestinal bleeding (OGIB)? Emergency DBE proves to be practical, safe, and effective in acute OGIB cases, potentially preventing major surgery by diagnosing and treating most patients successfully. Using real-time CE viewing alongside DBE is particularly helpful in detecting recurrent bleeding vascular lesions.",4.737194547137081e-08,0.08032944945809639,0.033856571252693125,0.0036268529295637453,0.03390155167568043,0.0,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
65,0.7,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy viewing be an effective approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is both feasible and safe for acute OGIB, often avoiding the need for major surgery by correctly diagnosing and treating the majority of patients. The combined method with real-time CE viewing is especially advantageous for spotting recurrent vascular lesions causing bleeding.",4.737194547137081e-08,0.05760331239055727,0.017467682363804228,0.0036268529295637453,0.03390155167568043,0.0,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
65,0.7,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as",Is emergency double-balloon enteroscopy with simultaneous real-time capsule endoscopy a feasible combined technique for acute overt-obscure gastrointestinal bleeding? Emergency DBE is an effective and safe procedure for acute OGIB and may prevent major surgery by diagnosing and successfully treating most patients. The combined use of real-time CE viewing is particularly useful for identifying recurrent bleeding from vascular lesions.,4.737194547137081e-08,0.01181410058452137,0.01631830594657067,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
65,0.7,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Does emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing represent a feasible approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, effective, and feasible intervention in acute OGIB, often avoiding the necessity of major surgery by diagnosing and treating most cases. The combined strategy with RT CE viewing is especially beneficial in detecting recurrent bleeding vascular lesions.",0.0,0.02349651459525237,0.016912457102871484,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
65,0.7,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing a practical approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE is feasible, safe, and effective in acute OGIB, potentially circumventing major surgery by diagnosing and treating the majority of patients. The combined approach using real-time CE viewing is particularly useful to identify recurrent bleeding vascular abnormalities.",4.737194547137081e-08,0.012506853119336192,0.033856571252693125,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
65,0.7,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as",Is emergency DBE coupled with real-time viewing of capsule endoscopy a practical and feasible combined technique in acute overt-obscure gastrointestinal bleeding? Emergency DBE is safe and effective in acute OGIB and may help avoid major surgical procedures by diagnosing and successfully treating most patients. The combined method with CE real-time viewing is especially useful in detecting recurrent vascular bleeding lesions.,0.0,0.02349651459525237,0.016844959359551777,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
65,0.7,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Can emergency double-balloon enteroscopy combined with live capsule endoscopy viewing be considered a feasible combined strategy for acute overt-obscure gastrointestinal bleeding? Emergency DBE is both feasible and safe for acute OGIB, often preventing major surgery by diagnosing and treating most patients. The combined use of real-time CE viewing is particularly valuable in identifying recurrent bleeding vascular lesions.",7.105791820705622e-08,0.029947980428634224,0.016005331583271633,0.005440279394345618,0.05310982531394792,0.0,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
65,0.7,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing a viable approach for treating acute overt-obscure gastrointestinal bleeding? Emergency DBE is effective, safe, and feasible, potentially avoiding major surgery by diagnosing and treating most patients with acute OGIB. This combined approach, especially with real-time CE viewing, is useful for detecting recurrent vascular lesions causing bleeding.",9.474389094274162e-08,0.048416581503104794,0.015680988262295324,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
65,0.7,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as",Is emergency double-balloon enteroscopy together with real-time capsule endoscopy viewing a feasible and practical method in cases of acute overt-obscure gastrointestinal bleeding? Emergency DBE is safe and effective in managing acute OGIB and may avoid the need for major surgery by diagnosing and treating the majority of patients. The combined approach with real-time CE viewing is particularly helpful in identifying recurrent bleeding from vascular lesions.,1.1842986367842703e-07,0.10667781925196085,0.018235508012582266,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
65,0.7,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Does the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing offer a feasible approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, feasible, and effective procedure for acute OGIB that can prevent major surgery by diagnosing and successfully treating most patients. The combined approach using real-time CE viewing is especially helpful to detect recurrent bleeding vascular lesions.",2.3685972735685406e-08,0.06380014750688545,0.033856571252693125,0.0018134264647818726,0.01709443335929972,0.0,0.0018108015409528666,0.01739174271186883,0.0,2.3685972735685406e-08,0.01769957709940062,0.0
66,0.7,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Does sex affect the outcome of intravenous thrombolysis in ischemic stroke? Answer: Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis could alter the typical survival and recovery advantage seen in men during ischemic stroke, potentially providing a greater beneficial effect in women.",1.8948778188548325e-07,0.1522442654248115,0.0027555974997080478,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
66,0.7,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Answer: Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis may change the usual survival and recovery benefit observed in men following ischemic stroke, possibly resulting in a more pronounced treatment benefit for women.",1.1842986367842703e-07,0.09240596745805885,0.0016248741078274467,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
66,0.7,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Does intravenous thrombolysis response in ischemic stroke vary by sex? Answer: Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis might modify the natural survival and recovery advantage seen in men, with a potentially greater positive treatment effect for women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.7,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Does sex impact the effectiveness of intravenous thrombolysis in ischemic stroke? Answer: Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the expected survival and recovery advantage for men, possibly leading to a larger beneficial effect in women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.7,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Is the outcome after intravenous thrombolysis in ischemic stroke influenced by patient sex? Answer: Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis could change the typical survival and recovery advantage in men, showing a potentially greater benefit for women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.7,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Does biological sex influence outcomes of intravenous thrombolysis in ischemic stroke? Answer: According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may modify the expected survival and recovery advantage of men, with possibly a larger beneficial effect in women.",3.316036182995957e-07,0.2838584397377497,0.005478908433114424,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
66,0.7,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Is there a sex difference in response to intravenous thrombolysis for ischemic stroke? Answer: Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the natural survival and recovery advantage usually seen in men, with a potential for greater benefit in women.",1.8948778188548325e-07,0.1522442654248115,0.0027555974997080478,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
66,0.7,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: How does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest that intravenous thrombolysis may modify the survival and recovery advantage typically observed in men, potentially providing a larger beneficial effect in women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.7,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Does gender affect the response to intravenous thrombolysis in ischemic stroke? Answer: Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis might change the usual survival and recovery advantage for men, possibly resulting in a greater treatment benefit for women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.7,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Question: Is the effectiveness of intravenous thrombolysis in ischemic stroke influenced by sex? Answer: Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may modify the survival and recovery advantage expected for men, with a possibly larger beneficial effect in women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
67,0.7,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers release GABA? Answer: No, mossy fibers in the cerebellar neuronal circuit do not release GABA. They mainly release glutamate, an excitatory neurotransmitter. GABA, an inhibitory neurotransmitter, is generally not linked to mossy fibers.",2.1317375462116823e-07,0.2308451866537644,0.005544358239163438,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
67,0.7,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Are GABA neurotransmitters released by mossy fibers? Answer: Mossy fibers, part of the cerebellum's neuronal network, do not release GABA. Instead, they predominantly release glutamate, which acts excitatorily. GABA is inhibitory and usually not associated with mossy fibers.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.7,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Is GABA released by mossy fibers? Answer: Mossy fibers, components of the cerebellar circuit, do not secrete GABA. Their primary neurotransmitter is glutamate, an excitatory chemical. GABA, being inhibitory, is not commonly released by mossy fibers.",2.1317375462116823e-07,0.26935336335153925,0.033152577997655086,0.016320838183036854,0.2684499827465596,0.02854671280276816,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
67,0.7,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers secrete GABA? Answer: No, mossy fibers, which belong to the cerebellum's neuronal pathways, do not secrete GABA. They mainly emit glutamate, an excitatory neurotransmitter. GABA is inhibitory and not typically produced by mossy fibers.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
67,0.7,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Are mossy fibers responsible for releasing GABA? Answer: Mossy fibers in the cerebellum do not release GABA. They mainly release glutamate, which excites neurons. GABA, an inhibitory neurotransmitter, is not typically released by mossy fibers.",2.3685972735685353e-07,0.26011629724039764,0.006335969001115268,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
67,0.7,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers discharge GABA? Answer: Mossy fibers, part of the cerebellar neuronal circuit, do not discharge GABA. Their primary neurotransmitter is glutamate, which excites nerve cells. GABA, an inhibitory neurotransmitter, is not usually associated with mossy fibers.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.7,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Is GABA a neurotransmitter released by mossy fibers? Answer: Mossy fibers within the cerebellum do not release GABA. They predominantly release glutamate, an excitatory neurotransmitter. GABA is inhibitory and typically not connected with mossy fibers.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
67,0.7,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers produce GABA? Answer: No, mossy fibers are not known to produce GABA. They primarily release glutamate, which is excitatory. GABA, an inhibitory neurotransmitter, is uncommon in mossy fibers.",3.3160361829959473e-07,0.3865879168663042,0.01001147842056931,0.02538797050694625,0.3829922522561069,0.0,0.025351221573340174,0.39390428570708913,0.0,3.316036182995957e-07,0.4054651081081637,0.0
67,0.7,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Are mossy fibers a source of GABA release? Answer: Mossy fibers in the neuronal circuit of the cerebellum do not release GABA. Instead, they mainly release glutamate, which is excitatory. GABA, being inhibitory, is not normally released by mossy fibers.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
67,0.7,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers emit GABA? Answer: Mossy fibers, which are part of the cerebellar neuronal network, do not emit GABA. They release glutamate primarily, an excitatory neurotransmitter. GABA is inhibitory and not typically emitted by mossy fibers.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
68,0.7,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is essential to understand and clarify gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to differ between men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.7,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements plays a key role in identifying and explaining gender differences in mortality risks according to marital status. The influence of living alone compared to living with a partner seems to differ for men and women.",4.737194547137081e-08,0.06829705626920646,0.020399305555555556,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
68,0.7,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is vital to uncover and interpret gender-specific differences in mortality risks linked to marital status. The impact of solitary living versus cohabiting with a partner varies between men and women.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
68,0.7,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Examining living arrangements is important for revealing and explaining the gender-based variations in mortality risks associated with marital status. The effects of living alone and living with a partner are distinct for men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.7,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living arrangements is key to identifying and comprehending gender differences in mortality risks by marital status. The consequences of living alone versus living with a partner appear to differ among men and women.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
68,0.7,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The assessment of living arrangements is crucial in understanding and explaining how mortality risks vary by gender and marital status. The impact of living alone compared to living with a partner seems to be gender-specific.",2.3685972735685406e-08,0.050089830593889495,0.021188596145767704,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.7,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Investigating living arrangements is fundamental for recognizing and clarifying gender disparities in mortality risks based on marital status. The influence of living alone and living with a partner differs between men and women.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
68,0.7,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Studying living arrangements is essential to detect and explain gender-related differences in mortality risks linked to marital status. The effects of living alone versus living with a partner vary between genders.",1.1842986367842703e-07,0.07933894253685692,0.020399305555555556,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
68,0.7,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Considering living arrangements is necessary to identify and interpret gender differences in mortality risks associated with marital status. The impact of living alone and living with a partner is different for men and women.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
68,0.7,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Exploring living arrangements is key to understanding and explaining gender-specific mortality risk differences by marital status. The influence of living alone compared to living with a partner appears to be different for men versus women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
69,0.7,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are aromatase inhibitor-related musculoskeletal symptoms primarily addressed by preventing osteoporosis? While osteoporosis prevention can reduce some symptoms, other factors like lifestyle, health, and concurrent treatments are also important.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.7,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the prevention of osteoporosis the main strategy to eliminate musculoskeletal symptoms caused by aromatase inhibitors? Although it helps, managing lifestyle, health, and additional therapies is equally vital.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.7,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Do aromatase inhibitor-induced musculoskeletal symptoms resolve mainly through osteoporosis prevention? Preventing osteoporosis aids symptom relief, but patient lifestyle, general health, and medical treatments also significantly impact management.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.7,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is stopping osteoporosis the key to eradicating aromatase inhibitor-related musculoskeletal symptoms? It contributes to symptom reduction, but broader factors like health status and concurrent treatments are essential.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.7,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Can preventing osteoporosis fully eliminate musculoskeletal symptoms linked to aromatase inhibitors? Osteoporosis prevention helps, but other elements such as patient lifestyle and overall health must be considered.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.7,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is preventing osteoporosis sufficient to address musculoskeletal symptoms associated with aromatase inhibitors? While helpful, factors including patient lifestyle and concurrent medical care are also crucial.",8.763809912203583e-07,0.8646416226227478,0.049048751486325794,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
69,0.7,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are musculoskeletal symptoms from aromatase inhibitors best managed by focusing on osteoporosis prevention? Preventing osteoporosis is beneficial, yet lifestyle and other health factors also play a key role.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.7,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does preventing osteoporosis fully solve musculoskeletal symptoms caused by aromatase inhibitors? It alleviates some symptoms, but overall health and treatment context are also important.",9.000669639560436e-07,0.9072012370415434,0.049048751486325794,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
69,0.7,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.",Is the key to resolving aromatase inhibitor-related musculoskeletal symptoms solely osteoporosis prevention? Osteoporosis prevention aids relief but managing lifestyle and other health aspects is necessary.,8.763809912203583e-07,0.8646416226227478,0.049048751486325794,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
69,0.7,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is targeting osteoporosis prevention the main way to eliminate aromatase inhibitor-associated musculoskeletal symptoms? It helps, but comprehensive management includes lifestyle and health considerations.",9.237529366917289e-07,0.9516529996123775,0.049048751486325794,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
70,0.7,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in young individuals might represent a distinct clinical entity. Additional studies are required to confirm our results and determine the best management strategy for this group.,0.0,4.440892098500626e-16,0.0,0.0,0.03648143055578679,0.026172568965361766,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.7,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be considered a separate clinical entity? Answer: Colorectal cancer seen in young patients may be a distinct clinical entity. More research is necessary to verify our observations and establish the optimal treatment approach for these patients.,7.105791820705611e-08,0.08172497413789737,0.0053829717291255935,0.005440279394345618,0.07865527994541788,0.0019215668371073726,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
70,0.7,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,"Question: Is colorectal cancer in younger patients a distinct clinical condition? Answer: In young patients, colorectal cancer may be a unique clinical entity. Further investigation is essential to validate these findings and to identify the most effective approach for this population.",2.36859727356853e-08,0.09729847673474801,0.051405325443786974,0.0018134264647818726,0.06245691695904432,0.026296566837107373,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.7,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Colorectal cancer among young people may form a distinct clinical entity. Additional research is needed to substantiate our findings and to define the best approach in this demographic.,2.36859727356853e-08,0.09729847673474801,0.051405325443786974,0.0018134264647818726,0.06245691695904432,0.026296566837107373,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.7,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young individuals a distinct clinical entity? Answer: Colorectal cancer affecting young individuals might be a distinct clinical entity. Further studies are required to confirm our data and to determine the ideal clinical management for these patients.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.7,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Can colorectal cancer in young patients be classified as a unique clinical entity? Answer: Colorectal cancer in young patients could constitute a unique clinical entity. More research is necessary to validate these findings and to outline the optimal treatment strategy for this subgroup.,9.474389094274152e-08,0.010840074860525295,0.0594767064361659,0.0072537058591274906,0.004536854720396555,0.06788625864765716,0.007243206163811466,0.035030038883502534,0.04865220249835634,9.474389094274162e-08,0.07070315662982951,0.02498356344510192
70,0.7,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,"Question: Is colorectal cancer in young adults a distinct clinical entity? Answer: In young adults, colorectal cancer may represent a distinct clinical entity. Further research is needed to confirm our results and to establish the best clinical approach for these patients.",2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.7,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in the young a separate clinical entity? Answer: Colorectal cancer occurring in young patients may be considered a distinct clinical entity. Additional studies are needed to verify this and to define the most effective management approach.,0.0,0.07109201851896874,0.05076562019082794,0.0,0.03648143055578634,0.026296566837107373,0.0,0.0,0.0,0.0,0.0,0.0
70,0.7,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be a unique clinical entity? Answer: Colorectal cancer in young patients might represent a unique clinical entity. Further research is essential to validate these findings and to determine optimal care strategies for this population.,2.36859727356853e-08,0.07598831840523879,0.06893983083429453,0.0018134264647818726,0.07972712007889182,0.07492792295881102,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
70,0.7,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is there a distinct clinical entity of colorectal cancer in young patients? Answer: Colorectal cancer in young patients may indeed be a distinct clinical entity. More research is required to confirm these findings and to identify the best clinical approach for this group.,9.474389094274152e-08,0.043079478607499944,0.03787703908895036,0.0072537058591274906,0.037543863318489024,0.044709350322655925,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
71,0.7,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: The current study indicates that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.7,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is there a change in the dimensions of compensatory hypertrophy of the middle turbinate following septoplasty? Answer: Findings from this study suggest septoplasty does not change compensatory hypertrophy of the middle turbinate, even after one year.",4.73719454713706e-08,0.06621916129824745,0.006180555555555592,0.003626852929563759,0.06604202917160773,0.005039062500000038,0.003621603081905747,0.06572129226172985,0.0036284722222222274,4.737194547137081e-08,0.06523060988674878,0.0019487847222222007
71,0.7,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty influence the extent of compensatory hypertrophy in the middle turbinate? Answer: According to the present study, compensatory hypertrophy of the middle turbinate remains unaffected by septoplasty, even a year post-operation.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.7,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Can septoplasty modify the size of compensatory hypertrophy of the middle turbinate? Answer: The study results suggest that compensatory hypertrophy of the middle turbinate is not altered by septoplasty, even after one year.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.03470999491993654,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.7,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does the procedure of septoplasty impact the compensatory hypertrophy dimensions of the middle turbinate? Answer: The current findings indicate that septoplasty does not affect compensatory hypertrophy of the middle turbinate, even after one year.",0.0,0.04077336356235017,0.02814660654410918,0.0,0.08401784006787238,0.05972656250000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222
71,0.7,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: The study’s findings reveal that septoplasty does not influence the compensatory hypertrophy of the middle turbinate, even after a year.",7.10579182070559e-08,0.10815655763902221,0.010644718792866922,0.005440279394345639,0.10791285581450571,0.008765432098765416,0.005432404622858621,0.10740318290669926,0.006364883401920436,7.105791820705622e-08,0.1065740342677306,0.0034430727023319757
71,0.7,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty result in changes to the compensatory hypertrophy of the middle turbinate? Answer: The present study suggests that septoplasty does not modify compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.034709994919936094,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.7,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: How does septoplasty affect the dimensions of compensatory hypertrophy in the middle turbinate? Answer: This study shows that compensatory hypertrophy in the middle turbinate is not affected by septoplasty, even one year later.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.034709994919936094,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.7,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the size of compensatory hypertrophy in the middle turbinate affected by septoplasty? Answer: Findings from the present study indicate that septoplasty does not change compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.11286417048722797,0.05862258953168049,0.0018134264647818796,0.1558797232514899,0.09000000000000004,0.0018108015409528735,0.11741505623674797,0.06222222222222223,2.3685972735685406e-08,0.07646787125393084,0.0322222222222222
71,0.7,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty have an effect on the compensatory hypertrophy of the middle turbinate? Answer: The study findings suggest that compensatory hypertrophy of the middle turbinate remains unchanged by septoplasty, even after one year.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.034709994919936094,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
72,0.7,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Do the features of general practices affect the adoption of IT innovations in primary care? Answer: Yes, the characteristics of general practices play a significant role in the uptake of IT innovations in primary care. Elements like practice size, technological proficiency of staff, leadership approach, openness to change, and existing infrastructure influence how quickly and effectively a new IT system is adopted and integrated.",1.4211583641411244e-07,0.11188473795342446,0.009324275833925519,0.010880558788691236,0.08502763007364411,0.010731094016548419,0.0108648092457172,0.057063521370590564,0.0322222222222222,1.4211583641411244e-07,0.08081454187330017,0.016388888888888897
72,0.7,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Are general practice attributes influential in the acceptance of IT innovations within primary care? Answer: Indeed, general practice attributes greatly affect the acceptance of IT innovations in primary care. Factors including the size of the practice, staff's tech skills, leadership style, readiness to change, and available infrastructure determine the rate and success of IT system adoption.",4.737194547137081e-08,0.07431207030903364,0.06119430020528922,0.0036268529295637453,0.06357662957195265,0.019810756546627374,0.003621603081905733,0.08771187976790795,0.036982248520710054,4.737194547137081e-08,0.06319776905997099,0.018860946745562133
72,0.7,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Does the nature of general practices impact the implementation of IT innovations in primary care? Answer: Yes, general practice nature significantly impacts IT innovation implementation in primary care. Variables such as the size of the practice, technological capability of the staff, leadership style, willingness to embrace change, and infrastructure availability affect the adoption speed and integration quality of new IT systems.",7.105791820705622e-08,0.1483883409869744,0.06932179592003249,0.005440279394345618,0.12425615549912283,0.05246913580246911,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
72,0.7,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Can characteristics of general practices influence the uptake of IT innovations in primary care settings? Answer: Yes, characteristics of general practices strongly influence the uptake of IT innovations in primary care. Aspects like practice size, staff technological literacy, leadership methods, change readiness, and infrastructure play key roles in the adoption and integration of new IT systems.",4.737194547137081e-08,0.13923412280180347,0.06806131922461713,0.0036268529295637453,0.16439803765339844,0.0887712444600931,0.003621603081905733,0.19040035096197494,0.109375,4.737194547137081e-08,0.14166726119883233,0.07496876301541025
72,0.7,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Are the traits of general practices key factors in adopting IT innovations in primary care? Answer: Yes, traits of general practices are crucial factors in adopting IT innovations in primary care. Elements such as the size of the practice, technological knowledge of the staff, leadership style, openness to change, and infrastructure resources affect how IT systems are adopted and integrated.",4.737194547137081e-08,0.05373774701580558,0.05792899408284029,0.0036268529295637453,0.057026564984024475,0.06402494703776757,0.003621603081905733,0.0844168147680322,0.08543965824136704,4.737194547137081e-08,0.03724477850949448,0.05246913580246911
72,0.7,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Do features of general practices determine how IT innovations are adopted in primary care? Answer: Yes, features of general practices determine the adoption of IT innovations in primary care. Factors including practice size, staff's tech literacy, leadership style, willingness to change, and existing infrastructure influence the adoption rate and integration success of IT systems.",9.474389094274162e-08,0.13342614487511462,0.04159629086922971,0.0072537058591274906,0.0782659853097174,0.003930864197530914,0.007243206163811466,0.12742698604294844,0.03840000000000001,9.474389094274162e-08,0.10268979488304542,0.019599999999999992
72,0.7,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Is the uptake of IT innovations in primary care influenced by general practice characteristics? Answer: Yes, the uptake of IT innovations in primary care is influenced by general practice characteristics. Key factors include practice size, staff technological skills, leadership style, readiness for change, and infrastructure, which affect adoption and integration of IT systems.",1.1842986367842703e-07,0.2443354131610862,0.13885869929825972,0.009067132323909363,0.23212074369845492,0.09629119477604325,0.009054007704764333,0.2566195122602237,0.11555555555555556,1.1842986367842703e-07,0.20621372869391674,0.07939508506616257
72,0.7,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Do general practice factors affect the acceptance of IT technology in primary care? Answer: Yes, general practice factors do affect the acceptance of IT technology in primary care. Important aspects such as practice size, staff's familiarity with technology, leadership approach, willingness to adapt, and infrastructure impact the adoption and integration of new IT systems.",9.474389094274162e-08,0.15909826267363103,0.05792899408284029,0.0072537058591274906,0.18289197482820008,0.07654787743004504,0.007243206163811466,0.20740550687678772,0.09506564056134,9.474389094274162e-08,0.18423652200774576,0.07786328655500228
72,0.7,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Does the uptake of IT innovations in primary care depend on general practice characteristics? Answer: Yes, uptake of IT innovations in primary care depends largely on general practice characteristics. These include the size of the practice, technological proficiency of staff, leadership style, openness to change, and the availability of infrastructure, all influencing adoption and integration.",7.105791820705622e-08,0.11134287998167958,0.03916937434540248,0.005440279394345618,0.135137066949802,0.05690586419753089,0.0054324046228586,0.1596857667015108,0.07496876301541024,7.105791820705622e-08,0.13606798748488336,0.057476051645147866
72,0.7,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Question: Are general practice characteristics important in the uptake of IT innovations in primary care? Answer: Yes, general practice characteristics are important in the uptake of IT innovations in primary care. Factors such as the practice's size, the technological literacy of its staff, leadership style, willingness to change, and infrastructural capacity all impact the adoption and integration of IT systems.",2.3685972735685406e-08,0.10682607829949387,0.1162449663050625,0.0018134264647818726,0.100858411503439,0.08193086419753084,0.0018108015409528666,0.12822614512374564,0.10380622837370242,2.3685972735685406e-08,0.10575777674016917,0.08842752787389466
73,0.7,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Yes, it is considered a pathognomonic sign, demonstrated by the delicate nature of the esophageal lining, which may tear or resemble crepe-paper during endoscopy, reflecting a significant eosinophil infiltration.",3.552895910352811e-07,0.1156839134681249,0.16019627040782602,0.02720139697172809,0.16814198222227006,0.09660464009518144,0.027162023114293,0.18800334178799405,0.08842752787389467,3.552895910352811e-07,0.2428376750574497,0.05436390532544381
73,0.7,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does fragility of the esophageal mucosa serve as a diagnostic endoscopic sign for primary eosinophilic esophagitis? Indeed, the fragile esophageal mucosa is a hallmark sign, showing lack of tissue resilience that can cause tearing and a crepe-paper appearance during endoscopy due to high eosinophil levels.",3.316036182995957e-07,0.059722277774929555,0.18388224115137314,0.025387970506946217,0.11160447621398406,0.1204,0.025351221573340132,0.16390579020893403,0.08842752787389467,3.316036182995957e-07,0.218145062467078,0.05436390532544381
73,0.7,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can fragility of the esophageal mucosa be identified as a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Yes, this fragility is a characteristic feature seen endoscopically, where the mucosa may tear easily, signifying abundant eosinophilic infiltration.",5.447773729207638e-07,0.25705716017832536,0.20659722222222224,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.40506784702582177,0.08842752787389467,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
73,0.7,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is fragility of the esophageal mucosa an endoscopic hallmark of primary eosinophilic esophagitis? Yes, the fragile mucosa is pathognomonic, often presenting as tears or a crepe-paper texture during endoscopy, indicating dense eosinophil presence.",6.158352911278197e-07,0.34666931886801233,0.20659722222222224,0.047149088084328716,0.43881738742239973,0.1204,0.047080840064774566,0.500378026830147,0.08842752787389467,6.158352911278206e-07,0.5644212991849127,0.05436390532544381
73,0.7,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the fragility of the esophageal mucosa indicate primary eosinophilic esophagitis in endoscopic exams? Yes, it is a pathognomonic sign, characterized by the mucosa's vulnerability to tearing and a crepe-paper-like appearance caused by elevated eosinophil counts.",5.447773729207638e-07,0.25705716017832536,0.20659722222222224,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.40506784702582177,0.08842752787389467,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
73,0.7,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is esophageal mucosal fragility an endoscopic diagnostic sign of primary eosinophilic esophagitis? Yes, the fragility is pathognomonic, observed as mucosal tears or crepe-paper texture during endoscopy, signaling heavy eosinophilic infiltration.",6.868932093348756e-07,0.4451093916812656,0.20659722222222224,0.052589367478674355,0.5406000817323422,0.1204,0.05251324468763319,0.6057385424879724,0.08842752787389467,6.868932093348768e-07,0.6736205911499034,0.05436390532544381
73,0.7,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragile nature of the esophageal mucosa a definitive endoscopic sign for primary eosinophilic esophagitis? Yes, this fragility is pathognomonic, with the mucosa prone to tearing or resembling crepe-paper during endoscopy due to high eosinophil concentration.",5.210914001850785e-07,0.22888628321162852,0.20659722222222224,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.37521488387614,0.08842752787389467,5.210914001850789e-07,0.4352095677049057,0.05436390532544381
73,0.7,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can the fragility of the esophageal mucosa be considered a pathognomonic sign during endoscopy for primary eosinophilic esophagitis? Yes, because this fragility manifests as mucosal tearing or a crepe-paper appearance linked to significant eosinophilic presence.",5.684633456564491e-07,0.28604469705157687,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.43583950569257546,0.08842752787389467,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
73,0.7,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is mucosal fragility in the esophagus a specific endoscopic sign of primary eosinophilic esophagitis? Yes, the fragile mucosa is pathognomonic, often tearing easily or appearing crepe-paper-like under endoscopy, indicative of dense eosinophil accumulation.",6.158352911278197e-07,0.34666931886801233,0.20659722222222224,0.047149088084328716,0.43881738742239973,0.1204,0.047080840064774566,0.500378026830147,0.08842752787389467,6.158352911278206e-07,0.5644212991849127,0.05436390532544381
73,0.7,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the fragility of the esophageal mucosa represent a pathognomonic endoscopic finding of primary eosinophilic esophagitis? Yes, this fragile mucosa is a hallmark sign, showing susceptibility to tears or crepe-paper texture during endoscopy due to high eosinophil infiltration.",4.974054274493932e-07,0.2014873090235132,0.20659722222222224,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.3462273470028885,0.08842752787389467,4.974054274493935e-07,0.40535660455522393,0.05436390532544381
74,0.7,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to perform spinal cord untethering before scoliosis correction in a patient with myelomeningocele? The study indicates that untethering might not be required in MM patients undergoing scoliosis surgery if they show no clinical signs of a tethered cord, despite radiographic evidence of tethering.",1.1842986367842703e-07,0.10536051565782589,0.0,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
74,0.7,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a myelomeningocele patient, is spinal cord untethering needed prior to scoliosis correction? Findings suggest that untethering the spinal cord may be unnecessary during scoliosis surgery when no clinical symptoms of tethering are present, even if imaging reveals tethering.",2.8423167282822466e-07,0.3109182762575453,0.026296566837107373,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.7,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele require untethering before scoliosis surgery? Research suggests that in MM patients without clinical tethered cord symptoms, untethering may not be needed despite radiographic tethering.",5.210914001850777e-07,0.5798184952529413,0.0,0.039895382225201254,0.5959834321062973,0.0,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
74,0.7,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele undergoing scoliosis correction, is untethering the spinal cord necessary? The study's results imply that spinal cord untethering might be unnecessary if there are no clinical signs of tethering, even though imaging shows tethering.",3.3160361829959526e-07,0.36701224366981,0.02775510204081633,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
74,0.7,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering required before scoliosis correction in myelomeningocele patients? According to the study, untethering could be unnecessary if the patient exhibits no clinical symptoms of tethered cord, despite radiographic evidence.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.7,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For scoliosis surgery in myelomeningocele patients, is prior untethering necessary? The study suggests that untethering may not be needed when no clinical tethered cord symptoms are present, even if tethering is visible on imaging.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.7,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should untethering be performed before scoliosis correction in myelomeningocele cases? Study findings indicate that untethering might not be essential if clinical signs of tethered cord are absent, despite radiographic tethering.",4.974054274493924e-07,0.5447271754416723,0.0,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
74,0.7,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering a prerequisite for scoliosis correction in patients with myelomeningocele? The study suggests that untethering may be unnecessary if clinical symptoms of tethering are not evident, even though imaging shows tethering.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.7,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Do patients with myelomeningocele require untethering before scoliosis corrective surgery? Research results indicate untethering might be unnecessary in the absence of clinical tethered cord symptoms, despite radiographic tethering.",5.44777372920763e-07,0.616186139423816,0.0,0.04170880868998313,0.6337237600891443,0.0,0.041648435441916,0.652325186039691,0.0,5.447773729207643e-07,0.6720937713621127,0.0
74,0.7,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In myelomeningocele patients undergoing scoliosis correction, is untethering required beforehand? The study suggests untethering may not be necessary if no clinical tethered cord symptoms exist, even with radiographic evidence of tethering.",4.7371945471370706e-07,0.5108256237659905,0.0,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
75,0.7,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How does the clinical significance of bile duct sludge compare to that of bile duct stones? Answer: Although bile duct sludge and stones are alike, their clinical implications differ. Bile duct sludge is a thickened bile fluid that typically causes temporary blockage and often resolves on its own. However, bile duct",1.8948778188548325e-07,0.10817493505676445,0.052225794795724756,0.014507411718254981,0.08071076260229315,0.10230873698506113,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
75,0.7,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Is the clinical importance of bile duct sludge distinct from that of bile duct stones? Answer: Bile duct sludge and stones share similarities but vary in clinical significance. Bile duct sludge, a concentrated bile fluid, usually leads to transient obstruction and tends to resolve spontaneously. Nevertheless, bile duct",1.1842986367842703e-07,0.07173279092873797,0.008426250184491835,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
75,0.7,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: While bile duct sludge and stones are similar, their clinical relevance differs. Bile duct sludge, which is thickened bile fluid, often results in temporary obstruction and usually clears up on its own. However, bile duct",1.8948778188548325e-07,0.14561694495645883,0.017514792899408604,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
75,0.7,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Does bile duct sludge have a different clinical significance compared to bile duct stones? Answer: Bile duct sludge and stones are similar entities but differ clinically. Bile duct sludge consists of thickened bile fluid that often causes a temporary blockage and tends to resolve without intervention. However, bile duct",1.4211583641411244e-07,0.08627379045448036,0.045909280173123346,0.010880558788691236,0.06486812458276647,0.08506616257088842,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.7,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How significant is bile duct sludge clinically in comparison to bile duct stones? Answer: Though bile duct sludge and stones are similar, their clinical significance is not the same. Bile duct sludge, a dense bile fluid, often causes transient obstruction and typically resolves spontaneously. However, bile duct",9.474389094274162e-08,0.07537900542299036,0.009147445960632827,0.0072537058591274906,0.06083494426833802,0.021728395061728398,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
75,0.7,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Is there a clinical difference between bile duct sludge and bile duct stones? Answer: Bile duct sludge and stones resemble each other but have different clinical outcomes. Bile duct sludge, being thickened bile fluid, generally leads to temporary blockage and resolves on its own. However, bile duct",9.474389094274162e-08,0.045883380718311884,0.017871551207935044,0.0072537058591274906,0.030698110330948936,0.043388429752066124,0.007243206163811466,0.06228388170779198,0.02221074380165289,9.474389094274162e-08,0.09531017980432566,0.0
75,0.7,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Can the clinical significance of bile duct sludge be distinguished from that of bile duct stones? Answer: Bile duct sludge and stones are similar but differ in clinical importance. Bile duct sludge is thickened bile fluid that frequently causes temporary obstruction and resolves spontaneously. However, bile duct",9.474389094274162e-08,0.005254816784600713,0.09463798487836944,0.0072537058591274906,0.010813683253495299,0.1114115738236885,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
75,0.7,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What clinical differences exist between bile duct sludge and bile duct stones? Answer: Although bile duct sludge and stones share similarities, they have distinct clinical implications. Bile duct sludge, a thickened bile fluid, commonly causes temporary blockage and often resolves without treatment. However, bile duct",4.737194547137081e-08,0.007833200048292355,0.03813280736357649,0.0036268529295637453,0.01649336441601079,0.045351473922902494,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
75,0.7,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: In terms of clinical significance, how does bile duct sludge differ from bile duct stones? Answer: Bile duct sludge and stones are alike but have differing clinical impacts. Bile duct sludge, which is thickened bile fluid, tends to cause temporary obstruction and usually resolves on its own. However, bile duct",1.6580180914979784e-07,0.14929715457506543,0.034304916356198756,0.012693985253473108,0.12585895817175086,0.020399305555555556,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
75,0.7,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Are the clinical implications of bile duct sludge different from those of bile duct stones? Answer: While bile duct sludge and stones are similar, they differ clinically. Bile duct sludge, a thickened bile fluid, often results in transient obstruction and typically resolves spontaneously. However, bile duct",7.105791820705622e-08,0.019372652701599602,0.027762984878369423,0.005440279394345618,0.007379788770512263,0.04434829637641968,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
76,0.7,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Do homebrew assays provide correlated results for BCRABL transcript detection by quantitative real-time PCR? The findings indicate that quantitative real-time PCR assays for BCRABL detection can yield comparable results across laboratories, even with methodological differences, provided the same positive control cell line and quality control gene are utilized. Standardizing assays between laboratories is essential.",3.079176455639103e-07,0.22966690319960925,0.007404378724529016,0.023574544042164344,0.20181594575851758,0.015380859375,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
76,0.7,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for",Can consistent results be obtained from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? The data suggest that quantitative real-time PCR assays for BCRABL detection are comparable between different labs despite significant methodological variations if the same positive control cell line and quality control gene are employed. There must be some level of assay standardization among labs.,1.8948778188548325e-07,0.15890769219365097,0.02129681043388431,0.014507411718254981,0.13432935020925285,0.0021574059311224546,0.014486412327622933,0.13353139262452185,0.0,1.8948778188548325e-07,0.13580154115906407,0.0
76,0.7,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Is it possible to achieve correlated results from homebrew assays detecting BCRABL transcripts by quantitative real-time PCR? These results imply that quantitative real-time PCR assays for BCRABL detection can be consistent between laboratories despite methodological differences, as long as the same positive control cell line and quality control gene are used. Adopting some assay standardization between labs is crucial.",1.8948778188548325e-07,0.11110443836192996,0.013037364862265314,0.014507411718254981,0.11000839650539529,0.015380859375,0.014486412327622933,0.13353139262452185,0.0,1.8948778188548325e-07,0.13580154115906407,0.0
76,0.7,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for",Are correlated results achievable from homebrew assays in quantitative real-time PCR detection of BCRABL transcripts? The evidence shows that quantitative real-time PCR assays for BCRABL detection may be comparable across laboratories despite methodological differences when the same positive control cell line and quality control gene are applied. Standardization of assays between labs is imperative.,3.079176455639103e-07,0.22966690319960925,0.007404378724529016,0.023574544042164344,0.22847545270313097,0.00384251624975971,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
76,0.7,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Can quantitative real-time PCR assays for BCRABL transcript detection from homebrew assays yield correlated outcomes? These findings suggest comparability between labs despite methodological differences if the same positive control cell line and quality control gene are used, highlighting the necessity for assay standardization across laboratories.",5.210914001850789e-07,0.3634561880742271,0.0302734375,0.0398953822252012,0.39185954864638317,0.015380859375,0.039837633900963065,0.42121346507630353,0.0,5.210914001850789e-07,0.4295626596872273,0.0
76,0.7,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Is the correlation of results possible from homebrew assays detecting BCRABL transcripts by quantitative real-time PCR? The data indicate that quantitative real-time PCR assays for BCRABL detection can be comparable across different laboratories, even with significant methodological differences, provided the same positive control cell line and quality control gene are implemented. Assay standardization between labs is essential.",2.3685972735685406e-07,0.14704938770590914,0.012422197830578508,0.018134264647818726,0.14572647910747438,0.015380859375,0.018108015409528666,0.16989903679539609,0.0,2.3685972735685406e-07,0.17284281283941416,0.0
76,0.7,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are comparable results feasible from homebrew assays for BCRABL transcript detection via quantitative real-time PCR? The results suggest that despite differences in methodologies, quantitative real-time PCR assays for BCRABL detection can be comparable between labs if the same positive control cell line and quality control gene are used. It is critical to adopt some level of assay standardization among laboratories.",1.6580180914979784e-07,0.1405979218725273,0.020428093112244902,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
76,0.7,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for",Can homebrew assays for BCRABL transcript detection by quantitative real-time PCR produce correlated results? Findings imply that quantitative real-time PCR assays for BCRABL detection can be comparable across labs regardless of methodological differences if the same positive control cell line and quality control gene are employed. A degree of assay standardization between labs is imperative.,2.8423167282822487e-07,0.26135024662228057,0.043326562499999985,0.02176111757738247,0.23508074554706582,0.022296956849529016,0.0217296184914344,0.20763936477824352,0.0,2.8423167282822487e-07,0.21130909366720996,0.0
76,0.7,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for",Is it possible for homebrew assays to yield correlated quantitative real-time PCR results in detecting BCRABL transcripts? The research suggests that quantitative real-time PCR assays for BCRABL detection can be consistent between laboratories despite methodological variations if the same positive control cell line and quality control gene are used. Standardization between labs is vital.,3.079176455639103e-07,0.22966690319960925,0.007404378724529016,0.023574544042164344,0.22847545270313097,0.00384251624975971,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
76,0.7,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are correlated quantitative real-time PCR results for BCRABL transcript detection achievable from homebrew assays? The data support that quantitative real-time PCR assays for BCRABL detection can be comparable across labs despite significant methodological differences, given the same positive control cell line and quality control gene are applied. Implementing assay standardization between labs is necessary.",3.079176455639103e-07,0.2558234005792297,0.026126562500000027,0.023574544042164344,0.22847545270313097,0.00384251624975971,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
77,0.7,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does cervical disk disease involve the fibronectin-aggrecan complex? Answer: Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, structural protein fragments such as FAC, and a link with pH. Additional assessment of FAC as a possible diagnostic or therapeutic biomarker is ongoing.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
77,0.7,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex found in cervical disk disease? Answer: Analysis of injured cervical intervertebral disks indicates inflammatory markers including MCP, fragments of matrix proteins like FAC, and a pH correlation. Further investigation into FAC as a diagnostic or treatment biomarker is underway.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999996,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
77,0.7,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does the fibronectin-aggrecan complex exist in cervical disk disease? Answer: Biochemical examination of damaged cervical intervertebral disks reveals inflammatory markers such as MCP, structural matrix protein fragments like FAC, and an association with pH. FAC is being further studied as a potential diagnostic or therapeutic biomarker.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999996,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
77,0.7,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Answer: Injured cervical intervertebral disks show biochemical evidence of inflammatory markers such as MCP, fragments of structural proteins including FAC, and a correlation with pH. FAC is being evaluated further as a diagnostic or therapeutic biomarker.",9.474389094274162e-08,0.05449578863936777,0.019599999999999996,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
77,0.7,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does cervical disk disease include the fibronectin-aggrecan complex? Answer: Biochemical analyses of damaged cervical intervertebral disks reveal inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a connection with pH levels. FAC is under further evaluation as a diagnostic or therapeutic biomarker.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999996,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
77,0.7,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex identified in cervical disk disease? Answer: Biochemical studies of injured cervical intervertebral disks detect inflammatory markers such as MCP, structural protein fragments like FAC, and a pH association. FAC is being further assessed as a potential diagnostic or therapeutic biomarker.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.7,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex detected in cervical disk disease? Answer: Analysis of damaged cervical intervertebral disks reveals inflammatory markers including MCP, fragments of matrix proteins such as FAC, and a relationship with pH. Further evaluation of FAC as a diagnostic or therapeutic biomarker is ongoing.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
77,0.7,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does the fibronectin-aggrecan complex appear in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks shows inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. FAC is being further evaluated as a potential diagnostic or therapeutic biomarker.",9.474389094274162e-08,0.05449578863936777,0.019599999999999996,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
77,0.7,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex involved in cervical disk disease? Answer: Injured cervical intervertebral disks exhibit inflammatory markers including MCP, structural protein fragments such as FAC, and a pH correlation. FAC is undergoing further study as a diagnostic or therapeutic biomarker.",2.6054570009253947e-07,0.2157639362354895,0.019599999999999996,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
77,0.7,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Can the fibronectin-aggrecan complex be found in cervical disk disease? Answer: Biochemical analysis of damaged cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and an association with pH. FAC is being further evaluated as a diagnostic or therapeutic biomarker.",9.474389094274162e-08,0.05449578863936777,0.019599999999999996,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
78,0.7,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Precursor to Bronchiectasis? A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. However, it is still unclear if this mechanism leads to the progression from PBB to bronchiectasis.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.7,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Could Alveolar Macrophage Phagocytic Dysfunction in Children Suffering from Protracted Bacterial Bronchitis Be an Early Indicator of Bronchiectasis? A weakened alveolar macrophage phagocytic response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and colonization by NTHi in both PBB and bronchiectasis, but its role in advancing PBB to bronchiectasis remains uncertain.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.058668538416332794,0.001088074047703811,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.7,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is the Dysfunction of Alveolar Macrophage Phagocytosis in Children with Protracted Bacterial Bronchitis a Potential Precursor to Bronchiectasis? A diminished phagocytic response by alveolar macrophages to apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization found in both PBB and bronchiectasis. Whether this process promotes the progression from PBB to bronchiectasis is still unknown.,2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.7,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Does Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Signal the Onset of Bronchiectasis? Reduced phagocytic activity of alveolar macrophages against apoptotic cells or NTHi may lead to neutrophilic inflammation and colonization by NTHi in both PBB and bronchiectasis, but its involvement in the disease progression remains to be determined.",9.474389094274162e-08,0.02509684846742255,0.03631185475258099,0.0072537058591274906,0.051288923337613035,0.01851192595229618,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
78,0.7,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis a Forerunner to the Development of Bronchiectasis? A lower phagocytic host response by alveolar macrophages to apoptotic cells or NTHi might contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism also drives the progression from PBB to bronchiectasis is not yet known.,4.737194547137081e-08,0.08612878664280244,0.03631185475258099,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.7,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Can Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Predict Bronchiectasis? The impaired phagocytic response of alveolar macrophages to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Its role in the progression from PBB to bronchiectasis remains unclear.,1.6580180914979784e-07,0.08572147028385668,0.03631185475258099,0.012693985253473108,0.11316432705570056,0.01851192595229618,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
78,0.7,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis a Possible Early Step Toward Bronchiectasis? Reduced alveolar macrophage phagocytic activity against apoptotic cells or NTHi might lead to neutrophilic inflammation and colonization by NTHi in PBB and bronchiectasis, though whether this underlies progression to bronchiectasis is unknown.",1.6580180914979784e-07,0.1434837353305185,0.005276046948742272,0.012693985253473108,0.14265995176037904,0.0027546146904259203,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
78,0.7,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Might Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Serve as a Precursor to Bronchiectasis? A decreased phagocytic host response by alveolar macrophages to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The potential role of this mechanism in disease progression remains to be clarified.,0.0,0.05041070404072334,0.03631185475258099,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
78,0.7,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Is Dysfunction in Alveolar Macrophage Phagocytosis among Children with Protracted Bacterial Bronchitis an Early Marker for Bronchiectasis? A reduced phagocytic response to apoptotic cells or NTHi by alveolar macrophages might contribute to neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis, but its influence on progression to bronchiectasis is not known.",7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.7,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Does Dysfunction in Alveolar Macrophage Phagocytosis in Children With Protracted Bacterial Bronchitis Indicate a Risk for Bronchiectasis? A lowered alveolar macrophage phagocytic response to apoptotic cells or NTHi could contribute to neutrophilic inflammation and colonization by NTHi in both PBB and bronchiectasis. Whether this contributes to the advancement from PBB to bronchiectasis is still unknown.,2.3685972735685406e-08,0.00638944757401072,0.017799928800284807,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
79,0.7,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover truly indicative of bone histomorphometry in 370 postmenopausal women? Biochemical markers might not consistently reflect bone histomorphometry in postmenopausal women, as variations can arise from age, hormone levels, and lifestyle factors. Hence,",1.6580180914979753e-07,0.09070254849010695,0.10093095105380112,0.012693985253473108,0.0872317389473305,0.0642896053885065,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
79,0.7,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? These markers may not always reliably indicate bone histomorphometry due to influences such as age, hormonal changes, and lifestyle habits. Therefore,",2.3685972735685343e-07,0.06616363941890935,0.1780659372796964,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
79,0.7,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Is there a correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Biochemical markers might not always correspond well with bone histomorphometry, given the effects of age, hormones, and lifestyle. Thus,",2.1317375462116813e-07,0.03601114930101934,0.1789039811344122,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
79,0.7,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Can biochemical markers of bone turnover serve as accurate indicators of bone histomorphometry in 370 postmenopausal women? They may not consistently mirror bone histomorphometry because of factors like age, hormonal status, and lifestyle variations. Consequently,",2.3685972735685343e-07,0.10693700298125952,0.14885694393718035,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
79,0.7,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover reliable representatives of bone histomorphometry in 370 postmenopausal women? These markers often do not perfectly represent bone histomorphometry, as age, hormone levels, and lifestyle can cause variation. Hence,",2.605457000925387e-07,0.09725215904017714,0.17717725643718035,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
79,0.7,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? They may not always provide an accurate representation due to influences such as age, hormonal fluctuations, and lifestyle factors. Therefore,",2.84231672828224e-07,0.08601489767299508,0.20745069393718035,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
79,0.7,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Is bone histomorphometry accurately represented by biochemical markers of bone turnover in 370 postmenopausal women? Such markers may not always be precise indicators because of factors including age, hormonal levels, and lifestyle. Thus,",2.84231672828224e-07,0.08601489767299508,0.20745069393718035,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
79,0.7,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover dependable indicators of bone histomorphometry in 370 postmenopausal women? They might not consistently represent bone histomorphometry owing to age, hormonal changes, and lifestyle influences. Consequently,",3.3160361829959463e-07,0.2429730428852257,0.1411241633249355,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.33945109091197967,0.047500000000000014,3.316036182995957e-07,0.3839231431116885,0.024375
79,0.7,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Can biochemical markers of bone turnover reliably indicate bone histomorphometry in 370 postmenopausal women? These markers may not always accurately represent bone histomorphometry due to variations in age, hormones, and lifestyle. Therefore,",3.0791764556390933e-07,0.16248276892692592,0.17522847171495815,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
79,0.7,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover consistently represent bone histomorphometry in 370 postmenopausal women? Often, they do not provide a fully accurate picture because of age, hormonal levels, and lifestyle factors. Hence,",3.0791764556390933e-07,0.11776359598757491,0.20745069393718035,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
80,0.7,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, opioid dependence and MMT are usually noted in medical records, including diagnosis, treatment plans, medication details, and patient response monitoring, which aids healthcare providers in managing care.",4.263475092423373e-07,0.19284048560979716,0.1567357263773469,0.03264167636607371,0.24478895503738585,0.09477673130193903,0.0325944277371516,0.26398924876591545,0.08842752787389466,4.263475092423373e-07,0.32079921652716026,0.05436390532544381
80,0.7,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in medical records? Yes, medical records commonly document both opioid dependence and MMT, covering diagnosis, treatment strategies, medication specifics, and monitoring of the patient's progress for healthcare professionals.",4.737194547137079e-07,0.2477819230529259,0.1541280864197531,0.03626852929563745,0.2993540944287232,0.09339382716049381,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.3763690676819724,0.05436390532544381
80,0.7,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Does the medical record include opioid dependence and methadone maintenance treatment (MMT)? Yes, these are generally documented, with details of diagnosis, treatment plans, medication information, and monitoring of patient responses to support ongoing care.",5.921493183921344e-07,0.3158976602012591,0.20659722222222224,0.04533566161954684,0.4070686891078199,0.12039999999999998,0.04527003852382169,0.4675882040071553,0.08842752787389466,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
80,0.7,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) documented in medical records? Yes, medical records typically include documentation of opioid dependence and MMT, detailing diagnosis, treatment plans, medication regimens, and patient response tracking for healthcare providers.",5.447773729207638e-07,0.3362739808137478,0.14966425619834714,0.04170880868998308,0.38721743085373417,0.09101524334251604,0.041648435441915946,0.40506784702582177,0.08842752787389466,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
80,0.7,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) noted in the patient's medical record? Yes, both are typically recorded, comprising diagnosis, treatment plans, medication details, and monitoring of the patient's reaction to therapy, which is vital for healthcare management.",4.737194547137079e-07,0.21130049249713911,0.18030065538511486,0.03626852929563745,0.26188667926332077,0.12039999999999998,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.3763690676819724,0.05436390532544381
80,0.7,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) found in the medical record? Yes, these conditions and treatments are commonly documented with diagnosis, treatment plans, medication details, and patient response monitoring, essential for healthcare professionals.",5.684633456564491e-07,0.2860446970515773,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.7,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and MMT recorded in the medical record? Yes, documentation usually includes opioid dependence diagnosis, MMT treatment plans, medication information, and monitoring of the patient's response to ensure comprehensive care.",6.39521263863505e-07,0.4231371901219436,0.17437500000000003,0.048962514549110596,0.47160721024539143,0.12039999999999998,0.04889164160572744,0.5342795785058287,0.08842752787389466,6.39521263863506e-07,0.5995126189961817,0.05436390532544381
80,0.7,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is the presence of opioid dependence and methadone maintenance treatment (MMT) documented in medical records? Yes, medical records often include this information, detailing diagnosis, treatment approaches, medication specifics, and patient progress monitoring.",6.39521263863505e-07,0.3784180171825926,0.20659722222222224,0.048962514549110596,0.47160721024539143,0.12039999999999998,0.04889164160572744,0.5342795785058287,0.08842752787389466,6.39521263863506e-07,0.5995126189961817,0.05436390532544381
80,0.7,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Does the medical record document opioid dependence and methadone maintenance treatment (MMT)? Yes, it usually contains records of diagnosis, treatment plans, medication details, and monitoring of the patient's response, which are crucial for healthcare providers.",5.684633456564491e-07,0.2860446970515773,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.7,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) included in medical records? Yes, these are typically documented, covering diagnosis, treatment plans, medication details, and patient monitoring, aiding both current and future healthcare professionals.",6.158352911278197e-07,0.3466693188680128,0.20659722222222224,0.047149088084328716,0.43881738742239973,0.12039999999999998,0.047080840064774566,0.500378026830147,0.08842752787389466,6.158352911278206e-07,0.5644212991849127,0.05436390532544381
81,0.7,1,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is it possible to estimate basal metabolic rate for Chinese individuals using existing prediction equations? Answer: Existing prediction equations might not be fully suitable for the Chinese population because of genetic, environmental, and lifestyle differences. Hence, developing a",1.6580180914979763e-07,0.051525053808620935,0.08307843316289262,0.012693985253473108,0.07875165119767935,0.06781677572873293,0.012675610786670066,0.14544177349047782,0.023242630385487524,1.6580180914979784e-07,0.18232155679395445,0.0
81,0.7,2,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Can the current basal metabolic rate prediction formulas be applied to the Chinese population? Answer: Due to genetic, environmental, and lifestyle variations, current prediction formulas for basal metabolic rate (BMR) might not be completely applicable to Chinese individuals. Therefore, there is a need to create a",2.3685972735685406e-08,0.08560111169770712,0.04447505408328825,0.0018134264647818726,0.0861863845701949,0.04560603192708004,0.0018108015409528666,0.05522892197167373,0.023242630385487524,2.3685972735685406e-08,0.023530497410194418,0.0
81,0.7,3,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the existing equations for predicting basal metabolic rate valid for Chinese people? Answer: The present equations used to estimate basal metabolic rate may not perfectly fit the Chinese population because of distinct genetic, environmental, and lifestyle influences. Thus, it is necessary to develop a",0.0,0.09241962407465909,0.06502670362358032,0.0,0.06301338005090429,0.04510179465788382,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
81,0.7,4,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: How accurate are current basal metabolic rate prediction equations for Chinese populations? Answer: Current prediction models for basal metabolic rate might not be entirely accurate for Chinese individuals due to specific genetic, environmental, and lifestyle factors. Consequently, there is a requirement for creating a",2.3685972735685406e-08,0.03703978086268389,0.04155822427126707,0.0018134264647818726,0.03929114810468315,0.04457414534324541,0.0018108015409528666,0.008708906336779787,0.023242630385487524,2.3685972735685406e-08,0.024097551579060017,0.0
81,0.7,5,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Do current BMR prediction equations apply to the Chinese population? Answer: The existing BMR estimation equations may not be fully applicable to Chinese people owing to unique genetic, environmental, and lifestyle characteristics. Hence, formulating a",2.3685972735685353e-07,0.09728172148980763,0.109375,0.018134264647818733,0.16330903922574302,0.06781677572873293,0.01810801540952868,0.23245315048010795,0.023242630385487524,2.3685972735685406e-07,0.2719337154836414,0.0
81,0.7,6,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is the basal metabolic rate estimation using current equations reliable for Chinese individuals? Answer: The reliability of current basal metabolic rate prediction equations for Chinese populations is questionable because of various genetic, environmental, and lifestyle differences. Therefore, it is important to develop a",4.737194547137081e-08,0.011852121473418187,0.04000000000000001,0.0036268529295637453,0.014993045843371355,0.044021415823914375,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.7,7,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the present basal metabolic rate equations suitable for use with the Chinese population? Answer: Present equations for estimating BMR might not be suitable for the Chinese population due to genetic, environmental, and lifestyle factors. As a result, it is essential to create a",2.3685972735685406e-08,0.06854647088813604,0.0640235260770975,0.0018134264647818726,0.07153055185165735,0.06781677572873293,0.0018108015409528666,0.008708906336779787,0.023242630385487524,2.3685972735685406e-08,0.024097551579060017,0.0
81,0.7,8,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Can current basal metabolic rate formulas be used for Chinese populations? Answer: Due to genetic, environmental, and lifestyle factors, current basal metabolic rate formulas may not be entirely applicable to Chinese individuals. Thus, creating a",2.3685972735685353e-07,0.2557153627606521,0.0030079344432882155,0.018134264647818733,0.2856291299127913,0.019592173282713482,0.01810801540952868,0.31647099054798034,0.03711116774146356,2.3685972735685406e-07,0.315255414268639,0.031217481789802305
81,0.7,9,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the current basal metabolic rate prediction models applicable to the Chinese population? Answer: Because of genetic, environmental, and lifestyle differences, current basal metabolic rate prediction models might not be fully applicable to Chinese people. Therefore, developing a",1.6580180914979763e-07,0.23393220658755487,0.04296875,0.012693985253473108,0.22862131185929035,0.0387029671546463,0.012675610786670066,0.26096630358380235,0.05940199771368602,1.6580180914979784e-07,0.26153837742937647,0.056932966023875105
81,0.7,10,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is it appropriate to use existing basal metabolic rate equations for Chinese individuals? Answer: Due to certain genetic, environmental, and lifestyle factors, existing equations for estimating basal metabolic rate may not be fully appropriate for the Chinese population. Thus, there is a need to create a",2.3685972735685406e-08,0.08560111169770668,0.04447505408328825,0.0018134264647818726,0.0861863845701949,0.04560603192708004,0.0018108015409528666,0.05522892197167373,0.023242630385487524,2.3685972735685406e-08,0.023530497410194418,0.0
82,0.7,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate inhibit colon cancer in patients with coronary artery disease? Our findings, based on patients with coronary artery disease, support the hypothesis that bezafibrate may help prevent colon cancer.",1.8948778188548272e-07,0.2279590739163595,0.015585937500000008,0.014507411718254988,0.2268418035957218,0.011093749999999986,0.014486412327622947,0.2252613676834736,0.005898437499999999,1.8948778188548325e-07,0.2231435513142097,0.0
82,0.7,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate effective in preventing colon cancer among patients with coronary artery disease? Data from patients with coronary artery disease back the idea that bezafibrate might have a protective effect against colon cancer.,1.1842986367842682e-07,0.13634003639361314,0.008992346938775514,0.009067132323909363,0.13567251877376396,0.006377551020408163,0.009054007704764333,0.13474924735768257,0.003380102040816329,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.7,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in coronary artery disease patients? Our data, obtained from patients with coronary artery disease, support the notion that bezafibrate could prevent colon cancer development.",2.1317375462116802e-07,0.2604414705235256,0.01803394901144642,0.016320838183036868,0.21715695965463944,0.017226562500000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,0.7,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, reduce the risk of colon cancer in patients with coronary artery disease? Evidence from coronary artery disease patients suggests a potential preventive role for bezafibrate against colon cancer.",1.8948778188548272e-07,0.14874225328093704,0.04082828719723183,0.014507411718254988,0.1452950764710219,0.047500000000000014,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
82,0.7,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is there a preventive effect of the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate on colon cancer in patients with coronary artery disease? Our research data from these patients support this possible preventive effect.,2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.7,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does treatment with bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevent colon cancer in individuals with coronary artery disease? Patient data indicate a possible protective effect of bezafibrate against colon cancer.",3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,0.7,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Could the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in patients suffering from coronary artery disease? Data from such patients support the hypothesis that bezafibrate may prevent colon cancer.,3.079176455639092e-07,0.30949433482781386,0.036081302021403076,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,0.7,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the use of bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, offer prevention against colon cancer in coronary artery disease patients? Our patient-derived data back the hypothesis of a preventive effect of bezafibrate.",2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.7,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, which is a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer in patients with coronary artery disease? Data from these patients support the hypothesis that bezafibrate might have a preventive impact on colon cancer development.",1.1842986367842682e-07,0.06337717528203912,0.043078433162892615,0.009067132323909363,0.06073768844295824,0.047500000000000014,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.7,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering ligand bezafibrate, targeting peroxisome proliferator-activated receptors, help prevent colon cancer in patients with coronary artery disease? Our findings from patients with coronary artery disease support the possible preventive effect of bezafibrate on colon cancer.",1.6580180914979742e-07,0.1964874960898535,0.01326962809917355,0.012693985253473108,0.19552436023319242,0.00943296602387509,0.012675610786670073,0.1941728480622058,0.005009756657483936,1.6580180914979784e-07,0.19237189264745602,0.0
83,0.7,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are UK radiologists content with the training and support provided for suspected child abuse cases? The survey reveals considerable dissatisfaction among consultant radiologists regarding the existing service, highlights a shortage of paediatric radiologists handling such cases, and indicates that enhancing training could boost the number of radiology child abuse specialists by 27%.",1.1842986367842703e-07,0.09595304393715409,0.0017487603305785006,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
83,0.7,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Do UK radiologists feel adequately trained and supported in cases of suspected child abuse? Findings show significant discontent among consultant radiologists with current provisions, a limited number of paediatric radiologists engaged in this area, and a potential 27% rise in specialists if training improves.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
83,0.7,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are consultant radiologists in the UK satisfied with their training and support for suspected child abuse? The survey indicates widespread dissatisfaction, a low count of paediatric radiologists involved, and suggests that better training could increase expert numbers by 27%.",4.263475092423371e-07,0.3630102745601933,0.017851239669421492,0.03264167636607371,0.3964152725882455,0.0,0.0325944277371516,0.40546510810816505,0.0,4.263475092423373e-07,0.41494385206270756,0.0
83,0.7,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","What is the level of satisfaction among UK radiologists regarding training and support for suspected child abuse? The survey uncovers notable dissatisfaction, a scarcity of paediatric radiologists working in this field, and a possibility to raise expert numbers by 27% through enhanced training.",3.316036182995957e-07,0.2629268160032119,0.017851239669421492,0.025387970506946217,0.2937611185281632,0.0,0.025351221573340132,0.30010459245033916,0.0,3.316036182995957e-07,0.30673026742247655,0.0
83,0.7,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","How satisfied are UK radiologists with the current training and support for suspected child abuse cases? Survey results demonstrate significant consultant radiologist dissatisfaction, a small number of paediatric radiologists participating, and a potential 27% increase in specialists with improved training.",4.026615365066518e-07,0.3370347881569353,0.017851239669421492,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
83,0.7,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are UK consultant radiologists happy with the training and support they receive for suspected child abuse? The survey highlights substantial dissatisfaction, few paediatric radiologists involved, and indicates that better training could expand expert numbers by 27%.",4.97405427449393e-07,0.44524837279716634,0.017851239669421492,0.03808195576041933,0.48097266061630917,0.0,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
83,0.7,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Is the training and support received by UK radiologists for suspected child abuse adequate? The survey shows marked dissatisfaction among consultants, a low involvement of paediatric radiologists, and suggests a 27% growth in experts if training is enhanced.",4.500334819780224e-07,0.38967852164235417,0.017851239669421492,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
83,0.7,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Do UK radiologists express satisfaction with their training and support in suspected child abuse cases? The survey reveals considerable unhappiness among consultants, few paediatric radiologists handling these cases, and a potential 27% increase in specialists through improved training.",4.500334819780224e-07,0.38967852164235417,0.017851239669421492,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
83,0.7,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","How do UK radiologists rate the training and support for suspected child abuse? The survey reports significant dissatisfaction among consultant radiologists, a limited number of paediatric radiologists, and the potential to increase specialists by 27% with better training.",4.500334819780224e-07,0.38967852164235417,0.017851239669421492,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
83,0.7,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are UK paediatric radiologists satisfied with their training and support regarding suspected child abuse? Survey data shows notable dissatisfaction among consultants, few paediatric radiologists engaged in this work, and suggests a 27% rise in expert numbers if training improves.",4.263475092423371e-07,0.39949170511597965,0.008445327167685882,0.03264167636607371,0.3964152725882455,0.0,0.0325944277371516,0.40546510810816505,0.0,4.263475092423373e-07,0.41494385206270756,0.0
84,0.7,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Criteria Forecast Success in Orthopaedic Surgery Residency? Answer: Our findings indicate that USMLE Step 2 scores, the count of honors received during medical school clerkships, and AOA membership have the most significant correlations with resident performance. The purpose of examining these data was to offer residency programs a better understanding of which criteria might be most predictive.",7.105791820705622e-08,0.05129329438754926,0.0,0.005440279394345618,0.05218575317056917,0.0,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
84,0.7,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Residency Selection Criteria Predictive of Performance in Orthopaedic Surgery Residency? Answer: We discovered that USMLE Step 2 results, the number of honors earned in medical school clerkships, and being an AOA member show the strongest links with resident performance. Our aim in reviewing this data was to help residency programs identify which criteria could be considered 'high yield.'",4.737194547137081e-08,0.03448617607116855,0.0,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
84,0.7,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Residency Selection Criteria Predict Outcomes in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2 scores, honors count in medical school clerkships, and AOA membership were the most strongly correlated with resident performance. The goal of analyzing this data was to guide residency programs in recognizing potentially valuable selection criteria.",1.1842986367842703e-07,0.09180754925312229,0.0,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
84,0.7,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does Residency Selection Criteria Indicate Performance in Orthopaedic Surgery Residency? Answer: The strongest correlations with resident performance were found with USMLE Step 2, number of honors in medical school clerkships, and AOA membership. Our objective in analyzing these results was to inform residency programs about which criteria may be considered 'high yield.'",1.1842986367842703e-07,0.09180754925312229,0.0,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
84,0.7,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Is There a Link Between Residency Selection Criteria and Performance in Orthopaedic Surgery Residency? Answer: Our study showed that USMLE Step 2 scores, honors earned during medical school clerkships, and AOA membership had the highest correlations with resident performance. The analysis aimed to provide residency programs insight into which criteria might be most effective.",7.105791820705622e-08,0.05406722127027486,0.0,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
84,0.7,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Selection Criteria Predict Resident Success in Orthopaedic Surgery Residency? Answer: We observed that USMLE Step 2 scores, the number of honors received in medical school clerkships, and AOA membership had the strongest association with resident performance. Our intention in analyzing these data was to help residency programs understand which criteria might be 'high yield.'",4.737194547137081e-08,0.03571808260207909,0.0,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
84,0.7,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Residency Selection Factors Predict Performance in Orthopaedic Surgery Residency? Answer: It was found that USMLE Step 2, the quantity of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident outcomes. The goal of this analysis was to assist residency programs in identifying key selection criteria.",1.4211583641411244e-07,0.11122563511022499,0.0,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
84,0.7,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Orthopaedic Surgery Residency Selection Criteria Predictive of Resident Performance? Answer: The data showed that USMLE Step 2 scores, number of honors during medical school clerkships, and AOA membership correlated most strongly with resident performance. The purpose of the analysis was to inform residency programs about potentially high-yield criteria.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.7,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does the Criteria for Residency Selection Predict Performance in Orthopaedic Surgery Residency? Answer: We identified that USMLE Step 2, honors in medical school clerkships, and AOA membership had the strongest correlations with resident performance. Our aim with this data analysis was to provide residency programs with an idea of which criteria may yield the best predictive value.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,0.7,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Metrics Predict Success in Orthopaedic Surgery Residency? Answer: Findings revealed that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership were the most predictive of resident performance. The goal of analyzing this data was to guide residency programs in selecting high-yield criteria.",1.4211583641411244e-07,0.11122563511022499,0.0,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
85,0.7,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, though more research is needed to clarify its role in palliative or adjuvant therapy.",2.1317375462116813e-07,0.2054366026956549,0.016804761120134334,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.7,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work for gallbladder carcinoma? External radiotherapy seems to be a safe and effective option for palliating gallbladder carcinoma, but additional studies are required to define its use in palliative or adjuvant care.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.7,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy an effective palliative treatment for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative approach for gallbladder carcinoma; nonetheless, further research is necessary to establish its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.25318184550457135,0.03729315417627105,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.7,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy in treating gallbladder carcinoma? External radiotherapy is seen as a safe and effective palliative method for gallbladder carcinoma, but more studies are needed to determine its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.7,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, although further investigation is needed to understand its role in palliative or adjuvant treatment.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.7,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy beneficial as palliative care for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative option for gallbladder carcinoma; however, additional studies are required to define its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.18519317155393722,0.008526077097505684,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.7,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative relief in gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma, but more research is necessary to establish its role in palliative or adjuvant care.",1.8948778188548283e-07,0.2146736688067965,0.01001184787640548,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.7,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.",What is the effectiveness of external palliative radiotherapy for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative management method for gallbladder carcinoma; further studies are needed to clarify its role in palliative or adjuvant treatment.,1.4211583641411222e-07,0.12007152469675697,0.01905490708579512,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.7,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy a safe and effective treatment for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative management approach for gallbladder carcinoma; however, more research is needed to determine its role in palliative or adjuvant therapy.",9.474389094274162e-08,0.17092623586540912,0.053413958175862974,0.0072537058591274906,0.13649108433591195,0.027889582908887926,0.007243206163811466,0.13656488911276776,0.026296566837107373,9.474389094274162e-08,0.10265415406008227,0.0
85,0.7,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How safe and effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, but further studies are necessary to define its role in palliative or adjuvant care.",1.4211583641411222e-07,0.193034385808331,0.03301587301587301,0.010880558788691236,0.15551021446776492,0.0037635424540186403,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
86,0.7,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Does central venous pressure indicate fluid responsiveness? No evidence supports using central venous pressure for guiding fluid therapy, so this method should be discontinued.",2.842316728282236e-07,0.4611843606743977,0.029234834429639624,0.021761117577382555,0.45755808774640094,0.01596671726541857,0.021729618491434483,0.45198512374305855,0.0,2.842316728282248e-07,0.47000362924573613,0.0
86,0.7,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Is central venous pressure a reliable predictor of fluid responsiveness? Data do not back the common use of central venous pressure to direct fluid therapy; this practice ought to be stopped.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.7,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Can central venous pressure forecast fluid responsiveness? There is no data endorsing the routine use of central venous pressure in fluid management, and this strategy should be abandoned.",1.894877818854824e-07,0.2829828460437285,0.01666703397612488,0.014507411718255037,0.28080963692155647,0.009015243342516074,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
86,0.7,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Does measuring central venous pressure help predict fluid responsiveness? The available evidence does not justify its widespread use for fluid therapy guidance, and this practice should be ceased.",1.894877818854824e-07,0.18029437484966193,0.056932966023875105,0.014507411718255037,0.2274906230323297,0.029384756657483937,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
86,0.7,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Is central venous pressure effective in predicting fluid responsiveness? No supporting data exist for using it broadly in fluid therapy decisions, so this practice should be halted.",2.131737546211677e-07,0.21803470283250892,0.056932966023875105,0.016320838183036916,0.26671133618561216,0.029384756657483937,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
86,0.7,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Does central venous pressure serve as an indicator for fluid responsiveness? Current data do not support its extensive use in guiding fluid resuscitation, thus this method should be abandoned.",1.658018091497971e-07,0.14392673067878725,0.056932966023875105,0.012693985253473157,0.1897502950494827,0.029384756657483937,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
86,0.7,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Can central venous pressure be used to predict fluid responsiveness? There is no evidence to endorse its routine use in fluid therapy, and it should no longer be employed.",1.658018091497971e-07,0.14392673067878725,0.056932966023875105,0.012693985253473157,0.1897502950494827,0.029384756657483937,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
86,0.7,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Is central venous pressure a valid tool for predicting fluid responsiveness? The lack of supporting data means this common approach should be discontinued.,3.079176455639089e-07,0.3850887874956759,0.056932966023875105,0.023574544042164434,0.4410647233303906,0.029384756657483937,0.023540420032387356,0.5007752879124898,0.0,3.079176455639102e-07,0.5212969236332863,0.0
86,0.7,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Does central venous pressure predict how a patient will respond to fluids? Data fail to support its widespread use in fluid therapy, indicating this practice should be stopped.",1.894877818854824e-07,0.18029437484966193,0.056932966023875105,0.014507411718255037,0.2274906230323297,0.029384756657483937,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
86,0.7,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Is using central venous pressure to predict fluid responsiveness supported by data? No, so the practice of guiding fluid therapy with it should be abandoned.",2.605457000925383e-07,0.2980774105060462,0.056932966023875105,0.019947691112600675,0.3500929451246626,0.029384756657483937,0.01991881695048161,0.4054651081081646,0.0,2.6054570009253947e-07,0.42121346507630486,0.0
87,0.7,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Can (18)F-FDG serve as a surrogate tracer for measuring tumor hypoxia? Answer: This research demonstrated that FDG is ineffective as a surrogate tracer for tumor hypoxia in both normal and low oxygen environments. Tumor hypoxia should be assessed only with specialized hypoxia tracers.,4.737194547137081e-08,0.01213279698074654,0.04155124653739603,0.0036268529295637453,0.015573502596850641,0.04602235371466138,0.003621603081905733,0.017613694601916308,0.04865220249835634,4.737194547137081e-08,0.016635935359553322,0.02498356344510192
87,0.7,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Is (18)F-FDG an appropriate surrogate tracer for tumor hypoxia measurement? Answer: Findings indicate that FDG does not reliably indicate tumor hypoxia under ambient or hypoxic conditions. Only dedicated hypoxia tracers are suitable for this purpose.,1.421158364141119e-07,0.09639624276773606,0.04416796863767507,0.010880558788691243,0.12786157046977786,0.02498356344510192,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
87,0.7,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Does (18)F-FDG act as a surrogate tracer for tumor hypoxia? Answer: The study revealed FDG is not a suitable surrogate tracer for tumor hypoxia whether in normal oxygen or hypoxic states. Specific hypoxia tracers are required to accurately measure tumor hypoxia.,0.0,4.440892098500626e-16,0.0,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
87,0.7,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Can tumor hypoxia be measured using (18)F-FDG as a surrogate tracer? Answer: This study concluded that FDG fails to serve as a good surrogate tracer for tumor hypoxia under both oxygen-rich and hypoxic conditions. Only hypoxia-specific tracers should be employed.,2.3685972735685406e-08,0.007428842118503809,0.02285318559556789,0.0018134264647818726,0.009339551043704652,0.02498356344510192,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
87,0.7,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia? Answer: The results showed that FDG is inadequate as a surrogate tracer for tumor hypoxia in ambient or hypoxic environments. Tumor hypoxia measurement should rely exclusively on hypoxia-specific tracers.,4.7371945471370706e-08,0.16185030336669826,0.07604564913806915,0.0036268529295637453,0.16256165758270047,0.07882266492860052,0.003621603081905733,0.16504597898162743,0.08044982698961935,4.737194547137081e-08,0.13108357466582587,0.055363321799307974
87,0.7,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Does (18)F-FDG function well as a surrogate tracer for tumor hypoxia measurement? Answer: Evidence from this study suggests that FDG is not a reliable surrogate tracer for tumor hypoxia either in normal oxygen or hypoxic conditions. Only tracers designed specifically for hypoxia should be used.,9.474389094274162e-08,0.07130043039800249,0.015328150207385427,0.0072537058591274906,0.03544746875596516,0.04283321228363101,0.007243206163811466,0.03315966206996945,0.046400951814396206,9.474389094274162e-08,0.06707644995888984,0.023795359904818555
87,0.7,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Is (18)F-FDG a valid surrogate tracer to assess tumor hypoxia? Answer: This study found that FDG does not serve as a good surrogate tracer for tumor hypoxia under both ambient and hypoxic states. Assessment of tumor hypoxia should be performed with specialized hypoxia tracers.,7.105791820705622e-08,0.10904035992791883,0.027363207517540733,0.005440279394345618,0.10697802060762251,0.02498356344510192,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
87,0.7,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Question: Can (18)F-FDG reliably indicate tumor hypoxia as a surrogate tracer? Answer: The study demonstrated that FDG is not effective for indicating tumor hypoxia in either normal oxygen or hypoxic conditions. Specific hypoxia tracers must be used for accurate measurement.,4.7371945471370706e-08,0.01587974293072225,0.04709141274238227,0.0036268529295637453,0.016635935359553322,0.02498356344510192,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
87,0.7,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,"Question: Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia detection? Answer: Results indicate that FDG is unsuitable as a surrogate tracer for tumor hypoxia under ambient or hypoxic conditions, and only specific hypoxia tracers should be utilized.",7.1057918207056e-08,0.19343831754777208,0.07962906855955677,0.005440279394345618,0.2306412582687276,0.10685237405489809,0.0054324046228586,0.23407541446463354,0.109375,7.105791820705622e-08,0.20106332919010672,0.0849609375
87,0.7,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,"Question: Does (18)F-FDG provide a surrogate measure of tumor hypoxia? Answer: According to the study, FDG is not a good surrogate tracer for tumor hypoxia in both normal and hypoxic environments; tumor hypoxia should be measured with dedicated hypoxia tracers.",4.7371945471370706e-08,0.01587974293072225,0.04709141274238228,0.0036268529295637453,0.016635935359553322,0.02498356344510192,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
88,0.7,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is a specialist breast pathology evaluation essential for handling ductal carcinoma in situ? Answer: Specialist breast pathology evaluations remain crucial in managing DCIS.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.7,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Do ductal carcinoma in situ cases require expert breast pathology reviews? Answer: Expert breast pathology reviews are still vital for the management of DCIS.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.7,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert assessment by breast pathologists needed for managing ductal carcinoma in situ? Answer: Expert breast pathology assessments continue to be necessary in DCIS management.,9.47438909427412e-08,0.042793010208607374,0.13439999999999996,0.007253705859127518,0.0551296540329802,0.07100591715976333,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.7,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is specialized breast pathology examination necessary for treating ductal carcinoma in situ? Answer: Specialized breast pathology examinations remain important for DCIS treatment.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.7,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Does managing ductal carcinoma in situ require expert breast pathology analysis? Answer: Expert breast pathology analysis is still essential for managing DCIS.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.7,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is an expert breast pathology evaluation required for ductal carcinoma in situ management? Answer: Expert breast pathology evaluations are necessary for managing DCIS.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.7,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is professional breast pathology assessment needed in the management of ductal carcinoma in situ? Answer: Professional breast pathology assessments continue to be needed for DCIS management.,7.10579182070559e-08,0.024624304416563714,0.05801111111111108,0.005440279394345639,0.06975943395752049,0.03107536160420777,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.7,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology review critical in managing ductal carcinoma in situ? Answer: Expert breast pathology reviews remain critical for DCIS management.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.7,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert evaluation by breast pathologists necessary for the management of ductal carcinoma in situ? Answer: Expert breast pathology evaluations continue to be necessary in the management of DCIS.,0.0,0.09560650766344025,0.0658128943758573,0.0,0.04951051289713959,0.03534062223520915,0.0,0.0,0.0,0.0,0.0,0.0
88,0.7,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is a specialized breast pathology assessment indispensable for managing ductal carcinoma in situ? Answer: Specialized breast pathology assessments remain indispensable in DCIS management.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
89,0.7,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys in women with multiple pregnancies? Our study indicates that pregnancy-related glomerular hyperfiltration does not negatively impact the kidneys in women with higher parity. Pregnancy might provide protective effects to the kidneys against the harmful consequences of glomerular hyperfiltration.,1.4211583641411244e-07,0.15853667338202637,0.06590401051939519,0.010880558788691236,0.1391757799190474,0.008061230233033498,0.0108648092457172,0.1385155465999972,0.005658534430964771,1.4211583641411244e-07,0.13765726869928407,0.0029714576866202713
89,0.7,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage caused by glomerular hyperfiltration in pregnant women with multiple births? According to our research, glomerular hyperfiltration associated with pregnancy does not damage the kidneys in women who have given birth multiple times. Pregnancy may offer protective mechanisms to the kidneys against the detrimental effects of hyperfiltration.",7.105791820705622e-08,0.04470656738630341,0.07396765385423232,0.005440279394345618,0.021302257949105563,0.05975554549569943,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
89,0.7,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy cause kidney harm in women with many childbirths? Our findings suggest that pregnancy-induced glomerular hyperfiltration does not adversely affect the kidneys of women with higher parity. Pregnancy could have protective roles against kidney damage from hyperfiltration.,2.6054570009253947e-07,0.14916744241698376,0.06569405971068024,0.0199476911126006,0.1652836976313079,0.05975554549569943,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
89,0.7,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy result in kidney injury in women with multiple pregnancies? Our study proposes that the increased glomerular filtration from pregnancy does not harm the kidneys of women with more parities. Pregnancy may protect the kidneys from the harmful impact of hyperfiltration.,1.6580180914979784e-07,0.047555924607568745,0.07020408163265307,0.012693985253473108,0.06764522806739004,0.05975554549569943,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.7,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage from glomerular hyperfiltration in pregnant women who have had several children? Our research suggests that glomerular hyperfiltration caused by pregnancy does not negatively affect the kidneys in women with numerous parities. Pregnancy might have protective mechanisms for the kidneys against hyperfiltration damage.,1.4211583641411244e-07,0.02368277142104569,0.07120725917913588,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.7,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does pregnancy-related glomerular hyperfiltration cause kidney damage in women with multiple births? Our study indicates that the increased kidney filtration during pregnancy does not adversely affect the kidneys of women with higher numbers of parities. Pregnancy could provide protection for kidneys against hyperfiltration harm.,1.8948778188548325e-07,0.03977146652833774,0.09231292517006803,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.7,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy damage kidneys in women who have had more children? Our study suggests that pregnancy-induced glomerular hyperfiltration does not produce adverse kidney effects in women with greater parity. Pregnancy may have protective effects on the kidneys against the negative consequences of hyperfiltration.,1.4211583641411244e-07,0.02368277142104569,0.07120725917913588,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.7,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does kidney damage occur due to glomerular hyperfiltration in pregnancy for women with multiple parities? We suggest from our study that glomerular hyperfiltration from pregnancy does not cause kidney damage in women with more parities. Pregnancy may offer possible protective mechanisms for kidney health against hyperfiltration effects.,1.1842986367842703e-07,0.030501283797998102,0.050655609638843815,0.009067132323909363,0.0221828539906328,0.05975554549569943,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.7,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there a risk of kidney damage from glomerular hyperfiltration in pregnant women with higher parity? Our findings suggest that glomerular hyperfiltration during pregnancy does not adversely impact kidneys in women with more parities. Pregnancy may provide protective mechanisms to guard kidneys against hyperfiltration damage.,1.6580180914979784e-07,0.047555924607568745,0.07020408163265307,0.012693985253473108,0.06764522806739004,0.05975554549569943,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.7,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration caused by pregnancy harm the kidneys of women with multiple childbirths? Our study suggests that this hyperfiltration does not have harmful effects on the kidneys in women with increased parity. Pregnancy might have protective mechanisms to shield kidneys from hyperfiltration's adverse effects.,1.6580180914979784e-07,0.047555924607568745,0.07020408163265307,0.012693985253473108,0.06764522806739004,0.05975554549569943,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
90,0.7,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are stroke patients' self-reported home blood pressure readings trustworthy? When done properly, these readings can be reliable. However, factors like wrong cuff size, poor measurement technique, or cognitive issues may affect accuracy. Hence, educating patients on correct measurement and reporting is essential.",4.026615365066519e-07,0.1795595554310898,0.1184159938485198,0.030828249901291835,0.20824609149746776,0.10380622837370242,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2689256174246375,0.07227989234909649
90,0.7,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients be trusted to report their home blood pressure readings accurately? If measured correctly, their reports can be dependable. Nonetheless, errors due to incorrect cuff sizing, improper technique, or cognitive impairments can impact reliability. Therefore, ensuring patients know how to measure and report properly is important.",2.6054570009253947e-07,0.042984020425339775,0.1184159938485198,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
90,0.7,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","How reliable are home blood pressure readings reported by stroke patients? These readings can be accurate if the patients follow correct procedures. Factors such as using the wrong cuff size, incorrect technique, or cognitive problems might affect measurement accuracy. Thus, proper patient education on measurement and reporting is critical.",2.3685972735685406e-07,0.021930611227506613,0.1184159938485198,0.018134264647818726,0.04697794390134602,0.10380622837370242,0.018108015409528666,0.07293401200320737,0.08842752787389466,2.3685972735685406e-07,0.09984928738070442,0.07227989234909649
90,0.7,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients provide dependable home blood pressure readings? Their reports can be reliable when measurements are taken correctly. However, accuracy may be compromised by issues like wrong cuff size, improper technique, or cognitive deficits. As a result, teaching patients the correct method of measurement and reporting is vital.",2.3685972735685406e-07,0.021930611227506613,0.1184159938485198,0.018134264647818726,0.04697794390134602,0.10380622837370242,0.018108015409528666,0.07293401200320737,0.08842752787389466,2.3685972735685406e-07,0.09984928738070442,0.07227989234909649
90,0.7,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is it reliable to trust stroke patients' reports of home blood pressure readings? When done properly, these readings can be accurate. Yet, factors such as incorrect cuff size, faulty technique, or cognitive impairments may reduce accuracy. Therefore, it is important to ensure patients understand how to measure and report their blood pressure correctly.",1.4211583641411244e-07,0.03145258950141683,0.09919261822376008,0.010880558788691236,0.034700087112921274,0.10380622837370242,0.0108648092457172,0.010447596935843517,0.08842752787389466,1.4211583641411244e-07,0.014691479040397137,0.07227989234909649
90,0.7,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are the home blood pressure readings reported by stroke patients dependable? They can be reliable if patients measure correctly. Accuracy might be affected by factors like improper cuff size, bad technique, or cognitive impairment. Hence, educating patients on proper measurement and reporting is essential.",3.552895910352811e-07,0.13193150644183538,0.1184159938485198,0.02720139697172809,0.15945592732803604,0.10380622837370242,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
90,0.7,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can we rely on stroke patients' reported home blood pressure readings? Such readings may be reliable if proper technique is used. However, the accuracy can be influenced by incorrect cuff size, poor technique, or cognitive issues. Thus, it's crucial to instruct patients on accurate measurement and reporting.",2.8423167282822487e-07,0.06449022564630313,0.1184159938485198,0.02176111757738247,0.09046305584108438,0.10380622837370242,0.0217296184914344,0.11738577457404009,0.08842752787389466,2.8423167282822487e-07,0.14531166145746166,0.07227989234909649
90,0.7,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","How trustworthy are stroke patients' reports of their home blood pressure? These can be reliable if the measurements are done correctly. However, factors like wrong cuff size, improper technique, or cognitive impairments can affect accuracy. Therefore, ensuring patients know how to measure and report properly is necessary.",2.8423167282822487e-07,0.06449022564630313,0.1184159938485198,0.02176111757738247,0.09046305584108438,0.10380622837370242,0.0217296184914344,0.11738577457404009,0.08842752787389466,2.8423167282822487e-07,0.14531166145746166,0.07227989234909649
90,0.7,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are home blood pressure readings reported by stroke patients accurate? They can be, provided measurements are taken correctly. Factors such as incorrect cuff size, poor technique, or cognitive deficits can influence accuracy. Thus, proper patient instruction on measurement and reporting is key.",4.026615365066519e-07,0.1795595554310898,0.1184159938485198,0.030828249901291835,0.20824609149746776,0.10380622837370242,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2689256174246375,0.07227989234909649
90,0.7,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is trusting stroke patients' home blood pressure readings reasonable? When measurements are done correctly, reports can be reliable. Nonetheless, accuracy may be compromised by issues such as wrong cuff size, improper technique, or cognitive impairment. Therefore, educating patients on correct measurement and reporting methods is important.",3.079176455639103e-07,0.08646913236507814,0.1184159938485198,0.023574544042164344,0.1129359116931421,0.10380622837370242,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.16884215886765608,0.07227989234909649
91,0.7,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are heightened carotid artery pulsatility and resistance indices early indicators of vascular issues in young obese males? Our findings indicate that reduced vessel compliance and elevated vascular resistance characterize young, obese, normotensive individuals, regardless of other cardiovascular risk factors. Alterations in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.7,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes signify early vascular abnormalities in young obese men? Our study suggests that young, obese, normotensive subjects exhibit decreased vessel compliance and raised vascular resistance, independent of traditional cardiovascular risk factors. Changes in arterial walls could...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.7,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is an increase in carotid artery pulsatility and resistance indexes an early marker of vascular abnormalities in young obese males? The data shows that young obese normotensive individuals have diminished vessel compliance and higher vascular resistance, beyond common cardiovascular risk factors. This may be due to arterial wall property changes...",7.105791820705622e-08,0.08771514212630915,0.020399305555555556,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
91,0.7,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Could elevated carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Our results reveal that depressed vessel compliance and increased vascular resistance are present in young, obese, normotensive subjects, independent of cardiovascular risk factors. Such changes might involve arterial wall properties...",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
91,0.7,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are early vascular abnormalities in young obese males indicated by increased carotid artery pulsatility and resistance indexes? According to our findings, young obese normotensive subjects have reduced vessel compliance and enhanced vascular resistance, independently of cardiovascular risk factors. This is possibly linked to changes in arterial wall structure...",1.1842986367842703e-07,0.13059174157604847,0.0212665406427221,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
91,0.7,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is increased carotid artery pulsatility and resistance index an early indicator of vascular problems in young obese males? Our results suggest that young, obese, normotensive individuals show features of lowered vessel compliance and raised vascular resistance, independently from cardiovascular risk factors. These alterations may stem from arterial wall changes...",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
91,0.7,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do young obese males with increased carotid artery pulsatility and resistance indexes exhibit early vascular abnormalities? Our findings indicate that these individuals have impaired vessel compliance and elevated vascular resistance, regardless of cardiovascular risk factors, likely due to changes in arterial wall properties...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.7,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are vascular abnormalities in young obese males first detected by increased carotid artery pulsatility and resistance indexes? The data suggests that young obese normotensive subjects have depressed vessel compliance and heightened vascular resistance, beyond established cardiovascular risk factors. This may reflect arterial wall property modifications...",1.8948778188548325e-07,0.19856077468861866,0.02271498107084911,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.7,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can increased carotid artery pulsatility and resistance indexes serve as early signs of vascular abnormalities in young obese males? Our study shows that young, obese normotensive subjects present with reduced vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. These findings might be due to changes in arterial wall properties...",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
91,0.7,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are early signs of vascular abnormalities in young obese males indicated by increased carotid artery pulsatility and resistance indexes? Our results demonstrate that young obese normotensive individuals have lower vessel compliance and higher vascular resistance, regardless of cardiovascular risk factors. This is possibly linked to alterations in arterial wall properties...",7.105791820705622e-08,0.08771514212630915,0.020399305555555556,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
92,0.7,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having an optimistic perspective predict better survival rates in advanced age? It seems that optimism is a strong indicator of survival among the oldest-old women. It might also be important for men, although the sample size is limited.",1.4211583641411222e-07,0.010929975935384029,0.11176857330703485,0.010880558788691236,0.05356399180841365,0.06937499999999999,0.0108648092457172,0.12114367122916603,0.023795359904818555,1.4211583641411244e-07,0.15822400521489444,0.0
92,0.7,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can optimism predict improved survival in very old age? An optimistic attitude seems to be a key predictor of longevity in the oldest-old women and possibly for men, though the male sample is small.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.7,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is an optimistic outlook linked to better survival at advanced ages? Optimism appears to significantly forecast survival among the oldest-old women and potentially among men, but the men's sample size is small.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.7,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does an optimistic mindset forecast enhanced survival among the very elderly? Among the oldest-old women, optimism is a notable predictor of survival and may also be relevant for men despite a small sample size.",2.605457000925387e-07,0.17215754235845804,0.08149513580703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.7,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can optimism serve as a predictor for longevity in advanced age? It looks like optimism is a significant survival predictor for the oldest-old women and possibly for men, though male numbers are limited.",2.84231672828224e-07,0.20424197977627356,0.08055109151723255,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.7,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is there a connection between optimism and survival in advanced age? Optimism seems to be an important survival predictor for the oldest-old women, and it might be significant for men as well, but the sample size for men is small.",1.1842986367842692e-07,0.0013594530791580794,0.0861453046089739,0.009067132323909363,0.02689574472625278,0.06937499999999999,0.009054007704764333,0.0937446970410507,0.023795359904818555,1.1842986367842703e-07,0.1300531282481976,0.0
92,0.7,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does a positive outlook predict better survival rates at advanced ages? Optimism is a significant survival indicator among the oldest-old women and could be for men, though the sample size for men is small.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.7,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is optimism a useful predictor of longevity in the very old? Among the oldest-old women, optimism appears to predict survival significantly and may do so for men, but the male sample is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.7,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having an optimistic view predict better survival in late life? Optimism is a significant survival predictor among the oldest-old women and may also be important for men, but the sample size for men is limited.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,0.7,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can a positive outlook forecast improved survival among the oldest-old? Optimism is a strong predictor of survival in the oldest-old women and potentially for men, although the sample size of men is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
93,0.7,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a correlation between the radiographic transition zone and the extent of aganglionosis observed in the specimen for Hirschsprung's disease? Answer: Yes, the radiographic transition zone typically corresponds to the level of aganglionosis in the specimen for Hirschsprung's disease, but it is not always perfectly accurate or conclusive.",1.1842986367842703e-07,0.2593771712537274,0.0773256246281975,0.009067132323909363,0.2879892700674156,0.10844469077420552,0.009054007704764333,0.28804717809739566,0.11639773799651125,1.1842986367842703e-07,0.2878048413771377,0.12031242126480225
93,0.7,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the level of aganglionosis in Hirschsprung's disease specimens match the radiographic transition zone? Answer: Generally, the radiographic transition zone aligns with the aganglionosis level on the specimen in Hirschsprung's disease, although it is not always definitive or precise.",1.1842986367842692e-07,0.15081426473835613,0.1579861111111111,0.009067132323909363,0.16229865094677987,0.18490637163855836,0.009054007704764333,0.1373043631455988,0.1799307958477509,1.1842986367842703e-07,0.07281921728154206,0.14204081632653065
93,0.7,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone often indicates the level of aganglionosis in Hirschsprung's disease specimens, but it is not consistently reliable or exact.",1.4211583641411222e-07,0.04906965333461688,0.10581668962350782,0.010880558788691236,0.059709588924196755,0.13075311148604635,0.0108648092457172,0.07139721225970863,0.15217569380693458,1.4211583641411244e-07,0.044648340314845214,0.14204081632653065
93,0.7,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correspond to the extent of aganglionosis seen in Hirschsprung's disease specimens? Answer: The radiographic transition zone usually corresponds with the aganglionosis level in Hirschsprung's disease specimens, but it may not always be accurate or definitive.",9.474389094274162e-08,0.10948330536111461,0.11192602040816327,0.0072537058591274906,0.11811754012737197,0.13481404958677684,0.007243206163811466,0.12749117967197332,0.15363422901064352,9.474389094274162e-08,0.10021819146965738,0.14204081632653065
93,0.7,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a relationship between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone often correlates with the aganglionosis level on Hirschsprung's disease specimens, yet it is not invariably precise or conclusive.",7.105791820705622e-08,0.10459036756173212,0.09233418367346935,0.005440279394345618,0.146101298806125,0.1366959991038615,0.0054324046228586,0.1544020873715337,0.15430752714968995,7.105791820705622e-08,0.12688643855181825,0.14204081632653065
93,0.7,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone reliably indicate the level of aganglionosis in Hirschsprung's disease specimens? Answer: While the radiographic transition zone frequently correlates with the aganglionosis level in Hirschsprung's disease specimens, it is not always a definitive or exact indicator.",9.474389094274162e-08,0.10948330536111461,0.11192602040816327,0.0072537058591274906,0.11811754012737197,0.13481404958677684,0.007243206163811466,0.12749117967197332,0.15363422901064352,9.474389094274162e-08,0.10021819146965738,0.14204081632653065
93,0.7,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the level of aganglionosis in Hirschsprung's disease specimens reflected by the radiographic transition zone? Answer: Yes, the radiographic transition zone commonly reflects the level of aganglionosis in Hirschsprung's disease specimens, though it is not always completely accurate or definitive.",9.474389094274162e-08,0.005511228277121916,0.046875,0.0072537058591274906,0.011479512348919751,0.062442607897153335,0.007243206163811466,0.018046888004612516,0.07612456747404847,9.474389094274162e-08,0.012184054026551205,0.0615909893369113
93,0.7,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone match the level of aganglionosis on specimens from Hirschsprung's disease cases? Answer: Typically, the radiographic transition zone matches the aganglionosis level on Hirschsprung's disease specimens, but this correlation is not always absolute or conclusive.",1.1842986367842692e-07,0.1152682554788722,0.13315051020408158,0.009067132323909363,0.12581722039099308,0.1587338026731966,0.009054007704764333,0.09983694798019638,0.15292462300824475,1.1842986367842703e-07,0.07281921728154206,0.14204081632653065
93,0.7,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Can the radiographic transition zone be used to determine the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone can often determine the level of aganglionosis in Hirschsprung's disease specimens, but it is not invariably precise or definitive.",4.737194547137081e-08,0.00149017868960577,0.01953125,0.0036268529295637453,0.004269527774167781,0.027548209366391185,0.003621603081905733,0.007321750447326192,0.03460207612456748,4.737194547137081e-08,0.010677887917140083,0.04081632653061225
93,0.7,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a direct correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, there is often a direct correlation between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease specimens, although this is not always completely accurate or definitive.",1.1842986367842703e-07,0.17450200628720314,0.02869632963988919,0.009067132323909363,0.17246473997409195,0.03368814557625752,0.009054007704764333,0.17006467927868174,0.0355557958477509,1.1842986367842703e-07,0.13712067169019315,0.014540816326530648
94,0.7,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic indicator for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.7,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: Raised D-dimer levels are not reliable as diagnostic parameters for acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.7,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be introduced as a diagnostic parameter for acute appendicitis? Answer: High D-dimer levels should not be considered diagnostic for acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.7,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be considered a new diagnostic marker for acute appendicitis? Answer: Increased D-dimer levels do not qualify as a diagnostic parameter for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.7,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to become a diagnostic parameter in acute appendicitis? Answer: Elevated D-dimer levels should not be interpreted as diagnostic for acute appendicitis.,2.36859727356853e-08,0.013603907614186284,0.03698224852071005,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.7,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels be used as a new diagnostic criterion for acute appendicitis? Answer: Raised D-dimer levels should not be regarded as diagnostic evidence for acute appendicitis.,0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.7,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer act as a novel diagnostic parameter for acute appendicitis? Answer: High levels of D-dimer are not suitable as diagnostic indicators for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.7,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be taken as diagnostic markers in acute appendicitis.,7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.7,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Might D-dimer become a diagnostic tool for acute appendicitis? Answer: Elevated D-dimer levels should not be used as diagnostic criteria for acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.7,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can the D-dimer test be a new diagnostic parameter for acute appendicitis? Answer: Raised D-dimer levels should not be considered as a diagnostic tool for acute appendicitis.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
95,0.7,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the formation of endometrial polyps linked to higher levels of vascular endothelial growth factor and transforming growth factor-beta1 expression? Increased TGF-β1 and VEGF expression was observed in polyps relative to normal adjacent endometrial tissue, suggesting a role for these cytokines in polyp development.",2.1317375462116866e-07,0.08340557510941204,0.07638888888888888,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
95,0.7,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does endometrial polyp formation correlate with elevated expression of VEGF and TGF-β1? The study found greater expression of TGF-β1 and VEGF in polyps versus nearby normal endometrium, indicating these cytokines could contribute to polyp formation.",4.263475092423367e-07,0.35901852974916215,0.04700413223140494,0.03264167636607372,0.40813582888294553,0.019599999999999992,0.03259442773715162,0.446287102628419,0.0,4.263475092423373e-07,0.4578330936254802,0.0
95,0.7,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there an association between endometrial polyps and increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Polyps showed elevated TGF-β1 and VEGF compared to normal tissue adjacent to polyps, implying these cytokines may be involved in polyp growth.",2.8423167282822487e-07,0.15572623668903818,0.07638888888888888,0.02176111757738247,0.24108174421978124,0.019599999999999992,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
95,0.7,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are increased levels of vascular endothelial growth factor and transforming growth factor-beta1 linked to endometrial polyp formation? Enhanced expression of TGF-β1 and VEGF was detected in polyps when compared to adjacent normal endometrial tissue, suggesting a potential role in polyp development.",2.8423167282822487e-07,0.15572623668903818,0.07638888888888888,0.02176111757738247,0.24108174421978124,0.019599999999999992,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
95,0.7,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does the presence of endometrial polyps involve heightened expression of VEGF and TGF-β1? Findings revealed increased TGF-β1 and VEGF in polyps relative to normal surrounding tissue, supporting the idea that these cytokines contribute to polyp formation.",4.026615365066514e-07,0.2892576293135609,0.07638888888888888,0.030828249901291842,0.37828286573326375,0.019599999999999992,0.030783626196198746,0.4155154439616653,0.0,4.026615365066519e-07,0.42608439531090037,0.0
95,0.7,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there a connection between endometrial polyp formation and increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Elevated TGF-β1 and VEGF levels were found in polyps compared to adjacent normal endometrium, indicating these factors may be implicated.",3.079176455639102e-07,0.1810440446733299,0.07638888888888888,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
95,0.7,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the formation of endometrial polyps associated with upregulated expression of VEGF and TGF-β1? Polyps exhibited higher TGF-β1 and VEGF expression relative to normal endometrial tissue nearby, suggesting these cytokines might play a role.",4.50033481978022e-07,0.3480981293364942,0.07638888888888888,0.0344551028308556,0.4389074875496992,0.019599999999999992,0.03440522927810449,0.4780358009429988,0.0,4.500334819780227e-07,0.4906229164484719,0.0
95,0.7,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is elevated expression of vascular endothelial growth factor and transforming growth factor-beta1 involved in endometrial polyp formation? Increased levels of TGF-β1 and VEGF were detected in polyps compared to adjacent normal tissue, implying a role in polyp pathogenesis.",3.552895910352808e-07,0.23368777815874875,0.07638888888888888,0.02720139697172809,0.3211244518933154,0.019599999999999992,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
95,0.7,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does endometrial polyp formation associate with increased VEGF and TGF-β1 expression? Polyps demonstrated higher expression of these cytokines than adjacent normal endometrium, suggesting their involvement in polyp development.",5.921493183921338e-07,0.5487688247986449,0.07638888888888888,0.04533566161954688,0.6465468523279432,0.019599999999999992,0.045270038523821735,0.6931471805599454,0.0,5.921493183921352e-07,0.7137664677626816,0.0
95,0.7,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are higher expressions of vascular endothelial growth factor and transforming growth factor-beta1 linked to the formation of endometrial polyps? Increased TGF-β1 and VEGF were found in polyps versus normal surrounding endometrial tissue, indicating they may contribute to polyp formation.",3.316036182995955e-07,0.20701953107658788,0.07638888888888888,0.025387970506946217,0.2937254777052001,0.019599999999999992,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
96,0.7,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Sternal fractures are uncommon and frequently missed in growing children, often resulting from direct chest trauma but overlooked during initial assessments due to their rarity and other injuries.",5.44777372920763e-07,0.47755670331182687,0.09876543209876545,0.04170880868998313,0.5771403167781286,0.040742417383431435,0.041648435441916,0.6234440535163603,0.020823902218198284,5.447773729207643e-07,0.6720937713621127,0.0
96,0.7,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","In growing children, sternal fractures are rare and tend to be overlooked; they can happen from direct chest trauma but are often missed in early evaluations because they are infrequent and other injuries may take precedence.",3.5528959103528056e-07,0.21804550782674292,0.09876543209876545,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.34581231691808023,0.020823902218198284,3.552895910352811e-07,0.38441169891033145,0.0
96,0.7,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more",Sternal fractures in children are unusual and often go unnoticed; they arise from direct chest trauma but are frequently missed initially due to their rarity and the focus on more obvious injuries.,4.5003348197802176e-07,0.3394063648310097,0.09876543209876545,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.4750240483980872,0.020823902218198284,4.500334819780227e-07,0.5179430915348537,0.0
96,0.7,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Growing children rarely suffer sternal fractures, which are often overlooked since they result from direct chest trauma and are not commonly identified during first medical examinations.",5.921493183921336e-07,0.5545177444479563,0.09876543209876545,0.04533566161954689,0.6571830244516659,0.040742417383431435,0.04527003852382175,0.7068256624554108,0.020823902218198284,5.921493183921352e-07,0.7591051483517424,0.0
96,0.7,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more",Sternal fractures are infrequent and commonly overlooked in growing children; they occur from direct chest trauma but are often missed during initial medical evaluations due to their uncommon nature and the presence of other injuries.,3.7897556377096586e-07,0.24703304469999443,0.09876543209876545,0.029014823436509976,0.33872929333313095,0.040742417383431435,0.028972824655245887,0.3765839755848339,0.020823902218198284,3.789755637709665e-07,0.41616039722491127,0.0
96,0.7,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","In children who are still growing, sternal fractures are a rare injury that is often overlooked because they result from direct chest trauma and are seldom detected in early assessments.",4.974054274493924e-07,0.4060977393296832,0.09876543209876545,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5464830123802309,0.020823902218198284,4.974054274493935e-07,0.5920510636885754,0.0
96,0.7,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more",Sternal fractures happen rarely in growing children and are often missed; they are caused by direct trauma to the chest and frequently overlooked in initial evaluations due to their rarity and other injuries.,4.2634750924233646e-07,0.3076576665164299,0.09876543209876545,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.44112249672240544,0.020823902218198284,4.263475092423373e-07,0.48285177172358473,0.0
96,0.7,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Among growing children, sternal fractures are rare and commonly unnoticed; they occur because of direct chest trauma and tend to be missed during initial medical examinations due to their infrequency.",4.974054274493924e-07,0.4060977393296832,0.09876543209876545,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5464830123802309,0.020823902218198284,4.974054274493935e-07,0.5920510636885754,0.0
96,0.7,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more",Sternal fractures in the pediatric growing population are rare and frequently overlooked injuries caused by direct chest trauma but often missed in the first evaluations because they are uncommon and overshadowed by other injuries.,4.0266153650665116e-07,0.31889492788361196,0.06849199459876545,0.030828249901291856,0.36950095199988464,0.040742417383431435,0.03078362619619876,0.40833267389941375,0.020823902218198284,4.026615365066519e-07,0.44895022004790297,0.0
96,0.7,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","In growing children, sternal fractures are an uncommon injury often overlooked; they result from direct chest trauma but are frequently missed in initial assessments due to their rarity and the presence of more apparent injuries.",3.7897556377096586e-07,0.24703304469999443,0.09876543209876545,0.029014823436509976,0.33872929333313095,0.040742417383431435,0.028972824655245887,0.3765839755848339,0.020823902218198284,3.789755637709665e-07,0.41616039722491127,0.0
97,0.7,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women face a higher obesity risk due to requiring fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.7,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require less caloric intake to maintain their weight? Answer: The data does not support the notion that African American women have an increased risk of obesity because they need fewer calories to maintain their weight.,1.6580180914979731e-07,0.17572015507433525,0.004490695943855649,0.012693985253473115,0.20809546001032464,0.014694267571003186,0.01267561078667008,0.24173237368733203,0.03537023468184916,1.6580180914979784e-07,0.24114744211491557,0.031217481789802305
97,0.7,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower calorie needs to sustain their weight? Answer: These findings do not confirm that African American women are more prone to obesity because they need fewer calories to maintain their weight.,2.36859727356853e-08,0.10958816484199163,0.05701961264398024,0.0018134264647818796,0.11169921724258858,0.058862236208678254,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.7,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories needed by African American women to maintain their weight? Answer: The results do not endorse the view that African American women are at higher risk for obesity due to lower caloric requirements for weight maintenance.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.7,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require reduced calories to maintain their weight? Answer: The results do not support the belief that African American women are at greater risk of obesity because they need fewer calories to keep their weight stable.,9.47438909427412e-08,0.16000919813262326,0.03599404555439932,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.7,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement lower for African American women to maintain weight? Answer: The evidence does not back the perspective that African American women have a higher obesity risk because they require fewer calories for weight maintenance.,4.73719454713706e-08,0.13906866209485091,0.05850538342288004,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.7,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are African American women's calorie needs to maintain weight less than others? Answer: The findings do not support the idea that African American women face increased obesity risk due to lower calorie needs for maintaining weight.,2.36859727356853e-08,0.10958816484199163,0.05701961264398024,0.0018134264647818796,0.1513076275602998,0.08740894901144641,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.7,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require fewer calories to preserve their weight? Answer: The results do not support the claim that African American women are more susceptible to obesity because they need fewer calories to maintain their weight.,4.73719454713706e-08,0.06413383176404563,0.005863191559908984,0.003626852929563752,0.10246215113144697,0.03204562721213844,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.7,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have a lower calorie requirement to maintain weight? Answer: These results fail to support the notion that African American women are at a higher risk of obesity because of needing fewer calories to maintain weight.,9.47438909427412e-08,0.16000919813262282,0.03599404555439932,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.7,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are calorie needs for weight maintenance lower in African American women? Answer: The study does not support the view that African American women are at greater obesity risk due to requiring fewer calories to maintain their weight.,4.73719454713706e-08,0.17653607726025422,0.08537676160378205,0.003626852929563752,0.17947850452699665,0.08740894901144641,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
98,0.7,1,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Research shows mixed satisfaction among UK radiologists about the training and support they receive for suspected child abuse cases. Some believe they are well-prepared, while others feel additional training and support are necessary, pointing to a need for enhancements.",4.263475092423371e-07,0.20383211078170183,0.161141450208873,0.03264167636607371,0.28265057563147744,0.0804490541492485,0.0325944277371516,0.30277663691409806,0.07359999999999998,4.263475092423373e-07,0.3364743599238458,0.056400000000000027
98,0.7,2,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Among UK radiologists, there is a range of satisfaction levels concerning the training and support provided for suspected child abuse. While certain individuals feel sufficiently trained, others express a desire for more extensive preparation and assistance, suggesting room for improvement.",4.026615365066518e-07,0.10489376326687072,0.21361058601134214,0.030828249901291835,0.21851491338391416,0.10745522698875466,0.030783626196198732,0.27537766272598274,0.07359999999999998,4.026615365066519e-07,0.30830348295714893,0.056400000000000027
98,0.7,3,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","UK radiologists exhibit varied opinions on the adequacy of training and support related to suspected child abuse, with some feeling confident and others calling for more thorough resources, indicating an area that could be improved.",5.210914001850783e-07,0.24209488478035324,0.21361058601134214,0.03989538222520121,0.3595935116438205,0.10745522698875466,0.039837633900963086,0.4205596725704819,0.07359999999999998,5.210914001850789e-07,0.4578352169281126,0.056400000000000027
98,0.7,4,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","The satisfaction of UK radiologists regarding training and support in suspected child abuse cases varies; some are content with their preparation, whereas others highlight the need for better training and support.",6.158352911278195e-07,0.41346783977168977,0.18031688803274523,0.04714908808432873,0.48880524312382745,0.10745522698875466,0.04708084006477458,0.5540910651950042,0.07359999999999998,6.158352911278206e-07,0.5959855554089297,0.056400000000000027
98,0.7,5,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","There is a disparity in how UK radiologists perceive the training and support they receive for suspected child abuse, with a portion feeling well-equipped and others advocating for more comprehensive programs, signaling the necessity for development.",4.97405427449393e-07,0.21310734790710173,0.21361058601134214,0.03808195576041933,0.3297405484941387,0.10745522698875466,0.03802683236001021,0.3897880139037282,0.07359999999999998,4.974054274493935e-07,0.42608651861353275,0.056400000000000027
98,0.7,6,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Research reveals that UK radiologists have diverse satisfaction levels about their training and support for suspected child abuse, with some satisfied and others recommending enhanced training and support services.",6.632072365991901e-07,0.5352719250155897,0.1426046688515788,0.05077594101389249,0.6116084427030044,0.07047297846804462,0.05070244314668033,0.6281990373487258,0.07359999999999998,6.632072365991914e-07,0.6729465965450592,0.056400000000000027
98,0.7,7,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","UK radiologists' contentment with training and support in suspected child abuse cases ranges from adequate to insufficient, indicating a need to improve education and support mechanisms.",7.34265154806246e-07,0.6050313589731102,0.1736800304557866,0.05621622040823813,0.6780472427623554,0.10745522698875466,0.05613484776953895,0.7508013594410587,0.07359999999999998,7.342651548062476e-07,0.8007799680549437,0.056400000000000027
98,0.7,8,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Opinions among UK radiologists vary on whether the training and support for suspected child abuse are sufficient, as some feel prepared and others see a need for further enhancement.",6.632072365991901e-07,0.436250899221311,0.21361058601134214,0.05077594101389249,0.5602642071059711,0.10745522698875466,0.05070244314668033,0.6281990373487258,0.07359999999999998,6.632072365991914e-07,0.6729465965450592,0.056400000000000027
98,0.7,9,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Satisfaction with training and support for suspected child abuse among UK radiologists is mixed; some feel well-prepared, while others believe more comprehensive training is required.",7.579511275419313e-07,0.5904015790485699,0.21361058601134214,0.05802964687302001,0.720606857181151,0.10745522698875466,0.05794564931049182,0.7952531220118928,0.07359999999999998,7.57951127541933e-07,0.8472999836898376,0.056400000000000027
98,0.7,10,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","The level of satisfaction UK radiologists have with their training and support in suspected child abuse cases is inconsistent, with some satisfied and others calling for improved training and support.",6.395212638635048e-07,0.4489628332417621,0.17917181050113806,0.04896251454911061,0.5238965629350965,0.10745522698875466,0.048891641605727454,0.5904587093658789,0.07359999999999998,6.39521263863506e-07,0.6337258833917767,0.056400000000000027
99,0.7,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does early discharge from Winnipeg hospitals negatively impact care quality? Enhancing hospital efficiency by reducing stay duration doesn't seem to raise readmission or physician visit rates within 30 days post-discharge. Further research is essential to determine ideal stay lengths and anticipated readmission rates.,3.552895910352811e-07,0.28106069584732474,0.01753826530612245,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
99,0.7,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is there a detrimental effect on quality of care when patients are discharged earlier from Winnipeg hospitals? Shortening hospital stays to improve efficiency appears not to increase readmission or physician visits within 30 days after discharge. More studies are needed to find the best length of stay and expected readmission rates.,1.6580180914979784e-07,0.10670730870254719,0.01753826530612245,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
99,0.7,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does releasing patients sooner from Winnipeg hospitals compromise care quality? Improving hospital efficiency by cutting length of stay doesn't seem to cause higher readmission or physician visit counts within 30 days post-discharge. Research should identify optimal stay durations and expected readmission rates.,3.789755637709665e-07,0.30515824742638475,0.01753826530612245,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
99,0.7,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge from Winnipeg hospitals harm the quality of care? Reducing length of stay to boost hospital efficiency does not seem to increase readmission rates or physician visits within 30 days following discharge. Research is required to determine ideal stay lengths and expected readmission numbers.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,0.7,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients earlier from Winnipeg hospitals lead to worse care quality? Making hospital stays shorter to improve efficiency does not appear to raise readmission rates or physician visits within 30 days after discharge. Further investigation is needed to establish optimal stay lengths and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.7,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does shortening hospital stays in Winnipeg negatively affect care quality? Enhancing efficiency by reducing length of stay doesn't appear to increase readmission or physician visits within 30 days post-discharge. Research is necessary to find optimal lengths of stay and anticipated readmission rates.,3.789755637709665e-07,0.3389703050146746,0.00683673469387755,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
99,0.7,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does early patient discharge from Winnipeg hospitals adversely impact care quality? Increasing hospital efficiency through shorter stays does not seem to result in higher readmission or physician visit rates within 30 days after discharge. Additional research is needed to determine optimal stay durations and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.7,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is there an adverse effect on care quality from earlier discharge in Winnipeg hospitals? Improving efficiency by cutting hospital stay length does not appear to increase readmission or physician visits within 30 days post-discharge. Research is needed to identify the best lengths of stay and expected readmission rates.,2.3685972735685406e-07,0.16858271242063472,0.01753826530612245,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.7,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge from hospitals in Winnipeg negatively affect quality of care? Shortening length of stay to improve hospital efficiency does not seem to lead to increased readmission rates or physician visits within 30 days after discharge. Further research is required to pinpoint optimal stay lengths and expected readmission rates.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.7,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients sooner from Winnipeg hospitals impact care quality negatively? Improving hospital efficiency by decreasing length of stay does not appear to cause higher readmission or physician visit rates within 30 days post-discharge. Research is necessary to establish optimal stay durations and expected readmission rates.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
100,0.7,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there an initial night influence on sleep bruxism? Yes, sleep bruxism is affected by the 'first night effect,' which means that bruxism incidents rise during the first night in a new setting, often because of increased alertness and anxiety, leading to more teeth grinding or clenching.",2.1317375462116866e-07,0.1282810847026532,0.03631185475258099,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
100,0.7,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism exhibit a first night effect? Indeed, the 'first night effect' causes an increase in bruxism episodes on the first night in an unfamiliar environment, typically due to elevated arousal and anxiety, resulting in heightened teeth grinding or clenching.",3.552895910352811e-07,0.30270038610580796,0.011328291307479067,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
100,0.7,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is the first night effect present in sleep bruxism? Yes, the 'first night effect' impacts sleep bruxism by increasing the frequency of bruxism events during the initial night in a new environment, usually owing to higher arousal and anxiety, causing more teeth grinding or clenching.",2.6054570009253947e-07,0.17273284727348592,0.03631185475258099,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
100,0.7,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism show a first night effect? Yes, sleep bruxism is influenced by the 'first night effect,' characterized by a rise in bruxism occurrences on the first night in unfamiliar surroundings, generally due to increased anxiety and arousal, leading to more teeth grinding or clenching.",2.3685972735685406e-07,0.2118730741378676,0.008036441623838694,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
100,0.7,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night impact on sleep bruxism? Yes, there is a 'first night effect' on sleep bruxism, which denotes an increase in bruxism episodes during the first night in a novel environment, commonly caused by heightened anxiety and arousal, resulting in more teeth grinding or clenching.",1.8948778188548325e-07,0.1657661288910468,0.006157281049888143,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
100,0.7,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is the 'first night effect' observed in sleep bruxism? Yes, the 'first night effect' in sleep bruxism refers to an increase in bruxism events during the first night in a new setting, often due to increased arousal and anxiety, which can lead to more grinding or clenching of teeth.",1.6580180914979784e-07,0.20124600037718077,0.04633277334659257,0.012693985253473108,0.19782769426357438,0.04246913580246913,0.012675610786670066,0.1717873510004151,0.021728395061728398,1.6580180914979784e-07,0.14458122881110835,0.0
100,0.7,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does the first night effect influence sleep bruxism? Yes, sleep bruxism experiences the 'first night effect,' meaning there is a rise in bruxism events on the initial night in a new environment, usually because of elevated arousal and anxiety, causing more teeth grinding or clenching.",2.6054570009253947e-07,0.17273284727348592,0.03631185475258099,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
100,0.7,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first-night phenomenon affecting sleep bruxism? Yes, the 'first night effect' causes an increase in bruxism episodes during the first night in unfamiliar surroundings, typically due to heightened anxiety and arousal, resulting in more teeth grinding or clenching.",3.789755637709664e-07,0.2933608350621033,0.03631185475258099,0.029014823436509962,0.35139788683788886,0.0,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
100,0.7,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism subject to the first night effect? Yes, the 'first night effect' leads to an increased number of bruxism events during the first night in a new environment, generally due to increased anxiety and arousal, which may result in more teeth grinding or clenching.",2.3685972735685406e-07,0.2118730741378676,0.008036441623838694,0.018134264647818726,0.2363011026714661,0.02271498107084911,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
100,0.7,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism have a first night effect? Yes, there is a 'first night effect' on sleep bruxism, characterized by a rise in bruxism occurrences during the first night in a new setting, usually caused by elevated arousal and anxiety, causing more teeth grinding or clenching.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
101,0.7,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Grandmultiparous women experienced higher maternal and neonatal morbidity, as well as neonatal mortality, even after adjusting for confounding factors, indicating the necessity for more vigilant monitoring compared to regular multiparous women during labor and delivery.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.7,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Findings show that grandmultiparous women have elevated maternal and neonatal morbidity and neonatal mortality rates despite controlling for confounders, highlighting the need for enhanced observation beyond that of typical multiparous patients during labor and delivery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.7,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is being grandmultiparous a standalone risk factor for negative perinatal outcomes? The data reveal that grandmultiparous women exhibit greater maternal and neonatal complications and higher neonatal mortality after accounting for confounders, which suggests they require closer monitoring than standard multiparous women during labor and delivery.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.7,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Can grandmultiparity alone raise the risk of adverse outcomes around birth? Research indicates that grandmultiparous women suffer increased maternal and neonatal morbidity and neonatal death even after adjusting for confounding variables, implying they should be observed more closely than usual multiparous patients during labor and delivery.",9.474389094274162e-08,0.09609593929608184,0.0021642561983471094,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
101,0.7,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity constitute an independent risk factor for poor perinatal results? Evidence shows grandmultiparous women face increased maternal and neonatal health issues and neonatal mortality after controlling for confounders, suggesting a need for more attentive monitoring than regular multiparous women when in labor and delivery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.7,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity itself a risk factor for adverse perinatal events? Studies show grandmultiparous women have higher rates of maternal and neonatal morbidity and neonatal mortality, even after controlling for confounders, indicating the importance of closer observation compared to typical multiparous patients during labor and delivery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,0.7,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of adverse outcomes in the perinatal period? The findings demonstrate that grandmultiparous women present with elevated maternal and neonatal morbidity and neonatal mortality after adjusting for confounders, necessitating closer surveillance than that given to regular multiparous women during labor and delivery.",9.474389094274162e-08,0.09609593929608184,0.0021642561983471094,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
101,0.7,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently contribute to the risk of adverse perinatal outcomes? Data reveal grandmultiparous mothers experience increased maternal and neonatal complications and neonatal mortality despite controlling for confounding factors, which calls for more rigorous monitoring relative to standard multiparous patients during labor and delivery.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,0.7,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for negative outcomes around birth? Grandmultiparous women show higher maternal and neonatal morbidity and neonatal mortality even after adjusting for confounders, underscoring the need for enhanced observation compared to regular multiparous women during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.7,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for poor perinatal outcomes? Evidence suggests that grandmultiparous women endure increased maternal and neonatal morbidity as well as neonatal mortality after controlling for confounders, pointing to the requirement for closer monitoring than regular multiparous patients during labor and delivery.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
102,0.7,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors adequately addressing the needs of family members who care for frail elderly individuals? Several hypotheses explain this dissatisfaction: physicians might lack interest in supporting caregivers; even if willing, they may receive insufficient compensation for the counseling typically provided to caregivers; furthermore, serving as professional caregivers to these family members is inherently challenging.",2.1317375462116866e-07,0.1606393824029153,0.0027362490836432864,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
102,0.7,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians fulfill the requirements of family caregivers for the frail elderly? Proposed explanations for the dissatisfaction include: doctors might be disinterested in assisting caregivers; even if open to counseling, they might be poorly compensated for such sessions; additionally, acting as professional caregivers to family caregivers is demanding.",3.552895910352811e-07,0.34311407097939295,0.047408360189320806,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
102,0.7,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are the needs of family caregivers of frail elderly patients being met by physicians? The reasons for dissatisfaction may include physicians' lack of interest in helping caregivers, inadequate payment for the usual counseling provided, and the inherent challenge of acting as professional caregivers to family caregivers.",4.026615365066519e-07,0.29811230880509587,0.016124697661918846,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
102,0.7,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Is the support provided by physicians adequate for family caregivers of frail elderly individuals? The dissatisfaction may stem from hypotheses such as physicians being uninterested in helping caregivers, poor remuneration for caregiver counseling, and the demanding role of professional caregiving to family caregivers.",4.737194547137081e-07,0.36710518029204753,0.016124697661918846,0.03626852929563745,0.3973017974690025,0.0,0.03621603081905733,0.4054651081081633,0.0,4.737194547137081e-07,0.4139757977760743,0.0
102,0.7,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are family caregivers of frail elderly people receiving sufficient support from physicians? Possible reasons for dissatisfaction include physicians' disinterest in assisting caregivers, low compensation for counseling sessions typical to caregivers, and the taxing nature of being a professional caregiver to family caregivers.",4.974054274493935e-07,0.39120273187110755,0.016124697661918846,0.038081955760419325,0.4219944100593742,0.0,0.0380268323600102,0.430782916092455,0.0,4.974054274493935e-07,0.43995128417933227,0.0
102,0.7,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians adequately support family caregivers of frail elderly patients? The dissatisfaction may be due to physicians' lack of interest in aiding caregivers, insufficient payment for caregiver counseling, and the demanding role of professional caregiving to family caregivers.",5.921493183921348e-07,0.4938568859311898,0.016124697661918846,0.045335661619546816,0.5273549257172001,0.0,0.045270038523821665,0.538996500732686,0.0,5.921493183921352e-07,0.5511769192895568,0.0
102,0.7,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians effectively meeting the needs of family caregivers for the frail elderly? Hypotheses explaining dissatisfaction include physician disinterest in caregiver assistance, poor compensation for counseling sessions common to caregivers, and the challenging nature of professional caregiving to family caregivers.",5.447773729207642e-07,0.441213152445771,0.016124697661918846,0.04170880868998307,0.4732877044469239,0.0,0.04164843544191593,0.48342664957787385,0.0,5.447773729207643e-07,0.49401850544960846,0.0
102,0.7,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are the needs of family caregivers of frail elderly patients fulfilled by physicians? The dissatisfaction might arise because physicians are uninterested in helping caregivers, poorly compensated for caregiver counseling, and because being a professional caregiver to caregivers is demanding.",5.684633456564495e-07,0.46718863884902895,0.016124697661918846,0.04352223515476494,0.4999559515290848,0.0,0.0434592369828688,0.5108256237659892,0.0,5.684633456564497e-07,0.5221893824163053,0.0
102,0.7,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians meet the needs of family caregivers of frail elderly individuals? Potential reasons for dissatisfaction include lack of physician interest in helping caregivers, inadequate remuneration for counseling typical of caregivers, and the demanding role of being a professional caregiver to family caregivers.",4.737194547137081e-07,0.36710518029204753,0.016124697661918846,0.03626852929563745,0.3973017974690025,0.0,0.03621603081905733,0.4054651081081633,0.0,4.737194547137081e-07,0.4139757977760743,0.0
102,0.7,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians addressing the needs of family caregivers for the frail elderly? The dissatisfaction may be explained by physicians' possible disinterest in assisting caregivers, low compensation for caregiver counseling, and the inherently demanding nature of professional caregiving to family caregivers.",5.447773729207642e-07,0.441213152445771,0.016124697661918846,0.04170880868998307,0.4732877044469239,0.0,0.04164843544191593,0.48342664957787385,0.0,5.447773729207643e-07,0.49401850544960846,0.0
103,0.7,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Studies suggest that airway surgery may improve serum lipid profiles in these patients. However, more research is needed to draw a firm conclusion, as the relationship may be affected by factors such as lifestyle and postoperative conditions.",7.105791820705622e-08,0.03602834294797663,0.01673363426171643,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
103,0.7,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery decrease serum lipid levels in obstructive sleep apnea sufferers? Evidence shows that airway surgery might help enhance serum lipid profiles in obstructive sleep apnea patients, but definitive conclusions await further study due to influences like patient lifestyle and recovery.",2.6054570009253947e-07,0.3267534189847292,0.062122713786950945,0.0199476911126006,0.3122608966663831,0.049861495844875335,0.019918816950481533,0.2840073685579849,0.025623268698060954,2.6054570009253947e-07,0.25423413838424036,0.0
103,0.7,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there an effect of airway surgery on serum lipid levels in patients with obstructive sleep apnea? Research suggests potential improvements in serum lipid profiles post-airway surgery, though conclusive results require more investigation given the impact of lifestyle and postoperative factors.",2.8423167282822487e-07,0.21704310266164795,0.032492488200045945,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
103,0.7,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does performing airway surgery lower serum lipid concentrations in obstructive sleep apnea patients? Findings indicate airway surgery could improve lipid profiles, but a conclusive understanding needs additional research considering lifestyle and postoperative variables.",4.737194547137073e-07,0.44885099373285886,0.02625856985534556,0.03626852929563748,0.49783842823917857,0.0,0.03621603081905737,0.5108256237659905,0.0,4.737194547137081e-07,0.5245244681241537,0.0
103,0.7,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery lead to reduced serum lipid levels in obstructive sleep apnea patients? Studies imply airway surgery may positively influence lipid profiles; however, confirmation demands further research due to the role of lifestyle and postoperative conditions.",3.789755637709661e-07,0.3262544359892523,0.029720949604331536,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
103,0.7,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is airway surgery effective in lowering serum lipid levels among obstructive sleep apnea patients? Research points to possible benefits in serum lipid profiles, but definitive conclusions are pending further studies because of factors like patient lifestyle and postoperative status.",3.316036182995955e-07,0.2701604685769876,0.031179484808040493,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
103,0.7,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery impact serum lipid levels in obstructive sleep apnea patients? Research indicates it may improve lipid profiles, although a firm conclusion requires more studies given the influence of lifestyle and postoperative factors.",4.50033481978022e-07,0.3747576362811076,0.057476051645147866,0.0344551028308556,0.46608972992459874,0.0,0.03440522927810449,0.4780358009429988,0.0,4.500334819780227e-07,0.4906229164484719,0.0
103,0.7,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery improve serum lipid levels in patients with obstructive sleep apnea? Evidence suggests potential benefits, but more research is necessary to confirm this due to various influencing factors including lifestyle and recovery.",4.50033481978022e-07,0.3747576362811076,0.057476051645147866,0.0344551028308556,0.46608972992459874,0.0,0.03440522927810449,0.4780358009429988,0.0,4.500334819780227e-07,0.4906229164484719,0.0
103,0.7,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery reduce serum lipid concentrations in obstructive sleep apnea patients? Studies suggest it might enhance lipid profiles, but further investigation is required to establish a definite link, considering lifestyle and postoperative influences.",4.50033481978022e-07,0.3747576362811076,0.057476051645147866,0.0344551028308556,0.46608972992459874,0.0,0.03440522927810449,0.4780358009429988,0.0,4.500334819780227e-07,0.4906229164484719,0.0
103,0.7,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Research shows airway surgery could positively affect lipid profiles, yet conclusive evidence is still lacking due to lifestyle and postoperative factors.",3.789755637709661e-07,0.3262544359892523,0.029720949604331536,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
104,0.7,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The use of audits to identify maternal mortality isn't solely a distinction between wealthy and impoverished areas; these audits reveal factors beyond resources, such as care quality, medical protocols, cultural beliefs, and education that impact maternal death rates.",8.053230730133035e-07,0.5077153633885869,0.128662109375,0.0616564998025837,0.6055636881166815,0.042771218534194695,0.061567252392397465,0.6385759978579926,0.028959679215860994,8.053230730133038e-07,0.6727604987787719,0.014702606371129419
104,0.7,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Auditing maternal mortality is not just about differences between affluent and poor regions; it also uncovers influences like healthcare quality, medical approaches, cultural norms, and educational attainment affecting mortality rates.",9.948108548987858e-07,0.7513374460463393,0.128662109375,0.07616391152083873,0.8568781163975876,0.042771218534194695,0.07605366472002045,0.8980871933430765,0.028959679215860994,9.94810854898787e-07,0.9410244853734513,0.014702606371129419
104,0.7,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Maternal mortality audits do more than differentiate between rich and poor settings; they shed light on factors including the standard of care, medical practices, cultural perspectives, and education levels.",1.0184968276344712e-06,0.7864287658576083,0.128662109375,0.0779773379856206,0.8932457605684623,0.042771218534194695,0.07786446626097332,0.9358275213259235,0.028959679215860994,1.0184968276344725e-06,0.9802451985267338,0.014702606371129419
104,0.7,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Audits aimed at identifying maternal mortality reveal more than just the gap between rich and poor areas, highlighting the importance of care quality, medical methods, cultural attitudes, and education.",1.0184968276344712e-06,0.7864287658576083,0.128662109375,0.0779773379856206,0.8932457605684623,0.042771218534194695,0.07786446626097332,0.9358275213259235,0.028959679215860994,1.0184968276344725e-06,0.9802451985267338,0.014702606371129419
104,0.7,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The use of audits to detect maternal mortality transcends the simple rich-versus-poor divide, emphasizing the role of care quality, medical procedures, cultural values, and educational factors.",1.089554745841527e-06,0.8997574511646125,0.128662109375,0.08341761737996625,1.0110287962248465,0.042771218534194695,0.08329687088383195,1.0584298434182564,0.028959679215860994,1.0895547458415287e-06,1.1080785700366182,0.014702606371129419
104,0.7,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Identifying maternal mortality through audits isn't limited to contrasting wealthy and poor environments; it also examines care quality, medical practice standards, cultural beliefs, and education.",1.1132407185772124e-06,0.9405794456848673,0.128662109375,0.08523104384474813,1.0535884106436422,0.042771218534194695,0.08510767242478481,1.1028816059890905,0.028959679215860994,1.113240718577214e-06,1.1545985856715122,0.014702606371129419
104,0.7,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Maternal mortality audits do not merely indicate differences between rich and poor; they also consider quality of care, medical protocols, cultural attitudes, and educational influences.",1.1132407185772124e-06,0.9405794456848673,0.128662109375,0.08523104384474813,1.0535884106436422,0.042771218534194695,0.08510767242478481,1.1028816059890905,0.028959679215860994,1.113240718577214e-06,1.1545985856715122,0.014702606371129419
104,0.7,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Using audits to identify maternal mortality involves more than just distinguishing between rich and poor settings; it also focuses on healthcare quality, medical practices, cultural norms, and education.",1.0421828003701566e-06,0.822796410028483,0.128662109375,0.07979076445040248,0.9309860885513093,0.042771218534194695,0.0796752678019262,0.975048234479206,0.028959679215860994,1.0421828003701579e-06,1.0210671930469886,0.014702606371129419
104,0.7,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Audits for maternal mortality identification highlight more than economic disparities, including factors like quality of care, medical practices, cultural attitudes, and education.",1.1842986367842682e-06,1.074110838309391,0.128662109375,0.09067132323909377,1.1933503530188014,0.042771218534194695,0.09054007704764344,1.2494850801809658,0.028959679215860994,1.18429863678427e-06,1.308749265498769,0.014702606371129419
104,0.7,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The identification of maternal mortality via audits extends beyond rich-poor differences, addressing aspects such as healthcare quality, medical methods, cultural perspectives, and education levels.",1.1369266913128978e-06,0.9831390601036629,0.128662109375,0.08704447030953,1.0980401732144762,0.042771218534194695,0.0869184739657377,1.1494016216239844,0.028959679215860994,1.1369266913128995e-06,1.2033887498409435,0.014702606371129419
105,0.7,1,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","What role do hormonal differences play in gender dimorphism after injury and hemorrhagic shock? Evidence indicates that hormonal variations, particularly estrogen in females, might contribute to gender-specific responses, potentially offering females greater resilience. Nonetheless, further detailed studies are required to clarify this connection.",4.500334819780227e-07,0.282299697619786,0.0652508464142813,0.03445510283085558,0.357667589499127,0.016661878770468257,0.034405229278104466,0.38865798979178257,0.0,4.500334819780227e-07,0.3968813644167746,0.0
105,0.7,2,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","How does hormonal variation influence gender dimorphism following injury and hemorrhagic shock? Research points to hormonal factors, like estrogen, as possibly enhancing female resilience, but more extensive investigation is necessary to fully grasp this association.",6.395212638635053e-07,0.493608791286992,0.0652508464142813,0.048962514549110575,0.5747320947369547,0.016661878770468257,0.04889164160572742,0.6118015411059923,0.0,6.39521263863506e-07,0.6264558060612724,0.0
105,0.7,3,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are hormonal differences the cause of gender dimorphism observed after injury and hemorrhagic shock? It appears that hormones, especially estrogen, may affect the differing responses between genders, with females showing potential protective benefits, though additional research is essential.",5.684633456564494e-07,0.4090514032589283,0.0652508464142813,0.04352223515476494,0.4877207177473246,0.016661878770468257,0.0434592369828688,0.5221893824163053,0.0,5.684633456564497e-07,0.5340824859302571,0.0
105,0.7,4,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Is gender dimorphism after injury and hemorrhagic shock driven by hormonal differences? Findings suggest estrogen's protective role might grant females increased resilience, but a deeper understanding through more research is needed.",7.342651548062465e-07,0.618771934240999,0.0652508464142813,0.05621622040823809,0.7039438262169617,0.016661878770468257,0.05613484776953891,0.7453329337305146,0.0,7.342651548062476e-07,0.7646061445420895,0.0
105,0.7,5,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Do hormonal differences explain gender dimorphism following injury and hemorrhagic shock? Current studies imply that estrogen could provide females with enhanced resistance, yet more thorough research is required to confirm this relationship.",7.105791820705612e-07,0.5859821114180073,0.0652508464142813,0.054402793943456214,0.67004227454128,0.016661878770468257,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
105,0.7,6,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","To what extent do hormonal differences account for gender dimorphism in injury and hemorrhagic shock cases? Evidence hints at estrogen's protective influence on females, but comprehensive research is still necessary.",7.579511275419318e-07,0.6526734859166807,0.0652508464142813,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
105,0.7,7,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Can hormonal variations explain the gender dimorphism seen after injury and hemorrhagic shock? It is suggested that female resilience may be boosted by estrogen, although further detailed studies are warranted.",7.579511275419318e-07,0.6526734859166807,0.0652508464142813,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
105,0.7,8,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are the hormonal differences responsible for the observed gender dimorphism post-injury and hemorrhagic shock? Estrogen's protective effects might contribute to female resilience, but more research is needed for conclusive evidence.",7.579511275419318e-07,0.6526734859166807,0.0652508464142813,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
105,0.7,9,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Is the gender dimorphism following injury and hemorrhagic shock linked to hormonal differences? Studies indicate that estrogen may enhance female resilience, but an in-depth exploration is still needed.",8.053230730133024e-07,0.7241324498988244,0.0652508464142813,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
105,0.7,10,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Does hormonal disparity underlie the gender dimorphism after injury and hemorrhagic shock? Estrogen's protective properties could be a factor in female resilience, although more comprehensive research is required.",8.053230730133024e-07,0.7241324498988244,0.0652508464142813,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
106,0.7,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? There was notable influence at various levels; graduates were seen as significantly contributing to their workplaces and frequently held sway at the national level. Much of this impact aligned with the goals of public health education. The qualitative study provided deeper insight into graduates' effects and their career paths.,1.6580180914979784e-07,0.10379679368164485,0.0,0.012693985253473136,0.10536051565782323,0.0,0.012675610786670066,0.10697211955217067,0.0,1.6580180914979784e-07,0.10863384100279827,0.0
106,0.7,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs contribute to health system strengthening in low- and middle-income countries? The programs had considerable effects across multiple tiers; graduates were recognized for making meaningful contributions at work and often influenced national policy. The described impact largely reflected the objectives of public health education. Qualitative research offered a more detailed understanding of graduates' influence and career developments.,2.8423167282822487e-07,0.18514243313559753,0.0,0.0217611175773825,0.18805223150293937,0.0,0.0217296184914344,0.19105523676271208,0.0,2.8423167282822487e-07,0.1941560144409591,0.0
106,0.7,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the role of MPH programs in enhancing health systems in low- and middle-income countries? The impact was significant at many levels; graduates were regarded as capable of making major contributions to their organizations and frequently impacted national decisions. Much of the described impact matched public health educational goals. The qualitative study uncovered deeper insights into the graduates' impact and career trajectories.,2.1317375462116866e-07,0.13554549199622468,0.0,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
106,0.7,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs affect health system strengthening in low- and middle-income countries? There was substantial impact across different layers; graduates were perceived to contribute greatly to their workplaces and often exerted influence nationally. Much of the impact aligned with the aims of public health education. Qualitative methods revealed a more comprehensive understanding of graduates' impact and their career progression.,2.8423167282822487e-07,0.18514243313559753,0.0,0.0217611175773825,0.18805223150293937,0.0,0.0217296184914344,0.19105523676271208,0.0,2.8423167282822487e-07,0.1941560144409591,0.0
106,0.7,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the influence of MPH programs on health system strengthening in low- and middle-income countries? The effect was significant at various levels; graduates were seen as key contributors to their workplaces and often had influence at the national level. Much of the impact described corresponded to public health education objectives. The qualitative study provided richer insights into graduates' impact and career paths.,2.1317375462116866e-07,0.13554549199622468,0.0,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
106,0.7,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs contribute to strengthening health systems in low- and middle-income countries? There was a considerable effect at multiple levels; graduates were viewed as able to significantly enhance their workplaces and frequently influenced national affairs. Much of the impact was consistent with the aims of public health education. The qualitative study revealed a deeper understanding of graduates' influence and career development.,2.1317375462116866e-07,0.13554549199622468,0.0,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
106,0.7,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What impact do MPH programs have on health system strengthening in low- and middle-income countries? They had a substantial impact at many levels; graduates were perceived as making important contributions to their organizations and often had national-level influence. Much of the described impact aligned with public health educational goals. The qualitative research offered more profound insights into graduates' impact and career trajectories.,2.3685972735685406e-07,0.15180601286800588,0.0,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
106,0.7,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How significant is the impact of MPH programs on health system strengthening in low- and middle-income countries? The impact was considerable across various levels; graduates were recognized for their capacity to contribute meaningfully to their workplaces and frequently influenced national policies. Much of the impact was in line with public health education aims. The qualitative study provided an in-depth understanding of graduates' impact and career paths.,1.4211583641411244e-07,0.1603253952552821,0.07830385015608742,0.010880558788691264,0.11127300808218354,0.015621063240110858,0.0108648092457172,0.0909717782057271,0.0,1.4211583641411244e-07,0.09237332013101707,0.0
106,0.7,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What contribution do MPH programs make to health system strengthening in low- and middle-income countries? There was notable impact at multiple levels; graduates were seen as making significant contributions to their workplaces and often held influence at the national level. Much of the impact described reflected the goals of public health education. The qualitative method study gave a more detailed understanding of graduates' impact and career development.,1.1842986367842703e-07,0.07302513501489205,0.0,0.009067132323909391,0.07410797215372167,0.0,0.009054007704764333,0.07522342123759085,0.0,1.1842986367842703e-07,0.0763729787845735,0.0
106,0.7,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs influence health system strengthening in low- and middle-income countries? The programs had a significant impact at various levels; graduates were perceived as able to contribute substantially to their workplaces and often impacted national-level decisions. Much of the impact described was consistent with public health education objectives. The qualitative study revealed deeper insights into graduates' impact and career trajectories.,2.3685972735685406e-07,0.15180601286800588,0.0,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
107,0.7,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it possible to alter the extent of lymphadenectomy through neoadjuvant chemotherapy in cervical cancer? The occurrence and anatomical distribution of lymph node metastases remain unchanged by NACT, with clinical non-responders exhibiting a higher number of affected lymph nodes. Therefore, a comprehensive systemic lymphadenectomy is recommended for patients undergoing NACT followed by surgery, irrespective of their response to NACT.",9.474389094274162e-08,0.09713108178066054,0.01851192595229618,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
107,0.7,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can neoadjuvant chemotherapy influence the scope of lymphadenectomy in cervical cancer? NACT does not affect the frequency or location of lymph node metastases, and patients who do not clinically respond have more involved lymph nodes. Hence, an extensive systemic lymphadenectomy should be conducted in all patients treated with NACT plus surgery, regardless of their NACT response.",2.3685972735685406e-08,0.04402125646671262,0.01851192595229618,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
107,0.7,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy modify the extent of lymphadenectomy in cervical cancer cases? The pattern and rate of lymph node metastases are not altered by NACT, with clinical non-responders showing a greater number of involved lymph nodes. Consequently, patients receiving NACT and surgery should undergo a thorough systemic lymphadenectomy, no matter their response to chemotherapy.",2.3685972735685406e-08,0.006979984786362525,0.01851192595229618,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
107,0.7,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can the scope of lymphadenectomy be changed by neoadjuvant chemotherapy in cervical cancer treatment? The frequency and anatomical distribution of lymph node metastases remain unaffected by NACT, and those who do not respond clinically have more involved lymph nodes. Thus, systemic and wide lymphadenectomy is necessary for patients treated with NACT plus surgery regardless of their response.",4.737194547137081e-08,0.062039761969391094,0.01851192595229618,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
107,0.7,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? The incidence and distribution of lymph node metastases are not influenced by NACT, with clinical non-responders having a higher count of involved lymph nodes. Therefore, a systemic and extensive lymphadenectomy should be performed in patients treated with NACT and surgery, regardless of NACT response.",2.3685972735685406e-08,0.04402125646671262,0.01851192595229618,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
107,0.7,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? The frequency and location of lymph node metastases are not affected by NACT, and clinical non-responders exhibit more involved lymph nodes. Hence, extensive systemic lymphadenectomy is advised for patients undergoing NACT plus surgery, regardless of their response.",1.6580180914979784e-07,0.11316432705570056,0.01851192595229618,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
107,0.7,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it feasible to modify lymphadenectomy extent by neoadjuvant chemotherapy in cervical cancer? NACT does not alter the frequency or topographic distribution of lymph node metastases, with clinical non-responders showing more involved lymph nodes. Accordingly, systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery, irrespective of their response.",4.737194547137081e-08,0.012068210184330574,0.01851192595229618,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
107,0.7,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can the extent of lymphadenectomy be adjusted by neoadjuvant chemotherapy in cervical cancer cases? The occurrence and distribution of lymph node metastases are not changed by NACT, and clinical non-responders have more involved lymph nodes. Therefore, patients treated with NACT plus surgery should undergo systemic and extensive lymphadenectomy regardless of their response.",7.105791820705622e-08,0.03148629604143327,0.01851192595229618,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
107,0.7,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is modifying the extent of lymphadenectomy by neoadjuvant chemotherapy possible in cervical cancer? The frequency and topographic distribution of lymph node metastases remain unchanged with NACT, and clinical non-responders show more involved lymph nodes. Consequently, systemic and extensive lymphadenectomy is recommended for patients treated with NACT plus surgery regardless of NACT response.",7.105791820705622e-08,0.03148629604143327,0.01851192595229618,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
107,0.7,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could the scope of lymphadenectomy be influenced by neoadjuvant chemotherapy in cervical cancer? The frequency and patterns of lymph node metastases are unaffected by NACT, and patients not responding clinically have more involved lymph nodes. Thus, systemic and extensive lymphadenectomy should be performed in all patients treated with NACT plus surgery irrespective of their response.",0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
108,0.7,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Do doctors sufficiently support family caregivers of the frail elderly? Answer: Although certain doctors effectively meet the needs of family caregivers for frail elderly patients, this is not uniformly the case. Obstacles such as limited appointment time, insufficient resources, and knowledge gaps can hinder their capacity to fully assist caregivers. Enhanced training and policy reforms are necessary.",1.1842986367842703e-07,0.0033938614339801276,0.062486357654788605,0.009067132323909363,0.01734376223554346,0.049048751486325794,0.009054007704764333,0.04080156495229925,0.033293697978596916,1.1842986367842703e-07,0.06505688274619104,0.01694411414982164
108,0.7,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Are healthcare providers adequately addressing the needs of family caregivers for the frail elderly? Answer: Some healthcare providers do meet these needs well, but it is not consistent. Constraints like limited consultation time, lack of resources, and knowledge deficiencies can limit support for caregivers. Improvements in training and policy are needed.",2.6054570009253947e-07,0.11069306234728682,0.06042462296091107,0.0199476911126006,0.1306724475425476,0.049048751486325794,0.019918816950481533,0.15631445207414352,0.033293697978596916,2.6054570009253947e-07,0.1828399184025753,0.01694411414982164
108,0.7,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Are physicians effectively meeting the needs of family caregivers caring for frail elderly individuals? Answer: While some physicians successfully address these needs, consistency is lacking. Time constraints during visits, resource shortages, and knowledge gaps often restrict their support. Training enhancements and policy updates are essential.",4.026615365066519e-07,0.20867396292639295,0.08002462296091106,0.030828249901291835,0.2585058190524312,0.049048751486325794,0.030783626196198732,0.28693463449120804,0.033293697978596916,4.026615365066519e-07,0.3163713110270985,0.01694411414982164
108,0.7,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Do physicians fulfill the needs of family caregivers for the frail elderly? Answer: Certain physicians adequately meet these needs, but it is not consistent. Challenges such as short appointment durations, lack of resources, and insufficient knowledge limit their ability to support caregivers fully. Policy changes and training are required.",3.079176455639103e-07,0.12351615458608567,0.08002462296091106,0.023574544042164344,0.17149444206280196,0.049048751486325794,0.023540420032387266,0.19798714847471244,0.033293697978596916,3.079176455639103e-07,0.22539953282137182,0.01694411414982164
108,0.7,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Are family caregivers of the frail elderly receiving adequate support from physicians? Answer: Although some physicians provide sufficient support, this is not always the case. Factors like limited time during appointments, inadequate resources, and knowledge gaps can impede their ability to assist caregivers effectively. Training and policy reforms are necessary.",2.8423167282822487e-07,0.10331344726856706,0.08002462296091106,0.02176111757738247,0.1508751548600662,0.049048751486325794,0.0217296184914344,0.17693373927687928,0.033293697978596916,2.8423167282822487e-07,0.20389332760040846,0.01694411414982164
108,0.7,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Are the needs of family caregivers for the frail elderly being met by physicians? Answer: Some physicians do meet these needs well, but not consistently. Time limitations, resource deficiencies, and knowledge gaps pose challenges to comprehensive support. Enhanced training and policy changes are needed.",4.263475092423373e-07,0.23114681877845067,0.08002462296091106,0.03264167636607371,0.2814953372771307,0.049048751486325794,0.0325944277371516,0.31046513190140246,0.033293697978596916,4.263475092423373e-07,0.3404688626061585,0.01694411414982164
108,0.7,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Do physicians consistently address the needs of family caregivers of frail elderly patients? Answer: While some do, this is not uniform. Restrictions such as limited appointment time, scarce resources, and gaps in knowledge can reduce their ability to fully support caregivers. Training improvements and policy adjustments are required.",3.316036182995957e-07,0.14413544178882143,0.08002462296091106,0.025387970506946217,0.19254785126063512,0.049048751486325794,0.025351221573340132,0.2194933536956758,0.033293697978596916,3.316036182995957e-07,0.24737843954014682,0.01694411414982164
108,0.7,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Are the needs of family caregivers for frail elderly individuals adequately met by physicians? Answer: Although some physicians meet these needs, it is not consistent. Barriers like insufficient time during appointments, lack of resources, and knowledge deficiencies can hinder their support. Training and policy reforms are essential.",3.552895910352811e-07,0.1651888509866546,0.08002462296091106,0.02720139697172809,0.21405405648159848,0.049048751486325794,0.027162023114293,0.2414722604144508,0.033293697978596916,3.552895910352811e-07,0.26985129539220454,0.01694411414982164
108,0.7,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Do physicians meet the needs of family caregivers caring for frail elderly people? Answer: Some physicians adequately address these needs, but it is not consistent across the board. Constraints such as limited time during visits, inadequate resources, and gaps in knowledge may restrict their ability to fully support caregivers. Training and policy changes are necessary.",1.6580180914979784e-07,0.008003267464241404,0.08002462296091106,0.012693985253473108,0.053711406406417694,0.049048751486325794,0.012675610786670066,0.07784283663264935,0.033293697978596916,1.6580180914979784e-07,0.10279721072903847,0.01694411414982164
108,0.7,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Question: Are physicians addressing the needs of family caregivers of frail elderly patients effectively? Answer: While certain physicians do, the support is not consistently provided. Challenges including short appointment times, resource limitations, and knowledge gaps can limit full caregiver support. Training and policy reforms are needed.",4.026615365066519e-07,0.20867396292639295,0.08002462296091106,0.030828249901291835,0.2585058190524312,0.049048751486325794,0.030783626196198732,0.28693463449120804,0.033293697978596916,4.026615365066519e-07,0.3163713110270985,0.01694411414982164
109,0.7,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain linked to a decline in health-related quality of life six months afterward? We discovered that neck pain negatively affects physical health-related quality of life but does not impact mental health. Our findings indicate that neck pain could be a factor in future poor physical HRQoL in the general population. Increasing awareness about the potential future consequences of neck pain is important.,1.8948778188548325e-07,0.07009917266458165,0.10502227851925086,0.014507411718254981,0.09674369687030548,0.029750067727680823,0.014486412327622933,0.11785581355365027,0.016388888888888897,1.8948778188548325e-07,0.14310084364067155,0.0
109,0.7,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Does neck pain correlate with a worse health-related quality of life half a year later? Our study showed that neck pain is associated with poorer physical HRQoL but not mental HRQoL. The results suggest neck pain might contribute to future declines in physical health quality of life among the population. It is vital to raise awareness about the possible long-term effects of neck pain.,1.8948778188548325e-07,0.14981233616799638,0.014397043719842989,0.014507411718254981,0.14146286980965694,0.0023872282903773384,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
109,0.7,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is there an association between neck pain and reduced health-related quality of life after six months? We found neck pain was linked to lower physical HRQoL but did not affect mental HRQoL. Our analysis implies that neck pain may lead to poorer physical health-related quality of life in the future. Promoting awareness of neck pain's potential future impact is recommended.,9.474389094274162e-08,0.05418808378615614,0.009560662803005465,0.0072537058591274906,0.04932782794894042,0.015926849557907907,0.007243206163811466,0.04843840057857163,0.017538265306122455,9.474389094274162e-08,0.07410797215372167,0.0
109,0.7,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does experiencing neck pain relate to worse health-related quality of life six months later? We observed that neck pain negatively influences physical HRQoL, while mental HRQoL remains unaffected. This suggests neck pain could be a cause of future poor physical health-related quality of life in the population. Awareness about the potential future effects of neck pain should be increased.",7.105791820705622e-08,0.0038665524017256203,0.10596004267816894,0.005440279394345618,0.031097431661075703,0.01652939636175342,0.0054324046228586,0.030304520734458773,0.017851239669421492,7.105791820705622e-08,0.056089466651043196,0.0
109,0.7,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is neck pain connected to a decline in health-related quality of life after six months? Our findings reveal that neck pain adversely affects physical, but not mental, HRQoL. The analysis suggests neck pain may contribute to future poor physical health quality of life in the population. Raising awareness of neck pain's possible long-term impact is important.",0.0,0.0,5.551115123125783e-17,0.0,0.0,3.469446951953614e-18,0.0,0.0,0.0,0.0,0.0,0.0
109,0.7,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is there a link between neck pain and poorer health-related quality of life six months later? We found neck pain was associated with diminished physical HRQoL but had no effect on mental HRQoL. Our analysis indicates that neck pain might be a factor in future poor physical health-related quality of life among the population. Increasing awareness about the potential future impact of neck pain is essential.,2.3685972735685406e-07,0.12809585646868005,0.08155239609630166,0.018134264647818726,0.15224945580891802,0.01270555583750611,0.018108015409528666,0.15083814044068644,0.01586888657648284,2.3685972735685406e-07,0.1758906664636637,0.0
109,0.7,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does neck pain lead to worse health-related quality of life six months afterward? Our research showed a negative association between neck pain and physical HRQoL, but not mental HRQoL. This suggests neck pain may contribute to a decline in physical health-related quality of life in the future. It is important to raise awareness of the possible future consequences of neck pain.",1.1842986367842703e-07,0.0731010551955773,0.0075126858392036006,0.009067132323909363,0.06723248594945552,0.01534464530039694,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
109,0.7,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain related to a decline in health-related quality of life six months post-occurrence? We found that neck pain negatively impacts physical HRQoL without affecting mental HRQoL. Our findings suggest neck pain could be a contributor to future poor physical health-related quality of life in the population. Awareness of the potential future effects of neck pain should be increased.,9.474389094274162e-08,0.016063667201828835,0.1021035669798114,0.0072537058591274906,0.04932782794894042,0.015926849557907907,0.007243206163811466,0.04843840057857163,0.017538265306122455,9.474389094274162e-08,0.07410797215372167,0.0
109,0.7,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is neck pain associated with a lower health-related quality of life six months later? Our study found a negative correlation between neck pain and physical HRQoL, but no link with mental HRQoL. The analysis indicates that neck pain may be a factor in future poor physical health-related quality of life among the population. Raising awareness of the possible future impact of neck pain is recommended.",2.1317375462116866e-07,0.11025896307506056,0.08469942732169697,0.016320838183036854,0.13581345282831947,0.013199979449477532,0.0162972138685758,0.13448288502329442,0.016124697661918846,2.1317375462116866e-07,0.1596301455918825,0.0
109,0.7,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Does neck pain affect health-related quality of life six months down the line? We observed that neck pain is negatively associated with physical HRQoL but not mental HRQoL. Our analysis suggests neck pain may contribute to future declines in physical health-related quality of life in the population. It is important to increase awareness about the potential long-term impact of neck pain.,1.1842986367842703e-07,0.07310105519557686,0.0075126858392036144,0.009067132323909363,0.06723248594945552,0.01534464530039694,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
110,0.7,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical importance of bile duct sludge compared to bile duct stones? Answer: The results suggest that symptomatic bile duct sludge (BDS) has a clinical significance comparable to that of common bile duct (CBD) stones. Bile duct sludge appears to represent an initial stage of choledocholithiasis.,1.1842986367842703e-07,0.047053424845119984,0.28888480599996236,0.009067132323909363,0.10836781198448397,0.03941358024691358,0.009054007704764333,0.14888138737307655,0.024375,1.1842986367842703e-07,0.11778303565638337,0.0
110,0.7,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical significance of bile duct sludge differ from that of bile duct stones? Answer: The data show that symptomatic BDS shares similar clinical implications with CBD stones. Bile duct sludge likely constitutes an early phase of choledocholithiasis.,7.105791820705622e-08,0.0506657210679613,0.012576519270886682,0.005440279394345618,0.07918597347650769,0.003632213294375436,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.7,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical significance of bile duct sludge distinct from bile duct stones? Answer: Findings reveal that symptomatic bile duct sludge has clinical significance akin to CBD stones. It seems that bile duct sludge marks the early development of choledocholithiasis.,7.105791820705622e-08,0.1546377981519531,0.21372533044503442,0.005440279394345618,0.09260259254739323,0.05768626734842948,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.7,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: The evidence indicates that symptomatic BDS is clinically similar to CBD stones. Bile duct sludge may represent the early stage of choledocholithiasis.,1.1842986367842682e-07,0.07346235541057267,0.03138730284357505,0.009067132323909363,0.09820510360836066,0.02049382716049385,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
110,0.7,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge have a different clinical significance than bile duct stones? Answer: The study suggests that symptomatic bile duct sludge exhibits clinical significance comparable to that of common bile duct stones. It appears to be an initial stage of choledocholithiasis.,2.3685972735685406e-08,0.04820696878098385,0.11213828562409853,0.0018134264647818726,0.008104408028834165,0.023125000000000014,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
110,0.7,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How clinically significant is bile duct sludge compared to bile duct stones? Answer: Findings indicate that symptomatic bile duct sludge carries clinical importance similar to CBD stones, and it seems to be an early form of choledocholithiasis.",1.4211583641411212e-07,0.10346071005114421,0.02762415052382361,0.010880558788691236,0.1266448393288484,0.019744897959183685,0.0108648092457172,0.12441194762660457,0.024375,1.4211583641411244e-07,0.16251892949777424,0.0
110,0.7,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Can the clinical significance of bile duct sludge be differentiated from bile duct stones? Answer: The results demonstrate that symptomatic BDS and CBD stones have alike clinical significance. Bile duct sludge is likely an early stage in the progression of choledocholithiasis.,4.737194547137081e-08,0.011539208615727325,0.041551246537396114,0.0036268529295637453,0.017433506001244048,0.022516436554898094,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,0.7,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: What clinical implications does bile duct sludge have compared to bile duct stones? Answer: The findings imply that symptomatic bile duct sludge has clinical effects similar to CBD stones, representing an early stage of choledocholithiasis.",1.8948778188548272e-07,0.16626165190421638,0.01943656942520769,0.014507411718254988,0.18606844003337164,0.018115243342516078,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
110,0.7,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is there a difference in clinical relevance between bile duct sludge and bile duct stones? Answer: The evidence points to symptomatic BDS being clinically equivalent to CBD stones. Bile duct sludge seems to indicate the initial phase of choledocholithiasis.,9.474389094274152e-08,0.044327536195488904,0.034953062480763186,0.0072537058591274906,0.07055087191658371,0.02120343316289264,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,0.7,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does symptomatic bile duct sludge compare clinically to bile duct stones? Answer: Clinical findings suggest that symptomatic bile duct sludge is as significant as CBD stones and may signify the early stage of choledocholithiasis.,1.8948778188548272e-07,0.2058700622219276,0.010001556550338547,0.014507411718254988,0.2268418035957218,0.011093749999999986,0.014486412327622947,0.2252613676834736,0.005898437499999999,1.8948778188548325e-07,0.2231435513142097,0.0
111,0.7,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy forecast the results for patients undergoing radical perineal prostatectomy? Prior benign prostate biopsy itself does not directly determine the outcome for patients treated with radical perineal prostatectomy. However, it can offer useful insights about the patient's condition.",2.3685972735685406e-08,0.1963780354812985,0.10796561201523547,0.0018134264647818726,0.23348206819806272,0.14275080348943986,0.0018108015409528666,0.20304785428171224,0.12543252595155707,2.3685972735685406e-08,0.13541977807061834,0.0783673469387755
111,0.7,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can prior benign prostate biopsy indicate the prognosis for patients receiving radical perineal prostatectomy? A prior benign prostate biopsy does not directly predict the outcome for patients undergoing radical perineal prostatectomy, although it may provide important information regarding the patient's health.",2.3685972735685406e-08,0.10632911056425254,0.07969945790816327,0.0018134264647818726,0.14619168669272087,0.11599359019506442,0.0018108015409528666,0.11527312933837619,0.0991359591144497,2.3685972735685406e-08,0.08277604458519949,0.0783673469387755
111,0.7,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is the outcome of radical perineal prostatectomy influenced by a previous benign prostate biopsy? The presence of a prior benign prostate biopsy does not directly forecast the outcome for patients treated with radical perineal prostatectomy, but it can yield valuable patient data.",0.0,0.20287234552973965,0.12943375605955676,0.0,0.2426015131959809,0.16712580348943987,0.0,0.1777300462974205,0.12543252595155707,0.0,0.10944429166736036,0.0783673469387755
111,0.7,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a history of benign prostate biopsy affect outcomes in patients treated with radical perineal prostatectomy? Previous benign prostate biopsy does not directly predict outcomes for these patients, even though it might contribute useful information about the patient's status.",7.1057918207056e-08,0.15535975020511517,0.14967930169753085,0.005440279394345618,0.1271725565608679,0.1401196306499337,0.0054324046228586,0.09768733862388634,0.12543252595155707,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
111,0.7,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"To what extent does prior benign prostate biopsy predict results after radical perineal prostatectomy? Prior benign prostate biopsy by itself does not directly determine the outcome for patients undergoing radical perineal prostatectomy, though it can provide beneficial insights into the patient's condition.",0.0,0.16906028794145023,0.10572769243060626,0.0,0.1732867951399868,0.11726430764456452,0.0,0.14218403703793658,0.09980925725349613,0.0,0.10944429166736036,0.0783673469387755
111,0.7,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a prior benign prostate biopsy serve as a predictive factor for outcomes in radical perineal prostatectomy patients? It does not directly predict the outcome for patients treated with radical perineal prostatectomy, but can supply valuable clinical information.",9.474389094274131e-08,0.164186949069125,0.17514226466049385,0.0072537058591274906,0.137240997538155,0.16712580348943987,0.007243206163811466,0.0695164616571895,0.12543252595155707,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
111,0.7,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can prior benign prostate biopsy outcomes predict the success of radical perineal prostatectomy? The prior benign prostate biopsy does not directly forecast the results for patients treated with radical perineal prostatectomy, while it can offer useful patient-related data.",9.474389094274131e-08,0.051784703572916424,0.09562869461662077,0.0072537058591274906,0.06022464414260531,0.11176248169013189,0.007243206163811466,0.02990805133947827,0.09688581314878891,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
111,0.7,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is there a predictive relationship between prior benign prostate biopsy and results following radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy, yet it can provide important patient insights.",4.7371945471370706e-08,0.11211406068201013,0.1009239477040816,0.0036268529295637453,0.11834535769685806,0.11465666768697072,0.003621603081905733,0.08761889764659925,0.0984263531120509,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
111,0.7,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy help predict the outcome for those undergoing radical perineal prostatectomy? Prior benign prostate biopsy itself is not a direct predictor of outcome for patients treated with this surgery, but it can give valuable information about the patient.",2.3685972735685406e-08,0.22938504407939098,0.1311425203402367,0.0018134264647818726,0.23348206819806272,0.14275080348943986,0.0018108015409528666,0.20304785428171224,0.12543252595155707,2.3685972735685406e-08,0.13541977807061834,0.0783673469387755
111,0.7,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does having had a benign prostate biopsy previously influence the prognosis of patients treated with radical perineal prostatectomy? While it does not directly predict the outcome, prior benign prostate biopsy can provide useful information about the patient's condition.",9.474389094274131e-08,0.1267195339037217,0.14827088647959183,0.0072537058591274906,0.09873282084038015,0.13937070144862354,0.007243206163811466,0.0695164616571895,0.12543252595155707,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
112,0.7,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy does not improve overall or disease-free survival rates. Tumor grade remains the sole independent prognostic factor for patient survival.,1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.7,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For advanced epithelial ovarian carcinoma in Thai women, is continued use of second-look laparotomy justified? Answer: Second-look laparotomy shows no beneficial effect on overall survival or disease-free survival. The only independent prognostic factor is tumor grade.",1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.7,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy still be performed for advanced epithelial ovarian carcinoma in Thai women? Answer: Performing second-look laparotomy does not favorably influence overall or disease-free survival. Tumor grade is the only independent predictor of patient survival.,1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.7,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still recommended? Answer: Second-look laparotomy does not positively affect overall or disease-free survival outcomes. Tumor grade stands as the sole independent prognostic indicator for survival.",1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.7,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is it beneficial to continue second-look laparotomy? Answer: There is no positive impact of second-look laparotomy on overall and disease-free survival. Tumor grade is the only independent survival prognostic factor.,9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,0.7,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: Should second-look laparotomy be maintained in treatment of advanced epithelial ovarian carcinoma in Thai women? Answer: The procedure does not improve overall or disease-free survival, with tumor grade being the only independent prognostic factor for survival.",1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.7,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy remain a standard practice? Answer: Second-look laparotomy fails to enhance overall and disease-free survival, while tumor grade is the only independent prognostic variable influencing survival.",1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.7,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In the management of advanced epithelial ovarian carcinoma among Thai women, is second-look laparotomy justified? Answer: The procedure does not confer benefits on overall or disease-free survival, and tumor grade alone independently predicts patient survival.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.7,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: Should we continue to perform second-look laparotomy in Thai women with advanced epithelial ovarian carcinoma? Answer: There is no survival advantage, either overall or disease-free, from second-look laparotomy; tumor grade is the sole independent prognostic factor.",1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.7,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: Is second-look laparotomy still warranted for advanced epithelial ovarian carcinoma in Thai women? Answer: Second-look laparotomy does not provide a survival benefit, with tumor grade being the only independent prognostic factor for patient survival.",1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
113,0.7,1,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment alone definitively rule out aspiration after an acute stroke?,9.948108548987845e-07,1.4677706512352682,0.07496876301541024,0.07616391152083879,1.5953396116981557,0.03840000000000001,0.07605366472002058,1.7074188130132062,0.019599999999999992,9.948108548987864e-07,1.8325814637483098,0.0
113,0.7,2,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment sufficient to exclude aspiration reliably following an acute stroke?,9.948108548987845e-07,1.4677706512352682,0.07496876301541024,0.07616391152083879,1.5953396116981557,0.03840000000000001,0.07605366472002058,1.7074188130132062,0.019599999999999992,9.948108548987864e-07,1.8325814637483098,0.0
113,0.7,3,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can aspiration after an acute stroke be reliably excluded using only bedside assessment?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.7,4,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Does bedside assessment provide a dependable way to exclude aspiration post-acute stroke?,9.948108548987845e-07,1.4677706512352682,0.07496876301541024,0.07616391152083879,1.5953396116981557,0.03840000000000001,0.07605366472002058,1.7074188130132062,0.019599999999999992,9.948108548987864e-07,1.8325814637483098,0.0
113,0.7,5,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is it possible to exclude aspiration following acute stroke solely through bedside assessment?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.7,6,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment by itself reliably detect the absence of aspiration after an acute stroke?,9.237529366917285e-07,1.2266085944183804,0.07496876301541024,0.07072363212649317,1.332975347230664,0.03840000000000001,0.07062126009716195,1.419736740561425,0.019599999999999992,9.237529366917303e-07,1.5141277326297748,0.0
113,0.7,7,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment a reliable method to rule out aspiration after an acute stroke?,9.474389094274138e-07,1.3007165665721017,0.07496876301541024,0.07253705859127504,1.4130180549042004,0.03840000000000001,0.07243206163811483,1.506748117551055,0.019599999999999992,9.474389094274156e-07,1.6094379124341,0.0
113,0.7,8,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can we rely on bedside assessment alone to exclude aspiration following an acute stroke?,9.474389094274138e-07,1.3007165665721017,0.07496876301541024,0.07253705859127504,1.4130180549042004,0.03840000000000001,0.07243206163811483,1.506748117551055,0.019599999999999992,9.474389094274156e-07,1.6094379124341,0.0
113,0.7,9,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment effective enough on its own to exclude aspiration after an acute stroke?,9.237529366917285e-07,1.2266085944183804,0.07496876301541024,0.07072363212649317,1.332975347230664,0.03840000000000001,0.07062126009716195,1.419736740561425,0.019599999999999992,9.237529366917303e-07,1.5141277326297748,0.0
113,0.7,10,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment independently guarantee the exclusion of aspiration following an acute stroke?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
114,0.7,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call impact polio vaccination rates in Kenya in 2015? Yes, it caused a notable drop in vaccination coverage and increased vaccine hesitancy, leading to a public health issue.",5.684633456564489e-07,0.26255271055258866,0.19834710743801648,0.04352223515476497,0.3717031645844311,0.14124038026256222,0.04345923698286883,0.43375395811102013,0.109375,5.684633456564497e-07,0.4983700940471656,0.07496876301541025
114,0.7,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' boycott influence polio vaccine uptake in Kenya? Indeed, their call significantly lowered immunization rates and fueled doubts about vaccines, resulting in a health crisis.",6.395212638635048e-07,0.36099278336584195,0.19834710743801648,0.04896251454911061,0.47348585889437356,0.14124038026256222,0.048891641605727454,0.5391144737688456,0.109375,6.39521263863506e-07,0.6075693860121563,0.07496876301541025
114,0.7,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the 2015 polio vaccination coverage in Kenya affected by the Catholic bishops' boycott appeal? Yes, it caused a marked decline in vaccination and amplified skepticism, contributing to a public health emergency.",5.921493183921342e-07,0.2943014088671685,0.19834710743801648,0.04533566161954685,0.4044929874074228,0.14124038026256222,0.04527003852382171,0.4676555097867019,0.109375,5.921493183921352e-07,0.5334614138584346,0.07496876301541025
114,0.7,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the boycott urged by Catholic bishops affect Kenya's polio vaccination in 2015? Yes, it significantly reduced coverage and raised vaccine doubts, triggering a public health crisis.",7.105791820705607e-07,0.4701920753308326,0.19834710743801648,0.05440279394345625,0.5868145442013777,0.14124038026256222,0.054324046228586075,0.6568975094252298,0.109375,7.105791820705622e-07,0.7301717081044892,0.07496876301541025
114,0.7,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' call for a boycott impact polio vaccine coverage in Kenya? Yes, it led to decreased immunization rates and increased suspicion toward vaccines, causing a health crisis.",5.921493183921342e-07,0.2943014088671685,0.19834710743801648,0.04533566161954685,0.4044929874074228,0.14124038026256222,0.04527003852382171,0.4676555097867019,0.109375,5.921493183921352e-07,0.5334614138584346,0.07496876301541025
114,0.7,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call in 2015 lower polio vaccination coverage in Kenya? Yes, it resulted in reduced immunization and heightened vaccine skepticism, which contributed to a public health problem.",6.158352911278195e-07,0.3270912316901602,0.19834710743801648,0.04714908808432873,0.43839453908310455,0.14124038026256222,0.04708084006477458,0.5027468295979709,0.109375,6.158352911278206e-07,0.5698290580293093,0.07496876301541025
114,0.7,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was polio vaccination coverage in Kenya in 2015 negatively affected by a boycott from Catholic bishops? Yes, it decreased vaccination rates and increased public mistrust of vaccines, leading to a health crisis.",5.921493183921342e-07,0.2943014088671685,0.19834710743801648,0.04533566161954685,0.4044929874074228,0.14124038026256222,0.04527003852382171,0.4676555097867019,0.109375,5.921493183921352e-07,0.5334614138584346,0.07496876301541025
114,0.7,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the 2015 boycott call by Catholic bishops influence polio vaccination in Kenya? Yes, it significantly dropped vaccine coverage and intensified skepticism, contributing to a public health crisis.",6.868932093348754e-07,0.43245174734798564,0.19834710743801648,0.05258936747867437,0.5475938310480952,0.14124038026256222,0.0525132446876332,0.616075514904975,0.109375,6.868932093348768e-07,0.6876120936856935,0.07496876301541025
114,0.7,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' 2015 boycott call impact polio vaccination rates in Kenya? Yes, it caused a decline in immunization and increased vaccine hesitancy, resulting in a public health crisis.",6.395212638635048e-07,0.36099278336584195,0.19834710743801648,0.04896251454911061,0.47348585889437356,0.14124038026256222,0.048891641605727454,0.5391144737688456,0.109375,6.39521263863506e-07,0.6075693860121563,0.07496876301541025
114,0.7,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' boycott affect polio vaccine coverage in Kenya? Yes, it led to a decrease in vaccination rates and heightened public doubt about vaccines, fueling a health crisis.",5.921493183921342e-07,0.2943014088671685,0.19834710743801648,0.04533566161954685,0.4044929874074228,0.14124038026256222,0.04527003852382171,0.4676555097867019,0.109375,5.921493183921352e-07,0.5334614138584346,0.07496876301541025
115,0.7,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy achievable? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically doable. Further experiments focusing on long-term survival are scheduled.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.7,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be performed? Answer: In a porcine model, transgastric endoscopic splenectomy appears technically possible. Additional studies on long-term survival will be conducted.",4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.7,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it possible to perform transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy in a pig model is technically feasible. More long-term survival research is planned.,4.73719454713706e-08,0.08820350236903352,0.0034578741965105714,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.7,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Transgastric endoscopic splenectomy: is it feasible? Answer: The procedure seems technically achievable in a porcine model, with further long-term survival tests planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.7,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can we perform transgastric endoscopic splenectomy? Answer: It appears technically feasible in a porcine model, and additional long-term survival experiments are intended.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.7,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy possible? Answer: In a pig model, this approach seems technically feasible. Further long-term survival studies are planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.7,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy achievable? Answer: The technique seems feasible in a porcine model, with plans for additional long-term survival experiments.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.7,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Question: Is transgastric endoscopic splenectomy technically possible? Answer: It appears feasible in a porcine model. Additional long-term survival experiments are forthcoming.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.7,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be done? Answer: It is technically feasible in a pig model, and more long-term survival studies are planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.7,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it technically possible to do transgastric endoscopic splenectomy? Answer: This procedure seems feasible in a porcine model, with further long-term survival experiments planned.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
116,0.7,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Is fondaparinux appropriate for use in perioperative bridging? The role of fondaparinux in perioperative bridging therapy remains unestablished, with notable limitations preventing its routine use as a bridging agent.",1.894877818854824e-07,0.22380858778249557,0.019698026874753798,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,0.7,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Does fondaparinux have a role in perioperative bridging? Its role in perioperative bridge therapy has not been clearly defined and it has significant limitations that restrict its routine application as a bridging agent.,9.47438909427412e-08,0.12741007983082842,0.006858900422914253,0.007253705859127518,0.12647161962590658,0.0036755094194540414,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
116,0.7,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Can fondaparinux be used for perioperative bridging? The use of fondaparinux for perioperative bridging has not been established and it faces important constraints that limit its routine usage.,2.131737546211677e-07,0.2620099546532644,0.018381073278597927,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,0.7,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","What is the role of fondaparinux in perioperative bridging? Fondaparinux's role in perioperative bridge therapy is not well established, and there are key limitations to using it routinely as a bridging agent.",1.184298636784265e-07,0.11723455351476497,0.023141099577085773,0.009067132323909398,0.11454226950954727,0.02854671280276816,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
116,0.7,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Is fondaparinux indicated for perioperative bridging? The role of fondaparinux in perioperative bridging therapy is yet to be established, with several important limitations to its routine use.",2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.7,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Does fondaparinux serve a role in perioperative bridging? Its role remains unproven in perioperative bridging therapy, and there are significant limitations to its regular use as a bridging agent.",1.894877818854824e-07,0.22380858778249557,0.019698026874753798,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,0.7,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Is fondaparinux suitable for perioperative bridging? Its role in perioperative bridge therapy is not established, and important limitations exist that prevent routine use.",3.316036182995942e-07,0.41546013170224505,0.055363321799307974,0.025387970506946314,0.4712172134482806,0.02854671280276816,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
116,0.7,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","What role does fondaparinux play in perioperative bridging? Fondaparinux has not been established as a standard perioperative bridge therapy, with notable limitations on its routine use.",2.605457000925383e-07,0.28762676019236055,0.055363321799307974,0.019947691112600675,0.337685820823757,0.02854671280276816,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
116,0.7,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Is there an established role for fondaparinux in perioperative bridging? No, the role of fondaparinux in perioperative bridging therapy has not been established and it has important restrictions limiting routine use.",1.421158364141118e-07,0.19772482747306475,0.0109632088129369,0.010880558788691277,0.19624707501694916,0.005892062707435933,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
116,0.7,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Can fondaparinux be routinely used for perioperative bridging? The role of fondaparinux in perioperative bridging therapy is not established and it has significant limitations preventing routine bridging use.,2.131737546211677e-07,0.2106657190562311,0.055363321799307974,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
117,0.7,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do individuals suffering from episodic migraines pay special attention to visual cues related to headaches? Studies suggest that those with episodic migraines tend to focus selectively on headache-related visual stimuli. This selective attention is attributed to a cognitive bias toward headache-associated signals, which may influence the occurrence and severity of migraine attacks. Nonetheless, experiences differ widely among individuals.",1.8948778188548325e-07,0.2683686242976058,0.08318487518974527,0.014507411718254981,0.24079407739725145,0.06222222222222222,0.014486412327622933,0.21617683293177015,0.04246913580246913,1.8948778188548325e-07,0.19047948401256942,0.021728395061728398
117,0.7,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraine sufferers more attentive to visual stimuli connected to headaches? Research shows that episodic migraineurs often selectively attend to headache-related visual information. This tendency stems from a cognitive bias toward headache cues, potentially impacting how frequently and intensely migraines occur. However, personal experiences can vary greatly.",4.737194547137081e-08,0.09978591187697106,0.10072314049586772,0.0036268529295637453,0.04408378315119643,0.06222222222222222,0.003621603081905733,0.015506137469618597,0.04246913580246913,4.737194547137081e-08,0.01431492863344408,0.021728395061728398
117,0.7,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people with episodic migraines have a selective focus on headache-related visual stimuli? Evidence points to episodic migraineurs exhibiting selective attention to visual cues linked to headaches. This behavior is linked to a cognitive bias toward headache-related stimuli, which might play a role in the frequency and severity of migraine episodes. Individual differences, however, are significant.",1.4211583641411244e-07,0.23176614337902235,0.08254755750546992,0.010880558788691236,0.2044264332263772,0.06222222222222222,0.0108648092457172,0.17913556125142005,0.04246913580246913,1.4211583641411244e-07,0.152739156029722,0.021728395061728398
117,0.7,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is selective attention to headache-related visual stimuli observed in episodic migraineurs? Research findings indicate that individuals with episodic migraines may show selective attention to headache-related visual cues. This selective attention arises from a cognitive bias toward headache-related stimuli, possibly contributing to migraine frequency and intensity. Still, the experience varies among individuals.",2.3685972735685406e-08,0.012566916607779088,0.04248673604734218,0.0018134264647818726,0.022387519806204903,0.0012581390464188463,0.0018108015409528666,0.022282393560528302,0.000881234101145871,2.3685972735685406e-08,0.02214741445367352,0.00046185441900629606
117,0.7,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraine patients selectively focus on visual stimuli associated with headaches? Studies indicate that episodic migraineurs may selectively attend to headache-related visual stimuli due to a cognitive bias. This bias towards headache cues could influence the frequency and severity of migraines, though individual experiences may differ considerably.",4.737194547137081e-08,0.07029028717229258,0.07945659985314563,0.0036268529295637453,0.04408378315119643,0.06222222222222222,0.003621603081905733,0.015506137469618597,0.04246913580246913,4.737194547137081e-08,0.01431492863344408,0.021728395061728398
117,0.7,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people with episodic migraines tend to selectively attend to headache-related visual cues? Research suggests that episodic migraine sufferers often focus selectively on visual stimuli tied to headaches. This selective attention is linked to a cognitive bias towards headache-related cues, which might contribute to how often and how intensely migraines occur. Experiences, however, can vary between individuals.",1.6580180914979784e-07,0.2749900009020627,0.10072314049586772,0.012693985253473108,0.22277557189457298,0.06222222222222222,0.012675610786670066,0.19782769426357438,0.04246913580246913,1.6580180914979784e-07,0.1717873510004151,0.021728395061728398
117,0.7,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are visual stimuli related to headaches selectively attended to by episodic migraineurs? Studies have found that episodic migraine patients may show selective attention to headache-associated visual cues. This selective attention is thought to result from a cognitive bias towards headache stimuli, potentially affecting migraine frequency and intensity. Individual experiences, nonetheless, vary widely.",4.737194547137081e-08,0.15428170051633883,0.08112314049586773,0.0036268529295637453,0.12746539209024732,0.06222222222222222,0.003621603081905733,0.10066394580992588,0.04246913580246913,4.737194547137081e-08,0.07269644835618516,0.021728395061728398
117,0.7,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraine sufferers preferentially attend to visual stimuli connected to headaches? Research indicates that episodic migraineurs may selectively focus on headache-related visual information. This focus is due to a cognitive bias toward headache cues, which may influence the frequency and severity of migraine attacks. However, individual experiences can differ significantly.",2.3685972735685406e-08,0.16166131559505859,0.10072314049586772,0.0018134264647818726,0.10726268477272871,0.06222222222222222,0.0018108015409528666,0.08004465860719012,0.04246913580246913,2.3685972735685406e-08,0.051643039158352,0.021728395061728398
117,0.7,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are individuals with episodic migraines more likely to attend selectively to headache-related visual stimuli? Evidence suggests that those with episodic migraines exhibit selective attention to headache-related visual cues. This selective attention stems from a cognitive bias toward headache stimuli, potentially affecting migraine episode frequency and intensity. Individual variability is considerable.",0.0,0.0,0.0,0.0,0.028881132523331132,0.02063432052089896,0.0,0.05899124940935696,0.04246913580246913,0.0,0.03013683393738864,0.021728395061728398
117,0.7,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraineurs demonstrate selective attention to visual stimuli associated with headaches? Research supports that episodic migraine sufferers may selectively attend to headache-related visual stimuli because of a cognitive bias. This bias toward headache cues could contribute to the frequency and intensity of migraine episodes, although individual experiences vary.",2.3685972735685406e-08,0.09195818855147353,0.07989923827766944,0.0018134264647818726,0.06558998837215979,0.06222222222222222,0.0018108015409528666,0.0374850441883936,0.04246913580246913,2.3685972735685406e-08,0.008157927218613636,0.021728395061728398
118,0.7,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is a surgeon's previous experience a factor in their ability to perform transurethral resection of the prostate? Yes, experience plays a significant role in mastering this procedure, which improves with practice, reducing complications and enhancing patient results. Hence, prior practice is vital for success.",3.789755637709665e-07,0.03437915306912931,0.19013128112267996,0.029014823436509962,0.0837571231044496,0.16493055555555555,0.028972824655245866,0.1349115714993805,0.136609745939192,3.789755637709665e-07,0.1879406979297964,0.10560000000000003
118,0.7,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does a surgeon's prior experience affect their skill in performing transurethral resection of the prostate? Indeed, the surgeon's experience contributes to better proficiency, fewer complications, and improved patient outcomes. Therefore, prior experience is essential for successful surgeries.",5.447773729207639e-07,0.2505685070043562,0.16237617908186364,0.04170880868998307,0.26607867989840406,0.16493055555555555,0.04164843544191594,0.32212311358752643,0.136609745939192,5.447773729207643e-07,0.3803125905772524,0.10560000000000003
118,0.7,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the capability to conduct transurethral resection of the prostate dependent on the surgeon's earlier experience? Yes, skill in this operation grows with experience, resulting in fewer complications and better patient outcomes, making prior experience crucial.",5.684633456564492e-07,0.24023120727327818,0.19013128112267996,0.04352223515476495,0.29506621677165557,0.16493055555555555,0.04345923698286881,0.3519760767372082,0.136609745939192,5.684633456564497e-07,0.4110842492440061,0.10560000000000003
118,0.7,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's previous experience influence their ability to carry out transurethral resection of the prostate? Yes, as surgeons gain experience, their proficiency increases, leading to reduced complications and improved outcomes for patients. Thus, prior experience is important.",5.210914001850786e-07,0.184661356118466,0.19013128112267996,0.0398953822252012,0.2379078029317072,0.16493055555555555,0.039837633900963065,0.2931355767142749,0.136609745939192,5.210914001850789e-07,0.35045962742757064,0.10560000000000003
118,0.7,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon's competency in performing transurethral resection of the prostate affected by their past experience? Yes, the ability improves with practice and experience, which lowers complication rates and enhances patient recovery, emphasizing the importance of prior experience.",5.210914001850786e-07,0.184661356118466,0.19013128112267996,0.0398953822252012,0.2379078029317072,0.16493055555555555,0.039837633900963065,0.2931355767142749,0.136609745939192,5.210914001850789e-07,0.35045962742757064,0.10560000000000003
118,0.7,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the experience a surgeon has impact their ability to perform transurethral resection of the prostate? Yes, proficiency improves with experience, resulting in fewer complications and better patient results, making previous experience critical for success.",5.921493183921345e-07,0.2692187441465297,0.19013128112267996,0.04533566161954683,0.32491917992133734,0.16493055555555555,0.045270038523821686,0.3827477354039619,0.136609745939192,5.921493183921352e-07,0.44283294755858593,0.10560000000000003
118,0.7,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is prior experience a determinant in a surgeon's skill at performing transurethral resection of the prostate? Yes, as experience grows, so does the surgeon's ability, leading to improved patient outcomes and fewer complications, highlighting the importance of experience.",5.210914001850786e-07,0.184661356118466,0.19013128112267996,0.0398953822252012,0.2379078029317072,0.16493055555555555,0.039837633900963065,0.2931355767142749,0.136609745939192,5.210914001850789e-07,0.35045962742757064,0.10560000000000003
118,0.7,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is a surgeon's previous practice relevant to their ability to perform transurethral resection of the prostate? Yes, increasing experience enhances proficiency, reduces complications, and improves patient outcomes, thus prior experience is key.",6.632072365991904e-07,0.361592064277545,0.19013128112267996,0.05077594101389247,0.42022935972566255,0.16493055555555555,0.05070244314668031,0.4811878082172152,0.136609745939192,6.632072365991914e-07,0.5446156418685284,0.10560000000000003
118,0.7,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the skill to perform transurethral resection of the prostate influenced by the surgeon's earlier experience? Yes, with greater experience, surgeons perform better, experience fewer complications, and achieve better patient outcomes, making prior experience essential.",5.921493183921345e-07,0.2692187441465297,0.19013128112267996,0.04533566161954683,0.32491917992133734,0.16493055555555555,0.045270038523821686,0.3827477354039619,0.136609745939192,5.921493183921352e-07,0.44283294755858593,0.10560000000000003
118,0.7,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does a surgeon's previous experience affect their performance in transurethral resection of the prostate? Yes, as experience accumulates, the surgeon's skill improves, leading to fewer complications and better outcomes, indicating the critical role of prior experience.",5.684633456564492e-07,0.24023120727327818,0.19013128112267996,0.04352223515476495,0.29506621677165557,0.16493055555555555,0.04345923698286881,0.3519760767372082,0.136609745939192,5.684633456564497e-07,0.4110842492440061,0.10560000000000003
119,0.7,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the relationship between marital status, living arrangements, and mortality differ by gender? Answer: Yes, gender influences how marital status and living arrangements relate to mortality. Research indicates men living alone or unmarried experience higher mortality, whereas women tend to exhibit higher rates in other contexts.",7.105791820705622e-08,0.04998798500049961,0.08098765432098766,0.005440279394345618,0.03565738861424084,0.020823902218198284,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
119,0.7,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is the link between marital status, living situation, and mortality influenced by gender? Answer: Indeed, the association varies by gender. Men usually have increased mortality risks when unmarried or living alone, while women often show different mortality patterns.",2.6054570009253926e-07,0.14106725176220847,0.08098765432098766,0.0199476911126006,0.23140196574033478,0.020823902218198284,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
119,0.7,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender affect the association between marital status, living arrangement, and mortality? Answer: Yes, gender plays a role. Studies reveal men living alone or unmarried face higher mortality, whereas women’s mortality rates differ under similar conditions.",3.0791764556390986e-07,0.19513447303248466,0.08098765432098766,0.023574544042164344,0.28697181689514695,0.020823902218198284,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
119,0.7,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does gender impact the association between marital status, living arrangement, and mortality? Answer: The connection varies with gender; men are more likely to have higher mortality when unmarried or living alone, while women often demonstrate distinct trends.",2.6054570009253926e-07,0.14106725176220847,0.08098765432098766,0.0199476911126006,0.23140196574033478,0.020823902218198284,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
119,0.7,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is there a gender variation in the relationship between marital status, living arrangement, and mortality? Answer: Yes, men tend to have higher mortality rates when unmarried or living alone, but women’s mortality associations differ.",3.5528959103528046e-07,0.252292886872433,0.08098765432098766,0.027201396971728103,0.34581231691808023,0.020823902218198284,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
119,0.7,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the association between marital status, living arrangement, and mortality change based on gender? Answer: Yes, mortality rates linked to marital status and living arrangements differ by gender, with men showing higher mortality when unmarried or living alone.",2.6054570009253926e-07,0.14106725176220847,0.08098765432098766,0.0199476911126006,0.23140196574033478,0.020823902218198284,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
119,0.7,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender influence how marital status and living arrangements relate to mortality? Answer: Yes, men often have elevated mortality rates when living alone or unmarried, while women display different mortality patterns.",4.2634750924233636e-07,0.3446662070034483,0.08098765432098766,0.03264167636607374,0.44112249672240544,0.020823902218198284,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
119,0.7,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Are there gender differences in the relationship between marital status, living arrangement, and mortality? Answer: Yes, men’s mortality rates increase with being unmarried or living alone, whereas women show varying mortality outcomes.",4.0266153650665106e-07,0.3129175086888685,0.08098765432098766,0.030828249901291863,0.40833267389941375,0.020823902218198284,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
119,0.7,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the impact of marital status and living arrangement on mortality vary between genders? Answer: Yes, men experience higher mortality when unmarried or living alone, while women’s mortality associations are different.",4.2634750924233636e-07,0.3446662070034483,0.08098765432098766,0.03264167636607374,0.44112249672240544,0.020823902218198284,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
119,0.7,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does marital status and living arrangement affect mortality differently by gender? Answer: The association does vary; men living alone or unmarried have higher mortality rates compared to women, who often show different outcomes.",3.5528959103528046e-07,0.252292886872433,0.08098765432098766,0.027201396971728103,0.34581231691808023,0.020823902218198284,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
120,0.7,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does living in an urban environment affect the risk of non-communicable diseases in Thailand depending on timing? Answer: Urban living was linked to higher behavioral and physiological risk factors, but these did not necessarily lead to increased biological risk factors. The biological risks likely result from complex interactions involving long-term accumulation.",1.8948778188548325e-07,0.07522226739563642,0.0507015306122449,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
120,0.7,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How does urban living influence non-communicable disease risks in Thailand, and does timing play a role? Answer: Urbanicity correlated with rises in behavioral and physiological risks; however, this does not directly cause higher biological risk factors, which are probably due to complex, long-term interactions.",3.552895910352811e-07,0.2228582662016998,0.0507015306122449,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
120,0.7,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: In Thailand, does the timing of living in an urban area affect non-communicable disease risk? Answer: Urban living is associated with increased behavioral and physiological risk factors, but these do not straightforwardly increase biological risks, which likely arise from complex long-term interactions.",4.026615365066519e-07,0.26937828183659374,0.0507015306122449,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
120,0.7,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the timing of urban residence impact non-communicable disease risk in Thailand? Answer: Urban environments are linked to elevated behavioral and physiological risk factors, though these may not directly lead to biological risk increases, which are likely due to complex long-term accumulations.",4.026615365066519e-07,0.26937828183659374,0.0507015306122449,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
120,0.7,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: What is the relationship between urban living and non-communicable disease risk timing in Thailand? Answer: Urbanicity relates to higher behavioral and physiological risks, but this does not directly translate into biological risk increases, which probably result from complex long-term factors.",4.500334819780227e-07,0.31816844600602545,0.0507015306122449,0.03445510283085558,0.3968813644167746,0.0,0.034405229278104466,0.4054651081081637,0.0,4.500334819780227e-07,0.41443377809092397,0.0
120,0.7,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Is timing important in the link between urban living and non-communicable disease risk in Thailand? Answer: Urban living raises behavioral and physiological risks, but these do not necessarily cause biological risk increases, which likely stem from complex long-term interactions.",4.73719454713708e-07,0.3790322632498011,0.02507826191418395,0.03626852929563745,0.42285685082003255,0.0,0.03621603081905733,0.4321333551903246,0.0,4.737194547137081e-07,0.4418327522790393,0.0
120,0.7,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How does living in an urban area affect non-communicable disease risks in Thailand, considering timing? Answer: Urbanicity is connected with increased behavioral and physiological risk factors, yet these may not directly lead to biological risk increases, which are likely complex and long-term.",4.026615365066519e-07,0.26937828183659374,0.0507015306122449,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
120,0.7,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the timing of exposure to urban environments influence non-communicable disease risk in Thailand? Answer: Urban living is associated with rises in behavioral and physiological risks, but these do not straightforwardly translate to biological risk increases, which probably involve complex long-term processes.",4.026615365066519e-07,0.26937828183659374,0.0507015306122449,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
120,0.7,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: In Thailand, does the timing of urban exposure impact non-communicable disease risk? Answer: Urbanicity correlates with increased behavioral and physiological risk factors, though this does not directly result in biological risk increases, which are likely due to complex long-term interactions.",4.500334819780227e-07,0.31816844600602545,0.0507015306122449,0.03445510283085558,0.3968813644167746,0.0,0.034405229278104466,0.4054651081081637,0.0,4.500334819780227e-07,0.41443377809092397,0.0
120,0.7,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does living in urban areas affect non-communicable disease risk in Thailand depending on timing? Answer: Urban environments are linked to higher behavioral and physiological risks, but these do not necessarily increase biological risk factors, which likely come from complex long-term accumulations.",4.263475092423373e-07,0.29347583341565375,0.0507015306122449,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
121,0.7,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex affect the response to intravenous thrombolysis in ischemic stroke? Yes, sex can impact the response to intravenous thrombolysis in ischemic stroke. Research shows that women might have an increased risk of symptomatic intracranial hemorrhage after treatment. Nonetheless, males and females typically achieve comparable functional outcomes following thrombolysis. More studies are required to fully understand this relationship.",2.3685972735685406e-08,0.003993923476006245,0.014609765474817377,0.0018134264647818726,0.004449862880897992,0.01537870049980776,0.0018108015409528666,0.004936368658722046,0.01614763552479817,2.3685972735685406e-08,0.00545591601770079,0.016916570549788526
121,0.7,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Yes, sex can influence the effectiveness of intravenous thrombolysis in ischemic stroke. Evidence suggests women may face a higher risk of symptomatic intracranial hemorrhage post-treatment. Despite this, both sexes usually have similar functional recovery after thrombolysis. Additional research is necessary for a deeper insight.",7.105791820705622e-08,0.038585507035988176,0.06405208852307599,0.005440279394345618,0.040514265355837686,0.06682397985299236,0.0054324046228586,0.042560007680198186,0.06956658112833253,7.105791820705622e-08,0.04473194143040393,0.07227989234909649
121,0.7,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex play a role in how patients respond to intravenous thrombolysis in ischemic stroke? Yes, sex is a factor in the response to intravenous thrombolysis in ischemic stroke. Studies have found that women may be at greater risk of symptomatic intracranial hemorrhage following treatment. However, functional outcomes after thrombolysis tend to be similar between men and women. Further investigation is needed to clarify these findings.",1.6580180914979784e-07,0.19594522553747762,0.05714214273322817,0.012693985253473108,0.19677498957077333,0.057044605154137784,0.012675610786670066,0.19754997310177602,0.05671562247212094,1.6580180914979784e-07,0.19826302142439145,0.05615519468717764
121,0.7,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can sex influence the outcomes of intravenous thrombolysis in ischemic stroke? Yes, sex can affect outcomes after intravenous thrombolysis in ischemic stroke. Research indicates that women might experience a higher incidence of symptomatic intracranial hemorrhage post-therapy. Still, functional results are generally alike for both males and females after thrombolysis. More research is essential to gain a comprehensive understanding.",2.3685972735685406e-08,0.07695678458757893,0.06594685804605069,0.0018134264647818726,0.07871563222660605,0.06814093344914825,0.0018108015409528666,0.08055242471980728,0.07025194488349686,2.3685972735685406e-08,0.08247226941325136,0.07227989234909649
121,0.7,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the effect of intravenous thrombolysis in ischemic stroke dependent on sex? Yes, the effect can vary by sex in ischemic stroke treated with intravenous thrombolysis. Women have been shown to have a higher risk of symptomatic intracranial hemorrhage after treatment. Yet, functional outcomes are largely similar between sexes following therapy. Further studies are needed to explore this fully.",0.0,0.09560650766344025,0.06684574591463549,0.0,0.1216047685192887,0.08626796306757996,0.0,0.12377628224284765,0.08842752787389466,0.0,0.10082140808144713,0.07227989234909649
121,0.7,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does intravenous thrombolysis response in ischemic stroke vary according to sex? Yes, sex may influence the response to intravenous thrombolysis in ischemic stroke. Data suggests women have an elevated risk of symptomatic intracranial hemorrhage post-treatment. Nonetheless, functional recovery is comparable between men and women after thrombolysis. Additional research is required for a thorough understanding.",1.1842986367842703e-07,0.024847296657481976,0.08073817762399077,0.009067132323909363,0.05411817297002397,0.10380622837370242,0.009054007704764333,0.03025022423202328,0.08842752787389466,1.1842986367842703e-07,0.0055112282771214716,0.07227989234909649
121,0.7,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is there a sex difference in the response to intravenous thrombolysis for ischemic stroke? Yes, sex differences exist in the response to intravenous thrombolysis in ischemic stroke. Women may be at increased risk for symptomatic intracranial hemorrhage following treatment. However, functional outcomes post-thrombolysis are generally similar across sexes. More research is needed to better understand this.",7.105791820705622e-08,0.011825197004735166,0.02841599384851981,0.005440279394345618,0.010829970241195586,0.030206228373702432,0.0054324046228586,0.009752987079042708,0.03202752787389463,7.105791820705622e-08,0.008587072458822842,0.033879892349096476
121,0.7,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex impact the therapeutic response to intravenous thrombolysis in ischemic stroke? Yes, sex can influence therapeutic responses to intravenous thrombolysis in ischemic stroke. Studies reveal women might have a higher chance of symptomatic intracranial hemorrhage after treatment. Despite this, functional outcomes tend to be similar in both sexes post-thrombolysis. Further research is necessary to provide a clearer picture.",0.0,0.07170488074758019,0.049828888224377144,0.0,0.07296286111157269,0.051337092571233305,0.0,0.07426576934570805,0.05276223294934049,0.0,0.07561605606108524,0.054104309358698685
121,0.7,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke affected by sex? Yes, sex affects the response to intravenous thrombolysis in ischemic stroke. Research suggests women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, functional outcomes after thrombolysis are generally comparable for men and women. Additional studies are needed for a complete understanding.",7.105791820705622e-08,0.03703054902509706,0.010960766859765131,0.005440279394345618,0.036502088039712,0.012177740243756507,0.0054324046228586,0.035909484458663155,0.01345876485848442,7.105791820705622e-08,0.03524657940343623,0.01480384070394862
121,0.7,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can sex differences influence outcomes after intravenous thrombolysis in ischemic stroke? Yes, sex differences can influence outcomes following intravenous thrombolysis in ischemic stroke. Women appear to have a greater risk of symptomatic intracranial hemorrhage after therapy. Nonetheless, functional outcomes are usually similar between males and females. More research is warranted to fully comprehend this effect.",9.474389094274162e-08,0.032508164563705755,0.026787505718573884,0.0072537058591274906,0.02085337318147573,0.0661284121491734,0.007243206163811466,0.02300880314451259,0.06920415224913495,9.474389094274162e-08,0.025313855573301236,0.07227989234909649
122,0.7,1,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal anxiety in alcoholism caused by a lack of beta-endorphin? Yes, anxiety triggered by withdrawal in alcoholism is linked to a deficiency in beta-endorphin. Beta-endorphin is a peptide that helps regulate stress and pain. When alcohol",7.10579182070559e-08,0.17452996039366342,0.06224489795918371,0.005440279394345639,0.17625555625968126,0.06222222222222223,0.005432404622858621,0.1370924930703663,0.0322222222222222,7.105791820705622e-08,0.09531017980432521,0.0
122,0.7,2,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does withdrawal anxiety in alcoholism stem from beta-endorphin deficiency? Indeed, withdrawal-induced anxiety in alcoholism is connected to a shortage of beta-endorphin, a peptide responsible for controlling stress and pain. When alcohol",7.10579182070559e-08,0.06170304377717617,0.023673469387755164,0.005440279394345639,0.05959992907497913,0.027783446712018135,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
122,0.7,3,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety from withdrawal in alcoholism due to a beta-endorphin deficit? Yes, the anxiety experienced during withdrawal in alcoholism relates to a deficiency in beta-endorphin, a peptide that manages stress and pain. When alcohol",2.36859727356853e-08,0.007213730997908563,0.025555555555555554,0.0018134264647818796,0.07540613620281222,0.03194878472222223,0.0018108015409528735,0.07646787125393084,0.0322222222222222,2.3685972735685406e-08,0.0327898228229917,0.0
122,0.7,4,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal-induced anxiety in alcoholism related to a deficiency of beta-endorphin? Yes, anxiety caused by withdrawal in alcoholism is associated with a lack of beta-endorphin, a peptide that helps regulate stress and pain. When alcohol",2.36859727356853e-08,0.11510635968914018,0.0606152433425161,0.0018134264647818796,0.11741505623674797,0.06222222222222223,0.0018108015409528735,0.07646787125393084,0.0322222222222222,2.3685972735685406e-08,0.0327898228229917,0.0
122,0.7,5,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety seen in alcoholism withdrawal caused by low levels of beta-endorphin? Yes, withdrawal-related anxiety in alcoholism is linked to beta-endorphin deficiency. Beta-endorphin is a peptide involved in the regulation of stress and pain. When alcohol",7.10579182070559e-08,0.17452996039366342,0.06224489795918371,0.005440279394345639,0.17625555625968126,0.06222222222222223,0.005432404622858621,0.1370924930703663,0.0322222222222222,7.105791820705622e-08,0.09531017980432521,0.0
122,0.7,6,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Yes, the anxiety experienced during withdrawal from alcoholism is due to a deficiency in beta-endorphin, a peptide that plays a key role in managing stress and pain. When alcohol",7.10579182070559e-08,0.21303813709143826,0.09000000000000004,0.005440279394345639,0.17625555625968126,0.06222222222222223,0.005432404622858621,0.1370924930703663,0.0322222222222222,7.105791820705622e-08,0.09531017980432521,0.0
122,0.7,7,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal anxiety in alcoholics caused by a lack of beta-endorphin? Yes, withdrawal-induced anxiety in alcoholism is indeed due to beta-endorphin deficiency. Beta-endorphin is a peptide that regulates stress and pain. When alcohol",2.36859727356853e-08,0.05193340265005686,0.05878251821019773,0.0018134264647818796,0.05489469925541446,0.06222222222222223,0.0018108015409528735,0.011929350116359316,0.0322222222222222,2.3685972735685406e-08,0.03390155167568176,0.0
122,0.7,8,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety during alcoholism withdrawal a result of beta-endorphin deficiency? Yes, the anxiety linked to withdrawal in alcoholism is associated with a deficiency in beta-endorphin, a peptide involved in stress and pain management. When alcohol",4.73719454713706e-08,0.1452588498070302,0.06145328719723188,0.003626852929563759,0.14726801938642975,0.06222222222222223,0.003621603081905747,0.10723952992068453,0.0322222222222222,4.737194547137081e-08,0.06453852113757153,0.0
122,0.7,9,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety caused by withdrawal in alcoholism due to a beta-endorphin shortfall? Yes, withdrawal anxiety in alcoholism is connected to beta-endorphin deficiency. Beta-endorphin is a peptide that helps control stress and pain. When alcohol",2.36859727356853e-08,0.11510635968914018,0.0606152433425161,0.0018134264647818796,0.11741505623674797,0.06222222222222223,0.0018108015409528735,0.07646787125393084,0.0322222222222222,2.3685972735685406e-08,0.0327898228229917,0.0
122,0.7,10,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal-induced anxiety in alcoholism caused by insufficient beta-endorphin? Yes, anxiety during withdrawal in alcoholism relates to a deficiency in beta-endorphin, a peptide responsible for regulating stress and pain. When alcohol",7.10579182070559e-08,0.015493231739846625,0.05670630202140312,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
123,0.7,1,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are we adhering to the guidelines when preparing high-risk fall patients for discharge home after rehabilitation? Compliance with these guidelines varies, requiring thorough assessments, tailored care plans, patient education, and home safety measures. Research indicates inconsistent application, signaling a need for enhancement.",5.210914001850789e-07,0.4295626596872273,0.0,0.0398953822252012,0.4382549309311554,0.0,0.039837633900963065,0.44731221804366594,0.0,5.210914001850789e-07,0.456758402495713,0.0
123,0.7,2,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we meet the standards for discharging high-fall-risk patients home post-rehabilitation? Guideline adherence is variable, emphasizing comprehensive evaluations, individualized care, education, and safety modifications at home. Studies show uneven implementation, revealing areas for improvement.",7.105791820705614e-07,0.646627164925055,0.0,0.0544027939434562,0.6613984822453651,0.0,0.054324046228586026,0.6768866596881637,0.0,7.105791820705622e-07,0.6931471805599445,0.0
123,0.7,3,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","When preparing patients at high risk of falls for discharge home post-rehabilitation, do we follow the guidelines? Compliance varies, with a necessity for detailed assessments, customized care plans, education, and home safety interventions. Evidence points to inconsistent practice, indicating the need for better adherence.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.7,4,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are the guidelines met in preparing patients prone to falls for discharge after rehabilitation? Compliance is inconsistent; essential steps include thorough evaluations, personalized care strategies, patient education, and home safety enhancements. Research suggests implementation gaps that need addressing.",6.158352911278202e-07,0.5322168137473096,0.0,0.04714908808432869,0.5436154465889813,0.0,0.04708084006477453,0.555525802683897,0.0,6.158352911278206e-07,0.5679840376059375,0.0
123,0.7,5,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is the preparation of high-fall-risk patients for home discharge after rehab aligned with guidelines? Adherence fluctuates, requiring comprehensive assessment, individualized planning, education, and home safety measures. Studies reveal inconsistent guideline application, underscoring the need for improvement.",6.632072365991908e-07,0.5877866649021217,0.0,0.05077594101389244,0.6007738604289297,0.0,0.05070244314668028,0.6143663027068302,0.0,6.632072365991914e-07,0.628608659422373,0.0
123,0.7,6,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we comply with discharge preparation guidelines for patients at high risk of falls after rehabilitation? Compliance varies, highlighting the importance of detailed assessments, tailored care plans, education, and home safety. Research indicates inconsistent adherence and the necessity for enhancement.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
123,0.7,7,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are guidelines being followed when preparing high-risk fall patients for discharge home post-rehabilitation? Compliance with these protocols varies, involving thorough assessments, personalized care, education, and home safety efforts. Studies show implementation is uneven, suggesting room for improvement.",6.395212638635055e-07,0.5596157879354249,0.0,0.04896251454911056,0.5717863235556782,0.0,0.048891641605727405,0.5845133395571485,0.0,6.39521263863506e-07,0.5978370007556193,0.0
123,0.7,8,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Does our preparation of high-fall-risk patients for home discharge after rehab meet guidelines? Compliance is inconsistent, emphasizing the need for comprehensive assessments, customized care, education, and home safety interventions. Evidence points to gaps in implementation requiring improvement.",6.395212638635055e-07,0.5596157879354249,0.0,0.04896251454911056,0.5717863235556782,0.0,0.048891641605727405,0.5845133395571485,0.0,6.39521263863506e-07,0.5978370007556193,0.0
123,0.7,9,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are patients at high risk of falls being prepared for home discharge after rehabilitation in line with guidelines? Adherence varies and requires detailed assessments, individualized care, education, and safety measures at home. Studies demonstrate inconsistent implementation, indicating a need for improvement.",5.447773729207643e-07,0.454255272277599,0.0,0.04170880868998307,0.46357273891544715,0.0,0.04164843544191593,0.4732877044469239,0.0,5.447773729207643e-07,0.48342664957787385,0.0
123,0.7,10,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","How well do we prepare high-risk fall patients for discharge home after rehabilitation according to guidelines? Compliance is variable, necessitating thorough assessments, personalized care plans, patient education, and home safety measures. Research highlights inconsistent adherence, stressing the need for better implementation.",5.447773729207643e-07,0.454255272277599,0.0,0.04170880868998307,0.46357273891544715,0.0,0.04164843544191593,0.4732877044469239,0.0,5.447773729207643e-07,0.48342664957787385,0.0
124,0.7,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage effective for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage appears to be both effective and safe in preventing CSF fistulas in cases of large dural tears and in debilitated or irradiated patients, as well as in treating CSF leaks.",7.105791820705622e-08,0.07473861686064831,0.0017409330596143968,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
124,0.7,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage work for postoperative cerebrospinal fluid fistula following spine surgery? It seems that lumbar drainage is a safe and effective method for preventing CSF fistulas in patients with significant dural tears or those who are debilitated or irradiated, and it also helps treat CSF leaks.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,0.7,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is the use of lumbar drainage successful in managing postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered effective and safe for both preventing CSF fistulas in cases with large dural tears or weakened patients and for treating existing CSF leaks.,4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.7,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage effectively manage postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage appears to be a safe and effective approach to prevent CSF fistulas in large dural tear cases and in debilitated or irradiated patients, as well as to treat CSF leaks.",7.105791820705622e-08,0.07473861686064831,0.0017409330596143968,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
124,0.7,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a reliable treatment for postoperative cerebrospinal fluid fistula following spine surgery? It seems lumbar drainage is both effective and safe for preventing CSF fistulas in patients with large dural tears or those debilitated or irradiated, and for treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.7,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide effective prevention and treatment for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is effective and safe in preventing CSF fistulas in large dural tear cases and debilitated or irradiated patients, and in treating CSF leaks.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
124,0.7,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage beneficial in preventing and treating cerebrospinal fluid fistula following spine surgery? Lumbar drainage seems to be a safe and effective measure to prevent CSF fistulas in cases of extensive dural tears and in debilitated or irradiated patients, as well as to treat CSF leaks.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,0.7,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage an effective and safe method for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage appears useful both in preventing CSF fistulas in patients with large dural tears or in debilitated/irradiated individuals and in treating CSF leaks.,2.36859727356853e-08,0.02620645821577927,0.000639705252959033,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
124,0.7,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage effective for managing cerebrospinal fluid fistula after spine surgery? It is considered both effective and safe for preventing CSF fistulas in cases with large dural tears and debilitated or irradiated patients, and also for treating CSF leaks.",2.36859727356853e-08,0.009339551043704652,0.02498356344510192,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
124,0.7,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Can lumbar drainage prevent and treat postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to be an effective and safe approach to prevent CSF fistulas in patients with large dural tears or debilitated/irradiated status and to treat CSF leaks.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
125,0.7,1,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Does using a neuroendoscope at the same time affect the rate of ventriculoperitoneal shunt infections? The simultaneous use does not directly impact infection rates but enables...,2.36859727356853e-07,0.059611866555897564,0.24,0.018134264647818796,0.022119785769418865,0.21301775147928986,0.018108015409528735,0.10895982533371429,0.1728395061728395,2.3685972735685406e-07,0.20140665430142368,0.12244897959183673
125,0.7,2,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is the incidence of ventriculoperitoneal shunt infection affected by concurrent use of a neuroendoscope? Using a neuroendoscope simultaneously does not directly change infection incidence, though it permits...",2.131737546211677e-07,0.09883257970918002,0.24,0.016320838183036916,0.018702208750835947,0.21301775147928986,0.016297213868575862,0.06640021091491866,0.1728395061728395,2.1317375462116866e-07,0.15695489173058963,0.12244897959183673
125,0.7,3,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Does the use of a neuroendoscope during ventriculoperitoneal shunting influence infection occurrence? The simultaneous neuroendoscope use does not directly alter infection rates but allows for...,2.605457000925383e-07,0.018789872035642752,0.24,0.019947691112600675,0.0646794001882145,0.21301775147928986,0.01991881695048161,0.15341158790454834,0.1728395061728395,2.6054570009253947e-07,0.24792666993631762,0.12244897959183673
125,0.7,4,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Does employing a neuroendoscope simultaneously impact ventriculoperitoneal shunt infection rates? Concurrent use does not directly affect the incidence of infection but facilitates...,3.316036182995942e-07,0.11474152058888087,0.24,0.025387970506946314,0.20444134256337376,0.21301775147928986,0.02535122157334023,0.3000150620964237,0.1728395061728395,3.3160361829959553e-07,0.40207734976357434,0.12244897959183673
125,0.7,5,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Does the simultaneous application of a neuroendoscope affect the frequency of ventriculoperitoneal shunt infections? Using a neuroendoscope at the same time does not directly influence infection frequency but enables...,1.658018091497971e-07,0.12343003896576255,0.20433470507544582,0.012693985253473157,0.0956632498869654,0.21301775147928986,0.012675610786670115,0.013642496758618616,0.1728395061728395,1.6580180914979784e-07,0.07357328279153919,0.12244897959183673
125,0.7,6,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Does performing neuroendoscopy alongside ventriculoperitoneal shunting change the infection incidence? The combined use does not directly affect infection rates but allows for...,3.316036182995942e-07,0.11474152058888087,0.24,0.025387970506946314,0.20444134256337376,0.21301775147928986,0.02535122157334023,0.3000150620964237,0.1728395061728395,3.3160361829959553e-07,0.40207734976357434,0.12244897959183673
125,0.7,7,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Is there an effect on ventriculoperitoneal shunt infection rates when a neuroendoscope is used simultaneously? Simultaneous use does not directly influence infection incidence but permits...,2.605457000925383e-07,0.018789872035642752,0.24,0.019947691112600675,0.0646794001882145,0.21301775147928986,0.01991881695048161,0.15341158790454834,0.1728395061728395,2.6054570009253947e-07,0.24792666993631762,0.12244897959183673
125,0.7,8,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the simultaneous deployment of a neuroendoscope alter the occurrence of ventriculoperitoneal shunt infections? Using both together does not directly impact infection rates, however, it allows for...",2.131737546211677e-07,0.09883257970918002,0.24,0.016320838183036916,0.018702208750835947,0.21301775147928986,0.016297213868575862,0.06640021091491866,0.1728395061728395,2.1317375462116866e-07,0.15695489173058963,0.12244897959183673
125,0.7,9,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Does simultaneous neuroendoscope use influence ventriculoperitoneal shunt infection rates? Concurrent use does not directly affect the incidence of infections but enables...,3.5528959103527956e-07,0.16353168475831215,0.24,0.027201396971728194,0.2557346369509239,0.21301775147928986,0.027162023114293103,0.354082283366699,0.1728395061728395,3.552895910352809e-07,0.45923576360352314,0.12244897959183673
125,0.7,10,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",Is the incidence of ventriculoperitoneal shunt infection influenced by the simultaneous use of a neuroendoscope? The simultaneous use does not directly impact infection occurrence but allows for...,2.131737546211677e-07,0.007805448069273524,0.1636111111111111,0.016320838183036916,0.03674956569395915,0.1730871959237343,0.016297213868575862,0.06640021091491866,0.1728395061728395,2.1317375462116866e-07,0.15695489173058963,0.12244897959183673
126,0.7,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does using automatic transmission enhance driving behavior among elderly drivers? Switching to automatic transmission might be advised for senior drivers to help preserve safe driving habits and maintain their mobility quality.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.7,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can automatic transmission positively affect the driving habits of older drivers? It is suggested that older drivers switch to automatic transmission to support safe driving and sustain their transportation mobility.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.7,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is driving behavior improved in older drivers by using automatic transmission? Recommending automatic transmission for older drivers can aid in ensuring safe driving and maintaining their transport mobility quality.,1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.7,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Does automatic transmission aid in better driving performance for elderly drivers? For older drivers, adopting automatic transmission could be beneficial in maintaining safe driving and preserving their mobility.",1.894877818854824e-07,0.271247020764406,0.008435535717941887,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
126,0.7,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can switching to an automatic transmission improve how older drivers behave on the road? It is often recommended that older drivers use automatic transmission to keep driving safely and maintain the quality of their transport.,2.36859727356853e-08,0.07092585368024018,0.03004703719723184,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
126,0.7,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does the use of automatic transmission enhance driving safety among older drivers? Older drivers may be advised to transition to automatic transmission to uphold safe driving and ensure continued mobility.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.7,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is it beneficial for older drivers to use automatic transmission to improve their driving? Switching to automatic transmission is recommended for elderly drivers to help maintain safe driving and their transportation quality.,9.47438909427412e-08,0.17119079256525804,0.03566256187024015,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
126,0.7,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does automatic transmission contribute to safer driving behavior in senior drivers? Advising older drivers to switch to automatic transmission could help them maintain safe driving and transport mobility.,1.894877818854824e-07,0.271247020764406,0.008435535717941887,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
126,0.7,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can automatic transmission help older drivers maintain better driving habits? Older drivers might be encouraged to adopt automatic transmission to preserve safe driving and the quality of their mobility.,1.658018091497971e-07,0.2825561667907768,0.04245920435699517,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.7,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is there an improvement in driving behavior for older drivers when using automatic transmission? Older drivers are often recommended to switch to automatic transmission to sustain safe driving and their transport mobility.,9.47438909427412e-08,0.12647161962590658,0.0036755094194540414,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
127,0.7,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact outcomes in colon and rectal surgeries? Answer: This extensive multicenter database study indicates that severe, moderate, and even mild preoperative anemia independently increase the risk of complications and prolong hospital stay following colon surgery.",1.1842986367842692e-07,0.12466730702264872,0.002908287627211844,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.7,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia associated with worse outcomes in colon and rectal surgery? Answer: Analysis of a large multicenter database shows that severe, moderate, and mild preoperative anemia are independent risk factors for complications and extended hospitalization after colon surgery.",1.1842986367842692e-07,0.12466730702264872,0.002908287627211844,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.7,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia affect colon and rectal surgery results? Answer: Findings from a large multicenter database reveal that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays post-colon surgery.",1.6580180914979753e-07,0.17923244641398606,0.004291191768657054,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
127,0.7,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having preoperative anemia influence the outcomes of colon and rectal surgeries? Answer: A large multicenter database analysis suggests that severe, moderate, and mild anemia before surgery independently increase the risk of complications and lengthen hospital stays after colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.7,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Can preoperative anemia impact the success of colon and rectal surgery? Answer: This analysis from a large multicenter database demonstrates that even mild preoperative anemia, along with moderate and severe forms, independently raises the likelihood of complications and prolonged hospitalization following colon surgery.",2.3685972735685406e-08,0.008517171800753065,0.02271498107084911,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
127,0.7,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there an adverse effect of preoperative anemia on colon and rectal surgery outcomes? Answer: The study of a large multicenter database indicates that severe, moderate, and mild preoperative anemia are independent risk factors for postoperative complications and longer hospital stays after colon surgery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
127,0.7,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia worsen outcomes in colon and rectal surgery? Answer: According to a large multicenter database review, the presence of severe, moderate, or mild preoperative anemia independently increases the risk of complications and extends hospital stay after colon surgery.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.7,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: What is the impact of preoperative anemia on colon and rectal surgery outcomes? Answer: Large multicenter database analysis suggests that severe, moderate, and mild preoperative anemia each independently contribute to a higher risk of complications and longer hospitalization following colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.7,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does the presence of preoperative anemia affect colon and rectal surgery results? Answer: An analysis of a large multicenter database reveals that severe, moderate, and mild preoperative anemia independently elevate the risk of complications and lengthen hospital stays after colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.7,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Are colon and rectal surgery outcomes negatively influenced by preoperative anemia? Answer: This large multicenter database analysis finds that severe, moderate, and mild preoperative anemia are independent predictors of complications and increased length of hospital stay following colon surgery.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
128,0.7,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict maternal and neonatal adverse outcomes? Answer: Studies suggest that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia can act as a prognostic indicator for adverse maternal and neonatal outcomes.,9.474389094274162e-08,0.1801556702957896,0.09874642918975071,0.0072537058591274906,0.18867216073307747,0.13616531099048582,0.007243206163811466,0.19777742390340158,0.16678416955017303,9.474389094274162e-08,0.174519377909367,0.16801020408163267
128,0.7,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Can the first urinary albumin/creatinine ratio (ACR) in women suspected of having preeclampsia predict negative maternal and neonatal outcomes? Answer: Research shows that the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia may be a prognostic marker for adverse maternal and neonatal results.,9.474389094274162e-08,0.11854258757935021,0.0615234375,0.0072537058591274906,0.12565878068217184,0.09453724441439434,0.007243206163811466,0.13329861640945406,0.12189324157233376,9.474389094274162e-08,0.10850536071317984,0.12132737859686817
128,0.7,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a predictor of maternal and neonatal adverse outcomes? Answer: Evidence suggests that the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia could serve as a prognostic factor for poor maternal and neonatal outcomes.,4.737194547137081e-08,0.23281719881031826,0.1046484375,0.0036268529295637453,0.23997320374422504,0.14085476472583713,0.003621603081905733,0.2475383851464228,0.16983263893792813,4.737194547137081e-08,0.22404003068954026,0.17015873015873018
128,0.7,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Does the first measurement of urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia forecast maternal and neonatal adverse outcomes? Answer: Research indicates that the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may predict adverse outcomes for both mother and newborn.,1.1842986367842703e-07,0.21579515382401127,0.13725486419296515,0.009067132323909363,0.1942584776477405,0.15588917686819784,0.009054007704764333,0.17194411193985149,0.16515325239040973,1.1842986367842703e-07,0.1488117283499113,0.16685800158327635
128,0.7,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Is the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia useful as a prognostic factor for adverse maternal and neonatal outcomes? Answer: Studies have found that the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia might serve as a predictor for maternal and neonatal complications.,0.0,0.11316688662203189,0.01831356095679007,0.0,0.14440566261665566,0.0540280671230054,0.0,0.1474781235233924,0.07310854496108696,0.0,0.12054733574955456,0.06823867219471619
128,0.7,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia indicate the risk of adverse maternal and neonatal outcomes? Answer: Research suggests that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may be a significant prognostic factor for poor outcomes in both mother and child.,2.3685972735685406e-08,0.3625325393491652,0.15025800540123455,0.0018134264647818726,0.3406693884306695,0.16694622997653302,0.0018108015409528666,0.31785313278866045,0.17393694732795079,2.3685972735685406e-08,0.2940201291228841,0.17304106827916355
128,0.7,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Is the first urinary albumin/creatinine ratio (ACR) measurement in women suspected of preeclampsia a reliable prognostic marker for maternal and neonatal adverse outcomes? Answer: Evidence shows that the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia might predict adverse results for both the mother and newborn.,2.3685972735685406e-08,0.2581720532775824,0.10744104606632954,0.0018134264647818726,0.2646854551287401,0.14305860085080863,0.0018108015409528666,0.2715264141276901,0.17125922363346127,2.3685972735685406e-08,0.278719725234283,0.1932994602799798
128,0.7,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia have prognostic value for maternal and neonatal adverse outcomes? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in suspected preeclamptic women may serve as a prognostic factor for negative outcomes in mother and neonate.,2.3685972735685406e-08,0.3448154508475758,0.16637880940082644,0.0018134264647818726,0.32367670453809705,0.18440082644628103,0.0018108015409528666,0.30166324806507916,0.19277073979810688,2.3685972735685406e-08,0.278719725234283,0.1932994602799798
128,0.7,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Can the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia be used to predict adverse maternal and neonatal outcomes? Answer: Studies suggest that the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia might be a useful predictor of poor outcomes for mother and newborn.,2.3685972735685406e-08,0.3159343183242447,0.14626518979853978,0.0018134264647818726,0.29418107983341857,0.16356395460579543,0.0018108015409528666,0.2715264141276905,0.17125922363346127,2.3685972735685406e-08,0.24791318387606331,0.171161907705213
128,0.7,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Question: Is the first urinary albumin/creatinine ratio (ACR) among women suspected of preeclampsia a prognostic factor for adverse outcomes in mothers and neonates? Answer: Research shows that the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia may indicate a risk of maternal and neonatal adverse outcomes.,4.737194547137081e-08,0.26231282351499585,0.12409779799970254,0.0036268529295637453,0.2701100376816137,0.16176608384400593,0.003621603081905733,0.2783449265046425,0.19181087317375334,4.737194547137081e-08,0.287053410740445,0.21551020408163268
129,0.7,1,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT really provide additional value over multidetector CT in the preoperative staging of patients with colorectal carcinoma liver metastases? Yes, PET/CT significantly enhances multidetector CT by offering detailed metabolic insights that improve tumor extent assessment, detect more lesions, and assist in better treatment planning.",4.737194547137081e-07,0.18959164554188046,0.12817665130226483,0.03626852929563745,0.20589723150814576,0.124297520661157,0.03621603081905733,0.2329476614739927,0.11107438016528923,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
129,0.7,2,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In the preoperative staging of colorectal carcinoma liver metastases, does PET/CT contribute beyond multidetector CT? Absolutely, PET/CT adds crucial metabolic information that refines tumor evaluation, uncovers additional lesions, and supports more precise treatment strategies.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.7,3,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is there added benefit of PET/CT over multidetector CT in staging patients with liver metastases from colorectal cancer preoperatively? Yes, PET/CT provides valuable metabolic details that enhance tumor extent accuracy, reveal further lesions, and inform optimal treatment planning.",6.395212638635056e-07,0.3313566767904641,0.15089163237311393,0.04896251454911056,0.3835784087455978,0.124297520661157,0.0488916416057274,0.41526921826794716,0.11107438016528923,6.39521263863506e-07,0.44815651715191285,0.09719008264462808
129,0.7,4,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","When staging liver metastases of colorectal cancer before surgery, does PET/CT offer more than multidetector CT? Indeed, PET/CT supplies significant metabolic data that aids in precise tumor delineation, detection of extra lesions, and guides effective therapeutic decisions.",6.63207236599191e-07,0.3587556509785794,0.15089163237311393,0.050775941013892434,0.41174928571229463,0.124297520661157,0.05070244314668027,0.44425675514119867,0.11107438016528923,6.632072365991914e-07,0.4780094803015946,0.09719008264462808
129,0.7,5,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does preoperative PET/CT add value to multidetector CT in assessing liver metastases from colorectal carcinoma? Yes, PET/CT delivers important metabolic information that improves tumor extent identification, detects additional lesions, and facilitates better treatment planning.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.7,6,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In pre-surgical staging of colorectal cancer liver metastases, is PET/CT superior to multidetector CT? Yes, PET/CT contributes key metabolic insights that enhance tumor assessment accuracy, reveal more lesions, and assist in treatment planning.",7.579511275419321e-07,0.47653868663496324,0.15089163237311393,0.05802964687301995,0.5331101427165614,0.124297520661157,0.057945649310491766,0.5694198980952057,0.11107438016528923,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
129,0.7,7,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT enhance multidetector CT in the preoperative evaluation of colorectal carcinoma liver metastases? Yes, it provides significant metabolic detail that allows for more accurate tumor extent evaluation, detection of additional lesions, and improved treatment planning.",6.868932093348762e-07,0.38692652794527627,0.15089163237311393,0.05258936747867431,0.44073682258554614,0.124297520661157,0.052513244687633145,0.47410971829088044,0.11107438016528923,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
129,0.7,8,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For preoperative staging of liver metastases in colorectal cancer patients, does PET/CT offer benefits beyond multidetector CT? Yes, PET/CT adds valuable metabolic information that aids in precise tumor extent determination, identification of further lesions, and guides treatment planning.",6.395212638635056e-07,0.3313566767904641,0.15089163237311393,0.04896251454911056,0.3835784087455978,0.124297520661157,0.0488916416057274,0.41526921826794716,0.11107438016528923,6.39521263863506e-07,0.44815651715191285,0.09719008264462808
129,0.7,9,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is PET/CT truly beneficial over multidetector CT for preoperative staging of liver metastases from colorectal carcinoma? Yes, it augments CT by providing detailed metabolic data, improving tumor extent assessment, lesion detection, and treatment guidance.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.7,10,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT contribute additional benefits to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Yes, PET/CT offers detailed metabolic insights that lead to better tumor extent accuracy, detection of extra lesions, and more effective treatment planning.",6.395212638635056e-07,0.3313566767904641,0.15089163237311393,0.04896251454911056,0.3835784087455978,0.124297520661157,0.0488916416057274,0.41526921826794716,0.11107438016528923,6.39521263863506e-07,0.44815651715191285,0.09719008264462808
130,0.7,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: A history of PIPE might increase the risk of developing IPE. However, multivariate analysis shows it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.7,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How significant are postictal psychotic episodes II in the long term? Are they indicative of interictal psychotic episodes? Answer: Having had PIPE may raise the risk for IPE, but multivariate analysis suggests it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.7,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term relevance of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Answer: PIPE history could be a risk factor for IPE, though multivariate analysis reveals it is not independently predictive.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.7,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the lasting significance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Answer: A prior history of PIPE may pose a risk for IPE development, but multivariate analysis indicates it isn’t an independent predictor.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
130,0.7,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What long-term importance do postictal psychotic episodes II hold? Are they predictive of interictal psychotic episodes? Answer: PIPE history may increase the risk of IPE, yet multivariate analysis shows it’s not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.7,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the prognostic value of postictal psychotic episodes II over the long term? Do they forecast interictal psychotic episodes? Answer: Having had PIPE could be a risk factor for IPE, but multivariate analysis demonstrates it is not independently predictive.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
130,0.7,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How do postictal psychotic episodes II impact long-term outcomes? Are they predictors of interictal psychotic episodes? Answer: A history of PIPE might contribute to IPE risk, yet multivariate analysis finds it not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.7,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the enduring significance of postictal psychotic episodes II? Are they indicative of interictal psychotic episodes? Answer: PIPE history may be a risk factor for IPE, but multivariate analysis reveals it is not independently predictive.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.7,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term predictive value of postictal psychotic episodes II? Are they linked to interictal psychotic episodes? Answer: A history of PIPE could increase the risk for IPE, although multivariate analysis shows it isn’t an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.7,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the lasting impact of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Answer: PIPE history might be a risk factor for IPE, but multivariate analysis indicates it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
131,0.7,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a previous benign prostate biopsy predict outcomes for patients undergoing radical perineal prostatectomy? A history of benign prostate biopsy may independently correlate with better surgical and biochemical results post-prostatectomy. Further research is necessary to validate these results.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.7,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a prior benign prostate biopsy forecast the outcomes for patients treated with radical perineal prostatectomy? Having a prior benign prostate biopsy might be independently linked to improved surgical and biochemical outcomes after prostatectomy. More studies are required to confirm this.,2.3685972735685406e-08,0.06188587593748984,0.02605075065832224,0.0018134264647818726,0.06264111770674985,0.02652739304401356,0.0018108015409528666,0.06339233825534718,0.026845867104408186,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
131,0.7,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is prior benign prostate biopsy a predictor of outcomes in patients treated with radical perineal prostatectomy? A previous benign prostate biopsy could be independently associated with more favorable surgical and biochemical outcomes following prostatectomy. Additional research is needed for confirmation.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.7,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a benign prostate biopsy done before radical perineal prostatectomy predict patient outcomes? Prior benign prostate biopsy may independently indicate better surgical and biochemical outcomes after prostatectomy. Further studies are needed to confirm these findings.,1.658018091497972e-07,0.1673220964479758,0.014120931440443227,0.012693985253473122,0.16506609462539767,0.019588058344875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
131,0.7,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a history of benign prostate biopsy predict the outcome for patients undergoing radical perineal prostatectomy? Prior benign biopsy of the prostate might be independently related to more favorable surgical and biochemical results post-prostatectomy. Confirmation through further studies is necessary.,4.7371945471370706e-08,0.05142575219020662,0.07271468144044323,0.0036268529295637453,0.018021423668444392,0.049861495844875335,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.7,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is the outcome of radical perineal prostatectomy influenced by a prior benign prostate biopsy? A previous benign biopsy may independently associate with improved surgical and biochemical outcomes after prostatectomy. More research is required to confirm these findings.,1.1842986367842661e-07,0.028616955483327544,0.07271468144044323,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
131,0.7,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does having had a benign prostate biopsy before radical perineal prostatectomy predict the treatment outcome? Prior benign prostate biopsy could independently correlate with better surgical and biochemical outcomes following prostatectomy. Additional studies are necessary to confirm this association.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.7,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can prior benign prostate biopsy serve as a predictor of outcomes for patients treated with radical perineal prostatectomy? Such prior biopsy may be independently linked to more favorable surgical and biochemical results after prostatectomy. Further investigation is needed to confirm these findings.,0.0,0.10143617276487005,0.07271468144044323,0.0,0.0693147180559941,0.049861495844875335,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.7,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is a prior benign prostate biopsy an indicator of outcomes in patients undergoing radical perineal prostatectomy? A previous benign biopsy might independently predict more favorable surgical and biochemical outcomes post-prostatectomy. Additional research is required for validation.,1.421158364141119e-07,0.05678783245002439,0.07271468144044323,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
131,0.7,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does undergoing a benign prostate biopsy before radical perineal prostatectomy predict patient outcomes? A prior benign biopsy may independently associate with improved surgical and biochemical outcomes following prostatectomy. More studies are needed to confirm this observation.,1.421158364141119e-07,0.05678783245002439,0.07271468144044323,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
132,0.7,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy in cervical cancer have the potential to alter the extent of lymphadenectomy? Yes, it might reduce tumor size and lymph node involvement, potentially limiting the surgical scope, though further study is necessary.",4.737194547137075e-07,0.33426293295553,0.09162848812994587,0.03626852929563747,0.39531485994677906,0.05640000000000001,0.03621603081905735,0.45884830883708805,0.01922337562475971,4.737194547137081e-07,0.49783842823917857,0.0
132,0.7,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? Yes, by shrinking the tumor and decreasing lymph node involvement, it may lessen the surgical extent, but additional research is needed.",5.447773729207634e-07,0.4266362530865453,0.09162848812994587,0.041708808689983105,0.4906250397511043,0.05640000000000001,0.041648435441915974,0.5572883816503413,0.01922337562475971,5.447773729207643e-07,0.599621122549121,0.0
132,0.7,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it possible for neoadjuvant chemotherapy to modify lymphadenectomy extent in cervical cancer? Yes, because it may reduce tumor burden and lymph node involvement, possibly decreasing surgery scope, though more studies are required.",5.210914001850781e-07,0.39488755477196547,0.09162848812994587,0.039895382225201226,0.4578352169281126,0.05640000000000001,0.0398376339009631,0.5233868299746596,0.01922337562475971,5.210914001850789e-07,0.564529802737852,0.0
132,0.7,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could neoadjuvant chemotherapy influence how extensive lymphadenectomy is in cervical cancer? Yes, it could shrink tumors and reduce affected lymph nodes, thereby limiting surgery, but further investigation is warranted.",6.158352911278193e-07,0.5284189473964878,0.09162848812994587,0.047149088084328744,0.5959855554089297,0.05640000000000001,0.047080840064774594,0.666487673615332,0.01922337562475971,6.158352911278206e-07,0.7129498078561252,0.0
132,0.7,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Might neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? Yes, since it can reduce tumor size and lymph node involvement, potentially reducing surgical extent, yet more research is needed.",5.684633456564487e-07,0.459426075909537,0.09162848812994587,0.043522235154764985,0.524526591426786,0.05640000000000001,0.04345923698286885,0.5923797014616103,0.01922337562475971,5.684633456564497e-07,0.6359887667199957,0.0
132,0.7,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can the scope of lymphadenectomy be affected by neoadjuvant chemotherapy in cervical cancer? Yes, as chemotherapy may decrease tumor and lymph node involvement, limiting surgery, but additional studies are necessary.",5.92149318392134e-07,0.49332762758521875,0.09162848812994587,0.045335661619546865,0.559617911238055,0.05640000000000001,0.04527003852382172,0.628747345632485,0.01922337562475971,5.921493183921352e-07,0.6737290947028427,0.0
132,0.7,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy have the potential to modify lymphadenectomy extent in cervical cancer? Yes, it may reduce tumor and lymph node involvement, thus lessening surgery scope, although more research is required.",5.684633456564487e-07,0.459426075909537,0.09162848812994587,0.043522235154764985,0.524526591426786,0.05640000000000001,0.04345923698286885,0.5923797014616103,0.01922337562475971,5.684633456564497e-07,0.6359887667199957,0.0
132,0.7,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is the extent of lymphadenectomy modifiable by neoadjuvant chemotherapy in cervical cancer? Yes, it might reduce tumor size and lymph nodes involved, decreasing surgical extent, but further research is needed.",5.92149318392134e-07,0.49332762758521875,0.09162848812994587,0.045335661619546865,0.559617911238055,0.05640000000000001,0.04527003852382172,0.628747345632485,0.01922337562475971,5.921493183921352e-07,0.6737290947028427,0.0
132,0.7,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could neoadjuvant chemotherapy impact the extent of lymphadenectomy in cervical cancer? Yes, by shrinking tumors and fewer lymph nodes involved, it may reduce surgery extent, though more studies are needed.",5.92149318392134e-07,0.49332762758521875,0.09162848812994587,0.045335661619546865,0.559617911238055,0.05640000000000001,0.04527003852382172,0.628747345632485,0.01922337562475971,5.921493183921352e-07,0.6737290947028427,0.0
132,0.7,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it feasible for neoadjuvant chemotherapy to modify lymphadenectomy extent in cervical cancer? Yes, as it may diminish tumor size and lymph node involvement, potentially limiting surgery, but further research is necessary.",5.447773729207634e-07,0.4266362530865453,0.09162848812994587,0.041708808689983105,0.4906250397511043,0.05640000000000001,0.041648435441915974,0.5572883816503413,0.01922337562475971,5.447773729207643e-07,0.599621122549121,0.0
133,0.7,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors play a crucial role in primary systemic vasculitis? Answer: For the first time, a strong link between farming and PSV has been discovered. Additionally, findings reinforce earlier reported connections with silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.7,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an impact of environmental elements on primary systemic vasculitis? Answer: A notable association between farming and PSV has been established for the first time. The results also back earlier reported links with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.7,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental influences significant in primary systemic vasculitis? Answer: A significant correlation between farming and PSV has been identified for the first time. The findings also confirm previously noted associations with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.7,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors matter in primary systemic vasculitis? Answer: For the first time, a meaningful association between farming and PSV has been found. The results also support earlier documented ties with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.7,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there a role of environmental factors in primary systemic vasculitis? Answer: A strong link between farming and PSV has been recognized for the first time. The study also corroborates previous reports linking silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.7,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental aspects important in primary systemic vasculitis? Answer: A significant connection between farming and PSV has been detected for the first time. The results further validate prior associations with silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.7,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Does the environment influence primary systemic vasculitis? Answer: For the first time, a significant relationship between farming and PSV has been observed. The findings also uphold earlier documented associations with silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.7,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental determinants relevant in primary systemic vasculitis? Answer: A notable association between farming and PSV has been identified for the first time. The results also confirm previous findings involving silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.7,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors linked to primary systemic vasculitis? Answer: A significant association between farming and PSV has been found for the first time. The study also supports previously established connections with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.7,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental conditions affect primary systemic vasculitis? Answer: For the first time, a meaningful correlation between farming and PSV has been established. The results also affirm earlier reports relating to silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.7,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.7,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: While the Supplemental Security Income program does not directly decrease disability among the elderly, it offers financial support that helps disabled seniors access essential medical care, medications, and therapies, thereby indirectly benefiting their health.",1.8948778188548325e-07,0.09638841478059623,0.039804351492663204,0.014507411718254981,0.11964569753464005,0.02646694214876033,0.014486412327622933,0.14359996455440793,0.011974892047241836,1.8948778188548325e-07,0.16827946776040026,0.0033497970560907586
134,0.7,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program itself does not directly lessen disability in elderly people, but by providing financial aid, it allows disabled elderly individuals to obtain crucial medical treatments and therapies, which can positively impact their overall health.",9.474389094274162e-08,0.034118711736801366,0.02738333903049678,0.0072537058591274906,0.031027519531036774,0.03140624999999998,0.007243206163811466,0.05539646218537486,0.015432766243752394,9.474389094274162e-08,0.08060683971738136,0.0015383588099934231
134,0.7,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Although the Supplemental Security Income program does not directly reduce disability rates among the elderly, it supplies financial resources that help disabled seniors afford medical care and treatments, indirectly supporting their health and well-being.",1.8948778188548325e-07,0.12526954730392736,0.019690731890376553,0.014507411718254981,0.11964569753464005,0.02646694214876033,0.014486412327622933,0.14359996455440793,0.011974892047241836,1.8948778188548325e-07,0.16827946776040026,0.0033497970560907586
134,0.7,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The SSI program does not directly diminish disability in elderly populations, but it offers monetary assistance that enables disabled elderly individuals to access necessary healthcare services, thereby indirectly improving their health outcomes.",2.3685972735685406e-07,0.05356033304345731,0.10072058453010838,0.018134264647818726,0.07464393536034297,0.08999999999999998,0.018108015409528666,0.12777805925046293,0.05536332179930796,2.3685972735685406e-07,0.1829353004789378,0.018860946745562133
134,0.7,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Directly, the Supplemental Security Income program does not reduce disability among elderly people, but it provides financial help that lets disabled seniors pay for medical treatments and therapies, which can indirectly enhance their health.",1.8948778188548325e-07,0.12526954730392736,0.019690731890376553,0.014507411718254981,0.11964569753464005,0.02646694214876033,0.014486412327622933,0.14359996455440793,0.011974892047241836,1.8948778188548325e-07,0.16827946776040026,0.0033497970560907586
134,0.7,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program doesn't directly lower disability in elderly individuals; however, it offers financial support that helps disabled elderly access important medical care, medications, and therapies, indirectly affecting their health positively.",2.1317375462116866e-07,0.1493954174084977,0.017573696145124745,0.016320838183036854,0.14307553045373433,0.025100054083288234,0.0162972138685758,0.1669182861148446,0.011015025422888278,2.1317375462116866e-07,0.19145247227969087,0.003854034325286977
134,0.7,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: While the SSI program does not directly cut down disability in the elderly, it provides financial aid that allows disabled seniors to afford necessary treatments and healthcare, thereby indirectly benefiting their health and quality of life.",1.4211583641411244e-07,0.0045063353881866774,0.08251842403628121,0.010880558788691236,0.017777848675543773,0.06960069444444443,0.0108648092457172,0.040766682260833687,0.05536332179930796,1.4211583641411244e-07,0.0939878144624422,0.018860946745562133
134,0.7,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in elderly populations, but by supplying financial assistance, it helps disabled elderly people obtain essential medical care, which can indirectly support their health and well-being.",1.6580180914979784e-07,0.12999492741758445,0.0023840796459200786,0.012693985253473108,0.12562994431609553,0.007355371900826427,0.012675610786670066,0.12081134086802381,0.01289418599683883,1.6580180914979784e-07,0.1456308536207942,0.002867448316166265
134,0.7,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Although the SSI program does not directly reduce disability among elderly individuals, it offers financial resources that enable disabled seniors to access medical treatments and therapies, indirectly improving their health outcomes.",2.6054570009253947e-07,0.07620894718306337,0.10023823579018389,0.0199476911126006,0.09711679121240069,0.08999999999999998,0.019918816950481533,0.15076757747516245,0.05536332179930796,2.6054570009253947e-07,0.20646579788913222,0.018860946745562133
135,0.7,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a valid alternative to thrombolysis? Yes, primary angioplasty is widely regarded as an acceptable and often better option compared to thrombolysis. It typically results in lower mortality, fewer reinfarctions, and a decreased risk of intracranial hemorrhage.",1.1842986367842682e-07,0.09561657902901377,0.020104384977288833,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
135,0.7,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty be used instead of thrombolysis? Yes, primary angioplasty is an accepted and frequently superior alternative to thrombolysis, usually linked with reduced death rates, lower reinfarction risk, and less intracranial bleeding.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
135,0.7,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty an appropriate substitute for thrombolysis? Yes, primary angioplasty is considered a suitable and often preferable alternative to thrombolysis, generally offering lower mortality, fewer cases of reinfarction, and a smaller chance of intracranial hemorrhage.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.7,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is it acceptable to use primary angioplasty instead of thrombolysis? Yes, primary angioplasty is an accepted and often better alternative to thrombolysis, associated with decreased mortality, reduced reinfarction, and less intracranial hemorrhage.",2.842316728282239e-07,0.3074532766538183,0.014178729592174005,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
135,0.7,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty replace thrombolysis as a treatment? Yes, primary angioplasty is recognized as an acceptable and often superior alternative, typically linked to lower death rates, reduced reinfarction, and less chance of intracranial bleeding.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
135,0.7,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty considered an alternative to thrombolysis? Yes, it is an acceptable and often better choice than thrombolysis, with generally lower mortality, fewer reinfarctions, and reduced intracranial hemorrhage risk.",3.316036182995945e-07,0.3294254782131407,0.046400951814396206,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
135,0.7,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a suitable alternative to thrombolysis? Yes, it is accepted and often preferred over thrombolysis, usually accompanied by lower mortality rates, less reinfarction, and decreased intracranial hemorrhage risk.",3.316036182995945e-07,0.3294254782131407,0.046400951814396206,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
135,0.7,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a preferable option compared to thrombolysis? Yes, it is an acceptable and often superior alternative that is generally associated with lower mortality, reduced reinfarction rates, and less intracranial hemorrhage.",2.842316728282239e-07,0.26273410371446726,0.046400951814396206,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
135,0.7,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a feasible alternative to thrombolysis? Yes, it is widely accepted and frequently superior, typically linked to lower death rates, fewer reinfarction incidents, and less risk of intracranial bleeding.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,0.7,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty favored over thrombolysis? Yes, it is considered an acceptable and often better option, generally resulting in lower mortality, decreased reinfarction, and less intracranial hemorrhage.",4.026615365066504e-07,0.4386247701781314,0.046400951814396206,0.030828249901291904,0.5187937934151678,0.0,0.03078362619619881,0.5355182363563626,0.0,4.026615365066519e-07,0.5533852381847866,0.0
136,0.7,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Recovery Outcome Measures: Should Culture, Attitudes, and Faith Be Included? Answer: Absolutely, these elements play a crucial role in shaping an individual's view and method of recovery.",2.36859727356853e-07,0.20989787034130325,0.08264462809917354,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
136,0.7,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Are Culture, Attitudes, and Faith Relevant in Recovery Outcome Measures? Answer: Yes, they are important as they deeply affect how a person perceives and engages with recovery.",2.36859727356853e-07,0.20989787034130325,0.08264462809917354,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
136,0.7,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Do Culture, Attitudes, and Faith Have a Role in Recovery Outcome Metrics? Answer: Indeed, these factors significantly impact one's recovery perspective and strategy.",3.316036182995942e-07,0.3769519550044702,0.08264462809917354,0.025387970506946314,0.4712172134482806,0.02854671280276816,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
136,0.7,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Is There Importance of Culture, Attitudes, and Faith in Measuring Recovery Outcomes? Answer: Yes, because they influence a person's understanding and management of recovery.",3.079176455639089e-07,0.33250019243363615,0.08264462809917354,0.023574544042164434,0.42469719781338666,0.02854671280276816,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
136,0.7,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Should Recovery Outcome Assessments Include Culture, Attitudes, and Faith? Answer: Yes, since these aspects can strongly shape how recovery is viewed and approached by individuals.",2.842316728282236e-07,0.2899405780148405,0.08264462809917354,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
136,0.7,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Can Culture, Attitudes, and Faith Affect Recovery Outcome Measures? Answer: Certainly, as they profoundly affect a person's perception and approach to recovery.",3.552895910352795e-07,0.42347197063936415,0.08264462809917354,0.027201396971728194,0.5200073776177119,0.02854671280276816,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
136,0.7,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Does Culture, Attitudes, and Faith Matter in Recovery Outcome Evaluation? Answer: Yes, these factors are pivotal in influencing a person's recovery mindset and tactics.",3.079176455639089e-07,0.33250019243363615,0.08264462809917354,0.023574544042164434,0.42469719781338666,0.02854671280276816,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
136,0.7,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Are Cultural Beliefs, Attitudes, and Faith Considered in Recovery Outcome Measures? Answer: Yes, they have a significant impact on how recovery is perceived and pursued.",2.842316728282236e-07,0.2899405780148405,0.08264462809917354,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
136,0.7,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Is It Necessary to Incorporate Culture, Attitudes, and Faith into Recovery Outcome Measures? Answer: Yes, because these elements greatly affect recovery perceptions and methods.",3.079176455639089e-07,0.33250019243363615,0.08264462809917354,0.023574544042164434,0.42469719781338666,0.02854671280276816,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
136,0.7,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Should Recovery Outcome Metrics Account for Culture, Attitudes, and Faith? Answer: Yes, as these factors play a vital role in shaping a person's recovery experience and approach.",2.36859727356853e-07,0.20989787034130325,0.08264462809917354,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
137,0.7,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is cholecystectomy truly an indication for a simultaneous splenectomy in mild hereditary spherocytosis? No, cholecystectomy alone does not automatically warrant a concurrent splenectomy in mild hereditary spherocytosis. Although both surgeries can treat hereditary spherocytosis, their application depends on the patient's specific condition. Splenectomy is generally reserved for severe cases. Decisions should be individualized.",2.3685972735685406e-08,0.08406876585281076,0.0715409615873663,0.0018134264647818726,0.08617447106077725,0.07427119607535931,0.0018108015409528666,0.08838269735592164,0.07688923723495802,2.3685972735685406e-08,0.09070084157207248,0.07939508506616257
137,0.7,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does cholecystectomy require a concomitant splenectomy in mild hereditary spherocytosis? No, performing a cholecystectomy does not necessarily mean a splenectomy must be done at the same time in mild hereditary spherocytosis. Both procedures can be used for treatment, but their necessity relies on the severity of the disease. Splenectomy is usually reserved for more severe cases. Treatment decisions should be tailored to the patient.",2.3685972735685406e-07,0.31192894969930096,0.09730510783074045,0.018134264647818726,0.31348812166166695,0.09729685243259915,0.018108015409528666,0.3149594433234846,0.09688090737240077,2.3685972735685406e-07,0.2932251056835451,0.07939508506616257
137,0.7,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is a cholecystectomy an indication to perform a splenectomy simultaneously in mild hereditary spherocytosis? No, cholecystectomy is not inherently an indication for splenectomy in mild hereditary spherocytosis. Both surgeries could be options, but splenectomy is typically considered only in severe cases. Decisions must be based on the individual patient's condition.",9.474389094274162e-08,0.01974870124932604,0.06805293005671079,0.0072537058591274906,0.05103320147081192,0.09259764787631972,0.007243206163811466,0.0542331808602321,0.09688090737240077,9.474389094274162e-08,0.027521939950540197,0.07939508506616257
137,0.7,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does a cholecystectomy justify a simultaneous splenectomy in mild hereditary spherocytosis? No, cholecystectomy does not automatically indicate that a splenectomy should be performed concurrently in mild hereditary spherocytosis. Both interventions are possible treatments, but splenectomy is generally reserved for more severe manifestations. Clinical decisions are patient-specific.",1.8948778188548325e-07,0.04214702484089683,0.08466871685609448,0.014507411718254981,0.038603733020939224,0.09070656902366889,0.014486412327622933,0.0347143051562635,0.09688090737240077,1.8948778188548325e-07,0.06344983825518646,0.07939508506616257
137,0.7,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is it necessary to do a splenectomy along with cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy alone does not necessitate a concomitant splenectomy in mild hereditary spherocytosis. While both procedures treat hereditary spherocytosis, splenectomy is usually reserved for severe forms of the disease. Treatment choices depend on individual patient factors.",9.474389094274162e-08,0.048040422904834124,0.08827459584908273,0.0072537058591274906,0.05103320147081192,0.09259764787631972,0.007243206163811466,0.0542331808602321,0.09688090737240077,9.474389094274162e-08,0.027521939950540197,0.07939508506616257
137,0.7,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Should a splenectomy be done at the same time as a cholecystectomy in mild hereditary spherocytosis? No, a cholecystectomy is not a definite indication for a simultaneous splenectomy in mild hereditary spherocytosis. Both surgeries serve as treatment options, but splenectomy is typically reserved for severe cases. The decision should be personalized.",7.105791820705622e-08,0.041648911866175364,0.06926146773681473,0.005440279394345618,0.07224189954137028,0.09302224453896245,0.0054324046228586,0.07528659005806526,0.09688090737240077,7.105791820705622e-08,0.04902814517150356,0.07939508506616257
137,0.7,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is concomitant splenectomy indicated when performing cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy does not necessarily indicate the need for splenectomy in mild hereditary spherocytosis. Both procedures may be treatments, but splenectomy is generally reserved for more severe disease. Decisions should be based on the patient's condition.",1.6580180914979784e-07,0.018828703280460157,0.08562858348044804,0.012693985253473108,0.015430728501648616,0.09121080629286511,0.012675610786670066,0.01172478693156398,0.09688090737240077,1.6580180914979784e-07,0.039919340844992046,0.07939508506616257
137,0.7,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does mild hereditary spherocytosis require splenectomy alongside cholecystectomy? No, in mild hereditary spherocytosis, cholecystectomy is not necessarily an indication for concurrent splenectomy. Both surgeries are potential treatments, but splenectomy is mainly for severe disease. Treatment decisions must be individualized.",3.552895910352809e-07,0.18609170272417686,0.10272044639540678,0.02720139697172809,0.18036876426952286,0.113421550094518,0.027162023114293,0.21239548239371553,0.09688090737240077,3.552895910352811e-07,0.24577139504914092,0.07939508506616257
137,0.7,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is splenectomy warranted along with cholecystectomy in mild hereditary spherocytosis? No, splenectomy is not generally indicated concurrently with cholecystectomy in mild hereditary spherocytosis. Both are treatment options depending on severity, with splenectomy reserved for severe cases. Decisions should be tailored to the patient.",2.6054570009253947e-07,0.1815548480037803,0.03483418774774964,0.0199476911126006,0.1791507829743102,0.040706868654074774,0.019918816950481533,0.17634968479188373,0.04701941152752543,2.6054570009253947e-07,0.17310381966839383,0.05377181636810161
137,0.7,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","In mild hereditary spherocytosis, does cholecystectomy indicate the need for splenectomy at the same time? No, cholecystectomy is not necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. Both procedures can treat the condition, but splenectomy is typically reserved for more severe cases. Treatment plans should be individualized.",1.1842986367842703e-07,0.02624231396645227,0.0874291115311909,0.009067132323909363,0.029365300091630964,0.0921550094517959,0.009054007704764333,0.03272697563926874,0.09688090737240077,1.1842986367842703e-07,0.005543033231765193,0.07939508506616257
138,0.7,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair appropriate for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? It is generally considered appropriate by doctors, depending mainly on the patient’s overall health and surgical fitness rather than age alone, while weighing risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.7,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients aged 80 or older who have suffered an aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? Physicians usually justify the repair based on the patient’s general health and ability to tolerate surgery rather than age by itself, taking risks and benefits into account.",2.3685972735685406e-07,0.0001601811784062157,0.14617283950617282,0.018134264647818726,0.053617058630380576,0.113421550094518,0.018108015409528666,0.08234235414551794,0.09688090737240077,2.3685972735685406e-07,0.11224000242461818,0.07939508506616257
138,0.7,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Should aneurysm repair be performed on patients 80 years or older after an aneurysmal subarachnoid hemorrhage? Typically, doctors justify this procedure if the patient’s overall health and surgical fitness are adequate, with age being a secondary factor alongside evaluating risks and benefits.",2.8423167282822487e-07,0.04746786781084822,0.14617283950617282,0.02176111757738247,0.10240722279981229,0.113421550094518,0.0217296184914344,0.13235277472018137,0.09688090737240077,2.8423167282822487e-07,0.16353329681216788,0.07939508506616257
138,0.7,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is it justified to perform aneurysm repair in patients aged 80 or more after experiencing an aneurysmal subarachnoid hemorrhage? Physicians generally support repair when the patient’s general condition and surgical suitability are favorable, focusing less on age and more on risks and benefits.",2.6054570009253947e-07,0.023370316231788202,0.14617283950617282,0.0199476911126006,0.0777146102094406,0.113421550094518,0.019918816950481533,0.10703496673588964,0.09688090737240077,2.6054570009253947e-07,0.1375578104089099,0.07939508506616257
138,0.7,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair warranted for patients aged 80 and older following aneurysmal subarachnoid hemorrhage? The decision is usually justified by physicians based on the patient’s overall health and fitness for surgery, rather than age alone, considering both risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.7,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Do doctors justify aneurysm repair in patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Typically, the justification depends primarily on the patient’s general health and surgical fitness, with age being a less critical factor, alongside evaluating risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.7,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients 80 years old or older who have had an aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? Physicians commonly justify the procedure based on general health and suitability for surgery, rather than age alone, while assessing risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.7,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair recommended for patients aged 80+ after aneurysmal subarachnoid hemorrhage? Medical professionals usually justify it by considering the patient’s overall health and fitness for surgery, not just their age, while balancing risks and benefits.",4.263475092423368e-07,0.20569187302574266,0.14617283950617282,0.032641676366073714,0.26492615229758654,0.113421550094518,0.03259442773715161,0.29940685938334566,0.09688090737240077,4.263475092423373e-07,0.3353835537388279,0.07939508506616257
138,0.7,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Can aneurysm repair be justified in patients 80 years or older after aneurysmal subarachnoid hemorrhage? Generally, physicians justify it based on the patient’s general health and surgical fitness rather than age alone, taking risks and benefits into consideration.",3.789755637709662e-07,0.1501220218709305,0.14617283950617282,0.029014823436509962,0.20776773845763818,0.113421550094518,0.028972824655245866,0.24056635936041237,0.09688090737240077,3.789755637709665e-07,0.2747589319223924,0.07939508506616257
138,0.7,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair suitable for patients aged 80 or older following an aneurysmal subarachnoid hemorrhage? Physicians typically justify the procedure by focusing on the patient’s overall health and readiness for surgery, rather than age alone, while evaluating risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
139,0.7,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does blood pressure vary in treated hypertensive patients based on whether it is measured by a physician or a nurse? The systolic BP recorded by the nurse is significantly lower than that recorded by the physician and closely matches ambulatory BP monitoring. Measuring blood pressure by the nurse is beneficial for both diagnosis and assessing control levels.,3.079176455639103e-07,0.19831698197568892,0.0011347487234614761,0.023574544042164344,0.22663053066119687,0.010340236686390537,0.023540420032387266,0.22068973001147718,0.0035899792121676325,3.079176455639103e-07,0.21936282847430322,0.0
139,0.7,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Nurse-measured systolic BP is considerably lower than physician measurements and nearly identical to ambulatory BP monitoring. Nurse-based measurements are recommended for diagnosis and evaluating control.",6.868932093348768e-07,0.37691396305254665,0.1467347487234615,0.052589367478674306,0.49478601370293873,0.044023668639053264,0.05251324468763313,0.5464154990508492,0.014921946740128552,6.868932093348768e-07,0.5787368293821986,0.0
139,0.7,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Is there a difference in blood pressure readings in treated hypertensive patients depending on whether a physician or nurse measures it? Systolic BP taken by the nurse is significantly less than that obtained by the physician, aligning closely with ambulatory BP monitoring. Nurse measurements are preferable for diagnosis and control assessment.",4.500334819780227e-07,0.18149629896073538,0.12674307858601877,0.03445510283085558,0.26652736172195635,0.044023668639053264,0.034405229278104466,0.3128006478693446,0.014921946740128552,4.500334819780227e-07,0.3395071403163663,0.0
139,0.7,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For treated hypertensive patients, does blood pressure change based on whether a physician or nurse takes the measurement? Systolic BP measured by nurses is notably lower than physician readings and almost equal to ambulatory BP monitoring. Nurse-measured BP is useful for diagnosing and evaluating control.",5.921493183921352e-07,0.281603783248221,0.1467347487234615,0.045335661619546816,0.39714754413902087,0.044023668639053264,0.045270038523821665,0.44633204049386777,0.014921946740128552,5.921493183921352e-07,0.47608267532211634,0.0
139,0.7,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does blood pressure in treated hypertensive patients change depending on whether it is measured by a nurse or a physician? The systolic BP recorded by nurses is significantly lower than that by physicians and closely matches ambulatory BP monitoring. Nurse measurements are ideal for diagnosis and control evaluation.,5.210914001850789e-07,0.21564581545642492,0.1467347487234615,0.0398953822252012,0.3297062633434886,0.044023668639053264,0.039837633900963065,0.3773391690069161,0.014921946740128552,5.210914001850789e-07,0.4054651081081624,0.0
139,0.7,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In patients treated for hypertension, does blood pressure differ if taken by a physician or nurse? Nurse-measured systolic BP is significantly lower than physician measurements and nearly identical to ambulatory BP monitoring. Blood pressure measurement by nurses is recommended for diagnosis and assessing control.",6.158352911278206e-07,0.3368327052198947,0.123492118337974,0.04714908808432869,0.4206780415492153,0.044023668639053264,0.04708084006477453,0.4704295920729278,0.014921946740128552,6.158352911278206e-07,0.500775287912488,0.0
139,0.7,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does blood pressure in treated hypertensive patients vary according to whether it is measured by a nurse or a physician? Systolic BP recorded by nurses is significantly lower than by physicians and almost matches ambulatory BP monitoring. Nurse measurement is preferred for diagnosis and control evaluation.,5.684633456564497e-07,0.2591309273961633,0.1467347487234615,0.04352223515476494,0.37415802591432135,0.044023668639053264,0.0434592369828688,0.42280154308367335,0.014921946740128552,5.684633456564497e-07,0.4519851237430563,0.0
139,0.7,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Is there a difference in blood pressure readings in treated hypertensive patients when measured by a nurse versus a physician? Nurses record significantly lower systolic BP than physicians, which closely matches ambulatory BP monitoring. Measuring BP by nurses is advisable for diagnosis and control assessment.",5.921493183921352e-07,0.281603783248221,0.1467347487234615,0.045335661619546816,0.39714754413902087,0.044023668639053264,0.045270038523821665,0.44633204049386777,0.014921946740128552,5.921493183921352e-07,0.47608267532211634,0.0
139,0.7,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does the blood pressure of treated hypertensive patients differ when measured by a nurse compared to a physician? Systolic BP measured by the nurse is significantly lower than the physician's readings and nearly identical to ambulatory BP monitoring. Nurse-measured BP is favorable for diagnosis and evaluating control.,5.447773729207643e-07,0.2672888546147769,0.12500635366173313,0.04170880868998307,0.35168517006226363,0.044023668639053264,0.04164843544191593,0.3998120248589738,0.014921946740128552,5.447773729207643e-07,0.4284546263328619,0.0
139,0.7,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, does blood pressure measurement by a nurse differ from that by a physician? Systolic BP taken by nurses is significantly lower than physician readings and almost identical to ambulatory BP monitoring. Blood pressure checks by nurses are desirable for diagnosis and assessing control.",5.447773729207643e-07,0.3275625224895551,0.08183480280674976,0.04170880868998307,0.35168517006226363,0.044023668639053264,0.04164843544191593,0.3998120248589738,0.014921946740128552,5.447773729207643e-07,0.4284546263328619,0.0
140,0.7,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The use of audits to detect maternal mortality across various settings is more complex than merely a disparity between wealthy and impoverished populations. Recognizing the scale of maternal mortality and mobilizing strong political commitment are crucial. Yet, there is no universal solution to decrease maternal mortality, and problem identification remains essential.",4.974054274493935e-07,0.2733867032107238,0.08032972563849852,0.03808195576041935,0.3170665336210208,0.02854671280276816,0.0380268323600102,0.3428142710644404,0.014489619377162637,4.974054274493935e-07,0.36936010346605075,0.0
140,0.7,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Auditing maternal mortality in different environments reveals differences that go beyond just economic status. Understanding the extent of maternal deaths and leveraging political will are key elements. However, reducing maternal mortality lacks a one-size-fits-all approach, and pinpointing issues is vital.",7.579511275419329e-07,0.5296681845463107,0.07469812707788029,0.05802964687301995,0.5713006720052611,0.02854671280276816,0.05794564931049173,0.6030973693281059,0.014489619377162637,7.57951127541933e-07,0.6359887667199984,0.0
140,0.7,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","When using audits to identify maternal mortality in diverse contexts, the disparity is not simply a matter of rich versus poor. It is important to acknowledge the severity of maternal mortality and engage robust political determination to address it. Still, no single, overarching solution exists to lower maternal mortality, making problem identification necessary.",4.500334819780227e-07,0.2330996097796567,0.08109802015118153,0.03445510283085561,0.2770611990073224,0.02854671280276816,0.034405229278104466,0.30199227654418603,0.014489619377162637,4.500334819780227e-07,0.32768740706548183,0.0
140,0.7,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The role of audit in spotting maternal mortality in varied settings extends beyond merely contrasting wealthy and poor groups. Recognizing the magnitude of maternal deaths and fostering strong political resolve are important. Nonetheless, there is no singular universal fix to reduce maternal mortality, and the identification of underlying problems is essential.",4.974054274493935e-07,0.2456608159883258,0.10032139577594125,0.03808195576041935,0.3170665336210208,0.02854671280276816,0.0380268323600102,0.3428142710644404,0.014489619377162637,4.974054274493935e-07,0.36936010346605075,0.0
140,0.7,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to identify maternal mortality across different contexts is not just about differences between affluent and poor populations. Acknowledgement of the scale of maternal mortality and the presence of strong political will are critical factors. However, no general solution exists to reduce maternal mortality, and identifying issues is key.",5.210914001850789e-07,0.2941552449613525,0.0799220902203857,0.039895382225201226,0.33768582082375653,0.02854671280276816,0.039837633900963065,0.36386768026227356,0.014489619377162637,5.210914001850789e-07,0.3908663086870141,0.0
140,0.7,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Audit application for identifying maternal mortality in various settings reflects more than a simple divide between rich and poor. It is crucial to recognize the extent of maternal mortality and to harness strong political will for solutions. Despite this, no single solution can reduce maternal mortality universally, and problem identification remains indispensable.",4.737194547137081e-07,0.2904824409667408,0.020354715226170314,0.03626852929563748,0.29686382630350217,0.02854671280276816,0.03621603081905733,0.32219498386170464,0.014489619377162637,4.737194547137081e-07,0.3483066942682176,0.0
140,0.7,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The identification of maternal mortality through audits in different settings highlights disparities beyond the rich-poor divide. Recognizing the magnitude of the problem and mobilizing political will are vital. Still, there is no one-size-fits-all solution to maternal mortality reduction, and problem identification is crucial.",6.868932093348768e-07,0.4530212117311949,0.0765260358711227,0.052589367478674334,0.49531476502733973,0.02854671280276816,0.05251324468763313,0.5251358278583953,0.014489619377162637,6.868932093348768e-07,0.5559460590464642,0.0
140,0.7,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Auditing maternal mortality in various settings does not merely reflect economic differences between rich and poor. Understanding the scale of maternal mortality and enlisting strong political will are important. However, no single, universal remedy exists to decrease maternal mortality, and identifying problems is necessary.",6.632072365991914e-07,0.4287231094698831,0.07707876539045372,0.05077594101389246,0.4712172134482797,0.02854671280276816,0.050702443146680265,0.5004432152680236,0.014489619377162637,6.632072365991914e-07,0.5306282510621725,0.0
140,0.7,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The use of audits to detect maternal mortality across different settings is more than a simple rich vs. poor issue. It requires acknowledging the magnitude of maternal deaths and harnessing strong political commitment. Yet, there is no universal solution to reduce maternal mortality, and recognizing the problems is essential.",5.447773729207643e-07,0.28648281050858015,0.10032139577594125,0.0417088086899831,0.3587392300215897,0.02854671280276816,0.04164843544191593,0.3853738854832369,0.014489619377162637,5.447773729207643e-07,0.4128452154057891,0.0
140,0.7,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Employing audits to identify maternal mortality in diverse settings reveals that it's not merely a question of economic disparity. Recognizing the severity of maternal mortality and fostering strong political will are important. Nevertheless, there is no single general solution to reduce maternal mortality, and identifying the issues is fundamental.",5.447773729207643e-07,0.31536394303191084,0.07949749355774297,0.0417088086899831,0.3587392300215897,0.02854671280276816,0.04164843544191593,0.3853738854832369,0.014489619377162637,5.447773729207643e-07,0.4128452154057891,0.0
141,0.7,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is measuring visceral adipose tissue (VAT) area at a single level sufficient to represent the total VAT volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is practical and correlates with changes in VAT volume and body weight. Insights: VAT area on a CT slice taken 3 cm above the lower margin of L3 can serve as an indicator of VAT volume.,1.4211583641411244e-07,0.18804882226827235,0.09543234702671648,0.010880558788691236,0.10769437118772585,0.007630315500685797,0.0108648092457172,0.05959992907498002,0.02778344671201812,1.4211583641411244e-07,0.05839039506465671,0.029961734693877553
141,0.7,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,"Can a single-level measurement of visceral adipose tissue area accurately represent the total visceral fat volume? Measuring VAT area at a single point, specifically 3 cm above the lower edge of the L3 vertebra, is feasible and reflects variations in VAT volume and body mass. Knowledge update: VAT area at a CT slice 3 cm above L3's lower margin can track VAT volume changes.",7.105791820705622e-08,0.15653199235978565,0.10581717451523547,0.005440279394345618,0.10000075470660574,0.03575721070959768,0.0054324046228586,0.07550797039107238,0.0180498866213152,7.105791820705622e-08,0.07561424809140682,0.017538265306122455
141,0.7,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does the measurement of visceral adipose tissue area at one level adequately reflect visceral adipose tissue volume? Measuring VAT area at a level 3 cm above the lower margin of the L3 vertebra is achievable and represents changes in VAT volume and body weight. Recent findings: VAT area on a CT image 3 cm above the lower margin of L3 corresponds to VAT volume.,7.105791820705622e-08,0.06851330276487433,0.04692061231755071,0.005440279394345618,0.032921995297578555,0.011644060916547766,0.0054324046228586,0.007329559188455903,0.030812070904077213,7.105791820705622e-08,0.00629953003541317,0.032323230538752884
141,0.7,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is visceral adipose tissue area measurement at a single anatomical level indicative of total visceral fat volume? VAT area measurement 3 cm above the lower border of the L3 vertebra is practical and can mirror changes in VAT volume and body weight. New knowledge: VAT area from a CT slice 3 cm above L3's lower margin reflects VAT volume.,4.737194547137081e-08,0.1102618032436018,0.13141289437585735,0.0036268529295637453,0.05867544320123441,0.06648093908345223,0.003621603081905733,0.012711934020450677,0.03443877551020409,4.737194547137081e-08,0.011397128898221531,0.017538265306122455
141,0.7,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,"Can a single-level measurement of VAT area represent visceral adipose tissue volume? Measuring VAT area at one level, 3 cm above the lower margin of the L3 vertebra, is feasible and reflects changes in VAT volume and body weight. Advances: VAT area at a CT slice 3 cm above the lower L3 margin correlates with VAT volume.",9.474389094274162e-08,0.011853520897151526,0.036734693877551045,0.0072537058591274906,0.05354309377843425,0.011739312040478206,0.007243206163811466,0.07499994574745683,0.0025434730105059616,9.474389094274162e-08,0.07459489795819252,0.0013226814394396783
141,0.7,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is it possible for a single-level VAT area measurement to represent the entire visceral adipose tissue volume? VAT area assessment at 3 cm above the lower margin of the L3 vertebra is practical and indicative of changes in VAT volume and body weight. Progress: VAT area on a CT slice 3 cm above L3's lower margin can reflect VAT volume.,2.3685972735685406e-08,0.09661155868390336,0.07894375857338826,0.0018134264647818726,0.07648651270110074,0.06678313175184,0.0018108015409528666,0.030411511119851298,0.03443877551020409,2.3685972735685406e-08,0.006621376604456941,0.017538265306122455
141,0.7,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does VAT area measurement at a single level accurately represent visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and can indicate changes in VAT volume and body weight. Scientific insight: VAT area from a CT slice 3 cm above L3's lower border reflects VAT volume.,1.1842986367842703e-07,0.04242347489774767,0.08850442137639368,0.009067132323909363,0.003257057836300259,0.06550727843727851,0.009054007704764333,0.04234784316257789,0.03443877551020409,1.1842986367842703e-07,0.06748659554926473,0.017538265306122455
141,0.7,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is a single-level measurement of visceral adipose tissue area enough to represent VAT volume? VAT area measurement at a level 3 cm above the lower margin of the L3 vertebra is feasible and corresponds to changes in VAT volume and body mass. Knowledge advancement: VAT area on a CT slice 3 cm above lower L3 margin indicates VAT volume.,4.737194547137081e-08,0.13416343015946142,0.14842975206611572,0.0036268529295637453,0.05867544320123441,0.06648093908345223,0.003621603081905733,0.012711934020450677,0.03443877551020409,4.737194547137081e-08,0.011397128898221531,0.017538265306122455
141,0.7,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can measuring visceral adipose tissue area at one level represent the total VAT volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. New findings: VAT area on a CT slice 3 cm above the lower L3 margin tracks VAT volume.,1.1842986367842703e-07,0.02673172549128644,0.11000000000000003,0.009067132323909363,0.04808717776073257,0.028655882590266732,0.009054007704764333,0.09466083792181923,0.003239040714324931,1.1842986367842703e-07,0.09414610249387811,0.0016851103186372555
141,0.7,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is measuring VAT area at a single level a valid representation of visceral adipose tissue volume? Assessment of VAT area 3 cm above the lower margin of the L3 vertebra is practical and reflects changes in VAT volume and body weight. Scientific progress: VAT area from a CT slice 3 cm above L3's lower margin can indicate VAT volume.,4.737194547137081e-08,0.07733865660766304,0.07682449270202919,0.0036268529295637453,0.05867544320123441,0.06648093908345223,0.003621603081905733,0.012711934020450677,0.03443877551020409,4.737194547137081e-08,0.011397128898221531,0.017538265306122455
142,0.7,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition impact quality of life? Yes, it does. Menopausal transition is commonly linked with physical symptoms including hot flashes and sleep problems, as well as psychological challenges like mood swings and depression.",1.658018091497972e-07,0.0927366752973362,0.0670359884119098,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.7,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life affected during menopausal transition? Indeed, menopausal transition influences quality of life, often accompanied by physical symptoms such as hot flashes and disrupted sleep, along with psychological issues like mood swings and depression.",1.421158364141119e-07,0.0625841851794462,0.06787403226662558,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.7,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does undergoing menopausal transition change one's quality of life? Yes, it can. The transition is frequently associated with physical symptoms like hot flashes and sleep disturbances, in addition to psychological effects such as mood swings and depression.",1.1842986367842661e-07,0.0051951021049618795,0.09642074506939374,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
142,0.7,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is the quality of life altered during menopause? Yes, menopausal transition affects quality of life, commonly presenting physical symptoms like hot flashes, sleep disturbances, and psychological problems including mood swings and depression.",2.368597273568531e-07,0.18905580480535278,0.06419852284717154,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
142,0.7,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Can menopausal transition affect quality of life? Yes, it has an impact. This phase often involves physical symptoms like hot flashes and sleep issues, as well as psychological conditions like mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.7,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does menopause transition influence quality of life? Yes, it does. It is typically accompanied by physical symptoms such as hot flashes and sleep disruption, and psychological concerns like mood swings and depression.",2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
142,0.7,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life influenced by menopausal transition? Yes, it is. Menopausal transition is often marked by physical symptoms including hot flashes, sleep disturbances, and psychological issues like mood swings and depression.",2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
142,0.7,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the transition during menopause affect quality of life? Yes, it affects quality of life, often linked to physical symptoms including hot flashes, sleep problems, and psychological issues like mood swings and depression.",2.131737546211678e-07,0.15590963233641952,0.06520326327959144,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
142,0.7,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life impacted by menopausal transition? Yes, menopausal transition impacts quality of life, frequently associated with physical symptoms such as hot flashes, sleep disturbances, and psychological challenges including mood swings and depression.",1.894877818854825e-07,0.123825194918604,0.06614730756939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.7,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does experiencing menopausal transition affect quality of life? Yes, it does. This period is commonly associated with physical symptoms like hot flashes and sleep disturbances, alongside psychological issues such as mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
143,0.7,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafness and does it always develop into Meniere's disease? We conclude that not all patients with low-tone sudden deafness (SD) experience endolymphatic hydrops, even if vertigo attacks occur at onset, and that electrocochleography (ECochG) serves as a valuable prognostic indicator.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
143,0.7,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably lead to Meniere's disease? Our findings suggest that not every patient with low-tone sudden deafness (SD) shows endolymphatic hydrops, even when vertigo attacks happen at the beginning, and electrocochleography (ECochG) is a beneficial prognostic tool.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.7,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease unavoidable in cases of low-tone sudden deafness? We determine that some low-tone sudden deafness (SD) patients do not have endolymphatic hydrops, despite vertigo attacks at onset, and that electrocochleography (ECochG) is useful for prognosis.",1.8948778188548304e-07,0.1672629994437167,0.01709186291495875,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.7,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? Our conclusion is that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients, even those with initial vertigo attacks, and that electrocochleography (ECochG) is a helpful prognostic method.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.7,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is low-tone sudden deafness destined to become Meniere's disease? We found that not all patients with low-tone sudden deafness (SD) have endolymphatic hydrops, even if they experience vertigo at onset, and electrocochleography (ECochG) proves to be a useful prognostic tool.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.7,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the outlook for low-tone sudden deafness regarding its progression to Meniere's disease? Our study concludes that low-tone sudden deafness (SD) does not always entail endolymphatic hydrops, even when vertigo attacks are present initially, and that electrocochleography (ECochG) is an effective prognostic tool.",7.105791820705622e-08,0.07164642041470293,0.003012522062330082,0.005440279394345618,0.07119333872682354,0.001584616103165664,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
143,0.7,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably evolve into Meniere's disease? We conclude that not all individuals with low-tone sudden deafness (SD) suffer from endolymphatic hydrops, even with vertigo attacks at onset, and that electrocochleography (ECochG) is a useful prognostic assessment.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.7,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Will low-tone sudden deafness always progress to Meniere's disease? Our conclusion is that endolymphatic hydrops does not affect all patients with low-tone sudden deafness (SD), even those who have vertigo attacks at the beginning, and electrocochleography (ECochG) serves as a valuable prognostic tool.",9.474389094274162e-08,0.09671212752713298,0.004111570247933891,0.0072537058591274906,0.09609593929608184,0.0021642561983471094,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
143,0.7,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does every case of low-tone sudden deafness lead to Meniere's disease? We determined that not all patients with low-tone sudden deafness (SD) exhibit endolymphatic hydrops, despite vertigo attacks at onset, and that electrocochleography (ECochG) is an important prognostic tool.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.7,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease an inevitable outcome of low-tone sudden deafness? We found that not all cases of low-tone sudden deafness (SD) involve endolymphatic hydrops, even if vertigo attacks are present initially, and that electrocochleography (ECochG) is a useful prognostic resource.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
144,0.7,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a connection between a resident's leadership abilities and their technical skill ratings? Answer: Yes, a resident's leadership abilities can be linked to their technical skill evaluations. Strong leaders frequently demonstrate excellent technical skills because they must comprehend and manage the work. Their technical expertise can impact their credibility, decision-making skills, and capacity to lead.",2.3685972735685406e-08,0.011375362080493279,0.0381447730112454,0.0018134264647818726,0.04542155380117752,0.019236094674556177,0.0018108015409528666,0.04533300997287881,0.019165890272232835,2.3685972735685406e-08,0.04570770191530649,0.01922337562475971
144,0.7,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are leadership skills of residents associated with their technical skill ratings? Answer: Yes, the leadership skills of residents may be related to how they are rated on technical skills. Leaders who are effective often have strong technical skills, as they need to grasp and supervise tasks. Their technical know-how can affect their credibility, choices, and leadership effectiveness.",4.737194547137081e-08,0.08966637990881798,0.037679506091638254,0.0036268529295637453,0.08954560246780163,0.037934705075445815,0.003621603081905733,0.06414891441922954,0.019502233234131215,4.737194547137081e-08,0.06439983492746082,0.01922337562475971
144,0.7,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Does a resident's leadership skill have any relation to their technical skill ratings? Answer: Yes, a resident's leadership skills can correspond with their technical skill ratings. Effective leadership often requires solid technical skills to understand and manage work processes. Technical proficiency contributes to their credibility, decision-making, and ability to lead.",1.1842986367842703e-07,0.08270750379414427,0.008689794889989208,0.009067132323909363,0.05105872057059724,0.032857582616568556,0.009054007704764333,0.04677790788498859,0.037677816224529016,1.1842986367842703e-07,0.0744366099267566,0.01922337562475971
144,0.7,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a relationship between residents' leadership capabilities and technical skill ratings? Answer: Yes, residents' leadership capabilities can be related to their technical skill assessments. Effective leaders typically possess strong technical skills since they must understand and oversee tasks. Their technical knowledge influences their credibility, decisions, and leadership capacity.",1.4211583641411244e-07,0.07744766162170569,0.026467572667767003,0.010880558788691236,0.04397569698564796,0.0527760977818017,0.0108648092457172,0.06783131708282175,0.037677816224529016,1.4211583641411244e-07,0.09594281514771996,0.01922337562475971
144,0.7,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do residents' leadership qualities influence their technical skill ratings? Answer: Yes, residents' leadership qualities can impact their technical skill ratings. Leaders who perform well often exhibit strong technical skills because they need to understand and direct work. Their technical competence affects their credibility, decision-making, and leadership abilities.",1.8948778188548325e-07,0.16456453415266825,0.045039104077004996,0.014507411718254981,0.11792784675589152,0.03021157024793386,0.014486412327622933,0.11131642902256011,0.037677816224529016,1.8948778188548325e-07,0.14039457771855268,0.01922337562475971
144,0.7,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Can a resident's leadership skills affect how their technical skills are rated? Answer: Yes, a resident's leadership skills can affect technical skill ratings. Effective leaders tend to have good technical skills as they need to comprehend and supervise the work. Their technical ability influences their credibility, decisions, and guidance skills.",1.1842986367842703e-07,0.08270750379414427,0.008689794889989208,0.009067132323909363,0.05105872057059724,0.03285758261656855,0.009054007704764333,0.07565904040831928,0.016853914006330732,1.1842986367842703e-07,0.0744366099267566,0.01922337562475971
144,0.7,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are residents' leadership skills connected to their technical skill ratings? Answer: Yes, residents' leadership skills can be connected to their technical skill ratings. Successful leaders often excel technically since they must understand and manage tasks. Their technical proficiency impacts their credibility, decision-making, and leadership effectiveness.",2.3685972735685406e-07,0.27671210937562085,0.09545336026886302,0.018134264647818726,0.22813270155375553,0.016400000000000012,0.018108015409528666,0.22125761059326576,0.00872313558986719,2.3685972735685406e-07,0.2199216019515382,0.004571984280058845
144,0.7,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a link between leadership skills of residents and their technical skill ratings? Answer: Yes, leadership skills of residents can link to technical skill ratings. Effective leadership usually involves strong technical skills to understand and oversee work. Technical expertise affects credibility, decisions, and the ability to lead.",1.6580180914979784e-07,0.10042459229573364,0.024810598889581106,0.012693985253473108,0.0951392230695074,0.031130864197530854,0.012675610786670066,0.11947435624117375,0.01594942116280062,1.6580180914979784e-07,0.11792172186649497,0.01922337562475971
144,0.7,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do leadership skills of residents correspond to their technical skill ratings? Answer: Yes, leadership skills of residents often correspond with their technical skill ratings. Effective leaders typically have solid technical skills necessary to understand and manage work tasks. Their technical proficiency influences credibility, decision-making, and leadership.",2.1317375462116866e-07,0.2196556398925944,0.07004477301124533,0.016320838183036854,0.1720527096745479,0.0072734693877550965,0.0162972138685758,0.16529597490007042,0.014962835153679906,2.1317375462116866e-07,0.1633840959432522,0.01922337562475971
144,0.7,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are the leadership skills of residents related to their technical skill ratings? Answer: Yes, the leadership skills of residents are related to their technical skill ratings. Effective leaders generally have strong technical skills as they need to understand and supervise tasks. Their technical expertise affects their credibility, decision-making, and leadership capabilities.",9.474389094274162e-08,0.17917538928486865,0.10853116756906851,0.0072537058591274906,0.14062789327644953,0.044168595041322284,0.007243206163811466,0.13932550730428472,0.04330983809645864,9.474389094274162e-08,0.11114546577558526,0.02236452607656355
145,0.7,1,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Can student examiners serve as reasonable substitute examiners for faculty in an undergraduate OSCE focused on medical emergencies? Answer: Student examiners can be regarded as reasonable alternatives to faculty examiners in an undergraduate OSCE on medical emergencies. They offer valuable peer review and assessment, though they may",4.737194547137081e-08,0.11296369457742683,0.04454112456106123,0.0036268529295637453,0.17321823484876697,0.0895755591676015,0.003621603081905733,0.17585285145340812,0.09205518417618637,4.737194547137081e-08,0.17854805002726515,0.09418282548476452
145,0.7,2,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Are student examiners acceptable substitutes for faculty examiners in an undergraduate OSCE on medical emergencies? Answer: Student examiners can act as reasonable substitutes for faculty in an undergraduate OSCE covering medical emergencies. They contribute meaningful peer evaluation and assessment, but may",9.474389094274162e-08,0.04951043772999286,0.027425947734828038,0.0072537058591274906,0.0102421167356046,0.05845704954786339,0.007243206163811466,0.028012539911468792,0.0886426592797783,9.474389094274162e-08,0.03194457583538979,0.09418282548476452
145,0.7,3,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Is it reasonable to use student examiners instead of faculty for an undergraduate OSCE on medical emergencies? Answer: Student examiners are reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They provide useful peer review and assessment, although they may",7.105791820705622e-08,0.012424416388343129,0.05259313367421482,0.005440279394345618,0.016986400173888416,0.0602493074792244,0.0054324046228586,0.01956163909925035,0.06440443213296393,7.105791820705622e-08,0.02237405297916384,0.06855955678670356
145,0.7,4,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: May student examiners be used as reasonable substitutes for faculty during an undergraduate OSCE on medical emergencies? Answer: Student examiners can serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies, offering important peer review and assessment, but they may",4.737194547137081e-08,0.08916467693376706,0.025169914139333394,0.0036268529295637453,0.05552192707073811,0.00592489996922127,0.003621603081905733,0.021679260607543327,0.017845182908445514,4.737194547137081e-08,0.013923152166945396,0.04432132963988918
145,0.7,5,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Can student examiners reasonably replace faculty examiners in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can offer valuable peer assessment and review; however, they may",7.105791820705622e-08,0.02058259220974934,0.030577875172469793,0.005440279394345618,0.01682565741440145,0.03654324385027388,0.0054324046228586,0.015095719928746476,0.03975898860603502,7.105791820705622e-08,0.01317195628032053,0.04305061219038907
145,0.7,6,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Are student examiners reasonable substitutes for faculty members in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be seen as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They provide beneficial peer review and assessment, though they may",4.737194547137081e-08,0.08916467693376662,0.025169914139333338,0.0036268529295637453,0.05552192707073811,0.00592489996922127,0.003621603081905733,0.021679260607543327,0.017845182908445514,4.737194547137081e-08,0.013923152166945396,0.04432132963988918
145,0.7,7,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may",Question: Is it appropriate for student examiners to substitute for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners are reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They facilitate valuable peer review and assessment but may,9.474389094274162e-08,0.11713455290657304,0.014187965047915863,0.0072537058591274906,0.11421419381959685,0.0123647308035158,0.007243206163811466,0.11417149712646779,0.011166597973717787,9.474389094274162e-08,0.11398114638775736,0.009623402888937899
145,0.7,8,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Could student examiners be reasonable replacements for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can reasonably substitute for faculty in an undergraduate OSCE on medical emergencies. They provide helpful peer review and assessment, albeit they may",1.1842986367842703e-07,0.14858957701460307,0.018033235938641312,0.009067132323909363,0.14486390319280984,0.015796341658844748,0.009054007704764333,0.14482409001123875,0.014292382398652922,1.1842986367842703e-07,0.14459333190838208,0.012336917398614713
145,0.7,9,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Might student examiners act as reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may function as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide significant peer review and assessment, however, they may",0.0,0.030806541358219697,0.018033235938641312,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.3877787807814457e-17
145,0.7,10,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Should student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners should be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They offer valuable peer review and assessment, but they may",4.737194547137081e-08,0.1858828881746888,0.06778609754113876,0.0036268529295637453,0.18754996146310754,0.08187976108033237,0.003621603081905733,0.19073954854899355,0.08788250952216074,4.737194547137081e-08,0.19402100200103867,0.09331717451523548
146,0.7,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Does the Supplemental Security Income program decrease disability among the elderly? Income support policies could be a powerful tool for enhancing public health, particularly for low-income individuals. While the results are strong, additional studies are necessary to verify their accuracy. Future investigations should explore various forms of income support.",1.8948778188548325e-07,0.1293954233786887,0.017851239669421492,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
146,0.7,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Can the Supplemental Security Income program reduce disability in older adults? Answer: Income support policies might serve as an important mechanism for improving health outcomes, especially for those with lower incomes. Despite robust findings, more research is required to validate these results. Subsequent studies should consider different types of income support.",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
146,0.7,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Does the Supplemental Security Income program help lower disability rates in elderly populations? Providing income support may be an effective strategy for boosting health, particularly among lower-income groups. Although the evidence is compelling, further analysis is needed to confirm its dependability. Future research should evaluate multiple income support approaches.",1.8948778188548325e-07,0.1582765559020194,0.0029726625487767923,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
146,0.7,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Are upstream solutions like the Supplemental Security Income program effective in reducing disability among the elderly? Answer: Policies offering income support could be a vital factor in enhancing health at the population level, especially for economically disadvantaged groups. The findings are strong, yet more detailed studies are needed to ensure their validity. Future work should assess a range of income support programs.",1.4211583641411244e-07,0.10417836428883565,0.0017265420075026489,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
146,0.7,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Does the Supplemental Security Income program contribute to reducing disability in the elderly? Income support initiatives may represent a key method for improving health, particularly for lower-income individuals. While the findings appear solid, additional research is necessary to confirm their reliability. Future studies ought to investigate various income support models.",1.6580180914979784e-07,0.13706785783146103,0.002548065886134064,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
146,0.7,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Is the Supplemental Security Income program an effective upstream solution to decrease disability in seniors? Answer: Income support policies may be a significant new tool for enhancing public health, especially benefiting those with lower incomes. Although the findings are robust, further research is required to confirm their consistency. Future investigations should explore different types of income support.",2.3685972735685406e-08,0.042454833547970416,0.017851239669421492,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
146,0.7,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Does the Supplemental Security Income program help in lowering disability among elderly people? Income support policies might be a crucial approach to improving population health, particularly for low-income groups. Despite strong findings, additional analyses are needed to confirm their reliability. Future research should examine diverse income support measures.",2.1317375462116866e-07,0.17994445728120034,0.00341530097330061,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
146,0.7,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Can income support through the Supplemental Security Income program reduce disability in elderly populations? Answer: Income support policies could be an important lever for better health outcomes, especially for disadvantaged income groups. The results are robust but need further validation through additional studies. Future research should analyze a variety of income support interventions.",7.105791820705622e-08,0.09249012197982376,0.059042262829617345,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.7,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Does the Supplemental Security Income program reduce disabilities in older adults? Providing income support may be an effective way to improve health at the population level, particularly among lower-income individuals. Although the findings are solid, more research is needed to confirm their reliability. Future studies should investigate multiple income support strategies.",1.4211583641411244e-07,0.11629931608083233,0.002140430468021242,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
146,0.7,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Are income support programs like Supplemental Security Income effective in decreasing disability among seniors? Answer: Income support policies may offer a significant new approach to improving population health, especially for those with lower incomes. While the findings are strong, further analyses are necessary to confirm their validity. Future research should explore different income support options.",2.3685972735685406e-08,0.053187555708733125,0.05619646413976323,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
147,0.7,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is there a correlation between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease specimens? The association between the transition zone on contrast enema and aganglionosis length is minimal. Preoperative biopsy via coelioscopy or umbilical incision is essential.,1.1842986367842692e-07,0.06569324620577666,0.038867786705624546,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
147,0.7,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the radiographic transition zone correspond with the aganglionosis level in Hirschsprung's disease specimens? The correlation between the transition zone seen on contrast enema and the extent of aganglionosis is low. Systematic preoperative biopsy through coelioscopy or umbilical incision is required.,9.474389094274162e-08,0.003940778730513017,0.06501643655489808,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
147,0.7,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is the radiographic transition zone linked to the aganglionosis level in Hirschsprung's disease samples? The connection between the transition zone on contrast enema and aganglionosis length is weak. Preoperative biopsy through coelioscopy or umbilical incision must be performed.,1.6580180914979753e-07,0.08471237633762962,0.06299382716049383,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
147,0.7,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the level of radiographic transition zone on contrast enema match the aganglionosis level in Hirschsprung's disease specimens? There is a low correlation between the transition zone and aganglionosis length. Preoperative biopsy via coelioscopy or umbilical incision is mandatory.,1.4211583641411222e-07,0.05705814464585268,0.06370343316289262,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
147,0.7,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is there a relationship between the radiographic transition zone and aganglionosis length in Hirschsprung's disease? The correlation on contrast enema is low. Systematic preoperative biopsy by coelioscopy or umbilical incision is necessary.,3.0791764556390933e-07,0.22417566933130617,0.09,0.02357454404216438,0.32776333028443316,0.023242630385487524,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
147,0.7,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone level correlate with aganglionosis length in Hirschsprung's disease specimens? The correlation remains minimal, and preoperative biopsy by coelioscopy or umbilical incision is mandatory.",4.0266153650665053e-07,0.3623260078121233,0.09,0.030828249901291897,0.4708641739251056,0.023242630385487524,0.0307836261961988,0.5187937934151678,0.0,4.026615365066519e-07,0.5355182363563626,0.0
147,0.7,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is the radiographic transition zone a reliable indicator of aganglionosis extent in Hirschsprung's disease? The correlation between transition zone on contrast enema and aganglionosis length is low. Preoperative biopsy through coelioscopy or umbilical incision is essential.,2.1317375462116813e-07,0.1424232226447506,0.06145328719723184,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
147,0.7,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone on contrast enema reflect the aganglionosis level in Hirschsprung's disease? There is a low correlation, so systematic preoperative biopsy by coelioscopy or umbilical incision is required.",3.3160361829959463e-07,0.25696549215429787,0.09,0.02538797050694626,0.3616648819601149,0.023242630385487524,0.02535122157334018,0.4054651081081637,0.0,3.316036182995957e-07,0.4177352006999784,0.0
147,0.7,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is there a strong correlation between the radiographic transition zone and aganglionosis level in Hirschsprung's disease? The link is weak, necessitating preoperative biopsy via coelioscopy or umbilical incision.",4.0266153650665053e-07,0.3623260078121233,0.09,0.030828249901291897,0.4708641739251056,0.023242630385487524,0.0307836261961988,0.5187937934151678,0.0,4.026615365066519e-07,0.5355182363563626,0.0
147,0.7,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone correspond to the aganglionosis level in Hirschsprung's disease specimens? The correlation is low, making preoperative biopsy by coelioscopy or umbilical incision essential.",4.2634750924233583e-07,0.4000663357949703,0.09,0.03264167636607378,0.5100848870783881,0.023242630385487524,0.032594427737151675,0.5596157879354227,0.0,4.263475092423373e-07,0.5780778507751583,0.0
148,0.7,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in growing children a rare and frequently missed injury? Answer: Isolated sternal fractures in children commonly result from age-specific traumatic events. Ultrasonography serves as an effective diagnostic tool for identifying fractures, while radiography is preferred for assessing the degree of displacement.",1.4211583641411244e-07,0.10010748428748562,0.01999167013744273,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
148,0.7,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children uncommon and often overlooked? Answer: In childhood, isolated sternal fractures typically arise from trauma related to the child's age. Ultrasonography is valuable for detecting fractures, and radiography is the chosen method to visualize the dislocation extent.",1.8948778188548325e-07,0.17963450852047114,0.003803689767375825,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
148,0.7,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Do sternal fractures in growing children occur rarely and are often unnoticed? Answer: Childhood isolated sternal fractures usually stem from typical age-related injuries. Ultrasonography helps in diagnosing fractures, whereas radiography is best for evaluating the dislocation severity.",3.0791764556390996e-07,0.31084662072692426,0.007014502702063434,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
148,0.7,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is a sternal fracture in children a rare injury that is frequently missed? Answer: Isolated sternal fractures in kids often happen due to common age-related trauma. Ultrasonography is a helpful tool for detecting fractures, while radiography is ideal for showing how much the fracture is displaced.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856674,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
148,0.7,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are isolated sternal fractures in growing children rare and commonly overlooked? Answer: Such fractures in childhood generally occur from usual traumatic incidents related to age. Ultrasonography is useful for fracture detection, and radiography is preferred to determine the extent of dislocation.",2.1317375462116866e-07,0.20453710908972944,0.0043833298625572704,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
148,0.7,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is the sternal fracture in growing children a rare and often unrecognized injury? Answer: In children, isolated sternal fractures are usually caused by typical age-related trauma. Ultrasonography is effective for diagnosis, and radiography is the best method to visualize dislocation.",2.3685972735685406e-07,0.23007502311980765,0.0049918933076591905,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
148,0.7,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in children a rare and frequently missed type of injury? Answer: Isolated sternal fractures during childhood often result from common age-specific trauma. Ultrasonography is a helpful diagnostic technique, with radiography favored for visualizing dislocation extent.",2.8423167282822466e-07,0.2831923890351473,0.006304896699664643,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
148,0.7,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is a sternal fracture in growing children an uncommon and often overlooked fracture? Answer: Childhood isolated sternal fractures are typically due to trauma related to the child's age. Ultrasonography aids in fracture diagnosis, and radiography is the preferred method to assess dislocation.",1.8948778188548325e-07,0.14662749992237956,0.01999167013744273,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
148,0.7,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in children rare and often disregarded? Answer: Isolated sternal fractures in childhood commonly arise from typical age-related trauma. Ultrasonography is useful for detecting fractures, while radiography is the best way to evaluate the degree of dislocation.",2.6054570009253936e-07,0.2918274905950713,0.03114054315693272,0.0199476911126006,0.2907155689400267,0.026296566837107373,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
148,0.7,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is isolated sternal fracture in growing children a rare and often unnoticed injury? Answer: These fractures usually result from common trauma related to the child's age. Ultrasonography is a valuable diagnostic tool, and radiography is the method of choice to visualize fracture displacement.",1.6580180914979784e-07,0.12309700251218514,0.01999167013744273,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
149,0.7,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might explain the development of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.7,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside earlier case reports. The mechanism of aripiprazole as a dopamine partial agonist could account for the emergence of pathological gambling.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
149,0.7,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Does aripiprazole present a new risk factor for pathological gambling? Answer: Adverse drug reactions were reviewed in the context of existing case reports. The dopamine partial agonist property of aripiprazole may explain why pathological gambling occurs.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.7,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Can aripiprazole be considered a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated with reference to other published case reports. The dopamine partial agonist mechanism of aripiprazole could underlie the onset of pathological gambling.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
149,0.7,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: could it be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were assessed against previously reported cases. The dopamine partial agonist effect of aripiprazole might explain the manifestation of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.7,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole linked to pathological gambling as a new risk factor? Answer: Adverse drug reactions were compared to other documented case reports. The partial agonist activity at dopamine receptors by aripiprazole may clarify the occurrence of pathological gambling.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
149,0.7,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were correlated with earlier published case reports. The dopamine partial agonist mechanism inherent to aripiprazole could explain pathological gambling's appearance.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.7,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is pathological gambling a new risk associated with aripiprazole? Answer: Adverse drug reactions were confronted with previously documented case reports. Aripiprazole's dopamine partial agonist activity might be responsible for pathological gambling.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
149,0.7,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Might aripiprazole be a novel risk factor contributing to pathological gambling? Answer: Adverse drug reactions were compared with existing case reports. The dopamine partial agonist mechanism of aripiprazole could explain the pathological gambling phenomenon.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.7,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could the dopamine partial agonist aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were examined alongside other published case studies. This mechanism may explain the development of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
150,0.7,1,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Do preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass grafting? Yes, studies show that taking statins before surgery decreases postoperative atrial fibrillation rates.",0.0,0.053319013889226774,0.03798888888888887,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.7,2,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Can preoperative statins help reduce atrial fibrillation after coronary artery bypass grafting? Yes, evidence suggests that administering statins prior to surgery reduces postoperative atrial fibrillation.",4.73719454713706e-08,0.026595320104916276,0.07638888888888888,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.7,3,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Are preoperative statins effective in decreasing atrial fibrillation after coronary artery bypass grafting? Yes, research supports that preoperative statin use lowers the occurrence of postoperative atrial fibrillation.",0.0,0.10663802777845355,0.07638888888888888,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.7,4,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Do statins given before coronary artery bypass grafting reduce atrial fibrillation? Yes, findings indicate that preoperative statin therapy reduces postoperative atrial fibrillation.",1.184298636784265e-07,0.10693607251960735,0.07638888888888888,0.009067132323909398,0.2231435513142097,0.0,0.009054007704764368,0.23361485118150505,0.0,1.1842986367842687e-07,0.2451224580329847,0.0
150,0.7,5,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Is there a reduction in atrial fibrillation after coronary artery bypass grafting with preoperative statins? Yes, studies confirm that preoperative statins help reduce the rate of postoperative atrial fibrillation.",4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
150,0.7,6,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Does taking statins before coronary artery bypass grafting reduce atrial fibrillation? Yes, research demonstrates that preoperative statins decrease postoperative atrial fibrillation.",1.4211583641411185e-07,0.15572623668903862,0.07638888888888888,0.010880558788691277,0.27443684570175986,0.0,0.010864809245717241,0.28768207245178035,0.0,1.4211583641411222e-07,0.3022808718729335,0.0
150,0.7,7,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Are preoperative statins associated with reduced atrial fibrillation following coronary artery bypass grafting? Yes, evidence indicates that statins given before surgery reduce postoperative atrial fibrillation.",4.73719454713706e-08,0.026595320104916276,0.07638888888888888,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.7,8,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Do preoperative statins contribute to lowering atrial fibrillation after coronary artery bypass grafting? Yes, research shows that preoperative statins can reduce postoperative atrial fibrillation occurrence.",4.73719454713706e-08,0.08892920998840648,0.006255739210284661,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.7,9,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Can the use of statins before coronary artery bypass grafting diminish atrial fibrillation rates? Yes, studies reveal that preoperative statins reduce postoperative atrial fibrillation.",7.10579182070559e-08,0.015964294313879357,0.07638888888888888,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
150,0.7,10,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Is the rate of postoperative atrial fibrillation reduced by administering statins prior to coronary artery bypass grafting? Yes, research indicates preoperative statins lower atrial fibrillation after surgery.",0.0,0.053319013889226774,0.03798888888888887,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.7,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a disagreement between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Significant differences exist in how clinicians and clinical pathologists view the clinical significance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the best method to make sure RBC morphology changes are understood as the pathologist intended. Reporting methods should be carefully reviewed.,1.1842986367842703e-07,0.037387496562156564,0.03073822121441168,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
151,0.7,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? There are notable discrepancies in the clinical importance attributed to certain RBC morphology terms by clinicians versus clinical pathologists. Including explanatory notes in CBC reports is the most effective way to guarantee that RBC morphology alterations are interpreted correctly by clinicians. Reporting standards should be scrutinized.,2.3685972735685406e-08,0.006196835116328181,0.016388888888888894,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
151,0.7,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a discord between clinicians and clinical pathologists regarding the reporting and interpretation of red blood cell morphology? Clinicians and clinical pathologists differ significantly on the clinical relevance of specific RBC morphology terminology. The best approach to ensure proper interpretation of RBC morphology changes is to include interpretive comments on CBC reports. Reporting protocols should be critically assessed.,4.737194547137081e-08,0.15340968625498208,0.08543965824136704,0.0036268529295637453,0.08312808347888456,0.035041322314049606,0.003621603081905733,0.059846576259839246,0.017851239669421492,4.737194547137081e-08,0.03571808260207909,0.0
151,0.7,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians differ in how they report and interpret red blood cell morphology? Important differences exist between these groups regarding the clinical meaning of certain RBC morphology terms. The clearest way to ensure RBC morphology is interpreted as intended is to add interpretive comments to CBC reports. Reporting practices warrant critical evaluation.,1.4211583641411244e-07,0.13103263345634097,0.018511925952296185,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
151,0.7,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a mismatch between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? There are key differences in the clinical interpretation of particular RBC morphology terms between clinicians and clinical pathologists. Incorporating interpretive comments in CBC reports ensures RBC morphology changes are understood as the pathologist intended. Reporting methods should be thoroughly reviewed.,9.474389094274162e-08,0.09374812793551968,0.017851239669421492,0.0072537058591274906,0.07020425867324764,0.0,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
151,0.7,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are there discrepancies between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Significant differences in the clinical relevance of certain RBC morphology terms exist between these professionals. The inclusion of interpretive remarks on CBC reports is the clearest way to guarantee the intended interpretation of RBC morphology alterations. Reporting practices require critical examination.,4.737194547137081e-08,0.10560643242326151,0.05157024793388431,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
151,0.7,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there inconsistency between clinicians and clinical pathologists when reporting and interpreting red blood cell morphology? Differences in clinical significance assigned to certain RBC morphology terms exist between these groups. Adding interpretive comments to CBC reports remains the best way to ensure RBC morphology changes are interpreted as intended. Reporting procedures should be critically reviewed.,1.4211583641411244e-07,0.13103263345634097,0.018511925952296185,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
151,0.7,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians see eye to eye in reporting and interpreting red blood cell morphology? There are notable differences in how these groups interpret the clinical relevance of certain RBC morphology terms. The clearest method to ensure proper interpretation is including interpretive comments on CBC reports. Reporting standards should be evaluated critically.,1.6580180914979784e-07,0.12405264866997845,0.0,0.012693985253473108,0.12629372532429084,0.0,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
151,0.7,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are clinical pathologists and clinicians aligned in their interpretation and reporting of red blood cell morphology? Important disparities exist in the clinical relevance attributed to certain RBC morphology terms by both groups. The inclusion of interpretive comments with CBC reports is the most straightforward way to ensure RBC morphology changes are interpreted correctly. Reporting protocols should be critically assessed.,4.737194547137081e-08,0.057803178591540494,0.017236072637734686,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
151,0.7,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a divergence between clinicians and clinical pathologists in reporting and interpreting red blood cell morphology? Differences regarding the clinical importance of certain RBC morphology terms exist between these professionals. Including interpretive comments on CBC reports is the clearest way to ensure RBC morphology alterations are understood as intended. Reporting approaches should be carefully examined.,1.1842986367842703e-07,0.11221672900999025,0.0181755829903978,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
152,0.7,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections contribute to benign paroxysmal positional vertigo? Yes, they can. Viral infections might cause inflammation or injury in the inner ear, resulting in the displacement of calcium crystals that lead to BPPV. However, this is only one factor.",2.8423167282822477e-07,0.14908030848935017,0.08264877844116175,0.02176111757738247,0.16353329681216788,0.07939508506616257,0.0217296184914344,0.19602722049987742,0.060964083175803374,2.8423167282822487e-07,0.22991980740511897,0.04158790170132326
152,0.7,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is there a connection between viral infections and benign paroxysmal positional vertigo? Yes, viral infections may influence BPPV by causing inner ear inflammation or damage, which dislodges calcium crystals and triggers the condition. Still, this is only one possible cause.",2.8423167282822477e-07,0.1135342992298658,0.10815772303747626,0.02176111757738247,0.16353329681216788,0.07939508506616257,0.0217296184914344,0.19602722049987742,0.060964083175803374,2.8423167282822487e-07,0.22991980740511897,0.04158790170132326
152,0.7,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections cause benign paroxysmal positional vertigo? Indeed, they can. Viruses can inflame or damage the inner ear, causing calcium crystals to become dislodged and produce BPPV symptoms, though this is just one contributing factor.",3.7897556377096597e-07,0.18620187461061288,0.1337809917355372,0.02901482343650997,0.2747589319223924,0.07939508506616257,0.02897282465524588,0.31043757167762287,0.060964083175803374,3.789755637709665e-07,0.3477028430615028,0.04158790170132326
152,0.7,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections involved in benign paroxysmal positional vertigo? Yes, they have a role. Viral-induced inflammation or damage to the inner ear can lead to the displacement of calcium crystals, which causes BPPV, but this is only one aspect.",3.0791764556391007e-07,0.1404452069294262,0.10748442489842983,0.023574544042164344,0.19020154389432875,0.07939508506616257,0.023540420032387266,0.22342619468799274,0.060964083175803374,3.079176455639103e-07,0.2580906843718158,0.04158790170132326
152,0.7,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections play a part in benign paroxysmal positional vertigo? Yes, they do. Viral infections may provoke inner ear inflammation or injury that dislodges calcium crystals, resulting in BPPV, although it is only one of several causes.",3.3160361829959537e-07,0.16809943862120313,0.10677481889603103,0.025387970506946217,0.21760051808244407,0.07939508506616257,0.025351221573340132,0.2515970716546896,0.060964083175803374,3.316036182995957e-07,0.2870782212450673,0.04158790170132326
152,0.7,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Does benign paroxysmal positional vertigo have any association with viral infections? Yes, viral infections can contribute by causing inner ear inflammation or damage, which leads to calcium crystal dislodgement and BPPV. Nonetheless, this is just one factor involved.",3.3160361829959537e-07,0.13063202345580072,0.1337809917355372,0.025387970506946217,0.21760051808244407,0.07939508506616257,0.025351221573340132,0.2515970716546896,0.060964083175803374,3.316036182995957e-07,0.2870782212450673,0.04158790170132326
152,0.7,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is there a role of viral infections in benign paroxysmal positional vertigo? Yes, viral infections can cause inflammation or harm in the inner ear, leading to calcium crystals being dislodged, which results in BPPV, though it is just one cause.",2.8423167282822477e-07,0.1135342992298658,0.10815772303747626,0.02176111757738247,0.16353329681216788,0.07939508506616257,0.0217296184914344,0.19602722049987742,0.060964083175803374,2.8423167282822487e-07,0.22991980740511897,0.04158790170132326
152,0.7,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections influence benign paroxysmal positional vertigo? Yes, because viruses may inflame or damage the inner ear, triggering the displacement of calcium crystals and causing BPPV, but this is only one cause of the condition.",3.7897556377096597e-07,0.18620187461061288,0.1337809917355372,0.02901482343650997,0.2747589319223924,0.07939508506616257,0.02897282465524588,0.31043757167762287,0.060964083175803374,3.789755637709665e-07,0.3477028430615028,0.04158790170132326
152,0.7,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections a factor in benign paroxysmal positional vertigo? Yes, they can be. Viral infections might cause inner ear inflammation or damage that dislodges calcium crystals and leads to BPPV, yet this is only one factor among others.",3.0791764556391007e-07,0.1404452069294262,0.10748442489842983,0.023574544042164344,0.19020154389432875,0.07939508506616257,0.023540420032387266,0.22342619468799274,0.060964083175803374,3.079176455639103e-07,0.2580906843718158,0.04158790170132326
152,0.7,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections have a link with benign paroxysmal positional vertigo? Yes, viral infections can lead to inflammation or damage in the inner ear, causing calcium crystals to become dislodged and resulting in BPPV, although this is only one contributing cause.",2.6054570009253947e-07,0.08732784101408653,0.10879742829043529,0.0199476911126006,0.1375578104089099,0.07939508506616257,0.019918816950481533,0.16935897341771655,0.060964083175803374,2.6054570009253947e-07,0.20252083321700365,0.04158790170132326
153,0.7,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): could polymorphisms in the beta-adrenergic receptor (ADRB) genes play a role? Answer: Studies indicate a possible involvement of polymorphisms in the beta-adrenergic receptor (ADRB) genes in TTN.,9.47438909427412e-08,0.04567769543806577,0.07124333406384684,0.007253705859127511,0.01218206069860539,0.07133058984910828,0.007243206163811494,0.022978676537694476,0.061299725651577486,9.474389094274162e-08,0.05992576125424787,0.04392184495236412
153,0.7,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is there a role of beta-adrenergic receptor (ADRB) gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: Research points to a potential contribution of ADRB gene polymorphisms in TTN.,1.658018091497971e-07,0.11000141176269818,0.17775630962444144,0.01269398525347315,0.08254722797861547,0.18778344671201808,0.012675610786670115,0.05411532090976845,0.1875,1.6580180914979784e-07,0.026656840800084236,0.14268727705112957
153,0.7,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): do polymorphisms in beta-adrenergic receptor (ADRB) genes influence it? Answer: Evidence suggests polymorphisms in ADRB genes may be involved in TTN.,2.36859727356853e-07,0.045716284582498545,0.20710059171597628,0.01813426464781879,0.02115118984534492,0.22222222222222218,0.018108015409528735,0.05921336439723568,0.1875,2.3685972735685406e-07,0.1444398764564685,0.14268727705112957
153,0.7,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes affect transient tachypnea of the newborn (TTN)? Answer: Research suggests a role for these polymorphisms in TTN.,2.605457000925383e-07,0.006001178307458055,0.20568284023668632,0.01994769111260067,0.01806952330793754,0.22222222222222218,0.01991881695048161,0.10003535891749049,0.1875,2.6054570009253947e-07,0.18699949087526413,0.14268727705112957
153,0.7,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): is there an association with beta-adrenergic receptor (ADRB) gene polymorphisms? Answer: Studies propose a link between ADRB gene polymorphisms and TTN.,2.36859727356853e-07,0.09706052017953182,0.24408284023668633,0.01813426464781879,0.02115118984534492,0.22222222222222218,0.018108015409528735,0.05921336439723568,0.1875,2.3685972735685406e-07,0.1444398764564685,0.14268727705112957
153,0.7,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: Current research indicates such polymorphisms could be implicated in TTN.,2.842316728282236e-07,0.02009947904340237,0.24408284023668633,0.021761117577382548,0.05889151782819235,0.22222222222222218,0.021729618491434483,0.14259497333628612,0.1875,2.8423167282822487e-07,0.23145125344609818,0.14268727705112957
153,0.7,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): might polymorphisms in the beta-adrenergic receptor (ADRB) genes contribute? Answer: Research supports the possibility of ADRB polymorphisms playing a role in TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.7,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Are polymorphisms in the beta-adrenergic receptor (ADRB) genes relevant to transient tachypnea of the newborn (TTN)? Answer: Evidence suggests they may be involved in TTN.,2.842316728282236e-07,0.02009947904340237,0.24408284023668633,0.021761117577382548,0.05889151782819235,0.22222222222222218,0.021729618491434483,0.14259497333628612,0.1875,2.8423167282822487e-07,0.23145125344609818,0.14268727705112957
153,0.7,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): role of polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: Research indicates these polymorphisms could play a role in TTN.,2.605457000925383e-07,0.05932019219668483,0.24408284023668633,0.01994769111260067,0.01806952330793754,0.22222222222222218,0.01991881695048161,0.10003535891749049,0.1875,2.6054570009253947e-07,0.18699949087526413,0.14268727705112957
153,0.7,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is there a potential role for beta-adrenergic receptor (ADRB) gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: Studies suggest these genetic variations might influence TTN.,2.36859727356853e-07,0.09706052017953182,0.24408284023668633,0.01813426464781879,0.02115118984534492,0.22222222222222218,0.018108015409528735,0.05921336439723568,0.1875,2.3685972735685406e-07,0.1444398764564685,0.14268727705112957
154,0.7,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Do parents, their children, and the children's doctors perceive body image differently? Answer: Yes, body image perceptions can vary between parents, children, and their doctors. Parents' opinions may be shaped by cultural or personal values, children by their self-esteem and peers, and doctors by clinical criteria and health considerations. Therefore, each group",7.105791820705622e-08,0.033792424479184735,0.01596390532544379,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
154,0.7,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Is there a difference in how parents, their children, and their children's physicians perceive body image? Answer: Yes, perceptions of body image often differ among these groups. Parents' views might be influenced by cultural or individual beliefs, children by their self-worth and social circles, and physicians by medical guidelines and health concerns. Thus, each group",0.0,0.07561605606108524,0.0543639053254438,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
154,0.7,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Do parents, kids, and their kids' doctors see body image differently? Answer: Yes, perceptions regarding body image can differ among parents, children, and physicians. Parents might be influenced by cultural or personal perspectives, children by their self-esteem and peer group, and doctors by medical standards and health factors. Consequently, each group",9.474389094274162e-08,0.02707373882196018,0.03476390532544381,0.0072537058591274906,0.051288923337613035,0.01851192595229618,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
154,0.7,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Are there differences in body image perception among parents, their children, and the children's doctors? Answer: Yes, body image perceptions may differ between parents, children, and physicians. Parents' views can stem from cultural or personal beliefs, children from self-esteem and peer influences, and physicians from medical and health viewpoints. Hence, each group",7.105791820705622e-08,0.033792424479184735,0.01596390532544379,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
154,0.7,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Do parents, their children, and their children's doctors have different perceptions of body image? Answer: Yes, the perception of body image may vary among these groups. Parents' opinions could reflect cultural or personal beliefs, children’s by self-esteem and peers, and physicians’ by medical standards and health implications. Therefore, each group",1.1842986367842703e-07,0.047420010965638415,0.03437223518800107,0.009067132323909363,0.07149163065513164,0.01851192595229618,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
154,0.7,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Is body image perceived differently by parents, their children, and the children's physicians? Answer: Yes, perceptions of body image differ among parents, children, and doctors. Parents might be influenced by cultural or personal beliefs, children by their self-esteem and peer groups, and physicians by clinical standards and health concerns. Thus, each group",7.105791820705622e-08,0.033792424479184735,0.01596390532544379,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
154,0.7,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: How do perceptions of body image vary between parents, children, and their children's healthcare providers? Answer: Perceptions differ, with parents influenced by cultural or personal beliefs, children by self-esteem and peer pressure, and physicians by medical and health considerations. Therefore, each group",3.079176455639103e-07,0.19404751088801797,0.0543639053254438,0.023574544042164344,0.2497398620614506,0.01851192595229618,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
154,0.7,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Do parents, children, and children's physicians have differing views on body image? Answer: Yes, body image perceptions may vary among these groups. Parents' views are often shaped by cultural or personal beliefs, children’s by their self-esteem and peers, and physicians’ by medical standards and health factors. Hence, each group",1.4211583641411244e-07,0.03989683106075903,0.0543639053254438,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
154,0.7,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Are body image perceptions different among parents, children, and their children's doctors? Answer: Yes, perceptions often vary. Parents' views may depend on cultural or personal beliefs, children’s on self-esteem and peer influence, and physicians’ on medical guidelines and health implications. Thus, each group",2.8423167282822487e-07,0.17051701347782355,0.0543639053254438,0.02176111757738247,0.22564231048239058,0.01851192595229618,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
154,0.7,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Do parents, their children, and the children's medical professionals perceive body image in different ways? Answer: Yes, perceptions of body image can differ. Parents may be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and doctors by medical and health considerations. Therefore, each group",1.6580180914979784e-07,0.08939725078682548,0.03354000310724552,0.012693985253473108,0.11316432705570056,0.01851192595229618,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
155,0.7,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain linked to poorer health-related quality of life after 6 months? Yes, studies indicate that neck pain is connected to a decline in health-related quality of life six months later. Chronic neck pain may lead to emotional stress, reduced physical capability, and difficulty performing daily tasks, affecting overall health and wellbeing.",7.105791820705622e-08,0.011706953099520412,0.04617473970122235,0.005440279394345618,0.008834427395682631,0.03444964598084129,0.0054324046228586,0.007525303207511769,0.03640832986255729,7.105791820705622e-08,0.006104406581574295,0.03840000000000001
155,0.7,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain correlate with a lower health-related quality of life half a year later? Research shows that neck pain is associated with a diminished health-related quality of life at the six-month mark. Ongoing neck pain can cause emotional distress, limit physical functions, and impair daily activities, negatively influencing overall health and wellbeing.",7.105791820705622e-08,0.014952553845092975,0.02689376078784081,0.005440279394345618,0.008834427395682631,0.03444964598084129,0.0054324046228586,0.007525303207511769,0.03640832986255729,7.105791820705622e-08,0.006104406581574295,0.03840000000000001
155,0.7,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there an association between neck pain and worsened health-related quality of life after six months? Evidence suggests that neck pain relates to a poorer health-related quality of life six months later. Persistent neck discomfort can result in emotional difficulties, restricted physical function, and challenges in daily living, impacting overall health and wellbeing.",7.105791820705622e-08,0.048428924347297286,0.10740468286303519,0.005440279394345618,0.008834427395682631,0.03444964598084129,0.0054324046228586,0.007525303207511769,0.03640832986255729,7.105791820705622e-08,0.006104406581574295,0.03840000000000001
155,0.7,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Can neck pain lead to a decline in health-related quality of life six months later? Research suggests that neck pain is linked to worse health-related quality of life at six months. Continuous neck pain may contribute to emotional distress, reduced physical functionality, and decreased ability to perform daily activities, affecting overall health and wellbeing.",4.737194547137081e-08,0.03346005371221805,0.04881093286303517,0.0036268529295637453,0.011629129321992782,0.035199999999999974,0.003621603081905733,0.012820968936166466,0.036800000000000034,4.737194547137081e-08,0.014098300735944314,0.03840000000000001
155,0.7,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain a factor in reduced health-related quality of life half a year afterwards? Studies indicate an association between neck pain and poorer health-related quality of life after six months. Long-lasting neck pain can cause emotional strain, limit physical capabilities, and hinder daily tasks, impacting overall health and wellbeing.",1.4211583641411244e-07,0.056493610168805386,0.0376158858015109,0.010880558788691236,0.07285682950897909,0.032012098298676725,0.0108648092457172,0.07117044440787978,0.03513345935727792,1.4211583641411244e-07,0.06928330820310658,0.03840000000000001
155,0.7,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does experiencing neck pain predict worse health-related quality of life six months later? Research supports that neck pain correlates with a decline in health-related quality of life six months on. Chronic neck pain can lead to emotional distress, diminished physical function, and difficulty with daily routines, affecting overall health and wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.7,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain connected to a lower health-related quality of life six months down the line? Evidence points to a link between neck pain and worsened health-related quality of life at six months post onset. Persistent neck pain can induce emotional stress, reduce physical abilities, and interfere with daily living, impacting overall health and wellbeing.",2.3685972735685406e-08,0.0034126750788998628,0.014486192847442458,0.0018134264647818726,0.03168334342267132,0.03592218377547097,0.0018108015409528666,0.0327617902235553,0.037176624375240316,2.3685972735685406e-08,0.03390092803212408,0.03840000000000001
155,0.7,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there a relationship between neck pain and poorer health-related quality of life six months later? Studies suggest neck pain is associated with a decline in health-related quality of life six months later. Ongoing neck pain may cause emotional distress, physical limitations, and reduced capacity for daily activities, influencing overall health and wellbeing.",7.105791820705622e-08,0.04161206078970636,0.007991102616121654,0.005440279394345618,0.06319891214548301,0.004263286555002299,0.0054324046228586,0.06297707765230687,0.0033555454956994066,7.105791820705622e-08,0.06268784989259002,0.002342417383431425
155,0.7,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Can persistent neck pain affect health-related quality of life after six months? Research indicates that neck pain is related to a worsened health-related quality of life half a year later. Chronic neck pain can contribute to emotional difficulties, limited physical function, and challenges in daily living, impacting overall health and wellbeing.",1.1842986367842703e-07,0.03324816001481112,0.04058369520871416,0.009067132323909363,0.05105872057059724,0.03285758261656855,0.009054007704764333,0.04950254302869883,0.03557609778180174,1.1842986367842703e-07,0.047777102982143216,0.03840000000000001
155,0.7,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain related to a decline in health-related quality of life six months later? Evidence suggests that neck pain is linked to poorer health-related quality of life six months later. Persistent neck pain can result in emotional distress, decreased physical functionality, and a reduced ability to perform daily activities, affecting overall health and wellbeing.",2.3685972735685406e-08,0.0034126750788998628,0.014486192847442458,0.0018134264647818726,0.020629651336569577,0.0013687630154102653,0.0018108015409528666,0.020557223665671476,0.0010760516451478394,2.3685972735685406e-08,0.020463556717675413,0.0007503540191586833
156,0.7,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG used as a surrogate tracer to assess tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia; it primarily measures tissue glucose metabolism. Other tracers like (18)F-fluoromisonidazole are employed for that purpose.",9.474389094274131e-08,0.0005780958213650322,0.11873384647976841,0.0072537058591274906,0.04374743294138739,0.043402110299457494,0.007243206163811466,0.04118396717949002,0.047842176086120736,9.474389094274162e-08,0.03826277399865141,0.05246913580246914
156,0.7,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG act as a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not suitable as a surrogate tracer for tumor hypoxia, as it is mainly used to evaluate glucose metabolism in tissues. Tumor hypoxia is assessed with other tracers such as (18)F-fluoromisonidazole.",2.3685972735685406e-08,0.07469700396625223,0.08231004308224388,0.0018134264647818726,0.02807381834920042,0.0023446870293717254,0.0018108015409528666,0.027983758678753023,0.0018819495170846606,2.3685972735685406e-08,0.027846328995862812,0.0013369225080936895
156,0.7,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a surrogate tracer to detect tumor hypoxia? No, (18)F-FDG is not used for measuring tumor hypoxia; it mainly tracks glucose metabolism rates in tissues. Specialized tracers, like (18)F-fluoromisonidazole, are preferred for hypoxia imaging.",1.658018091497972e-07,0.028422953289509945,0.19918367346938776,0.012693985253473122,0.05374245653546783,0.09876543209876547,0.012675610786670087,0.09118771555146576,0.0763888888888889,1.6580180914979784e-07,0.1306360941296667,0.05246913580246914
156,0.7,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG serve as a surrogate tracer for tumor hypoxia measurement? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia and is primarily used to measure glucose metabolism in tissues. Other tracers, such as (18)F-fluoromisonidazole, are utilized for tumor hypoxia.",2.3685972735685406e-08,0.030083474974812674,0.004968575665560332,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
156,0.7,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a tracer used to measure tumor hypoxia indirectly? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia; it is mainly used for assessing glucose metabolism in tissues. Tumor hypoxia is measured using other specialized tracers like (18)F-fluoromisonidazole.",4.7371945471370706e-08,0.13007806554350854,0.1735604047713268,0.0036268529295637453,0.08733614172443849,0.09876543209876547,0.003621603081905733,0.053994294293033374,0.0763888888888889,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
156,0.7,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG be used as a surrogate tracer to gauge tumor hypoxia? No, (18)F-FDG is not employed as a surrogate tracer for tumor hypoxia. Its primary use is to evaluate glucose metabolism rates in tissues. Other tracers such as (18)F-fluoromisonidazole are used for hypoxia measurement.",7.105791820705622e-08,0.19173199251525297,0.13136689774065483,0.005440279394345618,0.14647129019766592,0.05236448028436926,0.0054324046228586,0.14773899133408408,0.05259352898407034,7.105791820705622e-08,0.14894876808949453,0.05246913580246914
156,0.7,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia; it mainly measures glucose metabolism in tissues. Specialized tracers like (18)F-fluoromisonidazole are used instead.",1.421158364141119e-07,0.1406315614257938,0.06029478458049889,0.010880558788691243,0.18698294763518453,0.016790123456790124,0.010864809245717214,0.1864428169865202,0.013611111111111143,1.4211583641411244e-07,0.18553079338508116,0.009753086419753088
156,0.7,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG an appropriate surrogate tracer for tumor hypoxia? No, (18)F-FDG is not appropriate for measuring tumor hypoxia because it primarily assesses glucose metabolism in tissues. Other tracers, including (18)F-fluoromisonidazole, are designed for hypoxia detection.",1.658018091497972e-07,0.028422953289509945,0.19918367346938776,0.012693985253473122,0.05374245653546783,0.09876543209876547,0.012675610786670087,0.09118771555146576,0.0763888888888889,1.6580180914979784e-07,0.1306360941296667,0.05246913580246914
156,0.7,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG utilized as a surrogate tracer to identify tumor hypoxia? No, (18)F-FDG is not utilized as a surrogate tracer for tumor hypoxia; it mainly measures the glucose metabolism rate in tissues. Tumor hypoxia identification uses other tracers like (18)F-fluoromisonidazole.",4.7371945471370706e-08,0.02344003776505632,0.09795918367346935,0.0036268529295637453,0.022108149942921873,0.020398085159989962,0.003621603081905733,0.02094053603777235,0.022511337868480717,4.737194547137081e-08,0.019612536856477902,0.02471403376165281
156,0.7,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a valid surrogate tracer for assessing tumor hypoxia? No, (18)F-FDG is not valid as a surrogate tracer to assess tumor hypoxia. It is primarily used to measure glucose metabolism in tissues, whereas other tracers such as (18)F-fluoromisonidazole are used for hypoxia evaluation.",4.737194547137081e-08,0.23102314061993612,0.17594104308390024,0.0036268529295637453,0.1874196002814199,0.09876543209876547,0.003621603081905733,0.15664844835311564,0.0763888888888889,4.737194547137081e-08,0.12425615549912283,0.05246913580246914
157,0.7,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically important issue in general adult psychiatry? Our findings indicate that pain is a notable clinical concern among psychiatric patients, often undervalued in psychiatry. Patients studied in general adult psychiatry display distinct risk factors.",2.1317375462116823e-07,0.20774028063509986,0.010963208812936914,0.016320838183036854,0.23694329272110703,0.005831731731919049,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
157,0.7,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a relevant clinical problem in the field of general adult psychiatry? Evidence suggests that pain represents a significant clinical challenge for psychiatric patients, and it appears to be underrecognized in psychiatric practice. The patients examined in general adult psychiatry have particular risk factors.",2.3685972735685406e-08,0.038440078197148786,0.043611549541395775,0.0018134264647818726,0.008517171800753065,0.02271498107084911,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
157,0.7,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Does pain constitute a clinically relevant issue in general adult psychiatry? Research shows that pain can be a major clinical problem for psychiatric patients, which seems to be underappreciated within psychiatry. The patients evaluated in general adult psychiatry possess specific risk factors.",9.474389094274162e-08,0.06829491416793232,0.017674328113888547,0.0072537058591274906,0.09846084880686945,0.002268582374252811,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
157,0.7,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain considered a clinically significant problem in general adult psychiatry? Data reveals that pain is a considerable clinical concern in psychiatric patients and tends to be underestimated in psychiatric care. The patients studied in general adult psychiatry are marked by unique risk factors.,4.737194547137081e-08,0.04976096124302121,0.003048469387755104,0.0036268529295637453,0.04802033420753293,0.0010803788339694455,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
157,0.7,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain an important clinical problem in general adult psychiatry? Our investigation found that pain can be a critical clinical issue for psychiatric patients and is often overlooked in psychiatry. The patients assessed in general adult psychiatry exhibit certain risk factors.,1.1842986367842703e-07,0.09467812963771838,0.016465034767369553,0.009067132323909363,0.12466730702264872,0.002908287627211844,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
157,0.7,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Does pain pose a clinically relevant problem in general adult psychiatry? The evidence indicates that pain is a substantial clinical issue among psychiatric patients, which appears to be underestimated in the psychiatric field. Patients in general adult psychiatry demonstrate specific risk factors.",9.474389094274162e-08,0.06829491416793232,0.017674328113888547,0.0072537058591274906,0.09846084880686945,0.002268582374252811,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
157,0.7,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a recognized clinical problem in general adult psychiatry? Findings suggest that pain can be a significant clinical challenge for psychiatric patients and is frequently underestimated in psychiatry. The patients investigated within general adult psychiatry show particular risk factors.,1.4211583641411233e-07,0.08622722882549994,0.040703261914183934,0.010880558788691236,0.11509678416642277,0.02271498107084911,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.7,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically meaningful problem in general adult psychiatry? The research found evidence that pain is a notable clinical issue for psychiatric patients, often underappreciated in psychiatric settings. The patients studied in general adult psychiatry have distinct risk factors.",1.4211583641411233e-07,0.1217732380849843,0.015194317317869438,0.010880558788691236,0.15157821472220911,0.0035815857662582634,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.7,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically relevant concern in general adult psychiatry? Evidence supports that pain can be a significant clinical problem in psychiatric patients and appears to be underestimated in the psychiatric discipline. The patients examined in general adult psychiatry are characterized by specific risk factors.,2.3685972735685406e-08,0.006933388171696642,0.020975056689342395,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
157,0.7,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a significant clinical issue in general adult psychiatry? Our evidence shows that pain can be a major problem among psychiatric patients, which seems to be undervalued in psychiatry. The patients in general adult psychiatry possess particular risk factors.",1.4211583641411233e-07,0.1217732380849843,0.015194317317869438,0.010880558788691236,0.15157821472220911,0.0035815857662582634,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
158,0.7,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Are clinical predictors sufficient to detect cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms?,4.2634750924233567e-07,0.3868115303152333,0.2304,0.03264167636607382,0.4943949201267168,0.1967455621301775,0.032594427737151724,0.5667483804744884,0.17751479289940827,4.263475092423369e-07,0.6454419823268527,0.15532544378698224
158,0.7,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,"In geriatric blunt trauma cases involving low-energy impacts, are clinical predictors reliable for identifying cervical spine fractures?",4.2634750924233567e-07,0.3868115303152333,0.2304,0.03264167636607382,0.4943949201267168,0.1967455621301775,0.032594427737151724,0.5667483804744884,0.17751479289940827,4.263475092423369e-07,0.6454419823268527,0.15532544378698224
158,0.7,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Do clinical predictors effectively identify cervical spine fractures in elderly patients who experience low-energy blunt trauma?,4.50033481978021e-07,0.45135005145280394,0.2304,0.0344551028308557,0.5633877916136689,0.1967455621301775,0.03440522927810459,0.6408563526282096,0.17751479289940827,4.5003348197802224e-07,0.7254846900003891,0.15532544378698224
158,0.7,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Is the use of clinical predictors adequate for diagnosing cervical spine fractures in geriatric patients suffering low-energy blunt trauma?,3.7897556377096496e-07,0.2690284946588495,0.2304,0.02901482343651007,0.36923177717271116,0.1967455621301775,0.028972824655245973,0.43321698784996565,0.17751479289940827,3.789755637709662e-07,0.5023411386861794,0.15532544378698224
158,0.7,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Can clinical predictors alone accurately detect cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms?,4.2634750924233567e-07,0.3868115303152333,0.2304,0.03264167636607382,0.4943949201267168,0.1967455621301775,0.032594427737151724,0.5667483804744884,0.17751479289940827,4.263475092423369e-07,0.6454419823268527,0.15532544378698224
158,0.7,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,"For geriatric blunt trauma patients with low-energy injuries, are clinical predictors adequate to identify cervical spine fractures?",4.2634750924233567e-07,0.3868115303152333,0.2304,0.03264167636607382,0.4943949201267168,0.1967455621301775,0.032594427737151724,0.5667483804744884,0.17751479289940827,4.263475092423369e-07,0.6454419823268527,0.15532544378698224
158,0.7,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Are clinical predictors dependable for the identification of cervical spine fractures in older adults with low-energy blunt trauma?,4.026615365066503e-07,0.3261869084987983,0.2304,0.030828249901291946,0.4298563989891462,0.1967455621301775,0.030783626196198847,0.4977555089875363,0.17751479289940827,4.0266153650665153e-07,0.5713340101731315,0.15532544378698224
158,0.7,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,"In low-energy blunt trauma among geriatric patients, how effective are clinical predictors in diagnosing cervical spine fractures?",4.2634750924233567e-07,0.3868115303152333,0.2304,0.03264167636607382,0.4943949201267168,0.1967455621301775,0.032594427737151724,0.5667483804744884,0.17751479289940827,4.263475092423369e-07,0.6454419823268527,0.15532544378698224
158,0.7,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Are clinical predictors sufficient to recognize cervical spine fractures in elderly patients subjected to low-energy blunt trauma?,4.2634750924233567e-07,0.3868115303152333,0.2304,0.03264167636607382,0.4943949201267168,0.1967455621301775,0.032594427737151724,0.5667483804744884,0.17751479289940827,4.263475092423369e-07,0.6454419823268527,0.15532544378698224
158,0.7,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Do clinical predictors provide an adequate assessment of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms?,3.7897556377096496e-07,0.2690284946588495,0.2304,0.02901482343651007,0.36923177717271116,0.1967455621301775,0.028972824655245973,0.43321698784996565,0.17751479289940827,3.789755637709662e-07,0.5023411386861794,0.15532544378698224
159,0.7,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Is there a difference in interfractional motion of the prostate bed target between the superior and inferior parts of the clinical target volume using RTOG consensus definitions and daily CT on rails? There are no statistically significant differences in motion between the superior and inferior CTV, and existing uniform PTV margins sufficiently cover both regions.",7.105791820705622e-08,0.1337859028551427,0.05658716581589627,0.005440279394345618,0.10877401287332056,0.03854876033057854,0.0054324046228586,0.10940848054026997,0.03840000000000001,7.105791820705622e-08,0.08434065621484965,0.019599999999999992
159,0.7,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Using RTOG consensus definitions and daily CT on rails, does the prostate bed target exhibit different interfractional motion in the superior versus inferior clinical target volume? No statistically significant motion differences were found between the superior and inferior CTV, indicating that current uniform PTV margins adequately cover both areas.",2.1317375462116866e-07,0.1520894820422738,0.014217420095851314,0.016320838183036854,0.15044883257652186,0.017851239669421492,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
159,0.7,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Does interfractional motion of the prostate bed target vary between the superior and inferior sections of the clinical target volume based on RTOG consensus and daily CT on rails? The results show no significant motion differences between the superior and inferior CTV, and current uniform PTV margins are sufficient for both.",1.6580180914979784e-07,0.22101579111067782,0.06372410978471585,0.012693985253473108,0.19365130114247675,0.04311284350638188,0.012675610786670066,0.19389443937124184,0.04158790170132326,1.6580180914979784e-07,0.1683320695588959,0.0212665406427221
159,0.7,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"According to RTOG consensus definitions and daily CT on rails, is there a difference in motion between the superior and inferior portions of the prostate bed clinical target volume? No significant differences in motion were observed, and the uniform planning target volume margins currently used adequately cover both areas.",2.1317375462116866e-07,0.1520894820422738,0.014217420095851314,0.016320838183036854,0.15044883257652186,0.017851239669421492,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
159,0.7,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"When assessing prostate bed target motion using RTOG consensus and daily CT on rails, does the movement differ between the superior and inferior clinical target volume? Findings indicate no statistically significant difference between these parts, and existing uniform PTV margins are adequate for coverage.",3.316036182995957e-07,0.23320924473327187,0.0350413223140496,0.025387970506946217,0.2629268160032119,0.017851239669421492,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
159,0.7,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Does the interfractional motion of the prostate bed target differ between superior and inferior sections of the clinical target volume as defined by RTOG consensus and daily CT on rails? No statistically significant difference was found, and current uniform PTV margins effectively cover both regions.",3.079176455639103e-07,0.24172641653402493,0.012326341243200489,0.023574544042164344,0.23939631859301747,0.017851239669421492,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
159,0.7,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Is there a variation in interfractional motion between superior and inferior portions of the prostate bed clinical target volume using RTOG consensus definitions and daily CT on rails? Motion differences are not statistically significant, and the uniform PTV margins currently applied sufficiently cover both sections.",3.079176455639103e-07,0.21021972650857235,0.0350413223140496,0.023574544042164344,0.23939631859301747,0.017851239669421492,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
159,0.7,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Using daily CT on rails and RTOG consensus definitions, does the prostate bed target show different interfractional motion in superior versus inferior clinical target volume parts? There is no statistically significant motion difference, and current uniform PTV margins adequately cover both portions.",3.789755637709665e-07,0.2808372937225263,0.0350413223140496,0.029014823436509962,0.3117169801726436,0.017851239669421492,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
159,0.7,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Does the prostate bed clinical target volume exhibit different interfractional motion between superior and inferior areas based on RTOG consensus and daily CT on rails? No statistically significant motion differences exist, and existing uniform PTV margins sufficiently cover both areas.",4.263475092423372e-07,0.33084771429718973,0.0350413223140496,0.03264167636607371,0.3630102745601933,0.017851239669421492,0.0325944277371516,0.3964152725882455,0.0,4.263475092423373e-07,0.40546510810816505,0.0
159,0.7,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Is there any statistically significant difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume using RTOG consensus and daily CT on rails? The answer is no, and current uniform planning target volume margins are sufficient to cover both parts.",2.6054570009253947e-07,0.19590479787512827,0.0133129272523212,0.0199476911126006,0.19393394451626023,0.017851239669421492,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
160,0.7,1,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are labs accurately reporting serum quantitative hCG results? The reliability of serum quantitative hCG results from laboratories varies based on the lab's protocols and quality control. Many labs produce accurate results, but errors may arise from equipment issues, reagent quality, or staff training. Consistent audits and quality assurance are vital for accuracy.",3.079176455639103e-07,0.20029993079755481,0.01897016841424877,0.023574544042164344,0.17081891859087328,0.04320855968157481,0.023540420032387266,0.16823532752543713,0.048261993679977015,3.079176455639103e-07,0.19422057913034108,0.03274920999712727
160,0.7,2,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories correctly report serum quantitative hCG results? The correctness of serum quantitative hCG testing is dependent on each laboratory's adherence to protocols and quality standards. While most labs are dependable, discrepancies might happen due to factors like calibration, reagents, and technician expertise. Regular quality checks help maintain accuracy.",3.789755637709665e-07,0.2371400905359513,0.03597601671292551,0.029014823436509962,0.2344640597912413,0.04193368917629545,0.028972824655245866,0.2314142291469694,0.048261993679977015,3.789755637709665e-07,0.2587591002679126,0.03274920999712727
160,0.7,3,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting of serum quantitative hCG results by laboratories accurate? Accuracy in serum quantitative hCG results depends on the laboratory's compliance with testing standards. Numerous labs deliver precise results, though inconsistencies can occur because of equipment calibration, reagent quality, or staff proficiency. Ongoing quality control and audits are crucial for ensuring correct reporting.",2.6054570009253947e-07,0.15875641498392135,0.021163918414248743,0.0199476911126006,0.1571913321044196,0.024800229819017534,0.019918816950481533,0.15541223528663828,0.028661993679977023,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.7,4,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results reported correctly by laboratories? The precision of serum quantitative hCG outcomes relies largely on the lab's procedures and quality controls. Many laboratories report accurate results; however, variations might arise from calibration errors, reagent issues, or technician training. Routine quality assessments are important for maintaining accuracy.",3.552895910352811e-07,0.21534198159756945,0.036821501030817334,0.02720139697172809,0.21279615841206034,0.04237632760081926,0.027162023114293,0.20990802392600605,0.048261993679977015,3.552895910352811e-07,0.2367801935491376,0.03274920999712727
160,0.7,5,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories provide accurate serum quantitative hCG results? The accuracy of serum quantitative hCG reporting is influenced by the specific laboratory’s adherence to testing protocols and quality assurance. While many labs are accurate, discrepancies can happen due to equipment calibration, reagent quality, or staff training. Regular audits and quality control are necessary to ensure correctness.",2.3685972735685406e-07,0.13861114322845536,0.02220059661494081,0.018134264647818726,0.11098062062412062,0.044339283073455416,0.018108015409528666,0.10881190705463606,0.048261993679977015,2.3685972735685406e-07,0.13359595731390694,0.03274920999712727
160,0.7,6,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Can laboratories be trusted to report serum quantitative hCG results correctly? The accuracy of serum quantitative hCG results depends on how well labs follow testing protocols and maintain quality control. Although most labs produce reliable results, factors such as equipment calibration, reagent quality, and technician expertise can cause discrepancies. Continuous quality checks are essential.",2.6054570009253947e-07,0.15875641498392135,0.021163918414248743,0.0199476911126006,0.1571913321044196,0.024800229819017534,0.019918816950481533,0.15541223528663828,0.028661993679977023,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.7,7,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results from laboratories reliable? The reliability of these results depends on each laboratory’s compliance with established testing standards and quality controls. Many labs yield accurate results, but discrepancies may arise from calibration, reagent integrity, or technician skill levels. Regular quality audits help ensure accuracy.",4.026615365066519e-07,0.20043123468712265,0.07756391841424877,0.030828249901291835,0.22647464030752618,0.06320022981901754,0.030783626196198732,0.2533931358657444,0.048261993679977015,4.026615365066519e-07,0.2812319561199703,0.03274920999712727
160,0.7,8,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","How accurate are laboratory reports of serum quantitative hCG results? Lab accuracy for serum quantitative hCG testing depends on adherence to protocols and quality assurance measures. Most laboratories provide accurate results, but errors can occur due to equipment calibration, reagent quality, and technician training. Quality control and audits are key to maintaining result accuracy.",2.6054570009253947e-07,0.1325999176043009,0.03988610218971975,0.0199476911126006,0.13053182515980621,0.043976854194257835,0.019918816950481533,0.12822999291173875,0.048261993679977015,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.7,9,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting accuracy of serum quantitative hCG results consistent across laboratories? The precision of serum quantitative hCG results depends on the laboratory’s protocol adherence and quality controls. While many labs are accurate, inconsistencies may be caused by equipment calibration, reagent issues, or technician proficiency. Routine quality checks are vital to ensure correctness.",2.8423167282822487e-07,0.2059731455942062,0.0011750295253598886,0.02176111757738247,0.20483713119699498,0.004606479819017545,0.0217296184914344,0.20348439465271406,0.008331438124421449,2.8423167282822487e-07,0.2018930135831134,0.012349904441571715
160,0.7,10,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories consistently report accurate serum quantitative hCG results? The correctness of serum quantitative hCG reporting is largely dependent on the lab's compliance with testing protocols and quality control. Many labs provide reliable results, but discrepancies can happen due to equipment calibration, reagent quality, or technician training. Regular audits and quality measures are crucial for accuracy.",2.1317375462116866e-07,0.1188617072257947,0.02320001308880497,0.016320838183036854,0.09180410803086225,0.04468830386672136,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.11417787145680425,0.03274920999712727
161,0.7,1,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis mainly relies on liver disease severity and kidney function, but emerging evidence indicates that factors like systemic inflammation, infections, circulatory issues, and genetic predispositions may also play important roles, warranting further study.",4.737194547137075e-07,0.4626235219481134,0.0,0.03626852929563747,0.47378435208564085,0.0,0.03621603081905735,0.48550781578170144,0.0,4.737194547137081e-07,0.49783842823917857,0.0
161,0.7,2,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The prognosis of hepatorenal syndrome is chiefly determined by the extent of liver disease and renal function, yet research suggests additional prognostic elements such as systemic inflammation, infections, circulatory dysfunction, and genetic factors might be overlooked and need more investigation.",3.55289591035281e-07,0.3254224004346309,0.0,0.02720139697172809,0.33270575382573453,0.0,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
161,0.7,3,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","While hepatorenal syndrome prognosis is traditionally based on liver disease severity and renal status, recent studies point to other potentially significant factors like systemic inflammation, infectious processes, circulatory impairment, and genetic predispositions that require more research.",4.500334819780222e-07,0.4336359850748619,0.0,0.03445510283085559,0.44393138893595907,0.0,0.03440522927810448,0.45473615711494775,0.0,4.500334819780227e-07,0.46608972992459874,0.0
161,0.7,4,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Prognosis in hepatorenal syndrome is currently assessed mainly through liver disease severity and kidney function, but there is growing evidence that systemic inflammation, infection, circulatory dysfunction, and genetic predispositions could also impact outcomes and should be studied further.",4.026615365066516e-07,0.37806613392004973,0.0,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
161,0.7,5,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The current understanding of hepatorenal syndrome prognosis focuses on liver and renal function, yet some studies highlight that systemic inflammation, infection, circulatory problems, and genetic predispositions might be missing pieces in predicting outcomes, needing further exploration.",4.500334819780222e-07,0.4336359850748619,0.0,0.03445510283085559,0.44393138893595907,0.0,0.03440522927810448,0.45473615711494775,0.0,4.500334819780227e-07,0.46608972992459874,0.0
161,0.7,6,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis depends largely on liver disease severity and renal function, but additional factors such as systemic inflammation, infection, circulatory dysfunction, and genetic predispositions may be under-recognized and merit further research.",5.447773729207634e-07,0.5549968420791287,0.0,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
161,0.7,7,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Although hepatorenal syndrome prognosis is primarily based on liver and kidney function, other factors like systemic inflammation, infections, circulatory dysfunction, and individual genetic predispositions may be overlooked and require more study.",5.684633456564487e-07,0.5877866649021204,0.0,0.043522235154764985,0.6029960835656478,0.0,0.04345923698286885,0.6190392084062237,0.0,5.684633456564497e-07,0.6359887667199957,0.0
161,0.7,8,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The prognosis of hepatorenal syndrome is predominantly guided by liver disease severity and kidney function, but systemic inflammation, infection, circulatory issues, and genetic predispositions might also influence prognosis and need further research.",5.447773729207634e-07,0.5549968420791287,0.0,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
161,0.7,9,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis is generally linked to the severity of liver disease and renal function, but additional prognostic factors such as systemic inflammation, infections, circulatory dysfunction, and genetic predispositions could be missing and should be further investigated.",4.263475092423369e-07,0.40546510810816505,0.0,0.03264167636607371,0.41494385206270756,0.0,0.032594427737151606,0.42488319396526597,0.0,4.263475092423373e-07,0.43531807125784505,0.0
161,0.7,10,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Primarily, hepatorenal syndrome prognosis is based on liver disease severity and kidney function; however, factors like systemic inflammation, infection, circulatory dysfunction, and genetic predispositions may be overlooked and require further research.",5.684633456564487e-07,0.5877866649021204,0.0,0.043522235154764985,0.6029960835656478,0.0,0.04345923698286885,0.6190392084062237,0.0,5.684633456564497e-07,0.6359887667199957,0.0
162,0.7,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction using oversized cups ensure initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most acetabular components in this group remained stable even though there was limited contact between the component and pelvic bone. However, 3 out of 10 showed migration beyond the thresholds that indicate future loosening in primary cases.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
162,0.7,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can oversized cups in cup-cage reconstruction provide initial stability in THA for osteoporotic acetabular fractures? The majority of acetabular components were stable despite minimal contact area with the pelvic bone, but 3 out of 10 migrated beyond limits that suggest potential loosening later on.",2.3685972735685406e-07,0.2090917978585587,0.0,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
162,0.7,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"In THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups offer initial stability? Most acetabular components maintained stability despite small contact surfaces with pelvic bone, though 3 of 10 exceeded migration limits predicting future loosening.",4.026615365066515e-07,0.3867729750960107,0.0,0.030828249901291835,0.39589565709201446,0.0,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
162,0.7,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability achieved with cup-cage reconstruction using oversized cups in THA for osteoporotic acetabular fractures? Most components were stable despite limited contact with pelvic bone; however, 3 out of 10 migrated beyond the threshold linked to later loosening.",3.552895910352809e-07,0.33270575382573453,0.0,0.02720139697172809,0.3403258059372023,0.0,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
162,0.7,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does the use of oversized cups in cup-cage reconstruction provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Stability was observed in most acetabular components despite a small contact interface, though 3 of 10 migrated beyond limits associated with future loosening.",2.6054570009253947e-07,0.2326222952687531,0.0,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
162,0.7,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction with oversized cups yield initial stability in THA for osteoporotic acetabular fractures? While most acetabular components remained stable with limited bone contact, 3 of 10 migrated beyond levels that predict loosening later.",4.500334819780221e-07,0.44393138893595907,0.0,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
162,0.7,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"In cases of osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups ensure initial stability during THA? The majority of components were stable despite small contact areas, but 3 of 10 migrated past limits predictive of future loosening.",3.789755637709662e-07,0.3593740009078954,0.0,0.029014823436509962,0.3677247801253176,0.0,0.028972824655245866,0.37647757123491177,0.0,3.789755637709665e-07,0.3856624808119835,0.0
162,0.7,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability provided by cup-cage reconstruction with oversized cups in osteoporotic acetabular fractures treated by THA? Most components remained stable even with minimal pelvic bone contact, but 3 out of 10 migrated beyond thresholds indicating later loosening.",3.789755637709662e-07,0.3593740009078954,0.0,0.029014823436509962,0.3677247801253176,0.0,0.028972824655245866,0.37647757123491177,0.0,3.789755637709665e-07,0.3856624808119835,0.0
162,0.7,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can initial stability be achieved in THA for osteoporotic acetabular fractures using cup-cage reconstruction with oversized cups? Most acetabular components were stable despite limited contact surfaces, although 3 of 10 migrated beyond limits forecasting future loosening.",4.263475092423368e-07,0.41494385206270756,0.0,0.032641676366073714,0.42488319396526597,0.0,0.03259442773715161,0.43531807125784505,0.0,4.263475092423373e-07,0.446287102628419,0.0
162,0.7,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does employing oversized cups in cup-cage reconstruction secure initial stability in THA for osteoporotic acetabular fractures? The majority of acetabular components showed stability despite small contact with pelvic bone, with 3 out of 10 migrating beyond limits that predict loosening later.",3.079176455639103e-07,0.2814124594381848,0.0,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
163,0.7,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study indicates a potential link between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.15021004549256967,0.005106302021403095,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.7,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does a relationship exist between cervical cord plaques and discopathy in individuals with multiple sclerosis? Data from the study implies a possible association between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.035494993470072345,0.0011450775316071762,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
163,0.7,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any association between cervical cord plaques and discopathy among patients with multiple sclerosis? The findings suggest a possible correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.7,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques related to discopathy in multiple sclerosis patients? The study suggests a potential correlation between cervical discopathy and cervical MS plaques.,1.658018091497971e-07,0.2194933536956758,0.033293697978596916,0.012693985253473157,0.27625337662815763,0.0,0.012675610786670115,0.28768207245178257,0.0,1.658018091497978e-07,0.30010459245033916,0.0
163,0.7,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a link between cervical cord plaques and discopathy in those with multiple sclerosis? Study data points to a possible connection between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.7,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Can cervical cord plaques be associated with discopathy in multiple sclerosis patients? The research data suggests a possible relationship between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.7,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any correlation between cervical cord plaques and discopathy in patients suffering from multiple sclerosis? The study suggests a potential link between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.7,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does cervical cord plaque presence relate to discopathy in multiple sclerosis patients? Data indicates a possible association between cervical discopathy and cervical MS plaques.,1.658018091497971e-07,0.2194933536956758,0.033293697978596916,0.012693985253473157,0.27625337662815763,0.0,0.012675610786670115,0.28768207245178257,0.0,1.658018091497978e-07,0.30010459245033916,0.0
163,0.7,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a relationship between cervical cord plaques and discopathy in multiple sclerosis cases? The study data suggests a potential correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.7,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques connected to discopathy in multiple sclerosis patients? The research suggests a possible correlation between cervical discopathy and cervical MS plaques.,1.658018091497971e-07,0.2194933536956758,0.033293697978596916,0.012693985253473157,0.27625337662815763,0.0,0.012675610786670115,0.28768207245178257,0.0,1.658018091497978e-07,0.30010459245033916,0.0
164,0.7,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair on patients aged 80 or above following aneurysmal subarachnoid hemorrhage? The study found that repairing a ruptured aneurysm in elderly patients led to better outcomes than conservative treatment. Therefore, definitive surgery should be confidently offered to elderly patients with aSAH.",1.6580180914979784e-07,0.11947435624117375,0.015949421162800625,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
164,0.7,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should patients aged 80 or older undergo aneurysm repair after aneurysmal subarachnoid hemorrhage? Results indicate that elderly patients who received surgical repair of ruptured aneurysms had improved prognoses compared to those managed conservatively. Hence, definitive surgery is advisable for elderly individuals with aSAH.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.7,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted in patients 80 years and older after aneurysmal subarachnoid hemorrhage? The findings show superior prognosis when ruptured aneurysms in elderly patients are surgically repaired rather than treated conservatively. Consequently, definitive surgery should be considered without hesitation in elderly aSAH patients.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.7,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 or older following aneurysmal subarachnoid hemorrhage? The study demonstrates that elderly patients who underwent repair of ruptured aneurysms had better outcomes than those receiving conservative care. Thus, definitive surgical intervention is justified in elderly aSAH cases.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.7,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is surgical repair of aneurysms justified for octogenarians after aneurysmal subarachnoid hemorrhage? Data reveals that elderly patients experienced better prognoses with aneurysm repair compared to conservative management. Therefore, definitive surgery should be offered to elderly patients with aSAH without reservation.",3.316036182995956e-07,0.28996328192271914,0.01205454752646807,0.025387970506946217,0.31365755885504143,0.0,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
164,0.7,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 and above with aneurysmal subarachnoid hemorrhage, is aneurysm repair advisable? The study results indicate improved prognosis following surgical repair of ruptured aneurysms over conservative treatment in the elderly. Hence, definitive surgery should be pursued confidently in elderly aSAH patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.7,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it beneficial to perform aneurysm repair in patients aged 80 or more after aneurysmal subarachnoid hemorrhage? Evidence from the study shows better outcomes with repair than with conservative management in elderly patients. Thus, definitive surgery should be considered a viable option for elderly aSAH patients.",1.8948778188548325e-07,0.11131642902256011,0.03767781622452902,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
164,0.7,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should elderly patients aged 80 or older with aneurysmal subarachnoid hemorrhage undergo aneurysm repair? The study found that repairing the ruptured aneurysm resulted in a better prognosis than conservative treatment in elderly individuals. Therefore, definitive surgery should not be withheld from elderly aSAH patients.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.7,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair a justified treatment for patients aged 80+ after aneurysmal subarachnoid hemorrhage? The findings suggest that elderly patients who received surgical repair of ruptured aneurysms had a more favorable prognosis than those treated conservatively. Accordingly, definitive surgery should be offered to elderly patients with aSAH.",1.6580180914979784e-07,0.11947435624117375,0.015949421162800625,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
164,0.7,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older, is aneurysm repair appropriate following aneurysmal subarachnoid hemorrhage? Results indicate that surgical repair of ruptured aneurysms yields better outcomes compared to conservative treatment in elderly patients. Thus, definitive surgery should be confidently recommended for elderly aSAH patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
165,0.7,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are individuals with episodic migraines more likely to focus on headache-related visual cues? Answer: Considering the extensive sample size and previous pilot tests of the images shown, the findings indicate that episodic migraine sufferers do not show a preference for attending to headache-related facial stimuli. Although there is limited evidence of attentional biases in chronic headache groups, these results...",2.3685972735685406e-07,0.2705923107616157,0.060964083175803374,0.018134264647818726,0.21812313216185863,0.020823902218198284,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
165,0.7,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do people with episodic migraines have a selective attention to visual stimuli associated with headaches? Answer: Based on the large sample and earlier pilot testing of the images, the data suggest that those with episodic migraines do not selectively focus on headache-related facial images. While some modest evidence exists for attentional biases in chronic headache populations, these findings...",2.1317375462116866e-07,0.20569462357059587,0.026525307665599282,0.016320838183036854,0.17641043574613224,0.0032856369120758296,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
165,0.7,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is selective attention to headache-related visuals present in episodic migraine patients? Answer: Given the significant sample size and prior pilot studies of the images presented, the results indicate that episodic migraineurs do not exhibit differential attention towards headache-related facial stimuli. There is only modest support for attentional biases in chronic headache sufferers, and these findings...",1.4211583641411244e-07,0.20038805208836807,0.060964083175803374,0.010880558788691236,0.14666416817971495,0.020823902218198284,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
165,0.7,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine sufferers selectively attend to visual stimuli related to headaches? Answer: Taking into account the large sample size and previous pilot testing of the images, the study suggests that episodic migraineurs do not show selective attention to headache-related facial stimuli. Although there is some modest evidence for attentional biases in chronic headache cases, these findings...",1.8948778188548325e-07,0.23610613469044717,0.060964083175803374,0.014507411718254981,0.18303181235058918,0.020823902218198284,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
165,0.7,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are headache-related visual stimuli selectively attended to by individuals with episodic migraines? Answer: With a large sample and prior pilot testing of the images, the evidence points to episodic migraineurs not exhibiting selective attention to headache-related facial cues. There is modest evidence for attentional biases in chronic headache groups, but these findings...",7.105791820705622e-08,0.14429858543732488,0.060964083175803374,0.005440279394345618,0.08950575433976482,0.020823902218198284,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
165,0.7,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do those with episodic migraines focus more on headache-related facial stimuli? Answer: Considering the extensive sample size and earlier pilot testing of the images, results indicate no differential attention by episodic migraineurs to headache-related facial stimuli. Modest evidence of attentional bias exists in chronic headache populations, yet these findings...",0.0,0.056583443311015724,0.04056477762024782,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0
165,0.7,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is selective attention toward headache-associated visual stimuli observed in episodic migraineurs? Answer: Given the large sample and prior pilot testing of the images, the results suggest that episodic migraineurs do not preferentially attend to headache-related facial stimuli. While modest evidence points to attentional biases in chronic headache sufferers, these findings...",2.3685972735685406e-08,0.10507787228404242,0.060964083175803374,0.0018134264647818726,0.04950041972606645,0.020823902218198284,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
165,0.7,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine patients exhibit selective attention to headache-related visual cues? Answer: Based on a large sample size and previous pilot testing of images, the findings imply that episodic migraineurs do not differentially attend to headache-related facial stimuli. There is modest evidence of attentional biases among chronic headache patients; however, these findings...",7.105791820705622e-08,0.11763907849271149,0.041740707551043664,0.005440279394345618,0.08950575433976482,0.020823902218198284,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
165,0.7,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are visual stimuli related to headaches selectively attended to by episodic migraineurs? Answer: With a large sample size and prior pilot testing of images, the results suggest that episodic migraineurs do not show a selective focus on headache-related facial stimuli. Although modest evidence exists for attentional biases in chronic headache groups, these findings...",9.474389094274162e-08,0.16334678040801798,0.060964083175803374,0.0072537058591274906,0.10892384019686752,0.020823902218198284,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
165,0.7,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do individuals with episodic migraines show selective attention to headache-related visual stimuli? Answer: Considering the large sample size and earlier pilot testing of the images, results indicate no differential attention by episodic migraineurs to headache-related facial stimuli. There is modest evidence for attentional biases in chronic headache sufferers, yet these findings...",4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.06970312704358506,0.020823902218198284,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
166,0.7,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's distribution of health care benefits align with the principles of universal coverage? While Kenya aims for universal health coverage, the distribution of benefits remains challenged by regional disparities, resource limitations, and service delivery gaps, meaning it does not yet fully adhere to universal coverage principles.",2.6054570009253947e-07,0.09862098305969802,0.08207783331197402,0.0199476911126006,0.11966817517055173,0.07100591715976332,0.019918816950481533,0.17273284727348592,0.03631185475258099,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
166,0.7,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the allocation of health care benefits in Kenya consistent with universal coverage principles? Kenya is working towards universal health coverage, but unequal regional access, resource constraints, and service delivery issues prevent it from fully achieving these principles.",4.737194547137078e-07,0.2862076329671783,0.10380622837370242,0.03626852929563745,0.342811726484761,0.07100591715976332,0.03621603081905733,0.4015744197023343,0.03631185475258099,4.737194547137081e-07,0.43695140414959655,0.01851192595229618
166,0.7,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's health care benefits distribution fulfill the universal coverage principles? Although Kenya is progressing towards universal health coverage, significant challenges such as regional inequalities, scarce resources, and service gaps mean it does not completely meet universal coverage standards.",4.500334819780225e-07,0.2960208164408038,0.07750966153659504,0.03445510283085558,0.31541275229664567,0.07100591715976332,0.034405229278104466,0.3734035427356375,0.03631185475258099,4.500334819780227e-07,0.40796386727634504,0.01851192595229618
166,0.7,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the health care benefits distribution in Kenya in line with universal coverage ideals? Despite efforts towards universal health coverage, Kenya faces major obstacles including unequal regional access and limited healthcare resources, resulting in incomplete adherence to universal coverage.",4.500334819780225e-07,0.25953938588501746,0.10380622837370242,0.03445510283085558,0.31541275229664567,0.07100591715976332,0.034405229278104466,0.3734035427356375,0.03631185475258099,4.500334819780227e-07,0.40796386727634504,0.01851192595229618
166,0.7,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the distribution of health care benefits in Kenya satisfy universal coverage principles? Kenya's pursuit of universal health coverage is ongoing, but disparities in access, resource shortages, and service delivery gaps hinder full compliance with universal coverage.",4.974054274493931e-07,0.31360660715529365,0.10380622837370242,0.038081955760419325,0.37098260345145784,0.07100591715976332,0.038026832360010206,0.4305619565755858,0.03631185475258099,4.974054274493935e-07,0.4668043672992783,0.01851192595229618
166,0.7,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's distribution of healthcare benefits meet the criteria for universal coverage? Kenya is advancing towards universal health coverage, yet uneven access across regions and resource limitations mean it does not fully meet universal coverage principles.",5.210914001850784e-07,0.3417774841219905,0.10380622837370242,0.039895382225201205,0.39997014032470934,0.07100591715976332,0.03983763390096308,0.4604149197252676,0.03631185475258099,5.210914001850789e-07,0.497576025966032,0.01851192595229618
166,0.7,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits in Kenya aligned with the universal coverage framework? Although Kenya aims for universal health coverage, challenges like unequal access, limited resources, and service gaps prevent full realization of universal coverage principles.",4.737194547137078e-07,0.32367504813258074,0.07680005553419625,0.03626852929563745,0.342811726484761,0.07100591715976332,0.03621603081905733,0.4015744197023343,0.03631185475258099,4.737194547137081e-07,0.43695140414959655,0.01851192595229618
166,0.7,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's distribution of health care benefits conform to universal coverage principles? While striving for universal health coverage, Kenya still struggles with regional disparities, resource constraints, and service delivery gaps, falling short of full universal coverage.",5.210914001850784e-07,0.3417774841219905,0.10380622837370242,0.039895382225201205,0.39997014032470934,0.07100591715976332,0.03983763390096308,0.4604149197252676,0.03631185475258099,5.210914001850789e-07,0.497576025966032,0.01851192595229618
166,0.7,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the health care benefits distribution in Kenya comply with universal coverage principles? Kenya is working towards universal health coverage, but significant issues such as unequal access and limited resources mean it does not yet fully meet these principles.",4.500334819780225e-07,0.25953938588501746,0.10380622837370242,0.03445510283085558,0.31541275229664567,0.07100591715976332,0.034405229278104466,0.3734035427356375,0.03631185475258099,4.500334819780227e-07,0.40796386727634504,0.01851192595229618
166,0.7,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the allocation of health care benefits in Kenya consistent with the principles of universal coverage? Despite efforts to achieve universal health coverage, Kenya faces considerable challenges including regional inequities and resource limitations, resulting in incomplete adherence to universal coverage.",4.263475092423372e-07,0.23356389948175948,0.10380622837370242,0.03264167636607371,0.2887445052144848,0.07100591715976332,0.0325944277371516,0.34600456854752215,0.03631185475258099,4.263475092423373e-07,0.3797929903096482,0.01851192595229618
167,0.7,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Can a new surgical method for the temporomandibular joint enhance access and minimize complications? A new surgical method for the temporomandibular joint has the potential to enhance access and minimize complications by using minimally invasive techniques, advanced imaging, and innovative instruments.",1.8948778188548325e-07,0.24008382184061627,0.028316405047706883,0.014507411718254981,0.23498903201886012,0.028416597055034742,0.014486412327622933,0.22912281647309518,0.024843749999999998,1.8948778188548325e-07,0.22238807235482616,0.018476911235550564
167,0.7,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Is it possible for an innovative surgical approach to the temporomandibular joint to improve access and lower complication rates? An innovative surgical approach to the temporomandibular joint might improve access and reduce complications with the help of minimally invasive methods, cutting-edge imaging technologies, and novel surgical tools.",4.737194547137081e-08,0.024979794621986073,0.009829849314763661,0.0036268529295637453,0.023165903809849286,0.012773616278836775,0.003621603081905733,0.02116420907375849,0.01573142669296515,4.737194547137081e-08,0.051193823631774826,0.004001875781494163
167,0.7,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Could a novel surgical technique for the temporomandibular joint offer better access and fewer complications? A novel surgical technique for the temporomandibular joint could offer better access and fewer complications by employing minimally invasive procedures, state-of-the-art imaging, and advanced instruments.",2.1317375462116855e-07,0.30983414139926246,0.04461459098874998,0.016320838183036854,0.30492931934832335,0.05098029098760837,0.0162972138685758,0.29917438637835314,0.051388888888888845,2.1317375462116866e-07,0.2924582693702038,0.047232922774647884
167,0.7,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Does a new surgical approach to the temporomandibular joint have the ability to improve access and decrease complications? Yes, a new surgical approach to the temporomandibular joint can potentially improve access and decrease complications through minimally invasive strategies, improved imaging technology, and innovative surgical tools.",9.474389094274162e-08,0.11326695201083936,0.01370663957288959,0.0072537058591274906,0.1108977183548614,0.01327590602315884,0.007243206163811466,0.10819282616994963,0.011388888888888893,9.474389094274162e-08,0.10511248798629236,0.008377913421565075
167,0.7,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Might a novel surgical approach to the temporomandibular joint enhance accessibility and reduce risks? A novel surgical approach to the temporomandibular joint may enhance accessibility and reduce risks by integrating minimally invasive techniques, enhanced imaging, and new surgical instruments.",2.3685972735685385e-07,0.3096178315060598,0.03568601956017864,0.018134264647818726,0.30300401275162425,0.03671156328249539,0.018108015409528666,0.29535051459529926,0.03250000000000003,2.3685972735685406e-07,0.2865219041188718,0.024340102795459548
167,0.7,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Is a novel surgical approach to the temporomandibular joint capable of improving access while reducing complications? A novel surgical approach to the temporomandibular joint could improve access and reduce complications by using minimally invasive techniques, advanced imaging, and innovative instruments.",2.1317375462116855e-07,0.1676501043613241,0.02300737967451527,0.016320838183036854,0.19548502768096387,0.010706874589086063,0.0162972138685758,0.2242395560475492,0.004335937499999998,2.1317375462116866e-07,0.25395009267242985,0.021332168352171332
167,0.7,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Can innovative surgery targeting the temporomandibular joint lead to improved access and fewer complications? Innovative surgery targeting the temporomandibular joint can lead to improved access and fewer complications through minimally invasive methods, advanced imaging technologies, and novel surgical equipment.",2.3685972735685385e-07,0.3096178315060607,0.03568601956017864,0.018134264647818726,0.30300401275162425,0.03671156328249539,0.018108015409528666,0.29535051459529926,0.03250000000000003,2.3685972735685406e-07,0.2865219041188718,0.024340102795459548
167,0.7,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Could a new surgical procedure for the temporomandibular joint improve surgical access and lower complication rates? A new surgical procedure for the temporomandibular joint might improve surgical access and lower complication rates with minimally invasive techniques, enhanced imaging, and innovative instruments.",1.8948778188548325e-07,0.30939853989661037,0.05099214200915822,0.014507411718254981,0.3060810505378284,0.06287089740853574,0.014486412327622933,0.30208567758466787,0.06805555555555551,1.8948778188548325e-07,0.2973229026856301,0.06804457730118285
167,0.7,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Is it feasible that a novel surgical approach to the temporomandibular joint improves access and reduces complications? It is feasible that a novel surgical approach to the temporomandibular joint improves access and reduces complications by employing minimally invasive techniques, advanced imaging tools, and novel surgical instruments.",7.105791820705622e-08,0.21864651144743918,0.11826900072350777,0.005440279394345618,0.20807325045979397,0.07132437541091394,0.0054324046228586,0.24125371838791576,0.0980859375,7.105791820705622e-08,0.27583679203499845,0.12680091835217133
167,0.7,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead","Does a novel surgical technique for the temporomandibular joint have the potential to enhance access and decrease complications? Yes, a novel surgical technique for the temporomandibular joint has the potential to enhance access and decrease complications through minimally invasive approaches, cutting-edge imaging, and new surgical instruments.",7.105791820705622e-08,0.1762122335611176,0.04730512032548473,0.005440279394345618,0.17656656043434138,0.059171597633136175,0.0054324046228586,0.1767749108939669,0.06713667820069202,7.105791820705622e-08,0.17681576624072148,0.07195716835217134
168,0.7,1,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the positioning of the head affect anterior chamber depth in pseudoexfoliation syndrome? Yes, the depth of the anterior chamber can be influenced by the position of the head in this condition. Certain positions, like lying flat, may increase anterior chamber depth and complicate management. Thus, head position should be factored into assessment and treatment.",1.1842986367842703e-07,0.09749006284594586,0.07621425049309666,0.009067132323909363,0.046857584090098214,0.030909289399613633,0.009054007704764333,0.018844688141548716,0.05246913580246911,1.1842986367842703e-07,0.04401554511368477,0.03566529492455417
168,0.7,2,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth in pseudoexfoliation syndrome affected by how the head is positioned? Indeed, head positioning can alter the anterior chamber depth. For example, lying flat can deepen the chamber, which may complicate condition management. Hence, head position must be considered during evaluation and therapy.",3.316036182995957e-07,0.1372058933268523,0.0942833390385838,0.025387970506946217,0.18064686896471605,0.06858710562414265,0.025351221573340132,0.2088882910294143,0.05246913580246911,3.316036182995957e-07,0.2381715595546421,0.03566529492455417
168,0.7,3,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can head position impact anterior chamber depth in pseudoexfoliation syndrome? Yes, it can. Specific head positions, such as a flat lying posture, can increase anterior chamber depth and may complicate treatment. Therefore, considering head position is important when assessing and managing the syndrome.",4.026615365066519e-07,0.274413249249863,0.04548816568047338,0.030828249901291835,0.28507649376695987,0.04421210562414265,0.030783626196198732,0.28120895260904044,0.05246913580246911,4.026615365066519e-07,0.31227953170836553,0.03566529492455417
168,0.7,4,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does anterior chamber depth vary with head positioning in pseudoexfoliation syndrome? Yes, head position can influence the anterior chamber depth. Positions like lying flat can increase the depth, potentially complicating disease management. Accordingly, head positioning should be taken into account in patient evaluation and care.",3.552895910352811e-07,0.19188558787159504,0.07114260891733419,0.02720139697172809,0.20363638718941557,0.06858710562414265,0.027162023114293,0.23241878843960873,0.05246913580246911,3.552895910352811e-07,0.2622691111337021,0.03566529492455417
168,0.7,5,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is the depth of the anterior chamber in pseudoexfoliation syndrome influenced by head position? Yes, head positioning does affect anterior chamber depth. Certain positions, such as lying flat, can deepen the chamber and complicate management, so head position should be part of the clinical assessment and treatment plan.",2.8423167282822487e-07,0.12190548943825119,0.07402494703776755,0.02176111757738247,0.13619510639388333,0.06858710562414265,0.0217296184914344,0.16342591695265707,0.05246913580246911,2.8423167282822487e-07,0.19165154391974815,0.03566529492455417
168,0.7,6,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does head positioning have an effect on anterior chamber depth in pseudoexfoliation syndrome? Yes, it does. The anterior chamber depth can be affected by the position of the head; lying flat can increase this depth and complicate treatment. Therefore, head position is an important consideration in managing this syndrome.",2.6054570009253947e-07,0.09962309587772289,0.07490618113891342,0.0199476911126006,0.14418452587759845,0.04732056498142055,0.019918816950481533,0.14144701023388206,0.05246913580246911,2.6054570009253947e-07,0.16917868806769043,0.03566529492455417
168,0.7,7,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can anterior chamber depth in pseudoexfoliation syndrome be affected by how the head is positioned? Yes, head position impacts anterior chamber depth. For instance, lying flat may deepen the chamber and complicate management, so head position should be considered in evaluation and treatment.",4.026615365066519e-07,0.2414062406517683,0.06899408284023667,0.030828249901291835,0.25126443617867,0.06858710562414265,0.030783626196198732,0.28120895260904044,0.05246913580246911,4.026615365066519e-07,0.31227953170836553,0.03566529492455417
168,0.7,8,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth in pseudoexfoliation syndrome dependent on head positioning? Yes, it depends on head position. Specific positions like lying flat can increase anterior chamber depth and make management more challenging, highlighting the need to consider head position in care.",4.500334819780227e-07,0.3281544647090069,0.04198714346843245,0.03445510283085558,0.33682086601281735,0.042963836926081696,0.034405229278104466,0.33250224699659015,0.05246913580246911,4.500334819780227e-07,0.3649232651937844,0.03566529492455417
168,0.7,9,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the position of the head alter anterior chamber depth in pseudoexfoliation syndrome? Yes, it can alter it. Positions such as lying flat increase anterior chamber depth, potentially complicating management. Hence, head position should be included in assessment and treatment strategies.",4.500334819780227e-07,0.25883974665301235,0.09151051939513477,0.03445510283085558,0.30127485675333343,0.06858710562414265,0.034405229278104466,0.33250224699659015,0.05246913580246911,4.500334819780227e-07,0.3649232651937844,0.03566529492455417
168,0.7,10,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth influenced by the positioning of the head in pseudoexfoliation syndrome? Yes, head positioning influences anterior chamber depth. Certain postures, like lying flat, can increase the depth and complicate management, making head position a key factor in assessment and therapy.",4.026615365066519e-07,0.20839923205367583,0.09269872293541813,0.030828249901291835,0.25126443617867,0.06858710562414265,0.030783626196198732,0.28120895260904044,0.05246913580246911,4.026615365066519e-07,0.31227953170836553,0.03566529492455417
169,0.7,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is there a link between the CYP2D6*4 allele and breast cancer risk? A potential reduction in the activation of procarcinogens by CYP2D6*4 poor metabolizers might provide protection against carcinogens.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
169,0.7,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer risk? Poor metabolizers with CYP2D6*4 may have a decreased conversion of procarcinogens, possibly offering a protective effect against carcinogens.",9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.7,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is there any association between the CYP2D6*4 allele and breast cancer risk? The reduced transformation of procarcinogens in CYP2D6*4 poor metabolizers could lead to a protective effect against carcinogens.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
169,0.7,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Can the CYP2D6*4 allele affect breast cancer risk? CYP2D6*4 poor metabolizers might have a lower rate of procarcinogen activation, which may protect against carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.7,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does carrying the CYP2D6*4 allele relate to breast cancer risk? Poor metabolizers of CYP2D6*4 may transform fewer procarcinogens, potentially providing protection from carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.7,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is the CYP2D6*4 allele associated with breast cancer risk? The decreased activation of procarcinogens in CYP2D6*4 poor metabolizers could result in a protective effect against carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.7,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What is the relationship between the CYP2D6*4 allele and breast cancer risk? Reduced metabolism of procarcinogens by CYP2D6*4 poor metabolizers may confer protection against carcinogens.,1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.7,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does the presence of the CYP2D6*4 allele impact breast cancer risk? The impaired transformation of procarcinogens by CYP2D6*4 poor metabolizers might offer a protective effect against carcinogens.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
169,0.7,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is breast cancer risk linked to the CYP2D6*4 allele? CYP2D6*4 poor metabolizers could have diminished procarcinogen activation, leading to protective effects against carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.7,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Could the CYP2D6*4 allele influence breast cancer susceptibility? A possible decrease in procarcinogen metabolism by CYP2D6*4 poor metabolizers might protect against carcinogens.,1.894877818854824e-07,0.3227733922630516,0.0,0.014507411718255037,0.33647223662121384,0.0,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
170,0.7,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott call from Catholic bishops impact Kenya's polio vaccination coverage in 2015? The boycott did not notably affect the campaign then, but repeating it could harm polio eradication efforts in the future, so precautions are needed.",4.500334819780224e-07,0.2505832475575245,0.21789178634416728,0.03445510283085558,0.30396563346711236,0.1507112648981161,0.034405229278104466,0.37260196903774423,0.07544378698224853,4.500334819780227e-07,0.44393138893595907,0.0
170,0.7,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the polio vaccination coverage in Kenya during 2015 influenced by the Catholic bishops' boycott call? The campaign was largely unaffected, yet future repetitions could negatively affect eradication efforts, making vigilance essential.",5.921493183921342e-07,0.390046540551201,0.24489795918367344,0.04533566161954685,0.4862871902610677,0.1507112648981161,0.04527003852382171,0.5606542005406845,0.07544378698224853,5.921493183921352e-07,0.6380874033769168,0.0
170,0.7,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call reduce polio vaccination coverage in Kenya in 2015? The campaign remained mostly unaffected, but similar future calls could seriously impact polio eradication, necessitating preventive measures.",6.158352911278195e-07,0.4228363633741927,0.24489795918367344,0.04714908808432873,0.5201887419367495,0.1507112648981161,0.04708084006477458,0.5957455203519535,0.07544378698224853,6.158352911278206e-07,0.6744550475477915,0.0
170,0.7,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott urging from Catholic bishops impact the 2015 polio vaccination efforts in Kenya? The campaign was not significantly hindered, though if repeated, the boycott could pose serious risks to polio eradication, so it's crucial to guard against it.",4.026615365066518e-07,0.19601810816618714,0.2192746904856125,0.030828249901291835,0.24989841219683617,0.1507112648981161,0.030783626196198732,0.31703211788293206,0.07544378698224853,4.026615365066519e-07,0.3867729750960107,0.0
170,0.7,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","In 2015, did the Catholic bishops' boycott call affect Kenya's polio vaccine coverage? The campaign was not notably impacted, but a future recurrence could threaten eradication efforts, making it important to address proactively.",5.684633456564489e-07,0.3582978422366212,0.24489795918367344,0.04352223515476497,0.453497367438076,0.1507112648981161,0.04345923698286883,0.5267526488650027,0.07544378698224853,5.684633456564497e-07,0.6029960835656478,0.0
170,0.7,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the polio vaccination campaign in Kenya in 2015 affected by a boycott call from Catholic bishops? The campaign proceeded without major disruption, but repeated calls could have negative consequences for eradication, so preventive steps are vital.",4.737194547137077e-07,0.24051480658023738,0.24489795918367344,0.03626852929563745,0.3321365104338092,0.1507112648981161,0.03621603081905734,0.40158950591099574,0.07544378698224853,4.737194547137081e-07,0.47378435208564085,0.0
170,0.7,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott in 2015 impact polio vaccination coverage in Kenya? The campaign was not significantly affected, yet future boycott calls could seriously undermine eradication efforts, highlighting the importance of vigilance.",5.684633456564489e-07,0.3582978422366212,0.24489795918367344,0.04352223515476497,0.453497367438076,0.1507112648981161,0.04345923698286883,0.5267526488650027,0.07544378698224853,5.684633456564497e-07,0.6029960835656478,0.0
170,0.7,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott call by Catholic bishops in 2015 influence polio vaccination coverage in Kenya? The impact was minimal then, but if repeated, it could significantly harm eradication efforts, so it is important to prevent such occurrences.",4.737194547137077e-07,0.24051480658023738,0.24489795918367344,0.03626852929563745,0.3321365104338092,0.1507112648981161,0.03621603081905734,0.40158950591099574,0.07544378698224853,4.737194547137081e-07,0.47378435208564085,0.0
170,0.7,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","In 2015, did the Catholic bishops' boycott affect the polio vaccination campaign in Kenya? The boycott did not have a significant effect, but future repetitions might pose serious challenges to eradication, warranting careful attention.",5.447773729207636e-07,0.3275261835698675,0.24489795918367344,0.04170880868998309,0.4217486691234962,0.1507112648981161,0.04164843544191596,0.493962826042011,0.07544378698224853,5.447773729207643e-07,0.5690945318899661,0.0
170,0.7,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' call for a boycott affect polio vaccine coverage in Kenya in 2015? The campaign was largely unaffected, but future similar calls could negatively impact eradication, so it is essential to ensure prevention.",4.97405427449393e-07,0.26868568354693423,0.24489795918367344,0.03808195576041933,0.3611240473070607,0.1507112648981161,0.03802683236001021,0.4314424690606775,0.07544378698224853,4.974054274493935e-07,0.5045560107523945,0.0
171,0.7,1,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation connect genetic and environmental factors in atrial fibrillation development? Yes, this mutation links genetic susceptibility with environmental influences in the disease's pathogenesis, affecting how the heart responds to stresses such as hypertension and potentially causing irregular heart rhythms.",5.447773729207643e-07,0.07937601983615661,0.3015410245730946,0.04170880868998307,0.20704167333788348,0.16447134211463157,0.04164843544191593,0.2562132206890433,0.13888888888888887,5.447773729207643e-07,0.28469604715804087,0.1262002743484225
171,0.7,2,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the stretch-sensitive KCNQ1 mutation a connection between genetic and environmental contributors to atrial fibrillation? Indeed, this mutation serves as a bridge between inherited traits and environmental stressors in atrial fibrillation by altering the heart's reaction to conditions like hypertension, which may lead to arrhythmias.",4.974054274493935e-07,0.06436269422671526,0.2788260435022455,0.038081955760419325,0.15941362434862905,0.16447134211463157,0.0380268323600102,0.20742305651961157,0.13888888888888887,4.974054274493935e-07,0.23468562658337744,0.1262002743484225
171,0.7,3,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Can the stretch-sensitive KCNQ1 mutation be seen as a link between genetic and environmental factors in atrial fibrillation? Yes, it acts as a molecular connection that integrates genetic predisposition with environmental triggers, influencing the heart's stress response and possibly inducing abnormal rhythms.",5.684633456564497e-07,0.1372856290035065,0.27716602457309464,0.04352223515476494,0.23173428592825518,0.16447134211463157,0.0434592369828688,0.281531028673335,0.13888888888888887,5.684633456564497e-07,0.31067153356129884,0.1262002743484225
171,0.7,4,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the mutation in stretch-sensitive KCNQ1 provide a genetic-environmental link in atrial fibrillation pathogenesis? Yes, this mutation connects inherited genetic factors with environmental stressors such as hypertension, affecting cardiac response and potentially causing atrial fibrillation.",7.34265154806247e-07,0.29068511350336257,0.3015410245730946,0.056216220408238066,0.4241061785757112,0.16447134211463157,0.056134847769538886,0.479356772003253,0.13888888888888887,7.342651548062476e-07,0.5142704888025387,0.1262002743484225
171,0.7,5,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is there a connection between genetic and environmental factors in atrial fibrillation through the stretch-sensitive KCNQ1 mutation? Absolutely, this mutation links genetic predisposition and environmental influences by modifying the heart's response to stress, which can trigger arrhythmias.",6.868932093348764e-07,0.27203487636118906,0.2737859225322783,0.052589367478674306,0.3652656785527779,0.16447134211463157,0.05251324468763314,0.41873215018681753,0.13888888888888887,6.868932093348768e-07,0.45175013182120516,0.1262002743484225
171,0.7,6,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation integrate genetic and environmental elements in the mechanism of atrial fibrillation? Yes, it bridges genetic susceptibility and environmental triggers by impacting how the heart reacts to stresses like hypertension, leading to abnormal heart rhythms.",6.395212638635058e-07,0.21594090894892437,0.27524445773598727,0.04896251454911056,0.30969582739796575,0.16447134211463157,0.0488916416057274,0.3615737363468692,0.13888888888888887,6.39521263863506e-07,0.3929096317982719,0.1262002743484225
171,0.7,7,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the stretch-sensitive KCNQ1 mutation a molecular link between genetic and environmental causes of atrial fibrillation? Indeed, this mutation connects the genetic background with environmental factors by influencing the cardiac response to stress, potentially resulting in arrhythmias.",6.868932093348764e-07,0.23352669966341422,0.3015410245730946,0.052589367478674306,0.3652656785527779,0.16447134211463157,0.05251324468763314,0.41873215018681753,0.13888888888888887,6.868932093348768e-07,0.45175013182120516,0.1262002743484225
171,0.7,8,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Can the stretch-sensitive KCNQ1 mutation explain the interaction between genetics and environment in atrial fibrillation? Yes, it represents a link where genetic predisposition meets environmental stress, altering the heart’s function and promoting abnormal rhythms.",7.579511275419323e-07,0.32053807665304435,0.3015410245730946,0.058029646873019945,0.4548778372424649,0.16447134211463157,0.05794564931049176,0.5111054703178328,0.13888888888888887,7.57951127541933e-07,0.5470603116255304,0.1262002743484225
171,0.7,9,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the mutation in the stretch-sensitive KCNQ1 gene bridge genetic and environmental contributors to atrial fibrillation? Yes, it connects inherited genetic factors with environmental stress conditions like hypertension, affecting the heart's electrophysiology and potentially causing arrhythmias.",7.105791820705617e-07,0.26169757663011106,0.3015410245730946,0.054402793943456186,0.3942532154260294,0.16447134211463157,0.05432404622858601,0.4485851133364993,0.13888888888888887,7.105791820705622e-07,0.48252179048795885,0.1262002743484225
171,0.7,10,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the stretch-sensitive KCNQ1 mutation responsible for linking genetic and environmental aspects in atrial fibrillation? Yes, this mutation serves as a connection between genetic vulnerability and environmental stressors, influencing the heart’s stress response and possibly triggering irregular heartbeats.",6.632072365991911e-07,0.2435951406407013,0.27453485173358844,0.050775941013892434,0.33709480158608107,0.16447134211463157,0.050702443146680265,0.389744613313566,0.13888888888888887,6.632072365991914e-07,0.4218971686715234,0.1262002743484225
172,0.7,1,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy?,7.105791820705596e-07,1.0789923907879073,0.16349480968858132,0.054402793943456325,1.3169796430638967,0.049861495844875335,0.05432404622858618,1.430791059533941,0.025623268698060954,7.105791820705615e-07,1.5581446180465508,0.0
172,0.7,2,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery effectively treat spinal cord sarcoidosis when compressive cervical myelopathy is present?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.7,3,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Does decompressive surgery help in cases of spinal cord sarcoidosis accompanied by compressive cervical myelopathy?,6.395212638635036e-07,0.8378303339710196,0.16349480968858132,0.0489625145491107,1.054615378596405,0.049861495844875335,0.04889164160572755,1.1431089870821598,0.025623268698060954,6.395212638635054e-07,1.2396908869280159,0.0
172,0.7,4,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.7,5,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery relieve symptoms in spinal cord sarcoidosis patients with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.7,6,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery useful for managing spinal cord sarcoidosis along with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.7,7,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Does decompressive surgery improve neurological outcomes in spinal cord sarcoidosis with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.7,8,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is surgery that decompresses the spinal cord effective for sarcoidosis with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.7,9,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery alleviate neurological symptoms caused by spinal cord sarcoidosis and compressive cervical myelopathy?,6.395212638635036e-07,0.8378303339710196,0.16349480968858132,0.0489625145491107,1.054615378596405,0.049861495844875335,0.04889164160572755,1.1431089870821598,0.025623268698060954,6.395212638635054e-07,1.2396908869280159,0.0
172,0.7,10,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is surgical decompression a viable option for spinal cord sarcoidosis accompanied by compressive cervical myelopathy?,6.395212638635036e-07,0.8378303339710196,0.16349480968858132,0.0489625145491107,1.054615378596405,0.049861495844875335,0.04889164160572755,1.1431089870821598,0.025623268698060954,6.395212638635054e-07,1.2396908869280159,0.0
173,0.7,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The concept that Indigenous Australians experience premature aging is not strongly backed by this study examining various specific conditions. The present emphasis and nature of services offered by the aged care sector might not be the most appropriate.,1.4211583641411212e-07,0.1502822030493367,0.0,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
173,0.7,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,This study on a range of particular conditions does not strongly support the notion that Indigenous Australians age prematurely. The current approach and kind of services given by aged care may not be suitable.,2.3685972735685332e-07,0.26469255422708216,0.0,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
173,0.7,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Indigenous Australians do not appear to age prematurely according to this study of several distinct conditions. The current focus and type of aged care services may not align well with their needs.,2.842316728282239e-07,0.32721291120841567,0.0,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
173,0.7,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The hypothesis that Indigenous Australians age faster is not well substantiated by this study of discrete health conditions. The existing aged care service focus and provision might not be optimal.,3.316036182995945e-07,0.39390428570708913,0.0,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
173,0.7,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"According to this study on specific health conditions, there is little evidence that Indigenous Australians age prematurely. The present aged care services and their focus may not be adequately addressing their requirements.",2.842316728282239e-07,0.32721291120841567,0.0,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
173,0.7,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,This investigation into various isolated conditions does not provide strong evidence that Indigenous Australians experience premature aging. The current aged care sector's focus and services might not be fully appropriate.,3.316036182995945e-07,0.39390428570708913,0.0,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
173,0.7,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The belief that Indigenous Australians age earlier than others is not strongly supported by this study of certain conditions. The aged care services currently offered might not be the most effective.,3.079176455639092e-07,0.36000273403140737,0.0,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
173,0.7,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,This study analyzing a series of particular conditions does not support the idea that Indigenous Australians age prematurely. The current aged care sector's service delivery and focus might not be suitable.,3.079176455639092e-07,0.36000273403140737,0.0,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
173,0.7,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Evidence from this study on discrete conditions does not strongly endorse the view that Indigenous Australians age prematurely. The aged care services and their current focus may not be fitting.,3.316036182995945e-07,0.39390428570708913,0.0,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
173,0.7,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,The idea that Indigenous Australians undergo premature aging lacks strong support from this study of distinct conditions. The current aged care sector's emphasis and service types may not be ideal.,3.316036182995945e-07,0.39390428570708913,0.0,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
174,0.7,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate achievable? Consistent, high-quality training, adherence to evidence-based protocols, and detailed documentation contribute significantly to reducing CLABSIs. Thoughtful organization helps units better comprehend how to manage peak demands and sustain exceptional performance over time.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
174,0.7,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be maintained? Effective training, strict following of evidence-based guidelines, and comprehensive record-keeping are linked to major decreases in CLABSIs. Careful structuring may improve understanding of how units handle peak loads and maintain long-term excellence.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
174,0.7,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero central line-associated bloodstream infection rate? High-quality education, rigorous compliance with proven guidelines, and meticulous documentation are key factors in lowering CLABSIs. Deliberate organizational efforts can enhance a unit's capacity to manage peak demands and uphold outstanding performance long-term.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.7,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is zero central line-associated bloodstream infection rate sustainable? Significant reductions in CLABSIs are associated with thorough training, strict adherence to evidence-based practices, and detailed documentation. Mindful organizational strategies could foster better insight into managing peak demand and sustaining top performance.",3.079176455639102e-07,0.28768207245178345,0.0,0.023574544042164344,0.29423947299793873,0.0,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
174,0.7,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero CLABSI rates be sustained? The combination of quality training, strict compliance with evidence-based protocols, and thorough documentation correlates with substantial CLABSI reduction. Organized and mindful approaches may improve understanding of sustaining exceptional unit performance during high demand.",3.316036182995955e-07,0.31365755885504143,0.0,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
174,0.7,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero central line-associated bloodstream infection rate maintainable? Consistent high-quality training, strict guideline compliance, and careful documentation are linked to notable CLABSI decreases. Thoughtful organization aids in understanding how to meet peak demands and sustain excellent performance.",3.552895910352808e-07,0.3403258059372023,0.0,0.02720139697172809,0.3483066942682149,0.0,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
174,0.7,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero rate of central line-associated bloodstream infections feasible? Rigorous training, strict adherence to evidence-based guidelines, and comprehensive documentation are associated with significant CLABSI reduction. Mindful organizational planning may enhance a unit's ability to handle peak demand and maintain exceptional long-term performance.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.7,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it achievable to keep the central line-associated bloodstream infection rate at zero? Effective high-quality training, strict compliance with evidence-based rules, and thorough documentation contribute significantly to reducing CLABSIs. Mindful organization helps units better grasp how to handle peak demands and sustain outstanding performance.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.7,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it feasible to maintain zero central line-associated bloodstream infection rates? High-quality training, strict adherence to evidence-based guidelines, and complete documentation are associated with major CLABSI reductions. Conscious organizational efforts may improve understanding of unit capacity during peak demand to sustain excellent performance long-term.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.7,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is zero central line-associated bloodstream infection rate a sustainable goal? Thorough training, strict compliance with evidence-based guidelines, and detailed documentation are linked to significant CLABSI declines. Mindful organizational methods can help units better manage peak demands and sustain extraordinary long-term performance.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
175,0.7,1,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF results in poor responders compared to oral contraceptive pills? Research shows no significant improvement, though slight benefits may occur in some cases; more studies are needed.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
175,0.7,2,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In poor responders undergoing IVF, does estradiol and antagonist pretreatment prior to microdose leuprolide improve outcomes versus oral contraceptive pills? Evidence suggests no major benefit, with only potential minor advantages; further research is required.",7.105791820705614e-07,0.3165570789441259,0.21484375,0.0544027939434562,0.39308344460925637,0.18240000000000006,0.054324046228586026,0.4723514260803108,0.14312130177514798,7.105791820705622e-07,0.5545177444479563,0.09876543209876548
175,0.7,3,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does using estradiol and antagonist before microdose leuprolide enhance IVF success in poor responders compared to oral contraceptive pills? Studies indicate no significant gain, but there could be small benefits in select cases, warranting more research.",6.632072365991908e-07,0.2577165789211926,0.21484375,0.05077594101389244,0.3324588227928209,0.18240000000000006,0.05070244314668028,0.40983106909897726,0.14312130177514798,6.632072365991914e-07,0.4899792233103848,0.09876543209876548
175,0.7,4,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is IVF outcome better in poor responders with estradiol and antagonist pretreatment prior to microdose leuprolide than with oral contraceptive pills? Findings reveal no substantial improvement, though minimal benefits might exist in some instances; further investigation is necessary.",6.158352911278202e-07,0.20214672776638043,0.21484375,0.04714908808432869,0.27530040895287256,0.18240000000000006,0.04708084006477453,0.350990569076044,0.14312130177514798,6.158352911278206e-07,0.42935460149394933,0.09876543209876548
175,0.7,5,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment involving estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Research indicates no clear advantage, yet slight benefits may occur in certain situations; additional studies are needed.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
175,0.7,6,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In IVF treatment for poor responders, does estradiol and antagonist pretreatment before microdose leuprolide outperform oral contraceptive pills? Data shows no significant improvement but suggests possible marginal benefits; further research is recommended.",7.57951127541932e-07,0.3790774359254594,0.21484375,0.05802964687301996,0.4576219657468279,0.18240000000000006,0.05794564931049177,0.5390428005789842,0.14312130177514798,7.57951127541933e-07,0.6235106159349071,0.09876543209876548
175,0.7,7,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Are IVF outcomes improved in poor responders by estradiol and antagonist pretreatment prior to microdose leuprolide versus oral contraceptive pill use? Evidence points to no major improvement, though minor benefits might be present; more studies are warranted.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
175,0.7,8,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies",Does administration of estradiol and antagonist before microdose leuprolide enhance IVF success rates in poor responders compared to oral contraceptive pills? Research does not show significant improvement but hints at slight benefits in some cases; further study is needed.,5.921493183921349e-07,0.17547848068421956,0.21484375,0.045335661619546816,0.24790143476475723,0.18240000000000006,0.045270038523821665,0.32281969210934713,0.14312130177514798,5.921493183921352e-07,0.4003670646206978,0.09876543209876548
175,0.7,9,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is there an improvement in IVF outcomes for poor responders with estradiol and antagonist pretreatment prior to microdose leuprolide compared to oral contraceptive pills? Studies suggest no significant benefit, although marginal gains could occur; further research is necessary.",6.158352911278202e-07,0.20214672776638043,0.21484375,0.04714908808432869,0.27530040895287256,0.18240000000000006,0.04708084006477453,0.350990569076044,0.14312130177514798,6.158352911278206e-07,0.42935460149394933,0.09876543209876548
175,0.7,10,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does estradiol and antagonist pretreatment before microdose leuprolide improve IVF outcomes in poor responders relative to oral contraceptive pills? Research findings indicate no significant enhancement, but slight benefits may be seen in specific situations; additional studies are required.",6.158352911278202e-07,0.20214672776638043,0.21484375,0.04714908808432869,0.27530040895287256,0.18240000000000006,0.04708084006477453,0.350990569076044,0.14312130177514798,6.158352911278206e-07,0.42935460149394933,0.09876543209876548
176,0.7,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count serves as a predictive marker for long-term survival in ESCC, particularly among patients with lymph node involvement. We suggest that a cutoff value of 205 (×10(9)/L) is optimal for forecasting survival in ESCC cases.",4.737194547137081e-08,0.021629006897032177,0.0809876543209877,0.0036268529295637453,0.014584877794231677,0.019475876740709334,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
176,0.7,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? The platelet count before surgery is a significant predictor of long-term survival in ESCC, especially in those with positive lymph nodes. Our findings indicate that 205 (×10(9)/L) is the best threshold for predicting survival in ESCC patients.",7.105791820705622e-08,0.028227745859835007,0.10074074074074077,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,0.7,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet levels forecast prognosis in esophageal squamous cell carcinoma? Platelet counts measured preoperatively are predictive of long-term survival in ESCC patients, notably in those with nodal metastases. We identify 205 (×10(9)/L) as the optimal cutoff for survival prediction in these patients.",1.8948778188548325e-07,0.025258988157498052,0.1432098765432099,0.014507411718254981,0.12166478809530323,0.040742417383431435,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
176,0.7,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is platelet count prior to surgery a prognostic factor in esophageal squamous cell carcinoma? The preoperative platelet count is a useful predictor for long-term survival in ESCC, particularly in patients with lymph node positivity. We propose that a cutoff of 205 (×10(9)/L) best predicts survival outcomes in ESCC patients.",4.737194547137081e-08,0.07939127194369444,0.12238597432501162,0.0036268529295637453,0.014910746910446804,0.040742417383431435,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
176,0.7,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","What is the role of preoperative platelet count in prognosis of esophageal squamous cell carcinoma? Pre-surgery platelet count predicts long-term survival in ESCC, especially in patients with nodal involvement. We conclude that a platelet count of 205 (×10(9)/L) is the optimal cutoff for predicting survival in ESCC.",9.474389094274162e-08,0.06620950534838244,0.009423028470647549,0.0072537058591274906,0.02857436502929156,0.040742417383431435,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
176,0.7,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the platelet count before surgery serve as a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC patients, most notably those with positive lymph nodes. The optimal cutoff point for platelet count to predict survival is 205 (×10(9)/L).",1.4211583641411244e-07,0.053644355840885005,0.05023935500125981,0.010880558788691236,0.0740367391060488,0.040742417383431435,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
176,0.7,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a significant prognostic marker in esophageal squamous cell carcinoma? It is predictive of long-term survival in ESCC, particularly for patients with nodal metastasis. Our study suggests that 205 (×10(9)/L) is the ideal cutoff for survival prediction.",2.3685972735685406e-07,0.10870651135492615,0.118226313098108,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,0.7,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","How does preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? A higher platelet count before surgery predicts better long-term survival in ESCC patients, especially those with lymph node positivity. The cutoff value of 205 (×10(9)/L) appears to be optimal for survival prediction.",1.6580180914979784e-07,0.03396789449427784,0.11996724615772239,0.012693985253473108,0.09756723651624322,0.040742417383431435,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
176,0.7,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count be used to predict survival in esophageal squamous cell carcinoma? Yes, it is a prognostic factor, particularly in nodal-positive ESCC patients. We determine that 205 (×10(9)/L) is the best cutoff point for survival prediction.",3.0791764556390996e-07,0.15201069379664034,0.1432098765432099,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
176,0.7,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count an effective prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially among patients with lymph node involvement. The optimal cutoff for platelet count in predicting survival is 205 (×10(9)/L).",1.6580180914979784e-07,0.11061526347112327,0.02383487654320987,0.012693985253473108,0.1305742451143348,0.01694705747861288,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
177,0.7,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly an indication for simultaneous splenectomy in mild hereditary spherocytosis? The recommendation to perform concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be reconsidered. With the advancement of minimally invasive surgery, the decision to perform splenectomy in these children should be evaluated independently.",9.474389094274162e-08,0.11397493698475625,0.02903209876543214,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
177,0.7,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy warrant a concomitant splenectomy in cases of mild hereditary spherocytosis? The current advice to carry out splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones merits re-evaluation. Given the progress in minimal access surgery, the necessity for splenectomy should be assessed on its own basis.",1.1842986367842703e-07,0.01074880401924494,0.09639999999999999,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
177,0.7,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is performing a splenectomy alongside cholecystectomy justified in mild hereditary spherocytosis? The guidance recommending simultaneous splenectomy during cholecystectomy for children with mild HS and symptomatic gallstones needs to be reviewed. In light of minimally invasive techniques, the need for splenectomy should be considered independently.",2.3685972735685406e-07,0.1207496992335737,0.09639999999999999,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,0.7,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should splenectomy be performed concurrently with cholecystectomy in mild hereditary spherocytosis? The suggestion to conduct concomitant splenectomy in children with mild HS undergoing cholecystectomy for gallstones requires reassessment. With the availability of minimal access surgery, splenectomy decisions should be based on individual clinical indications.",2.3685972735685406e-07,0.1207496992335737,0.09639999999999999,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,0.7,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is concomitant splenectomy indicated when performing cholecystectomy in mild hereditary spherocytosis? The recommendation to perform splenectomy simultaneously with cholecystectomy in children with mild HS and symptomatic gallstones needs to be reconsidered. Advances in minimal access surgery mean the necessity of splenectomy should be judged independently.,2.1317375462116866e-07,0.12926687103432677,0.07368501892915087,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.7,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis require splenectomy when cholecystectomy is done? The advice to do concomitant splenectomy during cholecystectomy in children with mild HS and symptomatic gallstones should be reexamined. Given minimal access surgery's role, splenectomy should be evaluated on its own merit.",2.8423167282822487e-07,0.202189805811118,0.07202499999999998,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
177,0.7,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is it necessary to do a splenectomy at the same time as cholecystectomy in mild hereditary spherocytosis? Reconsideration is needed for the advice to perform simultaneous splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones. The rise of minimal access surgery calls for assessing splenectomy necessity separately.,1.1842986367842703e-07,0.01074880401924494,0.09639999999999999,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
177,0.7,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis justify concomitant splenectomy during cholecystectomy? The advice to perform splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones should be revisited. With minimal access surgery, splenectomy decisions should stand on their own.",3.789755637709662e-07,0.2710319022829104,0.09639999999999999,0.029014823436509962,0.34106527318070423,0.01922337562475971,0.028972824655245866,0.37647757123491177,0.0,3.789755637709665e-07,0.3856624808119835,0.0
177,0.7,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is concomitant splenectomy really needed in children with mild hereditary spherocytosis undergoing cholecystectomy? The current recommendation for simultaneous splenectomy in these cases needs reconsideration. Minimal access surgery advances mean splenectomy indications should be independently judged.,4.500334819780221e-07,0.3555892903109741,0.09639999999999999,0.034455102830855594,0.42807665017033436,0.01922337562475971,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
177,0.7,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","When performing cholecystectomy on children with mild hereditary spherocytosis, is a splenectomy also necessary? The suggestion to do concomitant splenectomy for symptomatic gallstones in mild HS cases requires reevaluation. The development of minimal access surgery suggests splenectomy should be considered on its individual merit.",2.3685972735685406e-07,0.1207496992335737,0.09639999999999999,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
178,0.7,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can measuring visceral adipose tissue area at one level represent the total visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at a single level can give an estimate but does not completely represent the full visceral adipose tissue volume, since adipose tissue distribution differs across the body and a single measurement may not reflect this variation accurately.",2.3685972735685406e-08,0.05543070755595858,0.09355666213973157,0.0018134264647818726,0.07405583877745459,0.06742567815678363,0.0018108015409528666,0.05305515767171887,0.04960187011469063,2.3685972735685406e-08,0.030073724818891368,0.03411042597256224
178,0.7,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is a single-level measurement of visceral adipose tissue area sufficient to represent its total volume? Answer: While a single-level measurement of visceral adipose tissue area can approximate the volume, it cannot fully represent it due to the variability of adipose tissue distribution throughout the body.",3.552895910352811e-07,0.1256626391894109,0.4431458485512539,0.02720139697172809,0.2239262895923928,0.15191731053889126,0.027162023114293,0.317030152092566,0.012194922060679514,3.552895910352811e-07,0.3401258691281219,0.02440710458764811
178,0.7,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Does measuring visceral adipose tissue area at one anatomical level represent the entire visceral adipose tissue volume? Answer: A single-level measurement of visceral adipose tissue area may provide a rough estimate but cannot fully capture the total volume because adipose tissue distribution varies across different body regions.,3.079176455639103e-07,0.04169977201759556,0.346619075946857,0.023574544042164344,0.09221984832807006,0.1734697256348704,0.023540420032387266,0.1411773006391579,0.07986026211550686,3.079176455639103e-07,0.16157781910085678,0.06977572089711641
178,0.7,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can a single-level visceral adipose tissue area measurement accurately represent the whole visceral adipose tissue volume? Answer: Although it may offer an approximation, a single-level measurement does not fully reflect visceral adipose tissue volume due to the heterogeneous distribution of adipose tissue in the body.",3.552895910352811e-07,0.0948560978311912,0.33136094674556227,0.02720139697172809,0.10979153275796172,0.1919107779166088,0.027162023114293,0.15583313335769544,0.10207100591715974,3.552895910352811e-07,0.20809783473575072,0.06977572089711641
178,0.7,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is visceral adipose tissue volume accurately represented by measuring its area at a single level? Answer: Measuring visceral adipose tissue area at one level might approximate the volume, but it cannot completely represent it because the distribution of adipose tissue varies throughout the body.",3.789755637709665e-07,0.027974191016794325,0.5266666666666666,0.029014823436509962,0.09011507141135455,0.2616386690730714,0.028972824655245866,0.17936363076788986,0.10207100591715974,3.789755637709665e-07,0.23219538631481074,0.06977572089711641
178,0.7,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can the volume of visceral adipose tissue be inferred from its area measurement at a single level? Answer: The area measurement at a single level can approximate visceral adipose tissue volume but cannot fully represent it, given the variable distribution of adipose tissue in the body.",3.316036182995957e-07,0.06793646228555472,0.46811308349769887,0.025387970506946217,0.1356394590205019,0.19683846781073022,0.025351221573340132,0.19585699518390065,0.05671953199425725,3.316036182995957e-07,0.2168067410725305,0.046533090511628884
178,0.7,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does a single-level visceral adipose tissue area measurement reflect the total visceral adipose tissue volume? Answer: It may provide an estimate, but it cannot fully represent visceral adipose tissue volume because the adipose tissue is unevenly distributed in the body.",4.737194547137081e-07,0.20639096521403166,0.3156462585034012,0.03626852929563745,0.24002277481815204,0.17969503211012938,0.03621603081905733,0.2794470893248713,0.10207100591715974,4.737194547137081e-07,0.334849540374893,0.06977572089711641
178,0.7,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is it possible to represent visceral adipose tissue volume by measuring its area at a single level? Answer: While a single-level measurement can serve as an approximation, it does not fully represent the visceral adipose tissue volume due to the body's varied adipose tissue distribution.",3.552895910352811e-07,0.002436473756531221,0.5298433472139599,0.02720139697172809,0.09789952949058556,0.23952982553565638,0.027162023114293,0.18807253710466965,0.07882837553167221,3.552895910352811e-07,0.20809783473575072,0.06977572089711641
178,0.7,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Can visceral adipose tissue area measured at one level stand in for the total volume? Answer: Measuring the area at a single level may give an approximate idea but cannot fully represent the total visceral adipose tissue volume because adipose tissue distribution changes across the body.,3.316036182995957e-07,0.022474039526612977,0.5328798185941043,0.025387970506946217,0.043219834945842805,0.262670555656906,0.025351221573340132,0.13284361513299592,0.10207100591715974,3.316036182995957e-07,0.1845673373255563,0.06977572089711641
178,0.7,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Does a single slice measurement of visceral adipose tissue area represent the entire visceral adipose tissue volume? Answer: A single slice measurement can approximate the volume but cannot represent it fully owing to the heterogeneous distribution of adipose tissue throughout the body.,4.263475092423373e-07,0.14707578400831034,0.4722222222222222,0.03264167636607371,0.20693988941850483,0.21216661801811565,0.0325944277371516,0.26281115396531796,0.07708744247205782,4.263475092423373e-07,0.28220580688947416,0.06977572089711641
179,0.7,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT enables localized entry of chemotherapy drugs into brain tissue, which could be beneficial for brain tumor treatment.",6.632072365991891e-07,0.9734491457141035,0.0,0.05077594101389256,1.0116009116784808,0.0,0.050702443146680404,1.0531499145913519,0.0,6.63207236599191e-07,1.0986122886681096,0.0
179,0.7,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Laser-induced thermal therapy allows chemotherapeutic agents to pass into brain tissue regionally, potentially aiding brain tumor therapies.",6.868932093348744e-07,1.0340737675305385,0.0,0.05258936747867443,1.0761394328160514,0.0,0.05251324468763327,1.122142786078304,0.0,6.868932093348764e-07,1.1727202608218308,0.0
179,0.7,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Using Nd:YAG laser-induced thermo therapy, chemotherapy drugs can locally penetrate the blood-brain barrier, offering new options for glioma treatment.",6.395212638635038e-07,0.9162907318741547,0.0,0.048962514549110686,0.9509762898620457,0.0,0.04889164160572752,0.9886113934537812,0.0,6.395212638635056e-07,1.0296194171811575,0.0
179,0.7,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"The locoregional opening of the blood-brain barrier by LITT facilitates the delivery of chemotherapy to brain tissue, presenting a promising approach for treating brain tumors.",4.974054274493918e-07,0.6286086594223743,0.0,0.03808195576041941,0.6486954179891122,0.0,0.03802683236001029,0.6701576623352468,0.0,4.974054274493935e-07,0.6931471805599463,0.0
179,0.7,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Thermo therapy induced by Nd:YAG laser creates a regional passage in the rodent blood-brain barrier, allowing chemotherapeutic access for glioma therapy.",5.92149318392133e-07,0.8109302162163292,0.0,0.04533566161954693,0.8397506547518216,0.0,0.04527003852382178,0.8708283577973974,0.0,5.921493183921349e-07,0.9044562742271518,0.0
179,0.7,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT causes localized permeability in the blood-brain barrier, enhancing chemotherapy drug delivery to brain tissue, which is relevant for brain tumor management.",5.684633456564477e-07,0.7621400520468979,0.0,0.04352223515476505,0.7884573603642715,0.0,0.04345923698286891,0.8167611365271221,0.0,5.684633456564495e-07,0.847297860387203,0.0
179,0.7,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Nd:YAG laser-induced thermo therapy promotes regional crossing of chemotherapeutic agents into brain tissue, suggesting a novel adjuvant glioma treatment.",6.395212638635038e-07,0.9162907318741547,0.0,0.048962514549110686,0.9509762898620457,0.0,0.04889164160572752,0.9886113934537812,0.0,6.395212638635056e-07,1.0296194171811575,0.0
179,0.7,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Locoregional disruption of the rodent blood-brain barrier by LITT permits chemotherapy agents to enter brain tissue, offering potential benefits for brain tumor treatment.",5.447773729207624e-07,0.715620036412004,0.0,0.04170880868998317,0.7396671961948402,0.0,0.041648435441916036,0.765467842139572,0.0,5.447773729207642e-07,0.7932306391169277,0.0
179,0.7,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"By using Nd:YAG laser-induced thermal therapy, chemotherapeutic drugs can locally cross the blood-brain barrier, opening new avenues in glioma therapy.",6.158352911278184e-07,0.8622235106038794,0.0,0.04714908808432881,0.893817876022097,0.0,0.04708084006477466,0.9279867716373462,0.0,6.158352911278203e-07,0.9650808960435868,0.0
179,0.7,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"LITT induces a targeted passage for chemotherapy drugs through the blood-brain barrier into brain tissue, which may improve treatment outcomes for brain tumors.",5.447773729207624e-07,0.715620036412004,0.0,0.04170880868998317,0.7396671961948402,0.0,0.041648435441916036,0.765467842139572,0.0,5.447773729207642e-07,0.7932306391169277,0.0
180,0.7,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? Yes, such a consultation can alter the treatment plan by evaluating the patient's overall health, functional abilities, and vulnerabilities, allowing doctors to customize care.",3.3160361829959526e-07,0.11747925866822984,0.1435714892738773,0.025387970506946217,0.1384301850326577,0.13888888888888887,0.02535122157334014,0.20043482367507393,0.10275824770146022,3.316036182995957e-07,0.2651531661295423,0.06353305785123965
180,0.7,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation affect the cancer treatment plan for older adults? Indeed, it can, as this consultation assesses the older patient's general health and functional status to help physicians adjust the treatment accordingly.",3.7897556377096586e-07,0.13612949581040334,0.17132659131469363,0.029014823436509976,0.19727068505559098,0.13888888888888887,0.028972824655245887,0.2610594454915094,0.10275824770146022,3.789755637709665e-07,0.32767352311087583,0.06353305785123965
180,0.7,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? Yes, because this specialized evaluation reviews the patient's health and vulnerabilities, enabling tailored treatment strategies.",5.210914001850777e-07,0.3302855102513611,0.17132659131469363,0.039895382225201254,0.39794138051774164,0.13888888888888887,0.03983763390096313,0.46869881026975335,0.10275824770146022,5.210914001850789e-07,0.5427849027278224,0.06353305785123965
180,0.7,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does consulting a geriatric oncologist lead to changes in cancer treatment for elderly patients? Yes, these consultations evaluate overall health and function, helping doctors adapt treatment plans for the elderly.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.7,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Will a geriatric oncology consultation influence the cancer treatment plan in older patients? Yes, it can, by assessing the patient's health and functional capabilities to customize the treatment approach.",5.210914001850777e-07,0.3302855102513611,0.17132659131469363,0.039895382225201254,0.39794138051774164,0.13888888888888887,0.03983763390096313,0.46869881026975335,0.10275824770146022,5.210914001850789e-07,0.5427849027278224,0.06353305785123965
180,0.7,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation modify elderly patients' cancer treatment? Yes, it involves evaluating health status and vulnerabilities to guide personalized treatment plans.",6.632072365991895e-07,0.5714475670682497,0.17132659131469363,0.05077594101389253,0.6492558087986495,0.13888888888888887,0.05070244314668037,0.7310630747372455,0.10275824770146022,6.632072365991913e-07,0.8172217484295823,0.06353305785123965
180,0.7,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology evaluation impact cancer treatment plans for elderly individuals? Yes, it assesses health and function to help physicians tailor the treatment accordingly.",6.158352911278189e-07,0.48443619007862004,0.17132659131469363,0.04714908808432877,0.5582840305929215,0.13888888888888887,0.04708084006477462,0.6357528949329203,0.10275824770146022,6.158352911278206e-07,0.7171382898726009,0.06353305785123965
180,0.7,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan adjusted after a geriatric oncology consultation for elderly patients? Yes, because this consultation reviews overall health and potential risks, aiding in personalized care.",5.44777372920763e-07,0.3666531544222358,0.17132659131469363,0.04170880868998313,0.4356817085005886,0.13888888888888887,0.041648435441916,0.5079195234230358,0.10275824770146022,5.447773729207643e-07,0.5836068972480772,0.06353305785123965
180,0.7,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Do geriatric oncology consultations change cancer treatment plans for older patients? Yes, by examining the patient's health and vulnerabilities, these consultations help customize treatment.",6.395212638635042e-07,0.5269958044974157,0.17132659131469363,0.04896251454911065,0.6027357931637556,0.13888888888888887,0.048891641605727496,0.6822729105678143,0.10275824770146022,6.39521263863506e-07,0.7659284540420321,0.06353305785123965
180,0.7,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation lead to modifications in the cancer treatment plan for elderly patients? Yes, as it assesses the patient's overall health and functional status, enabling tailored treatment decisions.",4.7371945471370706e-07,0.26129263876441033,0.17132659131469363,0.036268529295637494,0.32648241653559795,0.13888888888888887,0.03621603081905738,0.3945908381160317,0.10275824770146022,4.737194547137081e-07,0.465823861591693,0.06353305785123965
181,0.7,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be implemented in community palliative care? Answer: Implementing an advance care planning model is achievable within community palliative care services. Quality audit procedures are crucial to the model, with documented advance care planning discussions serving as a key outcome metric.",2.3685972735685406e-08,0.02647871068598251,0.005460634451018881,0.0018134264647818726,0.024910513283144198,0.003036471380144401,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.7,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it possible to apply an advance care planning model in community palliative care? Answer: An advance care planning model can be effectively applied in community palliative care settings. Quality audits play a vital role in the model, and recording advance care planning discussions is an important outcome indicator.",4.737194547137081e-08,0.02271710745488864,0.010235350981558533,0.0036268529295637453,0.019175244203657016,0.015483027535874605,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,0.7,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can community palliative care utilize an advance care planning model? Answer: Yes, an advance care planning model is practical for community palliative care services. The model relies heavily on quality audit processes, and documenting advance care planning discussions is a significant measure of success.",7.105791820705622e-08,0.08155355311389823,0.017129747991234345,0.005440279394345618,0.07664516186971415,0.00953991063881171,0.0054324046228586,0.040386797368603844,0.020552936471601127,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
181,0.7,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the use of an advance care planning model viable in community palliative care? Answer: The advance care planning model is viable for community palliative care services. Integral to the model are quality audit processes, with the documentation of advance care planning discussions recognized as a crucial outcome measure.",4.737194547137081e-08,0.07930055076590481,0.03128684424012981,0.0036268529295637453,0.07693750925031928,0.02712018140589574,0.003621603081905733,0.07560256995149928,0.02308175573369758,4.737194547137081e-08,0.07595845259628531,0.02271498107084911
181,0.7,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Does an advance care planning model work in community palliative care? Answer: An advance care planning model works well within community palliative care services. Essential to the model are quality audit procedures, and the documentation of advance care planning discussions is an important outcome metric.",4.737194547137081e-08,0.053651123112664845,0.011165166204986032,0.0036268529295637453,0.0504482305434073,0.006213151927437682,0.003621603081905733,0.048328098854266255,0.0020526554379765236,4.737194547137081e-08,0.04802033420753293,0.0010803788339694455
181,0.7,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be effectively implemented in community palliative care? Answer: Yes, such a model is feasible in community palliative care services. The model depends on quality audit processes, with establishing documentation of advance care planning discussions as a key outcome measure.",4.737194547137081e-08,0.06202397401819715,0.1563321683521714,0.0036268529295637453,0.024457152774873148,0.08843537414965986,0.003621603081905733,0.016150708639682154,0.04434829637641968,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
181,0.7,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model suitable for community palliative care? Answer: An advance care planning model is suitable and feasible for community palliative care services. Quality audit measures are fundamental to the model, with documentation of advance care planning discussions regarded as an important outcome.",2.3685972735685406e-08,0.056615544623371594,0.027093144044321227,0.0018134264647818726,0.055717054641363895,0.02558815192743763,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.7,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it feasible to use an advance care planning model in community palliative care? Answer: Using an advance care planning model is feasible in community palliative care. Quality audits are essential components of the model, and documenting advance care planning discussions is a vital outcome measure.",2.3685972735685406e-08,0.056615544623371594,0.02709314404432117,0.0018134264647818726,0.055717054641363895,0.02558815192743763,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.7,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be incorporated into community palliative care? Answer: Incorporation of an advance care planning model into community palliative care services is feasible. The model includes quality audit processes, with documented advance care planning discussions as an important outcome metric.",7.105791820705622e-08,0.11306024313935037,0.03957561728395059,0.005440279394345618,0.1088845656166888,0.03311065885264533,0.0054324046228586,0.07339380596669631,0.003151703623580332,7.105791820705622e-08,0.07292293477679124,0.0016600189291508909
181,0.7,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is implementing an advance care planning model practical in community palliative care? Answer: Implementing an advance care planning model is practical for community palliative care services. Quality audit procedures are key to the model, and the documentation of advance care planning discussions is a significant outcome measure.",0.0,0.029495624704679813,0.021239727153188726,0.0,0.03013683393738864,0.022072759303999184,0.0,0.030806541358219697,0.021978234235825206,0.0,0.031506690025452144,0.022636492852053384
182,0.7,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure indicate fluid responsiveness? Central venous pressure (CVP) is not a reliable predictor of fluid responsiveness. Fluid responsiveness depends mainly on the heart and circulatory system interaction.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.7,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can central venous pressure forecast fluid responsiveness? Central venous pressure (CVP) cannot consistently predict fluid responsiveness. Fluid responsiveness is chiefly governed by heart and circulatory system dynamics.,2.131737546211677e-07,0.28506432029325124,0.008572048611111119,0.016320838183036916,0.32216311063040726,0.010545798898071623,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
182,0.7,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness predicted by central venous pressure? Central venous pressure (CVP) does not serve as a dependable indicator for fluid responsiveness. The primary factor for fluid responsiveness is the relationship between the heart and circulation.,0.0,0.0,0.0,0.0,0.04077336356234973,0.029384756657483937,0.0,0.0,0.0,0.0,0.0,0.0
182,0.7,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does measuring central venous pressure help predict fluid responsiveness? Central venous pressure (CVP) is unreliable for predicting fluid responsiveness. Fluid responsiveness is mainly influenced by how the heart interacts with the circulatory system.,7.10579182070559e-08,0.057430325306548013,0.022738715277777773,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
182,0.7,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can fluid responsiveness be forecasted using central venous pressure? Central venous pressure (CVP) fails to reliably predict fluid responsiveness. The key determinant of fluid responsiveness is the interaction between heart function and circulation.,7.10579182070559e-08,0.057430325306548013,0.022738715277777773,0.005440279394345639,0.05159995656866556,0.029384756657483937,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
182,0.7,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure an accurate predictor of fluid responsiveness? Central venous pressure (CVP) does not reliably indicate fluid responsiveness. Fluid responsiveness depends on the interplay between the heart and the circulatory system.,7.10579182070559e-08,0.057430325306548013,0.022738715277777773,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
182,0.7,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure provide a reliable assessment of fluid responsiveness? Central venous pressure (CVP) does not consistently predict fluid responsiveness. Fluid responsiveness is primarily influenced by heart-circulation interaction.,1.658018091497971e-07,0.20333934615535476,0.01395502034023667,0.012693985253473157,0.24109453064651598,0.00759749186322611,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
182,0.7,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure useful for predicting fluid responsiveness? Central venous pressure (CVP) is not a reliable metric for fluid responsiveness. Fluid responsiveness is chiefly determined by the heart’s interaction with the circulatory system.,4.73719454713706e-08,0.024033109137672426,0.024607139373048918,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.7,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can central venous pressure measurements predict fluid responsiveness? Central venous pressure (CVP) does not reliably forecast fluid responsiveness. The main factor affecting fluid responsiveness is the heart and circulatory system relationship.,1.184298636784265e-07,0.12774507294878434,0.018634406887755126,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.7,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure serve as a predictor for fluid responsiveness? Central venous pressure (CVP) is not a dependable predictor of fluid responsiveness. Fluid responsiveness largely depends on the interaction between the heart and circulation.,2.36859727356853e-08,0.008290966955181833,0.0263671875,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
183,0.7,1,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine insertion of a nasobiliary drainage tube required after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, it is not routinely necessary. The decision should be",4.974054274493926e-07,0.09070440298246885,0.24691358024691368,0.03808195576041936,0.17725910018847202,0.22506925207756232,0.03802683236001024,0.2397424159952961,0.20249835634451027,4.974054274493935e-07,0.3049902930358508,0.174375
183,0.7,2,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Should a nasobiliary drainage tube be routinely placed after endoscopic removal of common bile duct stones in patients with choledocholithiasis-induced cholangitis? No, routine insertion is not required. The decision depends on",5.210914001850779e-07,0.12349422580546054,0.24691358024691368,0.03989538222520124,0.21116065186415378,0.22506925207756232,0.039837633900963114,0.2748337358065651,0.20249835634451027,5.210914001850789e-07,0.34135793720672547,0.174375
183,0.7,3,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it mandatory to insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? No, routine insertion is not needed. The choice should be",5.210914001850779e-07,0.12349422580546054,0.24691358024691368,0.03989538222520124,0.21116065186415378,0.22506925207756232,0.039837633900963114,0.2748337358065651,0.20249835634451027,5.210914001850789e-07,0.34135793720672547,0.174375
183,0.7,4,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Do patients with choledocholithiasis-induced cholangitis need a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct? No, it is not routinely necessary. The decision should be",5.684633456564485e-07,0.1924870972924113,0.24691358024691368,0.043522235154765,0.28261961584629747,0.22506925207756232,0.04345923698286886,0.3489417079602868,0.20249835634451027,5.684633456564497e-07,0.4183189783428549,0.174375
183,0.7,5,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine nasobiliary drainage tube placement necessary after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, it is not routinely required. The decision should be",5.447773729207632e-07,0.1573957774811423,0.24691358024691368,0.04170880868998312,0.2462519716754228,0.22506925207756232,0.04164843544191599,0.3112013799774398,0.20249835634451027,5.447773729207643e-07,0.37909826518957246,0.174375
183,0.7,6,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","After endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients, is nasobiliary drainage tube insertion routinely needed? No, routine insertion is not necessary. The decision should be",5.684633456564485e-07,0.1924870972924113,0.24691358024691368,0.043522235154765,0.28261961584629747,0.22506925207756232,0.04345923698286886,0.3489417079602868,0.20249835634451027,5.684633456564497e-07,0.4183189783428549,0.174375
183,0.7,7,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is the routine use of a nasobiliary drainage tube required after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, it is not routinely needed. The decision should be",4.737194547137073e-07,0.05895570466788902,0.24691358024691368,0.03626852929563748,0.14446927736548032,0.22506925207756232,0.03621603081905737,0.20584086431961435,0.20249835634451027,4.737194547137081e-07,0.2698989732245818,0.174375
183,0.7,8,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Must a nasobiliary drainage tube be routinely placed following endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis? No, routine placement is not necessary. The decision should be",5.684633456564485e-07,0.1924870972924113,0.24691358024691368,0.043522235154765,0.28261961584629747,0.22506925207756232,0.04345923698286886,0.3489417079602868,0.20249835634451027,5.684633456564497e-07,0.4183189783428549,0.174375
183,0.7,9,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it standard practice to insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? No, routine insertion is not necessary. The decision should be",4.974054274493926e-07,0.09070440298246885,0.24691358024691368,0.03808195576041936,0.17725910018847202,0.22506925207756232,0.03802683236001024,0.2397424159952961,0.20249835634451027,4.974054274493935e-07,0.3049902930358508,0.174375
183,0.7,10,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients necessary? No, it is not required routinely. The decision should be",5.210914001850779e-07,0.12349422580546054,0.24691358024691368,0.03989538222520124,0.21116065186415378,0.22506925207756232,0.039837633900963114,0.2748337358065651,0.20249835634451027,5.210914001850789e-07,0.34135793720672547,0.174375
184,0.7,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of psychological treatment for depression influence the likelihood of returning to treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of re-entering mental health care for certain populations. Nevertheless, due to the study's design, causality cannot be established. Additional research, ideally randomized controlled trials, is necessary to confirm this.",4.737194547137081e-08,0.03724477850949448,0.05246913580246911,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
184,0.7,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there a connection between how long psychological treatment for depression lasts and the probability of returning to treatment? Answer: The evidence suggests that longer treatment periods could help prevent some groups from coming back to mental health services. However, because of the study methodology, no cause-and-effect conclusion can be made. More studies, preferably randomized controlled trials, are required to verify this.",1.1842986367842703e-07,0.15704597832211498,0.05246913580246911,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
184,0.7,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the duration of psychological therapy for depression affect the rate of returning for further treatment? Answer: Results imply that longer therapy might deter some individuals from returning to mental health care. Yet, due to the nature of the study, causal relationships cannot be inferred. Further investigation, ideally through randomized controlled trials, is needed to clarify this.",0.0,0.07296286111157357,0.05246913580246911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
184,0.7,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the length of psychological depression treatment associated with the likelihood of returning to treatment? Answer: The data suggest that prolonged treatment could reduce return rates in certain groups, but the study's design limits causal conclusions. More research, especially randomized controlled trials, is needed to establish causality.",2.3685972735685406e-07,0.1199408050129187,0.05246913580246911,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
184,0.7,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the time span of psychological treatment for depression relate to whether patients return for further treatment? Answer: Findings indicate that a longer treatment period may prevent some patients from re-entering mental health care. However, due to study design constraints, no causal inference is possible. Further research, preferably RCTs, is necessary to determine this.",7.105791820705622e-08,0.018895639841298717,0.05246913580246911,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
184,0.7,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there an association between treatment duration for depression and the likelihood of repeated treatment? Answer: The study suggests longer treatment may help avoid return visits to mental health care in some groups, but causal links cannot be drawn because of the study design. Additional RCT research is needed to confirm this.",1.1842986367842703e-07,0.0455041950861621,0.0332457601777094,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
184,0.7,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of psychological treatment impact the chance of patients returning for depression care? Answer: The results suggest that extended treatment might reduce the chance of returning to mental health services among some groups; however, the study design precludes causal conclusions. Further randomized trials are required to establish this.",1.6580180914979784e-07,0.11351717573962672,0.012538580246913546,0.012693985253473108,0.16182311428003082,0.020399305555555556,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
184,0.7,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the duration of depression treatment related to patients' likelihood of seeking treatment again? Answer: Evidence points to longer treatment potentially preventing return to mental health care in some populations, but causal inference is limited by study design. More RCT studies are necessary to explore this.",2.6054570009253947e-07,0.14144701023388206,0.05246913580246911,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
184,0.7,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the time patients spend in psychological treatment for depression influence their likelihood of relapse into treatment? Answer: Results indicate that longer treatment durations may lower the risk of returning to mental health care for certain groups, yet causation cannot be confirmed due to study design. Further randomized controlled research is needed.",1.1842986367842703e-07,0.018844688141548716,0.05246913580246911,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
184,0.7,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is prolonged psychological treatment for depression linked to reduced rates of returning to treatment? Answer: The findings suggest that longer treatment periods might help prevent some groups from returning to mental health care, but causal relationships cannot be established due to the study design. Additional RCT research is warranted.",1.8948778188548325e-07,0.10655983026785787,0.03206983024691355,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
185,0.7,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to predict discordance between TEOAE and AABR results in newborns? No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes cannot be reliably predicted in newborns due to multiple influencing factors such as ear canal debris and ambient noise.",1.4211583641411244e-07,0.06928330820310658,0.03840000000000001,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
185,0.7,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in TEOAE and AABR outcomes be forecasted in newborns? No, the differences between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns are unpredictable because of various factors like ear canal debris or background noise.",2.6054570009253947e-07,0.18435263798789325,0.03840000000000001,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
185,0.7,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is predicting discordance in TEOAE and AABR test outcomes in newborns possible? No, the inconsistency between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results is not predictable in newborns, as factors such as ear canal debris and environmental noise affect the results.",1.6580180914979784e-07,0.09126221492188158,0.03840000000000001,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
185,0.7,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Are discordant results between TEOAE and AABR in newborns predictable? No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns because of influences like ear canal debris and ambient noise levels.",2.8423167282822487e-07,0.24370260960626133,0.01341643655489809,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
185,0.7,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can we foresee discordance between TEOAE and AABR outcomes in newborns? No, variations in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results are unpredictable in newborns due to factors such as debris in the ear canal and noise in the environment.",1.8948778188548325e-07,0.14524176079939188,0.015685018929150904,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
185,0.7,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it feasible to predict discordance in TEOAE and AABR outcomes among newborns? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) in newborns is not foreseeable because of factors like ear canal debris and ambient noise interference.",2.3685972735685406e-07,0.16025508640883324,0.03840000000000001,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
185,0.7,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in newborns' TEOAE and AABR test results be anticipated? No, the unpredictability of discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns arises from factors such as debris in the ear canal and environmental noise.",2.1317375462116866e-07,0.13672458899863882,0.03840000000000001,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
185,0.7,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to anticipate discordance in TEOAE and AABR results in newborns? No, because of influences including ear canal debris and ambient noise, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be predicted.",2.3685972735685406e-07,0.16025508640883324,0.03840000000000001,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
185,0.7,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in TEOAE and AABR outcomes for newborns be predicted? No, predictions are unreliable due to various factors like debris in the ear canal and background noise affecting Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns.",2.3685972735685406e-07,0.16025508640883324,0.03840000000000001,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
185,0.7,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is the discordance in TEOAE and AABR outcomes among newborns predictable? No, due to multiple factors such as ear canal debris and ambient noise, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be reliably predicted.",1.8948778188548325e-07,0.14524176079939188,0.0156850189291509,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
186,0.7,1,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Present research does not show direct evidence of laparoscopic cholecystectomy impacting peri-sinusoidal cell function. Since this procedure targets the gallbladder, it is not typically linked to changes in peri-sinusoidal cells found in the liver.",2.3685972735685406e-07,0.19881564482771896,0.05244724114018582,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
186,0.7,2,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Current studies do not provide direct proof that laparoscopic cholecystectomy alters peri-sinusoidal cell activity. The surgery mainly involves the gallbladder, so its effects generally do not involve peri-sinusoidal cells in the liver.",2.6054570009253936e-07,0.2259107532749849,0.051176523690685705,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.7,3,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cells? There is no direct scientific evidence indicating that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. This procedure primarily targets the gallbladder and is not commonly associated with peri-sinusoidal liver cells.,3.0791764556390996e-07,0.24492988340683786,0.07530256414555499,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
186,0.7,4,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Can laparoscopic cholecystectomy impact peri-sinusoidal cell activity? Existing scientific literature lacks direct evidence that laparoscopic cholecystectomy affects peri-sinusoidal cells. The operation is focused on the gallbladder and usually does not involve peri-sinusoidal cells located in the liver.,3.3160361829959526e-07,0.2733696191273256,0.07455363494424483,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
186,0.7,5,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does the activity of peri-sinusoidal cells change after laparoscopic cholecystectomy? According to current scientific findings, there is no direct link between laparoscopic cholecystectomy and peri-sinusoidal cell activity. The procedure is centered on the gallbladder, and peri-sinusoidal cells are mainly in the liver, thus typically unaffected.",1.4211583641411244e-07,0.09720412701830394,0.05695726306215866,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
186,0.7,6,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there any influence of laparoscopic cholecystectomy on peri-sinusoidal cell activity? To date, scientific research does not demonstrate a direct effect of laparoscopic cholecystectomy on peri-sinusoidal cells. Since the procedure focuses on the gallbladder, peri-sinusoidal liver cells are generally not impacted.",2.3685972735685406e-07,0.26813036288371306,0.0035433048862957006,0.018134264647818726,0.3348966797594346,0.0763888888888889,0.018108015409528666,0.30657771229307773,0.05246913580246914,2.3685972735685406e-07,0.2766971042312347,0.027006172839506164
186,0.7,7,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does laparoscopic cholecystectomy modify peri-sinusoidal cell activity? The scientific literature currently shows no direct evidence that this procedure influences peri-sinusoidal cells. Laparoscopic cholecystectomy is primarily concerned with the gallbladder and does not usually affect peri-sinusoidal liver cells.,3.3160361829959526e-07,0.2733696191273256,0.07455363494424483,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
186,0.7,8,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Presently, no direct scientific evidence supports an effect of laparoscopic cholecystectomy on peri-sinusoidal cells. The surgery is mainly related to the gallbladder, so peri-sinusoidal cells in the liver are generally not influenced.",2.6054570009253936e-07,0.1548187347560166,0.10230873698506115,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.7,9,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Current research does not directly link laparoscopic cholecystectomy to changes in peri-sinusoidal cell activity. The procedure targets the gallbladder and is typically not associated with peri-sinusoidal cells in the liver.,3.3160361829959526e-07,0.31187779582510045,0.04694541518575318,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
186,0.7,10,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there a direct impact of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Scientific evidence to date does not indicate that laparoscopic cholecystectomy affects peri-sinusoidal cells. The operation primarily involves the gallbladder, so peri-sinusoidal cell activity in the liver is usually not impacted.",2.1317375462116866e-07,0.1724324293579329,0.053656534486704814,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
187,0.7,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? Yes, it does encourage healthcare providers to organize their services efficiently, fostering a process-oriented approach that can improve patient outcomes and optimize resource use.",5.210914001850783e-07,0.3257043709790013,0.12244897959183677,0.03989538222520121,0.38479886366418237,0.08999999999999998,0.039837633900963086,0.44623179036899874,0.05536332179930796,5.210914001850789e-07,0.483991714307733,0.037677816224529016
187,0.7,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? Indeed, case-mix based reimbursement incentivizes providers to deliver care more efficiently, promoting process-focused healthcare that enhances patient results and resource management.",5.684633456564489e-07,0.42965069158043434,0.09123149780203446,0.04352223515476497,0.4473192206455159,0.08999999999999998,0.04345923698286883,0.5107703115065703,0.05536332179930796,5.684633456564497e-07,0.5506830888064065,0.037677816224529016
187,0.7,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix based reimbursement promote process-oriented care delivery? Yes, by motivating healthcare providers to structure their services effectively, it supports a process-driven approach that improves patient outcomes and resource allocation.",6.395212638635048e-07,0.48476906560869004,0.12244897959183677,0.04896251454911061,0.5491019149554583,0.08999999999999998,0.048891641605727454,0.6161308271643957,0.05536332179930796,6.39521263863506e-07,0.6598823807713972,0.037677816224529016
187,0.7,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does reimbursement based on case-mix encourage the development of process-oriented healthcare delivery? Yes, it motivates providers to streamline their services, leading to a process-oriented care approach with better patient outcomes and resource use.",5.684633456564489e-07,0.38632899279543675,0.12244897959183677,0.04352223515476497,0.4473192206455159,0.08999999999999998,0.04345923698286883,0.5107703115065703,0.05536332179930796,5.684633456564497e-07,0.5506830888064065,0.037677816224529016
187,0.7,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is process-oriented care delivery development driven by case-mix based reimbursement? Yes, this type of reimbursement incentivizes efficient service structuring, fostering process-oriented care that benefits patient outcomes and health system resources.",6.395212638635048e-07,0.5325723194404102,0.08801020408163268,0.04896251454911061,0.5491019149554583,0.08999999999999998,0.048891641605727454,0.6161308271643957,0.05536332179930796,6.39521263863506e-07,0.6598823807713972,0.037677816224529016
187,0.7,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix reimbursement stimulate process-focused care delivery? Yes, it encourages healthcare providers to organize services more efficiently, resulting in improved patient outcomes and more effective allocation of resources.",6.868932093348754e-07,0.5562280295908337,0.12244897959183677,0.05258936747867437,0.62320988710918,0.08999999999999998,0.0525132446876332,0.6930918683005252,0.05536332179930796,6.868932093348768e-07,0.7399250884449344,0.037677816224529016
187,0.7,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can process-oriented care development be promoted through case-mix based reimbursement? Yes, it incentivizes healthcare providers to adopt efficient processes, which enhances patient care quality and resource distribution.",7.105791820705607e-07,0.5939683575736807,0.12244897959183677,0.05440279394345625,0.6624306002624625,0.08999999999999998,0.054324046228586075,0.73391386282078,0.05536332179930796,7.105791820705622e-07,0.7824847028637301,0.037677816224529016
187,0.7,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement lead to the growth of process-oriented care delivery? Yes, it encourages efficient service design by providers, supporting a process-oriented approach that improves outcomes and resource utilization.",6.395212638635048e-07,0.48476906560869004,0.12244897959183677,0.04896251454911061,0.5491019149554583,0.08999999999999998,0.048891641605727454,0.6161308271643957,0.05536332179930796,6.39521263863506e-07,0.6598823807713972,0.037677816224529016
187,0.7,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the advancement of process-oriented care driven by case-mix based reimbursement? Yes, it motivates providers to structure care efficiently, promoting better patient outcomes and optimal use of resources.",6.868932093348754e-07,0.5562280295908337,0.12244897959183677,0.05258936747867437,0.62320988710918,0.08999999999999998,0.0525132446876332,0.6930918683005252,0.05536332179930796,6.868932093348768e-07,0.7399250884449344,0.037677816224529016
187,0.7,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix reimbursement foster process-oriented healthcare delivery? Yes, by incentivizing efficient service provision, it encourages a process-focused approach that benefits patient outcomes and resource management.",7.579511275419313e-07,0.674011065247218,0.12244897959183677,0.05802964687302001,0.7458122092015129,0.08999999999999998,0.05794564931049182,0.8209252398104097,0.05536332179930796,7.57951127541933e-07,0.8734564810694581,0.037677816224529016
188,0.7,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside evaluation dependable in ruling out aspiration after an acute stroke? Answer: Bedside swallowing assessment does not have sufficient sensitivity to serve as a screening tool in acute stroke cases, though there are doubts about relying on videofluoroscopy as the definitive standard. The significance of aspiration and bedside tests in forecasting complications and",2.3685972735685406e-08,0.10703423163713932,0.09639999999999999,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
188,0.7,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Inquiry: Can bedside tests effectively exclude aspiration following an acute stroke? Response: Bedside swallowing assessments lack adequate sensitivity for screening acute stroke patients, and there are reservations about considering videofluoroscopy the gold standard. The relative roles of aspiration and bedside evaluation in predicting complications and",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
188,0.7,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is it possible to reliably rule out aspiration after acute stroke through bedside assessment? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening tools in acute stroke, and there are concerns regarding videofluoroscopy's status as the gold standard. The importance of aspiration and bedside evaluations in anticipating complications and",0.0,0.08834209862498499,0.09639999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
188,0.7,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Query: Can aspiration be reliably excluded by bedside assessment after an acute stroke? Answer: Bedside swallowing assessments lack the necessary sensitivity to act as screening tools in acute stroke, while videofluoroscopy's role as the gold standard is questioned. The relative significance of aspiration and bedside assessment in predicting complications and",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
188,0.7,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside assessment reliably exclude aspiration in acute stroke patients? Answer: Bedside swallowing assessments are insufficiently sensitive to function as screening instruments in acute stroke, and the use of videofluoroscopy as the gold standard raises concerns. The importance of aspiration and bedside assessment in forecasting complications and",1.4211583641411244e-07,0.09079346262643506,0.053930864197530855,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
188,0.7,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration following acute stroke be confidently ruled out by bedside assessment? Answer: Bedside swallowing assessments do not have the sensitivity required for screening in acute stroke, and the validity of videofluoroscopy as a gold standard is debated. The relative importance of aspiration and bedside tests in predicting complications and",7.105791820705622e-08,0.030073190501009428,0.09639999999999999,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
188,0.7,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment a reliable method to exclude aspiration after acute stroke? Answer: Bedside swallowing assessment lacks the sensitivity needed to be a screening tool in acute stroke, and there are issues with considering videofluoroscopy as the gold standard. The relative roles of aspiration and bedside assessment in predicting complications and",4.737194547137081e-08,0.02269357542228967,0.0768,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
188,0.7,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can bedside evaluation be trusted to exclude aspiration post-acute stroke? Answer: Bedside swallowing assessments are not sensitive enough for screening purposes in acute stroke, and the use of videofluoroscopy as the definitive standard is questioned. The significance of aspiration and bedside assessment in predicting complications and",1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
188,0.7,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside swallowing assessment effectively exclude aspiration after acute stroke? Answer: Bedside swallowing tests lack the sensitivity necessary for screening acute stroke patients, and concerns exist about videofluoroscopy as the gold standard. The relative importance of aspiration and bedside assessment in forecasting complications and",2.1317375462116866e-07,0.12926687103432677,0.07368501892915087,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
188,0.7,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment sufficiently reliable to rule out aspiration following an acute stroke? Answer: Bedside swallowing assessment does not possess the sensitivity required for screening in acute stroke, and videofluoroscopy's role as the gold standard is under scrutiny. The importance of aspiration and bedside assessment in predicting complications and",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
189,0.7,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Are aromatase inhibitor-related musculoskeletal symptoms best managed by preventing osteoporosis? Answer: Patients treated with AIs who develop osteoporosis face a higher risk of musculoskeletal symptoms and bone fractures. Using calcium and bisphosphonates together lowers the chance of osteoporosis and related musculoskeletal issues. Those who had tamoxifen prior to AIs showed a reduced incidence of AI-related musculoskeletal symptoms. Our recommendation is for patients on AIs to take preventive measures.,1.6580180914979784e-07,0.15642557042424077,0.03434614511519638,0.012693985253473108,0.13345296318752986,0.016661878770468257,0.012675610786670066,0.11211729812070548,0.0,1.6580180914979784e-07,0.1139442593492177,0.0
189,0.7,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is the prevention of osteoporosis crucial to eliminating musculoskeletal symptoms caused by aromatase inhibitors? Answer: Osteoporosis in patients on AIs increases their risk of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates decreases this risk. Patients previously treated with tamoxifen before starting AIs tend to have fewer musculoskeletal symptoms associated with AI use. We advise patients on AIs accordingly.,2.3685972735685406e-08,0.04949131721932787,0.052992064840204814,0.0018134264647818726,0.01719872689296853,0.00028223537935338425,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
189,0.7,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Does preventing osteoporosis hold the key to stopping aromatase inhibitor-associated musculoskeletal symptoms? Answer: Patients receiving aromatase inhibitors who develop osteoporosis are more prone to musculoskeletal pain and fractures. Concurrent use of calcium and bisphosphonates reduces the risk of osteoporosis and musculoskeletal complaints. Prior tamoxifen treatment lowers the likelihood of AI-related musculoskeletal symptoms. We recommend preventive strategies for patients on AIs.,2.3685972735685406e-08,0.05164910925140642,0.0490487514863258,0.0018134264647818726,0.006297787702283841,0.016661878770468257,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
189,0.7,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Are musculoskeletal symptoms related to aromatase inhibitors prevented by controlling osteoporosis? Answer: AI patients with osteoporosis have an increased chance of musculoskeletal symptoms and fractures. Combined therapy with calcium and bisphosphonates helps reduce these risks. Those who had tamoxifen before starting AIs are less susceptible to these musculoskeletal symptoms. We suggest that patients on AIs follow these recommendations.,7.105791820705622e-08,0.006154069340134072,0.03181267884859111,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
189,0.7,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is osteoporosis prevention essential to avoid musculoskeletal symptoms from aromatase inhibitors? Answer: Patients on aromatase inhibitors who develop osteoporosis are at greater risk for bone fractures and musculoskeletal symptoms. Calcium and bisphosphonate co-treatment lowers the incidence of such conditions. Tamoxifen use before AIs is linked to fewer musculoskeletal symptoms caused by AIs. We recommend appropriate preventive care for AI patients.,2.3685972735685406e-08,0.02854420323274187,0.032386872715857544,0.0018134264647818726,0.006297787702283841,0.016661878770468257,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
189,0.7,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Can preventing osteoporosis eliminate musculoskeletal symptoms related to aromatase inhibitors? Answer: Those on AIs who develop osteoporosis exhibit higher rates of musculoskeletal symptoms and fractures. Calcium and bisphosphonate comedication reduces these risks. Prior tamoxifen therapy decreases the chance of AI-related musculoskeletal symptoms. We advise patients receiving AIs to consider prevention strategies.,2.3685972735685406e-07,0.13805206262126735,0.029448751486325808,0.018134264647818726,0.15921665077528946,0.016661878770468257,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
189,0.7,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is managing osteoporosis the key to reducing musculoskeletal symptoms in patients on aromatase inhibitors? Answer: Osteoporosis increases musculoskeletal symptoms and fracture risks in AI-treated patients. Using calcium and bisphosphonates together diminishes this risk. Patients treated with tamoxifen before AIs experience fewer musculoskeletal symptoms. We recommend preventive management for those on AIs.,2.3685972735685406e-07,0.13805206262126735,0.029448751486325808,0.018134264647818726,0.15921665077528946,0.016661878770468257,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
189,0.7,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Does the prevention of osteoporosis help in eliminating aromatase inhibitor-related musculoskeletal symptoms? Answer: Patients on AIs with osteoporosis face higher risks of musculoskeletal issues and fractures. Combined calcium and bisphosphonate therapy reduces this risk. Tamoxifen treatment prior to AIs is associated with lower musculoskeletal symptom incidence. Our recommendation is to implement preventive measures in patients on AIs.,9.474389094274162e-08,0.0239651388400004,0.03151048618020334,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
189,0.7,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is osteoporosis prevention the solution to aromatase inhibitor-induced musculoskeletal symptoms? Answer: AI patients developing osteoporosis have increased musculoskeletal symptoms and fracture risks. Co-administration of calcium and bisphosphonates lowers these risks. Those who used tamoxifen before AIs are less likely to experience such symptoms. We advise patients on AIs to follow preventive protocols.,2.1317375462116866e-07,0.09145173438926513,0.0490487514863258,0.016320838183036854,0.1394140234791097,0.016661878770468257,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
189,0.7,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Could preventing osteoporosis be the key to stopping musculoskeletal symptoms caused by aromatase inhibitors? Answer: Patients receiving AIs who develop osteoporosis are at a heightened risk of musculoskeletal symptoms and fractures. Calcium and bisphosphonate co-treatment decreases these risks. Prior tamoxifen use reduces the chance of AI-related musculoskeletal symptoms. We recommend preventive strategies for patients on AIs.,1.1842986367842703e-07,0.042099018684113254,0.03119751181690431,0.009067132323909363,0.0639064709709638,0.016661878770468257,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
190,0.7,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Do women report depressive symptoms more frequently, explaining higher depression rates? Answer: In this community sample, men and women reported depressive symptoms similarly, showing no gender difference in symptom presentation.",2.36859727356853e-07,0.2992345254611144,0.008310134533494998,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.7,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Is the higher depression rate in women due to reporting differences? Answer: Both men and women in the community sample showed similar depressive symptom patterns, with no gender-based differences found.",2.36859727356853e-07,0.25302471342378485,0.024983563445101917,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.7,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates explained by how symptoms are reported? Answer: Men and women reported comparable depressive symptoms in this sample, with no evidence of gender differences in symptom presentation.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.7,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Could women's increased depression rates be due to differential symptom reporting? Answer: The community sample showed men and women had similar depressive symptom patterns, indicating no gender difference.",2.842316728282236e-07,0.3220175849107356,0.024983563445101917,0.021761117577382527,0.36772478012531495,0.0,0.02172961849143446,0.37948962170490397,0.0,2.8423167282822487e-07,0.39204208777602556,0.0
190,0.7,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Is the gender disparity in depression rates linked to symptom reporting differences? Answer: Data from this sample revealed men and women experienced and reported depressive symptoms similarly, with no gender-based variation.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.7,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Does symptom reporting explain why women have higher depression rates? Answer: Men and women in the community sample reported depressive symptoms in similar ways, with no gender difference detected.",2.605457000925383e-07,0.2869262650994666,0.024983563445101917,0.019947691112600648,0.3313571359544403,0.0,0.019918816950481588,0.341749293722057,0.0,2.6054570009253947e-07,0.3528213746227431,0.0
190,0.7,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are higher depression rates in women a result of how symptoms are reported? Answer: This community sample found men and women shared similar depressive symptom patterns, with no difference in symptom presentation by gender.",1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.7,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the difference in depression rates between genders due to symptom reporting? Answer: No evidence was found showing men and women differ in depressive symptom presentation within this community sample.,2.36859727356853e-07,0.25302471342378485,0.024983563445101917,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.7,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Could differing symptom reporting explain why women have more depression? Answer: Men and women reported similar depressive symptoms in this community sample, with no gender difference identified.",3.079176455639089e-07,0.3583852290816103,0.024983563445101917,0.023574544042164407,0.40546510810816194,0.0,0.023540420032387335,0.41871033485818643,0.0,3.079176455639103e-07,0.4328640822962804,0.0
190,0.7,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates accounted for by how they report symptoms? Answer: The sample showed men and women had comparable patterns of depressive symptoms, with no gender-based differences.",2.605457000925383e-07,0.2869262650994666,0.024983563445101917,0.019947691112600648,0.3313571359544403,0.0,0.019918816950481588,0.341749293722057,0.0,2.6054570009253947e-07,0.3528213746227431,0.0
191,0.7,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is implementing an advance care planning model viable in community palliative care? Yes, it is feasible. Such a model supports proactive conversations about care preferences, medical choices, and end-of-life wishes, allowing healthcare providers to deliver patient-focused care. Additionally, it improves the",1.6580180914979784e-07,0.045201225336627626,0.144375,0.012693985253473108,0.014395580672506014,0.10707911957168353,0.012675610786670066,0.07665670596927399,0.06632653061224489,1.6580180914979784e-07,0.14176503124858364,0.02271498107084911
191,0.7,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be effectively used in community palliative care? Yes, it can. This model promotes early discussions regarding care preferences, medical decisions, and end-of-life desires, helping healthcare professionals offer care centered on the patient. Furthermore, it enhances the",1.4211583641411244e-07,0.06989383792699932,0.144375,0.010880558788691236,0.010922227311785715,0.10707911957168353,0.0108648092457172,0.05068121956601601,0.06632653061224489,1.4211583641411244e-07,0.11509678416642277,0.02271498107084911
191,0.7,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is the use of an advance care planning model practical within community palliative care? The answer is yes. It encourages proactive dialogue about care preferences, medical decisions, and end-of-life wishes, enabling healthcare workers to provide care that focuses on the patient. It also improves the",7.105791820705622e-08,0.14051140514095328,0.144375,0.005440279394345618,0.08324288889141185,0.10707911957168353,0.0054324046228586,0.023426752587707433,0.06632653061224489,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
191,0.7,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model applicable in community palliative care? Yes, it is applicable. It facilitates early conversations about care preferences, medical decisions, and end-of-life wishes, which helps healthcare professionals deliver patient-centered care. Moreover, it enhances the",2.3685972735685374e-07,0.032760316133082945,0.144375,0.018134264647818726,0.09443828834604018,0.10707911957168353,0.018108015409528666,0.15889480420624702,0.06632653061224489,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
191,0.7,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be feasibly implemented in community palliative care? Yes, it can be. This approach supports proactive discussions on care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to offer care that is centered on the patient. It also improves the",4.737194547137081e-08,0.162984260993011,0.144375,0.0036268529295637453,0.10623240711611137,0.10707911957168353,0.003621603081905733,0.04695724999790185,0.06632653061224489,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
191,0.7,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it feasible to use an advance care planning model in community palliative care? Yes, it is feasible. The model encourages proactive conversations about care preferences, medical decisions, and end-of-life wishes, helping healthcare professionals provide care focused on the patient. Additionally, it enhances the",9.474389094274162e-08,0.11752188691625376,0.144375,0.0072537058591274906,0.05971239148121743,0.10707911957168353,0.007243206163811466,0.0006707989913525836,0.06632653061224489,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
191,0.7,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model workable in community palliative care? Yes, it works. It promotes proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to deliver patient-centric care. Furthermore, it improves the",2.6054570009253904e-07,0.06015929032119827,0.144375,0.0199476911126006,0.12260916531273702,0.10707911957168353,0.01991881695048154,0.18788234107949853,0.06632653061224489,2.6054570009253947e-07,0.2561753824263291,0.02271498107084911
191,0.7,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Could an advance care planning model be successfully applied in community palliative care? Yes, it could. This model facilitates proactive discussions on care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to offer patient-centered care. Moreover, it enhances the",1.8948778188548314e-07,0.019883417352335897,0.144375,0.014507411718254981,0.04037106707576399,0.10707911957168353,0.014486412327622933,0.10332495305143485,0.06632653061224489,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
191,0.7,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it possible to implement an advance care planning model in community palliative care? Yes, it is possible. This model supports proactive dialogue concerning care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Additionally, it improves the",1.4211583641411244e-07,0.06989383792699932,0.144375,0.010880558788691236,0.010922227311785715,0.10707911957168353,0.0108648092457172,0.05068121956601601,0.06632653061224489,1.4211583641411244e-07,0.11509678416642277,0.02271498107084911
191,0.7,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Does an advance care planning model work in community palliative care? Yes, it works effectively. It encourages early and proactive discussions about care preferences, medical decisions, and end-of-life wishes, empowering healthcare providers to deliver care that centers on the patient. Furthermore, it enhances the",9.474389094274162e-08,0.11752188691625376,0.144375,0.0072537058591274906,0.05971239148121743,0.10707911957168353,0.007243206163811466,0.0006707989913525836,0.06632653061224489,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
192,0.7,1,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is it advisable to keep performing second-look laparotomy? Answer: The use of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women remains controversial. Although it offers important insights into the disease status,",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,0.7,2,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy still be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: The role of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is debated. It can yield critical information regarding the disease condition,",4.7371945471370706e-08,0.02313416967115023,0.018374275636180423,0.0036268529295637453,0.014373280612865358,0.04629629629629633,0.003621603081905733,0.016526879127630956,0.04938271604938273,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
192,0.7,3,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy recommended? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a debated topic. It may provide essential information about the patient's disease status,",9.474389094274131e-08,0.15839835711104744,0.03648864351691271,0.0072537058591274906,0.12076378633693707,0.010609567901234532,0.007243206163811466,0.12040078781491248,0.008572048611111105,9.474389094274162e-08,0.11980950112335131,0.00612461419753086
192,0.7,4,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: In Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy be maintained? Answer: The practice of second-look laparotomy in advanced epithelial ovarian carcinoma cases in Thai women is controversial. It can deliver valuable data on the disease progression,",4.7371945471370706e-08,0.0586801789306346,0.0058337605194582615,0.0036268529295637453,0.014373280612865358,0.04629629629629633,0.003621603081905733,0.053994294293033374,0.0763888888888889,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
192,0.7,5,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still justified? Answer: The application of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is debated. It helps in assessing the current status of the disease,",7.1057918207056e-08,0.12581420237119234,0.03274498456790119,0.005440279394345618,0.08920176601933338,0.007754310784613763,0.0054324046228586,0.08892920998840648,0.006255739210284647,7.105791820705622e-08,0.08849205776082192,0.004463830221405965
192,0.7,6,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy continue to be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: Second-look laparotomy in Thai women with advanced epithelial ovarian carcinoma is a matter of debate. It provides useful information about the disease status,",4.7371945471370706e-08,0.0586801789306346,0.0058337605194582615,0.0036268529295637453,0.014373280612865358,0.04629629629629633,0.003621603081905733,0.016526879127630956,0.04938271604938273,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
192,0.7,7,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: does second-look laparotomy remain a viable option? Answer: There is ongoing debate about second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women. This procedure can provide critical information regarding disease status,",4.7371945471370706e-08,0.09422618819011852,0.029161565146413562,0.0036268529295637453,0.05858958049870866,0.005040796274936948,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.7,8,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy be continued? Answer: The decision to perform second-look laparotomy in Thai women with advanced epithelial ovarian carcinoma is controversial. It can offer significant insights into the disease state,",4.7371945471370706e-08,0.0586801789306346,0.0058337605194582615,0.0036268529295637453,0.014373280612865358,0.04629629629629633,0.003621603081905733,0.016526879127630956,0.04938271604938273,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
192,0.7,9,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is it appropriate to continue second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a debated issue. It can provide valuable details about the condition of the disease,",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,0.7,10,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should we persist with second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? Answer: The use of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is contested. It can supply important information about the disease status,",4.7371945471370706e-08,0.02313416967115023,0.01837427563618041,0.0036268529295637453,0.014373280612865358,0.04629629629629633,0.003621603081905733,0.016526879127630956,0.04938271604938273,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
193,0.7,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Yes, it does. Obstructive sleep apnea lowers maximum aerobic capacity by causing frequent sleep disruptions, resulting in daytime tiredness and decreased endurance for aerobic exercises. Long-term sleep deprivation also harms cardiovascular health, further reducing aerobic fitness.",1.4211583641411244e-07,0.08402087972738315,0.035144628099173555,0.010880558788691236,0.14089196788936142,0.003108459357277899,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
193,0.7,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can obstructive sleep apnea influence aerobic fitness? Indeed, it can. Obstructive sleep apnea diminishes peak aerobic capacity because of repeated interruptions in sleep, which cause daytime fatigue and less stamina for aerobic workouts. Persistent sleep loss also negatively affects heart function, further lowering aerobic fitness.",9.474389094274162e-08,0.03450022694720989,0.037293154176271076,0.0072537058591274906,0.09169126505879133,0.0019760897427654224,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
193,0.7,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Yes, obstructive sleep apnea can impair aerobic fitness. It decreases maximum aerobic capability due to ongoing sleep disturbances, leading to tiredness during the day and reduced endurance in aerobic activities. Chronic lack of sleep also impacts cardiac health, further reducing aerobic performance.",2.3685972735685406e-08,0.10785209564055176,0.06224532254361802,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
193,0.7,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea have an effect on aerobic fitness? Yes, it can impair aerobic fitness. The condition reduces the maximum aerobic capacity by disrupting sleep frequently, resulting in daytime exhaustion and diminished stamina for aerobic exercises. Long-term sleep deprivation also affects heart health, lowering aerobic fitness further.",2.3685972735685406e-08,0.09447112089549092,0.08264462809917357,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
193,0.7,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can aerobic fitness be impacted by obstructive sleep apnea? Yes, obstructive sleep apnea affects it by lowering maximum aerobic capacity through frequent sleep interruptions, which cause daytime fatigue and reduced endurance for aerobic activities. Chronic sleep deprivation also damages heart health, further decreasing aerobic fitness.",9.474389094274162e-08,0.0029935369217577446,0.059929647028324456,0.0072537058591274906,0.05945186131181712,0.0212665406427221,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
193,0.7,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea reduce aerobic fitness? Yes, it does. This disorder lowers maximum aerobic capacity due to frequent sleep interruptions, causing daytime tiredness and less stamina for aerobic exercise. Persistent sleep deprivation also harms cardiovascular health, which further diminishes aerobic fitness.",1.6580180914979784e-07,0.042104414110259114,0.08264462809917357,0.012693985253473108,0.13177252289144326,0.0212665406427221,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
193,0.7,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is there an effect of obstructive sleep apnea on aerobic fitness? Yes, obstructive sleep apnea can reduce aerobic fitness. It decreases the maximum aerobic capacity by causing repeated sleep disruptions, leading to fatigue during the day and lower endurance for aerobic activities. Long-term sleep deprivation also impacts heart health, further reducing aerobic fitness.",9.474389094274162e-08,0.11558871693302075,0.025168576454025704,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
193,0.7,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea influence aerobic fitness? Yes, it negatively affects it by lowering maximum aerobic capacity because of frequent sleep interruptions, which cause daytime fatigue and reduced stamina for aerobic workouts. Chronic sleep loss also impairs cardiac health, further diminishing aerobic fitness.",1.4211583641411244e-07,0.018006862531199097,0.08264462809917357,0.010880558788691236,0.10707991030107156,0.0212665406427221,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
193,0.7,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can obstructive sleep apnea affect aerobic fitness? Yes, it can. The condition reduces maximum aerobic capacity by causing frequent sleep disturbances that lead to daytime fatigue and decreased endurance in aerobic activities. Ongoing sleep deprivation also affects heart health, which further decreases aerobic fitness.",1.1842986367842703e-07,0.0055236348789953205,0.08264462809917357,0.009067132323909363,0.08298235872201154,0.0212665406427221,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
193,0.7,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Yes, obstructive sleep apnea can impact it by lowering the maximum aerobic capacity due to frequent sleep interruptions, resulting in daytime tiredness and reduced stamina for aerobic exercises. Chronic sleep deprivation also negatively influences heart health, further lowering aerobic fitness.",2.3685972735685406e-08,0.06497549619081244,0.06137808745645147,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
194,0.7,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for laparoscopic surgery to treat GERD? No, advanced age alone does not contraindicate GERD laparoscopic surgery. However, the patient's general health, other existing conditions, and surgical tolerance are key considerations.",1.8948778188548261e-07,0.08704741423909201,0.08748887372965994,0.014507411718254995,0.11562833247295812,0.07271468144044323,0.014486412327622954,0.1538288332582156,0.049861495844875335,1.8948778188548325e-07,0.19402843238501388,0.025623268698060954
194,0.7,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age prevent patients from undergoing laparoscopic surgery for GERD? Advanced age is not a contraindication for GERD laparoscopic surgery. The important factors are the patient's overall health, other illnesses, and capacity to handle surgery.",1.6580180914979731e-07,0.056894924121202006,0.08832691758437572,0.012693985253473115,0.08577536932327634,0.07271468144044323,0.01267561078667008,0.12305717459146193,0.049861495844875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
194,0.7,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is laparoscopic surgery for GERD contraindicated in elderly patients? No, being elderly is not a contraindication for GERD laparoscopic surgery, but the patient's general health status, coexisting diseases, and ability to withstand surgery are crucial.",1.8948778188548261e-07,0.08704741423909201,0.08748887372965994,0.014507411718254995,0.11562833247295812,0.07271468144044323,0.014486412327622954,0.1538288332582156,0.049861495844875335,1.8948778188548325e-07,0.19402843238501388,0.025623268698060954
194,0.7,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a reason to avoid GERD laparoscopic surgery? No, advanced age itself is not a contraindication for GERD laparoscopic surgery. The decision depends on the patient's overall health, presence of other diseases, and surgical resilience.",1.42115836414112e-07,0.06613199023234362,0.061510308587835905,0.010880558788691236,0.05678783245002483,0.07271468144044323,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.7,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Can elderly patients undergo GERD laparoscopic surgery? Yes, advanced age is not a contraindication, but considerations include the patient's general health, other medical conditions, and tolerance for surgery.",3.552895910352797e-07,0.2767977092885747,0.11687363038714388,0.027201396971728152,0.35403935591795577,0.07271468144044323,0.02716202311429307,0.40068891118974204,0.049861495844875335,3.552895910352811e-07,0.4499618065222153,0.025623268698060954
194,0.7,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is older age a contraindication for GERD laparoscopic surgery? No, advanced age does not contraindicate GERD laparoscopic surgery, though patient health, comorbidities, and surgical endurance are important factors.",3.552895910352797e-07,0.328141944885608,0.07989138186643382,0.027201396971728152,0.35403935591795577,0.07271468144044323,0.02716202311429307,0.40068891118974204,0.049861495844875335,3.552895910352811e-07,0.4499618065222153,0.025623268698060954
194,0.7,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does being of advanced age exclude one from GERD laparoscopic surgery? No, advanced age alone is not a contraindication; overall health, other diseases, and ability to endure surgery play significant roles.",2.842316728282238e-07,0.21764700566807882,0.08357993240854697,0.021761117577382513,0.2448400639529651,0.07271468144044323,0.021729618491434448,0.2873602258827379,0.049861495844875335,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
194,0.7,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is age considered a contraindication for laparoscopic surgery in GERD patients? Advanced age itself is not a contraindication. The patient's overall health, comorbidities, and surgical fitness are more important.",3.316036182995944e-07,0.24043006511770004,0.11687363038714388,0.025387970506946272,0.3162990279351088,0.07271468144044323,0.025351221573340195,0.3614681980364596,0.049861495844875335,3.316036182995957e-07,0.4091398120019605,0.025623268698060954
194,0.7,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age prevent GERD patients from having laparoscopic surgery? No, advanced age is not a contraindication. The key factors are the patient's health condition, other diseases, and ability to tolerate surgery.",2.605457000925385e-07,0.1833665437471086,0.08465140816492167,0.019947691112600634,0.21093851227728333,0.07271468144044323,0.019918816950481574,0.2522689060714689,0.049861495844875335,2.6054570009253947e-07,0.29581112669495635,0.025623268698060954
194,0.7,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is elderly age a contraindication for GERD laparoscopic surgery? No, advanced age is not a contraindication, but the patient's overall health, presence of other illnesses, and endurance for surgery must be evaluated.",2.605457000925385e-07,0.13864737080775758,0.11687363038714388,0.019947691112600634,0.21093851227728333,0.07271468144044323,0.019918816950481574,0.2522689060714689,0.049861495844875335,2.6054570009253947e-07,0.29581112669495635,0.025623268698060954
195,0.7,1,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT showed strong correlations with traditional cardiovascular risk factors, yet no independent association was found between hsCRP levels and carotid IMT in healthy Korean adults.",7.105791820705622e-08,0.11664984173171522,0.030404272162513887,0.005440279394345618,0.14773899133408408,0.05259352898407034,0.0054324046228586,0.14894876808949453,0.05246913580246914,7.105791820705622e-08,0.11542895663511299,0.027006172839506164
195,0.7,2,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein relate to carotid atherosclerosis among healthy Koreans? While hsCRP and carotid IMT were closely connected to conventional cardiovascular risk factors, hsCRP levels did not independently associate with carotid IMT in healthy Korean individuals.",1.6580180914979742e-07,0.0872317389473305,0.06428960538850652,0.012693985253473108,0.14931454819586287,0.023795359904818555,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.7,3,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a connection between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean adults? Both hsCRP levels and carotid IMT correlated significantly with standard cardiovascular risk factors, but no independent link existed between hsCRP and carotid IMT.",1.4211583641411212e-07,0.11040126011561258,0.018975700733942474,0.010880558788691236,0.12114367122916603,0.023795359904818555,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
195,0.7,4,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Are hsCRP levels associated with carotid atherosclerosis in healthy Koreans? Although both hsCRP and carotid IMT were strongly related to conventional cardiovascular risks, no independent association was observed between hsCRP levels and carotid IMT.",2.3685972735685332e-07,0.21975277930705817,0.03169090930237176,0.018134264647818747,0.23892670688554984,0.023795359904818555,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
195,0.7,5,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Korean adults? Both hsCRP levels and carotid IMT were highly correlated with traditional cardiovascular risk factors, but hsCRP levels showed no independent association with carotid IMT.",1.4211583641411212e-07,0.13372683355764892,0.01159488043970347,0.010880558788691236,0.15965184792694087,0.003959742135997774,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
195,0.7,6,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT closely correlated with conventional cardiovascular risk factors, yet no independent connection between hsCRP levels and carotid IMT was found.",1.4211583641411212e-07,0.147868675281015,0.04722864897206126,0.010880558788691236,0.15965184792694087,0.003959742135997774,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
195,0.7,7,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Korean adults? While hsCRP and carotid IMT strongly linked to standard cardiovascular risk factors, hsCRP levels were not independently associated with carotid IMT.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.27067540520012967,0.023795359904818555,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
195,0.7,8,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Are high-sensitivity C-reactive protein levels associated with carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT showed strong correlations with traditional cardiovascular risk factors; however, hsCRP levels had no independent association with carotid IMT.",2.1317375462116802e-07,0.14665533965185373,0.0626599507718389,0.016320838183036868,0.20815504821879616,0.023795359904818555,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
195,0.7,9,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT were significantly correlated with conventional cardiovascular risk factors, but no independent association was found between hsCRP levels and carotid IMT.",9.474389094274152e-08,0.12428151068484405,0.0663226395094527,0.0072537058591274906,0.14003931107046297,0.028673775897650584,0.007243206163811466,0.1401215692254847,0.027006172839506164,9.474389094274162e-08,0.10536051565782589,0.0
195,0.7,10,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis in healthy Korean adults? Both hsCRP levels and carotid IMT were strongly associated with traditional cardiovascular risk factors, though no independent association existed between hsCRP and carotid IMT.",1.8948778188548272e-07,0.11650284953396373,0.06349799462655469,0.014507411718254988,0.17830208506911438,0.023795359904818555,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
196,0.7,1,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux used for perioperative bridging? Yes, fondaparinux is utilized in perioperative bridging, commonly serving as an alternative to heparin for high-risk patients.",3.316036182995942e-07,0.2999356016089214,0.13527575442247655,0.025387970506946314,0.35239198249514736,0.11238293444328822,0.02535122157334023,0.4083081603751233,0.08740894901144641,3.316036182995956e-07,0.4680507422321676,0.06035379812695108
196,0.7,2,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a role in perioperative bridging? Indeed, fondaparinux plays a role in perioperative bridging and is frequently chosen over heparin for patients at elevated risk.",2.36859727356853e-07,0.292838558613433,0.021854204327958607,0.018134264647818796,0.2889421442399609,0.03298784937712562,0.018108015409528735,0.2837488686278289,0.04582104731012315,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.7,3,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Can fondaparinux be used in perioperative bridging? Yes, fondaparinux is employed in perioperative bridging, often replacing heparin in patients with significant risk.",3.552895910352795e-07,0.4124696344400003,0.08777575442247654,0.027201396971728194,0.40118214666457863,0.11238293444328822,0.027162023114293103,0.45960145476267344,0.08740894901144641,3.5528959103528093e-07,0.5221179635024429,0.06035379812695108
196,0.7,4,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of",Is fondaparinux applicable in perioperative bridging? Fondaparinux is indeed applicable and is often used as a substitute for heparin in patients with high risk during perioperative bridging.,2.36859727356853e-07,0.13288151694575445,0.13527575442247655,0.018134264647818796,0.17803859535036892,0.11238293444328822,0.018108015409528735,0.2259866035811684,0.08740894901144641,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.7,5,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux serve a function in perioperative bridging? Yes, fondaparinux serves a function in perioperative bridging and is commonly used as an alternative anticoagulant to heparin for high-risk patients.",1.894877818854824e-07,0.20730508348345023,0.029675754422476525,0.014507411718255037,0.20376602540830602,0.03878293444328823,0.014486412327622988,0.1992629097968579,0.0490089490114464,1.8948778188548325e-07,0.19361389653040773,0.06035379812695108
196,0.7,6,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is there an indication for fondaparinux in perioperative bridging? Yes, fondaparinux is indicated for perioperative bridging and is frequently utilized instead of heparin in patients with increased risk.",2.131737546211677e-07,0.09514118896290746,0.13527575442247655,0.016320838183036916,0.13881788219708646,0.11238293444328822,0.016297213868575862,0.1851646090609136,0.08740894901144641,2.1317375462116866e-07,0.23443589105066254,0.06035379812695108
196,0.7,7,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux recommended for perioperative bridging? Yes, fondaparinux is recommended for use in perioperative bridging, often as an alternative to heparin for high-risk individuals.",3.079176455639089e-07,0.3157575069128655,0.09188732467041041,0.023574544042164434,0.3058719668602534,0.11238293444328822,0.023540420032387356,0.359517996205692,0.08740894901144641,3.0791764556391023e-07,0.41675744784461743,0.06035379812695108
196,0.7,8,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux play a part in perioperative bridging? Yes, fondaparinux plays a part in perioperative bridging and is often preferred over heparin for patients at high risk.",2.36859727356853e-07,0.292838558613433,0.021854204327958607,0.018134264647818796,0.2889421442399609,0.03298784937712562,0.018108015409528735,0.2837488686278289,0.04582104731012315,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.7,9,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Can fondaparinux be considered for perioperative bridging? Yes, fondaparinux can be considered for perioperative bridging and is regularly used as an alternative to heparin in high-risk patients.",2.36859727356853e-07,0.292838558613433,0.021854204327958607,0.018134264647818796,0.2889421442399609,0.03298784937712562,0.018108015409528735,0.2837488686278289,0.04582104731012315,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.7,10,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of",Is fondaparinux utilized during perioperative bridging? Fondaparinux is utilized during perioperative bridging and is often chosen as an alternative to heparin for patients with elevated risk.,2.605457000925383e-07,0.2830057789886289,0.05588066935631396,0.019947691112600675,0.2766228549172842,0.07079503274196496,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
197,0.7,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors significant in primary systemic vasculitis? Yes, they are. Exposure to infections, drugs, or harmful substances can provoke an abnormal immune reaction, playing a crucial role in the disease.",9.47438909427412e-08,0.00284305226695869,0.08740894901144641,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.7,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors matter in primary systemic vasculitis? Indeed, they do. Contact with certain infections, medications, or toxic materials can initiate an abnormal immune response linked to the condition.",1.421158364141118e-07,0.07183592375390946,0.08740894901144641,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
197,0.7,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is there an importance of environmental factors in primary systemic vasculitis? Yes, environmental influences are important. Exposure to specific infections, medicines, or hazardous materials can trigger abnormal immune system activity.",1.184298636784265e-07,0.03674460394264045,0.08740894901144641,0.009067132323909398,0.12229413125734023,0.0302734375,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
197,0.7,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors key in primary systemic vasculitis? Yes, they significantly contribute. Being exposed to infections, drugs, or dangerous substances may cause an abnormal immune reaction leading to the disease.",1.184298636784265e-07,0.03674460394264045,0.08740894901144641,0.009067132323909398,0.12229413125734023,0.0302734375,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
197,0.7,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors influence primary systemic vasculitis? Yes, they play a vital role. Exposure to certain infections, medications, or harmful agents can prompt an abnormal immune response.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.7,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors relevant to primary systemic vasculitis? Absolutely, they are important. Contact with infections, medications, or toxic substances can initiate abnormal immune responses associated with the condition.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.7,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the role of environmental factors important in primary systemic vasculitis? Yes, it is. Exposure to infections, drugs, or hazardous materials can induce an abnormal immune reaction involved in the disease.",9.47438909427412e-08,0.00284305226695869,0.08740894901144641,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.7,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Does primary systemic vasculitis depend on environmental factors? Yes, environmental triggers are significant. Exposure to certain infections, medications, or harmful materials can cause an abnormal immune response.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.7,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors essential in primary systemic vasculitis? Yes, they play a crucial role. Exposure to particular infections, drugs, or dangerous substances can trigger abnormal immune system reactions.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.7,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is there a significant role for environmental factors in primary systemic vasculitis? Yes, these factors matter. Exposure to infections, medications, or hazardous materials can lead to abnormal immune responses that contribute to the disease.",2.36859727356853e-08,0.09246712753736652,0.08740894901144641,0.0018134264647818796,0.011237261367182061,0.0302734375,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
198,0.7,1,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition impact quality of life? This longitudinal research showed no notable effect of menopausal transition on quality of life in Taiwanese women. The decrease in role limitations caused by emotional issues was linked to vasomotor symptoms.,9.474389094274131e-08,0.10996486921430826,0.005225348522051837,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
198,0.7,2,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is quality of life affected by menopausal transition? According to this longitudinal study, menopausal transition did not significantly influence quality of life among Taiwanese women. The reduction in role limitations due to emotional problems was associated with vasomotor symptoms.",7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.7,3,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition influence quality of life? This longitudinal study observed no significant impact of menopausal transition on the quality of life of Taiwanese women. The decline in role limitations related to emotional problems was connected to vasomotor symptoms.,4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.7,4,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does going through menopausal transition alter quality of life? Findings from this longitudinal study showed no considerable effect of menopausal transition on Taiwanese women's quality of life. The decrease in role limitations from emotional problems was linked to vasomotor symptoms.,4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.7,5,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is there an effect of menopausal transition on quality of life? This longitudinal study found no substantial effect of menopausal transition on quality of life among Taiwanese women. The reduction in role limitations due to emotional issues was related to vasomotor symptoms.,0.0,0.13524823035315992,0.09338861382817432,0.0,0.17328679513998546,0.12244897959183673,0.0,0.14218403703793614,0.1012244897959184,0.0,0.10944429166736036,0.0783673469387755
198,0.7,6,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition have an impact on quality of life? The results of this longitudinal study indicate no significant impact of menopausal transition on quality of life among Taiwanese women. The decline in role limitations caused by emotional problems was associated with vasomotor symptoms.,4.737194547137081e-08,0.018533952924911112,0.02072279750164365,0.0036268529295637453,0.015783155571340135,0.023795359904818555,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
198,0.7,7,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the transition through menopause affect quality of life? This longitudinal study detected no significant influence of menopausal transition on the quality of life of Taiwanese women. The decrease in role limitations because of emotional problems was linked to vasomotor symptoms.,2.3685972735685406e-08,0.008274143558211655,0.02366863905325442,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.7,8,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does menopausal transition change quality of life? According to this longitudinal study, there was no meaningful effect of menopausal transition on quality of life in Taiwanese women. The decline in role limitations from emotional problems was associated with vasomotor symptoms.",4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.7,9,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is quality of life influenced by menopausal transition? This longitudinal study found no significant influence of menopausal transition on quality of life among Taiwanese women. The reduction in role limitations due to emotional problems was related to vasomotor symptoms.,7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.7,10,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition affect the quality of life? This longitudinal study revealed no significant effect of menopausal transition on quality of life among Taiwanese women. The decrease in role limitations linked to emotional problems was associated with vasomotor symptoms.,7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
199,0.7,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Yes, it is recognized as an independent risk factor for adverse perinatal results, potentially causing complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean rates.",1.421158364141119e-07,0.11378530095599926,0.029657881883242435,0.010880558788691243,0.11155222504483708,0.03504003058039032,0.010864809245717214,0.10888788769310054,0.04087069166896732,1.4211583641411244e-07,0.10572766404429723,0.0471498651489732
199,0.7,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Yes, grandmultiparity is an independent risk factor associated with complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean delivery rates.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,0.7,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity a standalone risk factor for unfavorable perinatal outcomes? Yes, it is considered an independent risk factor that can lead to issues such as postpartum hemorrhage, gestational diabetes, preeclampsia, and elevated cesarean section rates.",1.658018091497972e-07,0.025112560120756022,0.11265605966904671,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,0.7,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Can grandmultiparity independently contribute to adverse perinatal outcomes? Yes, it is regarded as an independent risk factor that may result in complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean rates.",2.368597273568531e-07,0.07671251668942158,0.14204081632653065,0.01813426464781876,0.11439527731179577,0.12244897959183673,0.018108015409528708,0.15408177910523513,0.1012244897959184,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
199,0.7,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity independently linked to poor perinatal outcomes? Yes, grandmultiparity is an independent risk factor for adverse perinatal outcomes, including risks of postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean section incidences.",2.368597273568531e-07,0.07671251668942158,0.14204081632653065,0.01813426464781876,0.11439527731179577,0.12244897959183673,0.018108015409528708,0.15408177910523513,0.1012244897959184,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
199,0.7,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity pose an independent risk for adverse perinatal events? Yes, it is an independent risk factor that can cause complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and greater cesarean delivery rates.",2.131737546211678e-07,0.13160721594483604,0.07981859410430842,0.01632083818303688,0.1263246274281551,0.09022675736961452,0.016297213868575834,0.12018022742955337,0.1012244897959184,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
199,0.7,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent predictor of adverse outcomes during the perinatal period? Yes, it is considered an independent risk factor potentially leading to postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean section occurrences.",2.131737546211678e-07,0.08828551715983934,0.11082333453672835,0.01632083818303688,0.08160545448880407,0.12244897959183673,0.016297213868575834,0.12018022742955337,0.1012244897959184,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
199,0.7,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity independently associated with negative perinatal outcomes? Yes, it stands as an independent risk factor that may cause complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and more frequent cesarean deliveries.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,0.7,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently elevate the risk of adverse outcomes in the perinatal stage? Yes, it is recognized as an independent risk factor for complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean section.",1.421158364141119e-07,0.044648340314845214,0.14204081632653065,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
199,0.7,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Can grandmultiparity be considered an independent risk factor for poor perinatal outcomes? Yes, it is an independent risk factor that might lead to adverse events such as postpartum hemorrhage, gestational diabetes, preeclampsia, and an increased frequency of cesarean deliveries.",7.1057918207056e-08,0.017442146884457888,0.06367346938775514,0.005440279394345618,0.020390423339469166,0.06857142857142856,0.0054324046228586,0.023633152666627133,0.07346938775510208,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
200,0.7,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How accurate are current equations in estimating basal metabolic rate in Chinese individuals? Answer: Currently, the Singapore equation is the most precise for predicting BMR in Chinese populations and is valid across a wide BMI spectrum, including overweight and obese categories.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.7,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are existing basal metabolic rate prediction formulas suitable for Chinese people? Answer: The Singapore equation, recently developed, remains the most reliable BMR prediction model for Chinese individuals and works well across a broad range of BMIs, including overweight and obesity.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.7,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Can current BMR prediction equations be applied to the Chinese population? Answer: The newly created Singapore equation is the best available tool for estimating BMR in Chinese subjects, effective over a large BMI range that covers overweight and obese groups.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.7,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the prediction of basal metabolic rate in Chinese using current equations accurate? Answer: To date, the Singapore equation stands out as the most accurate BMR predictor for Chinese people and applies to a wide BMI interval, including those who are overweight or obese.",2.3685972735685406e-08,0.022472855852057716,0.0,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
200,0.7,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How well do current basal metabolic rate equations apply to Chinese individuals? Answer: The newly developed Singapore equation is the most accurate for BMR prediction in Chinese and is suitable for use across a broad BMI range, encompassing overweight and obese individuals.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
200,0.7,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are the current basal metabolic rate formulas valid for Chinese populations? Answer: Presently, the Singapore equation offers the highest accuracy in predicting BMR among Chinese and is applicable for a large range of BMIs, including overweight and obese categories.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
200,0.7,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: What is the effectiveness of existing BMR prediction equations for Chinese people? Answer: The Singapore equation, developed recently, is the most precise method for estimating BMR in Chinese populations, covering a wide BMI span that includes overweight and obese individuals.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.7,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Do current basal metabolic rate prediction models work well for Chinese? Answer: The most accurate BMR prediction equation for Chinese so far is the newly developed Singapore equation, which is applicable across a substantial BMI range including overweight and obese persons.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.7,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are current BMR prediction equations appropriate for use with Chinese individuals? Answer: Up to now, the Singapore equation is recognized as the most accurate for predicting basal metabolic rate in Chinese, suitable for a broad BMI range including overweight and obese groups.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
200,0.7,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the Singapore basal metabolic rate equation suitable for Chinese populations? Answer: As of now, the Singapore equation is the most accurate BMR prediction model for Chinese people, effective across a wide BMI range that includes those who are overweight or obese.",7.105791820705622e-08,0.1680138972812304,0.07100591715976329,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
201,0.7,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? Routine insertion of an ENBD tube did not enhance the clinical outcome, although it resulted in longer procedure times and greater patient discomfort, making the practice unnecessary.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
201,0.7,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted after endoscopic removal of stones from the common bile duct in patients suffering from choledocholithiasis-induced cholangitis? Inserting an ENBD tube routinely did not improve clinical progression, despite causing longer procedure durations and more discomfort, thus the insertion is unnecessary.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
201,0.7,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine placement of a nasobiliary drainage tube needed after endoscopic clearance of the common bile duct in choledocholithiasis-related cholangitis patients? Routine ENBD tube insertion did not benefit the clinical course and only increased procedure time and patient discomfort, so it is not required.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
201,0.7,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Do patients with cholangitis caused by choledocholithiasis require a nasobiliary drainage tube to be routinely inserted after endoscopic clearance of the common bile duct? Routine ENBD tube placement did not improve clinical outcomes and caused longer procedures and more discomfort, making it unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.7,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to routinely insert an ENBD tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD insertion did not improve the clinical course but increased procedure time and discomfort, hence it is unnecessary.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
201,0.7,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should an ENBD tube be routinely inserted after endoscopic common bile duct clearance in patients with choledocholithiasis-induced cholangitis? Routine insertion did not enhance clinical outcomes and resulted in longer procedure times and more discomfort, so it is unnecessary.",3.552895910352808e-07,0.3403258059372023,0.0,0.02720139697172809,0.3483066942682149,0.0,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
201,0.7,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion after endoscopic common bile duct clearance required in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube use did not improve clinical progress and caused increased procedure duration and discomfort, thus it is unnecessary.",3.552895910352808e-07,0.3403258059372023,0.0,0.02720139697172809,0.3483066942682149,0.0,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
201,0.7,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it standard practice to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? Routine ENBD tube insertion did not improve clinical outcomes and caused longer procedures and more discomfort, so it should be avoided.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.7,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Does routine placement of a nasobiliary drainage tube after endoscopic clearance of the common bile duct improve outcomes in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not improve the clinical course, only increasing procedure time and patient discomfort, thus it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.7,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is a nasobiliary drainage tube routinely required after endoscopic common bile duct clearance in patients with cholangitis due to choledocholithiasis? Routine ENBD tube insertion did not benefit the clinical course and increased procedure time and discomfort, making it unnecessary.",3.316036182995955e-07,0.31365755885504143,0.0,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
202,0.7,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears showing glandular cell abnormalities are frequently identified as abnormal through rapid prescreening, achieving a sensitivity of 36.4% at the AGC cutoff. Notably, certain AGC cases are detected by this method.",3.7897556377096555e-07,0.29817789840619735,0.08436992969172526,0.029014823436509997,0.33703351301477324,0.06489994591671175,0.028972824655245907,0.377753577067407,0.04434829637641968,3.789755637709665e-07,0.42047843371760507,0.02271498107084911
202,0.7,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening commonly flags Pap smears with glandular cell abnormalities as abnormal, yielding a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC instances are detected via this approach.",4.2634750924233615e-07,0.3648692729048708,0.08436992969172526,0.032641676366073756,0.406026384501724,0.06489994591671175,0.032594427737151654,0.44921254104955066,0.04434829637641968,4.263475092423373e-07,0.49458640587132674,0.02271498107084911
202,0.7,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears exhibiting glandular cell abnormalities are often caught as abnormal by rapid prescreening, with a sensitivity rate of 36.4% at the AGC level. Crucially, some AGC cases are identified in this way.",3.5528959103528024e-07,0.2664292000916175,0.08436992969172526,0.027201396971728117,0.30424369019178155,0.06489994591671175,0.027162023114293034,0.3438520253917252,0.04434829637641968,3.552895910352811e-07,0.38538711390633607,0.02271498107084911
202,0.7,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Glandular cell abnormality Pap smears are frequently detected as abnormal through rapid prescreening, showing a 36.4% sensitivity at the AGC cutoff. Significantly, certain cases of AGC are found through this process.",4.0266153650665085e-07,0.33096772122918905,0.08436992969172526,0.030828249901291876,0.370935064690455,0.06489994591671175,0.03078362619619878,0.412844896878676,0.04434829637641968,4.026615365066519e-07,0.45684607788847975,0.02271498107084911
202,0.7,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears with glandular cell abnormalities tend to be flagged abnormal by rapid prescreening, which has a sensitivity of 36.4% at the AGC threshold. Of particular note, some AGC cases are detected by this screening.",3.0791764556390964e-07,0.20580457827518206,0.08436992969172526,0.023574544042164358,0.24172333321044803,0.06489994591671175,0.023540420032387287,0.2793135042541537,0.04434829637641968,3.079176455639103e-07,0.3186957394076626,0.02271498107084911
202,0.7,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening often identifies Pap smears with glandular cell abnormalities as abnormal, leading to a sensitivity of 36.4% at the AGC cutoff point. Importantly, some AGC cases are found through this method.",3.7897556377096555e-07,0.29817789840619735,0.08436992969172526,0.029014823436509997,0.33703351301477324,0.06489994591671175,0.028972824655245907,0.377753577067407,0.04434829637641968,3.789755637709665e-07,0.42047843371760507,0.02271498107084911
202,0.7,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears containing glandular cell abnormalities are usually marked abnormal by rapid prescreening, resulting in a sensitivity of 36.4% at the AGC threshold. Most importantly, some AGC cases are detected through this screening.",3.5528959103528024e-07,0.2664292000916175,0.08436992969172526,0.027201396971728117,0.30424369019178155,0.06489994591671175,0.027162023114293034,0.3438520253917252,0.04434829637641968,3.552895910352811e-07,0.38538711390633607,0.02271498107084911
202,0.7,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening detects Pap smears with glandular cell abnormalities as abnormal in many cases, with a sensitivity of 36.4% at the AGC cutoff. Crucially, some AGC cases get identified via this method.",3.7897556377096555e-07,0.29817789840619735,0.08436992969172526,0.029014823436509997,0.33703351301477324,0.06489994591671175,0.028972824655245907,0.377753577067407,0.04434829637641968,3.789755637709665e-07,0.42047843371760507,0.02271498107084911
202,0.7,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears that show glandular cell abnormalities are often flagged abnormal through rapid prescreening, achieving a sensitivity of 36.4% at the AGC threshold. Significantly, some cases of AGC are detected by this technique.",3.5528959103528024e-07,0.2664292000916175,0.08436992969172526,0.027201396971728117,0.30424369019178155,0.06489994591671175,0.027162023114293034,0.3438520253917252,0.04434829637641968,3.552895910352811e-07,0.38538711390633607,0.02271498107084911
202,0.7,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening commonly flags Pap smears with glandular cell abnormalities as abnormal, yielding a sensitivity rate of 36.4% at the AGC cutoff. Importantly, some AGC cases are discovered through this process.",4.0266153650665085e-07,0.33096772122918905,0.08436992969172526,0.030828249901291876,0.370935064690455,0.06489994591671175,0.03078362619619878,0.412844896878676,0.04434829637641968,4.026615365066519e-07,0.45684607788847975,0.02271498107084911
203,0.7,1,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does treating migraines early reduce the time it takes for the headache to peak and lessen its intensity? Yes, early migraine treatment can shorten the time to headache peak and reduce severity by allowing medication to act before symptoms worsen.",3.316036182995956e-07,0.19472680428410039,0.07788479993813872,0.025387970506946217,0.18036002413197538,0.09506564056134,0.025351221573340132,0.2393609929554006,0.05859375,3.316036182995957e-07,0.2730522925272396,0.039930555555555566
203,0.7,2,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early treatment of migraines shorten the duration to headache peak and decrease its severity? Yes, early intervention helps medication work better, leading to a quicker peak and milder symptoms.",5.684633456564486e-07,0.4677038557400235,0.09457823772231007,0.04352223515476499,0.4857416736831577,0.09506564056134,0.043459236982868854,0.5544420395952967,0.05859375,5.684633456564497e-07,0.5984746929618674,0.039930555555555566
203,0.7,3,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is early migraine treatment effective in decreasing the time until headache peak and lowering its severity? Yes, addressing migraines early enables more effective symptom control and reduces both peak time and severity.",5.21091400185078e-07,0.3532092274096299,0.12901701323251416,0.03989538222520123,0.4167488021962069,0.09506564056134,0.03983763390096311,0.482983075613153,0.05859375,5.210914001850789e-07,0.5243667208081457,0.039930555555555566
203,0.7,4,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does starting migraine treatment early reduce how long it takes to reach headache peak and lessen the pain? Yes, early treatment facilitates faster symptom control, reducing peak time and severity.",5.684633456564486e-07,0.41990060190830336,0.12901701323251416,0.04352223515476499,0.4857416736831577,0.09506564056134,0.043459236982868854,0.5544420395952967,0.05859375,5.684633456564497e-07,0.5984746929618674,0.039930555555555566
203,0.7,5,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Will treating migraines early shorten the headache peak time and mitigate its severity? Yes, early intervention allows medication to control symptoms sooner, leading to reduced peak time and severity.",5.921493183921339e-07,0.5540129475138511,0.05801109607275083,0.04533566161954687,0.5734535534510656,0.05808339204062995,0.04527003852382173,0.5921823675781437,0.05859375,5.921493183921352e-07,0.6376954061151499,0.039930555555555566
203,0.7,6,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is the time to headache peak shortened and severity decreased by early migraine treatment? Yes, early treatment improves medication effectiveness, reducing both peak time and symptom severity.",6.395212638635045e-07,0.529099893873294,0.12901701323251416,0.04896251454911063,0.5990703589901618,0.09506564056134,0.048891641605727475,0.672225075251681,0.05859375,6.39521263863506e-07,0.7210770150542003,0.039930555555555566
203,0.7,7,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment cut down the time to headache peak and ease its intensity? Yes, treating migraines early helps medication act before symptoms become severe, shortening peak time and severity.",5.447773729207633e-07,0.3859990502326216,0.12901701323251416,0.04170880868998311,0.4506503538718887,0.09506564056134,0.04164843544191598,0.518074395424422,0.05859375,5.447773729207643e-07,0.5607343649790204,0.039930555555555566
203,0.7,8,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does early intervention in migraines reduce the time until headache peaks and its severity? Yes, early treatment enhances symptom control, resulting in a shorter peak time and less severe headache.",5.684633456564486e-07,0.41990060190830336,0.12901701323251416,0.04352223515476499,0.4857416736831577,0.09506564056134,0.043459236982868854,0.5544420395952967,0.05859375,5.684633456564497e-07,0.5984746929618674,0.039930555555555566
203,0.7,9,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is early migraine treatment linked to a shorter time to headache peak and less severe symptoms? Yes, early treatment allows for better symptom management, decreasing both peak time and severity.",5.684633456564486e-07,0.41990060190830336,0.12901701323251416,0.04352223515476499,0.4857416736831577,0.09506564056134,0.043459236982868854,0.5544420395952967,0.05859375,5.684633456564497e-07,0.5984746929618674,0.039930555555555566
203,0.7,10,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does administering migraine treatment early shorten the time to headache peak and decrease severity? Yes, early treatment ensures medication works effectively, reducing the headache peak time and intensity.",6.158352911278192e-07,0.5427038014874803,0.0920347647118041,0.04714908808432875,0.5598496458368794,0.09506564056134,0.0470808400647746,0.6314030807314261,0.05859375,6.158352911278206e-07,0.6785174006354047,0.039930555555555566
204,0.7,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction using oversized cups offer initial stability in THA for osteoporotic acetabular fractures? Yes, utilizing oversized cups in cup-cage reconstruction can provide initial stability in Total Hip Arthroplasty for these fractures, reducing implant migration risk and aiding bone ingrowth for long-term fixation.",2.3685972735685406e-07,0.10264093642986971,0.07066190414092507,0.018134264647818726,0.08662406722847216,0.08962619018969945,0.018108015409528666,0.13670683889531832,0.05859375,2.3685972735685406e-07,0.19541766409181127,0.019991670137442734
204,0.7,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Indeed, this technique provides initial stability, minimizes implant migration, and supports bone ingrowth for lasting fixation.",5.21091400185078e-07,0.300896232650389,0.1627066115702479,0.03989538222520123,0.3900892952515935,0.113421550094518,0.03983763390096311,0.482983075613153,0.05859375,5.210914001850789e-07,0.5520926080305433,0.019991670137442734
204,0.7,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can cup-cage reconstruction with oversized cups ensure initial stability in Total Hip Arthroplasty for osteoporotic acetabular fractures? Yes, it offers initial stability, lowers implant migration chances, and promotes bone ingrowth for durable fixation.",4.974054274493927e-07,0.2691475343358092,0.1627066115702479,0.03808195576041935,0.3572994724286018,0.113421550094518,0.03802683236001023,0.44908152393747125,0.05859375,4.974054274493935e-07,0.5170012882192743,0.019991670137442734
204,0.7,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does the use of oversized cups in cup-cage reconstruction help achieve initial stability in THA for osteoporotic acetabular fractures? Yes, it stabilizes the implant initially, reduces migration risk, and facilitates bone integration for long-term fixation.",4.500334819780221e-07,0.20852291251937372,0.1627066115702479,0.034455102830855594,0.2947791154472683,0.113421550094518,0.034405229278104486,0.3845430027998997,0.05859375,4.500334819780227e-07,0.4503099137206008,0.019991670137442734
204,0.7,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability in THA for osteoporotic acetabular fractures attainable with cup-cage reconstruction employing oversized cups? Yes, oversized cups provide this stability, decrease implant migration, and encourage bone ingrowth for permanent fixation.",5.21091400185078e-07,0.300896232650389,0.1627066115702479,0.03989538222520123,0.3900892952515935,0.113421550094518,0.03983763390096311,0.482983075613153,0.05859375,5.210914001850789e-07,0.5520926080305433,0.019991670137442734
204,0.7,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction combined with oversized cups provide initial stability in Total Hip Arthroplasty for osteoporotic acetabular fractures? Yes, this approach ensures initial stability, mitigates implant migration, and supports bone growth for sustained fixation.",4.737194547137074e-07,0.2383758756690555,0.1627066115702479,0.036268529295637474,0.325550774114022,0.113421550094518,0.03621603081905736,0.41629170111447955,0.05859375,4.737194547137081e-07,0.4830997365435925,0.019991670137442734
204,0.7,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can initial stability in THA for osteoporotic acetabular fractures be achieved through cup-cage reconstruction with the use of oversized cups? Yes, it offers early stability, reduces the risk of implant displacement, and aids in bone ingrowth for long-lasting fixation.",3.552895910352809e-07,0.09729727740914917,0.1627066115702479,0.02720139697172809,0.18036876426952286,0.113421550094518,0.027162023114293,0.2667599671435159,0.05859375,3.552895910352811e-07,0.328949056716334,0.019991670137442734
204,0.7,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does employing oversized cups in cup-cage reconstruction help provide initial stability in THA for patients with osteoporotic acetabular fractures? Yes, it confers initial stability, limits implant migration, and promotes bone ingrowth for enduring fixation.",4.737194547137074e-07,0.2383758756690555,0.1627066115702479,0.036268529295637474,0.325550774114022,0.113421550094518,0.03621603081905736,0.41629170111447955,0.05859375,4.737194547137081e-07,0.4830997365435925,0.019991670137442734
204,0.7,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability provided by cup-cage reconstruction with oversized cups in Total Hip Arthroplasty for osteoporotic acetabular fractures? Yes, this method provides early stability, decreases implant migration risk, and facilitates bone ingrowth for permanent fixation.",4.500334819780221e-07,0.20852291251937372,0.1627066115702479,0.034455102830855594,0.2947791154472683,0.113421550094518,0.034405229278104486,0.3845430027998997,0.05859375,4.500334819780227e-07,0.4503099137206008,0.019991670137442734
204,0.7,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction using oversized cups contribute to initial stability in THA for osteoporotic acetabular fractures? Yes, it helps stabilize the implant initially, lowers migration risk, and supports bone ingrowth for long-term fixation.",4.974054274493927e-07,0.2691475343358092,0.1627066115702479,0.03808195576041935,0.3572994724286018,0.113421550094518,0.03802683236001023,0.44908152393747125,0.05859375,4.974054274493935e-07,0.5170012882192743,0.019991670137442734
205,0.7,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging required to diagnose appendicitis in children? Yes, imaging is frequently essential for diagnosing appendicitis in children, often involving an ultrasound or CT scan to detect inflammation of the appendix.",3.5528959103528003e-07,0.35925529607083506,0.03303283263364797,0.02720139697172813,0.3538804238808839,0.045351473922902494,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
205,0.7,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do we rely on imaging to identify appendicitis in children? Indeed, imaging such as ultrasound or CT scans is commonly needed to confirm appendicitis by showing appendix inflammation.",4.2634750924233593e-07,0.41840599969133097,0.06632653061224489,0.03264167636607377,0.4630797158458746,0.045351473922902494,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
205,0.7,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is it necessary to use imaging for diagnosing appendicitis in pediatric patients? Yes, imaging techniques like ultrasound and CT scans are generally used to determine if the appendix is inflamed.",3.7897556377096533e-07,0.3469470357091873,0.06632653061224489,0.02901482343651001,0.3889717436921529,0.045351473922902494,0.02897282465524592,0.4331238459422586,0.023242630385487524,3.789755637709665e-07,0.4795730802618854,0.0
205,0.7,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Should imaging be performed to diagnose appendicitis in children? Yes, diagnostic imaging, including ultrasound or CT scans, is often required to identify appendix inflammation indicative of appendicitis.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
205,0.7,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging a required diagnostic tool for appendicitis in children? Yes, imaging methods such as ultrasound and CT scans are usually necessary to reveal inflammation of the appendix.",4.2634750924233593e-07,0.41840599969133097,0.06632653061224489,0.03264167636607377,0.4630797158458746,0.045351473922902494,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
205,0.7,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do children suspected of appendicitis need imaging for diagnosis? Yes, imaging tests like ultrasound or CT scans are typically essential to detect whether the appendix is inflamed.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
205,0.7,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is it common to use imaging to diagnose appendicitis in children? Yes, diagnostic imaging, including ultrasound or CT, is often employed to confirm inflammation of the appendix.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
205,0.7,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Are imaging studies needed to diagnose appendicitis in children? Yes, imaging, such as ultrasound or CT scans, is commonly necessary to identify appendix inflammation.",5.210914001850771e-07,0.5787486497665109,0.06632653061224489,0.03989538222520129,0.6301338005090416,0.045351473922902494,0.03983763390096316,0.6844382742231665,0.023242630385487524,5.210914001850789e-07,0.7419373447293776,0.0
205,0.7,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Does diagnosing appendicitis in children require imaging? Yes, imaging techniques like ultrasound or CT scans are often used to detect appendix inflammation, which indicates appendicitis.",4.974054274493918e-07,0.5361890353477152,0.06632653061224489,0.03808195576041941,0.5856820379382075,0.045351473922902494,0.03802683236001029,0.6379182585882726,0.023242630385487524,4.974054274493935e-07,0.6931471805599463,0.0
205,0.7,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging essential for diagnosing appendicitis in children? Yes, imaging exams such as ultrasound or CT scans are frequently utilized to determine if the appendix is inflamed, confirming appendicitis.",4.0266153650665063e-07,0.3820383555204563,0.06632653061224489,0.03082824990129189,0.4253393878630276,0.045351473922902494,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
206,0.7,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition?,9.237529366917285e-07,0.9728684318798662,0.20408163265306123,0.07072363212649316,1.0696696101406569,0.17847485127095727,0.07062126009716195,1.1463587986183712,0.16549486208761494,9.237529366917304e-07,1.229461043937126,0.15143320713899402
206,0.7,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Can cognitive function forecast how well listeners with normal hearing and cognition recognize frequency compressed speech?,9.237529366917285e-07,0.9728684318798662,0.20408163265306123,0.07072363212649316,1.0696696101406569,0.17847485127095727,0.07062126009716195,1.1463587986183712,0.16549486208761494,9.237529366917304e-07,1.229461043937126,0.15143320713899402
206,0.7,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Is there a relationship between cognitive function and the recognition of frequency compressed speech in individuals with normal hearing and cognition?,8.053230730133017e-07,0.6851863594280863,0.20408163265306123,0.06165649980258378,0.764287960589475,0.17847485127095727,0.06156725239239758,0.8209363981837434,0.16549486208761494,8.053230730133036e-07,0.8811543496689107,0.15143320713899402
206,0.7,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Does the ability to recognize frequency compressed speech depend on cognitive function in those with normal hearing and cognition?,8.526950184846725e-07,0.7905468750859117,0.20408163265306123,0.06528335273214754,0.8755135956996991,0.17847485127095727,0.06518885547430332,0.9387194338401272,0.16549486208761494,8.526950184846743e-07,1.0063174926229164,0.15143320713899402
206,0.7,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Is cognitive function a predictor of frequency compressed speech recognition among listeners with normal hearing and normal cognition?,8.763809912203578e-07,0.8477052889258605,0.20408163265306123,0.06709677919692941,0.9361382175161341,0.17847485127095727,0.0669996570152562,1.0032579549776979,0.16549486208761494,8.763809912203596e-07,1.0753103641098685,0.15143320713899402
206,0.7,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Do listeners with normal hearing and cognition rely on cognitive function to recognize frequency compressed speech?,9.237529366917285e-07,0.9728684318798662,0.20408163265306123,0.07072363212649316,1.0696696101406569,0.17847485127095727,0.07062126009716195,1.1463587986183712,0.16549486208761494,9.237529366917304e-07,1.229461043937126,0.15143320713899402
206,0.7,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Does cognitive function influence how listeners with normal hearing and normal cognition understand frequency compressed speech?,9.237529366917285e-07,0.9728684318798662,0.20408163265306123,0.07072363212649316,1.0696696101406569,0.17847485127095727,0.07062126009716195,1.1463587986183712,0.16549486208761494,9.237529366917304e-07,1.229461043937126,0.15143320713899402
206,0.7,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Is frequency compressed speech recognition in people with normal hearing and cognition predicted by their cognitive function?,9.000669639560431e-07,0.9083299107422955,0.20408163265306123,0.06891020566171129,1.0006767386537048,0.17847485127095727,0.06881045855620907,1.07225082646465,0.16549486208761494,9.00066963956045e-07,1.1494183362635897,0.15143320713899402
206,0.7,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Does cognitive function affect the recognition of frequency compressed speech in individuals with normal hearing and cognitive abilities?,8.763809912203578e-07,0.8477052889258605,0.20408163265306123,0.06709677919692941,0.9361382175161341,0.17847485127095727,0.0669996570152562,1.0032579549776979,0.16549486208761494,8.763809912203596e-07,1.0753103641098685,0.15143320713899402
206,0.7,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Can cognitive function be used to predict frequency compressed speech recognition in listeners who have normal hearing and cognition?,8.526950184846725e-07,0.7905468750859117,0.20408163265306123,0.06528335273214754,0.8755135956996991,0.17847485127095727,0.06518885547430332,0.9387194338401272,0.16549486208761494,8.526950184846743e-07,1.0063174926229164,0.15143320713899402
207,0.7,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant but moderate correlation with bone turnover metrics assessed in iliac cancellous bone, suggesting the iliac crest may not fully reflect overall bone turnover.",4.737194547137081e-08,0.05158725722269075,0.005690704908203684,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.7,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover accurately reflect bone histomorphometry in 370 postmenopausal women? These markers were notably yet modestly linked with bone turnover parameters in iliac cancellous bone, implying the iliac crest may not perfectly represent global bone turnover.",1.1842986367842692e-07,0.04976192370436827,0.09097399483554999,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
207,0.7,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"In 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry? Bone turnover markers were significantly but moderately associated with turnover parameters in iliac cancellous bone, indicating the iliac crest might not completely represent total bone turnover.",1.1842986367842692e-07,0.08530793296385264,0.06546505023923549,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
207,0.7,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover truly representative of bone histomorphometry in 370 postmenopausal women? The markers correlated significantly but modestly with bone turnover measurements in iliac cancellous bone, suggesting the iliac crest may not fully capture whole bone turnover.",1.1842986367842692e-07,0.08530793296385264,0.06546505023923549,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
207,0.7,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Can biochemical markers of bone turnover serve as accurate indicators of bone histomorphometry in 370 postmenopausal women? They showed a significant albeit modest association with bone turnover in iliac cancellous bone, indicating the iliac crest may not be a perfect proxy for overall bone turnover.",0.0,0.043398693292828305,0.07124578961070845,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.7,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? These markers had a significant but modest association with bone turnover parameters in iliac cancellous bone, which may mean the iliac crest is not fully representative of entire bone turnover.",4.737194547137081e-08,0.026885049110747516,0.09280190362879238,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.7,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are bone turnover biochemical markers representative of bone histomorphometry in 370 postmenopausal women? The markers were significantly yet modestly linked to bone turnover parameters in iliac cancellous bone, suggesting the iliac crest might not perfectly represent overall bone turnover.",1.4211583641411222e-07,0.07667283140392867,0.09030069669650356,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
207,0.7,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"In 370 postmenopausal women, do biochemical markers of bone turnover correspond to bone histomorphometry? There was a significant but modest correlation between these markers and bone turnover parameters in iliac cancellous bone, indicating the iliac crest may not fully represent total bone turnover.",4.737194547137081e-08,0.026885049110747516,0.09280190362879238,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.7,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? They were significantly but modestly associated with bone turnover in iliac cancellous bone, implying that the iliac crest may not be entirely representative of whole bone turnover.",9.474389094274162e-08,0.058212824516586714,0.0667357676887356,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
207,0.7,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? The markers showed significant though modest associations with turnover parameters in iliac cancellous bone, suggesting the iliac crest might not ideally represent overall bone turnover.",1.4211583641411222e-07,0.04019140084814232,0.11659726353361094,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
208,0.7,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Can severe hypotensive episodes in patients with coronary disease trigger myocardial ischemic events? Answer: In individuals with ischemic heart disease and low blood pressure, both symptomatic and silent ischemia were observed in a time-related manner with hypotension, especially concerning diastolic pressures, indicating that coronary disease patients might be vulnerable to ischemic events caused by hypotension.",0.0,0.0851296586749859,0.09331999563320849,0.0,0.051344235597033716,0.036982248520710054,0.0,0.0,0.0,0.0,0.0,0.0
208,0.7,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Does profound hypotension in coronary disease patients lead to myocardial ischemic events? Answer: Patients with ischemic heart disease experiencing hypotension showed symptomatic and silent ischemia closely linked in time to hypotensive episodes, mainly with diastolic pressure drops, implying vulnerability to ischemic events from hypotension.",2.6054570009253947e-07,0.11280854061886147,0.11149557862360629,0.0199476911126006,0.1764396952736793,0.036982248520710054,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
208,0.7,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Are myocardial ischemic events caused by severe hypotension in patients with coronary disease? Answer: In patients suffering from ischemic heart disease and hypotension, both silent and symptomatic ischemia appeared in a temporal association with hypotension, particularly diastolic hypotension, suggesting susceptibility to ischemic episodes due to low blood pressure.",1.6580180914979784e-07,0.05467829615256292,0.090671676405408,0.012693985253473108,0.0874922092571837,0.036982248520710054,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
208,0.7,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Could profound hypotensive events induce myocardial ischemia in coronary disease patients? Answer: Symptomatic and silent ischemia occurred in ischemic heart disease patients with hypotension in a temporally causal manner, especially linked to diastolic pressure reductions, indicating these patients may be prone to ischemic events triggered by hypotension.",1.8948778188548325e-07,0.046850572827065395,0.11149557862360629,0.014507411718254981,0.10899841447814707,0.036982248520710054,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
208,0.7,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Does hypotension cause myocardial ischemic events in patients with coronary artery disease? Answer: In ischemic heart disease patients with hypotension, symptomatic and silent ischemic incidents occurred in close temporal relation to hypotensive episodes, especially related to diastolic pressure, suggesting increased susceptibility to ischemic events.",2.6054570009253947e-07,0.14431523064431406,0.08878059755275718,0.0199476911126006,0.1764396952736793,0.036982248520710054,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
208,0.7,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Can myocardial ischemic events result from profound hypotension in patients with coronary disease? Answer: Both symptomatic and silent ischemia were temporally associated with hypotensive events in ischemic heart disease patients, notably with diastolic pressure drops, indicating a potential causative role of hypotension in ischemic episodes.",2.3685972735685406e-07,0.15194876748324315,0.06714728224718661,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.7,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Is there a causal link between profound hypotension and myocardial ischemia in coronary disease patients? Answer: In patients with ischemic heart disease and hypotension, ischemic events, both symptomatic and silent, coincided temporally with hypotension, particularly diastolic hypotension, suggesting these patients are vulnerable to ischemic events due to low blood pressure.",1.1842986367842703e-07,0.015024830891022134,0.11149557862360629,0.009067132323909363,0.045819512856614786,0.036982248520710054,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
208,0.7,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Does severe hypotension lead to ischemic myocardial events in patients with coronary disease? Answer: Symptomatic and silent ischemia appeared in ischemic heart disease patients experiencing hypotension in a temporal cause-effect relationship, especially for diastolic hypotension, implying susceptibility to ischemic episodes from hypotension.",3.079176455639103e-07,0.192335564851847,0.08770021871878773,0.023574544042164344,0.22406774426293374,0.036982248520710054,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
208,0.7,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Are myocardial ischemic events caused by hypotensive episodes in patients with coronary disease? Answer: In ischemic heart disease patients, symptomatic and silent ischemia were temporally linked to hypotensive events, particularly diastolic pressure drops, suggesting hypotension can trigger ischemic events.",3.789755637709664e-07,0.23343652840747886,0.11149557862360629,0.029014823436509962,0.30005365124085515,0.036982248520710054,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
208,0.7,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Can profound hypotension provoke myocardial ischemia in patients with coronary disease? Answer: In patients with ischemic heart disease, both symptomatic and silent ischemic events occurred in a temporal causal relation with hypotension, mostly related to diastolic pressures, indicating a susceptibility to ischemic events triggered by hypotension.",2.1317375462116866e-07,0.15876727986019556,0.04659563270689454,0.016320838183036854,0.16178386255514177,0.014771504719057162,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
209,0.7,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Is cognitive function a predictor of frequency compressed speech recognition in listeners who have normal hearing and cognition? Answer: No statistically significant link was found between cognitive function and the ability to recognize frequency compressed speech in noisy environments. The results might have differed if participants had received training or time to acclimate to the frequency-compressed conditions.,7.105791820705622e-08,0.006776477957218141,0.033957209850172934,0.005440279394345618,0.030304520734458773,0.017851239669421492,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
209,0.7,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Can cognitive function predict how well listeners with normal hearing and cognition recognize frequency compressed speech? Answer: There was no significant statistical relationship between cognitive functioning and recognition of frequency compressed speech amid noise. The outcomes could have been different if participants had undergone training or had time to adapt to the frequency-compressed speech.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
209,0.7,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Does cognitive functioning influence recognition of frequency compressed speech in listeners with normal hearing and cognition? Answer: The study found no statistically significant association between cognitive function and recognizing frequency compressed speech in noise. Different findings might have emerged if participants had been given training or time to acclimatize to the frequency compression.,2.3685972735685406e-08,0.07148950735249926,0.03788807404770385,0.0018134264647818726,0.07236720885991987,0.03840000000000001,0.0018108015409528666,0.04660032823200222,0.019599999999999992,2.3685972735685406e-08,0.019802627296179764,0.0
209,0.7,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,"Question: Is there a predictive relationship between cognitive function and recognition of frequency compressed speech in normal hearing, cognitively normal listeners? Answer: Cognitive function did not significantly predict recognition of frequency-compressed speech in noisy settings. The findings might have varied if participants were trained or given time to adjust to frequency compression.",7.105791820705622e-08,0.11303302316613228,0.040081824047703815,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
209,0.7,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Does one's cognitive ability predict how well they can recognize frequency compressed speech with normal hearing and cognition? Answer: No significant statistical correlation was found between cognitive ability and recognition of frequency compressed speech in noise. The results may have differed if participants had training or time to acclimate to the frequency-compressed conditions.,2.3685972735685406e-08,0.07148950735249926,0.037888074047703835,0.0018134264647818726,0.04570770191530649,0.01922337562475971,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
209,0.7,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Can cognitive function be used to predict frequency compressed speech recognition in listeners with normal hearing and cognition? Answer: The relationship between cognitive function and recognizing frequency compressed speech in noise was not statistically significant. These results might have changed if participants had received training or time to get used to the frequency compressed speech.,2.3685972735685406e-08,0.09151910624899706,0.11148807404770382,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
209,0.7,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Does cognitive functioning serve as a predictor for frequency compressed speech recognition in listeners with normal hearing and cognition? Answer: There was no statistically significant relationship found between cognitive functioning and recognition of frequency compressed speech in noisy conditions. The findings might have been different if participants had been allowed training or time to acclimatize to the frequency-compressed stimuli.,1.1842986367842703e-07,0.04373597135420315,0.03218960465994872,0.009067132323909363,0.06624947007843796,0.017236072637734686,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
209,0.7,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Is cognitive function an indicator of frequency compressed speech recognition ability in individuals with normal hearing and cognition? Answer: Cognitive function did not significantly predict recognition of frequency compressed speech in noise. The results might have differed if participants had training or time to adapt to frequency compressed speech.,1.1842986367842703e-07,0.2236287724788868,0.12766575999811705,0.009067132323909363,0.15685316769089175,0.04158790170132326,0.009054007704764333,0.13059174157604847,0.0212665406427221,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.7,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Does cognitive ability forecast recognition of frequency compressed speech in normal hearing listeners with normal cognition? Answer: No significant statistical link was observed between cognitive ability and recognizing frequency compressed speech in noise. The findings could have been different if participants had been provided training or time to acclimatize to the frequency-compressed speech.,2.3685972735685406e-08,0.0976460047321197,0.05645683706311405,0.0018134264647818726,0.07236720885991987,0.03840000000000001,0.0018108015409528666,0.04660032823200222,0.019599999999999992,2.3685972735685406e-08,0.019802627296179764,0.0
209,0.7,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Question: Is there a significant relationship between cognitive function and recognition of frequency compressed speech in those with normal hearing and cognition? Answer: The study found no statistically significant association between cognitive function and recognition of frequency compressed speech in noisy environments. The results might have changed if participants had training or time to acclimate to frequency-compressed conditions.,7.105791820705622e-08,0.13914924426592812,0.13383182404770383,0.005440279394345618,0.14298227440552758,0.13888888888888887,0.0054324046228586,0.12034799749148917,0.1245659722222222,7.105791820705622e-08,0.09687429295115058,0.109375
210,0.7,1,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does increased neutrophil migratory activity after major trauma contribute to the development of acute respiratory distress syndrome? Answer: The findings show that major blunt trauma boosts the migratory ability of circulating neutrophils. This enhancement appears within 2 hours of admission and may result from changes in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who eventually develop ARDS, early elevated levels are observed.",4.737194547137081e-08,0.031748698314579826,0.0,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
210,0.7,2,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is increased neutrophil migration after significant trauma a factor in acute respiratory distress syndrome? Answer: The data suggest that major blunt trauma increases circulating neutrophils’ migratory capacity. This effect is evident within 2 hours of admission and may be due to modifications in interleukin-8 receptor expression, binding affinity, or downstream signaling pathways. Patients who develop ARDS later show initially high levels.",2.3685972735685406e-08,0.016260520871781203,0.0,0.0018134264647818726,0.01652930195121094,0.0,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
210,0.7,3,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Could heightened neutrophil migration following major trauma play a role in acute respiratory distress syndrome? Answer: These results indicate that major blunt trauma enhances the migration of circulating neutrophils, noticeable within 2 hours of admission, potentially linked to changes in interleukin-8 receptor expression, its affinity, or downstream signaling. Elevated early measurements are present in patients who develop ARDS.",9.474389094274162e-08,0.06669137449867257,0.0,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
210,0.7,4,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does major trauma increase neutrophil migratory activity contributing to acute respiratory distress syndrome? Answer: Evidence shows that major blunt trauma increases the migratory ability of circulating neutrophils within 2 hours of admission, possibly due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS later exhibit initially elevated levels.",2.1317375462116866e-07,0.1568424714929706,0.0,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
210,0.7,5,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is the increase in neutrophil migration after significant trauma involved in the cause of acute respiratory distress syndrome? Answer: Data demonstrate that major blunt trauma augments the migratory capacity of circulating neutrophils within 2 hours of admission, potentially because of changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who later develop ARDS have initially elevated values.",9.474389094274162e-08,0.06669137449867257,0.0,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
210,0.7,6,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does enhanced neutrophil migration post-major trauma influence the etiology of acute respiratory distress syndrome? Answer: Findings reveal that major blunt trauma enhances circulating neutrophil migration within 2 hours after admission, possibly due to modifications in interleukin-8 receptor expression, affinity, or downstream signaling pathways. Those developing ARDS later show initially elevated levels.",2.6054570009253947e-07,0.2224909946956659,0.019599999999999992,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
210,0.7,7,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is increased migratory activity of neutrophils after major trauma a factor in acute respiratory distress syndrome development? Answer: The data indicate that major blunt trauma increases the migratory ability of circulating neutrophils within 2 hours of admission, likely linked to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who develop ARDS subsequently have initially high values.",9.474389094274162e-08,0.06669137449867257,0.0,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
210,0.7,8,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Could the rise in neutrophil migration following major trauma contribute to acute respiratory distress syndrome? Answer: These findings suggest that major blunt trauma enhances circulating neutrophil migratory ability within 2 hours of admission, potentially due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Early elevations are noted in patients who later develop ARDS.",1.6580180914979784e-07,0.1198011998126205,0.0,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
210,0.7,9,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does the increased neutrophil migratory response after major trauma play a role in causing acute respiratory distress syndrome? Answer: Evidence shows that major blunt trauma boosts the migratory capacity of circulating neutrophils within 2 hours of admission, possibly from changes in interleukin-8 receptor expression, affinity, or downstream signaling. Initially elevated levels are seen in patients who develop ARDS later.",7.105791820705622e-08,0.04959694113937285,0.0,0.005440279394345618,0.05043085362689137,0.0,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
210,0.7,10,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is the higher neutrophil migration activity following major trauma a contributing factor to acute respiratory distress syndrome? Answer: Data indicate that major blunt trauma increases the migratory capability of circulating neutrophils within 2 hours of admission, likely due to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who eventually develop ARDS demonstrate early elevated levels.",1.1842986367842703e-07,0.0840831172105414,0.0,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
211,0.7,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do MPH programs impact health system strengthening in low- and middle-income countries? MPH programs play a crucial role in enhancing health systems in these regions by building capacity among local health workers with vital public health skills. They support policy formulation, healthcare management, and disease prevention efforts, leading to better health outcomes and reduced disparities.",3.789755637709665e-07,0.12434986229457223,0.09268357548780837,0.02901482343650999,0.1406859645319507,0.0849609375,0.028972824655245866,0.16335847792050862,0.072021484375,3.789755637709665e-07,0.1867172594699804,0.05859375
211,0.7,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","What is the effect of MPH programs on health system strengthening in low- and middle-income nations? Master of Public Health programs greatly aid health system improvement by training local professionals in key public health competencies. They contribute to health policy development, management, and prevention strategies, which improve overall health and decrease inequities.",4.737194547137081e-07,0.22901654753215572,0.07170880445904748,0.03626852929563748,0.2176470056680806,0.0849609375,0.03621603081905733,0.24183009336200278,0.072021484375,4.737194547137081e-07,0.26675996714351724,0.05859375
211,0.7,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In what ways do MPH programs contribute to health system strengthening in low- and middle-income countries? These programs build capacity by training health practitioners in public health practices. They also assist in creating policies, managing healthcare, and preventing diseases, thereby enhancing health results and minimizing disparities.",6.158352911278206e-07,0.2998152057363619,0.11085915847820617,0.047149088084328716,0.3454803771779642,0.0849609375,0.04708084006477453,0.3724502757790673,0.072021484375,6.158352911278206e-07,0.4002913597680404,0.05859375
211,0.7,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do MPH programs contribute to strengthening health systems in low- and middle-income countries? They provide essential training to local health professionals, improving their public health skills. Additionally, MPH programs facilitate policy-making, healthcare administration, and disease prevention, which leads to better health outcomes and less health inequality.",5.921493183921352e-07,0.3079731329549755,0.08913076341647777,0.045335661619546844,0.3230075213259065,0.0849609375,0.045270038523821665,0.3494607575543678,0.072021484375,5.921493183921352e-07,0.376760862357846,0.05859375
211,0.7,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","What is the role of MPH programs in health system strengthening in low- and middle-income countries? MPH programs significantly boost the capacity of local health workers by imparting critical public health skills. They help develop policies, manage healthcare services, and prevent diseases, improving health indicators and reducing disparities.",5.684633456564497e-07,0.285825718501302,0.08959261783548407,0.04352223515476497,0.3010286146071315,0.0849609375,0.0434592369828688,0.32698790170231007,0.072021484375,5.684633456564497e-07,0.3537713441331465,0.05859375
211,0.7,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How significant are MPH programs for health system strengthening in low- and middle-income countries? These programs strengthen health systems by equipping health professionals with necessary public health expertise. They also contribute to policy development, healthcare management, and disease prevention, enhancing health outcomes and equity.",6.632072365991914e-07,0.34527757981311913,0.11085915847820617,0.05077594101389246,0.39200039281285814,0.0849609375,0.050702443146680265,0.42007832476832174,0.072021484375,6.632072365991914e-07,0.44908152393747214,0.05859375
211,0.7,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","To what extent do MPH programs impact health system strengthening in low- and middle-income countries? MPH programs enhance the skills of local health professionals in public health, supporting policy creation, healthcare management, and disease prevention, which improves health outcomes and diminishes disparities.",7.105791820705622e-07,0.42671768639066343,0.08648415847820617,0.05440279394345621,0.44079055698228986,0.0849609375,0.054324046228586,0.47008874534298517,0.072021484375,7.105791820705622e-07,0.5003748183250218,0.05859375
211,0.7,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do MPH programs influence health system strengthening in low- and middle-income countries? They provide capacity building by training local health workers in essential public health skills and support policy formulation, healthcare management, and prevention efforts, leading to improved health and reduced inequalities.",6.868932093348768e-07,0.36880807722331355,0.11085915847820617,0.052589367478674334,0.41609794439191816,0.0849609375,0.05251324468763313,0.44477093735869344,0.072021484375,6.868932093348768e-07,0.47439933192176387,0.05859375
211,0.7,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","What contribution do MPH programs make to health system strengthening in low- and middle-income countries? MPH programs develop local health professionals’ competencies in public health, aid in policy and healthcare management, and promote disease prevention, resulting in better health outcomes and less disparity.",6.868932093348768e-07,0.4018150858214051,0.08706379857338761,0.052589367478674334,0.41609794439191816,0.0849609375,0.05251324468763313,0.44477093735869344,0.072021484375,6.868932093348768e-07,0.47439933192176387,0.05859375
211,0.7,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do Master of Public Health programs affect health system strengthening in low- and middle-income countries? They play a vital role by enhancing local health professionals’ public health skills and supporting policy development, healthcare administration, and disease prevention, which improves health outcomes and reduces health disparities.",6.158352911278206e-07,0.3306217470945816,0.08864841467655328,0.047149088084328716,0.3454803771779642,0.0849609375,0.04708084006477453,0.3724502757790673,0.072021484375,6.158352911278206e-07,0.4002913597680404,0.05859375
212,0.7,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in beta-adrenergic receptor (ADRB) genes contribute to transient tachypnea of the newborn (TTN)? Answer: We conclude that homozygosity for beta1Gly49 and the TACC haplotype of the ADRB2 gene, both representing loss-of-function variants, might increase susceptibility to TTN.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
212,0.7,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for beta-adrenergic receptor (ADRB) gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: Our findings suggest that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, could predispose infants to TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.7,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Do polymorphisms in genes encoding beta-adrenergic receptors (ADRB) influence transient tachypnea of the newborn (TTN)? Answer: We determine that the presence of beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, both associated with loss-of-function, may increase the risk of TTN.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.7,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could beta-adrenergic receptor (ADRB) gene polymorphisms be linked to transient tachypnea of the newborn (TTN)? Answer: It is concluded that homozygosity for beta1Gly49 and the TACC haplotype in the ADRB2 gene, both loss-of-function variants, might predispose to TTN.",2.36859727356853e-08,0.026668247082160867,0.0,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.7,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both causing loss-of-function, may contribute to TTN susceptibility.",0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.7,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Do genetic variations in beta-adrenergic receptor (ADRB) encoding genes play a role in transient tachypnea of the newborn (TTN)? Answer: Our conclusion is that beta1Gly49 homozygosity and the ADRB2 gene's TACC haplotype, both loss-of-function mutations, may predispose newborns to TTN.",7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.7,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there evidence that beta-adrenergic receptor (ADRB) gene polymorphisms affect transient tachypnea of the newborn (TTN)? Answer: We find that the beta1Gly49 homozygous state and the TACC haplotype in the ADRB2 gene, both loss-of-function genetic variants, may increase susceptibility to TTN.",9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.7,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could genetic polymorphisms in the beta-adrenergic receptor (ADRB) genes influence transient tachypnea of the newborn (TTN)? Answer: It appears that both beta1Gly49 homozygosity and the TACC haplotype in ADRB2, as loss-of-function alterations, may predispose to TTN.",2.36859727356853e-08,0.02739897418811532,0.0,0.0018134264647818726,0.028170876966696845,0.0,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
212,0.7,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Are polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes implicated in transient tachypnea of the newborn (TTN)? Answer: We conclude that loss-of-function variants beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene may predispose to TTN.,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.7,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: What is the role of beta-adrenergic receptor (ADRB) gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: We conclude that the presence of beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, both loss-of-function variants, might predispose newborns to TTN.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
213,0.7,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic features of child bipolar I disorder: can the 'Treatment of Early Age Mania (TEAM)' sample be generalized? Answer: Generalization of the RCT sample was confirmed, as only 7.8% of Phenomenology participants did not meet RCT criteria. However, since RCT subjects were more severely ill, it remains uncertain if RCT treatment outcomes apply to children with milder mania.",1.4211583641411244e-07,0.011796675243260779,0.1451222789572694,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.7,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: What are the diagnostic characteristics of child bipolar I disorder, and does the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: The RCT sample was largely generalizable, with only 7.8% of Phenomenology subjects excluded by RCT criteria. Still, due to greater severity in RCT patients, applicability of RCT treatment results to less severe cases is unclear.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.7,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' sample generalize regarding diagnostic traits of child bipolar I disorder? Answer: Generalization is supported since only 7.8% of Phenomenology subjects fell outside RCT criteria. Yet, because RCT subjects showed more severe illness, it is uncertain if treatment findings extend to children with less severe mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,0.7,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic characteristics of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: The RCT sample generalizes well, as only 7.8% of Phenomenology subjects were excluded by RCT criteria. Nevertheless, the higher severity among RCT subjects raises questions about applicability to less severe mania cases.",2.8423167282822487e-07,0.1209959672082519,0.1451222789572694,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
213,0.7,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic traits of child bipolar I disorder: does the 'Treatment of Early Age Mania (TEAM)' sample apply broadly? Answer: The RCT sample is supported for generalization because only 7.8% of Phenomenology participants did not fit RCT criteria. However, the more severe illness in RCT subjects makes it unclear if results translate to children with milder mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.7,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Regarding child bipolar I disorder diagnosis, does the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: Generalization holds as only 7.8% of Phenomenology subjects were excluded by RCT criteria. Still, since RCT subjects were more severely ill, it is unclear if treatment results apply to less severe mania in children.",3.079176455639103e-07,0.16759629544025412,0.1255222789572694,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
213,0.7,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Can the 'Treatment of Early Age Mania (TEAM)' sample be generalized for child bipolar I disorder diagnosis? Answer: Yes, as only 7.8% of Phenomenology subjects did not meet RCT criteria, supporting generalization. Yet, the greater severity in RCT patients leaves uncertainty about applicability to milder cases.",4.263475092423373e-07,0.24359828930058525,0.1451222789572694,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
213,0.7,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic characteristics of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: The RCT sample generalizes since only 7.8% of Phenomenology subjects failed to meet RCT criteria. Nonetheless, the higher severity among RCT subjects questions whether findings apply to children with less severe mania.",3.316036182995957e-07,0.16021668036153436,0.1451222789572694,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
213,0.7,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Child bipolar I disorder diagnostic features: does the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: Generalization is supported by the fact that just 7.8% of Phenomenology subjects did not fit RCT criteria. However, the RCT subjects’ greater illness severity makes it unclear if treatment findings are applicable to less severe mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,0.7,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Do the diagnostic characteristics of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: Generalization is supported as only 7.8% of Phenomenology participants failed to meet RCT criteria. Still, due to greater severity in RCT subjects, it is uncertain if treatment results apply to children with milder mania.",2.3685972735685406e-07,0.08325563922540447,0.1451222789572694,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
214,0.7,1,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy effective for treating gallbladder carcinoma? It can help alleviate symptoms like pain and obstruction, though its impact on survival is limited given the disease's advanced stage.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.7,2,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy manage gallbladder carcinoma effectively? This treatment can relieve symptoms such as pain and obstruction, but it has minimal effect on extending survival due to the disease's progression.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.7,3,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy work for gallbladder carcinoma? It is useful for symptom control, including pain and obstruction, though it offers limited survival benefit because of the disease's advanced condition.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.7,4,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",How effective is external palliative radiotherapy for gallbladder carcinoma? It can reduce symptoms like pain and obstruction but does not significantly improve survival due to the late stage of the cancer.,3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.7,5,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy beneficial for gallbladder carcinoma? It helps manage symptoms such as pain and obstruction, but its effect on survival rates is constrained by the advanced disease state.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.7,6,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",What is the efficacy of external palliative radiotherapy in gallbladder carcinoma? This approach can alleviate symptoms including pain and obstruction but has limited impact on survival owing to the advanced nature of the cancer.,2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
214,0.7,7,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy be effective for gallbladder carcinoma? It aids in symptom relief, particularly pain and obstruction, though it does not greatly enhance survival because of the disease's progression.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.7,8,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",Is external palliative radiotherapy a useful treatment for gallbladder carcinoma? It can manage symptoms like pain and obstruction but has limited influence on survival due to the advanced stage of illness.,3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.7,9,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How well does external palliative radiotherapy work for gallbladder carcinoma? It is effective in symptom control such as pain and obstruction, but its ability to improve survival is restricted by the disease's advanced phase.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
214,0.7,10,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy provide effective symptom management for gallbladder carcinoma? Yes, it can ease pain and obstruction symptoms, although it offers only limited improvement in survival because of the advanced stage of the disease.",2.3685972735685343e-07,0.14106902273719024,0.08238381664955091,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.1729126896893627,0.0710059171597633,2.3685972735685406e-07,0.2119607470425815,0.04865220249835634
215,0.7,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Can antral follicle assessment predict IVF outcomes more effectively than age and FSH? Answer: The success of in vitro fertilization is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Among these, antral follicle assessment proved to be a superior predictor of IVF results compared to age or follicle-stimulating hormone. This assessment could serve as a unique marker for ovarian aging distinct from other measures.",2.3685972735685406e-08,0.13360475093918467,0.1846172627061644,0.0018134264647818865,0.06814347300543755,0.08250229001843684,0.0018108015409528666,0.005197011581635103,0.013695987654320991,2.3685972735685406e-08,0.013986241974738078,0.0
215,0.7,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle assessment a superior predictor for IVF outcomes compared to age and FSH? Answer: IVF success is highly associated with maternal age, baseline cycle day 3 follicle count, stimulated hormone levels, and the antral follicle count. The antral follicle measurement outperformed age and FSH levels in predicting IVF outcomes. It may represent a distinct indicator of ovarian aging separate from conventional markers.",2.6054570009253947e-07,0.04312436511184092,0.15769888231426685,0.019947691112600682,0.08219558043617425,0.080329391096275,0.019918816950481547,0.14433472238932765,0.013695987654320991,2.6054570009253947e-07,0.16579225484274396,0.0
215,0.7,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Does antral follicle assessment outperform age and FSH in predicting IVF outcomes? Answer: Outcomes of in vitro fertilization correlate strongly with maternal age, basal cycle day 3 follicles, stimulated hormone, and antral follicle counts. Antral follicle count was found to be a better predictor of IVF success than age or FSH. It may offer a unique marker of ovarian age different from other parameters.",2.6054570009253947e-07,0.0001973336731557751,0.18977889156389102,0.019947691112600682,0.06019090803744653,0.09619827767275783,0.019918816950481547,0.14433472238932765,0.013695987654320991,2.6054570009253947e-07,0.16579225484274396,0.0
215,0.7,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: How does antral follicle assessment compare to age and FSH in predicting IVF success? Answer: The outcome of IVF is closely related to maternal age, day 3 follicle count, stimulated hormone, and antral follicle assessment. Of these, antral follicle assessment was a more accurate predictor than age or follicle stimulating hormone. It might provide a distinct measure of ovarian aging.",3.552895910352811e-07,0.09087925688516929,0.1683052227267014,0.027201396971728173,0.14928470511851533,0.0792541635229362,0.027162023114293013,0.21102609688800023,0.013695987654320991,3.552895910352811e-07,0.23361485118150416,0.0
215,0.7,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is the antral follicle count a better predictor of IVF outcomes than age and FSH? Answer: IVF outcomes show strong correlation with maternal age, basal cycle day 3 follicle counts, stimulated hormone, and antral follicle levels. Antral follicle count was superior in predicting IVF success compared to age or FSH levels, potentially serving as a unique marker for ovarian age.",3.552895910352811e-07,0.11398416290383206,0.15121362154329177,0.027201396971728173,0.14928470511851533,0.0792541635229362,0.027162023114293013,0.21102609688800023,0.013695987654320991,3.552895910352811e-07,0.23361485118150416,0.0
215,0.7,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Can antral follicle assessment predict IVF results better than age and follicle stimulating hormone? Answer: IVF success is strongly linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle count. The antral follicle assessment provided a better prediction of IVF outcomes than age or FSH, suggesting it may be a distinctive ovarian aging marker.",3.552895910352811e-07,0.11398416290383384,0.15121362154329177,0.027201396971728173,0.14928470511851533,0.0792541635229362,0.027162023114293013,0.21102609688800023,0.013695987654320991,3.552895910352811e-07,0.23361485118150416,0.0
215,0.7,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Does assessing antral follicles offer better IVF outcome prediction than age and FSH? Answer: The outcome of in vitro fertilization correlates with maternal age, basal cycle day 3 follicle count, hormone stimulation, and antral follicle assessment. Antral follicle assessment emerged as a better predictor than age or follicle-stimulating hormone, potentially indicating a unique marker of ovarian aging.",4.263475092423373e-07,0.11277893822836482,0.21821311555577277,0.03264167636607379,0.17797394369383213,0.09619827767275783,0.03259442773715161,0.26413592220194815,0.013695987654320991,4.263475092423373e-07,0.287682072451779,0.0
215,0.7,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle evaluation a more reliable predictor for IVF outcomes than age and FSH? Answer: IVF outcomes are strongly associated with maternal age, basal day 3 follicle count, stimulated hormone levels, and antral follicle evaluation. This evaluation was a better predictor than age or FSH, possibly providing a distinct marker of ovarian age.",4.974054274493935e-07,0.1952206054864738,0.1978911160705144,0.03808195576041941,0.2330337208768607,0.09619827767275783,0.03802683236001021,0.32022538885299134,0.013695987654320991,4.974054274493935e-07,0.34484048629172914,0.0
215,0.7,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: How effective is antral follicle assessment compared to age and FSH in predicting IVF outcome? Answer: IVF outcome is strongly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Among these, antral follicle assessment was the superior predictor over age and FSH, potentially representing a unique ovarian aging marker.",4.500334819780227e-07,0.1902013505672664,0.1437869822485206,0.03445510283085566,0.2211978012168725,0.07802269468236003,0.03440522927810448,0.2824850608701439,0.013695987654320991,4.500334819780227e-07,0.30637420546393335,0.0
215,0.7,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle count a better indicator of IVF success than maternal age and FSH levels? Answer: The success of in vitro fertilization is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormones, and antral follicle count. Antral follicle count was found to be a better predictor than age or follicle stimulating hormone, possibly indicating a distinct ovarian aging marker.",2.6054570009253947e-07,0.04312436511184092,0.15769888231426685,0.019947691112600682,0.08219558043617425,0.08032939109627499,0.019918816950481547,0.14433472238932765,0.013695987654320991,2.6054570009253947e-07,0.16579225484274396,0.0
216,0.7,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are home blood pressure readings reported by stroke patients reliable? This cohort of elderly stroke patients demonstrated reliable home BP measurement. Any bias detected was minimal and unlikely to impact clinical decisions. Given that BP readings at GP surgeries often do not reflect true BP, GPs could consider utilizing readings from hypertensive patients at home.",9.474389094274162e-08,0.09713108178066054,0.01851192595229618,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
216,0.7,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients be trusted to accurately report their home blood pressure readings? These elderly stroke patients were capable of reliably recording their blood pressure at home. The slight bias observed is unlikely to influence treatment. Since BP measurements at GP clinics frequently fail to represent actual BP, GPs might use home readings from hypertensive patients instead.",4.737194547137081e-08,0.08460183270840904,0.03566529492455417,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
216,0.7,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Do stroke patients provide reliable home blood pressure readings? This group of elderly stroke patients reliably recorded their blood pressures at home. Any bias was minor and unlikely to affect management decisions. Because BP readings in GP offices often poorly indicate true BP, GPs could consider relying on hypertensive patients' home readings.",1.6580180914979784e-07,0.15579962019699334,0.019599999999999992,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
216,0.7,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is the reliability of home blood pressure readings by stroke patients trustworthy? Elderly stroke patients in this group showed reliable home BP monitoring. The small bias present is unlikely to alter management. Since GP surgery BP readings often do not reflect true BP, GPs may want to use home BP readings from hypertensive patients.",1.1842986367842703e-07,0.1686205891331598,0.05640000000000001,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.7,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are blood pressure reports from stroke patients taken at home dependable? This elderly stroke patient group managed to record their BP reliably at home. The minimal bias found would probably not affect clinical management. Because BP readings at GP surgeries often poorly represent actual BP, GPs might consider home BP readings from hypertensive patients.",1.1842986367842703e-07,0.11630759437391891,0.018860946745562133,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.7,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can elderly stroke patients reliably record their blood pressure at home? This cohort successfully measured their BP reliably at home. The slight bias is unlikely to impact treatment decisions. Given that BP readings at GP offices often do not accurately reflect true BP, GPs may consider using hypertensive patients' home readings.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
216,0.7,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Do reports of home blood pressure readings from stroke patients hold reliability? This group of elderly stroke patients effectively recorded their blood pressure at home. Any bias was minimal and unlikely to influence management. Since BP measurements in GP surgeries often poorly indicate true BP, GPs might consider relying on hypertensive patients' home measurements.",1.1842986367842703e-07,0.14246409175353936,0.037677816224529016,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.7,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is it reliable to trust home blood pressure readings reported by stroke patients? These elderly stroke patients showed reliable home BP recordings. The small bias noted would unlikely affect clinical management. Given that BP readings in GP surgeries often do not reflect real BP, GPs could consider using home BP readings from hypertensive patients.",1.1842986367842703e-07,0.14246409175353936,0.03767781622452903,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.7,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are stroke patients' self-reported home blood pressure readings trustworthy? This elderly group with stroke was able to reliably measure their BP at home. The minor bias present would probably not impact management. As BP measurements in GP clinics often poorly represent true BP, GPs might use readings taken at home by hypertensive patients.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
216,0.7,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can elderly stroke patients be trusted to accurately report their home blood pressure readings? This group reliably recorded their blood pressure at home. The small bias seen is unlikely to affect clinical decisions. Since BP readings at GP surgeries often do not reflect true BP, GPs might consider using home readings from hypertensive patients.",1.1842986367842703e-07,0.11630759437391891,0.018860946745562133,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
217,0.7,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering required before correcting scoliosis in a patient with myelomeningocele? Typically, untethering is necessary prior to scoliosis correction in such patients to prevent neurological worsening that scoliosis surgery might cause. However, the choice depends on the patient's specific circumstances.",2.6054570009253936e-07,0.1375578104089099,0.07939508506616258,0.0199476911126006,0.19765069507322464,0.040742417383431435,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
217,0.7,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For a patient with myelomeningocele, is it essential to perform untethering before scoliosis correction? Usually, untethering is performed before scoliosis surgery to avoid additional neurological damage that could result from the correction. The decision is individualized based on patient factors.",2.6054570009253936e-07,0.17310381966839383,0.053771816368101626,0.0199476911126006,0.19765069507322464,0.040742417383431435,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
217,0.7,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does a patient with myelomeningocele need untethering before undergoing scoliosis correction? Generally, untethering is required first to prevent neurological decline that can be triggered by the scoliosis procedure, but this depends on the patient’s condition.",3.7897556377096586e-07,0.2747589319223924,0.07939508506616258,0.029014823436509976,0.33872929333313095,0.040742417383431435,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
217,0.7,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering recommended prior to scoliosis correction in myelomeningocele patients? In most cases, untethering is necessary before scoliosis surgery to reduce the risk of neurological deterioration, although the final decision depends on the individual patient’s status.",3.5528959103528056e-07,0.24577139504914092,0.07939508506616258,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
217,0.7,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Should untethering be done before scoliosis correction for a patient who has myelomeningocele? Typically, untethering is necessary to prevent worsening neurological function caused by scoliosis correction, but the approach varies with patient-specific factors.",4.2634750924233646e-07,0.3353835537388279,0.07939508506616258,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
217,0.7,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","When treating scoliosis in a patient with myelomeningocele, is preoperative untethering necessary? Untethering is usually needed before scoliosis correction to avoid neurological complications, but the decision is tailored to the patient's unique condition.",4.2634750924233646e-07,0.3353835537388279,0.07939508506616258,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
217,0.7,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is it necessary to untether a patient with myelomeningocele before scoliosis correction? Usually, untethering precedes scoliosis surgery to mitigate the risk of neurological deterioration, though the decision depends on individual patient factors.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,0.7,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For scoliosis correction in myelomeningocele patients, is untethering required beforehand? Generally, untethering is performed prior to the correction to prevent neurological decline, but the necessity depends on the patient’s specific clinical context.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,0.7,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","In patients with myelomeningocele, must untethering be done before scoliosis correction? Untethering is typically necessary to prevent neurological worsening associated with scoliosis surgery, but the final decision depends on individual factors.",4.7371945471370706e-07,0.3999220748763994,0.07939508506616258,0.036268529295637494,0.46794102481313793,0.040742417383431435,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
217,0.7,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering mandatory before scoliosis correction in myelomeningocele cases? It is usually necessary to untether first to avoid neurological deterioration during scoliosis correction, though the decision is patient-dependent.",5.44777372920763e-07,0.5052825905342249,0.07939508506616258,0.04170880868998313,0.5771403167781286,0.040742417383431435,0.041648435441916,0.652325186039691,0.0,5.447773729207643e-07,0.6720937713621127,0.0
218,0.7,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair unnecessary? No, it is a crucial step to prevent spinal cord ischemia and reduce paralysis risk, making it an essential part of the surgery.",6.868932093348761e-07,0.40719064286020856,0.1758667226324568,0.05258936747867432,0.4964693047605566,0.09566326530612247,0.05251324468763315,0.5769595501709666,0.049048751486325794,6.868932093348768e-07,0.6372524517182883,0.016661878770468257
218,0.7,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During thoracic and thoracoabdominal aneurysm repair, reimplantation of spinal cord arteries is vital, not futile, as it helps avoid spinal cord ischemia and lowers the chances of paralysis.",8.526950184846732e-07,0.6482851735067245,0.1682692307692307,0.06528335273214747,0.7348803282055543,0.09566326530612247,0.06518885547430327,0.823819628102493,0.049048751486325794,8.526950184846746e-07,0.8931858258554897,0.016661878770468257
218,0.7,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplanting spinal cord arteries is an important procedure in thoracic and thoracoabdominal aneurysm repair, effectively preventing spinal cord ischemia and paralysis, rather than being a waste of time.",8.526950184846732e-07,0.6482851735067245,0.1682692307692307,0.06528335273214747,0.7348803282055543,0.09566326530612247,0.06518885547430327,0.823819628102493,0.049048751486325794,8.526950184846746e-07,0.8931858258554897,0.016661878770468257
218,0.7,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The process of reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm surgery is necessary and effective in preventing spinal cord ischemia and paralysis, so it is not pointless.",8.290090457489879e-07,0.6100838066359557,0.16958618436538658,0.0634699262673656,0.6971400002227073,0.09566326530612247,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8523638313352349,0.016661878770468257
218,0.7,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is an essential surgical step, critical for minimizing spinal cord ischemia and paralysis risk.",9.237529366917291e-07,0.772486238612736,0.1636635775886175,0.07072363212649312,0.8574826502978872,0.09566326530612247,0.07062126009716188,0.9516529996123775,0.049048751486325794,9.237529366917308e-07,1.0267172184800133,0.016661878770468257
218,0.7,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.",It is not a waste of time to reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm repair; this procedure is key to preventing spinal cord ischemia and paralysis.,8.290090457489879e-07,0.6100838066359557,0.16958618436538658,0.0634699262673656,0.6971400002227073,0.09566326530612247,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8523638313352349,0.016661878770468257
218,0.7,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During repair of thoracic and thoracoabdominal aneurysms, reimplanting spinal cord arteries plays a crucial role in reducing the risk of spinal cord ischemia and paralysis, making it indispensable.",8.526950184846732e-07,0.6482851735067245,0.1682692307692307,0.06528335273214747,0.7348803282055543,0.09566326530612247,0.06518885547430327,0.823819628102493,0.049048751486325794,8.526950184846746e-07,0.8931858258554897,0.016661878770468257
218,0.7,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a fundamental part of the surgery, aimed at preventing spinal cord ischemia and subsequent paralysis.",8.763809912203585e-07,0.688000279781765,0.16685147928994074,0.06709677919692936,0.7741010413588367,0.09566326530612247,0.06699965701525615,0.8646416226227478,0.049048751486325794,8.7638099122036e-07,0.9357454402742853,0.016661878770468257
218,0.7,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The reimplantation of spinal cord arteries is a vital component of thoracic and thoracoabdominal aneurysm repair, helping to avert spinal cord ischemia and lessen paralysis risk.",9.000669639560438e-07,0.7293537534906158,0.1653209237343852,0.06891020566171124,0.8149230358790915,0.09566326530612247,0.06881045855620901,0.9072012370415434,0.049048751486325794,9.000669639560454e-07,0.9801972028451194,0.016661878770468257
218,0.7,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","In thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is a key procedure that prevents spinal cord ischemia and reduces the likelihood of paralysis, thus it is not a waste of time.",7.342651548062467e-07,0.4703635998992919,0.17403399750013845,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.7039438262169617,0.016661878770468257
219,0.7,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program enhance bariatric surgery outcomes? MSWM does not seem to provide extra advantages over the standard preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes after LAGB in our patient group.,1.4211583641411233e-07,0.152579779443204,0.006783916917955768,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.7,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a medically supervised weight loss program before surgery beneficial for bariatric surgery results? MSWM appears to offer no additional benefit compared to the typical preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes following LAGB in our patients.,7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.7,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does undergoing a medically supervised weight loss program before bariatric surgery improve outcomes? In our patient population, MSWM does not appear to add benefit beyond the standard preoperative bariatric surgery protocol concerning weight loss and most behavioral outcomes after LAGB.",1.4211583641411233e-07,0.152579779443204,0.006783916917955768,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.7,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Can a preoperative medically supervised weight loss program improve the outcomes of bariatric surgery? MSWM does not seem to provide extra benefits compared to the usual preoperative bariatric surgery protocol for weight loss and most behavioral outcomes following LAGB in our patients.,9.474389094274162e-08,0.06528939793786215,0.01997329637641968,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.7,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative weight loss program under medical supervision improve bariatric surgery outcomes? MSWM does not appear to offer any additional advantages over the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes post-LAGB in our patient population.,7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.7,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is there an improvement in bariatric surgery outcomes with a medically supervised preoperative weight loss program? MSWM seems to confer no extra benefit compared to the standard preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes after LAGB in our patients.,7.105791820705622e-08,0.07339380596669631,0.003151703623580318,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.7,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participating in a medically supervised weight loss program before surgery enhance bariatric surgery results? MSWM does not seem to offer additional benefits over the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes post-LAGB in our patient group.,9.474389094274162e-08,0.09910145552615202,0.004303906121936658,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.7,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Will a preoperative medically supervised weight loss program improve outcomes of bariatric surgery? MSWM does not appear to confer benefits beyond the standard preoperative bariatric surgery protocol concerning weight loss and most behavioral outcomes following LAGB in our patients.,1.6580180914979763e-07,0.14394467788328003,0.01805172953931231,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.7,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically monitored weight loss program lead to better bariatric surgery outcomes? MSWM does not seem to provide extra advantage compared to the conventional preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,2.3685972735685406e-08,0.023873153186523055,0.0010031775464828113,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
219,0.7,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does the implementation of a preoperative medically supervised weight loss program improve bariatric surgery results? MSWM does not appear to offer additional benefits relative to the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB in our patient population.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765236,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
220,0.7,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care during a woman's initial pregnancy influence her later reproductive outcomes? Answer: In Sweden, the type of care model, including birth center care, during a woman's first pregnancy does not appear to significantly impact her future reproduction.",1.1842986367842703e-07,0.12609500073748992,0.007814735523731478,0.009067132323909363,0.15244039468437975,0.02498356344510192,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.7,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Is there an effect of birth center care during a woman's first pregnancy on her subsequent reproductive history? Answer: Birth center care as a model during the first pregnancy does not seem to be a critical factor influencing later reproduction in Sweden.,9.474389094274162e-08,0.09958230218783859,0.006105971243051553,0.0072537058591274906,0.12690248065430154,0.024375,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.7,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the care provided at a birth center during a woman's first pregnancy affect her future childbearing? Answer: The model of care, such as birth center care, during the first pregnancy does not seem to play a significant role in future reproduction in Sweden.",4.737194547137081e-08,0.017054640809570643,0.019548471993809255,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
220,0.7,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can birth center care during a woman’s initial pregnancy impact her reproductive outcomes later on? Answer: In Sweden, birth center care during the first pregnancy is not considered an important factor affecting subsequent reproduction.",2.8423167282822424e-07,0.3341904607478141,0.022509003094734664,0.021761117577382486,0.3941727683717118,0.06035379812695108,0.02172961849143442,0.36177542990353295,0.031217481789802305,2.8423167282822487e-07,0.32721291120841567,0.0
220,0.7,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does a woman's experience with birth center care in her first pregnancy influence her future reproductive behavior? Answer: The care model, including birth center care during the first pregnancy, does not appear to be a significant factor for later reproduction in Sweden.",9.474389094274162e-08,0.0665752935897439,0.017399945916711734,0.0072537058591274906,0.12690248065430154,0.024375,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.7,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is birth center care during the first pregnancy associated with changes in future reproduction for women? Answer: In Sweden, receiving birth center care in the first pregnancy does not seem to be a sufficiently influential factor on subsequent reproduction.",1.6580180914979774e-07,0.21685328558521944,0.03632454387920665,0.012693985253473108,0.2420391911555062,0.05246913580246914,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
220,0.7,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the model of care, such as birth center care, during a woman’s first pregnancy alter her future reproductive outcomes? Answer: Birth center care during the initial pregnancy does not seem to be a key determinant of later reproduction in Sweden.",1.1842986367842703e-07,0.058470885560909736,0.04052494591671175,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.7,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care in a woman’s first pregnancy impact her future reproduction? Answer: The care model during the first pregnancy, including birth center care, does not appear to significantly affect subsequent reproduction in Sweden.",2.3685972735685364e-07,0.1932201329185923,0.03714484387589542,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
220,0.7,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Is there a relationship between birth center care during a woman’s first pregnancy and her future reproductive patterns? Answer: Birth center care as a model during the first pregnancy does not seem to be an important factor influencing later reproduction in Sweden.,9.474389094274162e-08,0.09958230218783859,0.006105971243051553,0.0072537058591274906,0.12690248065430154,0.024375,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.7,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care during a woman's first pregnancy have any bearing on her future reproduction? Answer: In Sweden, the model of care during the first pregnancy, such as birth center care, does not appear to be a significant factor affecting subsequent reproduction.",7.105791820705622e-08,0.04150958647731384,0.018498994102315543,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
221,0.7,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia negatively impact the outcomes of colon and rectal surgery? Yes, having anemia before surgery can worsen the results of colon and rectal operations. Studies indicate it raises the chance of postoperative complications such as infections, extended hospitalization, and increased mortality rates.",2.3685972735685406e-08,0.00631903063618644,0.020625000000000004,0.0018134264647818726,0.05730511085940426,0.02425736961451249,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
221,0.7,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia harmful to the results of colon and rectal surgeries? Indeed, anemia prior to surgery can lead to poorer outcomes in colon and rectal procedures. Research demonstrates it is associated with a higher risk of postoperative issues like infection, longer hospital stays, and greater death rates.",7.105791820705622e-08,0.13299347848424814,0.047530864197530866,0.005440279394345618,0.06954385060511781,0.0015142353237591263,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
221,0.7,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can anemia before surgery adversely influence colon and rectal surgery outcomes? Yes, preoperative anemia is linked to worse outcomes in these surgeries. Evidence shows it increases the likelihood of postoperative complications including infections, prolonged hospital stays, and elevated mortality.",1.4211583641411222e-07,0.02057671409006634,0.09,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
221,0.7,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does anemia before colon and rectal surgery negatively affect surgical outcomes? Yes, preoperative anemia can lead to adverse effects on the results of these surgeries. Studies reveal it causes a higher risk of complications after surgery such as infections, extended hospitalization, and increased chances of death.",2.3685972735685406e-08,0.14849961595386674,0.09,0.0018134264647818726,0.05522892197167373,0.023242630385487524,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.7,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is the presence of anemia before colon and rectal surgery detrimental to the surgery outcomes? Yes, anemia prior to surgery can adversely affect the results. Research shows a correlation with increased postoperative complications, longer hospital stays, and higher mortality rates.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
221,0.7,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does having anemia before colon and rectal surgery worsen the surgical outcomes? Yes, preoperative anemia can negatively influence outcomes. Evidence suggests it contributes to an increased risk of postoperative infections, prolonged hospital stays, and elevated mortality.",2.1317375462116813e-07,0.10281481232703937,0.09,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
221,0.7,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can preoperative anemia lead to negative outcomes in colon and rectal surgery? Yes, anemia before surgery is linked with adverse results. Studies indicate it raises the risk of postoperative complications, including infections, longer hospital stays, and higher mortality.",1.6580180914979753e-07,0.04724496117222721,0.09,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
221,0.7,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does anemia present before colon and rectal surgery impact outcomes adversely? Yes, preoperative anemia can lead to worse surgical outcomes. Research shows it is associated with increased postoperative infection risks, extended hospitalization, and higher death rates.",2.1317375462116813e-07,0.10281481232703937,0.09,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
221,0.7,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia a factor that worsens colon and rectal surgery outcomes? Yes, having anemia before surgery can cause poorer outcomes. Evidence demonstrates it increases the risk of postoperative complications like infections, longer hospital stays, and increased mortality.",1.6580180914979753e-07,0.04724496117222721,0.09,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
221,0.7,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia affect the success of colon and rectal surgeries negatively? Yes, anemia before surgery can adversely affect these outcomes. Studies have shown it increases the likelihood of postoperative complications, including infections, longer hospital stays, and higher mortality rates.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
222,0.7,1,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis an early indicator of bronchiectasis? Yes, this dysfunction can act as a precursor by impairing bacterial clearance, causing ongoing infections and inflammation that may lead to bronchiectasis.",4.26347509242337e-07,0.16956710440499023,0.15737240075614362,0.03264167636607371,0.20008816572003285,0.14366729678638948,0.0325944277371516,0.23184837040536355,0.12901701323251416,4.263475092423373e-07,0.26492615229758654,0.113421550094518
222,0.7,2,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Can alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis signal the onset of bronchiectasis? Indeed, this dysfunction hampers the lung’s ability to remove bacteria, resulting in persistent infections and inflammation that can progress to bronchiectasis.",4.26347509242337e-07,0.16956710440499023,0.15737240075614362,0.03264167636607371,0.20008816572003285,0.14366729678638948,0.0325944277371516,0.23184837040536355,0.12901701323251416,4.263475092423373e-07,0.26492615229758654,0.113421550094518
222,0.7,3,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does alveolar macrophage phagocytic dysfunction in kids with protracted bacterial bronchitis precede bronchiectasis? Yes, because this impairment reduces bacterial clearance from the lungs, leading to chronic infections and inflammation that may cause bronchiectasis.",5.447773729207635e-07,0.31474911424948937,0.15737240075614362,0.0417088086899831,0.3496198996909965,0.14366729678638948,0.04164843544191597,0.38599905023262204,0.12901701323251416,5.447773729207643e-07,0.4239908469272753,0.113421550094518
222,0.7,4,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with prolonged bacterial bronchitis a potential early sign of bronchiectasis? Yes, the dysfunction compromises bacterial clearance, fostering persistent lung infections and inflammation that can eventually cause bronchiectasis.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.7,5,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be a precursor to bronchiectasis? Yes, since it diminishes the lungs’ ability to eliminate bacteria, resulting in ongoing infections and inflammation that can develop into bronchiectasis.",4.500334819780223e-07,0.19696607859310555,0.15737240075614362,0.03445510283085558,0.2282590426867297,0.14366729678638948,0.03440522927810447,0.26083590727861505,0.12901701323251416,4.500334819780227e-07,0.2947791154472683,0.113421550094518
222,0.7,6,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is the phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis indicative of future bronchiectasis? Yes, because this dysfunction prevents effective bacterial clearance, leading to chronic infection and inflammation that might culminate in bronchiectasis.",4.737194547137076e-07,0.2251369555598024,0.15737240075614362,0.03626852929563746,0.2572465795599812,0.14366729678638948,0.036216030819057346,0.29068887042829683,0.12901701323251416,4.737194547137081e-07,0.325550774114022,0.113421550094518
222,0.7,7,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does phagocytic dysfunction in alveolar macrophages among children with protracted bacterial bronchitis lead to bronchiectasis? Yes, it impairs bacterial clearance, causing repeated infections and inflammation that can eventually result in bronchiectasis.",5.921493183921341e-07,0.3792876353870609,0.15737240075614362,0.04533566161954686,0.41631127418966996,0.14366729678638948,0.045270038523821714,0.4549919217195728,0.12901701323251416,5.921493183921352e-07,0.495449810909419,0.113421550094518
222,0.7,8,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction observed in children with protracted bacterial bronchitis a forerunner to bronchiectasis? Yes, this condition impedes bacterial clearance, promoting persistent infections and inflammation that can trigger bronchiectasis.",5.921493183921341e-07,0.3792876353870609,0.15737240075614362,0.04533566161954686,0.41631127418966996,0.14366729678638948,0.045270038523821714,0.4549919217195728,0.12901701323251416,5.921493183921352e-07,0.495449810909419,0.113421550094518
222,0.7,9,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Can dysfunction in alveolar macrophage phagocytosis in children with protracted bacterial bronchitis herald bronchiectasis? Yes, because it weakens bacterial removal from the lungs, leading to chronic infections and inflammation that may lead to bronchiectasis.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.7,10,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis a precursor to bronchiectasis? Yes, as it hinders the lungs’ bacterial clearance, resulting in ongoing infections and inflammation that can cause bronchiectasis.",5.447773729207635e-07,0.31474911424948937,0.15737240075614362,0.0417088086899831,0.3496198996909965,0.14366729678638948,0.04164843544191597,0.38599905023262204,0.12901701323251416,5.447773729207643e-07,0.4239908469272753,0.113421550094518
223,0.7,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection necessary for metastatic carcinoma to the cervical nodes when the primary head and neck site is unknown? Yes, neck dissection is frequently required to manage regional disease, reduce the risk of further metastasis, and enhance survival, though individual assessment is essential to weigh benefits against risks.",4.974054274493935e-07,0.15069195471358787,0.1453810839313862,0.038081955760419325,0.1451066038731259,0.15574022776238844,0.0380268323600102,0.16914161676457384,0.14465989535241613,4.974054274493935e-07,0.1939521121033927,0.13296398891966757
223,0.7,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma involving cervical nodes from an unknown primary head and neck tumor, is neck dissection needed? Typically, yes; it helps control local disease, prevents additional metastases, and improves survival outcomes, but decisions should be personalized based on patient risk-benefit analysis.",6.632072365991914e-07,0.2794397663938404,0.1662049861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
223,0.7,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","When metastatic carcinoma affects cervical lymph nodes with an unknown primary in the head and neck, is neck dissection indicated? Yes, it is commonly performed to manage the disease regionally, hinder further metastasis, and increase survival chances, while individual case evaluation is important.",6.39521263863506e-07,0.25534221481478037,0.1662049861495845,0.04896251454911056,0.28168213887887594,0.15574022776238844,0.0488916416057274,0.3089035591397322,0.14465989535241613,6.39521263863506e-07,0.3370529557440678,0.13296398891966757
223,0.7,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Does metastatic carcinoma to cervical nodes from an unknown primary head and neck site require neck dissection? Yes, neck dissection is often necessary to control regional disease and prevent future spread, boosting survival rates, but should be tailored per case.",7.105791820705621e-07,0.3294501869685038,0.1662049861495845,0.05440279394345618,0.35766804585679735,0.15574022776238844,0.054324046228586,0.3868651006094428,0.14465989535241613,7.105791820705622e-07,0.41709566341760196,0.13296398891966757
223,0.7,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection needed for metastatic carcinoma in cervical nodes of unknown head and neck origin? Neck dissection is generally required to help control local disease, limit metastasis, and improve survival, with individualized case assessment recommended.",8.053230730133033e-07,0.47727218192644605,0.13765827334681635,0.06165649980258368,0.4688936809670219,0.15574022776238844,0.06156725239239748,0.5012754517871882,0.14465989535241613,8.053230730133038e-07,0.5348786990739858,0.13296398891966757
223,0.7,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma to cervical lymph nodes with an unknown head and neck primary, is neck dissection warranted? Yes, it often plays a critical role in managing regional disease, preventing further metastases, and enhancing survival, though careful case-by-case evaluation is necessary.",6.868932093348768e-07,0.3041323789842121,0.1662049861495845,0.052589367478674306,0.33169255945353937,0.15574022776238844,0.05251324468763313,0.3601968535272819,0.14465989535241613,6.868932093348768e-07,0.38969668922948664,0.13296398891966757
223,0.7,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","In cases of metastatic carcinoma to cervical nodes from an unknown head and neck primary tumor, should neck dissection be performed? Yes, it is frequently necessary to control disease locally and improve overall prognosis, with individualized risk-benefit consideration.",7.579511275419327e-07,0.38209392045392265,0.1662049861495845,0.058029646873019924,0.41173526712707353,0.15574022776238844,0.05794564931049173,0.44243495176425496,0.14465989535241613,7.57951127541933e-07,0.4742540772575503,0.13296398891966757
223,0.7,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection indicated for metastatic carcinoma to cervical nodes when the primary head and neck tumor is unknown? Yes, it aids in regional disease control, metastasis prevention, and survival improvement, but each patient should be assessed individually.",7.579511275419327e-07,0.38209392045392265,0.1662049861495845,0.058029646873019924,0.41173526712707353,0.15574022776238844,0.05794564931049173,0.44243495176425496,0.14465989535241613,7.57951127541933e-07,0.4742540772575503,0.13296398891966757
223,0.7,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","When metastatic carcinoma is found in cervical nodes with an unknown primary site in the head and neck, is neck dissection required? Yes, it is important for regional control and survival benefits, while balancing potential risks on a case basis.",7.105791820705621e-07,0.3294501869685038,0.1662049861495845,0.05440279394345618,0.35766804585679735,0.15574022776238844,0.054324046228586,0.3868651006094428,0.14465989535241613,7.105791820705622e-07,0.41709566341760196,0.13296398891966757
223,0.7,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma involving cervical nodes from an unknown head and neck primary, is neck dissection needed? Yes, it is often necessary to manage regional disease, prevent metastasis, and improve survival, with individual case evaluation advised.",8.053230730133033e-07,0.4376637716087348,0.1662049861495845,0.06165649980258368,0.4688936809670219,0.15574022776238844,0.06156725239239748,0.5012754517871882,0.14465989535241613,8.053230730133038e-07,0.5348786990739858,0.13296398891966757
224,0.7,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is 30-day and 1-year mortality in emergency general surgery laparotomies a significant concern requiring improvement? Answer: Emergency laparotomy has a high mortality rate, notably among patients over 70, necessitating enhanced efforts to improve results, especially for this age group, possibly by boosting acute surgical care staff and early patient identification.",2.6054570009253947e-07,0.19885085874516495,0.0,0.0199476911126006,0.20252426411147262,0.0,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
224,0.7,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are 30-day and 1-year mortality rates in emergency general surgery laparotomies problematic and in need of improvement? Answer: Emergency laparotomy shows a high death rate, particularly in those older than 70, highlighting the need for better outcomes through increased surgical manpower and earlier recognition of critical patients.",3.316036182995957e-07,0.2607262624632525,0.0,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
224,0.7,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Does emergency general surgery laparotomy present concerning 30-day and 1-year mortality rates that require improvement? Answer: The mortality rate after emergency laparotomy is high, especially in patients over 70 years old, indicating a need for better care strategies such as augmenting surgical staff and prompt detection of at-risk patients.",2.8423167282822487e-07,0.21905356606268356,0.0,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
224,0.7,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is there a concern about 30-day and 1-year mortality rates following emergency general surgery laparotomies that calls for improvement? Answer: Emergency laparotomy mortality is notably high in patients above 70, suggesting urgent action to enhance outcomes by increasing acute surgical workforce and early patient assessment.",3.789755637709665e-07,0.30421137440299084,0.0,0.029014823436509962,0.3101549283038376,0.0,0.028972824655245866,0.31633732821215643,0.0,3.789755637709665e-07,0.32277339226305113,0.0
224,0.7,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are the mortality rates at 30 days and one year post-emergency general surgery laparotomies an area of concern needing improvement? Answer: Mortality following emergency laparotomy is significantly elevated, particularly in elderly patients over 70, prompting the need for improved care through more surgical staff and earlier identification of patients.",2.8423167282822487e-07,0.21905356606268356,0.0,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
224,0.7,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Should the 30-day and 1-year mortality after emergency general surgery laparotomies be viewed as a concern requiring improvement? Answer: Emergency laparotomy carries a high death rate, especially in those older than 70 years, and efforts should be made to improve outcomes by increasing acute surgical care resources and early patient detection.",2.3685972735685406e-07,0.17904823144898518,0.0,0.018134264647818726,0.182321556793954,0.0,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
224,0.7,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is high mortality at 30 days and one year post-emergency general surgery laparotomy an issue demanding improvement? Answer: The mortality rate after emergency laparotomy is high, particularly for patients over 70, underscoring the need for enhanced acute surgical manpower and early recognition of those needing care.",3.552895910352811e-07,0.28223246768421584,0.0,0.02720139697172809,0.2876820724517799,0.0,0.027162023114293,0.2933478099874569,0.0,3.552895910352811e-07,0.2992428948528567,0.0
224,0.7,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are the 30-day and 1-year mortality rates for emergency general surgery laparotomies a significant concern that needs addressing? Answer: Emergency laparotomy results in high mortality, especially in patients older than 70, indicating the necessity for improved outcomes through additional surgical staff and prompt patient identification.",3.789755637709665e-07,0.30421137440299084,0.0,0.029014823436509962,0.3101549283038376,0.0,0.028972824655245866,0.31633732821215643,0.0,3.789755637709665e-07,0.32277339226305113,0.0
224,0.7,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Does emergency general surgery laparotomy have concerning 30-day and 1-year mortality rates that require attention and improvement? Answer: Mortality rates are high following emergency laparotomy, notably in those over 70 years, calling for increased acute surgical manpower and early detection of at-risk patients to improve outcomes.",3.552895910352811e-07,0.3123693016216045,0.021728395061728398,0.02720139697172809,0.2876820724517799,0.0,0.027162023114293,0.2933478099874569,0.0,3.552895910352811e-07,0.2992428948528567,0.0
224,0.7,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is there a need to improve 30-day and 1-year mortality rates in emergency general surgery laparotomies due to concern? Answer: Emergency laparotomy has a high mortality rate, particularly in patients over 70 years old, highlighting the importance of enhancing outcomes by expanding surgical care staff and early recognition of patient needs.",2.3685972735685406e-07,0.17904823144898518,0.0,0.018134264647818726,0.182321556793954,0.0,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
225,0.7,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss caused by amblyopia permanent? Answer: Amblyopia, commonly called lazy eye, usually begins in childhood. Without treatment, it may cause irreversible vision loss. But if detected and treated early, such as through vision therapy or corrective glasses, normal or near-normal vision can often be regained.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.7,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia result in permanent vision loss? Answer: Amblyopia, also known as lazy eye, typically develops in childhood. If not treated, it can cause lasting vision impairment. Early diagnosis and treatment, including vision therapy or corrective lenses, can often restore normal or near-normal sight.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.7,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is visual impairment from amblyopia permanent? Answer: Amblyopia, or lazy eye, usually occurs during childhood. If untreated, it can lead to permanent vision damage. However, early detection and intervention, like vision therapy or glasses, can frequently reverse the condition and restore normal vision.",1.4211583641411244e-07,0.13062018241706452,0.0,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
225,0.7,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia cause permanent vision loss? Answer: Known as lazy eye, amblyopia often starts in childhood. If left untreated, it can result in permanent loss of vision. Early treatment through vision therapy or corrective eyewear can often restore normal or near-normal vision.",1.6580180914979784e-07,0.15415067982725894,0.0,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
225,0.7,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss in amblyopia irreversible? Answer: Amblyopia, or lazy eye, generally begins during childhood. Without treatment, it may cause permanent visual loss. Yet, with early detection and appropriate treatment such as vision therapy or corrective glasses, the condition can often be reversed.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.7,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Can amblyopia lead to permanent loss of vision? Answer: Amblyopia, also called lazy eye, usually develops in childhood. If untreated, it can cause lasting vision loss. Early diagnosis and treatment with vision therapy or corrective lenses can often restore normal or near-normal vision.",1.4211583641411244e-07,0.13062018241706452,0.0,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
225,0.7,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss from amblyopia permanent? Answer: Amblyopia, commonly known as lazy eye, often starts in childhood. If untreated, it can cause permanent visual impairment. Nevertheless, early detection and treatment, including vision therapy or corrective eyewear, often enable restoration of normal vision.",1.4211583641411244e-07,0.13062018241706452,0.0,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
225,0.7,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does lazy eye result in permanent vision loss? Answer: Amblyopia, or lazy eye, typically begins in childhood. When untreated, it can lead to permanent vision loss. However, if detected early and treated with vision therapy or corrective lenses, the vision loss can often be reversed.",9.474389094274162e-08,0.11596434969852698,0.02221074380165289,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
225,0.7,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the visual loss in amblyopia lasting? Answer: Also called lazy eye, amblyopia generally starts during childhood. If left untreated, it may cause permanent vision loss. Early detection and treatment, such as vision therapy or glasses, can often restore normal or near-normal vision.",1.4211583641411244e-07,0.13062018241706452,0.0,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
225,0.7,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is vision loss caused by amblyopia permanent? Answer: Amblyopia, known as lazy eye, usually starts in childhood. Without treatment, it can result in permanent vision loss. Early intervention with vision therapy or corrective eyewear can often reverse the condition and restore normal vision.",1.4211583641411244e-07,0.13062018241706452,0.0,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
226,0.7,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it acceptable for student examiners to serve as reasonable substitutes for faculty in an undergraduate OSCE focusing on medical emergencies? It appears quite permissible and justified to allow medical students to act as examiners during formative assessments in emergency medicine OSCEs, though this may not apply to summative evaluations.",9.474389094274162e-08,0.08515780834030728,0.0,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
226,0.7,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably substitute faculty in an undergraduate medical emergencies OSCE? Encouraging medical students to officiate as examiners in formative OSCE testing for emergency medicine seems justified and acceptable, but this does not necessarily hold true for summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.7,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners suitable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems reasonable and justified to permit medical students to serve as examiners in formative emergency medicine OSCEs, but not necessarily during summative assessments.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.7,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May medical students reasonably replace faculty examiners in an undergraduate OSCE on medical emergencies? Allowing medical students to act as examiners in formative OSCE assessments appears admissible and justified, though this might not be appropriate for summative evaluations.",1.8948778188548293e-07,0.27067940745689967,0.05387755102040818,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.7,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.",Is it reasonable to have student examiners substitute for faculty in an undergraduate OSCE on medical emergencies? It seems justified and acceptable to encourage medical students to officiate in formative emergency medicine OSCE testing but not necessarily in summative assessments.,1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.7,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners be considered reasonable replacements for faculty in an undergraduate OSCE focused on medical emergencies? It appears quite justified and acceptable to have medical students examine in formative OSCEs for emergency medicine, but not necessarily in summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.7,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners appropriate substitutes for faculty in undergraduate medical emergency OSCEs? It seems justified and reasonable to allow medical students to officiate in formative OSCE testing, though this may not extend to summative evaluation.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
226,0.7,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.",Is it permissible for student examiners to substitute reasonably for faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to serve as examiners in formative emergency medicine OSCE testing seems justified but not necessarily in summative assessments.,1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.7,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Could student examiners reasonably replace faculty in undergraduate emergency medicine OSCEs? It appears acceptable and justified to let medical students officiate in formative OSCE assessments, but this might not be suitable for summative evaluations.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
226,0.7,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it justified for student examiners to act as reasonable substitutes for faculty during an undergraduate OSCE on medical emergencies? Encouraging medical students to be examiners in formative assessments of emergency medicine OSCEs seems admissible, though it may not be appropriate for summative assessments.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
227,0.7,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? At the studied gas flow rates, HFNC are not louder than BCPAP for preterm infants.",2.36859727356853e-08,0.04168988456723399,0.0027888888888888963,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
227,0.7,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? The gas flows analyzed show that HFNC are not noisier than BCPAP for preterm infants.,2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.7,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Is the noise level of high flow nasal cannulae greater than that of bubble CPAP for preterm infants? At the gas flows examined, HFNC do not generate more noise than BCPAP for preterm infants.",1.421158364141118e-07,0.26135024662228146,0.043326562499999985,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.7,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae noisier compared to bubble CPAP for preterm infants? Based on the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
227,0.7,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Do high flow nasal cannulae create more noise than bubble CPAP in preterm infants? According to the gas flow rates studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.7,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Is the noise from high flow nasal cannulae higher than that from bubble CPAP for preterm infants? At the gas flows investigated, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.16183917481456245,0.04030630202140307,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.7,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Are high flow nasal cannulae associated with greater noise than bubble CPAP for preterm infants? The gas flows tested indicate that HFNC are not noisier than BCPAP for preterm infants.,4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.7,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Do high flow nasal cannulae emit more noise than bubble CPAP in preterm infants? The studied gas flows reveal that HFNC are not noisier than BCPAP for preterm infants.,2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.7,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Is there more noise from high flow nasal cannulae than bubble CPAP for preterm infants? At the gas flows studied, HFNC do not produce more noise than BCPAP for preterm infants.",7.10579182070559e-08,0.1156293627772329,0.00727346938775511,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.7,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? At the gas flows assessed, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.029724344386858004,0.033669444444444425,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
228,0.7,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the coexistence of major depression and alcohol use disorder during adolescence result in worse depression outcomes? Yes, having both major depression and alcohol use disorder in adolescence frequently results in more severe depression outcomes. The simultaneous occurrence of these disorders can intensify the symptoms and severity of depression, complicating treatment and possibly causing deeper and more enduring effects.",1.6580180914979784e-07,0.04150394392730394,0.049445545840265615,0.012693985253473108,0.06148968459306525,0.03794973308872539,0.012675610786670066,0.08202544300845149,0.02537548113779007,1.6580180914979784e-07,0.1031331444443162,0.011950138927396027
228,0.7,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Question: In adolescents, does having both major depression and alcohol use disorder lead to poorer depression outcomes? Answer: Indeed, the comorbidity of major depression and alcohol use disorder in adolescence often results in worse depression outcomes. The presence of both conditions simultaneously can worsen depressive symptoms, making treatment more difficult and potentially leading to more significant and lasting consequences.",1.6580180914979784e-07,0.04150394392730394,0.049445545840265615,0.012693985253473108,0.06148968459306525,0.03794973308872539,0.012675610786670066,0.08202544300845149,0.02537548113779007,1.6580180914979784e-07,0.1031331444443162,0.011950138927396027
228,0.7,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does comorbidity of major depression and alcohol use disorder in adolescence lead to poorer depression outcomes? Yes, adolescents with both major depression and alcohol use disorder generally experience worse depression outcomes. The coexistence of these disorders can heighten depression severity and symptoms, complicating effective treatment and possibly resulting in more severe and persistent effects.",2.8423167282822487e-07,0.14292939324040344,0.04156923185941046,0.02176111757738247,0.1626514468092095,0.031336565096952915,0.0217296184914344,0.18283245879826593,0.020181517538644472,2.8423167282822487e-07,0.20348439465271406,0.008331438124421449
228,0.7,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Question: Does having both major depression and alcohol use disorder during adolescence cause poorer outcomes for depression? Answer: Yes, when adolescents suffer from both major depression and alcohol use disorder, it often leads to worse depression outcomes. The combined presence of these disorders can aggravate the symptoms and intensity of depression, making treatment more challenging and potentially causing greater and longer-lasting impacts.",9.474389094274162e-08,0.01480435894119303,0.05357142857142859,0.0072537058591274906,0.005332199464740839,0.04139892337359692,0.007243206163811466,0.026063464277930493,0.02807373692639957,9.474389094274162e-08,0.04741586892136507,0.013823218169772923
228,0.7,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the combination of major depression and alcohol use disorder in adolescence lead to more adverse depression outcomes? Yes, comorbid major depression and alcohol use disorder in adolescence commonly result in poorer outcomes for depression. The dual diagnosis can exacerbate depressive symptoms and severity, hindering effective treatment and possibly leading to more profound and enduring effects.",2.3685972735685406e-07,0.17674845082484403,0.006355176180929595,0.018134264647818726,0.17230579783900923,0.0016495460141582041,0.018108015409528666,0.1936019377438738,0.014540704683577724,2.3685972735685406e-07,0.2154499348330896,0.028126895208911866
228,0.7,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Question: In adolescence, does the presence of both major depression and alcohol use disorder worsen depression outcomes? Answer: Yes, adolescents with comorbid major depression and alcohol use disorder often face poorer outcomes in terms of depression. The simultaneous occurrence of these disorders may intensify symptoms and severity, complicating treatment and potentially causing more lasting and severe consequences.",2.1317375462116866e-07,0.08086341140211983,0.046457676207738,0.016320838183036854,0.1007453604611599,0.03544556163674531,0.0162972138685758,0.12114367122916692,0.023411945739336512,2.1317375462116866e-07,0.1420767068431843,0.010584177455447999
228,0.7,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the coexistence of major depression and alcohol use disorder during adolescence lead to worse depression outcomes? Yes, the comorbidity of these disorders in adolescence frequently results in more severe depressive outcomes. Having both conditions simultaneously can worsen symptoms and severity, making effective treatment more difficult and possibly leading to more enduring effects.",3.079176455639103e-07,0.031195101312993856,0.13488520408163265,0.023574544042164344,0.07543150488785866,0.1077254539858418,0.023540420032387266,0.12108835896974668,0.07877526753864447,3.079176455639103e-07,0.16823532752543713,0.048261993679977015
228,0.7,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Question: Does the presence of both major depression and alcohol use disorder in adolescence result in poorer depression outcomes? Answer: Yes, comorbid major depression and alcohol use disorder during adolescence often cause worse depression outcomes. The combined presence of these disorders can intensify depressive symptoms and severity, complicating treatment efforts and potentially leading to more severe and persistent effects.",1.6580180914979784e-07,0.06540557084316401,0.03281419816447291,0.012693985253473108,0.06148968459306525,0.03794973308872539,0.012675610786670066,0.08202544300845149,0.02537548113779007,1.6580180914979784e-07,0.1031331444443162,0.011950138927396027
228,0.7,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does comorbidity of major depression and alcohol use disorder in adolescence lead to worse depression outcomes? Yes, adolescents experiencing both conditions generally have poorer depression outcomes. The concurrent presence of these disorders can exacerbate depressive symptoms and severity, making treatment more challenging and possibly resulting in more profound and long-lasting effects.",3.552895910352811e-07,0.07041581446627632,0.13488520408163265,0.02720139697172809,0.11543683950155703,0.1077254539858418,0.027162023114293,0.16191035349000105,0.07877526753864447,3.552895910352811e-07,0.20990802392600605,0.048261993679977015
228,0.7,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Question: In adolescence, does having both major depression and alcohol use disorder cause poorer depression outcomes? Answer: Yes, the comorbidity of major depression and alcohol use disorder in adolescence often leads to more unfavorable depression outcomes. The coexistence of these disorders can worsen symptoms and severity of depression, complicating treatment and potentially leading to more significant and enduring effects.",1.6580180914979784e-07,0.06540557084316401,0.03281419816447291,0.012693985253473108,0.06148968459306525,0.03794973308872539,0.012675610786670066,0.08202544300845149,0.02537548113779007,1.6580180914979784e-07,0.1031331444443162,0.011950138927396027
229,0.7,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Does profound hypotension in patients with coronary disease lead to myocardial ischemic events?,1.01849682763447e-06,1.345989071301938,0.12456597222222221,0.07797733798562066,1.4884003025718378,0.0736,0.07786446626097343,1.6415503231784547,0.018860946745562133,1.0184968276344718e-06,1.7540191412452084,0.0
229,0.7,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Can severe hypotensive episodes trigger myocardial ischemia in coronary disease patients?,1.0658687731058407e-06,1.5283106280958934,0.12456597222222221,0.08160419091518442,1.6890709980339889,0.0736,0.08148606934287918,1.8646938744926644,0.018860946745562133,1.0658687731058426e-06,2.005333569526114,0.0
229,0.7,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Are myocardial ischemic events possible due to profound hypotension in those with coronary disease?,9.948108548987845e-07,1.2659463636284016,0.12456597222222221,0.07616391152083879,1.4013889255822076,0.0736,0.07605366472002056,1.5462401433741295,0.018860946745562133,9.948108548987864e-07,1.6486586255873825,0.0
229,0.7,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Is there a risk of myocardial ischemia from significant hypotensive events in patients with coronary disease?,9.474389094274139e-07,1.1228455199877283,0.12456597222222221,0.07253705859127504,1.24723824575495,0.0736,0.07243206163811482,1.379186058710963,0.018860946745562133,9.474389094274158e-07,1.4663370687934272,0.0
229,0.7,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Can patients with coronary disease experience myocardial ischemia due to severe drops in blood pressure?,9.711248821630993e-07,1.1918383914746804,0.12456597222222221,0.07435048505605692,1.3213462179086712,0.0736,0.07424286317906768,1.4592287663844994,0.018860946745562133,9.71124882163101e-07,1.5533484457830573,0.0
229,0.7,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Does a marked decrease in blood pressure cause myocardial ischemic events in individuals with coronary disease?,9.474389094274139e-07,1.1228455199877283,0.12456597222222221,0.07253705859127504,1.24723824575495,0.0736,0.07243206163811482,1.379186058710963,0.018860946745562133,9.474389094274158e-07,1.4663370687934272,0.0
229,0.7,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Is myocardial ischemia caused by profound hypotension in patients suffering from coronary disease?,1.01849682763447e-06,1.345989071301938,0.12456597222222221,0.07797733798562066,1.4884003025718378,0.0736,0.07786446626097343,1.6415503231784547,0.018860946745562133,1.0184968276344718e-06,1.7540191412452084,0.0
229,0.7,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Can critical hypotensive incidents result in myocardial ischemia in coronary disease cases?,1.0421828003701553e-06,1.4330004482915681,0.12456597222222221,0.07979076445040253,1.583710482376163,0.0736,0.07967526780192631,1.7469108388362806,0.018860946745562133,1.0421828003701572e-06,1.8718021769015922,0.0
229,0.7,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Are myocardial ischemic events triggered by profound hypotension among patients with coronary disease?,1.01849682763447e-06,1.345989071301938,0.12456597222222221,0.07797733798562066,1.4884003025718378,0.0736,0.07786446626097343,1.6415503231784547,0.018860946745562133,1.0184968276344718e-06,1.7540191412452084,0.0
229,0.7,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.",Does profound hypotension in coronary disease patients potentially cause myocardial ischemic events?,1.0421828003701553e-06,1.4330004482915681,0.12456597222222221,0.07979076445040253,1.583710482376163,0.0736,0.07967526780192631,1.7469108388362806,0.018860946745562133,1.0421828003701572e-06,1.8718021769015922,0.0
230,0.7,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Screening in this group showed about four times higher positivity compared to the general population, suggesting physicians might recommend more systematic screening.",3.789755637709665e-07,0.24436037366678542,0.03121748178980229,0.029014823436509962,0.29298712468147725,0.0,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
230,0.7,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it advisable to screen HIV-infected men older than 52 with two or more cardiovascular risk factors for silent myocardial ischaemia via gated myocardial perfusion SPECT? These patients had a roughly fourfold increased chance of positive results compared to the general population, potentially encouraging more routine screening.",4.263475092423373e-07,0.28691998808558195,0.03121748178980229,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
230,0.7,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","For male HIV-positive patients over 52 years old who have at least two other cardiovascular risk factors, should screening for silent myocardial ischaemia using gated myocardial perfusion SPECT be performed? Screening was found to be about four times more likely to yield positive results than in the general population, possibly prompting physicians to recommend more systematic testing.",1.8948778188548325e-07,0.09020969383952693,0.03121748178980229,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
230,0.7,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should silent myocardial ischaemia screening via gated myocardial perfusion SPECT be recommended for HIV-infected male patients older than 52 with two or more cardiovascular risk factors? The likelihood of positive findings was roughly four times higher than in the general population, motivating consideration of more structured screening approaches.",4.026615365066519e-07,0.2654137828646186,0.03121748178980229,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
230,0.7,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","In male HIV patients over 52 years old with at least two additional cardiovascular risk factors, does screening for silent myocardial ischaemia using gated myocardial perfusion SPECT have clinical value? Such screening was about four times more likely to be positive than in the general population, which may encourage physicians to advise more regular screening.",2.3685972735685406e-07,0.12657733801040116,0.03121748178980229,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
230,0.7,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is screening for silent myocardial ischaemia with gated myocardial perfusion SPECT warranted in HIV-infected men older than 52 who have two or more cardiovascular risk factors? This group showed a fourfold increase in positive screening results compared to the general population, suggesting that more systematic screening might be beneficial.",3.789755637709665e-07,0.24436037366678542,0.03121748178980229,0.029014823436509962,0.29298712468147725,0.0,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
230,0.7,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should physicians recommend gated myocardial perfusion SPECT screening for silent myocardial ischaemia in male HIV-positive patients older than 52 with at least two cardiovascular risk factors? Screening in these patients was approximately four times more likely to be positive than in the general population, possibly supporting more routine screening protocols.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.7,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it appropriate to screen HIV-infected men over the age of 52 with multiple cardiovascular risk factors for silent myocardial ischaemia using gated myocardial perfusion SPECT? The rate of positive screening was about four times higher than that of the general population, indicating a potential need for more consistent screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.7,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","For male HIV-infected patients older than 52 years who have at least two cardiovascular risk factors, should silent myocardial ischaemia screening via gated myocardial perfusion SPECT be implemented? The screening positivity was around four times higher than in the general population, which could prompt physicians to recommend more systematic screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.7,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Does screening for silent myocardial ischaemia with gated myocardial perfusion SPECT in HIV-infected men over 52 with at least two other cardiovascular risk factors yield a significantly higher positive rate? The positivity was about four times greater than in the general population, possibly motivating more thorough screening efforts.",4.026615365066519e-07,0.2654137828646186,0.03121748178980229,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
231,0.7,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? Yes, it is regarded as less invasive than retropubic radical prostatectomy.",1.184298636784265e-07,0.07882647318150093,0.1538321995464853,0.009067132323909398,0.10327100093618391,0.20408163265306126,0.009054007704764368,0.00029804474115557866,0.14876033057851235,1.1842986367842698e-07,0.11224000242461774,0.0793950850661626
231,0.7,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Does robotically assisted laparoscopic radical prostatectomy offer a less invasive option than retropubic radical prostatectomy? Yes, it is considered less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.7,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the robotically assisted laparoscopic radical prostatectomy a less invasive procedure than the retropubic radical prostatectomy? Yes, it is thought to be less invasive.",1.184298636784265e-07,0.19937380893105683,0.24000000000000005,0.009067132323909398,0.10327100093618391,0.20408163265306126,0.009054007704764368,0.00029804474115557866,0.14876033057851235,1.1842986367842698e-07,0.11224000242461774,0.0793950850661626
231,0.7,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than its retropubic counterpart? Yes, it is deemed less invasive.",2.605457000925385e-07,0.10290706294187668,0.24000000000000005,0.01994769111260067,0.21518273018235057,0.20408163265306126,0.019918816950481606,0.33677028136236675,0.14876033057851235,2.605457000925391e-07,0.46891494636334974,0.0793950850661626
231,0.7,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the robotically assisted laparoscopic radical prostatectomy procedure less invasive than retropubic radical prostatectomy? Yes, it is considered less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.7,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is generally viewed as less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.7,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy a less invasive alternative to retropubic radical prostatectomy? Yes, it is recognized as less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.7,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is often considered less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
231,0.7,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is widely regarded as less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.7,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is accepted as less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
232,0.7,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy represents a new method in glioma treatment, enabling local opening of the rodent blood-brain barrier to facilitate the",0.0,0.09241962407465998,0.06009176406135869,0.0,0.06301338005090251,0.04395179757830192,0.0,0.06447880749394885,0.04613236961451247,0.0,0.06601401719618405,0.047500000000000014
232,0.7,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: Nd:YAG laser-induced thermo therapy introduces a novel strategy for glioma therapy by locally disrupting the rodent blood-brain barrier to permit the,4.737194547137081e-08,0.052626686020529334,0.004890927977839257,0.0036268529295637453,0.0510209713528158,0.0031891414310303706,0.003621603081905733,0.0492007028305701,0.0011323696145124768,4.737194547137081e-08,0.048790164169431716,0.0
232,0.7,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: Utilizing Nd:YAG laser-induced thermo therapy offers a new glioma treatment approach by locally opening the rodent blood-brain barrier to enable the,4.737194547137081e-08,0.08486608976750354,0.026490595325054794,0.0036268529295637453,0.0510209713528158,0.0031891414310303706,0.003621603081905733,0.0492007028305701,0.0011323696145124768,4.737194547137081e-08,0.048790164169431716,0.0
232,0.7,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The novel glioma treatment method involving Nd:YAG laser-induced thermo therapy allows local opening of the rodent blood-brain barrier to facilitate the,4.737194547137081e-08,0.11710549351447819,0.047260802469135776,0.0036268529295637453,0.11703498854900074,0.049056854658410934,0.003621603081905733,0.11682481800715028,0.0494720510549557,4.737194547137081e-08,0.11810488222542581,0.049861495844875335
232,0.7,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: Nd:YAG laser-induced thermo therapy is an innovative glioma treatment technique that locally opens the rodent blood-brain barrier to permit the,7.105791820705622e-08,0.07999520768631685,0.007498630387143879,0.005440279394345618,0.07753366990246713,0.004897905711710296,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
232,0.7,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: As a new concept in glioma therapy, Nd:YAG laser-induced thermo therapy locally opens the rodent blood-brain barrier to allow the",7.105791820705622e-08,0.1460092248825018,0.05062500000000003,0.005440279394345618,0.11134572749075655,0.028603969340660812,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
232,0.7,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In glioma therapy, the Nd:YAG laser-induced thermo therapy is a novel approach that involves local opening of the rodent blood-brain barrier to enable the",2.3685972735685406e-08,0.03494622405184966,0.037896531886916496,0.0018134264647818726,0.03703978086268389,0.04155822427126707,0.0018108015409528666,0.03929114810468315,0.04457414534324541,2.3685972735685406e-08,0.04094831008375399,0.046400951814396206
232,0.7,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The use of Nd:YAG laser-induced thermo therapy in glioma treatment is a new method that achieves local opening of the rodent blood-brain barrier to facilitate the,7.105791820705622e-08,0.012477832257978605,0.05062500000000006,0.005440279394345618,0.012999914344760555,0.0370585077179791,0.0054324046228586,0.009270182730339638,0.041657315531224225,7.105791820705622e-08,0.007379788770512263,0.04434829637641968
232,0.7,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: Nd:YAG laser-induced thermo therapy offers a groundbreaking approach in glioma therapy by locally disrupting the rodent blood-brain barrier to allow the,4.737194547137081e-08,0.052626686020529334,0.004890927977839257,0.0036268529295637453,0.0510209713528158,0.0031891414310303706,0.003621603081905733,0.0492007028305701,0.0011323696145124768,4.737194547137081e-08,0.048790164169431716,0.0
232,0.7,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: This novel glioma treatment strategy using Nd:YAG laser-induced thermo therapy enables the local opening of the rodent blood-brain barrier to permit the,2.3685972735685406e-08,0.12049366926457594,0.0634645061728395,0.0018134264647818726,0.12190587063018787,0.06804881959632186,0.0018108015409528666,0.12331912805559142,0.07094019509927701,2.3685972735685406e-08,0.09172166675563975,0.04865220249835634
233,0.7,1,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Yes, it is regarded as a distinct clinical entity, characterized by increased aggressiveness and frequent diagnosis at later stages, often linked to genetic factors.",9.47438909427412e-08,0.0695164616571895,0.12543252595155707,0.0072537058591274975,0.0017813434428641806,0.0783673469387755,0.00724320616381148,0.07694293601234303,0.027006172839506164,9.474389094274162e-08,0.11778303565638382,0.0
233,0.7,2,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young individuals represent a unique clinical entity? Answer: Indeed, colorectal cancer in young patients is considered a distinct clinical form, typically more aggressive and commonly detected at advanced stages, with genetic predisposition playing a role.",0.0,0.07109201851896829,0.04904363706266818,0.0,0.03648143055578723,0.025898211136306366,0.0,0.0,0.0,0.0,0.0,0.0
233,0.7,3,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is early-onset colorectal cancer a distinct clinical condition? Answer: Yes, colorectal cancer occurring in young patients is viewed as a separate clinical entity, usually more aggressive and often found at advanced stages, influenced by genetic predisposition.",7.10579182070559e-08,0.0591791619261115,0.09767742391074075,0.005440279394345618,0.027206193430387327,0.0783673469387755,0.005432404622858607,0.047089972862661256,0.027006172839506164,7.105791820705622e-08,0.08701137698963013,0.0
233,0.7,4,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in youth recognized as a distinct clinical entity? Answer: Yes, it is recognized as a distinct clinical entity, marked by higher aggressiveness and frequent late-stage diagnosis, often associated with genetic predisposition.",1.184298636784265e-07,0.12256452946546048,0.00987697039600148,0.009067132323909377,0.1576610666943541,0.011632653061224532,0.009054007704764354,0.194357992249091,0.035216049382716066,1.1842986367842703e-07,0.19425090691031466,0.0322222222222222
233,0.7,5,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in younger patients constitute a distinct clinical entity? Answer: Yes, colorectal cancer in younger individuals is considered a separate clinical entity, known for its aggressive nature and late-stage diagnosis, often linked to genetic factors.",4.73719454713706e-08,0.01268406731579308,0.044982698961937725,0.0036268529295637453,0.021639282998465514,0.023004025139467532,0.003621603081905733,0.05771084630712098,0.001540539963261995,4.737194547137081e-08,0.05715841383994835,0.0
233,0.7,6,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients classified as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is classified distinctly, showing more aggressive behavior and commonly diagnosed at advanced stages, with genetic predisposition involved.",7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.09161903752274592,0.006593590561224494,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.7,7,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer among young people a distinct clinical entity? Answer: Yes, it is viewed as a unique clinical entity, generally more aggressive and often diagnosed late, with genetic predisposition as a contributing factor.",1.184298636784265e-07,0.00024443877841173745,0.09604776929407313,0.009067132323909377,0.03163430659254596,0.0783673469387755,0.009054007704764354,0.10771459467909672,0.027006172839506164,1.1842986367842703e-07,0.14953173397096364,0.0
233,0.7,8,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young adults represent a distinct clinical entity? Answer: Yes, colorectal cancer in young adults is seen as a distinct clinical entity, characterized by its aggressiveness and frequent advanced-stage diagnosis, often related to genetic predisposition.",2.36859727356853e-08,0.06713402344055774,0.026911224048442928,0.0018134264647818726,0.06709361607641151,0.028152395944603725,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.7,9,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Yes, it is considered a separate clinical entity due to its aggressive nature and tendency to be diagnosed at advanced stages, often influenced by genetic predisposition.",4.73719454713706e-08,0.05015148248119594,0.0715549749311489,0.0036268529295637453,0.01686889369930933,0.05061224489795918,0.003621603081905733,0.01810243598940975,0.027006172839506164,4.737194547137081e-08,0.05715841383994835,0.0
233,0.7,10,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients identified as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is identified as a distinct clinical entity, notable for being more aggressive and often detected at later stages, frequently associated with genetic predisposition.",7.105791820705611e-08,0.01221805033359713,0.05449826989619383,0.005440279394345618,0.017442146884457888,0.06367346938775514,0.0054324046228586,0.023200479476875202,0.0717592592592593,7.105791820705622e-08,0.008950689154565872,0.05113221329437545
234,0.7,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can analyzing APC mutations aid in making therapeutic choices for familial adenomatous polyposis? Yes, APC mutation analysis can assist in therapeutic decisions for familial adenomatous polyposis by identifying mutation types, guiding targeted therapy selection, and predicting disease progression to tailor treatments.",2.6054570009253947e-07,0.09480295766718472,0.10157171129411868,0.0199476911126006,0.11765204522359829,0.09214532634326131,0.019918816950481533,0.14106725176220847,0.08098765432098766,2.6054570009253947e-07,0.17363970069367252,0.06222222222222222
234,0.7,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis useful for therapeutic decision-making in familial adenomatous polyposis? Indeed, it helps determine specific mutations, informs targeted therapy options, and forecasts disease course, supporting personalized treatment strategies.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.7,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation analysis influence treatment decisions in familial adenomatous polyposis? Yes, it can pinpoint mutation types, direct targeted therapy choices, and anticipate disease progression, facilitating customized treatment plans.",5.447773729207631e-07,0.3821631835499226,0.15143320713899402,0.041708808689983126,0.4498308160894293,0.11776859504132227,0.041648435441915994,0.5205568734671124,0.08098765432098766,5.447773729207643e-07,0.5656817884696981,0.06222222222222222
234,0.7,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can therapeutic decisions in familial adenomatous polyposis benefit from APC mutation analysis? Yes, by identifying mutation variants, guiding targeted therapies, and predicting disease outcomes, APC mutation analysis supports personalized treatment.",5.210914001850778e-07,0.39487511757037375,0.11699443162878993,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.7,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis valuable for guiding therapy in familial adenomatous polyposis? Yes, it helps identify mutation specifics, select targeted treatments, and predict disease trajectory, enabling individualized care.",5.684633456564484e-07,0.4185308277207973,0.15143320713899402,0.043522235154765006,0.4875711440722763,0.11776859504132227,0.04345923698286887,0.5597775866203949,0.08098765432098766,5.684633456564497e-07,0.6065037829899529,0.06222222222222222
234,0.7,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation testing contribute to therapy planning in familial adenomatous polyposis? Yes, it reveals mutation details, aids in choosing targeted therapies, and forecasts disease progression, allowing tailored treatments.",5.447773729207631e-07,0.3821631835499226,0.15143320713899402,0.041708808689983126,0.4498308160894293,0.11776859504132227,0.041648435441915994,0.5205568734671124,0.08098765432098766,5.447773729207643e-07,0.5656817884696981,0.06222222222222222
234,0.7,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis aid therapeutic strategies in familial adenomatous polyposis? Yes, it clarifies mutation types, assists in targeted therapy decisions, and predicts disease evolution, thus supporting personalized management.",5.447773729207631e-07,0.3821631835499226,0.15143320713899402,0.041708808689983126,0.4498308160894293,0.11776859504132227,0.041648435441915994,0.5205568734671124,0.08098765432098766,5.447773729207643e-07,0.5656817884696981,0.06222222222222222
234,0.7,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation assessment important for therapeutic decisions in familial adenomatous polyposis? Yes, it identifies mutations, guides targeted treatment choices, and predicts disease progression for customized care.",5.921493183921337e-07,0.4562711557036443,0.15143320713899402,0.045335661619546885,0.5267918572255588,0.11776859504132227,0.04527003852382174,0.6005995811406497,0.08098765432098766,5.921493183921352e-07,0.6490633974087485,0.06222222222222222
234,0.7,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can analyzing APC mutations help in selecting treatments for familial adenomatous polyposis? Yes, APC mutation analysis identifies mutation types, informs targeted therapy selection, and predicts disease progression, enabling personalized therapeutic plans.",4.974054274493925e-07,0.31317031206297186,0.15143320713899402,0.03808195576041937,0.37837185210728563,0.11776859504132227,0.03802683236001025,0.44644890131339077,0.08098765432098766,4.974054274493935e-07,0.48872074733356863,0.06222222222222222
234,0.7,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation analysis play a role in treatment decisions for familial adenomatous polyposis? Yes, it detects mutation specifics, guides targeted therapies, and forecasts disease course to tailor treatments accordingly.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
235,0.7,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults in PICT with more symptoms might compromise quality of life for experimental therapy.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
235,0.7,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered in patient selection for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms may trade off quality of life for experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.7,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in choosing patients for phase I clinical trials? Answer: Older adults enrolled in PICT with a higher symptom burden may give up quality of life in exchange for experimental treatment.,2.131737546211677e-07,0.29725152346793093,0.0,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
235,0.7,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence relevant when evaluating patients for phase I clinical trials? Answer: Older adults involved in PICT experiencing more symptoms may sacrifice their quality of life to receive experimental therapy.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.7,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are patient symptoms significant in deciding eligibility for phase I clinical trials? Answer: Older adults with more symptoms enrolled in PICT might lose quality of life to undergo experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.7,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom severity be factored in when considering patients for phase I clinical trials? Answer: Older adults in PICT who have more symptoms may accept a reduction in quality of life for experimental treatment.,1.894877818854824e-07,0.2682639865946794,0.0,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
235,0.7,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence patient selection in phase I clinical trials? Answer: Older adults participating in PICT with greater symptoms might compromise quality of life for experimental treatment.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
235,0.7,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is the presence of symptoms a consideration for patients in phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms could sacrifice quality of life to pursue experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.7,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor when selecting patients for phase I clinical trials? Answer: Older adults in PICT with increased symptoms may give up quality of life for experimental treatment.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.7,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom status matter in the selection of patients for phase I clinical trials? Answer: Older adults with more symptoms enrolled in PICT may trade quality of life for access to experimental therapy.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
236,0.7,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does a surgeon's prior experience affect their skill in performing transurethral resection of the prostate? Answer: The senior urologist was able to resect tissue at a rate four times faster than less experienced surgeons. Hence, a surgeon's experience could be crucial in lowering the chances of secondary TURP caused by recurring or partially removed adenomas.",9.474389094274162e-08,0.09540961069360954,0.0181755829903978,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
236,0.7,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely",Question: Is the proficiency in transurethral resection of the prostate linked to the surgeon's experience? Answer: The senior urologist resected tissue four times more quickly than surgeons with less experience. This suggests that experience may be key to minimizing the risk of secondary TURP due to recurring or incompletely resected adenomas.,2.1317375462116866e-07,0.1655144384775733,0.0,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
236,0.7,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does a surgeon's experience impact their ability to perform transurethral resection of the prostate? Answer: The senior urologist was capable of removing tissue at a rate four times higher than that of less experienced surgeons. Therefore, surgeon experience may play a vital role in reducing secondary TURP risk from recurrent or incompletely excised adenomas.",1.1842986367842703e-07,0.08855339734144341,0.0,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
236,0.7,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Is the skill to execute transurethral resection of the prostate influenced by prior surgical experience? Answer: Compared to less experienced surgeons, the senior urologist resected four times more tissue per unit time. Thus, experience might be important to decrease the chances of secondary TURP caused by recurring or partially resected adenomas.",1.8948778188548325e-07,0.14571181118139354,0.0,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
236,0.7,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does previous experience of the surgeon affect the efficiency of transurethral resection of the prostate? Answer: The senior urologist removed tissue four times faster than less experienced surgeons, implying that experience could be critical to reduce secondary TURP risks from adenomas that recur or were incompletely resected.",2.8423167282822487e-07,0.2568854669003393,0.0212665406427221,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
236,0.7,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Is the capacity to perform transurethral resection of the prostate dependent on the surgeon's experience? Answer: The senior urologist achieved a tissue resection rate four times greater than that of less experienced surgeons, indicating experience may help reduce the likelihood of secondary TURP due to recurrent or incompletely removed adenomas.",2.1317375462116866e-07,0.1655144384775733,0.0,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
236,0.7,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does the surgeon's previous experience influence their ability to perform transurethral resection of the prostate? Answer: The senior urologist could resect tissue four times faster than less experienced colleagues, suggesting that experience might be essential to lower the risk of secondary TURP from recurring or incompletely excised adenomas.",2.6054570009253947e-07,0.20633643299782767,0.0,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
236,0.7,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Is the effectiveness in performing transurethral resection of the prostate related to the surgeon's experience? Answer: The senior urologist resected tissue at a rate four times that of less experienced surgeons, indicating that experience may be important to reduce secondary TURP risk caused by recurrent or partially removed adenomas.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.7,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Does a surgeon's prior experience impact their ability to perform transurethral resection of the prostate? Answer: The senior urologist was able to resect tissue four times faster than less experienced surgeons, implying that experience could be crucial to minimize the risk of secondary TURP due to adenomas that are recurrent or incompletely resected.",1.4211583641411244e-07,0.10724553035359774,0.0,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
236,0.7,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Question: Is the ability to conduct transurethral resection of the prostate affected by the surgeon's previous experience? Answer: The senior urologist removed tissue at a rate four times higher than less experienced surgeons, suggesting that experience may be important to reduce the risk of secondary TURP caused by recurring or incompletely excised adenomas.",1.6580180914979784e-07,0.12629372532429084,0.0,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
237,0.7,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF results in poor responders compared to oral contraceptive pills? The evidence suggests that E2 plus antagonist pretreatment does not improve IVF outcomes in the microdose leuprolide protocol versus standard OCP in poor responders. Well-powered randomized trials to determine the best steroid pretreatment method are warranted.,1.8948778188548325e-07,0.07618888320614436,0.0424634127860635,0.014507411718254981,0.0934311655414648,0.0322222222222222,0.014486412327622933,0.11785581355365027,0.016388888888888897,1.8948778188548325e-07,0.14310084364067155,0.0
237,0.7,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"In poor responders undergoing IVF, does estradiol and antagonist pretreatment before microdose leuprolide yield better outcomes than oral contraceptive pills? Findings indicate no improvement in IVF results with E2 plus antagonist pretreatment compared to standard OCP in this protocol. Robust randomized controlled trials are needed to identify the optimal steroid pretreatment approach.",2.8423167282822487e-07,0.12846797404846644,0.059175267538644494,0.02176111757738247,0.1703922066775947,0.0322222222222222,0.0217296184914344,0.19632742899514444,0.016388888888888897,2.8423167282822487e-07,0.22314355131420838,0.0
237,0.7,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Is IVF success in poor responders improved by estradiol and antagonist pretreatment prior to microdose leuprolide compared to oral contraceptive pill use? Current data show no benefit of E2 plus antagonist pretreatment over standard OCP in the microdose leuprolide protocol. Properly powered randomized studies are justified to explore the best steroid pretreatment strategy.,2.6054570009253947e-07,0.135186659705691,0.040375267538644476,0.0199476911126006,0.15058957938141493,0.0322222222222222,0.019918816950481533,0.17612472167762583,0.016388888888888897,2.6054570009253947e-07,0.20252426411147262,0.0
237,0.7,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Does administering estradiol and an antagonist before microdose leuprolide enhance IVF outcomes for poor responders relative to oral contraceptive pills? The results indicate that E2 and antagonist pretreatment does not improve IVF success compared to OCP in poor responders. Randomized trials with sufficient sample size are needed to determine optimal steroid pretreatment.,2.8423167282822487e-07,0.10128573167356691,0.07877526753864449,0.02176111757738247,0.1703922066775947,0.0322222222222222,0.0217296184914344,0.19632742899514444,0.016388888888888897,2.8423167282822487e-07,0.22314355131420838,0.0
237,0.7,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Comparing estradiol and antagonist pretreatment to oral contraceptive pills before microdose leuprolide in poor responders: does it improve IVF outcomes? Evidence suggests no improvement in IVF results with E2 plus antagonist pretreatment over standard OCP. Adequately powered randomized trials are justified to define the best steroid pretreatment method.,3.789755637709665e-07,0.2124593873925127,0.05750872689592239,0.029014823436509962,0.2537738156166456,0.0322222222222222,0.028972824655245866,0.2814852373354517,0.016388888888888897,3.789755637709665e-07,0.3101549283038376,0.0
237,0.7,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Data show no IVF benefit with E2 plus antagonist pretreatment versus standard OCP in poor responders. Randomized controlled trials with adequate power are warranted to study optimal steroid pretreatment techniques.,3.316036182995957e-07,0.16958278794277337,0.058375961983088934,0.025387970506946217,0.21121420119784906,0.0322222222222222,0.025351221573340132,0.23800012539571336,0.016388888888888897,3.316036182995957e-07,0.2657031657330049,0.0
237,0.7,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"In poor responder IVF patients, does estradiol and antagonist pretreatment prior to microdose leuprolide enhance outcomes compared to oral contraceptive pills? The evidence does not support improved IVF results with E2 plus antagonist pretreatment over OCP. Well-designed randomized trials are justified to investigate the best steroid pretreatment protocol.",3.789755637709665e-07,0.2124593873925127,0.05750872689592239,0.029014823436509962,0.2537738156166456,0.0322222222222222,0.028972824655245866,0.2814852373354517,0.016388888888888897,3.789755637709665e-07,0.3101549283038376,0.0
237,0.7,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Is there an improvement in IVF outcomes for poor responders when estradiol and antagonist are given before microdose leuprolide versus oral contraceptive pills? Current findings show no advantage of E2 plus antagonist pretreatment compared to OCP. Randomized trials with sufficient power are needed to identify optimal steroid pretreatment methods.,3.552895910352811e-07,0.16191035349000105,0.07877526753864449,0.02720139697172809,0.23226761039568222,0.0322222222222222,0.027162023114293,0.2595063306166767,0.016388888888888897,3.552895910352811e-07,0.2876820724517799,0.0
237,0.7,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Does estradiol and antagonist pretreatment before microdose leuprolide lead to better IVF results in poor responders than oral contraceptive pills? Studies indicate no improvement in IVF outcomes using E2 plus antagonist pretreatment relative to standard OCP. Adequately powered randomized trials are necessary to determine the best steroid pretreatment approach.,3.552895910352811e-07,0.19079148601333173,0.0579513653204462,0.02720139697172809,0.23226761039568222,0.0322222222222222,0.027162023114293,0.2595063306166767,0.016388888888888897,3.552895910352811e-07,0.2876820724517799,0.0
237,0.7,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,"Does using estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? The evidence suggests no benefit for IVF success from E2 plus antagonist pretreatment over standard OCP, and randomized trials with enough power to evaluate steroid pretreatment methods are justified.",3.316036182995957e-07,0.16958278794277337,0.058375961983088934,0.025387970506946217,0.21121420119784906,0.0322222222222222,0.025351221573340132,0.23800012539571336,0.016388888888888897,3.316036182995957e-07,0.2657031657330049,0.0
238,0.7,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access major surgery in newborns result in less pain? Minimal access major surgery in newborns is typically thought to cause less pain compared to conventional open surgery because,7.10579182070559e-08,0.1641695468318667,0.04248157596371885,0.005440279394345639,0.16566722708044512,0.043225623582766395,0.005432404622858621,0.16697359837426617,0.043048469387755126,7.105791820705622e-08,0.1680340659117241,0.04195011337868479
238,0.7,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Is pain reduced in newborns undergoing minimal access major surgery? Generally, minimal access major surgery in newborns is believed to lead to less pain than traditional open surgery due to",7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.7,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does newborn minimal access major surgery cause less pain? Minimal access major surgery in newborns usually causes less pain than traditional open surgery because,2.131737546211677e-07,0.33777589535492325,0.00505102040816327,0.016320838183036916,0.3348139924105853,0.005663265306122475,0.016297213868575862,0.3302693370602592,0.01882653061224486,2.131737546211686e-07,0.3237603026007627,0.03443877551020409
238,0.7,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is pain less with minimal access major surgery in newborns? Minimal access major surgery is commonly considered to be less painful than open surgery in newborns due to,1.184298636784265e-07,0.2019891840435415,0.02121831719455264,0.009067132323909398,0.14837117542406375,0.01927437641723359,0.009054007704764368,0.1453537071640909,0.026395975056689315,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.7,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Do newborns experience less pain with minimal access major surgery? Minimal access major surgery in newborns is often regarded as causing less pain than open surgery because,1.421158364141118e-07,0.19430961130593527,0.009027429497318787,0.010880558788691277,0.13640563524368776,0.05573270975056691,0.010864809245717241,0.13072392723955062,0.06632653061224487,1.4211583641411244e-07,0.18399836022560345,0.03443877551020409
238,0.7,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access surgery in newborns lead to less pain? Newborns undergoing minimal access major surgery generally feel less pain compared to those undergoing traditional open surgery due to,9.47438909427412e-08,0.009755110381674204,0.08678368466728256,0.007253705859127518,0.003992819662763214,0.09566326530612247,0.007243206163811494,0.05068121956601335,0.06632653061224487,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
238,0.7,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is pain minimized in newborns by using minimal access surgery? Minimal access major surgery tends to cause less pain in newborns than traditional open surgery because,1.658018091497971e-07,0.18447683168113116,0.04305389452567414,0.012693985253473157,0.12177585531914747,0.09566326530612247,0.012675610786670115,0.17328354165834625,0.06632653061224487,1.6580180914979784e-07,0.2284501227964375,0.03443877551020409
238,0.7,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Are newborns less in pain after minimal access major surgery? Compared to traditional open surgery, minimal access major surgery in newborns is usually less painful due to",1.421158364141118e-07,0.14099059741671027,0.04606009070294785,0.010880558788691277,0.13640563524368776,0.05573270975056691,0.010864809245717241,0.13072392723955062,0.06632653061224487,1.4211583641411244e-07,0.18399836022560345,0.03443877551020409
238,0.7,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access major surgery reduce pain in newborns? Minimal access surgery for newborns typically results in less pain than conventional open surgery because,2.131737546211677e-07,0.2172285596053678,0.0790605498397706,0.016320838183036916,0.20878723230877716,0.09566326530612247,0.016297213868575862,0.26425531986407425,0.06632653061224487,2.131737546211686e-07,0.3237603026007627,0.03443877551020409
238,0.7,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is there less pain in newborns after minimal access major surgery? Minimal access major surgery is generally considered to be less painful for newborns than traditional open surgery due to,7.10579182070559e-08,0.020759785336706305,0.05386187396769407,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
239,0.7,1,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there an association between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in patients with hypertension? Research suggests a possible connection between ACE-1 gene polymorphism and chronic kidney disease among those with high blood pressure, though the correlation is not fully established.",1.1842986367842682e-07,0.18130552056702554,0.03807782202216074,0.009067132323909363,0.14459333190838208,0.012336917398614713,0.009054007704764333,0.10563330887887767,0.017351359641135253,1.1842986367842703e-07,0.10382508488623987,0.021314783042107176
239,0.7,2,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in hypertensive individuals? Studies show a potential link between ACE-1 gene variations and chronic kidney disease in patients with hypertension, but the relationship is not completely clear.",4.73719454713706e-08,0.16620980063827906,0.07783681062819577,0.0036268529295637453,0.13142137562806155,0.05538752958900378,0.003621603081905733,0.09460214411003953,0.0290667549622006,4.737194547137081e-08,0.0951782614725234,0.02854671280276816
239,0.7,3,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in patients suffering from hypertension? Evidence points to a possible association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, although the connection remains somewhat uncertain.",2.36859727356853e-08,0.042350675590948406,0.04582400711662077,0.0018134264647818726,0.045454333077945996,0.05115642108407126,0.0018108015409528666,0.009237066111141612,0.026816608996539815,2.3685972735685406e-08,0.010620873444459722,0.02854671280276816
239,0.7,4,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is chronic kidney disease among hypertensive patients influenced by polymorphisms in the angiotensin-converting enzyme-1 (ACE-1) gene? Research indicates a potential relationship between ACE-1 gene polymorphism and chronic kidney disease in hypertensive individuals, but the link is not definitive.",2.36859727356853e-08,0.11728550592175369,0.09846619897959183,0.0018134264647818726,0.08396250977572084,0.0787646408425629,0.0018108015409528666,0.04884547642885284,0.055363321799307974,2.3685972735685406e-08,0.010620873444459722,0.02854671280276816
239,0.7,5,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism increase the risk of chronic kidney disease in hypertensive patients? Some studies suggest a potential association between ACE-1 gene polymorphism and chronic kidney disease among hypertensive patients, yet the association is not fully confirmed.",9.474389094274141e-08,0.21995101609742296,0.0813378328402367,0.0072537058591274906,0.2187117571334034,0.08214474288337922,0.007243206163811466,0.18237686905337558,0.055363321799307974,9.474389094274162e-08,0.14782199495794224,0.02854671280276816
239,0.7,6,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there a causal link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and the development of chronic kidney disease in hypertensive patients? Research has indicated a possible connection between ACE-1 gene polymorphism and chronic kidney disease in those with hypertension, but the evidence is not entirely conclusive.",1.6580180914979763e-07,0.23393220658755487,0.04296875,0.012693985253473108,0.22862131185929035,0.0387029671546463,0.012675610786670066,0.2224581268860275,0.03212069141382045,1.6580180914979784e-07,0.22192996711166568,0.02854671280276816
239,0.7,7,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism play a role in chronic kidney disease among patients with hypertension? Studies suggest that ACE-1 gene polymorphism might be associated with chronic kidney disease in hypertensive patients, although the relationship is not completely understood.",2.36859727356853e-08,0.13822604195952604,0.0759548611111111,0.0018134264647818726,0.14005647718798553,0.08022317604627185,0.0018108015409528666,0.10441532758366501,0.055363321799307974,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
239,0.7,8,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can variations in the angiotensin-converting enzyme-1 (ACE-1) gene lead to chronic kidney disease in individuals with hypertension? Research points to a potential link between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, but the association is not fully established.",4.73719454713706e-08,0.16620980063827906,0.07783681062819577,0.0036268529295637453,0.13142137562806155,0.05538752958900378,0.003621603081905733,0.09460214411003953,0.0290667549622006,4.737194547137081e-08,0.0951782614725234,0.02854671280276816
239,0.7,9,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is chronic kidney disease in hypertensive patients linked to polymorphisms in the angiotensin-converting enzyme-1 (ACE-1) gene? Evidence suggests a possible relationship between ACE-1 gene polymorphism and chronic kidney disease among hypertensive individuals, though the connection is not entirely clear.",0.0,0.14592572222314715,0.09987461419753085,0.0,0.11240224549620859,0.07951357004387306,0.0,0.07701635339554969,0.055363321799307974,0.0,0.03960841031771123,0.02854671280276816
239,0.7,10,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism have an impact on chronic kidney disease development in patients with hypertension? Some studies indicate a potential association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, but the link is not wholly confirmed.",7.1057918207056e-08,0.19343831754777163,0.07962906855955677,0.005440279394345618,0.1931738431033252,0.08153617943827732,0.0054324046228586,0.15705906106908385,0.055363321799307974,7.105791820705622e-08,0.12184650855468426,0.02854671280276816
240,0.7,1,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care during a woman's initial pregnancy affect her subsequent reproductive outcomes? Yes, care at a birth center during the first pregnancy can influence future reproduction by offering thorough prenatal care, encouraging healthy pregnancy behaviors, and lowering complication risks.",1.1842986367842703e-07,0.09221328412603524,0.14182998614958445,0.009067132323909363,0.0670562124929357,0.13017751479289946,0.009054007704764333,0.036905462338642,0.11176857330703485,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
240,0.7,2,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care in a woman's first pregnancy influence her future reproductive health? Indeed, birth center care during the initial pregnancy supports future reproduction by delivering comprehensive prenatal services, fostering healthy habits, and minimizing complications.",2.6054570009253894e-07,0.11141548413599134,0.10927202012570936,0.019947691112600606,0.13623608056718828,0.10079275813541552,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
240,0.7,3,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an impact of birth center care during a woman's first pregnancy on her later reproductive health? Yes, birth center care during the first pregnancy positively affects future reproduction through extensive prenatal care, promotion of healthy habits, and reduced risk of pregnancy complications.",7.105791820705622e-08,0.04469577571568317,0.07416027872026162,0.005440279394345618,0.04983235946618336,0.08267751479289945,0.0054324046228586,0.05310382532501556,0.08739357330703484,7.105791820705622e-08,0.05663695340827024,0.09204470742932283
240,0.7,4,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does care at a birth center during a woman’s first pregnancy affect her subsequent fertility? Yes, birth center care in the first pregnancy impacts future reproduction by providing complete prenatal care, encouraging healthy pregnancy practices, and decreasing complication risks.",1.8948778188548304e-07,0.02292342637516942,0.11373585034711531,0.014507411718254981,0.010905328976774875,0.13017751479289946,0.014486412327622933,0.04313724533489216,0.11176857330703485,1.8948778188548325e-07,0.0768944392162525,0.09204470742932283
240,0.7,5,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care during a woman’s initial pregnancy influence her future reproductive outcomes? Yes, such care ensures comprehensive prenatal support, promotes healthful pregnancy behaviors, and lowers the chance of complications, thereby affecting future reproduction.",2.8423167282822424e-07,0.06118620037382083,0.16620498614958445,0.021761117577382486,0.12531568015452033,0.13017751479289946,0.02172961849143442,0.16092028099127598,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
240,0.7,6,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is birth center care during a woman's first pregnancy linked to her future reproductive health? Yes, it plays a role by offering thorough prenatal care, supporting healthy lifestyle choices during pregnancy, and reducing risks of complications.",2.6054570009253894e-07,0.032198663500569324,0.16620498614958445,0.019947691112600606,0.09546271700483855,0.13017751479289946,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
240,0.7,7,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care in a woman's first pregnancy have consequences for her later reproduction? Yes, birth center care impacts future reproduction by delivering full prenatal care, encouraging healthy pregnancy habits, and diminishing complication risks.",2.6054570009253894e-07,0.11141548413599134,0.10927202012570936,0.019947691112600606,0.13623608056718828,0.10079275813541552,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
240,0.7,8,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care during the first pregnancy affect a woman’s future reproductive prospects? Yes, it influences future reproduction by providing extensive prenatal care, fostering healthy behaviors, and lowering complication risks.",3.7897556377096544e-07,0.18634934332782782,0.16620498614958445,0.029014823436510004,0.2545274116345273,0.13017751479289946,0.028972824655245914,0.29445167361579827,0.11176857330703485,3.789755637709665e-07,0.33640563470133644,0.09204470742932283
240,0.7,9,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an effect of birth center care during a woman’s initial pregnancy on her subsequent reproduction? Yes, birth center care during the first pregnancy affects future reproductive health by offering comprehensive prenatal care, promoting healthy habits, and reducing complications.",1.6580180914979774e-07,0.03062310663879053,0.08981609726069556,0.012693985253473108,0.05719994300618714,0.07770837899043032,0.012675610786670066,0.05320568631217926,0.08476240046752868,1.6580180914979784e-07,0.04872356224955565,0.09204470742932283
240,0.7,10,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does birth center care during a woman’s first pregnancy impact her future reproduction? Yes, it does by providing holistic prenatal care, encouraging healthy pregnancy practices, and lessening the risk of complications.",3.7897556377096544e-07,0.18634934332782782,0.16620498614958445,0.029014823436510004,0.2545274116345273,0.13017751479289946,0.028972824655245914,0.29445167361579827,0.11176857330703485,3.789755637709665e-07,0.33640563470133644,0.09204470742932283
241,0.7,1,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there a link between the CYP2D6*4 allele and breast cancer risk? Yes, multiple studies suggest an association between the CYP2D6*4 allele and breast cancer susceptibility.",9.47438909427412e-08,0.1762680893565669,0.06370667490535112,0.007253705859127518,0.2449199534720119,0.055016928285626404,0.007243206163811494,0.2987488503802247,0.09260498614958453,9.474389094274162e-08,0.30277521092665216,0.09456398891966755
241,0.7,2,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele relate to breast cancer risk? Indeed, several research studies have found evidence of an association between the CYP2D6*4 allele and the risk of developing breast cancer.",0.0,0.20925605476703923,0.21118605127566825,0.0,0.14853153869141744,0.1032235939643347,0.0,0.10268847119406654,0.07359999999999998,0.0,0.053319013889226774,0.03840000000000001
241,0.7,3,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Question: Is the CYP2D6*4 allele connected to breast cancer risk? Answer: Yes, numerous studies have demonstrated a connection between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.009912766022181607,0.16200456185848866,0.007253705859127518,0.01387089328536284,0.09730098718756561,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.7,4,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there any correlation between the CYP2D6*4 allele and breast cancer risk? Yes, various studies have reported an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.12425081286987005,0.06977315689981095,0.005440279394345639,0.1925455059424257,0.04861111111111113,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.7,5,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does possessing the CYP2D6*4 allele influence breast cancer risk? Yes, several investigations have indicated a link between the CYP2D6*4 allele and increased breast cancer risk.",1.184298636784265e-07,0.057666232348033475,0.1573241773079742,0.009067132323909398,0.058941910532276154,0.09550045913682273,0.009054007704764368,0.1021059414519474,0.07359999999999998,1.1842986367842703e-07,0.16025508640883412,0.03840000000000001
241,0.7,6,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Question: Is the CYP2D6*4 allele associated with breast cancer risk? Answer: Yes, research has shown that the CYP2D6*4 allele is linked to breast cancer risk in multiple studies.",4.73719454713706e-08,0.07937089165723599,0.17039815689981092,0.003626852929563759,0.07061506554560815,0.10048888888888885,0.003621603081905747,0.025727430057937095,0.07359999999999998,4.737194547137081e-08,0.026723693784310498,0.03840000000000001
241,0.7,7,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is the CYP2D6*4 allele a factor in breast cancer risk? Yes, many studies have found an association between the CYP2D6*4 allele and the risk of breast cancer.",7.10579182070559e-08,0.08902524268703527,0.20338426801092202,0.005440279394345639,0.02926159183675736,0.09895833333333331,0.005432404622858621,0.015094564462317717,0.07359999999999998,7.105791820705622e-08,0.06928330820310613,0.03840000000000001
241,0.7,8,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there an association between the CYP2D6*4 allele and breast cancer risk? Yes, evidence from several studies supports a connection between the CYP2D6*4 allele and breast cancer susceptibility.",4.73719454713706e-08,0.07466181513386205,0.07569152424674966,0.003626852929563759,0.14266099001129717,0.04251700680272108,0.003621603081905747,0.19607966772124596,0.08059501133786852,4.737194547137081e-08,0.20001048892429552,0.08404897959183669
241,0.7,9,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele have any association with breast cancer risk? Yes, a number of studies have indicated that the CYP2D6*4 allele is linked to breast cancer risk.",4.73719454713706e-08,0.07937089165723599,0.17039815689981092,0.003626852929563759,0.07061506554560815,0.10048888888888885,0.003621603081905747,0.025727430057937095,0.07359999999999998,4.737194547137081e-08,0.026723693784310498,0.03840000000000001
241,0.7,10,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Question: Is there any association between the CYP2D6*4 allele and breast cancer risk? Answer: Yes, multiple studies have identified an association between the CYP2D6*4 allele and the risk of breast cancer.",2.36859727356853e-08,0.10771505391951308,0.11977315689981088,0.0018134264647818796,0.041920356072945086,0.004488888888888903,0.0018108015409528735,0.00947542332647533,0.032000000000000056,2.3685972735685406e-08,0.011629129321992782,0.035199999999999974
242,0.7,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, studies indicate a significant relationship between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean individuals. Elevated hs-CRP levels serve as a dependable marker for carotid disease.",2.3685972735685406e-08,0.036360293218594464,0.039130711905287066,0.0018134264647818726,0.03864549553039742,0.043260010818075956,0.0018108015409528666,0.041111416626928854,0.0466309171597633,2.3685972735685406e-08,0.009119444997918169,0.024375
242,0.7,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid",Question: Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis in healthy Koreans? Answer: Research shows a notable association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis among healthy Koreans. Increased hs-CRP is a trustworthy indicator of carotid atherosclerosis.,1.4211583641411212e-07,0.10148742981067471,0.03381610098821991,0.010880558788691236,0.09363783073075371,0.043250815118946975,0.0108648092457172,0.12441194762660457,0.024375,1.4211583641411244e-07,0.16251892949777424,0.0
242,0.7,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Korean people? Answer: Yes, evidence supports a strong association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Higher hs-CRP levels are recognized as reliable markers of carotid artery disease.",2.3685972735685406e-08,0.027368521665787515,0.0026077024093046214,0.0018134264647818726,0.026512698549651326,0.0017087642806799253,0.0018108015409528666,0.025537914030078213,0.0006085634451019201,2.3685972735685406e-08,0.02531780798429173,0.0
242,0.7,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Are high levels of high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Koreans? Answer: Yes, data suggests a significant connection between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean individuals. Elevated hs-CRP levels are considered reliable indicators of carotid atherosclerosis.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,0.7,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Does research show an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, research indicates a meaningful association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. High hs-CRP levels are viewed as dependable signs of carotid artery disease.",4.737194547137081e-08,0.039792938054130644,0.05520083608351943,0.0036268529295637453,0.0434990987235393,0.061958071759904323,0.003621603081905733,0.04751750841035207,0.06766970742932282,4.737194547137081e-08,0.017223853026752334,0.047500000000000014
242,0.7,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, studies confirm a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean individuals. Elevated hs-CRP is a reliable marker for carotid disease.",2.3685972735685406e-08,0.12638954746006492,0.06566486786991164,0.0018134264647818726,0.12794887131452093,0.07103489916676735,0.0018108015409528666,0.12950999111407002,0.07439043209876545,2.3685972735685406e-08,0.09640982650326002,0.05113221329437545
242,0.7,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Can high-sensitivity C-reactive protein levels indicate carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests a strong link between elevated high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. High hs-CRP levels are considered reliable indicators of carotid atherosclerosis.",7.105791820705622e-08,0.08441043798474102,0.008183051613997475,0.005440279394345618,0.08172497413789692,0.0053829717291255935,0.0054324046228586,0.07865527994541788,0.0019215668371073726,7.105791820705622e-08,0.07796154146971057,0.0
242,0.7,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Is there a significant relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, evidence points to a significant relationship between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Korean individuals. Elevated hs-CRP levels serve as dependable markers of carotid artery disease.",7.105791820705622e-08,0.0727300398434867,0.086351355972778,0.005440279394345618,0.07843843358452807,0.09846084690159539,0.0054324046228586,0.08461051535046815,0.10858898891966762,7.105791820705622e-08,0.05663695340827024,0.09204470742932283
242,0.7,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Are elevated high-sensitivity C-reactive protein levels associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, studies demonstrate a significant association between elevated high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. High hs-CRP is considered a reliable indicator of carotid artery disease.",0.0,0.032239403746974205,0.021599667347215537,0.0,0.03300700859809247,0.02317690832500123,0.0,0.03381205758828987,0.02427720249835634,0.0,0.0,0.0
242,0.7,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Question: Does high-sensitivity C-reactive protein serve as a marker for carotid atherosclerosis in healthy Koreans? Answer: Yes, evidence shows that high-sensitivity C-reactive protein (hs-CRP) is significantly associated with carotid atherosclerosis in healthy Korean individuals. Elevated hs-CRP levels are reliable markers of carotid atherosclerosis.",2.3685972735685406e-08,0.027368521665787515,0.0026077024093046075,0.0018134264647818726,0.02651269854965088,0.0017087642806799253,0.0018108015409528666,0.025537914030078213,0.0006085634451019201,2.3685972735685406e-08,0.02531780798429173,0.0
243,0.7,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Is the fragility of the esophageal mucosa a defining endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis features a delicate esophageal mucosa that easily tears from slight trauma during routine diagnostic endoscopy. This ""crêpe-paper"" appearance can help endoscopists identify the disease even when other mucosal changes are absent. Dilation has proven to be effective for",2.3685972735685406e-08,0.018230396287864714,0.0006025468038455134,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
243,0.7,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Can the fragile nature of esophageal mucosa serve as a pathognomonic endoscopic indicator for primary eosinophilic esophagitis? Answer: In primary eosinophilic esophagitis, the esophageal mucosa is notably fragile and tears easily with minimal trauma during standard diagnostic endoscopy. The so-called ""crêpe-paper"" sign may help clinicians recognize the disease when other mucosal abnormalities are not present. Dilation remains an effective treatment option.",7.105791820705622e-08,0.052781833323533256,0.0016895655130768211,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
243,0.7,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Does fragility of the esophageal mucosa represent a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is marked by a fragile esophageal lining that tears easily even with minor trauma during routine diagnostic endoscopy. This characteristic ""crêpe-paper"" sign may serve as a clue to endoscopists, especially when other mucosal changes are missing. Dilation is an effective intervention.",4.737194547137081e-08,0.05859989948873601,0.017776896739735835,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
243,0.7,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Is esophageal mucosa fragility a hallmark endoscopic feature of primary eosinophilic esophagitis? Answer: The hallmark of primary eosinophilic esophagitis includes fragile esophageal mucosa that tears easily under minor trauma during diagnostic endoscopy. This ""crêpe-paper"" sign can alert endoscopists to the disease's presence in the absence of other mucosal changes. Dilation therapy is beneficial.",1.1842986367842703e-07,0.12081733530143968,0.02196122448979592,0.009067132323909363,0.11846705619773568,0.01922337562475971,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
243,0.7,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Could fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign in primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis presents with an esophageal mucosa that is fragile and prone to tearing with minimal trauma during diagnostic endoscopy. The distinctive ""crêpe-paper"" sign may help detect the disease when other mucosal signs are lacking. Dilation proves effective for treatment.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
243,0.7,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Is the fragile nature of the esophageal mucosa a diagnostic endoscopic sign of primary eosinophilic esophagitis? Answer: In primary eosinophilic esophagitis, the esophageal mucosa is fragile and tears easily with slight trauma during diagnostic endoscopy. This ""crêpe-paper"" sign can provide an important clue to endoscopists when other mucosal abnormalities are not visible. Dilation is an effective therapeutic measure.",0.0,0.023901626915861396,0.017131472423680204,0.0,0.024320953703857562,0.017538265306122455,0.0,0.0,0.0,0.0,0.0,0.0
243,0.7,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Does the fragility of the esophageal mucosa act as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Answer: The fragile esophageal mucosa in primary eosinophilic esophagitis tears readily from minor trauma during diagnostic endoscopy, producing the characteristic ""crêpe-paper"" sign that may alert clinicians even when other mucosal changes are absent. Dilation is an effective treatment modality.",4.737194547137081e-08,0.036798578876688914,0.0012265194143500774,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
243,0.7,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Is fragile esophageal mucosa an endoscopic hallmark of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by easily torn esophageal mucosa during minor trauma in diagnostic endoscopy. This ""crêpe-paper"" sign can indicate the disease in the absence of other mucosal alterations. Dilation is an effective option.",2.6054570009253947e-07,0.22148340441399794,0.008030360292265039,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
243,0.7,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Can the fragile esophageal mucosa be seen as a pathognomonic endoscopic feature of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa, which causes it to tear easily during minor trauma in diagnostic endoscopy, defines primary eosinophilic esophagitis. The resulting ""crêpe-paper"" sign may alert endoscopists when other mucosal changes are not evident. Dilation is effective.",7.105791820705622e-08,0.03051192350258969,0.01626319251980629,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
243,0.7,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Question: Is the fragility of the esophageal mucosa a key endoscopic marker for primary eosinophilic esophagitis? Answer: The hallmark of primary eosinophilic esophagitis includes fragile esophageal mucosa that tears with minimal trauma during diagnostic endoscopy, producing a ""crêpe-paper"" sign that can guide endoscopists in diagnosis even when other mucosal abnormalities are absent. Dilation is an effective treatment method.",2.3685972735685406e-08,0.018230396287864714,0.0006025468038455134,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
244,0.7,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does earlier discharge of patients from Winnipeg hospitals negatively impact care quality? Answer: Earlier discharge from Winnipeg hospitals might influence care quality based on the patient's health status and the support they receive after discharge. Insufficient home or follow-up care could raise readmission risks, signaling a drop in overall care quality.",1.4211583641411244e-07,0.07116759371563441,0.028314534023668667,0.010880558788691236,0.06678880318369318,0.03340811626341167,0.0108648092457172,0.06510218308112092,0.03631185475258099,1.4211583641411244e-07,0.0921109178578674,0.01851192595229618
244,0.7,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Is the quality of care compromised by discharging patients early from Winnipeg hospitals? Answer: The quality of care may be affected when patients are discharged early from Winnipeg hospitals, contingent on their specific health needs and the adequacy of post-discharge support. A lack of proper home care could lead to higher readmission rates, reflecting poorer care outcomes.",0.0,0.0,0.0,0.0,0.0,6.938893903907228e-18,0.0,0.02520535202036145,0.018136271762183187,0.0,0.025672117798516858,0.01851192595229618
244,0.7,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does releasing patients sooner from Winnipeg hospitals reduce care quality? Answer: Releasing patients sooner from Winnipeg hospitals has the potential to affect care quality, depending on individual patient conditions and the availability of follow-up care. Without sufficient post-discharge support, patients face a greater chance of readmission, which may indicate diminished care quality.",1.1842986367842703e-07,0.10350031545689875,0.008157356537671329,0.009067132323909363,0.1279892581647153,0.02446350015414788,0.009054007704764333,0.1280771374307954,0.023443690743118445,1.1842986367842703e-07,0.12807507396614737,0.022230491431135254
244,0.7,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: How does early discharge from Winnipeg hospitals impact quality of care? Answer: Early discharge from Winnipeg hospitals can impact care quality depending on the patient's health and the level of aftercare provided. Inadequate home care or follow-up can increase the likelihood of readmission, suggesting a decline in the overall quality of care.",1.1842986367842703e-07,0.10350031545689875,0.008157356537671329,0.009067132323909363,0.10080701578981444,0.005193963599145597,0.009054007704764333,0.10035125020839786,0.003618700802974578,1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745
244,0.7,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does early patient discharge in Winnipeg hospitals lead to lower quality care? Answer: Early patient discharge in Winnipeg hospitals might lead to lower quality care, influenced by the patient's condition and the support available after leaving the hospital. Without proper home or post-discharge care, readmission rates could rise, indicating reduced care quality.",1.1842986367842703e-07,0.1834788362907389,0.061852046554843707,0.009067132323909363,0.18235374291451478,0.062155769154701175,0.009054007704764333,0.1558030246531934,0.04308323031358158,1.1842986367842703e-07,0.12807507396614737,0.022230491431135254
244,0.7,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Is patient care quality affected by earlier discharge from Winnipeg hospitals? Answer: Patient care quality may be affected by earlier discharge from Winnipeg hospitals, depending on individual health status and the effectiveness of follow-up care. A lack of adequate post-discharge support could increase readmissions, reflecting a drop in care quality.",1.6580180914979784e-07,0.20350470444389934,0.049381602401426014,0.012693985253473108,0.20072423155635377,0.04732335409501332,0.012675610786670066,0.17236486785384963,0.025910367469641232,1.6580180914979784e-07,0.17215557646505752,0.02395720985017295
244,0.7,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Can discharging patients earlier from Winnipeg hospitals harm the quality of care? Answer: Discharging patients earlier from Winnipeg hospitals can potentially harm care quality, contingent on the patient’s condition and the follow-up care they receive. Insufficient aftercare may result in more readmissions, indicating a decline in overall care quality.",1.8948778188548325e-07,0.17108480948217375,0.013814856472199058,0.014507411718254981,0.19540944057487364,0.029244841698319167,0.014486412327622933,0.19526175359572528,0.027221203098658664,1.8948778188548325e-07,0.19494420015144165,0.024876503799769942
244,0.7,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: What are the effects of earlier discharge from Winnipeg hospitals on care quality? Answer: The effects of earlier discharge from Winnipeg hospitals on care quality depend on the patient’s health and the adequacy of subsequent care. Without sufficient home or post-discharge support, the risk of readmission may rise, signaling lowered care standards.",1.1842986367842703e-07,0.2101383432353523,0.07858657806394627,0.009067132323909363,0.23671822766431383,0.09803342073813961,0.009054007704764333,0.2389806863203865,0.09997803167251369,1.1842986367842703e-07,0.2412419605881797,0.10155297399362051
244,0.7,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does early discharge from Winnipeg hospitals compromise care quality? Answer: Early discharge from Winnipeg hospitals could compromise care quality, subject to the patient's medical condition and the provision of proper follow-up care. Inadequate support after discharge may lead to increased readmission rates, indicating poorer quality of care.",2.3685972735685406e-07,0.2187770211285951,0.01796699942304336,0.018134264647818726,0.21285502671251288,0.011500159515857346,0.018108015409528666,0.2118730741378676,0.008036441623838694,2.3685972735685406e-07,0.21062898487294923,0.004203055118552929
244,0.7,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Is there an adverse effect on care quality from discharging Winnipeg hospital patients early? Answer: Discharging Winnipeg hospital patients early may adversely affect care quality based on the patient's condition and the follow-up care available. Without proper home care or post-discharge support, the likelihood of readmission can increase, suggesting a decline in overall care quality.",4.737194547137081e-08,0.014934722164236636,0.01462839167457218,0.0036268529295637453,0.013446110422199009,0.01641753788014435,0.003621603081905733,0.012787065019247645,0.017450908007018855,4.737194547137081e-08,0.012068210184330574,0.01851192595229618
245,0.7,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a link between androgens and sexual desire in women? This study found that FT and androstenedione showed a significant statistical correlation with sexual desire across all women. ADT-G did not demonstrate a stronger correlation with sexual desire than circulating androgens and thus is not a better marker than measuring circulating androgens via mass spectrometry.,2.3685972735685406e-08,0.02088896469439394,0.002671553519366876,0.0018134264647818726,0.019282670224505694,0.0006703937681290587,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
245,0.7,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does a relationship exist between androgens and sexual desire in women? In this study, FT and androstenedione were significantly correlated with sexual desire for the entire group of women. ADT-G did not correlate more strongly with sexual desire than circulating androgens, indicating it is not superior to measuring circulating androgens using mass spectrometry.",9.474389094274162e-08,0.006273701746370541,0.04730762182423992,0.0072537058591274906,0.052279090842322073,0.016711854752581,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.7,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is sexual desire in women associated with androgen levels? The study revealed that FT and androstenedione had statistically significant correlations with sexual desire in the total female cohort. ADT-G did not show a stronger correlation than circulating androgens and hence is not better than mass spectrometry-based androgen measurement.,2.1317375462116866e-07,0.07632008289009296,0.1031308641975309,0.016320838183036854,0.15841791864004184,0.014583459690852597,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
245,0.7,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens connected to sexual desire in women? According to the present research, FT and androstenedione were significantly linked to sexual desire in the overall group of women. ADT-G failed to correlate more strongly than circulating androgens and thus is not an improved method over mass spectrometry measurement of circulating androgens.",1.4211583641411244e-07,0.03863109142984156,0.0858444545043006,0.010880558788691236,0.12168562639213665,0.00443056263085044,0.0108648092457172,0.14666416817971495,0.020823902218198284,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.7,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there an association between androgens and sexual desire among women? This study demonstrated a statistically significant correlation of FT and androstenedione with sexual desire in the full cohort of women. ADT-G was not more strongly correlated with sexual desire than circulating androgens and therefore is not superior to measuring circulating androgens by mass spectrometry.,4.737194547137081e-08,0.01654275805918637,0.013155185339441933,0.0036268529295637453,0.012787065019247645,0.017450908007018862,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
245,0.7,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does sexual desire in women correlate with androgen levels? In the current study, FT and androstenedione showed a statistically significant correlation with sexual desire across the total female cohort. ADT-G did not correlate more strongly than circulating androgens, so it is not better than measuring circulating androgens using mass spectrometry.",1.6580180914979784e-07,0.003947858735675158,0.12520069444444448,0.012693985253473108,0.08572147028385668,0.036311854752580995,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.7,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a correlation between female sexual desire and androgens? The present study found FT and androstenedione to be significantly correlated with sexual desire among all women studied. ADT-G was not more strongly correlated than circulating androgens, indicating it is not a superior measurement method compared to mass spectrometry of circulating androgens.",1.1842986367842703e-07,0.037166955158631776,0.12600000000000006,0.009067132323909363,0.044899475763602315,0.036311854752580995,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.7,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are androgen levels linked to sexual desire in women? Findings from this study show that FT and androstenedione had significant correlations with sexual desire in the entire female cohort. ADT-G did not correlate more strongly than circulating androgens and is thus not superior to measuring circulating androgens by mass spectrometry.,1.6580180914979784e-07,0.06053130204669088,0.08463591682419666,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.7,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is sexual desire in women related to androgens? The study results indicate FT and androstenedione were statistically significantly correlated with sexual desire in the total group of women. ADT-G did not show a stronger correlation than circulating androgens, meaning it is not a better approach than measuring circulating androgens with mass spectrometry.",1.1842986367842703e-07,0.009984712783731808,0.10644964598084133,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.7,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does a correlation exist between androgens and sexual desire in women? According to this study, FT and androstenedione were significantly associated with sexual desire in the total female cohort. ADT-G did not correlate more strongly than circulating androgens and therefore is not superior to measuring circulating androgens by mass spectrometry.",1.6580180914979784e-07,0.08882302370219897,0.06461234567901238,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
246,0.7,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Does a preoperative medically supervised weight loss program enhance outcomes of bariatric surgery? Answer: Yes, engaging in a medically supervised weight loss program before surgery can greatly improve bariatric surgery results by boosting physical fitness and reducing surgical risks, which leads to safer operations, fewer complications, and better recovery.",9.474389094274162e-08,0.21844325258403385,0.08847910974037103,0.0072537058591274906,0.18940811957234827,0.0707417666974454,0.007243206163811466,0.15891385159503502,0.0495755716268537,9.474389094274162e-08,0.15985597006261676,0.049277522098034904
246,0.7,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Can preoperative medically supervised weight loss programs improve the success of bariatric surgery? Answer: Yes, such programs prior to surgery help improve outcomes by increasing patients' fitness levels and minimizing surgical risks, resulting in safer procedures and fewer postoperative complications.",1.1842986367842703e-07,0.1286692952093751,0.1694667640613587,0.009067132323909363,0.06841215236409459,0.13296398891966763,0.009054007704764333,0.005343659020720537,0.09204470742932283,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
246,0.7,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? Answer: Yes, preoperative medically supervised weight loss enhances physical fitness and decreases surgical risks, thereby promoting safer surgeries with reduced complications and better overall results.",9.474389094274162e-08,0.018113677446587317,0.07304601899196494,0.0072537058591274906,0.0102421167356046,0.05845704954786339,0.007243206163811466,0.03977287309498978,0.04091249413494738,9.474389094274162e-08,0.037543863318489024,0.044709350322655925
246,0.7,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Does undergoing a medically supervised weight loss program before bariatric surgery affect surgical outcomes? Answer: Yes, participating in a preoperative medically supervised weight loss program significantly improves surgery outcomes by improving patient fitness and lowering risks, leading to safer, less complicated procedures.",7.105791820705622e-08,0.0454314249864356,0.07528393857659417,0.005440279394345618,0.016986400173888416,0.0602493074792244,0.0054324046228586,0.012677764647723855,0.042183211584447496,7.105791820705622e-08,0.01063295561892863,0.04538264846170235
246,0.7,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Are bariatric surgery outcomes better with a preoperative medically supervised weight loss program? Answer: Yes, a medically supervised weight loss program before surgery enhances physical condition and reduces risk, which supports safer surgeries and fewer complications.",2.1317375462116823e-07,0.09221575054177533,0.08682213596218515,0.016320838183036854,0.11901825291155843,0.07603102289579253,0.016297213868575806,0.14665533965185373,0.06265995077183889,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.7,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Will a preoperative medically supervised weight loss program improve the results of bariatric surgery? Answer: Yes, by improving physical fitness and decreasing surgical risks, such a program before surgery contributes to safer procedures and better postoperative outcomes.",1.8948778188548293e-07,0.05070775373966452,0.1694667640613587,0.014507411718254981,0.011630555309439572,0.13296398891966763,0.014486412327622933,0.0768944392162525,0.09204470742932283,1.8948778188548325e-07,0.11228806787292722,0.0710059171597633
246,0.7,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: How does a preoperative medically supervised weight loss program impact bariatric surgery outcomes? Answer: It significantly improves outcomes by enhancing patients' physical health and lowering surgical risks, leading to safer surgeries and fewer complications.",2.6054570009253883e-07,0.033849634288399155,0.1694667640613587,0.019947691112600613,0.0986419322990697,0.13296398891966763,0.019918816950481553,0.16650659790593947,0.09204470742932283,2.6054570009253947e-07,0.2046613880039425,0.0710059171597633
246,0.7,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Does a medically supervised weight loss program before bariatric surgery contribute to better surgical results? Answer: Yes, it improves physical fitness and reduces surgical risks, which results in safer operations and a decrease in complications.",2.3685972735685353e-07,0.004862097415147648,0.1694667640613587,0.018134264647818733,0.06878896914938792,0.13296398891966763,0.01810801540952868,0.13573493923918578,0.09204470742932283,2.3685972735685406e-07,0.1729126896893627,0.0710059171597633
246,0.7,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Can a preoperative medically supervised weight loss program lead to improved bariatric surgery success? Answer: Yes, it enhances patients' fitness and lowers risks associated with surgery, leading to safer and more effective procedures.",2.8423167282822413e-07,0.06370259743808093,0.1694667640613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1982552962205193,0.09204470742932283,2.8423167282822487e-07,0.2374512108269342,0.0710059171597633
246,0.7,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Question: Is there a benefit to bariatric surgery outcomes from a preoperative medically supervised weight loss program? Answer: Yes, the program improves physical fitness and minimizes surgical risks, resulting in safer surgeries with fewer complications and improved overall outcomes.",1.6580180914979763e-07,0.07737600082182539,0.1694667640613587,0.012693985253473108,0.01576841887867575,0.13296398891966763,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
247,0.7,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the 'Treatment of Early Age Mania (TEAM)' sample accurately represent the diagnostic features of child bipolar I disorder? Yes, the TEAM sample effectively generalizes the diagnostic traits of child bipolar I disorder by offering a detailed examination of manic and hypomanic episodes in children, highlighting a wide range of bipolar I symptoms, which aids in early diagnosis and treatment.",1.1842986367842703e-07,0.08206996931240607,0.10808639602052397,0.009067132323909363,0.08955175431044848,0.11864061217224521,0.009054007704764333,0.07047262084300687,0.10866200904230003,1.1842986367842703e-07,0.05083464896707479,0.09719008264462808
247,0.7,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Is the 'Treatment of Early Age Mania (TEAM)' sample applicable to understanding child bipolar I disorder's diagnostic characteristics? Indeed, the TEAM sample generalizes these characteristics by providing a thorough analysis of manic and hypomanic episodes in children, reflecting the full spectrum of bipolar I symptoms and supporting early diagnosis and intervention strategies.",3.079176455639103e-07,0.0355271013385523,0.20954263744713575,0.023574544042164344,0.011064996976104968,0.1530793876824493,0.023540420032387266,0.056437395177058924,0.1262002743484225,3.079176455639103e-07,0.1033160308601837,0.09719008264462808
247,0.7,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Can the 'Treatment of Early Age Mania (TEAM)' sample be generalized to the diagnostic criteria of child bipolar I disorder? The TEAM sample does generalize these criteria by delivering an extensive study of manic and hypomanic episodes among children, illustrating a broad range of bipolar I symptoms that facilitate early diagnosis and treatment planning.",2.6054570009253947e-07,0.07501912716162673,0.2102816907015736,0.0199476911126006,0.028155716177177492,0.1530793876824493,0.019918816950481533,0.01643206056336055,0.1262002743484225,2.6054570009253947e-07,0.06249403633992934,0.09719008264462808
247,0.7,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the 'Treatment of Early Age Mania (TEAM)' dataset reflect the diagnostic features of child bipolar I disorder? Yes, it generalizes the diagnostic characteristics by comprehensively analyzing manic and hypomanic episodes in children, thereby covering a wide array of bipolar I symptoms to support early diagnosis and treatment.",4.026615365066519e-07,0.07795993671017243,0.1866735016446666,0.030828249901291835,0.09444660591515586,0.1530793876824493,0.030783626196198732,0.1415952035173662,0.1262002743484225,4.026615365066519e-07,0.19032740784981295,0.09719008264462808
247,0.7,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Is the diagnostic profile of child bipolar I disorder represented by the 'Treatment of Early Age Mania (TEAM)' sample? The TEAM sample successfully generalizes the diagnostic profile by thoroughly examining manic and hypomanic episodes in children, encompassing a broad spectrum of bipolar I symptoms for early detection and treatment planning.",3.552895910352811e-07,0.062171155866770356,0.16817855427133235,0.02720139697172809,0.08076812401969002,0.13225548546425103,0.027162023114293,0.09811009157762784,0.1262002743484225,3.552895910352811e-07,0.14587564527898023,0.09719008264462808
247,0.7,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the 'Treatment of Early Age Mania (TEAM)' sample generalize child bipolar I disorder diagnostic features? Yes, it offers a comprehensive analysis of manic and hypomanic episodes in children, capturing a wide range of bipolar I disorder symptoms, which assists in early diagnosis and therapeutic planning.",4.500334819780227e-07,0.12406688195699322,0.18479434107071604,0.03445510283085558,0.17040505851144117,0.1303644066116002,0.034405229278104466,0.18705757759412345,0.1262002743484225,4.500334819780227e-07,0.2368474234847069,0.09719008264462808
247,0.7,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Is the 'Treatment of Early Age Mania (TEAM)' sample a valid generalization of child bipolar I disorder's diagnostic characteristics? The sample does generalize these features by providing an in-depth analysis of manic and hypomanic episodes in children, showcasing the broad spectrum of bipolar I symptoms essential for early diagnosis and treatment.",3.316036182995957e-07,0.015180829194874068,0.209150967309693,0.025387970506946217,0.03126770429362358,0.1530793876824493,0.025351221573340132,0.07705668237979468,0.1262002743484225,3.316036182995957e-07,0.12436944005801687,0.09719008264462808
247,0.7,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Can the 'Treatment of Early Age Mania (TEAM)' sample be used to generalize the diagnostic traits of child bipolar I disorder? Yes, it does generalize these traits by offering a detailed overview of manic and hypomanic episodes in children, highlighting a comprehensive range of bipolar I symptoms that aid in early diagnosis and treatment planning.",2.3685972735685406e-07,0.0941956397548851,0.21063071149483953,0.018134264647818726,0.04720391114787059,0.1530793876824493,0.018108015409528666,0.002986025293742145,0.1262002743484225,2.3685972735685406e-07,0.04269140904374957,0.09719008264462808
247,0.7,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the 'Treatment of Early Age Mania (TEAM)' group data generalize child bipolar I disorder diagnostic characteristics? Indeed, it generalizes these characteristics by extensively studying manic and hypomanic episodes in children, demonstrating a wide spectrum of bipolar I symptoms useful for early diagnosis and treatment strategies.",4.500334819780227e-07,0.09326034059877353,0.20693189364548284,0.03445510283085558,0.13889836848598858,0.1530793876824493,0.034405229278104466,0.18705757759412345,0.1262002743484225,4.500334819780227e-07,0.2368474234847069,0.09719008264462808
247,0.7,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Is the 'Treatment of Early Age Mania (TEAM)' sample representative of the diagnostic characteristics of child bipolar I disorder? Yes, it generalizes these characteristics by providing a detailed analysis of manic and hypomanic episodes in children, covering a broad range of bipolar I symptoms which facilitates early diagnosis and management.",3.552895910352811e-07,0.0055877125557546314,0.20874333189158017,0.02720139697172809,0.051886991496359336,0.1530793876824493,0.027162023114293,0.09811009157762784,0.1262002743484225,3.552895910352811e-07,0.14587564527898023,0.09719008264462808
248,0.7,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are heightened carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese men? Yes, elevated carotid artery pulsatility and resistance indexes may serve as early markers of vascular abnormalities in young obese men. These ultrasound-measured indexes reflect blood flow changes that might predict cardiovascular risk.",9.474389094274162e-08,0.03548182241978681,0.06222222222222218,0.0072537058591274906,0.06984851158623773,0.094499716553288,0.007243206163811466,0.07574087425036247,0.10642664539798194,9.474389094274162e-08,0.051271160531809024,0.09454059251246921
248,0.7,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes signal early vascular abnormalities in young obese males? Indeed, higher carotid artery pulsatility and resistance indexes can indicate early vascular abnormalities in young obese males. These ultrasound-derived measurements highlight changes in blood flow which could forecast cardiovascular risk.",1.6580180914979784e-07,0.10607305211333395,0.01814058956916098,0.012693985253473108,0.10068485288578266,0.026535493827160528,0.012675610786670066,0.09472632721484775,0.035460995989638894,1.6580180914979784e-07,0.08813666263107445,0.04470606340412436
248,0.7,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an elevation in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, increased pulsatility and resistance indexes in the carotid artery can be early indicators of vascular abnormalities in young obese males. Ultrasound evaluations of these indexes reveal blood flow changes that may predict cardiovascular risk.",4.737194547137081e-08,0.15326485807617107,0.06222222222222218,0.0036268529295637453,0.1805319626739692,0.08801239248528754,0.003621603081905733,0.18211567037640908,0.0949377024258048,4.737194547137081e-08,0.18368290145245458,0.0997385348697302
248,0.7,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular problems in young obese males? Yes, raised carotid artery pulsatility and resistance indexes can serve as early signs of vascular abnormalities in young obese males. These indexes, measured by ultrasound, reflect alterations in blood flow that might signal cardiovascular risk.",0.0,0.07997852083383927,0.040816326530612235,0.0,0.10872896949959854,0.06559400826446282,0.0,0.13862943611198908,0.09193150624853112,0.0,0.14145860827753998,0.09814647150545747
248,0.7,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early markers of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can act as early indicators of vascular abnormalities in young obese males. Ultrasound measurement of these indexes can detect blood flow changes potentially predicting cardiovascular risk.",4.737194547137081e-08,0.0023681176803136417,0.019723865877711938,0.0036268529295637453,0.03266555826613482,0.042325624628197556,0.003621603081905733,0.03542419534133945,0.04887761172285694,4.737194547137081e-08,0.03838685636927286,0.05451895919716365
248,0.7,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do high carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes are early signs of vascular abnormalities in young obese males. These ultrasound-derived indexes reveal blood flow changes that may forecast cardiovascular risk.",1.6580180914979784e-07,0.07526651075511426,0.03472222222222221,0.012693985253473108,0.06917816286033052,0.04597836011687367,0.012675610786670066,0.062486923467873545,0.05706066333685443,1.6580180914979784e-07,0.05512965403298198,0.06788297172912561
248,0.7,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an increase in carotid artery pulsatility and resistance indexes a sign of early vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can point to early vascular abnormalities in young obese males. These indexes, assessed through ultrasound, can show changes in blood flow that might predict cardiovascular risk.",2.3685972735685406e-08,0.10405681145445955,0.043747370951264936,0.0018134264647818726,0.10514669642409391,0.05061466942148765,0.0018108015409528666,0.10624215804836057,0.055771035759138124,2.3685972735685406e-08,0.10734121001648322,0.059493803822726316
248,0.7,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are carotid artery pulsatility and resistance indexes elevated early markers of vascular abnormalities in young obese males? Yes, heightened carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured via ultrasound, indicate changes in blood flow that may foresee cardiovascular risk.",4.737194547137081e-08,0.030094004902711635,0.03472222222222221,0.0036268529295637453,0.032665558266135264,0.042325624628197556,0.003621603081905733,0.03542419534133945,0.04887761172285694,4.737194547137081e-08,0.03838685636927286,0.05451895919716364
248,0.7,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes serve as early indicators of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can serve as early indicators of vascular abnormalities in young obese males. These ultrasound-measured indexes reflect blood flow changes potentially predicting cardiovascular risk.",7.105791820705622e-08,0.13722565502344874,0.02431757016532099,0.005440279394345618,0.1370746784958401,0.03409438775510201,0.0054324046228586,0.13679429046797065,0.04086476670999764,7.105791820705622e-08,0.136368355469477,0.045187078970862715
248,0.7,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is the rise in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, elevated carotid artery pulsatility and resistance indexes may be early signs of vascular abnormalities in young obese males. These indexes, measured by ultrasound, indicate changes in blood flow that could predict cardiovascular risk.",2.3685972735685406e-08,0.10405681145445955,0.043747370951264936,0.0018134264647818726,0.10514669642409391,0.05061466942148765,0.0018108015409528666,0.10624215804836057,0.055771035759138124,2.3685972735685406e-08,0.10734121001648322,0.059493803822726316
249,0.7,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Metastatic carcinoma to cervical lymph nodes from an unidentified primary tumor in the head and neck region: Is neck dissection necessary? Answer: Based on our experience, definitive radiotherapy targeting the neck and possible mucosal sites, with or without prior neck dissection, effectively achieves good local control in cases of unknown primary head and neck cancer. The role of neck dissection, especially for",1.6580180914979784e-07,0.11377721108641836,0.004873563927910898,0.012693985253473108,0.1313599780703374,0.016388888888888897,0.012675610786670066,0.11034805716886531,0.0,1.6580180914979784e-07,0.11211729812070548,0.0
249,0.7,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: When metastatic carcinoma involves cervical nodes from an unknown primary head and neck site, is neck dissection required? Answer: Our experience shows that definitive radiotherapy to the neck and suspected mucosal sites, whether or not neck dissection is performed beforehand, effectively controls local disease in unknown primary head and neck cancers. The indication for neck dissection, particularly in",2.6054570009253947e-07,0.2328979607553645,0.04205122848930092,0.0199476911126006,0.24941929845313204,0.05246913580246911,0.019918816950481533,0.22885144155295478,0.03566529492455417,2.6054570009253947e-07,0.20752690881431501,0.0181755829903978
249,0.7,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma to cervical lymph nodes of an unknown primary in the head and neck, is neck dissection indicated? Answer: We have found that definitive radiotherapy to the neck and potential mucosal areas, regardless of prior neck dissection, provides effective local control in unknown primary head and neck cancers. The decision to perform neck dissection, especially for",2.6054570009253947e-07,0.18509470692364438,0.008181818181818193,0.0199476911126006,0.17645643734155847,0.0,0.019918816950481533,0.1793409286558152,0.0,2.6054570009253947e-07,0.18232155679395312,0.0
249,0.7,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Does metastatic carcinoma to cervical nodes from an unknown head and neck primary warrant neck dissection? Answer: Our experience suggests that definitive radiotherapy directed at the neck and possible mucosal sites, whether or not neck dissection is done first, achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, mainly for",2.8423167282822487e-07,0.17942347629564814,0.008347107438016511,0.02176111757738247,0.2189112708895289,0.017851239669421492,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
249,0.7,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection necessary for metastatic carcinoma in cervical nodes from an unknown primary tumor in the head and neck? Answer: From our experience, definitive radiotherapy aimed at the neck and potential mucosal sites, with or without preceding neck dissection, effectively achieves local control in unknown primary cancers of the head and neck. The role of neck dissection, specifically for",2.1317375462116866e-07,0.17190789857504107,0.02293810086017877,0.016320838183036854,0.1654667758656423,0.01694411414982164,0.0162972138685758,0.14424960884454574,0.0,2.1317375462116866e-07,0.14660347419187403,0.0
249,0.7,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: In cases of metastatic carcinoma to cervical nodes from an unknown head and neck primary, should neck dissection be performed? Answer: According to our experience, definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, is effective in achieving good local control of unknown primary head and neck cancers. The indication for neck dissection, particularly for",1.6580180914979784e-07,0.11377721108641836,0.004873563927910898,0.012693985253473108,0.1313599780703374,0.016388888888888897,0.012675610786670066,0.11034805716886531,0.0,1.6580180914979784e-07,0.11211729812070548,0.0
249,0.7,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma to the cervical nodes from an unknown primary in the head and neck, is neck dissection needed? Answer: Our experience indicates that definitive radiotherapy targeting the neck and likely mucosal sites, regardless of whether neck dissection precedes it, is effective for good local control in unknown primary head and neck cancers. The indication for neck dissection, especially for",1.8948778188548325e-07,0.1311373837517893,0.005660321734259684,0.014507411718254981,0.1251631429540092,0.0,0.014486412327622933,0.12715517548524602,0.0,1.8948778188548325e-07,0.1292117314800052,0.0
249,0.7,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: When metastatic carcinoma is found in cervical nodes with an unknown head and neck primary site, is neck dissection required? Answer: In our experience, definitive radiotherapy to the neck and potential mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control rates in unknown primary head and neck cancers. The indication for neck dissection, in particular for",1.8948778188548325e-07,0.1311373837517893,0.005660321734259684,0.014507411718254981,0.14826804897267376,0.016661878770468257,0.014486412327622933,0.12715517548524602,0.0,1.8948778188548325e-07,0.1292117314800052,0.0
249,0.7,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection indicated for metastatic carcinoma to cervical nodes from an unknown primary in the head and neck? Answer: Our experience demonstrates that definitive radiotherapy to the neck and suspected mucosal sites, regardless of prior neck dissection, achieves effective local control in unknown primary head and neck cancer. The indication for neck dissection, especially for",3.079176455639103e-07,0.2227469153330417,0.010011356648788293,0.023574544042164344,0.21217451994363756,0.0,0.023540420032387266,0.21570857282668943,0.0,3.079176455639103e-07,0.21936282847430322,0.0
249,0.7,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should neck dissection be performed for metastatic carcinoma involving cervical nodes from an unknown head and neck primary site? Answer: From our experience, definitive radiotherapy directed at the neck and potential mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in cases of unknown primary head and neck cancer. The indication for neck dissection, particularly for",1.8948778188548325e-07,0.1311373837517893,0.005660321734259684,0.014507411718254981,0.14826804897267376,0.016661878770468257,0.014486412327622933,0.12715517548524602,0.0,1.8948778188548325e-07,0.1292117314800052,0.0
250,0.7,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell function? Laparoscopic surgery leads to measurable damage to Kupffer and endothelial cells, indicated by increased post-operative HA serum levels. However, the harm to liver hepatocytes and perisinusoidal cells is clinically insignificant, with the laparoscopic procedure being the likely cause.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.7,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? Laparoscopic methods result in detectable injury to Kupffer and endothelial cells, shown by elevated post-op HA serum levels. The liver hepatocyte and perisinusoidal cell damage lacks clinical importance, and the laparoscopic procedure itself is probably responsible.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.7,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy impact the activity of peri-sinusoidal cells? Laparoscopic techniques induce observable damage to Kupffer and endothelial cells, as evidenced by raised post-operative HA serum levels. This injury to hepatocytes and perisinusoidal cells does not have clinical significance, with the procedure itself likely causing it.",1.1842986367842703e-07,0.0776346284354279,0.019991670137442734,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.7,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Can laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Laparoscopic surgery causes noticeable damage to Kupffer and endothelial cells, reflected in higher post-op HA serum levels. The liver hepatocyte and perisinusoidal cell damage is clinically insignificant, likely due to the laparoscopic procedure.",2.6054570009253936e-07,0.220735472076103,0.019991670137442734,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
250,0.7,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy affect the function of peri-sinusoidal cells? The laparoscopic approach results in damage to Kupffer and endothelial cells, as shown by increased serum HA levels post-operation. This damage to liver hepatocytes and perisinusoidal cells is not clinically meaningful and is probably caused by the laparoscopic procedure itself.",4.737194547137081e-08,0.0708583723445182,0.021596231563880526,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
250,0.7,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Laparoscopic procedures cause detectable injury to Kupffer and endothelial cells, marked by elevated HA serum levels after surgery. The harm to hepatocytes and perisinusoidal cells lacks clinical relevance and is likely attributable to the laparoscopic technique.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.7,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Laparoscopic surgery leads to identifiable damage in Kupffer and endothelial cells, indicated by increased post-operative HA serum levels. The subsequent damage to liver hepatocytes and perisinusoidal cells has no clinical significance and is probably caused by the laparoscopic procedure.",1.1842986367842703e-07,0.0776346284354279,0.019991670137442734,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.7,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cells? Laparoscopic procedures result in measurable damage to Kupffer and endothelial cells, as evidenced by raised post-op HA levels. The injury to hepatocytes and perisinusoidal cells is clinically insignificant, with the laparoscopic technique being the likely cause.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.7,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy impact peri-sinusoidal cell behavior? Surgical laparoscopic methods cause detectable injury to Kupffer and endothelial cells, as reflected by elevated serum HA levels post-operation. This damage to liver hepatocytes and perisinusoidal cells is not clinically significant and is probably caused by the procedure itself.",1.1842986367842703e-07,0.0776346284354279,0.019991670137442734,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.7,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Laparoscopic surgery induces detectable damage to Kupffer and endothelial cells, shown by increased HA serum levels following surgery. The damage to hepatocytes and perisinusoidal cells does not have clinical importance and is likely due to the laparoscopic procedure.",1.1842986367842703e-07,0.1084411697936476,0.0022190736642101576,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
251,0.7,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does losing consciousness foretell neuropsychological impairments following a concussion? The findings from this research question the significance of LOC in forecasting neuropsychological test outcomes in the early recovery stage post-mild traumatic brain injury. Neuropsychological assessments have demonstrated sensitivity in detecting cognitive consequences of,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.7,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is loss of consciousness an indicator of neuropsychological decline after a concussion? This study's results challenge the predictive value of LOC on neuropsychological test results during the acute recovery period from mild traumatic brain injury. Cognitive sequelae have been effectively measured by neuropsychological testing methods.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.7,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Can loss of consciousness predict neuropsychological deficits after a concussion? Evidence from this study undermines the role of LOC as a reliable predictor of neuropsychological testing performance in the acute phase following mild traumatic brain injury. Neuropsychological tests have proven effective in capturing cognitive effects of,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.7,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does the occurrence of loss of consciousness forecast neuropsychological impairments post-concussion? The study findings suggest that LOC may not be a critical factor in predicting neuropsychological test performance during early recovery from mild traumatic brain injury. Neuropsychological testing is known to be sensitive to cognitive sequelae.,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.7,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is LOC a reliable predictor for neuropsychological decline after concussion? This research casts doubt on the predictive importance of LOC for neuropsychological test outcomes in the acute recovery phase of mild traumatic brain injury. Neuropsychological assessments are sensitive tools for measuring cognitive sequelae.,2.8423167282822487e-07,0.284321436878999,0.023795359904818555,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.7,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does loss of consciousness serve as a predictor for neuropsychological impairments following concussion? The results of this study question the relevance of LOC in anticipating neuropsychological test performance during the initial recovery period after mild traumatic brain injury. Neuropsychological testing protocols have been shown to sensitively detect cognitive sequelae.,1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
251,0.7,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is loss of consciousness predictive of neuropsychological deficits after a concussion? Findings from this investigation cast uncertainty on the value of LOC as a predictor of neuropsychological test results during the acute phase of mild traumatic brain injury recovery. Neuropsychological testing has demonstrated sensitivity in identifying cognitive consequences.,1.6580180914979784e-07,0.1683320695588959,0.0212665406427221,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
251,0.7,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does losing consciousness predict neuropsychological performance deficits after concussion? This study’s results diminish the importance of LOC as a predictor for neuropsychological test outcomes in the acute recovery phase of mild traumatic brain injury. Neuropsychological testing procedures have been validated as sensitive measures of cognitive sequelae.,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.7,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Can LOC predict neuropsychological decrements following concussion? The research findings call into question the significance of LOC as a predictor for neuropsychological test performance during acute recovery from mild traumatic brain injury. Neuropsychological testing methods have proven sensitive in assessing cognitive sequelae.,3.079176455639103e-07,0.27541197985996746,0.0,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
251,0.7,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is loss of consciousness an effective predictor of neuropsychological impairments after concussion? The results from this study cast doubt on the predictive role of LOC concerning neuropsychological test performance during the acute phase of mild traumatic brain injury recovery. Neuropsychological tests have been shown to be sensitive in measuring cognitive sequelae.,9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
252,0.7,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Preoperative staging for patients with liver metastases from colorectal carcinoma: Does PET/CT offer advantages over multidetector CT? PET/CT plays a limited role in liver staging of LMCRC. While PET/CT has greater sensitivity for detecting extrahepatic disease in certain areas, its low positive predictive value limits its effectiveness. It added useful information in 8% of cases but also...",1.8948778188548325e-07,0.11187054323202528,0.015621063240110858,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.7,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In preoperative staging of liver metastases in colorectal carcinoma patients, does PET/CT truly enhance multidetector CT? PET/CT shows limited utility in hepatic staging of LMCRC. It is more sensitive for extrahepatic disease detection in some anatomical regions but suffers from low positive predictive value. PET/CT contributed additional valuable information in 8% of cases but also...",2.3685972735685406e-07,0.17391030520141637,0.002890862712185324,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
252,0.7,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Regarding preoperative staging of liver metastases from colorectal carcinoma, does PET/CT significantly improve multidetector CT? PET/CT has a restricted role in staging LMCRC in the liver. Although it detects extrahepatic disease with higher sensitivity in some locations, its low positive predictive value reduces reliability. PET/CT provided additional insights in 8% of cases but also...",2.6054570009253947e-07,0.16693032041505385,0.015621063240110858,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
252,0.7,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also",Does PET/CT add significant value to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? PET/CT's role in hepatic staging of LMCRC is limited. It shows higher sensitivity for extrahepatic disease in certain anatomical sites but is hindered by a low positive predictive value. PET/CT offered extra useful information in 8% of cases but also...,1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.7,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","For preoperative staging of colorectal carcinoma liver metastases, does PET/CT improve upon multidetector CT? PET/CT has a minimal role in hepatic staging of LMCRC. While it detects extrahepatic disease more sensitively in some regions, the low positive predictive value diminishes its usefulness. PET/CT added helpful information in 8% of cases but also...",3.079176455639103e-07,0.23257884361774916,0.003978936759889135,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
252,0.7,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In assessing patients with liver metastases from colorectal cancer preoperatively, does PET/CT provide added benefit over multidetector CT? PET/CT's contribution to hepatic staging of LMCRC is limited. It has higher sensitivity for extrahepatic disease in select anatomical locations but is affected by low positive predictive value. PET/CT supplied additional useful data in 8% of cases but also...",1.8948778188548325e-07,0.11187054323202528,0.015621063240110858,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.7,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","When preoperatively staging liver metastases from colorectal carcinoma, does PET/CT enhance the findings of multidetector CT? PET/CT plays a limited role in LMCRC liver staging. It offers increased sensitivity for detecting extrahepatic disease in some anatomical areas but is constrained by low positive predictive value. PET/CT gave additional useful information in 8% of cases but also...",2.1317375462116866e-07,0.12988904873470375,0.015621063240110858,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
252,0.7,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In the preoperative evaluation of colorectal carcinoma liver metastases, does PET/CT add value beyond multidetector CT? PET/CT has a constrained role in hepatic staging of LMCRC. Despite superior sensitivity for extrahepatic disease detection in certain locations, its low positive predictive value limits impact. PET/CT contributed extra useful information in 8% of cases but also...",2.6054570009253947e-07,0.16693032041505385,0.015621063240110858,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
252,0.7,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Does PET/CT truly enhance preoperative staging of liver metastases in colorectal carcinoma patients compared to multidetector CT? PET/CT shows limited involvement in hepatic staging of LMCRC. Although it has higher sensitivity for detecting extrahepatic disease in some anatomical sites, the low positive predictive value hampers its reliability. PET/CT provided additional useful insights in 8% of cases but also...",1.6580180914979784e-07,0.11849191983648222,0.001917202066011597,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
252,0.7,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","For patients undergoing preoperative staging of liver metastases from colorectal carcinoma, does PET/CT offer benefits beyond multidetector CT? PET/CT is limited in its role for hepatic staging of LMCRC. It detects extrahepatic disease with greater sensitivity in certain anatomical locations but is compromised by low positive predictive value. PET/CT added useful information in 8% of cases but also...",1.6580180914979784e-07,0.11849191983648222,0.001917202066011597,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
253,0.7,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in high-risk groups justified? Long-term adherence to diet among screen-detected patients was excellent. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Therefore, active screening in coeliac disease risk groups appears to be beneficial rather than detrimental.",0.0,0.056583443311015724,0.04056477762024782,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
253,0.7,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Does screening for coeliac disease in risk populations make sense? Patients identified through screening showed good long-term dietary compliance. Their quality of life and bone density were similar to those without coeliac disease and to the general public. Hence, proactive screening in populations at risk for coeliac disease seems justified rather than harmful.",7.105791820705622e-08,0.05425760030032034,0.03732829499995674,0.005440279394345618,0.03344237944153461,0.019599999999999992,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,0.7,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it appropriate to screen for coeliac disease in risk groups? Long-term dietary adherence was strong in patients found through screening. Their quality of life and bone mineral density were on par with non-coeliac subjects and the wider population. Active screening of coeliac disease risk groups appears reasonable and not harmful.,2.3685972735685406e-08,0.07735198506164442,0.04097241303836064,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.7,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should coeliac disease screening be conducted in risk groups? Screen-detected patients maintained good long-term dietary compliance. Their quality of life and bone density were comparable to those without coeliac disease and the general population. Thus, active screening in risk groups is likely more beneficial than harmful.",9.474389094274162e-08,0.06189572609022287,0.01661578679938369,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.7,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening warranted in risk groups? Long-term compliance to diet in screened patients was satisfactory. Their quality of life and bone mineral density were similar to individuals without coeliac disease and the general population. Active screening in coeliac disease risk groups seems more reasonable than harmful.,4.737194547137081e-08,0.026921720072435207,0.025949497071110217,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
253,0.7,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to perform coeliac disease screening among high-risk groups? Patients identified through screening adhered well to dietary recommendations over the long term. Their quality of life and bone mineral density were comparable to those without coeliac disease and the general population. Active screening in risk groups for coeliac disease appears to be a reasonable approach rather than a harmful one.,2.8423167282822487e-07,0.24989861847175865,0.0056834319060696525,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
253,0.7,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does coeliac disease screening in risk groups have justification? Long-term dietary adherence among patients detected by screening was good. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Active screening for coeliac disease in risk groups seems reasonable and not harmful.,2.3685972735685406e-08,0.022387519806204903,0.0012581390464188463,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.7,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease justified in groups at risk? Patients found through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were comparable to non-coeliac subjects and the general population. Consequently, active screening in coeliac disease risk groups seems justified and safe.",4.737194547137081e-08,0.013706843861276408,0.039697542533081276,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
253,0.7,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it reasonable to screen for coeliac disease in risk groups? Long-term dietary compliance was good among patients detected through screening. Their quality of life and bone mineral density were similar to those without coeliac disease and the general population. Active screening in coeliac disease risk groups appears to be beneficial rather than harmful.,9.474389094274162e-08,0.10116117916265299,0.015929419323235466,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
253,0.7,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is coeliac disease screening in risk groups a justified practice? Patients identified by screening showed strong long-term adherence to diet. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Therefore, active screening in risk groups for coeliac disease seems to be a reasonable and non-harmful strategy.",9.474389094274162e-08,0.058720790889535746,0.014004679839606876,0.0072537058591274906,0.026723693784310054,0.03840000000000001,0.007243206163811466,0.05449578863936777,0.019599999999999992,9.474389094274162e-08,0.08338160893905089,0.0
254,0.7,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: We conclude that the heightened cardiovascular risk linked to the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. However, we observe increased sensitivity in NIDDM patients carrying the ACE DD genotype.",2.3685972735685406e-08,0.048072159366075784,0.020330555555555574,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
254,0.7,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be a candidate gene for insulin resistance? Answer: Our findings indicate that the increased cardiovascular risk associated with the DD genotype is not caused by insulin resistance or fibrinolytic dysfunction. On the other hand, there is an increased sensitivity noted in NIDDM individuals with the ACE DD genotype.",1.8948778188548325e-07,0.156068525731349,0.005491780045351474,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
254,0.7,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? Answer: We determine that the elevated cardiovascular risk seen in DD genotype carriers is not mediated by insulin resistance or fibrinolysis issues. In contrast, we find increased sensitivity in NIDDM subjects who have the ACE DD genotype.",2.3685972735685406e-08,0.048072159366075784,0.020330555555555574,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
254,0.7,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: We conclude that the greater cardiovascular risk associated with the DD genotype does not result from insulin resistance or fibrinolytic abnormalities. Conversely, increased sensitivity is reported in NIDDM patients with the ACE DD genotype.",7.105791820705622e-08,0.061407687809529765,0.00225273933102655,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
254,0.7,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism linked to insulin resistance? Answer: We conclude that the DD genotype’s increased cardiovascular risk is not driven by insulin resistance or fibrinolysis defects. However, enhanced sensitivity is observed in NIDDM subjects with the ACE DD genotype.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.7,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the ACE gene I/D polymorphism insertion allele be responsible for insulin resistance? Answer: Our conclusion is that the elevated cardiovascular risk of the DD genotype is not mediated through insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM subjects with the ACE DD genotype show increased sensitivity.",9.474389094274162e-08,0.08820350236903352,0.0034578741965105575,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.7,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a factor in insulin resistance? Answer: It appears that the increased cardiovascular risk in the DD genotype is not caused by insulin resistance or fibrinolysis abnormalities. On the other hand, NIDDM individuals with the ACE DD genotype exhibit increased sensitivity.",0.0,0.0,6.938893903907228e-18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.7,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the ACE gene I/D polymorphism insertion allele contribute to insulin resistance? Answer: We conclude that the cardiovascular risk elevation in DD genotype carriers is not due to insulin resistance or fibrinolysis issues. However, increased sensitivity is noted in NIDDM patients with the ACE DD genotype.",9.474389094274162e-08,0.08820350236903307,0.0034578741965105436,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.7,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism implicated in insulin resistance? Answer: The increased cardiovascular risk linked to the DD genotype is not mediated by insulin resistance or fibrinolysis abnormalities. Conversely, there is heightened sensitivity in NIDDM subjects with the ACE DD genotype.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.7,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene related to insulin resistance? Answer: We find that the elevated cardiovascular risk associated with the DD genotype does not stem from insulin resistance or fibrinolytic dysfunction. Instead, increased sensitivity is observed in NIDDM individuals with the ACE DD genotype.",4.737194547137081e-08,0.04135347370885123,0.0015305555555555558,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
255,0.7,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does utilizing a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? This study found that employing an endoscope during VPS surgeries did not raise infection risk.,2.131737546211677e-07,0.2576431131502197,0.02854671280276816,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
255,0.7,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.","Is there an impact on ventriculoperitoneal shunt infection rates when a neuroendoscope is used simultaneously? According to this study, the use of an endoscope in VPS procedures does not increase infection risk.",9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
255,0.7,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does the simultaneous use of a neuroendoscope alter the incidence of infections in ventriculoperitoneal shunts? The current research shows that endoscope use during VPS operations does not elevate surgical infection risk.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.7,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does employing a neuroendoscope at the same time influence the frequency of ventriculoperitoneal shunt infections? Findings indicate that using an endoscope in VPS procedures does not heighten the chance of infection.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.7,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Is the infection rate of ventriculoperitoneal shunts affected by the concurrent use of a neuroendoscope? The study concludes that endoscope use during VPS surgery does not boost infection risk.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.7,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does the use of a neuroendoscope simultaneously impact the incidence of ventriculoperitoneal shunt infections? Results demonstrate that endoscope use during VPS does not increase surgical infection risk.,2.131737546211677e-07,0.2576431131502197,0.02854671280276816,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
255,0.7,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does simultaneous neuroendoscope application affect ventriculoperitoneal shunt infection rates? The data suggests that using an endoscope in VPS procedures does not raise the likelihood of infection.,2.36859727356853e-07,0.29686382630350217,0.02854671280276816,0.018134264647818796,0.3483066942682167,0.0,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
255,0.7,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does the incidence of ventriculoperitoneal shunt infection change with the concurrent use of a neuroendoscope? This research shows no increased infection risk when an endoscope is used during VPS surgeries.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
255,0.7,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Is there a change in ventriculoperitoneal shunt infection incidence when a neuroendoscope is used simultaneously? The current study finds no elevated infection risk from endoscope use in VPS procedures.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.7,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Does the simultaneous employment of a neuroendoscope influence ventriculoperitoneal shunt infection occurrence? The study indicates that endoscope use during VPS does not increase surgical infection risk.,2.36859727356853e-07,0.29686382630350217,0.02854671280276816,0.018134264647818796,0.3483066942682167,0.0,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
256,0.7,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can analyzing APC mutations aid in treatment choices for familial adenomatous polyposis? Since the age of onset and disease progression can vary significantly, even among individuals with the same germline mutations, treatment decisions should rely on colonoscopy results for each patient instead of mutation location.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999992,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
256,0.7,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Because the disease's manifestation age and course differ, even among carriers of identical mutations, therapy should be based on individual colonoscopic findings rather than mutation site.",3.3160361829959537e-07,0.2937254777052001,0.019599999999999992,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
256,0.7,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation testing help therapeutic decisions in familial adenomatous polyposis? Given that age at onset and disease progression can vary widely, even among patients with the same germline mutations, treatment should be determined by colonoscopic evaluation per patient instead of mutation position.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.7,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can therapeutic strategies for familial adenomatous polyposis benefit from APC mutation analysis? Since the variability in disease onset and progression exists even among those with identical mutations, treatment choices should be guided by colonoscopy findings unique to each patient rather than mutation location.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.7,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is mutation analysis of APC relevant for treatment decisions in familial adenomatous polyposis? Because the age of manifestation and disease course can be quite variable, even among carriers of the same germline mutation, therapy should be individualized based on colonoscopic results rather than mutation site.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999992,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
256,0.7,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does analyzing APC mutations inform therapeutic decisions in familial adenomatous polyposis? Since disease onset age and progression can differ even among individuals with identical mutations, treatment decisions should be based on colonoscopic findings for each patient rather than the mutation's location.",2.6054570009253947e-07,0.2157639362354895,0.019599999999999992,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
256,0.7,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC gene mutation analysis influence treatment plans in familial adenomatous polyposis? Given that disease manifestation age and course vary, even among carriers of identical mutations, therapeutic choices should depend on colonoscopy results per patient instead of mutation site.",3.0791764556391007e-07,0.2670572306230392,0.019599999999999992,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
256,0.7,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation analysis a useful tool for determining therapy in familial adenomatous polyposis? Because the age at disease onset and progression can be variable, even among those with the same mutations, decisions should be made based on individual colonoscopic findings rather than mutation position.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999992,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
256,0.7,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can the analysis of APC mutations guide therapeutic choices in familial adenomatous polyposis? Since disease manifestation and progression vary even in patients with identical germline mutations, treatment should be determined by colonoscopic findings on a case-by-case basis instead of mutation location.",2.6054570009253947e-07,0.2157639362354895,0.019599999999999992,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
256,0.7,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation evaluation contribute to therapy decisions in familial adenomatous polyposis? Given the variability in age at onset and disease course among carriers of the same mutation, therapeutic decisions should rely on colonoscopy findings from each patient rather than the mutation site.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
257,0.7,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Are general practice features linked to the adoption of an IT innovation in primary care? Answer: The analysis indicates that structural features of a practice do not affect adoption of a new IT tool, though usage may be impacted by post-graduate training in the related clinical area. At least for this diabetes system, practice nurses...",7.105791820705622e-08,0.05571727552295114,0.001873079242376903,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
257,0.7,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Do characteristics of general practices affect the uptake of IT innovations in primary care? Answer: Findings suggest that the structural attributes of a practice are not related to adopting new IT facilities, but usage might be influenced by post-graduate education in the relevant clinical field. For this diabetes system in particular, practice nurses...",1.1842986367842703e-07,0.04234784316257789,0.034438775510204085,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
257,0.7,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Is the uptake of IT innovations in primary care influenced by general practice characteristics? Answer: Data show no association between practice structural characteristics and adoption of new IT systems, but usage could be affected by post-graduate clinical training. At least with this diabetes system, practice nurses...",2.8423167282822487e-07,0.18399836022560434,0.034438775510204085,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
257,0.7,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Does the nature of general practices influence the adoption of IT innovations in primary care? Answer: Results show that practice structural characteristics do not correlate with uptake of new IT facilities, though usage may depend on post-graduate education in the pertinent clinical area. For this diabetes system, practice nurses...",2.1317375462116866e-07,0.12081945860407206,0.034438775510204085,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
257,0.7,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Are the features of general practice linked to IT innovation uptake in primary care? Answer: The research finds that structural aspects of a practice are unrelated to new IT adoption, but post-graduate education in the clinical condition may affect usage. Regarding this diabetes system, practice nurses...",2.8423167282822487e-07,0.18399836022560434,0.034438775510204085,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
257,0.7,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Do structural characteristics of general practices impact the adoption of IT innovations in primary care? Answer: Analysis reveals no connection between practice structure and uptake of new IT tools, but use might be influenced by post-graduate education in the relevant clinical condition. With this diabetes system at least, practice nurses...",1.8948778188548325e-07,0.10061675128655345,0.034438775510204085,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
257,0.7,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: How do general practice characteristics influence IT innovation adoption in primary care? Answer: The study shows structural practice characteristics are not tied to uptake of new IT facilities, but usage could be influenced by post-graduate training in the clinical condition. For this diabetes system, practice nurses...",2.8423167282822487e-07,0.21413519416299298,0.012710380448475687,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
257,0.7,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Is uptake of IT innovations in primary care affected by general practice characteristics? Answer: The findings indicate no link between practice structural characteristics and IT innovation adoption, but post-graduate education in the relevant clinical area may influence usage. At least for this diabetes system, practice nurses...",2.8423167282822487e-07,0.18399836022560434,0.034438775510204085,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
257,0.7,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Do general practice structural features influence the adoption of IT innovations in primary care? Answer: The analysis demonstrates no association between practice structure and uptake of new IT facilities, but usage might be affected by post-graduate clinical education. For this diabetes system particularly, practice nurses...",3.079176455639103e-07,0.20597726694437934,0.034438775510204085,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
257,0.7,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Are uptake rates of IT innovations in primary care impacted by general practice characteristics? Answer: Results suggest no correlation between the structural attributes of a practice and adoption of IT innovations, but usage may be shaped by post-graduate education in the relevant clinical condition. Regarding this diabetes system, practice nurses...",1.8948778188548325e-07,0.12834263850895145,0.014447105372761351,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
258,0.7,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in an urban environment in Thailand affect the risk of non-communicable diseases? Yes, it does. Factors such as pollution, stress, and lifestyle choices linked to urban living can heighten the risk, and rapid urbanization without proper planning worsens these risks, making timing important.",2.8423167282822487e-07,0.13340378381465268,0.06743801652892563,0.02176111757738247,0.16009673330974294,0.051570247933884296,0.0217296184914344,0.18774687065651463,0.035041322314049606,2.8423167282822487e-07,0.21640680036831794,0.017851239669421492
258,0.7,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing significant in the relationship between living in an urban area in Thailand and the risk of non-communicable diseases? Indeed, timing is important. Urban living increases risks due to pollution, stress, and lifestyle factors, and when urbanization happens quickly without sufficient health services, these risks become more pronounced.",2.6054570009253947e-07,0.11235037461681951,0.06743801652892563,0.0199476911126006,0.13859052808877959,0.051570247933884296,0.019918816950481533,0.16576796393773963,0.035041322314049606,2.6054570009253947e-07,0.19393394451626023,0.017851239669421492
258,0.7,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does timing influence the risk of non-communicable diseases associated with urban living in Thailand? Yes, it does matter. The urban environment brings risks like pollution and stress, and rapid, unplanned urban growth can heighten these risks, highlighting the importance of timing.",4.500334819780227e-07,0.2946719314107744,0.06743801652892563,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
258,0.7,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is there a connection between the timing of residing in an urban environment in Thailand and the risk of non-communicable diseases? Yes, timing plays a role. Urban living increases risk factors such as pollution and stress, and rapid urbanization without adequate health infrastructure can amplify these risks.",3.079176455639103e-07,0.15490998903561604,0.06743801652892563,0.023574544042164344,0.18207564002851795,0.051570247933884296,0.023540420032387266,0.21021972650857235,0.035041322314049606,3.079176455639103e-07,0.23939631859301747,0.017851239669421492
258,0.7,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in Thailand's urban areas affect non-communicable disease risk? Yes, it does. Urban lifestyles linked with pollution and stress can increase risk, and rapid, poorly planned urbanization makes timing a critical factor.",5.684633456564492e-07,0.42820332403529715,0.06743801652892563,0.04352223515476495,0.46237760518267557,0.051570247933884296,0.04345923698286881,0.497901798960354,0.035041322314049606,5.684633456564497e-07,0.5348605314868533,0.017851239669421492
258,0.7,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing a factor in the increased risk of non-communicable diseases from living in an urban environment in Thailand? Yes, timing matters. The combination of pollution, stress, and lifestyle habits in urban settings, especially with rapid urbanization lacking proper planning, raises health risks.",4.026615365066519e-07,0.2458817672413427,0.06743801652892563,0.030828249901291835,0.2751660630945296,0.051570247933884296,0.030783626196198732,0.305529906312898,0.035041322314049606,4.026615365066519e-07,0.3370347881569353,0.017851239669421492
258,0.7,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does timing impact the non-communicable disease risk associated with urban living in Thailand? Yes, it does. Factors such as pollution, stress, and lifestyle habits in urban settings contribute to increased risk, and rapid urban growth without planning makes timing essential.",4.73719454713708e-07,0.31998973939506614,0.06743801652892563,0.03626852929563745,0.351151970072451,0.051570247933884296,0.03621603081905733,0.3834914477826086,0.035041322314049606,4.737194547137081e-07,0.4170774958304695,0.017851239669421492
258,0.7,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of living in urban areas in Thailand relevant to the risk of non-communicable diseases? Yes, timing is relevant. Urban environments bring risks like pollution and stress, and rapid unplanned urbanization can worsen these, making timing crucial.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.7,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of urban residence in Thailand influence the risk of non-communicable diseases? Yes, timing matters. Pollution, stress, and lifestyle factors linked with cities increase risk, and rapid, unplanned urbanization further exacerbates these risks, highlighting timing's importance.",5.210914001850786e-07,0.372633472880485,0.06743801652892563,0.0398953822252012,0.4052191913427272,0.051570247933884296,0.039837633900963065,0.43906129893742074,0.035041322314049606,5.210914001850789e-07,0.47423590967041784,0.017851239669421492
258,0.7,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing important when considering the link between living in an urban environment in Thailand and non-communicable disease risk? Yes, it is. Urban living can elevate risk through pollution, stress, and lifestyle, and rapid, poorly planned urbanization intensifies these risks, making timing a key factor.",3.552895910352811e-07,0.19936175160644876,0.06743801652892563,0.02720139697172809,0.2275380141052752,0.051570247933884296,0.027162023114293,0.2567397421434663,0.035041322314049606,3.552895910352811e-07,0.2870243675822719,0.017851239669421492
259,0.7,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is anxiety caused by withdrawal in alcoholism linked to a deficiency of beta-endorphin? Answer: Our findings provide initial evidence that reduced beta-endorphin levels during alcohol withdrawal might contribute to the anxiety commonly experienced in this condition.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.7,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Answer: The results suggest for the first time that decreased beta-endorphin during alcohol withdrawal may play a role in anxiety, a frequent issue during this phase.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.7,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety seen in alcoholism withdrawal due to a lack of beta-endorphin? Answer: Our study presents the first evidence indicating that a drop in beta-endorphin during alcohol withdrawal could be linked to the anxiety often observed in this state.,1.658018091497971e-07,0.15771453361945964,0.02498356344510192,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
259,0.7,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Could beta-endorphin deficiency be responsible for withdrawal-related anxiety in alcoholism? Answer: The data provide initial support that lowered beta-endorphin during alcohol withdrawal might contribute to the common anxiety symptoms during this period.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
259,0.7,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal anxiety in alcoholism caused by beta-endorphin deficiency? Answer: Our findings offer the first evidence that decreased beta-endorphin levels during alcohol withdrawal may be a factor in the anxiety frequently occurring at this time.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.7,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does a beta-endorphin shortage cause anxiety during alcohol withdrawal in alcoholism? Answer: The results supply first evidence that reduced beta-endorphin during withdrawal could contribute to anxiety as a typical disturbance in this state.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.7,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is beta-endorphin deficiency the basis of anxiety induced by withdrawal in alcoholism? Answer: Our findings provide initial proof that lowered beta-endorphin levels during alcohol withdrawal may be linked to anxiety, a common symptom during withdrawal.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.7,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety from alcohol withdrawal in alcoholism due to a decline in beta-endorphin? Answer: We present the first evidence that beta-endorphin reduction during alcohol withdrawal might be responsible for anxiety commonly seen in this condition.,7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.7,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is withdrawal-induced anxiety in alcoholism related to a beta-endorphin deficit? Answer: Our results indicate for the first time that decreased beta-endorphin during alcohol withdrawal could contribute to anxiety, a frequent problem during this phase.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.7,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does alcohol withdrawal anxiety in alcoholism stem from beta-endorphin deficiency? Answer: The findings provide initial evidence that lowered beta-endorphin during withdrawal may underlie the anxiety often observed during this state.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
260,0.7,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts truly a distinct entity? Answer: Based on our study findings and international literature, the concept of the globulomaxillary cyst is no longer supported.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.7,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts actually exist? Answer: Our research and global data indicate that the term globulomaxillary cyst is not justified anymore.,1.658018091497971e-07,0.28768207245178257,0.0,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.7,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a real pathological condition? Answer: Evidence from our study and international sources suggests that the globulomaxillary cyst entity is obsolete.,9.47438909427412e-08,0.2696752099205817,0.08264462809917354,0.007253705859127518,0.22061631794995806,0.04338842975206613,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.7,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts valid clinical entities? Answer: The results from our investigation and worldwide literature show that globulomaxillary cysts are no longer recognized as valid.,7.10579182070559e-08,0.16878045975179923,0.03993055555555556,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.7,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts really exist as a distinct diagnosis? Answer: According to both our research and international studies, the classification of globulomaxillary cysts is no longer warranted.",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.7,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a genuine clinical entity? Answer: Findings from our study, supported by international literature, indicate that this entity is no longer justified.",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.7,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts confirmed entities in pathology? Answer: The data from our study and global literature conclude that the globulomaxillary cyst entity should no longer be considered legitimate.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
260,0.7,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Does the globulomaxillary cyst truly exist? Answer: According to our research results and international literature, the globulomaxillary cyst is an outdated concept.",1.421158364141118e-07,0.36718881691869676,0.09,0.010880558788691277,0.3173284454770928,0.047500000000000014,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
260,0.7,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the existence of globulomaxillary cysts validated? Answer: Our research and international evidence demonstrate that the globulomaxillary cyst entity is no longer valid.,1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.7,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts substantiated by scientific evidence? Answer: Based on findings from our study and worldwide literature, the entity known as globulomaxillary cyst is no longer justified.",2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
261,0.7,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, OSA generally does not correlate with reduced aerobic fitness via cycle ergometry, but individuals with an apnea-hypopnea index over 20 show a significant fitness decline.",2.6054570009253915e-07,0.17363970069367252,0.06222222222222221,0.0199476911126006,0.20763741384459067,0.04246913580246913,0.019918816950481533,0.24315650106229247,0.021728395061728398,2.6054570009253947e-07,0.2803019651541576,0.0
261,0.7,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is aerobic fitness affected by obstructive sleep apnea? Among US Air Force members, OSA is not linked to lower aerobic fitness measured by cycle ergometry, except those with apnea-hypopnea index above 20 exhibit a meaningful decrease.",3.0791764556390975e-07,0.2688179621661959,0.03367550941945405,0.02357454404216435,0.264795827684539,0.04246913580246913,0.02354042003238728,0.30199700108522576,0.021728395061728398,3.079176455639103e-07,0.3409265869705931,0.0
261,0.7,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea influence aerobic fitness levels? For the US Air Force group, OSA doesn’t predict aerobic fitness reduction by cycle ergometry, yet patients with apnea-hypopnea index >20 experience statistically significant decline.",3.7897556377096565e-07,0.36214340932316924,0.0310047404324199,0.02901482343650999,0.3571691478155543,0.04246913580246913,0.0289728246552459,0.39730718088955097,0.021728395061728398,3.789755637709665e-07,0.43936665978384637,0.0
261,0.7,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","How does obstructive sleep apnea affect aerobic fitness? In a US Air Force sample, OSA is not a predictor of decreased aerobic fitness on cycle ergometry, but those with apnea-hypopnea index higher than 20 show a significant fitness drop.",2.3685972735685385e-07,0.14697145361151165,0.06222222222222221,0.018134264647818726,0.18023843965647535,0.04246913580246913,0.018108015409528666,0.21498562409559563,0.021728395061728398,2.3685972735685406e-07,0.2513144282809061,0.0
261,0.7,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does OSA affect aerobic fitness? Within a US Air Force population, obstructive sleep apnea generally does not reduce cycle ergometry measured aerobic fitness, however, individuals with an apnea-hypopnea index greater than 20 have significantly lowered fitness.",3.0791764556390975e-07,0.22920955184848468,0.06222222222222221,0.02357454404216435,0.264795827684539,0.04246913580246913,0.02354042003238728,0.30199700108522576,0.021728395061728398,3.079176455639103e-07,0.3409265869705931,0.0
261,0.7,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is aerobic fitness reduced by obstructive sleep apnea? In US Air Force personnel, OSA does not predict lower aerobic fitness via cycle ergometry, apart from patients with apnea-hypopnea index >20 who show significant decreases.",3.5528959103528035e-07,0.3300589719053537,0.03194878472222221,0.02720139697172811,0.3254204495009745,0.04246913580246913,0.027162023114293027,0.36451735806655927,0.021728395061728398,3.552895910352811e-07,0.4054651081081646,0.0
261,0.7,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea cause declines in aerobic fitness? For US Air Force members, OSA is not typically associated with aerobic fitness loss by cycle ergometry, but those with apnea-hypopnea index over 20 have statistically significant reductions.",2.8423167282822445e-07,0.20103867488178784,0.06222222222222221,0.02176111757738247,0.2358082908112875,0.04246913580246913,0.021729618491434406,0.272144037935544,0.021728395061728398,2.8423167282822487e-07,0.3101549283038394,0.0
261,0.7,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Can obstructive sleep apnea affect aerobic fitness? Among a US Air Force population, OSA generally does not lead to decreased aerobic fitness on cycle ergometry, though patients with apnea-hypopnea index above 20 have significant declines.",3.3160361829959505e-07,0.2581970887217362,0.06222222222222221,0.02538797050694623,0.2946487908342208,0.04246913580246913,0.025351221573340153,0.33276865975197945,0.021728395061728398,3.316036182995957e-07,0.3726752852851729,0.0
261,0.7,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea impact aerobic fitness capacity? In US Air Force individuals, OSA doesn't usually predict aerobic fitness decreases measured by cycle ergometry, but those with apnea-hypopnea index >20 exhibit significant fitness reductions.",3.5528959103528035e-07,0.3300589719053537,0.03194878472222221,0.02720139697172811,0.3254204495009745,0.04246913580246913,0.027162023114293027,0.36451735806655927,0.021728395061728398,3.552895910352811e-07,0.4054651081081646,0.0
261,0.7,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","What is the effect of obstructive sleep apnea on aerobic fitness? Overall, in a US Air Force group, OSA is not associated with reduced aerobic fitness via cycle ergometry, except patients with apnea-hypopnea index greater than 20 show statistically significant decreases.",1.8948778188548325e-07,0.09567815922396194,0.06222222222222221,0.014507411718254981,0.1275947061710565,0.04246913580246913,0.014486412327622933,0.16091840282531944,0.021728395061728398,1.8948778188548325e-07,0.19574457712609394,0.0
262,0.7,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts truly real? Answer: Globulomaxillary cysts were previously believed to be a distinct cyst type originating from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.7,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts actually exist? Answer: Globulomaxillary cysts were once considered to be a particular kind of cyst formed at the fusion site of two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.7,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the globulomaxillary cyst a genuine entity? Answer: Globulomaxillary cysts were historically regarded as a unique cyst type developing along the fusion line of two embryonic processes. However,",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.7,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts a real phenomenon? Answer: Globulomaxillary cysts used to be thought of as a specific cyst type arising from the junction of two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.7,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts exist in reality? Answer: It was once believed that globulomaxillary cysts were a special type of cyst originating from the fusion line between two embryonic processes. However,",4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.7,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is there such a thing as a globulomaxillary cyst? Answer: Globulomaxillary cysts were formerly assumed to be a particular cyst type formed from the fusion line of two embryonic processes. However,",7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,0.7,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts an actual medical condition? Answer: Globulomaxillary cysts were once thought to represent a specific cyst arising at the fusion line between two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.7,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Can globulomaxillary cysts be considered real? Answer: Historically, globulomaxillary cysts were believed to be a distinct cyst type originating from the fusion line of two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.7,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts exist as a distinct type? Answer: Globulomaxillary cysts were once regarded as a unique cyst type developing along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.06051518785217125,0.06858710562414266,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,0.7,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the existence of globulomaxillary cysts confirmed? Answer: Globulomaxillary cysts were historically thought to be a specific cyst type arising from the fusion line between two embryonic processes. However,",2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
263,0.7,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Among patients undergoing MMT and receiving care at various locations, most have opioid dependence and MMT documented in their medical records, though a notable portion lack this documentation. Many of these patients are prescribed drugs that may interact with",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.7,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) noted in medical records? For patients on MMT receiving care across different sites, documentation of opioid dependence and MMT is present for the majority, yet a significant number of patients do not have this recorded. Most patients are prescribed medications that could interact with",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.7,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Do medical records document opioid dependence and methadone maintenance treatment (MMT)? Among patients treated with MMT at diverse facilities, the majority have opioid dependence and MMT documented in their records, but a considerable number do not. Many of these patients receive prescriptions for medications that might interact with",2.6054570009253947e-07,0.17368015058227693,0.02611796982167352,0.0199476911126006,0.19590479787512827,0.0133129272523212,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
263,0.7,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical records? Among patients on MMT and cared for at different locations, documentation occurs for most patients, but it is absent in a substantial number. A large number of these patients are prescribed drugs that potentially interact with",1.8948778188548325e-07,0.052813497454832437,0.06858710562414265,0.014507411718254981,0.10258906231620735,0.0350413223140496,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.7,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical files? For patients receiving MMT and medical care at multiple sites, the majority have opioid dependence and MMT documented, although a significant number of patients lack this documentation. Many are prescribed medications that may interact with",2.6054570009253947e-07,0.17368015058227693,0.02611796982167352,0.0199476911126006,0.19590479787512827,0.0133129272523212,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
263,0.7,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) included in medical records? Among patients undergoing MMT at various care sites, documentation for the majority is present, but a notable portion of patients have missing records. Most of these patients are prescribed medications with potential interactions",3.316036182995957e-07,0.18064686896471605,0.06858710562414265,0.025387970506946217,0.23320924473327187,0.0350413223140496,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
263,0.7,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Do medical records indicate opioid dependence and methadone maintenance treatment (MMT)? In patients receiving MMT and medical care from different facilities, documentation is found in most cases, yet a considerable number of patients’ records lack this information. Many of these patients are prescribed drugs that could interact with",2.6054570009253947e-07,0.11468890117291997,0.06858710562414265,0.0199476911126006,0.16576796393773963,0.0350413223140496,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
263,0.7,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the patients’ medical records? For those receiving MMT and care at diverse sites, documentation exists for most patients, but a significant portion do not have it recorded. Most are prescribed medications that might interact with",3.316036182995957e-07,0.18064686896471605,0.06858710562414265,0.025387970506946217,0.23320924473327187,0.0350413223140496,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
263,0.7,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) noted in patient medical records? Among patients on MMT and receiving care at various locations, the majority have this documentation, though a substantial number are missing it. Most patients are prescribed medicines that potentially interact with",3.552895910352811e-07,0.20363638718941557,0.06858710562414265,0.02720139697172809,0.2567397421434663,0.0350413223140496,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
263,0.7,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) reflected in medical records? Among patients treated with MMT across different sites, the majority have documentation, but a significant number do not. Many of these patients are prescribed medications that could interact with",4.263475092423373e-07,0.2759570487690417,0.06858710562414265,0.03264167636607371,0.33084771429718973,0.0350413223140496,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
264,0.7,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Does the number of needles affect acupuncture treatment for neck pain? It appears that whether 5 or 11 needles are used doesn't significantly impact the therapeutic outcome, provided the stimulation time is equal.",3.3160361829959484e-07,0.30263182581459036,0.043388429752066124,0.025387970506946245,0.3418687439269532,0.02221074380165289,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
264,0.7,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In acupuncture for neck pain, the therapeutic effect seems independent of whether 5 or 11 needles are used, as long as stimulation duration is consistent across groups.",4.7371945471370664e-07,0.5102711905928343,0.043388429752066124,0.03626852929563752,0.5569801235438998,0.02221074380165289,0.03621603081905741,0.6061358035703166,0.0,4.737194547137081e-07,0.6257058997644127,0.0
264,0.7,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","When treating neck pain with acupuncture, the quantity of needles—5 or 11—does not seem to influence the treatment effect if the stimulation time is the same for both groups.",4.2634750924233604e-07,0.43616321843911265,0.043388429752066124,0.03264167636607376,0.48001908240777036,0.02221074380165289,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
264,0.7,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","For neck pain acupuncture treatment, using 5 versus 11 needles does not appear to alter therapeutic results, given that both groups receive equal stimulation time.",5.210914001850772e-07,0.5903138982663716,0.043388429752066124,0.03989538222520128,0.6403617324829503,0.02221074380165289,0.039837633900963156,0.6931471805599463,0.0,5.210914001850789e-07,0.7166776779701407,0.0
264,0.7,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","The number of needles, either 5 or 11, does not seem to be a crucial factor in acupuncture therapy for neck pain when stimulation time is consistent.",4.7371945471370664e-07,0.5102711905928343,0.043388429752066124,0.03626852929563752,0.5569801235438998,0.02221074380165289,0.03621603081905741,0.6061358035703166,0.0,4.737194547137081e-07,0.6257058997644127,0.0
264,0.7,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In the context of neck pain treated with acupuncture, the therapeutic effect is similar whether 5 or 11 needles are applied, as long as the stimulation period is identical.",4.2634750924233604e-07,0.43616321843911265,0.043388429752066124,0.03264167636607376,0.48001908240777036,0.02221074380165289,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
264,0.7,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Acupuncture treatment for neck pain shows that the number of needles used—5 or 11—does not significantly affect the outcome if stimulation time remains constant.,5.447773729207625e-07,0.6328735126851672,0.043388429752066124,0.04170880868998316,0.6848134950537843,0.02221074380165289,0.04164843544191603,0.7396671961948402,0.0,5.447773729207643e-07,0.765467842139572,0.0
264,0.7,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Using either 5 or 11 needles in acupuncture for neck pain yields comparable therapeutic effects when both groups have the same stimulation duration.,5.684633456564478e-07,0.6773252752560013,0.043388429752066124,0.04352223515476504,0.7313335106886782,0.02221074380165289,0.0434592369828689,0.7884573603642715,0.0,5.684633456564496e-07,0.8167611365271221,0.0
264,0.7,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","The effectiveness of acupuncture for neck pain does not seem to depend on the number of needles used, 5 or 11, provided the stimulation time is equal.",4.7371945471370664e-07,0.5102711905928343,0.043388429752066124,0.03626852929563752,0.5569801235438998,0.02221074380165289,0.03621603081905741,0.6061358035703166,0.0,4.737194547137081e-07,0.6257058997644127,0.0
264,0.7,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In treating neck pain with acupuncture, the difference between using 5 or 11 needles does not significantly influence the therapeutic effect if stimulation time is maintained equally.",4.7371945471370664e-07,0.5102711905928343,0.043388429752066124,0.03626852929563752,0.5569801235438998,0.02221074380165289,0.03621603081905741,0.6061358035703166,0.0,4.737194547137081e-07,0.6257058997644127,0.0
265,0.7,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is the development of endometrial polyps linked to higher levels of vascular endothelial growth factor and transforming growth factor-beta1?,8.053230730133017e-07,0.7142983704052908,0.22222222222222215,0.061656499802583795,0.7996076225442117,0.19937500000000002,0.06156725239239759,0.8899012981867842,0.17132659131469363,8.053230730133035e-07,0.9574363237643526,0.15704937537180244
265,0.7,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Does endometrial polyp formation correlate with an elevated expression of vascular endothelial growth factor and transforming growth factor-beta1?,8.29009045748987e-07,0.7714567842452396,0.22222222222222215,0.06346992626736567,0.8602322443606467,0.19937500000000002,0.06337805393335047,0.9544398193243548,0.17132659131469363,8.290090457489888e-07,1.0264291952513047,0.15704937537180244
265,0.7,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Are increased expressions of vascular endothelial growth factor and transforming growth factor-beta1 associated with the formation of endometrial polyps?,8.053230730133017e-07,0.7142983704052908,0.22222222222222215,0.061656499802583795,0.7996076225442117,0.19937500000000002,0.06156725239239759,0.8899012981867842,0.17132659131469363,8.053230730133035e-07,0.9574363237643526,0.15704937537180244
265,0.7,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is there an association between endometrial polyp formation and raised levels of vascular endothelial growth factor and transforming growth factor-beta1?,7.816371002776163e-07,0.6602311491350155,0.22222222222222215,0.059843073337801915,0.7424492087042629,0.19937500000000002,0.05975645085144472,0.8292766763703492,0.17132659131469363,7.816371002776182e-07,0.892897802626782,0.15704937537180244
265,0.7,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Does the formation of endometrial polyps involve increased production of vascular endothelial growth factor and transforming growth factor-beta1?,8.29009045748987e-07,0.7714567842452396,0.22222222222222215,0.06346992626736567,0.8602322443606467,0.19937500000000002,0.06337805393335047,0.9544398193243548,0.17132659131469363,8.290090457489888e-07,1.0264291952513047,0.15704937537180244
265,0.7,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is endometrial polyp development connected to higher expression levels of vascular endothelial growth factor and transforming growth factor-beta1?,8.29009045748987e-07,0.7714567842452396,0.22222222222222215,0.06346992626736567,0.8602322443606467,0.19937500000000002,0.06337805393335047,0.9544398193243548,0.17132659131469363,8.290090457489888e-07,1.0264291952513047,0.15704937537180244
265,0.7,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Are vascular endothelial growth factor and transforming growth factor-beta1 expressed more during the formation of endometrial polyps?,8.526950184846723e-07,0.8320814060616746,0.22222222222222215,0.06528335273214754,0.9247707654982174,0.19937500000000002,0.06518885547430334,1.023432690811307,0.17132659131469363,8.526950184846742e-07,1.100537167405026,0.15704937537180244
265,0.7,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is the occurrence of endometrial polyps related to an increase in vascular endothelial growth factor and transforming growth factor-beta1?,8.053230730133017e-07,0.7142983704052908,0.22222222222222215,0.061656499802583795,0.7996076225442117,0.19937500000000002,0.06156725239239759,0.8899012981867842,0.17132659131469363,8.053230730133035e-07,0.9574363237643526,0.15704937537180244
265,0.7,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Does the expression of vascular endothelial growth factor and transforming growth factor-beta1 rise in association with endometrial polyp formation?,8.053230730133017e-07,0.7142983704052908,0.22222222222222215,0.061656499802583795,0.7996076225442117,0.19937500000000002,0.06156725239239759,0.8899012981867842,0.17132659131469363,8.053230730133035e-07,0.9574363237643526,0.15704937537180244
265,0.7,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.",Is the formation of endometrial polyps associated with upregulated vascular endothelial growth factor and transforming growth factor-beta1?,8.526950184846723e-07,0.8320814060616746,0.22222222222222215,0.06528335273214754,0.9247707654982174,0.19937500000000002,0.06518885547430334,1.023432690811307,0.17132659131469363,8.526950184846742e-07,1.100537167405026,0.15704937537180244
266,0.7,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification account for the birthweight differences between Australian Aborigines and whites? No, it does not completely explain the disparity in birthweights; other elements like genetics, maternal health, socio-economic status, and healthcare access also play roles.",1.6580180914979753e-07,0.07878179892958048,0.1728395061728395,0.012693985253473108,0.016484158502581447,0.11426592797783926,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
266,0.7,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification the reason for the birthweight differences between Australian Aborigines and white populations? No, it cannot entirely explain the difference; factors including genetic variations, maternal health, socio-economic conditions, and availability of healthcare are also influential.",1.6580180914979753e-07,0.07878179892958048,0.1728395061728395,0.012693985253473108,0.016484158502581447,0.11426592797783926,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
266,0.7,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can the difference in birthweights between Australian Aborigines and whites be attributed to gestational age misclassification? No, gestational age misclassification alone does not fully account for the birthweight gap; other contributors include genetics, maternal well-being, socio-economic factors, and healthcare access.",1.1842986367842692e-07,0.0958795231555154,0.14721623747477855,0.009067132323909363,0.03758306276769474,0.11426592797783926,0.009054007704764333,0.06073768844295824,0.047500000000000014,1.1842986367842703e-07,0.09624107065990772,0.024375
266,0.7,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does misclassifying gestational age explain why Australian Aborigines have different birthweights compared to whites? No, this misclassification does not fully explain the birthweight differences; additional factors such as genetic makeup, maternal health, socio-economic inequalities, and access to medical care are involved.",9.474389094274162e-08,0.15674334039929105,0.1728395061728395,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03406944136079737,0.047500000000000014,9.474389094274162e-08,0.0688420964717924,0.024375
266,0.7,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification the full explanation for birthweight differences between Australian Aborigines and white individuals? No, it does not fully explain the variation; other factors like genetics, maternal health status, socio-economic disparities, and healthcare availability also contribute.",1.6580180914979753e-07,0.07878179892958048,0.1728395061728395,0.012693985253473108,0.016484158502581447,0.11426592797783926,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
266,0.7,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does the misclassification of gestational age explain the birthweight differences between Australian Aborigines and whites? No, it only partially explains the difference; genetic differences, maternal health, socio-economic status, and access to healthcare also affect birthweights.",2.3685972735685343e-07,0.0057755890984831915,0.1728395061728395,0.01813426464781874,0.10349553549221158,0.11426592797783926,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
266,0.7,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the discrepancy in birthweights between Australian Aborigines and whites due to gestational age misclassification? No, gestational age misclassification does not fully account for the discrepancy; additional factors such as genetics, maternal health, socio-economic conditions, and healthcare access play a role.",9.474389094274162e-08,0.12208598137129467,0.14785594272773758,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03406944136079737,0.047500000000000014,9.474389094274162e-08,0.0688420964717924,0.024375
266,0.7,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification fully explain the birthweight differences observed between Australian Aborigines and white populations? No, it does not; other factors including genetics, maternal health, socio-economic status, and healthcare accessibility contribute as well.",2.605457000925387e-07,0.03562855224816497,0.1728395061728395,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
266,0.7,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can gestational age misclassification be considered the sole reason for birthweight differences between Australian Aborigines and whites? No, it cannot fully explain the differences; other influences include genetic factors, maternal health, socio-economic disparities, and access to care.",1.8948778188548283e-07,0.05138282474146516,0.1728395061728395,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
266,0.7,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? No, it does not completely explain the difference; other elements such as genetic variations, maternal health, socio-economic factors, and healthcare access also play important roles.",1.4211583641411222e-07,0.10545004601174135,0.1728395061728395,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
267,0.7,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the distribution of health care benefits in Kenya satisfy the principles of universal coverage? Answer: Universal coverage principles dictate that everyone should receive health care benefits based on their need. However, Kenya's health sector is evidently inequitable, with benefits not allocated according to need. Intentional measures must be taken to restructure the",9.474389094274162e-08,0.027788534226238948,0.03209790467258739,0.0072537058591274906,0.051256966201195464,0.01644191929979446,0.007243206163811466,0.050302200487784,0.0181755829903978,9.474389094274162e-08,0.07696104113612989,0.0
267,0.7,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya aligned with universal coverage principles? Answer: Universal coverage principles demand that health care benefits be provided to all according to need. The Kenyan health system, however, is clearly unequal, with benefits not distributed on the basis of need. Focused efforts are needed to restructure the",7.105791820705622e-08,0.03379975985039341,0.014412399097808448,0.005440279394345618,0.03170576166550987,0.016804348178992037,0.0054324046228586,0.030884114630681303,0.0181755829903978,7.105791820705622e-08,0.05715841383995013,0.0
267,0.7,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does Kenya's health care benefits distribution adhere to the principles of universal coverage? Answer: The principles of universal coverage require health care benefits to be allocated based on need to all individuals. The Kenyan health sector currently exhibits inequity, as benefits are not distributed according to need. Active steps should be taken to restructure the",4.737194547137081e-08,0.06446102788845609,0.020224279102883574,0.0036268529295637453,0.06387348466928477,0.01969802687475379,0.003621603081905733,0.037992417039609094,0.0006853637551643317,4.737194547137081e-08,0.03774032798284743,0.0
267,0.7,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Are the health care benefits in Kenya distributed in line with universal coverage principles? Answer: According to universal coverage principles, everyone should benefit from health care based on need. The Kenyan health sector shows clear inequities, and benefits are not allocated on the basis of need. There should be deliberate efforts aimed at restructuring the",4.737194547137081e-08,0.011155028172629144,0.03346386614453542,0.0036268529295637453,0.013142868726265355,0.03566529492455417,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
267,0.7,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the Kenyan health care benefits distribution fulfill the principles of universal coverage? Answer: The universal coverage principles state that all people should receive health care benefits according to their needs. Kenya’s health sector is evidently inequitable, with benefits not distributed based on need. Targeted efforts must be made to restructure the",1.1842986367842703e-07,0.047842748326917484,0.0313757208971164,0.009067132323909363,0.0711977874885843,0.016065294924554177,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
267,0.7,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya consistent with the principles of universal coverage? Answer: Universal coverage principles require that benefits be provided to all according to need. The Kenyan health sector is clearly inequitable, as benefits are not distributed based on need. Deliberate actions are necessary to restructure the",1.1842986367842703e-07,0.00547626556230929,0.06977572089711641,0.009067132323909363,0.04401554511368477,0.03566529492455417,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
267,0.7,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the distribution of health care benefits in Kenya conform to universal coverage principles? Answer: The principles of universal coverage mandate that health care benefits should be given to everyone based on need. The Kenyan health sector is evidently inequitable, with benefits not allocated according to need. Focused efforts should be directed at restructuring the",4.737194547137081e-08,0.03925567586809464,0.002504171451980078,0.0036268529295637453,0.012529249072251503,0.017153368972257988,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
267,0.7,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,Question: Are the health care benefits in Kenya aligned with the principles of universal coverage? Answer: Universal coverage principles require that all individuals benefit from health care according to need. Kenya’s health sector is clearly inequitable and benefits are not distributed on the basis of need. Intentional restructuring efforts should be undertaken to,1.1842986367842703e-07,0.021183241382304097,0.0505523452723567,0.009067132323909363,0.04401554511368477,0.03566529492455417,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
267,0.7,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the Kenyan distribution of health care benefits meet universal coverage principles? Answer: Universal coverage requires that all receive health care benefits based on their need. The Kenyan health sector is evidently inequitable, with benefits not distributed according to need. Purposeful efforts should be made to restructure the",2.1317375462116866e-07,0.19009097220455162,0.012868907202057162,0.016320838183036854,0.15518920083263055,0.014398754281832068,0.0162972138685758,0.15348643672301465,0.0181755829903978,2.1317375462116866e-07,0.18232155679395579,0.0
267,0.7,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is Kenya’s distribution of health care benefits in accordance with the principles of universal coverage? Answer: The principles of universal coverage state that everyone should benefit from health care according to need. The Kenyan health sector is clearly inequitable, with benefits not distributed on the basis of need. Deliberate restructuring efforts should be pursued to",4.737194547137081e-08,0.0392556758680942,0.0025041714519800917,0.0036268529295637453,0.03820136687076836,0.0013169535961558843,0.003621603081905733,0.037992417039609094,0.0006853637551643317,4.737194547137081e-08,0.03774032798284743,0.0
268,0.7,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: Postictal psychotic episodes may signal an increased risk of interictal psychotic episodes. Frequent occurrences after seizures imply the patient could have psychotic episodes independently.,9.474389094274162e-08,0.07544035994788745,0.008900200876552272,0.0072537058591274906,0.0669541587814173,0.020367910477800573,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
268,0.7,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: How significant are postictal psychotic episodes II over the long term? Can they forecast interictal psychotic episodes? Answer: Postictal psychotic episodes can serve as indicators of a higher chance for interictal psychotic episodes, especially if they happen repeatedly after seizures.",1.1842986367842703e-07,0.0560946694211748,0.08486806062819575,0.009067132323909363,0.09316061699719658,0.01972820522484154,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
268,0.7,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What is the long-term relevance of postictal psychotic episodes II? Are they predictors of interictal psychotic episodes? Answer: The presence of postictal psychotic episodes often suggests a greater likelihood of interictal psychotic episodes, particularly when these episodes follow seizures frequently.",1.1842986367842703e-07,0.12540938747716934,0.03692602040816326,0.009067132323909363,0.1642526355161653,0.0310374149659864,0.009054007704764333,0.16009538652296218,0.026296566837107373,1.1842986367842703e-07,0.1267517056391423,0.0
268,0.7,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: How do postictal psychotic episodes II relate to long-term outcomes? Do they predict interictal psychotic episodes? Answer: Postictal psychotic episodes can be predictive of interictal psychotic episodes, with frequent post-seizure episodes indicating a probable future occurrence.",2.1317375462116823e-07,0.1730076380883343,0.07673037190082645,0.016320838183036854,0.2054366026956549,0.016804761120134334,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
268,0.7,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What long-term significance do postictal psychotic episodes II hold? Can they indicate interictal psychotic episodes? Answer: Experiencing postictal psychotic episodes frequently after seizures may predict a higher risk of interictal psychotic episodes.,3.0791764556390943e-07,0.30523124000638413,0.06662826991676576,0.023574544042164372,0.3319082223215615,0.013129251700680293,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
268,0.7,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Are postictal psychotic episodes II predictive of interictal psychotic episodes in the long term? Answer: Yes, frequent postictal psychotic episodes following seizures can be a sign that interictal psychotic episodes may occur.",3.0791764556390943e-07,0.4351963363613738,0.21373885459533615,0.023574544042164372,0.37662739526091293,0.01885780075010582,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
268,0.7,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term predictive value of postictal psychotic episodes II for interictal psychotic episodes? Answer: Postictal psychotic episodes occurring regularly after seizures suggest an elevated chance of interictal psychotic episodes.,3.3160361829959473e-07,0.34117236078402735,0.06371173469387752,0.02538797050694625,0.3661886842425317,0.012057775944305578,0.025351221573340174,0.39390428570708913,0.0,3.316036182995957e-07,0.4054651081081637,0.0
268,0.7,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: Do postictal psychotic episodes II have long-term significance in predicting interictal psychotic episodes? Answer: Recurrent postictal psychotic episodes post-seizure indicate the patient might also experience interictal psychotic episodes.,4.0266153650665063e-07,0.45732907496733244,0.05377499999999996,0.03082824990129189,0.4766836234600609,0.008369225402192447,0.030783626196198795,0.5031035776720798,0.0,4.026615365066519e-07,0.5187937934151678,0.0
268,0.7,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How important are postictal psychotic episodes II for long-term prediction of interictal psychotic episodes? Answer: Frequent postictal psychotic episodes after seizures imply a higher probability of interictal psychotic episodes.,3.7897556377096533e-07,0.46491923179152783,0.024974999999999997,0.02901482343651001,0.48799276948643167,0.025654443236860835,0.02897282465524592,0.4653632496892328,0.0,3.789755637709665e-07,0.4795730802618854,0.0
268,0.7,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Can postictal psychotic episodes II serve as predictors for interictal psychotic episodes over the long term? Answer: Yes, frequent postictal psychotic episodes following seizures may denote a greater likelihood of interictal psychotic episodes.",2.8423167282822413e-07,0.3283861694768855,0.02849658145065395,0.021761117577382492,0.2987620498526282,0.014133992133100189,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
269,0.7,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness affect microvascular function in healthy adults who are at risk for Type 2 diabetes? Yes, aerobic fitness has a significant impact on microvascular function in these individuals. Engaging in regular aerobic exercise enhances insulin sensitivity and endothelial function, which helps lower the risk of microvascular complications related to prediabetes or early stages of diabetes.",2.3685972735685406e-08,0.25573056301521024,0.19430167384792865,0.0018134264647818726,0.22419284683448293,0.14182441700960224,0.0018108015409528666,0.2279441120491188,0.14617283950617282,2.3685972735685406e-08,0.20566474358298592,0.131358024691358
269,0.7,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is microvascular function in healthy adults at risk for Type 2 diabetes influenced by aerobic fitness? Indeed, aerobic fitness plays a crucial role in microvascular function for these adults. Consistent aerobic workouts improve insulin sensitivity and the health of the endothelium, reducing the likelihood of microvascular issues linked to prediabetes or early diabetes.",7.105791820705622e-08,0.22922885326258413,0.22847808462402336,0.005440279394345618,0.17389064634669893,0.16000000000000003,0.0054324046228586,0.1509830709129889,0.14617283950617282,7.105791820705622e-08,0.12719312814149175,0.131358024691358
269,0.7,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness play a role in microvascular function among healthy adults at risk of developing Type 2 diabetes? Yes, it does. Aerobic fitness greatly affects microvascular function by enhancing insulin sensitivity and endothelial performance, thus lowering the risk of microvascular complications in prediabetic or early diabetic stages.",1.8948778188548325e-07,0.06630536922179209,0.1841684023975434,0.014507411718254981,0.07070641011146828,0.16000000000000003,0.014486412327622933,0.04562255525516301,0.14617283950617282,1.8948778188548325e-07,0.01956246394912675,0.131358024691358
269,0.7,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness influence microvascular function in healthy adults at risk of Type 2 diabetes? Yes, aerobic fitness significantly impacts microvascular function in such individuals. Regular aerobic activity boosts insulin sensitivity and endothelial function, decreasing the risk of microvascular complications associated with prediabetes or early-stage diabetes.",2.3685972735685406e-07,0.011919034036789622,0.1596586286009544,0.018134264647818726,0.005252042484817032,0.13728501892915093,0.018108015409528666,0.00016018117840577162,0.14617283950617282,2.3685972735685406e-07,0.02695755168576719,0.131358024691358
269,0.7,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness considerably influences microvascular function. Engaging in regular aerobic exercise improves insulin sensitivity as well as endothelial function, helping to reduce microvascular complications in individuals with prediabetes or early diabetes.",1.1842986367842703e-07,0.18894175983151706,0.22770979011134032,0.009067132323909363,0.13388531173300056,0.16000000000000003,0.009054007704764333,0.11016107639273454,0.14617283950617282,1.1842986367842703e-07,0.08552043174092283,0.131358024691358
269,0.7,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness affect the microvascular function of healthy adults at risk of Type 2 diabetes? Yes, aerobic fitness markedly influences microvascular function in these adults. Regular aerobic exercise enhances insulin sensitivity and endothelial health, thereby mitigating risks of microvascular complications related to prediabetes or early diabetes stages.",1.8948778188548325e-07,0.09580099392647057,0.20523232444631392,0.014507411718254981,0.07070641011146828,0.16000000000000003,0.014486412327622933,0.04562255525516301,0.14617283950617282,1.8948778188548325e-07,0.01956246394912675,0.131358024691358
269,0.7,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","How does aerobic fitness impact microvascular function in healthy adults at risk of developing Type 2 diabetes? Aerobic fitness significantly affects microvascular function by improving insulin sensitivity and endothelial function, which reduces the risk of microvascular complications in prediabetes or early-stage diabetes.",3.316036182995957e-07,0.08321946443479256,0.17498677880833985,0.025387970506946217,0.0690555322636901,0.16000000000000003,0.025351221573340132,0.09747828838551209,0.14617283950617282,3.316036182995957e-07,0.1270410102427486,0.131358024691358
269,0.7,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is the microvascular function of healthy adults at risk for Type 2 diabetes affected by aerobic fitness? Yes, aerobic fitness has a substantial effect. Consistent aerobic exercise improves both insulin sensitivity and endothelial function, thus lowering the risk of microvascular complications in early or prediabetic phases.",2.3685972735685406e-07,0.11130713139608917,0.24770146024878306,0.018134264647818726,0.026254647540635556,0.16000000000000003,0.018108015409528666,0.00016018117840577162,0.14617283950617282,2.3685972735685406e-07,0.02695755168576719,0.131358024691358
269,0.7,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness influence microvascular function in healthy adults who may develop Type 2 diabetes? Yes, aerobic fitness plays an important role by significantly enhancing microvascular function through improved insulin sensitivity and endothelial health, which lowers the risk of microvascular complications in prediabetic or early diabetic individuals.",2.1317375462116866e-07,0.07301237024008644,0.20431303049671695,0.016320838183036854,0.04872750339269327,0.16000000000000003,0.0162972138685758,0.023149699403105295,0.14617283950617282,2.1317375462116866e-07,0.0034270542755727718,0.131358024691358
269,0.7,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is aerobic fitness a factor in microvascular function among healthy adults at risk for Type 2 diabetes? Yes, it significantly influences microvascular function. Regular aerobic exercise promotes better insulin sensitivity and endothelial function, reducing the risk of microvascular complications associated with prediabetes or early-stage diabetes.",2.6054570009253947e-07,0.08883427554403145,0.24770146024878306,0.0199476911126006,0.003265129315936033,0.16000000000000003,0.019918816950481533,0.023370316231788646,0.14617283950617282,2.6054570009253947e-07,0.051055103264827206,0.131358024691358
270,0.7,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does treating migraines early reduce the time to headache peak and lessen its severity? Early intervention and triptan use may shorten the time from migraine onset to peak but do not decrease headache severity at peak, potentially lowering overall migraine burden by reducing total headache duration.",1.8948778188548325e-07,0.16827946776040026,0.0033497970560907586,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
270,0.7,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can early migraine treatment shorten the time to the headache peak and reduce its intensity? Early treatment with triptans may lead to a quicker progression from migraine onset to peak but does not diminish the headache's peak severity, possibly lowering the overall migraine burden by shortening the total headache duration.",9.474389094274162e-08,0.05231511806187328,0.018860946745562133,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
270,0.7,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Is early treatment of migraines effective in decreasing the time to the headache peak and its severity? Using triptans early may reduce the duration from migraine onset to peak without reducing the severity at peak, which could lessen the overall migraine burden by cutting down headache duration.",1.6580180914979784e-07,0.11549401968340556,0.018860946745562133,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
270,0.7,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does administering migraine treatment early shorten the time to headache peak and reduce severity? Early use of triptans can shorten the time from migraine onset to peak but does not alleviate peak headache severity, potentially decreasing the total migraine burden by reducing headache duration.",2.3685972735685406e-07,0.2474141079728862,0.027540005068834073,0.018134264647818726,0.2465811088961516,0.023795359904818555,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
270,0.7,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Will early migraine treatment shorten time to headache peak and reduce its severity? Early intervention and triptan use might speed up the time from migraine start to peak but don’t lessen headache severity at peak, potentially lowering migraine burden by reducing headache duration.",2.6054570009253947e-07,0.20646579788913222,0.018860946745562133,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
270,0.7,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can early treatment of migraine reduce the time until headache peak and its severity? Early use of triptans may shorten the interval from migraine onset to peak but does not reduce headache severity at peak, which might decrease the total burden by shortening migraine duration.",2.1317375462116866e-07,0.15994578225423828,0.018860946745562133,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.7,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does early migraine intervention shorten time to headache peak and mitigate severity? Using triptans early might lead to a faster progression to headache peak but does not decrease severity at peak, possibly reducing migraine burden by shortening headache duration.",3.552895910352809e-07,0.37951211755768677,0.033608189056907004,0.02720139697172809,0.3777932211026047,0.027006172839506164,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
270,0.7,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Is early treatment effective in reducing time to headache peak and severity in migraines? Early triptan use may shorten the time from migraine onset to peak but does not reduce peak headache severity, potentially lowering migraine burden by minimizing headache duration.",3.079176455639103e-07,0.25525596205856393,0.018860946745562133,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
270,0.7,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does early migraine therapy reduce time to headache peak and its severity? Early use of triptans can accelerate the time from migraine onset to peak but does not alleviate severity at peak, which might cut down the total migraine burden by reducing headache duration.",2.3685972735685406e-07,0.1829353004789378,0.018860946745562133,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
270,0.7,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can early management of migraines shorten the time to headache peak and lessen severity? Early treatment and triptan use may lead to a shorter duration from migraine onset to peak without reducing headache severity at peak, thereby potentially decreasing migraine burden by shortening headache duration.",2.1317375462116866e-07,0.15994578225423828,0.018860946745562133,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
271,0.7,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncology specialist change the cancer treatment approach for elderly patients? It was found that the consultation resulted in changes to the treatment plan in over one third of cases. Additional research is necessary to assess if these changes enhance outcomes for older patients.,9.474389094274162e-08,0.05524782717293819,0.09876543209876545,0.0072537058591274906,0.0002826433737834755,0.060964083175803374,0.007243206163811466,0.05813024446629855,0.020823902218198284,9.474389094274162e-08,0.0889474860164956,0.0
271,0.7,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation alter cancer treatment plans in elderly patients? More than one third of cases saw treatment plan modifications following the consultation. Further studies are required to evaluate whether these adjustments lead to better results for older patients.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.7,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients modified after a geriatric oncology consultation? The consultation led to changes in the treatment plan in over a third of cases. More research is needed to determine if these changes improve outcomes for elderly patients.,1.8948778188548325e-07,0.10173796822897252,0.05126543209876544,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.1534404242706242,0.020823902218198284,1.8948778188548325e-07,0.18658595558041347,0.0
271,0.7,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a consultation in geriatric oncology influence the cancer treatment plan for older patients? Treatment plans were changed in over one third of cases after the consultation. Additional studies are needed to verify if these modifications benefit older patients' outcomes.,2.6054570009253936e-07,0.10983192318651191,0.09876543209876545,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.7,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation change the cancer treatment strategy for elderly patients? Such consultations resulted in treatment plan modifications in more than a third of cases. Further investigation is warranted to see if these changes improve patient outcomes.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.7,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? In over one third of cases, the consultation led to alterations in the treatment plan. More studies are necessary to confirm whether these changes improve outcomes for older individuals.",2.1317375462116866e-07,0.05982150261184849,0.09876543209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.7,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients adjusted following a geriatric oncology consultation? The consultation caused modifications in over one third of cases. Further research is needed to assess if these modifications enhance outcomes for elderly patients.,3.0791764556390996e-07,0.19994307183733318,0.07175925925925929,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.7,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncologist modify the cancer treatment plan for elderly patients? More than one third of cases saw the treatment plan changed after the consultation. Additional studies are required to determine if these changes improve outcomes for older patients.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.7,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation result in changes to the cancer treatment plan for elderly patients? Treatment plans were modified in over one third of cases following the consultation. Further research is essential to establish if these changes lead to better outcomes for older patients.,1.4211583641411244e-07,0.01079606460210547,0.09876543209876545,0.010880558788691236,0.045745017450540715,0.060964083175803374,0.0108648092457172,0.1046502601011925,0.020823902218198284,1.4211583641411244e-07,0.13657553500575004,0.0
271,0.7,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting with a geriatric oncology specialist lead to changes in the cancer treatment plan for elderly patients? The consultation resulted in treatment plan modifications in more than a third of cases. More studies are needed to evaluate if these changes improve outcomes for older patients.,1.1842986367842703e-07,0.00246237909594349,0.07655468829711257,0.009067132323909363,0.02275549922584119,0.060964083175803374,0.009054007704764333,0.08111976269099808,0.020823902218198284,1.1842986367842703e-07,0.11247798342669002,0.0
272,0.7,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is computerised tomography a suitable replacement for bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot completely substitute bone scintigraphy in identifying bone metastases from breast cancer. Although CT is useful in detecting,7.10579182070559e-08,0.18334377720586703,0.051513462923852726,0.005440279394345625,0.2575686874683032,0.11159406875798007,0.005432404622858614,0.300556720495472,0.14508440413202317,7.105791820705622e-08,0.30622065261467046,0.1508916323731139
272,0.7,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can CT scan replace bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: CT cannot entirely replace bone scintigraphy in the detection of bone metastases from breast cancer. While CT is efficient in spotting,2.36859727356853e-08,0.2691220397327725,0.143686732847572,0.0018134264647818796,0.2747926714919884,0.16349718294483126,0.0018108015409528735,0.2819064833532985,0.1728395061728395,2.3685972735685406e-08,0.24738015259173718,0.1508916323731139
272,0.7,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is it possible for computerised tomography to replace bone scintigraphy when detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy for detecting bone metastases in breast cancer. CT is effective at identifying,7.10579182070559e-08,0.2563066383174397,0.09777305057025337,0.005440279394345625,0.29503610263370605,0.13816634472719125,0.005432404622858614,0.33906489719324684,0.1728395061728395,7.105791820705622e-08,0.30622065261467046,0.1508916323731139
272,0.7,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can computerised tomography serve as a replacement for bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerised tomography (CT) is not capable of completely replacing bone scintigraphy in detecting bone metastases from breast cancer. CT does have utility in recognizing,2.1317375462116813e-07,0.3962771251355375,0.09336737202707793,0.01632083818303686,0.4235349247729254,0.12266889574759943,0.016297213868575813,0.46020856842241287,0.14904414626802093,2.1317375462116866e-07,0.4644446578295649,0.1508916323731139
272,0.7,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Does computerised tomography offer a viable alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Computerised tomography (CT) cannot entirely replace bone scintigraphy for detecting bone metastases from breast cancer. CT is effective in detecting,7.10579182070559e-08,0.21982520776165293,0.07398761094674555,0.005440279394345625,0.22010127230290077,0.08552415286422019,0.005432404622858614,0.2235403670999223,0.09019487807366595,7.105791820705622e-08,0.22700383197924845,0.0939586663492388
272,0.7,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can CT scans fully substitute bone scintigraphy in the detection of bone metastases caused by breast cancer? Answer: CT scans cannot fully replace bone scintigraphy in identifying bone metastases from breast cancer. Although CT is proficient in detecting,7.10579182070559e-08,0.29278806887322606,0.12252513257304314,0.005440279394345625,0.33250351779910936,0.16503772290809327,0.005432404622858614,0.33906489719324684,0.1728395061728395,7.105791820705622e-08,0.30622065261467046,0.1508916323731139
272,0.7,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is computerised tomography an adequate replacement for bone scintigraphy in finding bone metastases from breast cancer? Answer: CT cannot completely replace bone scintigraphy in detecting bone metastases caused by breast cancer. CT is useful for identifying,2.36859727356853e-08,0.2691220397327725,0.143686732847572,0.0018134264647818796,0.2747926714919884,0.16349718294483126,0.0018108015409528735,0.2819064833532985,0.1728395061728395,2.3685972735685406e-08,0.24738015259173718,0.1508916323731139
272,0.7,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can computerised tomography be used instead of bone scintigraphy to detect bone metastases in breast cancer patients? Answer: Computerised tomography (CT) cannot entirely substitute bone scintigraphy in the detection of bone metastases from breast cancer. CT is effective at spotting,1.184298636784265e-07,0.3513776493719347,0.1275659288479801,0.00906713232390937,0.4226146664499306,0.19204389574759942,0.009054007704764347,0.39313211846352303,0.1728395061728395,1.1842986367842703e-07,0.36179050376948263,0.1508916323731139
272,0.7,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Could computerised tomography replace bone scintigraphy in the detection of bone metastases in patients with breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy when detecting bone metastases from breast cancer. While CT is useful in identifying,9.47438909427412e-08,0.32250524046169504,0.12510687115082714,0.0072537058591274975,0.3601577494908863,0.16574732891049204,0.00724320616381148,0.36646387138136216,0.1728395061728395,9.474389094274162e-08,0.3343915295813673,0.1508916323731139
272,0.7,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is computerised tomography capable of replacing bone scintigraphy for the detection of bone metastases in breast cancer? Answer: Computerised tomography (CT) cannot completely replace bone scintigraphy for detecting bone metastases from breast cancer. CT remains effective in identifying,7.10579182070559e-08,0.29278806887322606,0.12252513257304312,0.005440279394345625,0.33250351779910936,0.16503772290809327,0.005432404622858614,0.33906489719324684,0.1728395061728395,7.105791820705622e-08,0.30622065261467046,0.1508916323731139
273,0.7,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should patients with HIV undergo screening for silent myocardial ischaemia with gated myocardial perfusion SPECT? Yes, HIV-positive individuals should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT because they are at greater risk of cardiovascular disease from the chronic inflammation caused by HIV and antiretroviral therapy. Early diagnosis allows for timely intervention and improved prognosis.",1.6580180914979784e-07,0.0208280901194291,0.06398334834944523,0.012693985253473108,0.016011425812267444,0.0708977342603026,0.012675610786670066,0.011510553454748607,0.09289879717489143,1.6580180914979784e-07,0.014467004796200555,0.09719008264462808
273,0.7,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it advisable to screen HIV-infected patients for silent myocardial ischaemia using gated myocardial perfusion SPECT? Indeed, screening is recommended since HIV patients face an elevated risk of cardiovascular complications due to chronic inflammation related to HIV infection and its treatment. Detecting the condition early enables prompt management and better clinical outcomes.",3.079176455639103e-07,0.010448956710364499,0.15089163237311393,0.023574544042164344,0.05507434177356263,0.124297520661157,0.023540420032387266,0.07879698164673377,0.11107438016528923,3.079176455639103e-07,0.1033160308601837,0.09719008264462808
273,0.7,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischaemia screening with gated myocardial perfusion SPECT be performed on HIV-infected individuals? Yes, screening is warranted because HIV infection and antiretroviral therapy induce chronic inflammation, increasing cardiovascular risk. Early identification facilitates timely therapy and enhances patient outcomes.",5.92149318392135e-07,0.27871294330504526,0.15089163237311393,0.045335661619546816,0.3295111874753216,0.124297520661157,0.045270038523821665,0.359699367113135,0.11107438016528923,5.921493183921352e-07,0.3909981033119645,0.09719008264462808
273,0.7,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Are HIV-positive patients candidates for gated myocardial perfusion SPECT screening for silent myocardial ischaemia? Yes, such screening is necessary as HIV and its treatment cause a chronic inflammatory state that raises cardiovascular disease risk. Early detection allows for early treatment and improved health results.",4.974054274493935e-07,0.1810744737411274,0.15089163237311393,0.038081955760419325,0.22942772891834018,0.124297520661157,0.0380268323600102,0.2570452130530527,0.11107438016528923,4.974054274493935e-07,0.2856375876541386,0.09719008264462808
273,0.7,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is gated myocardial perfusion SPECT screening for silent myocardial ischaemia recommended in HIV-infected patients? Yes, it should be performed because HIV infection and antiretroviral drugs contribute to chronic inflammation, heightening cardiovascular disease risk. Early diagnosis helps in initiating timely treatment and achieving better outcomes.",4.974054274493935e-07,0.1810744737411274,0.15089163237311393,0.038081955760419325,0.22942772891834018,0.124297520661157,0.0380268323600102,0.2570452130530527,0.11107438016528923,4.974054274493935e-07,0.2856375876541386,0.09719008264462808
273,0.7,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should HIV patients be assessed for silent myocardial ischaemia via gated myocardial perfusion SPECT? Yes, screening is advised since the chronic inflammation from HIV and its therapies increases cardiovascular risk. Early detection can lead to timely treatment and better prognosis.",5.92149318392135e-07,0.27871294330504526,0.15089163237311393,0.045335661619546816,0.3295111874753216,0.124297520661157,0.045270038523821665,0.359699367113135,0.11107438016528923,5.921493183921352e-07,0.3909981033119645,0.09719008264462808
273,0.7,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Do HIV-infected patients require screening for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, because the chronic inflammatory condition caused by HIV and antiretroviral treatment elevates cardiovascular risk. Early identification promotes timely intervention and improved outcomes.",6.63207236599191e-07,0.3587556509785794,0.15089163237311393,0.050775941013892434,0.41174928571229463,0.124297520661157,0.05070244314668027,0.44425675514119867,0.11107438016528923,6.632072365991914e-07,0.4780094803015946,0.09719008264462808
273,0.7,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it appropriate to use gated myocardial perfusion SPECT to screen HIV patients for silent myocardial ischaemia? Yes, given that HIV infection and antiretroviral therapy induce chronic inflammation, raising cardiovascular risk; early detection leads to timely management and better outcomes.",5.92149318392135e-07,0.27871294330504526,0.15089163237311393,0.045335661619546816,0.3295111874753216,0.124297520661157,0.045270038523821665,0.359699367113135,0.11107438016528923,5.921493183921352e-07,0.3909981033119645,0.09719008264462808
273,0.7,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischaemia be screened in HIV-infected patients using gated myocardial perfusion SPECT? Yes, due to the increased cardiovascular risk from the chronic inflammatory effects of HIV and antiretroviral treatment. Early screening allows for prompt treatment and improved patient prognosis.",5.684633456564497e-07,0.25339513532075353,0.15089163237311393,0.04352223515476494,0.3035357010720636,0.124297520661157,0.0434592369828688,0.3330311200309741,0.11107438016528923,5.684633456564497e-07,0.3635991291238492,0.09719008264462808
273,0.7,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is screening for silent myocardial ischaemia using gated myocardial perfusion SPECT recommended for HIV-infected patients? Yes, because these patients have a heightened cardiovascular risk caused by chronic inflammation from HIV infection and antiretroviral therapy. Early detection enables timely treatment and enhances outcomes.",5.447773729207643e-07,0.22870252273038183,0.15089163237311393,0.04170880868998307,0.2782178930877719,0.124297520661157,0.04164843544191593,0.30705563362771615,0.11107438016528923,5.447773729207643e-07,0.3369308820416883,0.09719008264462808
274,0.7,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a link between crime and the sale of syringes over the counter at pharmacies? Although no direct connection exists, misuse is possible since syringes might be used for illegal drug consumption.",2.36859727356853e-08,0.0532461814011187,0.06035379812695108,0.0018134264647818796,0.01157300047041776,0.031217481789802305,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
274,0.7,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does selling syringes over the counter at pharmacies relate to crime? There is no direct correlation, but improper use can happen, as syringes may be utilized for illicit drug use.",9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.09020969383952471,0.031217481789802305,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
274,0.7,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Can crime be linked to the over-the-counter sale of syringes at pharmacies? While no direct association is found, syringes can be misused, including for illegal drug activities.",1.658018091497971e-07,0.15439318337712526,0.06035379812695108,0.012693985253473157,0.20353837914652884,0.031217481789802305,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
274,0.7,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are over-the-counter pharmacy syringe sales connected to crime? No direct link is evident, but syringes can be misused, potentially for illicit drug use.",2.605457000925383e-07,0.3214472680402922,0.06035379812695108,0.019947691112600675,0.3778917662913073,0.031217481789802305,0.01991881695048161,0.4382549309311563,0.0,2.6054570009253936e-07,0.45675840249571475,0.0
274,0.7,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is crime associated with pharmacy syringe sales over the counter? There is no direct association, yet misuse can occur, such as syringes being used for illegal drug use.",1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.16431766599324638,0.031217481789802305,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
274,0.7,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Do over-the-counter syringe sales at pharmacies contribute to crime? Direct association is lacking, but misuse remains a concern due to potential illicit drug use.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.7,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a crime connection with over-the-counter pharmacy syringe sales? Although not directly linked, syringes can be misused for unlawful drug use.",2.842316728282236e-07,0.36796728367518616,0.06035379812695108,0.021761117577382555,0.42668193046073855,0.031217481789802305,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
274,0.7,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are sales of syringes over the counter at pharmacies related to crime? No direct connection exists, but misuse for illegal drug purposes can happen.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.7,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does over-the-counter syringe availability at pharmacies associate with crime? No direct association is present, but misuse, including for illicit drug use, may occur.",2.605457000925383e-07,0.3214472680402922,0.06035379812695108,0.019947691112600675,0.3778917662913073,0.031217481789802305,0.01991881695048161,0.4382549309311563,0.0,2.6054570009253936e-07,0.45675840249571475,0.0
274,0.7,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a relationship between crime and over-the-counter syringe sales in pharmacies? While no direct link exists, misuse can take place, such as syringes being used for drug-related offenses.",1.184298636784265e-07,0.0802852112234036,0.06035379812695108,0.009067132323909398,0.1265773380103994,0.031217481789802305,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
275,0.7,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Although investigations are still in progress, existing research indicates that D-dimer levels might act as a new",4.73719454713706e-08,0.07499994574745683,0.0025434730105059547,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
275,0.7,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer a potential new diagnostic parameter for acute appendicitis? Answer: Current studies, while ongoing, suggest that D-dimer levels could possibly be used as a new",2.36859727356853e-08,0.013603907614186284,0.03698224852071005,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.7,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer be introduced as a new diagnostic tool for acute appendicitis? Answer: Research is ongoing, but current evidence suggests D-dimer levels may function as a new",0.0,0.05134423559703327,0.03661775147928994,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0
275,0.7,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer become an innovative diagnostic marker for acute appendicitis? Answer: Although research continues, current findings imply that D-dimer levels have potential as a new",4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,0.7,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is it possible for D-dimer to be a new diagnostic parameter in acute appendicitis? Answer: While studies are still underway, current data suggest that D-dimer levels might serve as a new",9.47438909427412e-08,0.1447754011384994,0.004760026298487846,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
275,0.7,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer be considered a new diagnostic indicator for acute appendicitis? Answer: Although research is ongoing, present studies propose that D-dimer levels could be a new",2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.7,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer emerge as a new diagnostic parameter for acute appendicitis? Answer: Current research, though ongoing, suggests that D-dimer levels may potentially be used as a new",0.0,0.05134423559703327,0.03661775147928994,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0
275,0.7,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer likely to become a new diagnostic marker for acute appendicitis? Answer: Research continues, but current studies indicate that D-dimer levels might act as a new",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.7,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer be established as a new diagnostic parameter for acute appendicitis? Answer: While investigations proceed, current evidence points to D-dimer levels potentially serving as a new",0.0,0.05134423559703327,0.03661775147928994,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0
275,0.7,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Might D-dimer be utilized as a new diagnostic marker for acute appendicitis? Answer: Although ongoing research is still needed, current studies suggest that D-dimer levels could become a new",4.73719454713706e-08,0.07499994574745683,0.0025434730105059547,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
276,0.7,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in patients suffering from coronary artery disease? Answer: Recent studies indicate that bezafibrate, a lipid-lowering ligand for peroxisome proliferator-activated receptors, may have anti-cancer effects. Nonetheless, targeted research confirming its effectiveness in colon cancer prevention is still lacking.",1.1842986367842703e-07,0.24567505264951217,0.09427769362373153,0.009067132323909363,0.2775130264171537,0.11687363038714388,0.009054007704764333,0.25031756013794615,0.09642074506939374,1.1842986367842703e-07,0.2217551127403743,0.07450693937180423
276,0.7,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is the lipid-lowering agent bezafibrate, which activates peroxisome proliferator-activated receptors, effective in preventing colon cancer in coronary artery disease patients? Answer: Current findings suggest that bezafibrate possesses potential anti-cancer properties, but definitive studies proving its role in colon cancer prevention have not yet been conducted.",4.737194547137081e-08,0.20809225520038277,0.1136548515234019,0.0036268529295637453,0.21155505862535762,0.11687363038714388,0.003621603081905733,0.1828762793424139,0.09642074506939374,4.737194547137081e-08,0.15276224125342264,0.07450693937180423
276,0.7,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does bezafibrate, a peroxisome proliferator-activated receptor ligand with lipid-lowering properties, prevent colon cancer in individuals with coronary artery disease? Answer: Evidence from ongoing research points to bezafibrate having possible anti-cancer benefits, although conclusive trials demonstrating its preventive effect on colon cancer are still required.",2.3685972735685406e-08,0.18491925068109216,0.11315061425420568,0.0018134264647818726,0.1885655404006581,0.11687363038714388,0.0018108015409528666,0.1593457819322195,0.09642074506939374,2.3685972735685406e-08,0.12866468967436262,0.07450693937180423
276,0.7,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, help in preventing colon cancer among patients with coronary artery disease? Answer: Research to date suggests bezafibrate may exhibit anti-cancer properties; however, specific studies verifying its preventive efficacy against colon cancer remain insufficient.",2.3685972735685406e-08,0.18491925068109216,0.11315061425420568,0.0018134264647818726,0.1885655404006581,0.11687363038714388,0.0018108015409528666,0.1593457819322195,0.09642074506939374,2.3685972735685406e-08,0.12866468967436262,0.07450693937180423
276,0.7,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, offer protection against colon cancer in coronary artery disease patients? Answer: Current research points to bezafibrate’s potential anti-cancer activity, but further studies are needed to establish its role in colon cancer prevention.",4.737194547137081e-08,0.11199631590430092,0.11149059532505479,0.0036268529295637453,0.11624487882103196,0.11687363038714388,0.003621603081905733,0.08523780977849604,0.09642074506939374,4.737194547137081e-08,0.05267878269644122,0.07450693937180423
276,0.7,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate effective at preventing colon cancer in those with coronary artery disease? Answer: Studies currently imply that bezafibrate has anti-cancer potential, though direct evidence of its preventive effect on colon cancer is still pending.",4.737194547137081e-08,0.11199631590430092,0.11149059532505479,0.0036268529295637453,0.11624487882103196,0.11687363038714388,0.003621603081905733,0.08523780977849604,0.09642074506939374,4.737194547137081e-08,0.05267878269644122,0.07450693937180423
276,0.7,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does the drug bezafibrate, which activates peroxisome proliferator-activated receptors and lowers lipids, prevent colon cancer in patients with coronary artery disease? Answer: Present research suggests bezafibrate may have anti-cancer properties, but more specific studies are necessary to confirm its efficacy in colon cancer prevention.",2.3685972735685406e-08,0.18491925068109216,0.11315061425420568,0.0018134264647818726,0.1885655404006581,0.11687363038714388,0.0018108015409528666,0.1593457819322195,0.09642074506939374,2.3685972735685406e-08,0.12866468967436262,0.07450693937180423
276,0.7,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevent colon cancer among patients with coronary artery disease? Answer: Research indicates bezafibrate could have anti-cancer benefits; however, dedicated studies to prove its preventive capacity against colon cancer are still needed.",9.474389094274152e-08,0.06025194365844344,0.11024232662699385,0.0072537058591274906,0.06495158443348226,0.11687363038714388,0.007243206163811466,0.0325940762930772,0.09642074506939374,9.474389094274162e-08,0.0013884385738349714,0.07450693937180423
276,0.7,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is there evidence that the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevents colon cancer in coronary artery disease patients? Answer: Current data suggest bezafibrate has potential anti-cancer effects, though conclusive studies demonstrating colon cancer prevention are lacking.",1.4211583641411212e-07,0.005686804267106105,0.10885942248554863,0.010880558788691236,0.010884363163206068,0.11687363038714388,0.0108648092457172,0.022975774861734966,0.09642074506939374,1.4211583641411244e-07,0.058546852413783323,0.07450693937180423
276,0.7,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does bezafibrate, a lipid-lowering ligand targeting peroxisome proliferator-activated receptors, reduce the risk of colon cancer in patients with coronary artery disease? Answer: Existing research suggests bezafibrate may possess anti-cancer properties, but specific investigations confirming its preventive role in colon cancer remain incomplete.",2.3685972735685406e-08,0.13689891647355923,0.11207023542023624,0.0018134264647818726,0.14093749141140366,0.11687363038714388,0.0018108015409528666,0.11055561776278777,0.09642074506939374,2.3685972735685406e-08,0.07865426909969919,0.07450693937180423
277,0.7,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The data indicate that the R14C KCNQ1 mutation by itself does not cause atrial fibrillation (AF). Instead, a model is proposed where a ""second hit,"" such as an environmental factor like hypertension that induces atrial stretch, reveals an inherited ion channel kinetic defect, the ""first hit.""",4.737194547137081e-07,0.34639717456962593,0.015380859375,0.03626852929563745,0.3746934494414096,0.0,0.03621603081905733,0.38193461069797285,0.0,4.737194547137081e-07,0.3894647667617237,0.0
277,0.7,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","These findings imply that the R14C KCNQ1 mutation alone is not enough to trigger AF. We propose a model where a ""second hit,"" for example, hypertension causing atrial stretch, exposes a genetic defect in ion channel function (the ""first hit"").",6.158352911278205e-07,0.48949801821030103,0.015380859375,0.04714908808432869,0.521296923633285,0.0,0.04708084006477453,0.5322168137473096,0.0,6.158352911278206e-07,0.5436154465889813,0.0
277,0.7,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The evidence suggests the R14C KCNQ1 mutation alone cannot cause AF. Rather, it is proposed that a ""second hit,"" like an environmental factor such as hypertension leading to atrial stretch, uncovers a pre-existing inherited ion channel defect (the ""first hit"").",6.158352911278205e-07,0.48949801821030103,0.015380859375,0.04714908808432869,0.521296923633285,0.0,0.04708084006477453,0.5322168137473096,0.0,6.158352911278206e-07,0.5436154465889813,0.0
277,0.7,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","According to the data, the R14C KCNQ1 mutation by itself is insufficient to cause atrial fibrillation. A model is suggested where a ""second hit,"" such as hypertension causing atrial stretch, unmasks an inherited ion channel kinetic defect, considered the ""first hit.""",5.921493183921352e-07,0.4641802102260093,0.015380859375,0.045335661619546816,0.495321437230027,0.0,0.045270038523821665,0.5055485666651487,0.0,5.921493183921352e-07,0.516216472400866,0.0
277,0.7,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","These results suggest that AF is not caused solely by the R14C KCNQ1 mutation. Instead, a ""second hit,"" such as an environmental trigger like hypertension-induced atrial stretch, reveals an inherited ion channel defect (the ""first hit"").",7.105791820705617e-07,0.597711602850532,0.015380859375,0.054402793943456186,0.6325225587435095,0.0,0.05432404622858601,0.646627164925055,0.0,7.105791820705622e-07,0.6613984822453651,0.0
277,0.7,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The R14C KCNQ1 mutation alone does not cause AF, according to the data. A model is proposed where a ""second hit,"" like hypertension causing atrial stretch, exposes an inherited defect in ion channel kinetics, referred to as the ""first hit.""",6.158352911278205e-07,0.48949801821030103,0.015380859375,0.04714908808432869,0.521296923633285,0.0,0.04708084006477453,0.5322168137473096,0.0,6.158352911278206e-07,0.5436154465889813,0.0
277,0.7,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Findings suggest that the R14C KCNQ1 mutation by itself is insufficient to induce AF. The hypothesis is that a ""second hit,"" for example, an environmental factor such as hypertension that promotes atrial stretch, reveals a genetic ion channel defect (the ""first hit"").",5.684633456564497e-07,0.4394875976356376,0.015380859375,0.04352223515476494,0.47000362924573524,0.0,0.0434592369828688,0.4795730802618907,0.0,5.684633456564497e-07,0.4895482253187051,0.0
277,0.7,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Data indicate that the R14C KCNQ1 mutation alone cannot cause AF. Instead, it is proposed that a ""second hit,"" including environmental factors like hypertension-induced atrial stretch, uncovers an inherited ion channel kinetic defect (the ""first hit"").",7.105791820705617e-07,0.597711602850532,0.015380859375,0.054402793943456186,0.6325225587435095,0.0,0.05432404622858601,0.646627164925055,0.0,7.105791820705622e-07,0.6613984822453651,0.0
277,0.7,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The data propose that the R14C KCNQ1 mutation alone is inadequate to cause AF. A model suggests that a ""second hit,"" such as hypertension leading to atrial stretch, unmasks an inherited ion channel defect, known as the ""first hit.""",6.395212638635058e-07,0.515473504613559,0.015380859375,0.04896251454911056,0.5479651707154458,0.0,0.0488916416057274,0.5596157879354249,0.0,6.39521263863506e-07,0.5717863235556782,0.0
277,0.7,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Evidence suggests that the R14C KCNQ1 mutation is not sufficient alone to cause AF. A model is proposed in which a ""second hit,"" such as an environmental factor like hypertension that causes atrial stretch, reveals a hereditary ion channel kinetic defect (the ""first hit"").",5.210914001850789e-07,0.39185954864638317,0.015380859375,0.0398953822252012,0.42121346507630353,0.0,0.039837633900963065,0.4295626596872273,0.0,5.210914001850789e-07,0.4382549309311554,0.0
278,0.7,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for identifying cervical spine fractures in elderly blunt trauma patients with low-energy injuries? Answer: Clinical predictors seem insufficient for assessing the cervical spine in elderly trauma patients experiencing low-energy mechanisms.,0.0,0.08154672712469946,0.052811791383219966,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.7,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors accurately detect cervical spine fractures in geriatric blunt trauma cases with low-energy mechanisms? Answer: Clinical predictors do not appear to be reliable for evaluating cervical spine injuries in elderly trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.21679532390595302,0.0879175199491562,0.005440279394345632,0.17102921705750251,0.06035379812695108,0.005432404622858621,0.13293385747468456,0.031217481789802305,7.105791820705622e-08,0.09237332013101529,0.0
278,0.7,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective in diagnosing cervical spine fractures in older adults with blunt trauma from low-energy impacts? Answer: Clinical predictors are inadequate when evaluating the cervical spine in elderly patients who sustain trauma through low-energy mechanisms.,7.10579182070559e-08,0.2542627390713559,0.11448979591836739,0.005440279394345632,0.17102921705750251,0.06035379812695108,0.005432404622858621,0.13293385747468456,0.031217481789802305,7.105791820705622e-08,0.09237332013101529,0.0
278,0.7,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors adequate for cervical spine fracture assessment in geriatric patients after low-energy blunt trauma? Answer: Clinical predictors seem to fall short in properly evaluating cervical spine injury in elderly trauma cases involving low-energy mechanisms.,1.184298636784265e-07,0.31074928436861216,0.11723513364440011,0.009067132323909377,0.2250964383277787,0.06035379812695108,0.009054007704764354,0.18850370862949672,0.031217481789802305,1.1842986367842703e-07,0.14953173397096364,0.0
278,0.7,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide an accurate evaluation of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear insufficient for cervical spine assessment in geriatric trauma patients with low-energy injury mechanisms.,4.73719454713706e-08,0.10925771172517296,0.03309159251629898,0.003626852929563759,0.06364151945538365,0.00342083210307597,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
278,0.7,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for detecting cervical spine fractures in elderly patients following low-energy blunt trauma? Answer: Clinical predictors seem inadequate for the cervical spine evaluation in geriatric trauma patients exposed to low-energy mechanisms.,0.0,0.16309345424939803,0.10977359693877556,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.7,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately evaluate cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear to be inadequate for assessing the cervical spine in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.03597725634108251,0.004276978329976561,0.0018134264647818796,0.03232407609285426,0.0017600481269510818,0.0018108015409528735,0.032084437417815526,0.0009440442898023052,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.7,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors enough to assess cervical spine fractures in geriatric patients after blunt trauma with low-energy mechanisms? Answer: Clinical predictors do not seem adequate for evaluating cervical spine injuries in elderly patients with low-energy trauma.,4.73719454713706e-08,0.18627406512072175,0.08572271883960202,0.003626852929563759,0.14285834009080567,0.06035379812695108,0.003621603081905747,0.10394632060143305,0.031217481789802305,4.737194547137081e-08,0.06252035698133351,0.0
278,0.7,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the assessment of cervical spine fractures using clinical predictors sufficient in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for cervical spine evaluation in geriatric patients experiencing low-energy trauma.,0.0,0.16309345424939803,0.10977359693877556,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.7,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors adequate for evaluating cervical spine fractures in elderly patients with blunt trauma from low-energy mechanisms? Answer: Clinical predictors appear insufficient for assessing cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.1548024872942162,0.08340640943877556,0.0018134264647818796,0.11387080321755416,0.06035379812695108,0.0018108015409528735,0.07409335745175127,0.031217481789802305,2.3685972735685406e-08,0.031748698314579826,0.0
279,0.7,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Question: Is there a difference in interfractional motion between the superior and inferior parts of the prostate bed target when assessed with RTOG consensus definitions and daily CT on rails? Answer: Studies indicate that the prostate bed target's interfractional motion, as defined by RTOG standards and monitored with daily CT on rails, exhibits some variation, particularly between the superior and inferior regions.",9.474389094274162e-08,0.22650685165245488,0.09141866298949089,0.0072537058591274906,0.2505314187764611,0.11570247933884296,0.007243206163811466,0.30047010170672106,0.15364342874730688,9.474389094274162e-08,0.3042785150514491,0.15838376207300908
279,0.7,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Question: Does interfractional motion of the prostate bed target vary between its superior and inferior sections according to RTOG consensus definitions and daily CT imaging? Answer: Evidence shows that the prostate bed target's interfractional motion, measured using RTOG guidelines and daily CT on rails, does present differences between its superior and inferior portions.",1.1842986367842703e-07,0.035409747043979145,0.07081781977302906,0.009067132323909363,0.06762580749751068,0.10146620006561571,0.009054007704764333,0.12649691797485696,0.14756944444444442,1.1842986367842703e-07,0.13126570787600889,0.15522052915518822
279,0.7,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Question: According to RTOG consensus criteria and daily CT on rails, does the interfractional motion of the prostate bed target differ between its upper and lower parts? Answer: Research findings suggest that interfractional motion of the prostate bed target, evaluated through RTOG consensus and daily CT on rails, varies between the superior and inferior areas.",7.105791820705622e-08,0.029704952598567758,0.04395831564079766,0.005440279394345618,0.05890781854246141,0.06933009420550235,0.0054324046228586,0.08787187084986892,0.09243435943865998,7.105791820705622e-08,0.11801603702051588,0.11702608471074377
279,0.7,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in prostate bed target interfractional motion between the superior and inferior clinical target volume? Answer: Studies reveal that the prostate bed target's interfractional motion under these conditions shows some variability between its superior and inferior segments.",1.8948778188548325e-07,0.07609549550805239,0.1385904960305538,0.014507411718254981,0.11403126503224525,0.17752320521981818,0.014486412327622933,0.12007328870156497,0.1875,1.8948778188548325e-07,0.09637852790998469,0.17561983471074377
279,0.7,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Question: Does the interfractional motion of the prostate bed target, as defined by RTOG consensus and observed via daily CT on rails, differ between the superior and inferior portions of the clinical target volume? Answer: Research indicates that there is some variation in interfractional motion between the superior and inferior sections of the prostate bed target.",4.737194547137081e-08,0.06841349845477307,0.018727488725832547,0.0036268529295637453,0.1323348442193768,0.1067186193080706,0.003621603081905733,0.16174810840476628,0.1311,4.737194547137081e-08,0.19232134305770465,0.15639645908598407
279,0.7,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Question: Is there a measurable difference in interfractional motion between the superior and inferior parts of the prostate bed target when assessed with daily CT on rails and RTOG consensus? Answer: Findings suggest that interfractional motion of the prostate bed target does vary between its superior and inferior regions according to RTOG consensus and daily CT imaging.,2.3685972735685406e-08,0.12475172316605088,0.08068926146265257,0.0018134264647818726,0.17822316379870884,0.12606721508892,0.0018108015409528666,0.20756549795874868,0.15051775147928995,2.3685972735685406e-08,0.21187254759339025,0.15675888796518164
279,0.7,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Question: According to daily CT on rails and RTOG consensus definitions, does interfractional motion differ between the upper and lower portions of the prostate bed clinical target volume? Answer: Research supports that there is some difference in interfractional motion between the superior and inferior parts of the prostate bed target.",1.8948778188548325e-07,0.04780377385254431,0.11885500985567371,0.014507411718254981,0.08515013250891412,0.15675920573669322,0.014486412327622933,0.09057766399688649,0.1662334593572779,1.8948778188548325e-07,0.09637852790998469,0.17561983471074377
279,0.7,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Question: Does the interfractional motion of the prostate bed target vary between its superior and inferior portions based on RTOG consensus and daily CT imaging? Answer: Studies confirm that interfractional motion does differ between the superior and inferior parts of the prostate bed clinical target volume.,2.8423167282822487e-07,0.08073467435954207,0.089400635558642,0.02176111757738247,0.038619049510410175,0.13053033170928358,0.0217296184914344,0.0011136010619048342,0.16425736961451248,2.8423167282822487e-07,0.005406749704258029,0.17561983471074377
279,0.7,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Question: Is interfractional motion of the prostate bed target different between the superior and inferior areas as defined by RTOG consensus and monitored by daily CT on rails? Answer: Research suggests a variation exists in the interfractional motion between the superior and inferior regions of the prostate bed target.,2.1317375462116866e-07,0.06240596525930009,0.059578150351541403,0.016320838183036854,0.02561913516564962,0.09347182399130445,0.0162972138685758,0.008156581668434804,0.12260005408328825,2.1317375462116866e-07,0.04359307983298999,0.15340909090909088
279,0.7,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Question: Using daily CT on rails and RTOG consensus definitions, is there a difference in interfractional motion of the prostate bed target between its superior and inferior parts? Answer: Evidence indicates that interfractional motion varies somewhat between the superior and inferior sections of the prostate bed clinical target volume.",2.1317375462116866e-07,0.004643700212637825,0.09712917075970469,0.016320838183036854,0.03337211424370734,0.13481404958677684,0.0162972138685758,0.06843024954321297,0.1657716049382716,2.1317375462116866e-07,0.07439962119120969,0.17561983471074377
280,0.7,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional magnetic resonance imaging (fMRI) forecast recovery outcomes in patients suffering from disorders of consciousness? Yes, mental imagery fMRI shows promise in predicting recovery by evaluating cognitive functions and neural activity, which supports prognosis development, though further comprehensive studies are necessary for conclusive evidence.",2.6054570009253947e-07,0.022983785459590678,0.16021867488156083,0.0199476911126006,0.004108107072295919,0.1548211860570394,0.019918816950481533,0.046706087171677346,0.12456597222222221,2.6054570009253947e-07,0.09942334187812918,0.09162848812994587
280,0.7,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it possible for mental imagery functional magnetic resonance imaging to anticipate recovery in patients with disorders of consciousness? Indeed, this imaging method can assess brain function and neural responses, providing valuable insights for prognosis, but more thorough research is needed to confirm its reliability.",3.079176455639103e-07,0.008668856826146598,0.18194706994328924,0.023574544042164344,0.04135426700446132,0.1548211860570394,0.023540420032387266,0.09322610280657129,0.12456597222222221,3.079176455639103e-07,0.1470513908673836,0.09162848812994587
280,0.7,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery fMRI have the capability to predict recovery in patients with consciousness disorders? Yes, it can analyze cognitive and neural responses to help predict recovery, yet definitive conclusions await further extensive investigation.",5.68463345656449e-07,0.2790132156256351,0.18194706994328924,0.043522235154764964,0.33681847989829716,0.1548211860570394,0.043459236982868826,0.39690851660479254,0.12456597222222221,5.684633456564497e-07,0.45942607590953655,0.09162848812994587
280,0.7,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can functional magnetic resonance imaging of mental imagery predict patient recovery in disorders of consciousness? Yes, this technique can evaluate brain activity related to cognition and aid in prognosis, but more in-depth research is essential to validate these findings.",4.500334819780225e-07,0.13793461736572876,0.18194706994328924,0.03445510283085558,0.19163647005379802,0.1548211860570394,0.034405229278104466,0.2473767826338289,0.12456597222222221,4.500334819780227e-07,0.30527539608227805,0.09162848812994587
280,0.7,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional MRI a predictor of recovery in patients with disorders of consciousness? Yes, it has potential by assessing cognitive and neural responses, assisting in prognosis formulation, though more comprehensive studies are required for definitive proof.",4.737194547137078e-07,0.16460286444788963,0.18194706994328924,0.03626852929563745,0.21903544424191335,0.1548211860570394,0.03621603081905733,0.27554765960052574,0.12456597222222221,4.737194547137081e-07,0.33426293295552956,0.09162848812994587
280,0.7,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI be used to predict recovery in patients with impaired consciousness? Yes, it helps measure cognitive function and neural activity to guide prognosis, but further detailed research is necessary to draw firm conclusions.",5.210914001850784e-07,0.2201727156027018,0.18194706994328924,0.039895382225201205,0.2761938580818617,0.1548211860570394,0.03983763390096308,0.334388159623459,0.12456597222222221,5.210914001850789e-07,0.394887554771965,0.09162848812994587
280,0.7,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery functional MRI predict outcomes for patients with consciousness disorders? Yes, it can evaluate brain function and neural response to aid prognosis, although more extensive research is needed for definitive conclusions.",5.921493183921343e-07,0.30978487429238877,0.18194706994328924,0.045335661619546844,0.368567178212877,0.1548211860570394,0.0452700385238217,0.42969833942778424,0.12456597222222221,5.921493183921352e-07,0.4933276275852183,0.09162848812994587
280,0.7,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI forecast recovery in patients with consciousness impairments? Yes, this imaging method helps assess cognitive and neural function to support prognosis, but conclusive evidence requires additional research.",6.632072365991902e-07,0.40822494710564206,0.18194706994328924,0.05077594101389248,0.47034987252281946,0.1548211860570394,0.05070244314668032,0.5350588550856097,0.12456597222222221,6.632072365991914e-07,0.602526919550209,0.09162848812994587
280,0.7,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional magnetic resonance imaging effective in predicting recovery in patients with disorders of consciousness? Yes, by analyzing cognitive and neural responses, it aids in prognosis, yet more extensive studies are needed to establish certainty.",4.974054274493931e-07,0.19200183863600495,0.18194706994328924,0.038081955760419325,0.2472063212086102,0.1548211860570394,0.038026832360010206,0.30453519647377725,0.12456597222222221,4.974054274493935e-07,0.36411589610521133,0.09162848812994587
280,0.7,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional MRI serve as a predictive tool for recovery in patients with disorders of consciousness? Yes, it can evaluate brain activity related to cognition and help formulate prognoses, but further comprehensive research is necessary to confirm its effectiveness.",4.026615365066519e-07,0.08664132297817906,0.18194706994328924,0.030828249901291835,0.13899273656837918,0.1548211860570394,0.030783626196198732,0.1933095613635527,0.12456597222222221,4.026615365066519e-07,0.24970554492746588,0.09162848812994587
281,0.7,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This study shows that hospital management can promote the creation of care programs by integrating case-mix reimbursement into hospital budgeting. Further research is needed to verify this result and to assess if care programs will eventually become established.,1.8948778188548325e-07,0.059255530107741095,0.06760362565569637,0.014507411718254981,0.08156952746132795,0.05436390532544379,0.014486412327622933,0.13467053227666392,0.01851192595229618,1.8948778188548325e-07,0.16362942378180145,0.0
281,0.7,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the use of case-mix reimbursement drive the development of process-focused care delivery? Findings indicate that hospital management can foster care program development by adopting case-mix reimbursement in budgeting processes. Additional studies are advised to confirm this and evaluate whether care programs will ultimately be established.,2.6054570009253947e-07,0.12571946008020163,0.06621678407224177,0.0199476911126006,0.14752749525312403,0.05436390532544379,0.019918816950481533,0.20211181307219617,0.01851192595229618,2.6054570009253947e-07,0.2326222952687531,0.0
281,0.7,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is process-oriented care delivery stimulated by case-mix based reimbursement? The study reveals that hospital management can encourage care program development through case-mix reimbursement adoption in budgeting. Future research should confirm these findings and explore if care programs will be established over time.,3.552895910352811e-07,0.1880033417879936,0.08842752787389466,0.02720139697172809,0.2428376750574497,0.05436390532544379,0.027162023114293,0.29975028263611403,0.01851192595229618,3.552895910352811e-07,0.33270575382573453,0.0
281,0.7,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does reimbursement based on case-mix promote the growth of process-oriented care delivery? This research shows hospital management can enhance care programs by incorporating case-mix reimbursement into budgets. Further investigation is recommended to validate this and determine if care programs will eventually be implemented.,3.316036182995957e-07,0.19691279880702517,0.0646321679690761,0.025387970506946217,0.218145062467078,0.05436390532544379,0.025351221573340132,0.2744324746518223,0.01851192595229618,3.316036182995957e-07,0.30673026742247655,0.0
281,0.7,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Can case-mix based reimbursement stimulate the advancement of process-oriented care delivery? The study demonstrates hospital management can encourage development of care programs by including case-mix reimbursement in budgeting. Future studies are needed to confirm this and see if care programs will be established in time.,2.8423167282822487e-07,0.14889246459949224,0.06571254680304554,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.7,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does adopting case-mix reimbursement stimulate process-oriented care delivery development? The study indicates hospital management can promote care program creation by integrating case-mix reimbursement within budgeting processes. Further research is required to confirm this and assess if care programs will ultimately take hold.,3.552895910352811e-07,0.22181539937628347,0.06405252787389465,0.02720139697172809,0.2428376750574497,0.05436390532544379,0.027162023114293,0.29975028263611403,0.01851192595229618,3.552895910352811e-07,0.33270575382573453,0.0
281,0.7,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is process-oriented care delivery fostered by case-mix based reimbursement? This study demonstrates hospital management's ability to stimulate care program development through case-mix reimbursement in budgeting. Future research is suggested to verify this and determine if care programs will be established over time.,3.552895910352811e-07,0.1880033417879936,0.08842752787389466,0.02720139697172809,0.2428376750574497,0.05436390532544379,0.027162023114293,0.29975028263611403,0.01851192595229618,3.552895910352811e-07,0.33270575382573453,0.0
281,0.7,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does implementing case-mix reimbursement encourage process-oriented care delivery development? The research shows hospital management can promote care programs by adopting case-mix reimbursement in their budgeting. Additional research is necessary to confirm this and evaluate whether care programs will be established in due course.,3.316036182995957e-07,0.22991980740511764,0.04092752787389464,0.025387970506946217,0.218145062467078,0.05436390532544379,0.025351221573340132,0.2744324746518223,0.01851192595229618,3.316036182995957e-07,0.30673026742247655,0.0
281,0.7,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix reimbursement stimulate the development of process-oriented care delivery? This study finds that hospital management can foster care programs by integrating case-mix reimbursement into hospital budgets. Further research is recommended to confirm this and determine if care programs will become established over time.,3.079176455639103e-07,0.20485410029268758,0.04202657605949845,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
281,0.7,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the use of case-mix based reimbursement promote process-oriented care delivery development? This study demonstrates hospital management can encourage care program creation by adopting case-mix reimbursement within budgeting. Future research is advised to verify this and assess whether care programs will indeed be established eventually.,2.8423167282822487e-07,0.11738577457403965,0.08842752787389466,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
282,0.7,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy harm the kidneys in women with multiple pregnancies? Glomerular hyperfiltration, a typical physiological change in pregnancy, does not inherently damage kidneys in women with several parities. Nevertheless, if there are pre-existing kidney issues, the elevated filtration could worsen them. Therefore, regular monitoring is advised.",7.105791820705622e-08,0.06572129226172763,0.0036284722222222204,0.005440279394345618,0.06541487868264895,0.0025385802469135646,0.0054324046228586,0.06502401390341284,0.0013290895061728418,7.105791820705622e-08,0.06453852113757153,0.0
282,0.7,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had many pregnancies? While glomerular hyperfiltration is a normal adaptation in pregnancy, it usually does not damage the kidneys in women with numerous parities. However, in cases of existing kidney disease, the higher filtration rate might aggravate the condition. Hence, routine check-ups are important.",9.474389094274162e-08,0.13184892761248346,0.0404181670096022,0.0072537058591274906,0.13241281558092544,0.039930555555555566,0.007243206163811466,0.10676333709700225,0.020399305555555556,9.474389094274162e-08,0.08004270767353683,0.0
282,0.7,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does increased glomerular filtration in pregnancy lead to kidney injury in women with higher parity? Glomerular hyperfiltration is a normal physiological response in pregnancy and typically does not cause kidney damage in women who have had multiple pregnancies. But if kidney disease pre-exists, the increased filtration can worsen the problem. Thus, regular medical follow-up is recommended.",9.474389094274162e-08,0.10664357559212201,0.022281895247419012,0.0072537058591274906,0.13241281558092544,0.039930555555555566,0.007243206163811466,0.10676333709700225,0.020399305555555556,9.474389094274162e-08,0.08004270767353683,0.0
282,0.7,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Can pregnancy-related glomerular hyperfiltration cause kidney damage in women with many childbirths? Although glomerular hyperfiltration is a common pregnancy adaptation, it generally does not harm kidneys in women with more parities. Still, if kidney disease is present before pregnancy, the enhanced filtration may exacerbate it. Therefore, ongoing monitoring is essential.",4.737194547137081e-08,0.04333377245552272,0.002370333175803374,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
282,0.7,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy damage kidneys in women with a higher number of births? This physiological increase in filtration is common and does not usually harm kidneys in women with multiple parities. Yet, if a woman has existing kidney conditions, the increased filtration could worsen these. Hence, routine surveillance is necessary.",0.0,4.440892098500626e-16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
282,0.7,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage a risk from glomerular hyperfiltration in pregnancy among women with more parities? The condition is a normal adaptation and generally does not cause kidney harm in such women. However, pre-existing kidney diseases may be aggravated by the elevated filtration rates. Thus, regular medical assessments are advised.",7.105791820705622e-08,0.020922105308265326,0.05859375,0.005440279394345618,0.006423629273291986,0.039930555555555566,0.0054324046228586,0.034887179966024195,0.020399305555555556,7.105791820705622e-08,0.06453852113757153,0.0
282,0.7,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration in pregnant women with multiple parities lead to kidney injury? It is a common physiological change that typically does not result in kidney damage. But for those with prior kidney disease, the increased filtration might worsen their condition. Therefore, routine kidney function monitoring is recommended.",9.474389094274162e-08,0.00013130388956783534,0.05859375,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
282,0.7,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does the increased glomerular filtration during pregnancy cause kidney damage in women who have given birth multiple times? This adaptation is generally harmless to the kidneys in women with several parities. However, if there are pre-existing kidney problems, the higher filtration rate could aggravate them. So, continuous medical evaluation is important.",2.3685972735685406e-08,0.0340182126061217,0.038602079862557266,0.0018134264647818726,0.035249067127276934,0.039930555555555566,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
282,0.7,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is there kidney damage from pregnancy-induced glomerular hyperfiltration in women with many childbirths? Glomerular hyperfiltration normally does not damage kidneys in women with multiple parities. Yet, if kidney disease exists beforehand, the condition may deteriorate due to the increased filtration. Hence, routine monitoring is crucial.",1.6580180914979784e-07,0.1606093417577208,0.009223025728732931,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
282,0.7,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration in pregnancy cause kidney damage in women with more parities? While it is a normal physiological adaptation that usually does not harm kidneys, existing kidney diseases may be worsened by the increased filtration rate. Therefore, regular clinical follow-up is essential.",2.1317375462116866e-07,0.11260928731625786,0.05859375,0.016320838183036854,0.14299916427904202,0.039930555555555566,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
283,0.7,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty, which corrects a deviated septum surgically, does not directly affect the size of compensatory hypertrophy in the middle turbinate.",7.10579182070559e-08,0.07922062220767723,0.006420529257067653,0.005440279394345639,0.07850661179075047,0.009245562130177493,0.005432404622858621,0.07752614926187462,0.012584237343852694,7.105791820705622e-08,0.07622888120174265,0.01643655489809337
283,0.7,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can septoplasty modify the dimensions of compensatory hypertrophy of the middle turbinate? The surgical procedure of septoplasty, aimed at correcting a deviated septum, does not directly change the size of compensatory hypertrophy in the middle turbinate.",2.36859727356853e-08,0.2363492144189161,0.1280568139792899,0.0018134264647818796,0.28314203982488495,0.16736080547269355,0.0018108015409528735,0.29070185137673343,0.17751479289940827,2.3685972735685406e-08,0.25534456301133623,0.15532544378698224
283,0.7,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is there a change in the dimensions of compensatory hypertrophy of the middle turbinate after septoplasty? Septoplasty, performed to fix a deviated septum, does not directly alter the compensatory hypertrophy size of the middle turbinate.",0.0,0.20386681781174953,0.12560880246784348,0.0,0.25205352020361715,0.1664721246301775,0.0,0.25993019270997975,0.17751479289940827,0.0,0.2235958646967564,0.15532544378698224
283,0.7,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does performing septoplasty impact the size of compensatory hypertrophy in the middle turbinate? Septoplasty, a surgery to correct septal deviation, does not directly modify the dimensions of compensatory hypertrophy in the middle turbinate.",4.73719454713706e-08,0.04895379275737888,0.06212611910617599,0.003626852929563759,0.052665391498813996,0.07054528778175498,0.003621603081905747,0.056762235460419586,0.07874936080064282,4.737194547137081e-08,0.06129798253464269,0.08673833816283957
283,0.7,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Will septoplasty influence the dimensions of compensatory hypertrophy of the middle turbinate? Septoplasty, intended to correct a deviated septum, does not cause a direct change in the compensatory hypertrophy size of the middle turbinate.",2.36859727356853e-08,0.17030718524730792,0.12301775147928985,0.0018134264647818796,0.21996908278580163,0.1655280803403752,0.0018108015409528735,0.22818149439539992,0.17751479289940827,2.3685972735685406e-08,0.1908060418737647,0.15532544378698224
283,0.7,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle",Does the surgical correction of a deviated septum via septoplasty change the size of compensatory hypertrophy of the middle turbinate? The procedure does not directly affect the dimensions of compensatory hypertrophy in the middle turbinate.,0.0,0.20386681781174953,0.12560880246784348,0.0,0.25205352020361715,0.1664721246301775,0.0,0.25993019270997975,0.17751479289940827,0.0,0.2235958646967564,0.15532544378698224
283,0.7,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is the size of compensatory hypertrophy of the middle turbinate altered by septoplasty? Septoplasty, used to correct a deviated septum, does not directly alter the hypertrophy dimensions of the middle turbinate.",9.47438909427412e-08,0.10860414147013175,0.146691220867045,0.007253705859127518,0.1170474549258258,0.1623067866199734,0.007243206163811494,0.12639880008545745,0.17751479289940827,9.474389094274162e-08,0.08544552621593926,0.15532544378698224
283,0.7,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle",Does septoplasty affect the compensatory hypertrophy dimensions of the middle turbinate? This surgical procedure to correct a deviated septum does not directly change the size of the middle turbinate's compensatory hypertrophy.,9.47438909427412e-08,0.10860414147013175,0.146691220867045,0.007253705859127518,0.1170474549258258,0.1623067866199734,0.007243206163811494,0.12639880008545745,0.17751479289940827,9.474389094274162e-08,0.08544552621593926,0.15532544378698224
283,0.7,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can the dimensions of compensatory hypertrophy in the middle turbinate be changed by septoplasty? Septoplasty, which corrects a deviated septum, does not directly modify these dimensions.",2.131737546211677e-07,0.018702208750835947,0.2130177514792899,0.016320838183036916,0.02439129088098202,0.1967455621301775,0.016297213868575862,0.07031149416059712,0.17751479289940827,2.1317375462116866e-07,0.11934888643007469,0.15532544378698224
283,0.7,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle",Does septoplasty bring about changes in the size of compensatory hypertrophy of the middle turbinate? Septoplasty as a surgery to fix a deviated septum does not directly change the hypertrophy size in the middle turbinate.,0.0,0.24464018137409793,0.1544240014792899,0.0,0.2940624402375529,0.1967455621301775,0.0,0.25993019270997975,0.17751479289940827,0.0,0.2235958646967564,0.15532544378698224
284,0.7,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research suggests Indigenous Australians might face some age-related health challenges earlier than non-Indigenous Australians because of socio-economic conditions, lifestyle, and healthcare access, but this doesn't imply they age prematurely.",3.552895910352798e-07,0.39675620177138393,0.023242630385487524,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
284,0.7,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Studies show that Indigenous Australians could develop certain health problems associated with aging sooner than non-Indigenous Australians, influenced by socio-economic status, lifestyle, and healthcare availability, though this isn't definitive evidence of premature aging.",2.605457000925386e-07,0.26322480914686164,0.023242630385487524,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
284,0.7,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Evidence points to Indigenous Australians encountering some age-related health issues earlier than non-Indigenous Australians, largely due to socio-economic, lifestyle, and healthcare disparities, but this doesn't confirm premature aging.",3.789755637709651e-07,0.4331238459422586,0.023242630385487524,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
284,0.7,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians may experience certain health conditions linked to aging at an earlier stage compared to non-Indigenous Australians, driven by socio-economic factors, lifestyle habits, and healthcare access, yet this doesn't necessarily indicate premature aging.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
284,0.7,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research highlights that health issues related to aging might appear earlier in Indigenous Australians than in non-Indigenous Australians due to socio-economic and lifestyle factors and healthcare access, although this is not conclusive proof of premature aging.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
284,0.7,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","There is research indicating that Indigenous Australians could face age-related health challenges sooner than non-Indigenous Australians because of socio-economic conditions, lifestyle choices, and healthcare access, but this shouldn't be interpreted as premature aging.",2.605457000925386e-07,0.26322480914686164,0.023242630385487524,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
284,0.7,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Studies indicate that some age-associated health problems may manifest earlier in Indigenous Australians compared to non-Indigenous Australians, influenced by socio-economic, lifestyle, and healthcare factors, but this does not equate to premature aging.",2.842316728282239e-07,0.29497350746144146,0.023242630385487524,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
284,0.7,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians might be prone to certain early onset age-related health issues compared to non-Indigenous Australians due to socio-economic and lifestyle factors and healthcare access, yet this does not necessarily mean they age prematurely.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
284,0.7,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research findings suggest Indigenous Australians may confront some health issues linked to aging earlier than non-Indigenous Australians, affected by socio-economic status, lifestyle, and healthcare access, but this doesn't imply they age prematurely.",2.842316728282239e-07,0.29497350746144146,0.023242630385487524,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
284,0.7,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","It is suggested by research that Indigenous Australians could experience some age-related health conditions earlier than non-Indigenous Australians owing to socio-economic, lifestyle, and healthcare disparities; however, this does not confirm premature aging.",2.842316728282239e-07,0.29497350746144146,0.023242630385487524,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
285,0.7,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there disagreement between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Yes, such discordance frequently occurs due to variations in training, interpretation abilities, and communication challenges. Clinicians may miss or misinterpret subtle morphological changes that experienced pathologists detect.",4.263475092423373e-07,0.14873078977074927,0.14532871972318342,0.03264167636607371,0.19948977503464427,0.11649408284023667,0.0325944277371516,0.2520554218531812,0.08543965824136704,4.263475092423373e-07,0.30652676059333217,0.05246913580246911
285,0.7,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Do clinical pathologists and clinicians differ in their reporting and interpretation of red blood cell morphology? Indeed, discrepancies often exist, arising from differences in expertise, interpretation skills, and communication barriers. Clinicians might fail to identify or correctly interpret subtle changes that pathologists recognize.",4.263475092423373e-07,0.14873078977074927,0.14532871972318342,0.03264167636607371,0.19948977503464427,0.11649408284023667,0.0325944277371516,0.2520554218531812,0.08543965824136704,4.263475092423373e-07,0.30652676059333217,0.05246913580246911
285,0.7,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there often a mismatch between clinical pathologists and clinicians regarding red blood cell morphology reporting and interpretation? Yes, this is common and is usually due to differences in training, interpretative experience, and communication lapses. Clinicians may overlook or misinterpret subtle morphological details that pathologists are trained to observe.",2.8423167282822487e-07,0.01519939714622609,0.14532871972318342,0.02176111757738247,0.06291424002889423,0.11649408284023667,0.0217296184914344,0.11229347947802282,0.08543965824136704,2.8423167282822487e-07,0.16342591695265707,0.05246913580246911
285,0.7,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are clinical pathologists and clinicians discordant in their interpretation and reporting of red blood cell morphology? Yes, due to differences in professional background, skills, and communication, such discordance frequently occurs, where clinicians might miss subtle changes that a pathologist would detect.",4.737194547137081e-07,0.197520953940181,0.14532871972318342,0.03626852929563745,0.2495001956093077,0.11649408284023667,0.03621603081905733,0.3033487162407309,0.08543965824136704,4.737194547137081e-07,0.359170494078751,0.05246913580246911
285,0.7,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a frequent discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Yes, often caused by differences in training, interpretation expertise, and communication gaps, leading clinicians to potentially overlook subtle morphological features detected by pathologists.",4.026615365066519e-07,0.12520029236055485,0.14532871972318342,0.030828249901291835,0.17539222345558425,0.11649408284023667,0.030783626196198732,0.2273628092628095,0.08543965824136704,4.026615365066519e-07,0.28120895260904044,0.05246913580246911
285,0.7,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Does discordance exist between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Yes, often resulting from varied training, interpretation capabilities, and communication issues, with clinicians sometimes missing subtle changes noticed by pathologists.",5.44777372920764e-07,0.27548249540989156,0.14532871972318342,0.04170880868998307,0.32954290328284186,0.11649408284023667,0.04164843544191593,0.38558681447770393,0.08543965824136704,5.447773729207643e-07,0.4437278821068147,0.05246913580246911
285,0.7,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a difference between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Yes, such differences are common due to disparities in training, interpretive skill, and communication, causing clinicians to occasionally misinterpret or miss subtle changes that pathologists would catch.",4.026615365066519e-07,0.12520029236055485,0.14532871972318342,0.030828249901291835,0.17539222345558425,0.11649408284023667,0.030783626196198732,0.2273628092628095,0.08543965824136704,4.026615365066519e-07,0.28120895260904044,0.05246913580246911
285,0.7,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are there discrepancies between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Yes, these occur frequently because of differences in training, interpretation skills, and communication gaps, leading clinicians to potentially overlook subtle morphological changes detected by pathologists.",4.263475092423373e-07,0.14873078977074927,0.14532871972318342,0.03264167636607371,0.19948977503464427,0.11649408284023667,0.0325944277371516,0.2520554218531812,0.08543965824136704,4.263475092423373e-07,0.30652676059333217,0.05246913580246911
285,0.7,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Do clinical pathologists and clinicians often disagree on red blood cell morphology reporting and interpretation? Yes, this discordance happens frequently due to variations in training, skill in interpretation, and communication, with clinicians possibly missing subtle changes identified by pathologists.",5.210914001850787e-07,0.2488142483277307,0.14532871972318342,0.0398953822252012,0.30214392909472654,0.11649408284023667,0.039837633900963065,0.3574159375110071,0.08543965824136704,5.210914001850789e-07,0.4147403452335632,0.05246913580246911
285,0.7,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a discordance between clinical pathologists and clinicians regarding the reporting and interpretation of red blood cell morphology? Yes, differences in training, interpretive expertise, and communication often cause discordance, with clinicians sometimes overlooking subtle changes that experienced pathologists detect.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
286,0.7,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes? Individuals diagnosed with type 2 diabetes who exhibit lower initial blood sugar levels, indicating an earlier stage of the disease, tend to experience fewer negative clinical effects despite comparable progression in blood sugar control. As many of these individuals show no symptoms at diagnosis, proactive case management is important.",2.6054570009253947e-07,0.16677855971176658,0.00901243945044583,0.0199476911126006,0.1865224487973478,0.003027653996314961,0.019918816950481533,0.1854032233313614,0.0,2.6054570009253947e-07,0.18859116980755042,0.0
286,0.7,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Does having lower fasting plasma glucose at the diagnosis of type 2 diabetes correlate with improved clinical outcomes? Patients who present with type 2 diabetes and lower baseline glucose, suggesting an earlier disease phase, demonstrate fewer adverse health events even though their glycemic progression is similar. Given that most are asymptomatic when diagnosed, active case detection is crucial.",2.3685972735685406e-08,0.0185681825888242,0.000623972610504564,0.0018134264647818726,0.01846860107447057,0.0003243433209763093,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
286,0.7,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and better patient outcomes? Those diagnosed with type 2 diabetes with lower initial blood sugar levels, possibly indicating earlier disease onset, have fewer negative clinical outcomes despite similar glycemic progression. Since most patients are asymptomatic at diagnosis, active case finding is beneficial.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
286,0.7,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are decreased fasting plasma glucose levels at type 2 diabetes diagnosis connected to improved outcomes? Individuals presenting with lower initial glycemia, potentially earlier in disease progression, experience fewer adverse clinical events despite similar glycemic trends. Most are asymptomatic at diagnosis, highlighting the need for active case identification.",2.3685972735685406e-07,0.14719978134891543,0.03566529492455417,0.018134264647818726,0.17546534344178966,0.0181755829903978,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
286,0.7,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Do lower fasting plasma glucose levels at the onset of type 2 diabetes relate to better clinical outcomes? Patients with type 2 diabetes who have lower initial blood sugar levels, likely earlier in their disease course, face fewer adverse outcomes despite similar glycemic progression. Because many are asymptomatic at diagnosis, active case detection is necessary.",4.737194547137081e-08,0.03820136687076836,0.0013169535961558843,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
286,0.7,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is there a link between lower fasting plasma glucose levels at diagnosis of type 2 diabetes and enhanced outcomes? People with type 2 diabetes who present with lower initial glycemia, suggesting an earlier disease stage, show fewer negative clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case identification is important.",4.737194547137081e-08,0.03820136687076836,0.0013169535961558843,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
286,0.7,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are lower fasting plasma glucose readings at the diagnosis of type 2 diabetes associated with better patient outcomes? Those who present with lower initial blood sugar, possibly earlier in the disease, tend to have fewer adverse clinical effects despite comparable glycemic progression. As most are asymptomatic when diagnosed, active case finding is essential.",9.474389094274162e-08,0.024597459256582077,0.03566529492455417,0.0072537058591274906,0.050302200487784,0.0181755829903978,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
286,0.7,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Does lower fasting plasma glucose at type 2 diabetes diagnosis predict improved outcomes? Individuals with lower baseline glycemia at diagnosis, indicating an earlier disease phase, have fewer adverse clinical outcomes despite similar glycemic progression. Given that most are asymptomatic, active case detection is vital.",3.079176455639103e-07,0.21464106214444767,0.03566529492455417,0.023574544042164344,0.2444582149287413,0.0181755829903978,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
286,0.7,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better outcomes? Patients with type 2 diabetes presenting with lower initial glucose, potentially earlier in the disease course, experience fewer negative clinical events despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case finding is important.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.7,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is having lower fasting plasma glucose at type 2 diabetes diagnosis associated with improved clinical outcomes? People with type 2 diabetes who have lower initial glycemia, possibly earlier in the disease, experience fewer adverse outcomes despite comparable glycemic progression. Because most are asymptomatic at diagnosis, active case detection is necessary.",1.6580180914979784e-07,0.14060432303839887,0.005077122458877266,0.012693985253473108,0.13980795482754882,0.002648319227800483,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
287,0.7,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.7,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children did not accurately assess how overweight they were. This misperception was common among their parents and even their doctors. The study highlights the importance of improving physician education to better identify obesity and overweight, enabling them to advise children and their families effectively.",1.1842986367842703e-07,0.0891118229913257,0.0015137042199295445,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
287,0.7,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children failed to acknowledge the extent of their overweight status. This misunderstanding was also present among their parents and the physicians who cared for them. The findings suggest an urgent need for enhanced training for doctors to detect obesity and overweight conditions and provide appropriate guidance to children and their families.",2.8423167282822487e-07,0.20187382556512645,0.0032536362502692488,0.02176111757738247,0.20067069546214888,0.0,0.0217296184914344,0.20409535634351572,0.0,2.8423167282822487e-07,0.20763936477824352,0.0
287,0.7,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A significant number of children underestimated how overweight they were. Their parents and even their attending physicians similarly misjudged this. The research indicates that physicians require further education to accurately identify obesity and overweight, so they can offer proper counseling to children and their families.",1.1842986367842703e-07,0.0891118229913257,0.0015137042199295445,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
287,0.7,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children did not realize the full extent of their overweight condition. This misperception extended to their parents and their doctors as well. The study emphasizes the need for better physician training in recognizing obesity and overweight to effectively counsel affected children and their families.",1.1842986367842703e-07,0.057286114576585945,0.04960087360888876,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
287,0.7,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children often underestimated their overweight status. This inaccurate perception was shared by their parents and the physicians who treat them. The results point to the necessity of educating physicians more thoroughly to identify and manage obesity and overweight in children and to provide appropriate counseling to families.",1.6580180914979784e-07,0.1450065518329824,0.0181755829903978,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
287,0.7,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their level of overweight, a misperception also held by their parents and their attending physicians. This study underscores the importance of enhancing physician education on obesity and overweight to better support children and their families through counseling.",0.0,0.034718954634262555,0.055872120818786924,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.7,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children did not recognize the true extent of their overweight status, a misunderstanding shared by their parents and doctors. The study reveals the need for improved training of physicians to identify obesity and overweight conditions and provide effective counseling to children and their families.",1.1842986367842703e-07,0.0891118229913257,0.0015137042199295445,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
287,0.7,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated how overweight they were, and this incorrect perception was also common among their parents and the physicians caring for them. This research shows the critical need for further physician education to recognize obesity and overweight and to counsel children and families appropriately.",1.1842986367842703e-07,0.11221672900999025,0.0181755829903978,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
287,0.7,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A number of children underestimated their overweight condition, with similar misperceptions found among their parents and doctors. The study highlights the necessity for better education of physicians to identify obesity and overweight and to guide children and their families effectively.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
288,0.7,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it appropriate to screen risk groups for coeliac disease? Yes, screening those at risk for coeliac disease is warranted as it enables early diagnosis and management, helping to avoid issues such as malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are particularly targeted.",9.474389094274162e-08,0.19377372633941325,0.0818621937503056,0.0072537058591274906,0.1955672377668609,0.08264462809917357,0.007243206163811466,0.17016490512830273,0.06353305785123965,9.474389094274162e-08,0.14365527681382861,0.043388429752066124
288,0.7,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should coeliac disease screening be performed in high-risk groups? Indeed, screening in these groups is justified because it allows prompt identification and treatment, preventing complications like malnutrition, osteoporosis, and lymphoma. People with family history, type 1 diabetes, Down syndrome, or autoimmune diseases are especially considered.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
288,0.7,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in risk groups justified? Yes, it is justified since early detection through screening facilitates timely treatment and prevents complications including malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune illnesses are particularly recommended for screening.",4.737194547137081e-08,0.09978591187697106,0.10072314049586772,0.0036268529295637453,0.07296491567452756,0.08264462809917357,0.003621603081905733,0.04500176217429708,0.06353305785123965,4.737194547137081e-08,0.015821905303945005,0.043388429752066124
288,0.7,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Does coeliac disease screening make sense in risk groups? Yes, screening is justified for at-risk populations as it helps detect the disease early, allowing treatment that prevents complications such as malnutrition, osteoporosis, and lymphoma. High-risk individuals include those with family history, type 1 diabetes, Down syndrome, or autoimmune conditions.",2.3685972735685406e-08,0.12083932107480422,0.10072314049586772,0.0018134264647818726,0.09447112089549092,0.08264462809917357,0.0018108015409528666,0.06698066889307208,0.06353305785123965,2.3685972735685406e-08,0.03829476115600272,0.043388429752066124
288,0.7,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it justified to screen risk groups for coeliac disease? Absolutely, screening in at-risk groups is justified because it supports early diagnosis and intervention, reducing the risk of malnutrition, osteoporosis, and lymphoma. People with family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially considered for this screening.",2.3685972735685406e-08,0.16166131559505859,0.10072314049586772,0.0018134264647818726,0.13614381729605984,0.08264462809917357,0.0018108015409528666,0.1095402833118686,0.06353305785123965,2.3685972735685406e-08,0.08177987309574108,0.043388429752066124
288,0.7,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should individuals in risk groups be screened for coeliac disease? Yes, screening is justified as it promotes early detection and treatment, helping avert complications like malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or autoimmune disorders are particularly recommended for screening.",7.105791820705622e-08,0.0782797066560077,0.10072314049586772,0.005440279394345618,0.05098600895575256,0.08264462809917357,0.0054324046228586,0.02252890632223936,0.06353305785123965,7.105791820705622e-08,0.007167612920754518,0.043388429752066124
288,0.7,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening warranted in high-risk groups? Yes, screening is warranted because it facilitates early diagnosis and treatment, preventing complications such as malnutrition, osteoporosis, and lymphoma. Individuals with family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially targeted.",1.6580180914979784e-07,0.012692071549718964,0.10072314049586772,0.012693985253473108,0.042104414110259114,0.08264462809917357,0.012675610786670066,0.0727812734820863,0.06353305785123965,1.6580180914979784e-07,0.10480608248467238,0.043388429752066124
288,0.7,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it reasonable to conduct coeliac disease screening in risk groups? Yes, it is reasonable since early screening allows for prompt treatment and reduces the risk of complications like malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or autoimmune conditions are specifically considered.",2.3685972735685406e-08,0.12083932107480422,0.10072314049586772,0.0018134264647818726,0.09447112089549092,0.08264462809917357,0.0018108015409528666,0.06698066889307208,0.06353305785123965,2.3685972735685406e-08,0.03829476115600272,0.043388429752066124
288,0.7,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening in risk groups appropriate? Yes, it is appropriate as it enables early detection and treatment, helping to avoid complications such as malnutrition, osteoporosis, and lymphoma. People with family history, type 1 diabetes, Down syndrome, or autoimmune diseases are especially considered for screening.",9.474389094274162e-08,0.05630079993723269,0.10072314049586772,0.0072537058591274906,0.028513153103694844,0.08264462809917357,0.007243206163811466,0.0004606119024601618,0.06353305785123965,9.474389094274162e-08,0.030698110330948936,0.043388429752066124
288,0.7,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in risk groups justified? Yes, it is justified because it aids in early diagnosis and treatment, preventing complications including malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are particularly recommended.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
289,0.7,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is family practice at residency teaching sites representative of community practice? Answer: The residency training locations at Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to those identified in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,0.7,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Do residency teaching sites offer family practice experiences that mirror community practice? Answer: Residency training sites at Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those documented in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,0.7,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice during residency at teaching sites reflect typical community practice? Answer: The Northeastern Ohio Universities College of Medicine residency sites deliver patient care opportunities akin to those reported in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.7,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Are family practice experiences at residency teaching sites aligned with community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care opportunities comparable to those found in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.7,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,"Question: Does the family practice at residency teaching locations represent community practice? Answer: At Northeastern Ohio Universities College of Medicine, residency training sites provide patient care opportunities similar to those identified in a national survey of family and general practitioners.",2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.7,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is family practice at residency sites indicative of community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine deliver patient care opportunities that closely resemble those found in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,0.7,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice at residency teaching sites reflect the nature of community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.7,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Are family practice residency sites reflective of community practice? Answer: Patient care opportunities at Northeastern Ohio Universities College of Medicine residency sites align with those identified in a national survey of family and general practitioners.,1.184298636784265e-07,0.17313980294223397,0.02854671280276816,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
289,0.7,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice at residency training sites mirror community practice? Answer: The residency training locations at Northeastern Ohio Universities College of Medicine offer patient care opportunities similar to those found in a national survey of family and general practitioners.,2.36859727356853e-08,0.06086381724377565,0.025623268698060954,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.7,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is family practice conducted at residency teaching sites representative of community practice? Answer: Residency training sites at Northeastern Ohio Universities College of Medicine provide patient care experiences that are similar to those noted in a national survey of family and general practitioners.,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
290,0.7,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does measurement of end-tidal carbon dioxide correlate with arterial carbon dioxide levels in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 can be useful for tracking or screening abnormal PaCO2 values in ELBW infants within the first week of life.,2.3685972735685406e-08,0.12924217724058495,0.10859088685232993,0.0018134264647818726,0.0795734343365817,0.04612592212120878,0.0018108015409528666,0.037165035928461876,0.015621063240110858,2.3685972735685406e-08,0.015748356968136257,0.0
290,0.7,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants during the initial week of life? End-tidal CO2 and arterial CO2 show good correlation and agreement in ELBW infants with EtCO2 levels between 30-50 mmHg. Using end-tidal CO2 monitoring helps in trending or screening for abnormal PaCO2 in these infants during their first week.,1.1842986367842703e-07,0.027282716207692292,0.10280086180363188,0.009067132323909363,0.005267714549224145,0.06127385111529162,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.7,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Do end-tidal carbon dioxide measurements align with arterial carbon dioxide in extremely low birth weight infants during their first week? There is a strong correlation and agreement between EtCO2 and arterial CO2 in ELBW infants when EtCO2 is in the 30-50 mmHg range. End-tidal CO2 monitoring is beneficial for trending or detecting abnormal PaCO2 values in these infants in the first week.,1.1842986367842703e-07,0.07273499034277053,0.1353024982207859,0.009067132323909363,0.005267714549224145,0.06127385111529162,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.7,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is end-tidal carbon dioxide measurement correlated with arterial carbon dioxide in ELBW infants within the first week of life? A good correlation and agreement exist between end-tidal and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 can assist in trending or screening for abnormal PaCO2 values in the first week.,2.1317375462116866e-07,0.046919146676343004,0.09827598732079677,0.016320838183036854,0.08848041338629553,0.04342261144587013,0.0162972138685758,0.12988904873470375,0.015621063240110858,2.1317375462116866e-07,0.15415067982725983,0.0
290,0.7,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement reflect arterial CO2 levels in extremely low birth weight infants during their first week? There is notable correlation and agreement between EtCO2 and arterial CO2 in ELBW infants within the 30-50 mmHg EtCO2 range. End-tidal CO2 monitoring is useful for trending or screening abnormal PaCO2 values in the initial week of life.,2.6054570009253947e-07,0.03576411850371386,0.13173985346533218,0.0199476911126006,0.10009280110859997,0.06127385111529162,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
290,0.7,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a relationship between end-tidal and arterial carbon dioxide measurements in extremely low birth weight infants in the first week? End-tidal CO2 correlates well and agrees with arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. Monitoring EtCO2 can help trend or screen for abnormal PaCO2 values in these infants during their first week.,1.8948778188548325e-07,0.0677564108509574,0.16805170821791318,0.014507411718254981,0.046025579838325115,0.06127385111529162,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
290,0.7,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement correspond with arterial CO2 in extremely low birth weight infants during their first week of life? Strong correlation and agreement are found between end-tidal and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring aids in trending or screening abnormal PaCO2 in the first week.,2.8423167282822487e-07,0.08071890652673686,0.11268838641860522,0.02176111757738247,0.1449414315003752,0.042412904369729484,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
290,0.7,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal CO2 and arterial CO2 in ELBW infants during the first week? End-tidal CO2 and arterial CO2 measurements show good agreement and correlation in ELBW infants when EtCO2 is 30-50 mmHg. End-tidal CO2 monitoring is helpful for trending or screening abnormal PaCO2 in the first week of life.,3.316036182995957e-07,0.2647814009741043,0.02616316781514469,0.025387970506946217,0.26598018444814997,0.016589435439710663,0.025351221573340132,0.28065100298382495,0.024309492315444707,3.316036182995957e-07,0.2796061499364164,0.020399305555555556
290,0.7,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Do measurements of end-tidal carbon dioxide correlate with arterial carbon dioxide in extremely low birth weight infants in the initial week? There is good correlation and agreement between EtCO2 and arterial CO2 for EtCO2 levels from 30 to 50 mmHg in ELBW infants. End-tidal CO2 monitoring can help trend or screen abnormal PaCO2 values in these infants during the first week.,1.4211583641411244e-07,0.07855305650797328,0.15138982944744492,0.010880558788691236,0.011539403767156564,0.06127385111529162,0.0108648092457172,0.07677922342075583,0.015621063240110858,1.4211583641411244e-07,0.10008345855698497,0.0
290,0.7,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,"In extremely low birth weight infants, does end-tidal CO2 measurement correlate with arterial CO2 within the first week? There is strong correlation and agreement between EtCO2 and arterial CO2 in ELBW infants at EtCO2 levels of 30-50 mmHg. End-tidal CO2 monitoring is useful for trending or screening for abnormal PaCO2 in the first week of life.",2.6054570009253947e-07,0.06096947052407575,0.1136878028924694,0.0199476911126006,0.10009280110859997,0.06127385111529162,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
291,0.7,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? Antral follicle count is a valuable method for forecasting IVF results. Although age and FSH are important metrics, the antral follicle count may better reflect ovarian reserve and response, leading to more accurate IVF success predictions. Using all indicators together could yield the most thorough prediction.",3.552895910352811e-07,0.18791986216356094,0.019715239036791135,0.027201396971728173,0.21255674872830088,0.010062058689684523,0.027162023114293013,0.23001643060197097,0.0,3.552895910352811e-07,0.23361485118150416,0.0
291,0.7,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle assessment predict IVF results better than age and FSH? The antral follicle count is an effective tool for anticipating IVF outcomes. While age and FSH remain significant markers, antral follicle assessment likely offers a clearer picture of ovarian reserve and response, thus improving prediction accuracy. Combining these measures might provide the best overall prognosis.",4.500334819780227e-07,0.2641370498269935,0.012288599742019943,0.03445510283085566,0.28446984482665805,0.008830589849108363,0.03440522927810448,0.30147539458411465,0.0,4.500334819780227e-07,0.30637420546393335,0.0
291,0.7,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle assessment outperform age and FSH in predicting IVF outcomes? Antral follicle count serves as a helpful predictor for IVF success. Though age and FSH are crucial factors, antral follicle assessment may more accurately gauge ovarian reserve and responsiveness, enhancing the prediction of IVF outcomes. Integrating all these factors may deliver the most comprehensive prediction.",4.500334819780227e-07,0.28889230627556284,0.005887158785082738,0.03445510283085566,0.3096751968470195,0.009305681913074824,0.03440522927810448,0.30147539458411465,0.0,4.500334819780227e-07,0.30637420546393335,0.0
291,0.7,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is assessing antral follicles better than age and FSH levels for predicting IVF success? Antral follicle count is a useful predictor for IVF results. Despite the importance of age and FSH, antral follicle assessment can provide a more precise evaluation of ovarian reserve and responsiveness, leading to improved IVF outcome prediction. The combination of all factors may offer the most complete forecast.",3.316036182995957e-07,0.11570240787669395,0.08900684536619449,0.0253879705069463,0.1722531158166678,0.027006172839506164,0.025351221573340146,0.21292199724267125,0.0,3.316036182995957e-07,0.21622310846963533,0.0
291,0.7,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","How does antral follicle assessment compare to age and FSH as a predictor of IVF outcomes? Antral follicle count is a valuable tool in predicting IVF success. While age and FSH are important, antral follicle assessment may more accurately represent ovarian reserve and reactivity, thus offering better prediction. Using all these indicators together could provide the most thorough assessment.",4.026615365066519e-07,0.24921064166788653,0.0014194519346490547,0.030828249901291918,0.2721883176119331,0.008035149474543441,0.030783626196198746,0.2651077504132404,0.0,4.026615365066519e-07,0.26933293378358325,0.0
291,0.7,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a better predictor than age and FSH for IVF outcomes? Antral follicle count is an effective way to predict IVF results. Age and FSH are important, but antral follicle number might more precisely reflect ovarian reserve and responsiveness, improving prediction accuracy. Combining these factors is likely to produce the most comprehensive prediction.",4.737194547137081e-07,0.28412582337780234,0.010260476739715405,0.036268529295637536,0.3032857492730088,0.008494246887209983,0.036216030819057346,0.320167527596269,0.0,4.737194547137081e-07,0.32542240043462645,0.0
291,0.7,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does assessing antral follicles offer a better IVF outcome prediction than age and FSH? Antral follicle count is a strong predictor of IVF success. Even though age and FSH levels are key, antral follicle assessment may more accurately indicate ovarian reserve and responsiveness, thus providing a more precise prediction. The best forecast may come from combining all three factors.",4.026615365066519e-07,0.1684842412002272,0.08731727985311766,0.030828249901291918,0.22354641020421706,0.027006172839506164,0.030783626196198746,0.2651077504132404,0.0,4.026615365066519e-07,0.26933293378358325,0.0
291,0.7,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle count predict IVF success more effectively than age and FSH? Antral follicle assessment is a useful measure for forecasting IVF outcomes. Age and FSH are significant as well, but antral follicle count potentially gives a better estimate of ovarian reserve and responsiveness, resulting in more accurate predictions. Combining these measures might yield the most reliable forecast.",4.026615365066519e-07,0.22530901475202691,0.016131912702142093,0.030828249901291918,0.24786736390807462,0.00946790753338371,0.030783626196198746,0.2651077504132404,0.0,4.026615365066519e-07,0.26933293378358325,0.0
291,0.7,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a more reliable predictor of IVF outcome than age and FSH? Antral follicle count is a helpful tool for predicting IVF results. Although age and FSH remain important, antral follicle assessment may better reflect ovarian reserve and response, leading to superior IVF success predictions. Using all these factors together could provide the most comprehensive prediction.",4.026615365066519e-07,0.22530901475202647,0.01613191270214208,0.030828249901291918,0.24786736390807462,0.00946790753338371,0.030783626196198746,0.2651077504132404,0.0,4.026615365066519e-07,0.26933293378358325,0.0
291,0.7,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","How effective is antral follicle assessment compared to age and FSH in predicting IVF success? Antral follicle count serves as a valuable predictor for IVF outcomes. While age and FSH are important indicators, antral follicle assessment might give a more accurate representation of ovarian reserve and responsiveness, yielding improved prediction accuracy. The most thorough forecast may involve considering all these factors.",3.552895910352811e-07,0.2110247681822255,0.0027477909005118456,0.027201396971728173,0.23605326332355325,0.006850398413186961,0.027162023114293013,0.23001643060197097,0.0,3.552895910352811e-07,0.23361485118150416,0.0
292,0.7,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Patients and their carers found the reorganization of care to include a primary angioplasty service acceptable. Satisfaction was generally high regardless of the care type, except for discharge and aftercare.",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
292,0.7,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty replace thrombolysis effectively? Offering primary angioplasty through a restructured care system was well-received by patients and carers. High satisfaction levels were reported across care types, except for discharge and aftercare.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.7,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable substitute for thrombolysis? Patients and carers accepted the reorganization to provide primary angioplasty. Satisfaction remained high regardless of care type, except in discharge and aftercare.",3.316036182995945e-07,0.3294254782131407,0.046400951814396206,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
292,0.7,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does primary angioplasty serve as an acceptable alternative to thrombolysis? The shift to provide primary angioplasty was accepted by patients and carers. Satisfaction was high overall, though discharge and aftercare were exceptions.",2.842316728282239e-07,0.3074532766538183,0.014178729592174005,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
292,0.7,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is it acceptable to reorganize care to offer primary angioplasty instead of thrombolysis? Patients and carers accepted the new primary angioplasty service, with high satisfaction levels across care types except for discharge and aftercare.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.7,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? Patients and carers accepted the care restructuring to provide primary angioplasty, with high satisfaction regardless of care type, except for discharge and aftercare.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.7,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is primary angioplasty an acceptable option compared to thrombolysis? Reorganizing care to include primary angioplasty was well accepted by patients and carers. Satisfaction was consistently high except for issues related to discharge and aftercare.,2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.7,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be considered an acceptable alternative to thrombolysis? Patients and carers accepted the introduction of primary angioplasty services. Satisfaction levels were high regardless of care type, except for discharge and aftercare.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.7,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a feasible alternative to thrombolysis? The reorganization to offer primary angioplasty was accepted by patients and carers, with high satisfaction overall except for discharge and aftercare.",3.552895910352798e-07,0.4140273109215489,0.01073565688984203,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
292,0.7,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is the provision of primary angioplasty an acceptable alternative to thrombolysis? Patients and carers found the reorganized care to include primary angioplasty acceptable, with high satisfaction levels except during discharge and aftercare.",2.842316728282239e-07,0.3074532766538183,0.014178729592174005,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
293,0.7,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better outcomes? Yes, lower fasting plasma glucose at diagnosis usually reflects superior glycemic control and correlates with improved outcomes, such as fewer diabetes complications and enhanced overall health, resulting in a better prognosis for patients.",1.4211583641411244e-07,0.12828261763103477,0.1584165518824609,0.010880558788691236,0.10824891142626436,0.15244020061728394,0.0108648092457172,0.08759390673174794,0.14366729678638948,1.4211583641411244e-07,0.06295116981528093,0.12901701323251416
293,0.7,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do lower fasting plasma glucose readings at the diagnosis of type 2 diabetes correspond to improved health outcomes? Indeed, lower fasting glucose levels at diagnosis typically indicate more effective glycemic control and are associated with better outcomes, including reduced diabetes-related complications and improved general health, leading to a more favorable prognosis.",1.4211583641411244e-07,0.15600850485343232,0.17835543730057374,0.010880558788691236,0.13654063308177244,0.1728395061728395,0.0108648092457172,0.08759390673174794,0.14366729678638948,1.4211583641411244e-07,0.06295116981528093,0.12901701323251416
293,0.7,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and improved outcomes? Yes, lower fasting glucose at diagnosis is generally a sign of better glycemic regulation and is linked with enhanced outcomes, like decreased complications from diabetes and better overall health, contributing to improved patient prognosis.",1.4211583641411244e-07,0.12828261763103477,0.1584165518824609,0.010880558788691236,0.13654063308177244,0.1728395061728395,0.0108648092457172,0.08759390673174794,0.14366729678638948,1.4211583641411244e-07,0.06295116981528093,0.12901701323251416
293,0.7,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are decreased fasting plasma glucose levels at the point of type 2 diabetes diagnosis related to better patient outcomes? Yes, patients with lower fasting glucose at diagnosis tend to have superior glycemic control, which is associated with fewer diabetes complications and an improved health status, resulting in a better prognosis.",1.6580180914979784e-07,0.1635316847583117,0.19834710743801648,0.012693985253473108,0.11592134587903669,0.1728395061728395,0.012675610786670066,0.06654049753391478,0.14366729678638948,1.6580180914979784e-07,0.04144496459431757,0.12901701323251416
293,0.7,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Does having lower fasting plasma glucose at diagnosis of type 2 diabetes predict improved outcomes? Yes, lower fasting plasma glucose at diagnosis often signals better glycemic control, correlating with fewer diabetes-related complications and better overall health, which leads to more favorable patient outcomes.",3.316036182995957e-07,0.15565403805941092,0.0814734770508726,0.025387970506946217,0.17695582867770598,0.07641876110344575,0.025351221573340132,0.19869972714619788,0.06916035741458525,3.316036182995957e-07,0.19472680428410083,0.07788479993813871
293,0.7,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is lower fasting plasma glucose at the time of type 2 diabetes diagnosis linked to enhanced outcomes? Yes, lower glucose levels at diagnosis generally indicate better glycemic management and are associated with improved outcomes such as fewer diabetes complications and better health status, yielding a better prognosis.",2.3685972735685406e-07,0.10035278313677942,0.19834710743801648,0.018134264647818726,0.05138282474146516,0.1728395061728395,0.018108015409528666,0.0005825297421186981,0.14366729678638948,2.3685972735685406e-07,0.025996316201214675,0.12901701323251416
293,0.7,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are better outcomes associated with lower fasting plasma glucose levels at the diagnosis of type 2 diabetes? Yes, generally, lower fasting glucose at diagnosis reflects improved glycemic control and correlates with fewer complications and improved overall health, leading to enhanced patient prognosis.",3.552895910352811e-07,0.048528604236297124,0.17397210743801647,0.02720139697172809,0.06640021091491821,0.1728395061728395,0.027162023114293,0.12004545804649869,0.14366729678638948,3.552895910352811e-07,0.1496102721683905,0.12901701323251416
293,0.7,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Does a lower fasting plasma glucose level at type 2 diabetes diagnosis lead to improved outcomes? Yes, it typically signifies superior glycemic control and is connected to better outcomes including fewer diabetes complications and improved health, resulting in a better patient prognosis.",3.552895910352811e-07,0.014716546648007256,0.19834710743801648,0.02720139697172809,0.06640021091491821,0.1728395061728395,0.027162023114293,0.12004545804649869,0.14366729678638948,3.552895910352811e-07,0.1496102721683905,0.12901701323251416
293,0.7,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there a connection between lower fasting plasma glucose at diagnosis and better outcomes in type 2 diabetes? Yes, lower fasting glucose at diagnosis usually means improved glycemic control and is linked to reduced diabetes-related complications and enhanced overall health, leading to a better prognosis.",2.8423167282822487e-07,0.038619049510410175,0.13053033170928355,0.02176111757738247,0.026318953082266283,0.14959687578735198,0.0217296184914344,0.04593748589277524,0.14366729678638948,2.8423167282822487e-07,0.07362436519046911,0.12901701323251416
293,0.7,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are improved outcomes linked to lower fasting plasma glucose levels at diagnosis of type 2 diabetes? Yes, lower fasting glucose at diagnosis generally indicates better glycemic control and associates with fewer complications and improved health, which translates to a more favorable patient prognosis.",3.316036182995957e-07,0.05663301226513129,0.15084710743801646,0.025387970506946217,0.04170759832454651,0.1728395061728395,0.025351221573340132,0.09472765006220696,0.14366729678638948,3.316036182995957e-07,0.12363478576513254,0.12901701323251416
294,0.7,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the position of the head affect anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the lens appears more mobile in the affected eye, causing a shallower anterior chamber when the head is prone. This mobility might cause transient pupillary block during certain activities.",3.079176455639103e-07,0.26217668610089717,0.009531858499372992,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
294,0.7,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Clinically, in unilateral pseudoexfoliation, the affected eye's lens shows increased mobility, leading to a shallower anterior chamber when the patient is prone. This could potentially cause transient pupillary block during some actions.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
294,0.7,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","How does head positioning impact anterior chamber depth in pseudoexfoliation syndrome? Patients with unilateral pseudoexfoliation have a more mobile lens in the affected eye, resulting in a shallower anterior chamber when lying prone. This may contribute to transient pupillary block during various activities.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
294,0.7,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head posture affect anterior chamber depth in pseudoexfoliation syndrome? In unilateral cases, the lens of the affected eye is more mobile, causing the anterior chamber to become shallower in the prone position. This might lead to transient pupillary block during certain movements.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
294,0.7,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Can head positioning change anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of unilateral pseudoexfoliation patients is more mobile, making the anterior chamber shallower when prone, which could induce transient pupillary block in some activities.",4.974054274493933e-07,0.42943968554461387,0.007560004415585759,0.038081955760419325,0.4495250979021934,0.0,0.0380268323600102,0.4595323293784399,0.0,4.974054274493935e-07,0.47000362924573613,0.0
294,0.7,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is there an effect of head position on anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation, the affected eye's lens mobility increases, resulting in a shallower anterior chamber when prone, possibly causing transient pupillary block during activities.",5.210914001850786e-07,0.4570939172363908,0.006850398413186968,0.0398953822252012,0.47692407209030874,0.0,0.039837633900963065,0.48770320634513675,0.0,5.210914001850789e-07,0.49899116611898764,0.0
294,0.7,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does anterior chamber depth vary with head positioning in pseudoexfoliation syndrome? In unilateral clinically evident pseudoexfoliation, the affected eye’s lens is more mobile, leading to a shallower anterior chamber in the prone position, which may cause transient pupillary block during certain tasks.",4.263475092423373e-07,0.350784405599196,0.009481571252693131,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
294,0.7,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","How does the position of the head influence anterior chamber depth in pseudoexfoliation syndrome? Unilateral pseudoexfoliation patients have a more mobile lens in the affected eye, making the anterior chamber shallower when prone, potentially leading to transient pupillary block during activities.",4.500334819780227e-07,0.3763223196292742,0.008873007807591211,0.03445510283085558,0.3968813644167746,0.0,0.034405229278104466,0.4054651081081637,0.0,4.500334819780227e-07,0.41443377809092397,0.0
294,0.7,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the anterior chamber depth change with head positioning in pseudoexfoliation syndrome? The lens of the affected eye in unilateral pseudoexfoliation appears more mobile, resulting in a shallower anterior chamber when prone, which might cause transient pupillary block during some actions.",4.500334819780227e-07,0.3763223196292742,0.008873007807591211,0.03445510283085558,0.3968813644167746,0.0,0.034405229278104466,0.4054651081081637,0.0,4.500334819780227e-07,0.41443377809092397,0.0
294,0.7,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is head positioning a factor in anterior chamber depth alteration in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, increased lens mobility in the affected eye causes a shallower anterior chamber in the prone position, possibly leading to transient pupillary block during activities.",4.263475092423373e-07,0.38459646318748586,0.014795631245663209,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
295,0.7,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission enhance driving performance in elderly drivers? Yes, automatic transmission can greatly enhance driving performance in elderly drivers by making the driving process simpler and removing the necessity to manually shift gears.",4.73719454713706e-08,0.07084304860405854,0.0077947845804988425,0.003626852929563759,0.06826962748437815,0.005337781071787839,0.003621603081905747,0.0679408627921636,0.0038554765460572307,4.737194547137081e-08,0.06742663438990348,0.0020762161887946107
295,0.7,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission lead to better driving habits in older adults? Indeed, automatic transmission can improve driving habits in older adults significantly by easing the driving task and eliminating manual gear changes.",9.47438909427412e-08,0.10219549717311693,0.012688614540466353,0.007253705859127518,0.09526267634161778,0.02108241839920154,0.007243206163811494,0.09299714524385472,0.02591502261674699,9.474389094274162e-08,0.09020969383952471,0.031217481789802305
295,0.7,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is there an improvement in driving behavior among seniors with automatic transmission? Yes, seniors benefit from automatic transmission as it simplifies driving and removes the need for manual gear shifts, thereby improving their driving behavior.",2.36859727356853e-08,0.16905451471530375,0.13888888888888887,0.0018134264647818796,0.09246712753736652,0.08740894901144641,0.0018108015409528735,0.0532461814011187,0.06035379812695108,2.3685972735685406e-08,0.01157300047041776,0.031217481789802305
295,0.7,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does using automatic transmission positively affect the driving skills of older drivers? Yes, using automatic transmission can positively affect older drivers' skills by simplifying gear changes and making driving easier overall.",1.184298636784265e-07,0.09473806435069188,0.04012345679012341,0.009067132323909398,0.08454785777436058,0.05297017350124232,0.009054007704764368,0.0802852112234036,0.06035379812695108,1.1842986367842703e-07,0.1265773380103994,0.031217481789802305
295,0.7,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission aid older drivers in exhibiting better driving behavior? Yes, automatic transmission aids older drivers by simplifying the driving process and removing the complexity of manual gear changes, which improves their driving behavior.",2.36859727356853e-08,0.08750778759060385,0.08029513888888887,0.0018134264647818796,0.09246712753736652,0.08740894901144641,0.0018108015409528735,0.0532461814011187,0.06035379812695108,2.3685972735685406e-08,0.01157300047041776,0.031217481789802305
295,0.7,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission contribute to safer driving among older individuals? Yes, it contributes by making driving less complex through automatic gear changes, thereby improving driving safety and behavior in older individuals.",1.184298636784265e-07,0.04389137176129676,0.13888888888888887,0.009067132323909398,0.03674460394264045,0.08740894901144641,0.009054007704764368,0.0802852112234036,0.06035379812695108,1.1842986367842703e-07,0.1265773380103994,0.031217481789802305
295,0.7,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Will automatic transmission improve the driving experience for elderly drivers? Absolutely, it improves the driving experience by simplifying gear shifting and reducing the cognitive load on elderly drivers.",1.894877818854824e-07,0.16415761509059523,0.06528888888888888,0.014507411718255037,0.1992629097968579,0.0490089490114464,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.7,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does the use of automatic transmission enhance the driving ability of older drivers? Yes, it enhances their ability by eliminating the need to manually change gears, making driving easier and more manageable for them.",4.73719454713706e-08,0.13920155156562197,0.13888888888888887,0.003626852929563759,0.061695468870612835,0.08740894901144641,0.003621603081905747,0.02149748308653887,0.06035379812695108,4.737194547137081e-08,0.02121682235257394,0.031217481789802305
295,0.7,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is automatic transmission beneficial for improving driving behavior in older adults? Yes, it benefits older adults by simplifying the gear shifting process, which helps improve their overall driving behavior.",1.658018091497971e-07,0.02510149972565401,0.13888888888888887,0.012693985253473157,0.10820356792478414,0.08740894901144641,0.012675610786670115,0.15439318337712526,0.06035379812695108,1.6580180914979784e-07,0.20353837914652884,0.031217481789802305
295,0.7,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission have a positive impact on driving behavior in senior drivers? Yes, it positively impacts senior drivers by simplifying the driving process and removing the need for manual gear changes, thereby improving their driving behavior.",2.36859727356853e-08,0.2262129285552521,0.13888888888888887,0.0018134264647818796,0.1513076275602998,0.08740894901144641,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
296,0.7,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does the use of provider service networks lead to lower costs compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to reduce PMPM expenditures. Demonstration PSNs achieved somewhat larger expenditure reductions than Demonstration HMOs. PSNs seem to be an effective approach for providing care to Medicaid enrollees.,7.105791820705622e-08,0.018595055433633156,0.05157024793388431,0.005440279394345618,0.029746267566417295,0.017538265306122455,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
296,0.7,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lower expenses relative to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows reductions in PMPM spending. Demonstration PSNs caused slightly bigger cuts in expenditures than Demonstration HMOs. PSNs appear to be a beneficial model for Medicaid care delivery.,2.6054570009253947e-07,0.1680861527934585,0.030303707291162208,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.7,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with decreased expenditures compared to HMOs or primary care case management within Florida’s Medicaid program? The Medicaid Demonstration in Florida appears to reduce PMPM costs. Demonstration PSNs led to marginally greater expenditure reductions than Demonstration HMOs. PSNs are a promising method for serving Medicaid enrollees.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.7,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks result in lower Medicaid spending than HMOs or primary care case management in Florida? Florida's Medicaid Demonstration produces lower PMPM expenditures. Demonstration PSNs show slightly more reduction in costs than Demonstration HMOs. PSNs appear to be a promising care delivery model for Medicaid.,2.8423167282822487e-07,0.1600967333097434,0.05157024793388431,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
296,0.7,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is there a reduction in expenditures when using provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida yields lower PMPM expenditures. Demonstration PSNs show a slightly greater decrease in costs than Demonstration HMOs. PSNs seem to be an effective model for Medicaid care delivery.,9.474389094274162e-08,0.0002459167654373928,0.05157024793388431,0.0072537058591274906,0.04843840057857163,0.017538265306122455,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
296,0.7,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to reduced costs compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration results in lower PMPM expenditures. Demonstration PSNs generated slightly larger expenditure reductions than Demonstration HMOs. PSNs appear to be a promising approach for Medicaid care.,2.6054570009253947e-07,0.1680861527934585,0.030303707291162205,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.7,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to lower PMPM spending. Demonstration PSNs achieved slightly greater cost reductions compared to Demonstration HMOs. PSNs look to be a promising model for care delivery to Medicaid enrollees.,1.4211583641411244e-07,0.03749441121741004,0.05157024793388431,0.010880558788691236,0.08690468140636742,0.017538265306122455,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
296,0.7,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks help reduce Medicaid expenditures compared to HMOs or primary care case management in Florida? The Florida Medicaid Demonstration results in lower PMPM costs. Demonstration PSNs showed slightly more reduction in expenditures than Demonstration HMOs. PSNs seem to be an encouraging model for delivering care to Medicaid enrollees.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.7,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks more cost-effective than HMOs or primary care case management in Florida’s Medicaid program? The Medicaid Demonstration in Florida is linked to lower PMPM expenditures. Demonstration PSNs produced marginally greater expenditure reductions than Demonstration HMOs. PSNs appear to be a promising way to deliver care to Medicaid enrollees.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.7,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does Florida's Medicaid program see lower expenditures with provider service networks compared to HMOs or primary care case management? The Medicaid Demonstration indicates lower PMPM expenditures. Demonstration PSNs caused slightly larger expenditure decreases than Demonstration HMOs. PSNs are considered a promising model for Medicaid care delivery.,3.079176455639103e-07,0.1820756400285184,0.05157024793388431,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
297,0.7,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers secrete GABA? We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal remains unclear but may play a role during development. Additional data imply that this GABAergic signal is,0.0,0.049985346188338386,0.0028170926355677584,0.0,0.06301338005090473,0.045351473922902494,0.0,0.0,0.0,0.0,0.0,0.0
297,0.7,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Are mossy fibers known to release GABA? Our findings offer compelling proof of a GABAergic signal originating from mossy fibers. The exact physiological purpose of this signal is still uncertain, though it might be important for development. Other studies suggest that this GABAergic signal is",2.3685972735685406e-08,0.03773992952991634,0.04269135772492619,0.0018134264647818726,0.04002386182620521,0.045351473922902494,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
297,0.7,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Is there GABA release from mossy fibers? We have provided persuasive evidence for a GABAergic signal linked to mossy fibers. The physiological significance of this mossy fiber GABAergic signal is not well understood but could be critical for developmental processes. Additional evidence indicates that this GABAergic signal is,4.737194547137081e-08,0.06709146402954858,0.020944771657956426,0.0036268529295637453,0.07732830868434881,0.023623078861174096,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
297,0.7,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers emit GABA? Our research has demonstrated convincing evidence that mossy fibers have a GABAergic signal. The physiological role of this signal is not clear yet, but it may have developmental relevance. Other research points to the idea that this GABAergic signal is",2.3685972735685406e-08,0.03773992952991634,0.04269135772492619,0.0018134264647818726,0.04002386182620521,0.045351473922902494,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
297,0.7,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Can mossy fibers release GABA? We have delivered strong evidence supporting the existence of a GABAergic signal from mossy fibers. The physiological role of this GABAergic signal remains uncertain but might be crucial during development. Further evidence suggests that this GABAergic signal is,7.105791820705622e-08,0.05724602098560272,0.03424513679398594,0.005440279394345618,0.04141624475133909,0.020976473922902493,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.7,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Is GABA released by mossy fibers? We have shown robust evidence indicating a mossy fiber-associated GABAergic signal. The physiological function of this GABAergic signal is unknown but may be important for developmental stages. Additional findings suggest that this GABAergic signal is,1.1842986367842703e-07,0.0985289473074955,0.013535892276024447,0.009067132323909363,0.12870662625668094,0.005780739371472957,0.009054007704764333,0.16009538652296218,0.026296566837107373,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.7,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers discharge GABA? Our data provide solid evidence of a mossy fiber GABAergic signal. The physiological role remains unclear, though it may be significant in development. Other studies suggest that this GABAergic signal is",2.3685972735685353e-07,0.12808826284802732,0.08804283164782868,0.018134264647818733,0.19481572925119517,0.045351473922902494,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
297,0.7,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers capable of releasing GABA? We have established compelling evidence supporting a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is uncertain but might hold developmental significance. Additional research indicates that this GABAergic signal is,7.105791820705622e-08,0.05724602098560272,0.03424513679398594,0.005440279394345618,0.04141624475133909,0.020976473922902493,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.7,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Is GABA release associated with mossy fibers? We have offered convincing evidence for a GABAergic signal tied to mossy fibers. While the physiological role is unclear, it may be important during development. Other evidence implies that this GABAergic signal is",1.4211583641411233e-07,0.05542068746728024,0.06241956294976773,0.010880558788691236,0.08359009414097063,0.045351473922902494,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
297,0.7,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers produce a GABAergic signal? We have presented strong evidence that mossy fibers have a GABAergic signal. The exact physiological role is uncertain but may be related to developmental processes. Other data suggest that this GABAergic signal is,1.4211583641411233e-07,0.0909666967267646,0.03691061835345323,0.010880558788691236,0.08359009414097063,0.045351473922902494,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
298,0.7,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always lead to Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily develop into Meniere's disease. Although it is a symptom of Meniere's, other causes such as viral infections can also result in low-tone sudden deafness.",1.1842986367842703e-07,0.0785834827106271,0.01826714081612804,0.009067132323909363,0.060020770609720664,0.04134296716714297,0.009054007704764333,0.0891212977631648,0.02271498107084911,1.1842986367842703e-07,0.12361395596717584,0.0
298,0.7,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is progression from low-tone sudden deafness to Meniere's disease inevitable? Answer: No, low-tone sudden deafness does not inevitably progress to Meniere's disease. It may be a symptom of Meniere's, but it can also arise from other causes like viral infections.",1.4211583641411244e-07,0.09304984977220432,0.0325721801998793,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.7,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Will low-tone sudden deafness always become Meniere's disease? Answer: No, low-tone sudden deafness doesn't always lead to Meniere's disease. While it is a symptom associated with Meniere's, other factors such as viral infections can cause it.",2.3685972735685364e-07,0.17145464174158898,0.05171579777237556,0.018134264647818726,0.19850321452395825,0.03777981780947673,0.018108015409528673,0.2263224192766473,0.02271498107084911,2.3685972735685406e-07,0.26469255422708216,0.0
298,0.7,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always evolve into Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily evolve into Meniere's disease. It can be a symptom of Meniere's disease but may also stem from causes like viral infections.",1.8948778188548304e-07,0.18629678929891025,0.0032728911979811037,0.014507411718254981,0.17825978338224058,0.01244897959183671,0.014486412327622933,0.16916400543669896,0.02271498107084911,1.8948778188548325e-07,0.20585205420414887,0.0
298,0.7,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is low-tone sudden deafness a guaranteed precursor to Meniere's disease? Answer: No, low-tone sudden deafness is not a guaranteed precursor to Meniere's disease. Although it is one symptom of Meniere's, various other factors including viral infections can cause it.",1.6580180914979774e-07,0.22767163622940956,0.04168121100682884,0.012693985253473108,0.22258242819242113,0.03747969776145753,0.012675610786670066,0.21669986157938936,0.031162569949559068,1.6580180914979784e-07,0.21618935393522687,0.02775510204081633
298,0.7,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does every case of low-tone sudden deafness progress to Meniere's disease? Answer: No, not every case of low-tone sudden deafness progresses to Meniere's disease. It can be caused by multiple factors, with Meniere's being just one possible cause.",1.8948778188548304e-07,0.2592596504104834,0.045264630428316466,0.014507411718254981,0.25319461371304586,0.04019321227113434,0.014486412327622933,0.2846885355300235,0.05992964702832443,1.8948778188548325e-07,0.2850688748395709,0.056932966023875105
298,0.7,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is the development of Meniere's disease inevitable after low-tone sudden deafness? Answer: No, the development of Meniere's disease is not inevitable following low-tone sudden deafness. This deafness can also result from other causes such as viral infections.",2.1317375462116834e-07,0.2543763899849374,0.024756817928316466,0.016320838183036854,0.2462484573328747,0.016318097486928654,0.0162972138685758,0.2765517030388178,0.034217984953026,2.1317375462116866e-07,0.2756129546397501,0.029384756657483937
298,0.7,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always indicate Meniere's disease? Answer: No, low-tone sudden deafness does not always indicate Meniere's disease. It is one symptom but may also be caused by other issues like viral infections.",2.8423167282822424e-07,0.3146901564353861,0.008476435983872058,0.021761117577382486,0.3017531442970527,0.005972732485293807,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
298,0.7,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Will low-tone sudden deafness surely lead to Meniere's disease? Answer: No, low-tone sudden deafness will not surely lead to Meniere's disease. While it can signal Meniere's disease, other causes including viral infections might be responsible.",2.6054570009253894e-07,0.32065121690129184,0.03180976931720533,0.019947691112600606,0.3102024317665468,0.021082418399201525,0.019918816950481547,0.29818430246026484,0.00755845642915089,2.6054570009253947e-07,0.29546421289383584,0.0
298,0.7,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is it certain that low-tone sudden deafness progresses to Meniere's disease? Answer: No, it is not certain that low-tone sudden deafness will progress to Meniere's disease. It may be linked to Meniere's but can also be caused by other factors such as viral infections.",4.737194547137081e-08,0.09469973630397543,0.07851644829535251,0.0036268529295637453,0.04976096124302121,0.003048469387755104,0.003621603081905733,0.0810273428056254,0.024785018929150904,4.737194547137081e-08,0.0814401065775443,0.024375
299,0.7,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is it possible for mental imagery functional magnetic resonance imaging to forecast recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm shows strong agreement with the subsequent clinical progression of patients in a vegetative state. All five patients in a vegetative state exhibiting significant ROI activation experienced a favorable clinical outcome by the end.,2.3685972735685406e-08,0.0052519038399987394,0.016117969821673538,0.0018134264647818726,0.006187073859744707,0.017190082644628103,0.0018108015409528666,0.0067367509458922115,0.01785123966942149,2.3685972735685406e-08,0.018349138668195764,0.0
299,0.7,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI be used to predict recovery in patients with disorders of consciousness? Answer: The mental imagery paradigm in fMRI demonstrates high concordance with the clinical trajectory of patients in a vegetative state. Every one of the five patients with notable ROI activation had a positive clinical progression until the conclusion of the study.,2.3685972735685406e-08,0.01900248533353599,0.0009306505983852978,0.0018134264647818726,0.0067367509458922115,0.01785123966942149,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
299,0.7,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Does mental imagery functional MRI predict recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm correlates strongly with the further clinical development of patients in a vegetative state. All five patients who showed significant activation in regions of interest had a favorable outcome through to the end.,1.4211583641411244e-07,0.06544501637355093,0.03286913580246912,0.010880558788691236,0.08857342885843345,0.01785123966942149,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
299,0.7,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery using functional MRI predict recovery outcomes in patients with consciousness disorders? Answer: The fMRI mental imagery paradigm aligns closely with the clinical course of patients in vegetative state. All five vegetative state patients with significant ROI activation exhibited favorable clinical outcomes by the end.,2.3685972735685406e-07,0.17893205442227567,0.009999999999999981,0.018134264647818726,0.17195503779748433,0.01785123966942149,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
299,0.7,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is mental imagery fMRI effective in predicting recovery for patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm shows high consistency with the clinical progression of vegetative state patients. All five patients with notable ROI activation had positive outcomes until the study's conclusion.,2.8423167282822487e-07,0.25584554102731616,0.013857394809775776,0.02176111757738247,0.24791349039376964,0.004863741401427622,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
299,0.7,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can functional MRI mental imagery paradigm forecast recovery in disorders of consciousness patients? Answer: The fMRI mental imagery paradigm is highly concordant with the clinical course of patients in vegetative state. All five patients with significant ROI activation experienced favorable clinical progression by the end.,2.8423167282822487e-07,0.22503899966909646,0.00812083942604943,0.02176111757738247,0.24791349039376964,0.004863741401427622,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
299,0.7,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Does the mental imagery fMRI paradigm predict recovery in patients with consciousness disorders? Answer: The fMRI mental imagery paradigm shows strong agreement with the clinical outcomes of vegetative state patients. All five patients with significant activation in ROIs had positive clinical courses through to the end.,2.6054570009253947e-07,0.2017206781086598,0.009080706050402988,0.0199476911126006,0.19393394451625934,0.01785123966942149,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
299,0.7,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery-based functional MRI predict recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm exhibits high concordance with the clinical progression in vegetative state patients. All five patients with significant ROI activation had favorable clinical outcomes until the end of the observation period.,2.1317375462116866e-07,0.12776852833841623,0.03164523358427083,0.016320838183036854,0.15044883257652097,0.01785123966942149,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
299,0.7,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is the mental imagery fMRI paradigm a predictor of recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm correlates well with the further clinical course of patients in a vegetative state. Each of the five patients showing significant ROI activation had a favorable clinical outcome by the end.,1.1842986367842703e-07,0.0455041950861621,0.0332457601777094,0.009067132323909363,0.06877080156225368,0.01785123966942149,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
299,0.7,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI predict recovery in patients with disorders of consciousness? Answer: The mental imagery paradigm using fMRI demonstrates strong concordance with the clinical course of patients in vegetative state. All five patients who showed significant activation in ROIs had favorable outcomes until the study's conclusion.,2.3685972735685406e-07,0.14943642971759719,0.03120259515974701,0.018134264647818726,0.17195503779748433,0.01785123966942149,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
